data_1ysf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ysf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.412 HD11 HG21 ' A' ' 8' ' ' ILE . 59.9 mt . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.014 0.435 . . . . 2.01 109.993 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 90.3 t -116.68 144.06 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.041 -1.037 . . . . 1.08 110.961 -175.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.437 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 27.7 tpt180 -128.15 159.21 35.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.464 -0.773 . . . . 2.25 109.711 177.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.437 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 70.3 mttt -85.74 147.67 26.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.103 -0.998 . . . . 2.66 110.401 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.536 ' CG2' HD12 ' B' ' 36' ' ' LEU . 3.7 t -84.06 129.0 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.292 -0.88 . . . . 1.09 109.942 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.68 -175.29 5.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.55 110.08 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -54.24 -40.91 68.16 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.151 -0.968 . . . . 2.19 111.671 -173.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.525 HD21 ' CZ ' ' A' ' 17' ' ' ARG . 14.3 tp -84.12 -5.64 59.28 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.739 -1.225 . . . . 1.97 111.581 -173.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.499 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.38 46.31 7.54 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.191 -1.48 . . . . 0.22 109.657 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.535 ' CD ' HG22 ' B' ' 19' ' ' VAL . 72.6 mtm180 -114.74 154.05 29.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.099 -1.236 . . . . 1.33 109.968 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.521 ' CG1' HD13 ' B' ' 36' ' ' LEU . 19.8 m -123.99 153.11 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 1.08 109.866 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.526 HG22 ' CD ' ' B' ' 17' ' ' ARG . 24.3 t -111.35 134.77 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 1.05 110.632 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.507 HD13 ' CD1' ' B' ' 45' ' ' ILE . 6.4 mt -82.53 135.14 46.81 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 2.03 109.487 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.528 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.2 Cg_endo -58.13 142.98 97.39 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.771 1.406 . . . . 0.4 110.044 177.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.522 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.14 -32.78 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.962 -1.086 . . . . 1.79 110.373 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -58.07 -35.64 71.66 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.113 -0.992 . . . . 2.37 109.861 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.528 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 54.9 mt -82.75 -29.78 29.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.382 -0.824 . . . . 2.3 110.627 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.522 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 72.8 mtt180 -57.56 -44.13 85.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.898 -1.126 . . . . 0.33 109.146 175.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -73.37 -49.14 28.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.537 -0.727 . . . . 3.74 110.742 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.0 m -63.94 -31.24 72.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.189 -0.944 . . . . 1.44 111.085 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.528 ' CD2' HG13 ' A' ' 30' ' ' ILE . 22.2 tp -87.57 -4.79 58.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.027 -1.046 . . . . 1.64 110.711 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.75 43.74 95.82 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.663 -1.375 . . . . 0.34 109.663 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.528 HG13 ' CD2' ' A' ' 28' ' ' LEU . 31.6 mm -115.28 138.99 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.241 -1.152 . . . . 1.16 110.699 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.79 167.11 22.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.631 -0.668 . . . . 1.08 109.945 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.515 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.52 146.02 13.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.047 -1.033 . . . . 1.13 110.554 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 40.7 tttt 74.81 -4.57 2.33 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.757 -0.589 . . . . 2.33 111.103 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.458 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.9 m-20 -76.93 165.54 24.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.773 -1.204 . . . . 1.1 110.028 174.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -106.26 132.52 52.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 1.17 110.734 -176.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.512 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 12.6 mt -108.9 142.74 39.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 1.21 109.49 175.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.453 ' OE1' ' HE2' ' A' ' 48' ' ' LYS . 85.8 tt0 -107.88 139.8 41.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.869 -1.144 . . . . 1.17 109.793 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 72.1 mt -112.61 136.85 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.393 -0.817 . . . . 1.45 110.68 -172.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.565 ' CE1' ' HD3' ' A' ' 48' ' ' LYS . 14.6 m-85 -114.16 158.61 21.08 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.977 -0.379 . . . . 1.05 109.977 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.9 t -130.66 121.92 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.973 -1.079 . . . . 1.08 110.739 172.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.476 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.9 p-10 -147.17 140.51 25.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 1.77 110.216 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 52.4 t0 43.56 48.39 6.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.02 -1.05 . . . . 1.22 111.154 175.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.8 mt-10 58.55 14.05 2.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.134 -0.979 . . . . 1.93 110.656 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -117.12 147.11 42.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 2.48 110.024 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.519 ' CD1' HD13 ' B' ' 20' ' ' ILE . 60.4 mt -99.98 128.17 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 1.86 110.093 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 24.1 mt -111.52 118.62 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.352 -0.843 . . . . 1.24 110.209 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.577 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 4.2 mp -108.04 136.54 47.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.067 -1.021 . . . . 2.25 110.093 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.565 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 27.2 pttt -138.64 162.23 35.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.501 -0.749 . . . . 2.26 110.189 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -58.84 146.55 36.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.09 -1.006 . . . . 2.12 109.965 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 9.1 t80 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.96 110.726 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.512 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 90.7 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.483 0.658 . . . . 1.11 110.937 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.434 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 27.8 tpt180 -128.16 159.03 36.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.49 -0.756 . . . . 2.26 109.793 177.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.434 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 70.4 mttt -85.65 147.6 26.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.013 . . . . 2.65 110.419 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.515 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 3.8 t -83.98 129.11 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.891 . . . . 1.06 109.844 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.93 -175.16 5.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.116 -0.99 . . . . 0.55 110.126 179.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . 0.422 ' OE1' ' CD ' ' A' ' 32' ' ' GLU . 46.9 tp10 -54.37 -40.84 68.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.147 -0.971 . . . . 2.19 111.599 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.513 HD22 ' CZ ' ' B' ' 17' ' ' ARG . 14.0 tp -84.12 -5.74 59.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.76 -1.213 . . . . 1.99 111.568 -173.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.515 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.05 47.02 7.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.521 -1.432 . . . . 0.23 109.521 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.526 ' CD ' HG22 ' A' ' 19' ' ' VAL . 72.7 mtm180 -114.93 154.08 29.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.102 -1.234 . . . . 1.33 109.94 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.526 HG23 ' CD2' ' A' ' 47' ' ' LEU . 19.7 m -124.04 153.09 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 1.08 109.891 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.535 HG22 ' CD ' ' A' ' 17' ' ' ARG . 24.3 t -111.4 134.76 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 1.07 110.619 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.519 HD13 ' CD1' ' A' ' 45' ' ' ILE . 6.4 mt -82.57 135.16 46.67 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 1.99 109.472 174.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.521 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.2 Cg_endo -58.21 143.0 97.63 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.797 1.419 . . . . 0.4 110.049 177.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.534 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.3 -32.59 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.135 -0.978 . . . . 1.78 110.336 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -57.86 -36.4 72.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.091 -1.006 . . . . 2.37 109.774 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.521 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 54.7 mt -81.97 -30.16 31.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.478 -0.764 . . . . 2.36 110.605 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.534 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 72.2 mtt180 -57.44 -43.92 84.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.89 -1.131 . . . . 0.33 109.204 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -73.37 -49.32 27.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 3.75 110.621 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 61.0 m -63.81 -31.73 73.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.177 -0.952 . . . . 1.38 110.862 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.512 ' CD2' HG13 ' B' ' 30' ' ' ILE . 22.4 tp -87.1 -5.17 59.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.053 -1.03 . . . . 1.61 110.701 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.07 43.65 95.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.578 -1.409 . . . . 0.34 109.578 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.512 HG13 ' CD2' ' B' ' 28' ' ' LEU . 31.1 mm -115.27 138.81 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -1.176 . . . . 1.13 110.725 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.48 167.27 22.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.628 -0.67 . . . . 1.07 109.935 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.515 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.55 146.12 13.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.988 . . . . 1.13 110.554 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 40.6 tttt 74.84 -4.77 2.29 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.688 -0.633 . . . . 2.39 111.164 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 90.0 m-20 -76.98 165.21 24.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.791 -1.193 . . . . 1.1 110.014 174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.455 ' O ' ' HB3' ' B' ' 50' ' ' TYR . . . -105.93 132.48 51.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 1.13 110.833 -176.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.536 HD12 ' CG2' ' A' ' 12' ' ' VAL . 12.5 mt -108.93 142.61 39.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.397 -0.815 . . . . 1.35 109.531 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.47 ' HA ' HG23 ' A' ' 9' ' ' VAL . 85.6 tt0 -107.7 139.79 41.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.902 -1.124 . . . . 1.17 109.92 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.416 HD11 HG22 ' B' ' 38' ' ' ILE . 72.1 mt -112.6 136.79 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.299 -0.876 . . . . 1.48 110.651 -172.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.567 ' CE1' ' HD3' ' B' ' 48' ' ' LYS . 14.3 m-85 -114.0 158.63 20.92 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 116.35 -0.386 . . . . 1.08 109.993 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 83.8 t -130.52 122.26 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.907 -1.121 . . . . 1.05 110.502 172.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.472 ' OD2' HD13 ' B' ' 46' ' ' ILE . 9.9 p-10 -147.6 140.5 24.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 1.77 110.176 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 53.3 t0 43.69 48.46 6.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.134 -0.979 . . . . 1.21 111.059 175.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.7 mt-10 58.41 14.01 2.74 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.199 -0.938 . . . . 1.92 110.679 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -117.0 147.37 42.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 2.49 109.959 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.507 ' CD1' HD13 ' A' ' 20' ' ' ILE . 60.2 mt -100.23 128.22 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -0.928 . . . . 1.85 110.102 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 25.0 mt -111.7 118.61 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 1.22 110.148 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.581 ' CD1' ' N ' ' B' ' 47' ' ' LEU . 4.3 mp -107.9 136.45 47.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 2.23 110.124 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.567 ' HD3' ' CE1' ' B' ' 39' ' ' TYR . 27.3 pttt -138.57 162.43 34.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.489 -0.757 . . . . 2.17 110.07 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -58.82 146.44 37.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.124 -0.985 . . . . 2.25 109.93 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.455 ' HB3' ' O ' ' B' ' 35' ' ' ALA . 9.3 t80 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 1.21 110.644 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.5 mt . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.089 0.471 . . . . 2.01 110.115 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 93.0 t -115.95 144.35 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.001 -1.062 . . . . 1.08 110.916 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.44 ' N ' HG13 ' A' ' 9' ' ' VAL . 61.1 ttm-85 -129.23 160.66 32.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.494 -0.753 . . . . 2.25 109.679 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -85.25 147.7 26.44 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.067 -1.021 . . . . 2.66 110.385 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.546 ' CG2' HD13 ' B' ' 36' ' ' LEU . 4.0 t -83.09 129.94 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 1.09 109.88 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.461 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.36 -175.18 5.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.96 . . . . 0.55 110.082 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.74 -39.51 74.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.073 -1.017 . . . . 2.19 111.652 -172.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.532 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.2 tp -83.25 -6.61 59.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.831 -1.168 . . . . 1.97 111.499 -174.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.457 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.36 46.76 7.28 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.259 -1.448 . . . . 0.22 109.615 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.536 ' CD ' HG21 ' B' ' 19' ' ' VAL . 70.1 mtm180 -114.33 154.73 27.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.079 -1.247 . . . . 1.33 110.078 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.525 ' CG1' HD11 ' B' ' 36' ' ' LEU . 17.9 m -123.87 152.37 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 1.08 109.763 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.523 HG21 ' CD ' ' B' ' 17' ' ' ARG . 19.9 t -112.97 135.32 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.138 -0.976 . . . . 1.05 110.643 -174.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.513 ' CD1' ' CD1' ' B' ' 45' ' ' ILE . 19.5 mt -81.57 135.96 49.15 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.255 -0.903 . . . . 2.03 109.763 174.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 11.0 Cg_endo -60.02 143.65 99.55 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.754 1.397 . . . . 0.4 109.942 176.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.52 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.12 -33.15 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.952 -1.093 . . . . 1.79 110.348 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.431 ' N ' HG22 ' A' ' 22' ' ' ILE . 48.6 tp10 -58.04 -35.41 71.29 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.181 -0.95 . . . . 2.37 109.884 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.531 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 59.6 mt -84.5 -28.25 26.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 2.3 110.664 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.52 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 70.8 mtt180 -57.44 -44.38 84.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.843 -1.161 . . . . 0.33 109.065 175.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.5 mmm180 -73.58 -49.12 27.88 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.862 -0.735 . . . . 3.74 110.671 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.8 m -63.96 -30.96 72.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.141 -0.974 . . . . 1.44 111.121 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.524 ' CD2' HG13 ' A' ' 30' ' ' ILE . 23.0 tp -87.59 -4.93 58.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.069 -1.019 . . . . 1.64 110.769 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.84 41.75 97.35 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.724 -1.35 . . . . 0.34 109.724 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.524 HG13 ' CD2' ' A' ' 28' ' ' LEU . 38.3 mm -116.38 138.45 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -1.17 . . . . 1.16 110.629 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.99 166.88 23.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.575 -0.703 . . . . 1.08 110.002 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.511 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.41 146.25 12.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.055 -1.028 . . . . 1.13 110.61 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 31.8 ttpt 74.35 -4.35 2.33 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.687 -0.633 . . . . 2.33 111.177 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.462 ' O ' HG23 ' B' ' 12' ' ' VAL . 90.1 m-20 -77.23 166.52 23.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.75 -1.219 . . . . 1.1 110.029 174.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.05 130.09 51.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.159 -0.963 . . . . 1.17 110.77 -176.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.508 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 12.4 mt -106.41 142.54 35.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.349 -0.845 . . . . 1.21 109.403 174.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.481 ' HG3' HG21 ' B' ' 9' ' ' VAL . 86.4 tt0 -106.33 138.45 42.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.773 -1.204 . . . . 1.17 109.564 173.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.2 mt -108.28 132.06 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.404 -0.81 . . . . 1.45 110.537 -171.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.569 ' CE1' ' HD2' ' A' ' 48' ' ' LYS . 10.0 m-85 -118.22 159.45 23.3 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 116.259 -0.428 . . . . 1.05 110.001 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.2 t -133.49 125.9 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.919 -1.113 . . . . 1.08 110.637 172.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 42.3 p-10 -147.41 143.22 27.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 1.77 110.499 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 51.8 t0 43.44 43.95 4.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.014 -1.054 . . . . 1.22 111.149 174.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 83.7 tt0 60.82 11.76 3.41 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.121 -0.987 . . . . 1.93 110.616 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 53.0 mtmt -111.54 154.64 24.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 2.48 109.779 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.587 ' CD1' ' CD1' ' B' ' 20' ' ' ILE . 66.1 mt -95.16 129.27 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 1.86 109.968 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 22.9 mm -115.12 120.65 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.719 . . . . 1.24 109.915 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.2 mp -117.63 135.17 54.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.981 -1.075 . . . . 2.25 110.25 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.569 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 8.2 ptpt -142.74 162.21 36.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.384 -0.823 . . . . 2.26 110.418 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.517 ' HD3' ' CD1' ' A' ' 30' ' ' ILE . 22.8 tptm -55.63 147.46 18.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.037 -1.039 . . . . 2.12 109.789 176.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.2 t80 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.35 -0.843 . . . . 0.96 110.524 -176.171 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.508 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 91.7 t . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.538 0.685 . . . . 1.11 110.925 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.429 ' N ' HG13 ' B' ' 9' ' ' VAL . 61.2 ttm-85 -129.19 160.45 32.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.457 -0.777 . . . . 2.26 109.759 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -85.19 147.59 26.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.038 -1.039 . . . . 2.65 110.425 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.487 ' CG2' ' HG ' ' A' ' 36' ' ' LEU . 4.0 t -82.95 129.97 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.4 -0.813 . . . . 1.06 109.894 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.449 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.61 -175.04 5.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.153 -0.967 . . . . 0.55 110.135 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . 0.47 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -56.87 -39.44 74.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.081 -1.012 . . . . 2.19 111.496 -172.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.526 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 15.1 tp -83.27 -6.56 59.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.787 -1.196 . . . . 1.99 111.527 -174.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.471 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.9 47.5 7.12 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.54 -1.424 . . . . 0.23 109.54 -177.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.526 ' HD3' ' CD2' ' B' ' 15' ' ' LEU . 70.0 mtm180 -114.5 154.67 27.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.028 -1.278 . . . . 1.33 110.131 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.503 HG23 ' CD2' ' A' ' 47' ' ' LEU . 17.8 m -123.93 152.31 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 1.08 109.737 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.536 HG21 ' CD ' ' A' ' 17' ' ' ARG . 19.8 t -113.0 135.26 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 1.07 110.712 -174.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.587 ' CD1' ' CD1' ' A' ' 45' ' ' ILE . 19.2 mt -81.5 135.96 49.36 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 1.99 109.734 174.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 11.0 Cg_endo -60.15 143.53 99.53 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.801 1.422 . . . . 0.4 110.036 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.533 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.2 tp -55.13 -32.92 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.018 -1.051 . . . . 1.78 110.399 -178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -57.93 -36.12 72.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.058 -1.026 . . . . 2.37 109.777 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.526 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 60.1 mt -83.74 -28.55 28.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.532 -0.73 . . . . 2.36 110.628 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.533 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 70.2 mtt180 -57.35 -44.32 84.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.792 -1.193 . . . . 0.33 109.044 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' B' ' 26' ' ' ARG . 32.5 mmm180 -73.49 -49.31 27.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.357 -0.84 . . . . 3.75 110.664 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.1 m -63.68 -31.64 72.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.896 . . . . 1.38 110.919 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.517 ' CD2' HG13 ' B' ' 30' ' ' ILE . 23.2 tp -87.01 -5.33 59.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.032 -1.042 . . . . 1.61 110.731 -176.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.24 41.53 96.75 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.562 -1.415 . . . . 0.34 109.562 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.527 ' CD1' ' HD3' ' B' ' 49' ' ' LYS . 37.9 mm -116.27 138.39 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -1.182 . . . . 1.13 110.694 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.78 167.04 23.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.612 -0.68 . . . . 1.07 109.987 -177.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.41 146.39 12.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.141 -0.975 . . . . 1.13 110.523 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 31.7 ttpt 74.42 -4.64 2.27 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.699 -0.626 . . . . 2.39 111.174 176.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 90.4 m-20 -77.21 166.26 23.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.853 -1.154 . . . . 1.1 110.067 174.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.97 130.09 51.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 1.13 110.753 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.546 HD13 ' CG2' ' A' ' 12' ' ' VAL . 12.2 mt -106.47 142.25 36.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 1.35 109.471 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.472 ' HA ' HG21 ' A' ' 9' ' ' VAL . 86.1 tt0 -106.06 138.44 42.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.825 -1.172 . . . . 1.17 109.72 173.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.22 132.06 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.367 -0.833 . . . . 1.48 110.486 -171.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.58 ' CE1' ' HD2' ' B' ' 48' ' ' LYS . 10.0 m-85 -118.31 159.34 23.56 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 116.261 -0.427 . . . . 1.08 110.001 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.416 HG23 HD13 ' A' ' 24' ' ' LEU . 72.4 t -133.22 126.27 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.936 -1.102 . . . . 1.05 110.466 172.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' B' ' 41' ' ' ASP . 42.5 p-10 -147.81 143.22 27.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 1.77 110.466 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 52.4 t0 43.47 44.04 4.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.934 . . . . 1.21 111.108 174.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.5 tt0 60.67 11.87 3.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.028 -1.045 . . . . 1.92 110.571 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 53.0 mtmt -111.56 154.76 24.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.185 -0.947 . . . . 2.49 109.71 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.513 ' CD1' ' CD1' ' A' ' 20' ' ' ILE . 66.2 mt -95.26 129.14 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 1.85 110.0 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 22.6 mm -115.15 120.7 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 1.22 109.817 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.3 mp -117.46 135.05 54.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.014 -1.054 . . . . 2.23 110.294 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.58 ' HD2' ' CE1' ' B' ' 39' ' ' TYR . 8.1 ptpt -142.65 162.39 35.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.843 . . . . 2.17 110.392 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.527 ' HD3' ' CD1' ' B' ' 30' ' ' ILE . 22.8 tptm -55.63 147.3 18.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.114 -0.992 . . . . 2.25 109.83 176.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.517 ' CZ ' HG22 ' A' ' 9' ' ' VAL . 5.3 t80 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 1.21 110.525 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 121.139 0.495 . . . . 2.01 110.087 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.646 ' CG1' ' CD2' ' B' ' 50' ' ' TYR . 92.7 t -115.1 144.34 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.033 -1.042 . . . . 1.08 110.856 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.527 ' CZ ' HG21 ' A' ' 19' ' ' VAL . 68.9 ttt-85 -129.91 160.07 34.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.48 -0.762 . . . . 2.25 109.684 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -86.44 149.03 25.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.103 -0.998 . . . . 2.66 110.466 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.544 ' CG2' HD13 ' B' ' 36' ' ' LEU . 3.9 t -82.99 129.64 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.241 -0.912 . . . . 1.09 109.873 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.19 -174.67 5.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.145 -0.972 . . . . 0.55 110.182 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -53.62 -41.81 67.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.18 -0.95 . . . . 2.19 111.783 -173.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.531 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.2 tp -85.79 -4.26 59.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.709 -1.244 . . . . 1.97 111.619 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.508 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.09 46.31 7.72 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.184 -1.484 . . . . 0.22 109.645 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.55 ' CD ' ' CG2' ' B' ' 19' ' ' VAL . 74.6 mtm180 -115.56 154.35 29.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.15 -1.206 . . . . 1.33 109.933 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.523 HG23 ' CD2' ' B' ' 47' ' ' LEU . 16.6 m -124.61 152.23 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 1.08 109.898 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.535 ' CG2' ' CD ' ' B' ' 17' ' ' ARG . 21.9 t -112.25 135.44 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.932 . . . . 1.05 110.514 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.491 HG22 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.04 134.57 46.11 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 2.03 109.577 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.9 Cg_endo -58.73 143.8 98.54 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.793 1.417 . . . . 0.4 110.104 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.518 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.19 -32.08 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.988 -1.07 . . . . 1.79 110.386 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.29 -34.88 72.82 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.118 -0.989 . . . . 2.37 109.901 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.526 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 62.4 mt -83.19 -29.68 28.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 2.3 110.57 178.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.518 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 73.6 mtt180 -57.55 -43.96 84.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.877 -1.139 . . . . 0.33 109.107 175.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -71.64 -50.11 33.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.518 -0.739 . . . . 3.74 110.707 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.0 m -63.38 -32.02 73.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.218 -0.926 . . . . 1.44 111.088 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.519 ' CD2' HG13 ' A' ' 30' ' ' ILE . 21.0 tp -88.39 -4.86 58.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.064 -1.022 . . . . 1.64 110.751 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.42 42.82 97.46 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.667 -1.373 . . . . 0.34 109.667 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.519 HG13 ' CD2' ' A' ' 28' ' ' LEU . 35.3 mm -116.36 138.75 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.242 -1.152 . . . . 1.16 110.74 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.06 167.26 22.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.617 -0.677 . . . . 1.08 110.092 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.2 tt0 -53.26 147.09 10.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.075 -1.016 . . . . 1.13 110.542 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 29.3 tttt 74.65 -4.92 2.23 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.781 -0.574 . . . . 2.33 111.123 177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.458 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.9 m-20 -77.49 165.36 24.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.81 -1.181 . . . . 1.1 110.019 174.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . . . -104.69 131.61 51.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.209 -0.932 . . . . 1.17 110.74 -176.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.495 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 13.6 mt -109.57 140.63 43.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 1.21 109.575 175.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.448 ' HA ' HG23 ' B' ' 9' ' ' VAL . 84.8 tt0 -103.67 138.56 40.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.823 -1.173 . . . . 1.17 109.528 171.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.6 mt -111.47 133.27 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.369 -0.832 . . . . 1.45 110.512 -173.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.574 ' CE1' ' HD2' ' A' ' 48' ' ' LYS . 8.5 m-85 -114.53 160.76 18.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 122.068 -0.395 . . . . 1.05 110.218 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.1 t -133.9 117.69 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 1.08 110.83 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.486 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 6.2 p-10 -147.69 160.23 42.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 1.77 110.031 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 22.5 t70 42.47 41.46 2.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.097 . . . . 1.22 111.332 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 75.5 mm-40 57.4 15.71 2.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.07 -1.019 . . . . 1.93 110.651 175.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 56.1 pttt -130.78 163.21 27.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.156 -0.965 . . . . 2.48 109.887 175.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.453 HD13 HG13 ' B' ' 20' ' ' ILE . 61.2 mt -104.21 134.74 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.046 -1.034 . . . . 1.86 110.516 -173.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.51 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 26.7 mt -112.96 119.27 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -0.833 . . . . 1.24 110.249 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.583 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 4.1 mp -108.12 134.84 50.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.932 . . . . 2.25 109.987 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.574 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 1.8 ptpm? -140.79 163.5 32.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.417 -0.802 . . . . 2.26 110.296 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.7 tttp -55.12 148.08 14.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.109 -0.995 . . . . 2.12 109.776 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.46 ' CD2' ' CG1' ' B' ' 9' ' ' VAL . 1.7 t80 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.96 110.565 -175.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 91.1 t . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.479 0.657 . . . . 1.11 110.855 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.507 ' CZ ' HG23 ' B' ' 19' ' ' VAL . 68.8 ttt-85 -129.85 159.89 35.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.479 -0.763 . . . . 2.26 109.782 177.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -86.32 148.88 25.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 2.65 110.472 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.528 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 3.9 t -82.83 129.73 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.265 -0.897 . . . . 1.06 109.867 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.454 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -85.46 -174.49 5.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.105 -0.997 . . . . 0.55 110.239 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . 0.462 ' OE1' ' OE2' ' A' ' 32' ' ' GLU . 47.5 tp10 -53.82 -41.61 67.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.17 -0.956 . . . . 2.19 111.765 -173.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.525 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.9 tp -85.99 -4.14 59.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.722 -1.236 . . . . 1.99 111.592 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.528 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.72 46.97 7.52 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.524 -1.431 . . . . 0.23 109.524 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.535 ' CD ' ' CG2' ' A' ' 19' ' ' VAL . 74.2 mtm180 -115.76 154.28 29.89 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.083 -1.245 . . . . 1.33 109.96 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.477 HG22 ' CD2' ' A' ' 47' ' ' LEU . 16.6 m -124.6 152.25 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 1.08 109.899 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.55 ' CG2' ' CD ' ' A' ' 17' ' ' ARG . 21.9 t -112.34 135.38 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.93 . . . . 1.07 110.505 -175.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.99 134.49 46.44 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 1.99 109.554 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.522 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.8 Cg_endo -58.83 143.84 98.92 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.803 1.423 . . . . 0.4 110.053 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.533 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.28 -31.86 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.042 -1.036 . . . . 1.78 110.446 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.18 -35.57 73.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.057 -1.027 . . . . 2.37 109.758 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.522 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 62.7 mt -82.49 -30.06 30.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.408 -0.808 . . . . 2.36 110.602 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.533 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 73.1 mtt180 -57.34 -43.85 83.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.877 -1.139 . . . . 0.33 109.106 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -71.53 -50.54 30.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.418 -0.801 . . . . 3.75 110.614 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 60.8 m -62.98 -32.58 73.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.342 -0.849 . . . . 1.38 110.948 -177.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.526 ' CD2' HG13 ' B' ' 30' ' ' ILE . 21.2 tp -87.84 -5.32 58.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.981 -1.074 . . . . 1.61 110.759 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.79 42.64 97.0 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.575 -1.41 . . . . 0.34 109.575 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.526 HG13 ' CD2' ' B' ' 28' ' ' LEU . 34.8 mm -116.2 138.63 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -1.199 . . . . 1.13 110.816 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.82 167.43 22.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.605 -0.685 . . . . 1.07 109.97 -178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.25 147.18 10.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 1.13 110.515 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.513 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 29.2 tttt 74.69 -5.01 2.21 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.733 -0.604 . . . . 2.39 111.206 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 89.5 m-20 -77.63 164.98 24.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.821 -1.174 . . . . 1.1 109.998 174.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' B' ' 50' ' ' TYR . . . -104.41 131.58 51.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 1.13 110.833 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.544 HD13 ' CG2' ' A' ' 12' ' ' VAL . 13.4 mt -109.62 140.42 43.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 1.35 109.632 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.473 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.7 tt0 -103.43 138.56 39.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.829 -1.169 . . . . 1.17 109.749 171.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.8 mt -111.4 133.19 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.882 . . . . 1.48 110.524 -172.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.568 ' CE1' ' HD2' ' B' ' 48' ' ' LYS . 8.4 m-85 -114.48 160.7 18.9 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 120.958 0.409 . . . . 1.08 110.275 -177.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 94.8 t -133.64 118.14 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.986 -1.071 . . . . 1.05 110.559 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.489 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 6.3 p-10 -148.29 160.2 43.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 1.77 110.033 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 22.7 t70 42.46 41.7 2.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -0.985 . . . . 1.21 111.225 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 75.5 mm-40 57.23 15.61 2.62 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.079 -1.013 . . . . 1.92 110.71 175.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 56.1 pttt -130.58 163.45 27.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.955 . . . . 2.49 109.866 174.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.422 HD11 HG13 ' A' ' 20' ' ' ILE . 60.5 mt -104.31 134.67 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.153 -0.967 . . . . 1.85 110.616 -173.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 27.5 mt -113.05 119.31 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 1.22 110.21 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' B' ' 47' ' ' LEU . 4.2 mp -108.04 134.75 50.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.214 -0.929 . . . . 2.23 109.978 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.568 ' HD2' ' CE1' ' B' ' 39' ' ' TYR . 1.8 ptpm? -140.69 163.63 32.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.422 -0.798 . . . . 2.17 110.288 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -55.12 147.93 15.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 2.25 109.696 176.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.646 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 1.7 t80 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 1.21 110.587 -175.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.1 mm . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 120.978 0.418 . . . . 2.01 110.016 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 87.0 t -117.91 144.03 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.024 -1.048 . . . . 1.08 110.94 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.461 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 27.7 tpt180 -128.57 160.56 32.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.549 -0.72 . . . . 2.25 109.65 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.461 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 94.8 mttt -84.92 146.87 27.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 2.66 110.297 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.546 ' CG2' HD13 ' B' ' 36' ' ' LEU . 4.1 t -82.27 127.49 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 1.09 109.757 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.27 -175.07 5.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.128 -0.983 . . . . 0.55 109.985 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.8 -39.14 73.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.998 -1.064 . . . . 2.19 111.596 -172.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.531 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 16.4 tp -83.0 -6.62 59.56 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.805 -1.185 . . . . 1.97 111.531 -174.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.48 46.62 7.3 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.173 -1.489 . . . . 0.22 109.654 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.535 ' CD ' HG23 ' B' ' 19' ' ' VAL . 69.1 mtm180 -114.07 154.44 27.72 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.018 -1.283 . . . . 1.33 110.007 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.531 ' CG1' HD11 ' B' ' 36' ' ' LEU . 17.7 m -123.56 151.97 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 1.08 109.799 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.525 HG21 ' CD ' ' B' ' 17' ' ' ARG . 17.1 t -113.61 133.56 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 1.05 110.762 -174.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.523 ' CD1' HD12 ' B' ' 45' ' ' ILE . 2.5 mm -85.28 136.97 37.23 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.908 . . . . 2.03 109.483 174.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.53 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -58.85 141.18 97.76 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.676 1.356 . . . . 0.4 109.965 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.525 ' HA ' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -55.83 -32.03 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.946 -1.096 . . . . 1.79 110.407 -177.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.64 -35.31 72.31 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.034 -1.041 . . . . 2.37 109.77 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.53 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 45.3 mt -81.4 -28.97 34.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 2.3 110.52 176.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.525 ' CD ' ' HA ' ' A' ' 22' ' ' ILE . 72.6 mtt180 -56.93 -44.25 82.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.916 -1.115 . . . . 0.33 108.942 175.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -72.03 -49.26 38.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.574 -0.704 . . . . 3.74 110.735 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.7 m -63.55 -31.22 72.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 1.44 111.119 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.479 ' CD2' HG13 ' A' ' 30' ' ' ILE . 21.4 tp -87.24 -4.66 59.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.004 -1.06 . . . . 1.64 110.712 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.18 40.92 95.09 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.721 -1.352 . . . . 0.34 109.721 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.479 HG13 ' CD2' ' A' ' 28' ' ' LEU . 35.4 mm -116.33 139.09 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.309 -1.112 . . . . 1.16 110.623 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -141.55 166.5 24.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.546 -0.721 . . . . 1.08 110.124 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.515 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.47 146.65 12.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.973 . . . . 1.13 110.591 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 15.1 tptt 74.83 -4.62 2.32 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.759 -0.588 . . . . 2.33 111.092 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.469 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.8 m-20 -77.42 166.74 22.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.792 -1.193 . . . . 1.1 110.021 174.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.53 131.94 52.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 1.17 110.748 -176.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.511 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 13.9 mt -109.03 142.05 40.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.422 -0.799 . . . . 1.21 109.519 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.452 ' HA ' HG23 ' B' ' 9' ' ' VAL . 85.0 tt0 -108.29 139.89 42.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.879 -1.138 . . . . 1.17 109.784 173.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.0 mm -111.86 133.98 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.332 -0.855 . . . . 1.45 110.553 -173.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.576 ' CE1' ' HD2' ' A' ' 48' ' ' LYS . 8.2 m-85 -115.34 162.03 17.69 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 120.955 0.407 . . . . 1.05 110.045 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.403 HG23 HD11 ' B' ' 24' ' ' LEU . 92.2 t -133.48 121.79 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.926 -1.108 . . . . 1.08 110.92 173.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.514 ' O ' ' CG ' ' A' ' 44' ' ' LYS . 6.3 p-10 -147.31 152.53 38.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 1.77 110.129 176.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 53.7 t0 43.02 45.34 4.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.122 -0.986 . . . . 1.22 111.32 173.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 96.0 mt-10 56.99 16.91 3.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.028 -1.045 . . . . 1.93 110.548 175.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' A' ' 41' ' ' ASP . 16.2 ptpt -129.73 159.61 35.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 2.48 109.872 176.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.487 ' CD1' ' CD1' ' B' ' 20' ' ' ILE . 57.8 mt -104.33 133.48 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 1.86 110.607 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 33.4 mt -112.11 120.53 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.507 -0.745 . . . . 1.24 110.283 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.5 mp -109.74 135.38 50.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.11 -0.994 . . . . 2.25 110.015 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.576 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 1.8 ptpm? -141.09 162.83 34.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 2.26 110.3 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -57.94 146.54 31.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.171 -0.956 . . . . 2.12 110.03 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 8.1 t80 . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.307 -0.871 . . . . 0.96 110.655 -176.146 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 86.7 t . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.453 0.644 . . . . 1.11 110.925 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.461 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 27.6 tpt180 -128.49 160.36 32.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.552 -0.717 . . . . 2.26 109.76 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.461 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 94.8 mttt -84.82 146.8 27.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.038 -1.039 . . . . 2.65 110.283 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.475 ' CG2' HD13 ' A' ' 36' ' ' LEU . 4.1 t -82.29 127.52 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 1.06 109.767 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.458 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -85.35 -174.86 5.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.18 -0.95 . . . . 0.55 110.111 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . 0.465 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.9 mt-10 -57.07 -38.91 73.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.099 -1.001 . . . . 2.19 111.554 -172.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.525 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 15.8 tp -83.09 -6.74 59.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.796 -1.19 . . . . 1.99 111.51 -174.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.18 47.31 7.07 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.508 -1.437 . . . . 0.23 109.508 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.525 ' HD3' ' CD2' ' B' ' 15' ' ' LEU . 69.2 mtm180 -114.17 154.35 27.99 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.082 -1.246 . . . . 1.33 110.074 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.521 HG22 ' CD2' ' A' ' 47' ' ' LEU . 17.7 m -123.52 152.0 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.86 . . . . 1.08 109.794 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.535 HG23 ' CD ' ' A' ' 17' ' ' ARG . 16.8 t -113.57 133.57 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.158 -0.963 . . . . 1.07 110.748 -174.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.487 ' CD1' ' CD1' ' A' ' 45' ' ' ILE . 2.6 mm -85.3 136.96 37.21 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 1.99 109.526 174.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.527 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.0 Cg_endo -58.94 141.19 97.96 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.547 1.288 . . . . 0.4 110.023 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.524 HD12 HG23 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -56.08 -31.7 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.09 -1.006 . . . . 1.78 110.373 -177.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.58 -35.94 73.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.051 -1.03 . . . . 2.37 109.661 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.527 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 45.4 mt -80.65 -29.35 36.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.448 -0.782 . . . . 2.36 110.526 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.517 ' CD ' ' HA ' ' B' ' 22' ' ' ILE . 72.1 mtt180 -56.81 -44.06 81.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.836 -1.165 . . . . 0.33 109.001 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -71.98 -49.56 36.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.542 -0.723 . . . . 3.75 110.628 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.0 m -63.22 -31.8 73.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.286 -0.884 . . . . 1.38 110.898 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.472 ' CD2' HG13 ' B' ' 30' ' ' ILE . 21.7 tp -86.72 -5.02 59.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.122 -0.986 . . . . 1.61 110.69 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.58 40.69 94.22 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.613 -1.395 . . . . 0.34 109.613 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.472 HG13 ' CD2' ' B' ' 28' ' ' LEU . 34.8 mm -116.39 139.03 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -1.123 . . . . 1.13 110.604 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.34 166.6 24.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.559 -0.713 . . . . 1.07 110.071 -177.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.521 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.43 146.71 11.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 1.13 110.508 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 15.1 tptt 74.88 -4.91 2.26 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.695 -0.628 . . . . 2.39 111.184 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 89.1 m-20 -77.4 166.48 23.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.769 -1.207 . . . . 1.1 110.094 174.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.401 ' HB2' ' HB3' ' B' ' 50' ' ' TYR . . . -105.32 131.86 52.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.134 -0.979 . . . . 1.13 110.781 -176.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.546 HD13 ' CG2' ' A' ' 12' ' ' VAL . 13.7 mt -109.1 141.77 40.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 1.35 109.6 175.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.471 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.9 tt0 -107.97 139.9 41.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.932 -1.105 . . . . 1.17 109.892 173.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.409 HD11 ' O ' ' B' ' 37' ' ' GLU . 21.9 mm -111.95 134.14 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.352 -0.842 . . . . 1.48 110.443 -173.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.572 ' CE1' ' HD2' ' B' ' 48' ' ' LYS . 8.0 m-85 -115.43 162.0 17.77 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 116.315 -0.402 . . . . 1.08 110.078 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 92.2 t -133.23 122.21 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.931 -1.106 . . . . 1.05 110.633 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.523 ' O ' ' CG ' ' B' ' 44' ' ' LYS . 6.5 p-10 -147.84 152.56 37.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 1.77 110.114 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 54.2 t0 42.98 45.54 4.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.164 -0.96 . . . . 1.21 111.258 173.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.9 mt-10 56.85 16.89 2.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.983 -1.073 . . . . 1.92 110.594 175.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' B' ' 41' ' ' ASP . 16.2 ptpt -129.67 159.88 35.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 2.49 109.763 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.523 HD12 ' CD1' ' A' ' 20' ' ' ILE . 57.3 mt -104.39 133.51 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.124 -0.985 . . . . 1.85 110.687 -173.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 34.7 mt -112.34 120.57 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.389 -0.819 . . . . 1.22 110.181 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.6 mp -109.63 135.24 50.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.196 -0.94 . . . . 2.23 110.071 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.572 ' HD2' ' CE1' ' B' ' 39' ' ' TYR . 1.8 ptpm? -140.99 163.03 34.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.454 -0.778 . . . . 2.17 110.248 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -57.93 146.55 31.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 2.25 109.988 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.424 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 8.3 t80 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 1.21 110.596 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 8' ' ' ILE . 61.8 mt . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 109.594 -0.521 . . . . 2.01 109.594 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 75.1 t -110.94 143.87 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.791 -1.193 . . . . 1.08 111.394 -170.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.489 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 28.7 tpt180 -125.85 163.11 23.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.645 -0.659 . . . . 2.25 109.527 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.489 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 56.6 mttm -84.98 146.54 27.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.986 -1.071 . . . . 2.66 110.453 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.549 ' CG2' HD12 ' B' ' 36' ' ' LEU . 3.9 t -83.51 130.29 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.385 -0.822 . . . . 1.09 109.876 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.74 -175.54 5.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.048 -1.032 . . . . 0.55 110.03 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.85 -39.33 74.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.998 -1.064 . . . . 2.19 111.677 -172.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.527 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.1 tp -83.26 -6.67 59.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.735 -1.228 . . . . 1.97 111.524 -174.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.45 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.47 46.58 7.32 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.176 -1.488 . . . . 0.22 109.715 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.532 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.5 mtm180 -113.88 154.73 27.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.953 -1.322 . . . . 1.33 110.043 -177.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.524 ' CG1' HD13 ' B' ' 36' ' ' LEU . 15.4 m -123.84 152.72 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 1.08 109.755 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.529 HG23 ' CD ' ' B' ' 17' ' ' ARG . 21.4 t -111.28 135.12 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 1.05 110.671 -175.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.53 ' CD1' HD13 ' B' ' 45' ' ' ILE . 16.2 mt -81.63 135.05 49.8 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.274 -0.891 . . . . 2.03 109.675 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.529 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.4 Cg_endo -58.32 142.61 97.68 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.67 1.352 . . . . 0.4 109.954 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.517 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.18 -32.16 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.899 -1.126 . . . . 1.79 110.389 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.39 -34.87 72.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.055 -1.028 . . . . 2.37 109.888 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.529 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 52.3 mt -81.86 -30.72 31.89 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.277 -0.889 . . . . 2.3 110.532 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.517 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 72.1 mtt180 -57.94 -44.19 86.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.95 -1.093 . . . . 0.33 109.2 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -73.82 -49.9 23.03 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.831 -0.748 . . . . 3.74 110.653 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.6 m -64.12 -31.15 72.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.201 -0.937 . . . . 1.44 111.11 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.44 HD23 HG13 ' A' ' 30' ' ' ILE . 18.7 tp -87.82 -4.68 58.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.039 -1.038 . . . . 1.64 110.739 -176.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.07 43.28 93.68 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.685 -1.366 . . . . 0.34 109.685 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.44 HG13 HD23 ' A' ' 28' ' ' LEU . 32.8 mm -115.96 138.19 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -1.162 . . . . 1.16 110.671 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.78 167.0 23.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.579 -0.7 . . . . 1.08 110.049 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.58 145.79 14.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 1.13 110.601 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 69.1 tttt 74.43 -4.34 2.34 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.708 -0.62 . . . . 2.33 111.073 176.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.469 ' O ' HG21 ' B' ' 12' ' ' VAL . 89.7 m-20 -76.97 168.29 20.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.816 -1.177 . . . . 1.1 109.962 174.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.82 131.37 53.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.937 . . . . 1.17 110.798 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.526 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 9.5 mt -107.61 144.23 34.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.369 -0.832 . . . . 1.21 109.267 174.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.455 ' HA ' HG23 ' B' ' 9' ' ' VAL . 86.4 tt0 -108.35 137.93 45.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.696 -1.253 . . . . 1.17 109.648 173.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.5 mt -108.42 133.29 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.452 -0.78 . . . . 1.45 110.571 -172.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.573 ' CE1' ' HD2' ' A' ' 48' ' ' LYS . 10.3 m-85 -119.38 159.98 23.16 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 116.319 -0.401 . . . . 1.05 110.001 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.408 ' CG2' HD12 ' B' ' 24' ' ' LEU . 76.8 t -133.22 127.25 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.98 -1.075 . . . . 1.08 110.564 173.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 39.1 p-10 -147.23 137.99 23.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 1.77 110.658 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.472 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.7 t0 43.74 47.36 6.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.043 -1.035 . . . . 1.22 111.306 174.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.5 tt0 61.02 11.8 3.57 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.193 -0.942 . . . . 1.93 110.622 175.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 35.4 mtmt -113.07 151.91 30.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 2.48 109.71 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.523 ' CD1' HD13 ' B' ' 20' ' ' ILE . 65.9 mt -94.73 129.78 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 1.86 109.977 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 27.6 mm -114.95 120.93 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.465 -0.772 . . . . 1.24 109.928 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.588 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.4 mp -118.34 136.04 53.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.973 -1.079 . . . . 2.25 110.257 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.573 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 5.0 ptpt -142.67 158.24 43.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.339 -0.85 . . . . 2.26 110.333 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -57.88 146.59 31.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -0.958 . . . . 2.12 109.934 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.436 ' CZ ' HG21 ' B' ' 9' ' ' VAL . 14.5 t80 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.96 110.729 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 74.0 t . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.643 0.735 . . . . 1.11 111.375 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.502 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 28.8 tpt180 -125.69 162.96 23.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.527 -0.733 . . . . 2.26 109.596 175.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.502 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 56.7 mttm -84.97 146.52 27.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.071 -1.018 . . . . 2.65 110.484 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.497 ' CG2' ' HG ' ' A' ' 36' ' ' LEU . 4.0 t -83.5 130.38 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.35 -0.844 . . . . 1.06 109.763 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.0 -175.33 5.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.076 -1.015 . . . . 0.55 110.054 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . 0.466 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -57.11 -39.19 74.59 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.028 -1.045 . . . . 2.19 111.554 -172.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.527 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.9 tp -83.23 -6.83 59.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.737 -1.227 . . . . 1.99 111.589 -174.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.457 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.12 47.38 7.06 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.483 -1.447 . . . . 0.23 109.483 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.529 ' CD ' HG23 ' A' ' 19' ' ' VAL . 69.6 mtm180 -114.08 154.67 27.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.026 -1.279 . . . . 1.33 110.059 -177.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.443 HG13 ' CD1' ' A' ' 36' ' ' LEU . 15.1 m -123.73 152.74 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 1.08 109.803 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.532 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.4 t -111.41 135.12 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 1.07 110.655 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.523 HD13 ' CD1' ' A' ' 45' ' ' ILE . 15.9 mt -81.64 135.03 49.78 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.326 -0.859 . . . . 1.99 109.602 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.52 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.5 Cg_endo -58.38 142.64 97.87 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.773 1.407 . . . . 0.4 110.045 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.529 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.42 -31.79 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.06 -1.025 . . . . 1.78 110.357 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.31 -35.59 74.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.019 -1.051 . . . . 2.37 109.787 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.52 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 51.9 mt -81.15 -31.02 34.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 2.36 110.569 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.529 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 71.7 mtt180 -57.85 -43.93 86.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.848 -1.157 . . . . 0.33 109.319 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -73.82 -50.1 22.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 3.75 110.62 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.5 m -63.81 -31.78 73.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.304 -0.872 . . . . 1.38 110.854 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.449 HD21 HG13 ' B' ' 30' ' ' ILE . 18.8 tp -87.35 -4.95 59.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.124 -0.985 . . . . 1.61 110.732 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.4 43.12 93.3 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.626 -1.39 . . . . 0.34 109.626 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.449 HG13 HD21 ' B' ' 28' ' ' LEU . 32.5 mm -115.96 138.11 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -1.144 . . . . 1.13 110.64 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.55 167.11 22.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.478 -0.764 . . . . 1.07 109.999 -177.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.64 145.93 14.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 1.13 110.565 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 69.2 tttt 74.49 -4.58 2.29 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.656 -0.653 . . . . 2.39 111.128 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.446 ' O ' HG22 ' A' ' 12' ' ' VAL . 89.9 m-20 -76.97 168.07 20.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.83 -1.169 . . . . 1.1 110.013 174.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.66 131.36 53.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 1.13 110.805 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.549 HD12 ' CG2' ' A' ' 12' ' ' VAL . 9.4 mt -107.71 144.04 35.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.391 -0.818 . . . . 1.35 109.291 174.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.45 ' HA ' HG21 ' A' ' 9' ' ' VAL . 86.3 tt0 -108.15 137.81 45.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.764 -1.21 . . . . 1.17 109.881 173.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -108.32 133.35 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.322 -0.861 . . . . 1.48 110.508 -172.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.573 ' CE1' ' HD2' ' B' ' 48' ' ' LYS . 10.3 m-85 -119.41 159.98 23.18 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 116.276 -0.42 . . . . 1.08 110.03 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 76.7 t -133.12 127.56 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.945 -1.097 . . . . 1.05 110.454 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.474 ' OD1' ' O ' ' B' ' 41' ' ' ASP . 39.2 p-10 -147.6 137.98 23.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.34 -0.85 . . . . 1.77 110.58 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 54.4 t0 43.89 47.42 6.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.136 -0.977 . . . . 1.21 111.278 174.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.3 tt0 60.85 11.74 3.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.133 -0.979 . . . . 1.92 110.636 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 35.3 mtmt -113.02 152.06 29.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.176 -0.952 . . . . 2.49 109.683 175.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.53 HD13 ' CD1' ' A' ' 20' ' ' ILE . 65.6 mt -94.81 129.57 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 1.85 110.108 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 27.2 mm -114.84 120.94 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.581 -0.699 . . . . 1.22 109.962 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.588 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.4 mp -118.2 135.88 53.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.999 -1.063 . . . . 2.23 110.235 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.573 ' HD2' ' CE1' ' B' ' 39' ' ' TYR . 5.0 ptpt -142.53 158.41 43.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 2.17 110.346 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -57.83 146.47 31.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 2.25 109.955 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.512 ' CZ ' HG22 ' A' ' 9' ' ' VAL . 15.0 t80 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 1.21 110.697 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.408 HG21 HD12 ' A' ' 8' ' ' ILE . 59.5 mt . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.047 0.451 . . . . 2.01 110.018 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.556 HG21 ' CZ ' ' B' ' 50' ' ' TYR . 89.2 t -115.71 144.25 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.013 -1.054 . . . . 1.08 110.855 -176.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.439 ' N ' HG11 ' A' ' 9' ' ' VAL . 69.8 ttt-85 -129.85 160.38 33.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.522 -0.736 . . . . 2.25 109.658 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -85.62 147.73 26.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.029 -1.044 . . . . 2.66 110.33 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.548 ' CG2' HD13 ' B' ' 36' ' ' LEU . 3.8 t -82.33 130.78 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -0.864 . . . . 1.09 109.825 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.469 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.8 -175.55 5.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.128 -0.982 . . . . 0.55 110.02 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.9 -40.77 70.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.134 -0.979 . . . . 2.19 111.733 -173.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.507 HD12 ' NH2' ' B' ' 25' ' ' ARG . 14.1 tp -84.09 -5.51 59.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.746 -1.221 . . . . 1.97 111.493 -173.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.516 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.34 46.37 7.53 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.193 -1.479 . . . . 0.22 109.704 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.533 ' CD ' HG23 ' B' ' 19' ' ' VAL . 70.0 mtm180 -114.93 154.53 28.57 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.028 -1.277 . . . . 1.33 109.994 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.516 ' CG1' HD11 ' B' ' 36' ' ' LEU . 16.6 m -123.86 152.01 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 1.08 109.768 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.525 HG22 ' CD ' ' B' ' 17' ' ' ARG . 36.0 t -111.23 134.87 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 1.05 110.724 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.484 HG21 ' HB2' ' A' ' 24' ' ' LEU . 19.0 mt -81.36 133.28 53.7 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.277 -0.89 . . . . 2.03 109.632 174.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.532 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.2 Cg_endo -58.85 143.32 99.34 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.701 1.369 . . . . 0.4 109.985 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.519 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.07 -32.82 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.934 -1.104 . . . . 1.79 110.33 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.11 -35.66 71.77 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.111 -0.993 . . . . 2.37 109.852 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.532 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 57.2 mt -82.83 -29.8 29.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.429 -0.795 . . . . 2.3 110.645 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.519 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 72.0 mtt180 -57.54 -43.88 84.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.887 -1.133 . . . . 0.33 109.166 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -73.06 -50.97 19.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.542 -0.724 . . . . 3.74 110.645 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.3 m -63.53 -31.32 72.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.259 -0.9 . . . . 1.44 111.195 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.519 ' CD2' HG13 ' A' ' 30' ' ' ILE . 20.8 tp -87.71 -4.8 58.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.037 -1.039 . . . . 1.64 110.783 -177.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.15 41.72 96.83 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.624 -1.391 . . . . 0.34 109.624 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.519 HG13 ' CD2' ' A' ' 28' ' ' LEU . 34.9 mm -116.4 138.05 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.228 -1.16 . . . . 1.16 110.633 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.68 166.74 23.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.652 -0.655 . . . . 1.08 110.005 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.53 146.56 12.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.065 -1.022 . . . . 1.13 110.532 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 28.6 tttm 74.57 -4.62 2.29 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.699 -0.626 . . . . 2.33 111.097 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.458 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.3 m-20 -77.65 166.74 22.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.81 -1.182 . . . . 1.1 110.078 174.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.14 130.69 51.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 1.17 110.747 -176.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.499 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 12.3 mt -107.3 143.21 35.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.351 -0.843 . . . . 1.21 109.424 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.474 ' HG3' HG23 ' B' ' 9' ' ' VAL . 86.5 tt0 -107.27 137.85 44.56 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.839 -1.163 . . . . 1.17 109.577 173.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.6 mt -108.6 133.44 53.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.361 -0.837 . . . . 1.45 110.583 -171.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.573 ' CE1' ' HD2' ' A' ' 48' ' ' LYS . 10.7 m-85 -120.13 159.44 24.85 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 116.309 -0.405 . . . . 1.05 110.014 -178.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.8 t -133.16 124.55 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.85 -1.156 . . . . 1.08 110.666 172.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.474 ' OD1' HG12 ' A' ' 46' ' ' ILE . 42.3 p-10 -147.54 145.08 28.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 1.77 110.577 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.472 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.1 t0 43.08 43.9 3.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.998 -1.064 . . . . 1.22 111.283 174.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 45.2 tp10 61.74 10.6 3.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.128 -0.983 . . . . 1.93 110.676 175.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -109.77 153.44 24.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 2.48 110.034 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.519 ' CD1' HD12 ' B' ' 20' ' ' ILE . 66.6 mt -93.32 128.34 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 1.86 109.752 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.0 mm -113.35 118.43 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.602 -0.687 . . . . 1.24 109.941 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.2 mp -115.84 134.67 54.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.944 -1.097 . . . . 2.25 110.284 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.573 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 15.9 ptpt -142.78 161.14 38.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.793 . . . . 2.26 110.317 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -56.59 147.67 21.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.042 -1.037 . . . . 2.12 109.882 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.5 t80 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.96 110.653 -175.578 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 87.2 t . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.504 0.669 . . . . 1.11 110.951 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.437 ' N ' HG13 ' B' ' 9' ' ' VAL . 69.8 ttt-85 -129.79 160.16 34.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.53 -0.731 . . . . 2.26 109.709 177.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -85.53 147.59 26.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.101 -1.0 . . . . 2.65 110.413 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.524 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 3.8 t -82.25 130.75 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.874 . . . . 1.06 109.743 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -83.95 -175.59 5.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.049 -1.032 . . . . 0.55 110.119 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.02 -40.62 70.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.133 -0.98 . . . . 2.19 111.649 -172.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.502 HD23 ' NH1' ' B' ' 17' ' ' ARG . 13.9 tp -84.1 -5.52 59.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.766 -1.209 . . . . 1.99 111.602 -173.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.524 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.92 47.12 7.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.606 -1.397 . . . . 0.23 109.606 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.525 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.0 mtm180 -115.09 154.57 28.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.071 -1.253 . . . . 1.33 109.996 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.516 HG23 ' CD2' ' A' ' 47' ' ' LEU . 16.6 m -123.96 152.01 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 1.08 109.823 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.533 HG23 ' CD ' ' A' ' 17' ' ' ARG . 35.9 t -111.29 134.85 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.935 . . . . 1.07 110.714 -175.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.519 HD12 ' CD1' ' A' ' 45' ' ' ILE . 18.5 mt -81.41 133.23 53.62 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.253 -0.904 . . . . 1.99 109.609 174.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.528 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.1 Cg_endo -58.96 143.25 99.76 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.735 1.387 . . . . 0.4 109.98 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.534 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.2 tp -55.09 -32.63 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.002 -1.061 . . . . 1.78 110.412 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.98 -36.39 72.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.11 -0.994 . . . . 2.37 109.747 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.528 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 57.6 mt -82.13 -30.01 31.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.494 -0.754 . . . . 2.36 110.638 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.534 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 71.6 mtt180 -57.56 -43.71 84.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.847 -1.158 . . . . 0.33 109.076 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -72.97 -51.21 19.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.482 -0.761 . . . . 3.75 110.6 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.2 m -63.29 -31.87 73.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.261 -0.899 . . . . 1.38 110.953 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.519 ' CD2' HG13 ' B' ' 30' ' ' ILE . 20.9 tp -87.12 -5.22 59.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.042 -1.036 . . . . 1.61 110.73 -176.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.46 41.54 96.29 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.563 -1.415 . . . . 0.34 109.563 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.519 HG13 ' CD2' ' B' ' 28' ' ' LEU . 34.2 mm -116.37 137.94 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -1.199 . . . . 1.13 110.598 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.41 166.86 23.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.624 -0.672 . . . . 1.07 109.965 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.51 146.61 12.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 1.13 110.48 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 28.5 tttm 74.66 -4.78 2.27 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.671 -0.643 . . . . 2.39 111.17 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 89.9 m-20 -77.73 166.5 22.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.789 -1.194 . . . . 1.1 110.092 175.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.06 130.63 51.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 1.13 110.837 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.548 HD13 ' CG2' ' A' ' 12' ' ' VAL . 12.1 mt -107.27 143.06 36.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 1.35 109.48 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.465 ' HA ' HG23 ' A' ' 9' ' ' VAL . 86.4 tt0 -107.05 137.85 44.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.763 -1.21 . . . . 1.17 109.688 172.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.474 HD13 HG21 ' B' ' 38' ' ' ILE . 70.8 mt -108.72 133.53 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.292 -0.88 . . . . 1.48 110.516 -171.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.577 ' CE1' ' HD2' ' B' ' 48' ' ' LYS . 10.7 m-85 -120.16 159.44 24.88 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 116.225 -0.443 . . . . 1.08 109.978 -178.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 81.5 t -133.03 125.02 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.885 -1.134 . . . . 1.05 110.451 172.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' B' ' 41' ' ' ASP . 42.1 p-10 -148.03 145.06 28.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 1.77 110.556 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.7 t0 43.25 43.91 4.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.077 -1.014 . . . . 1.21 111.242 174.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 45.0 tp10 61.61 10.61 3.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.147 -0.971 . . . . 1.92 110.703 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -109.87 153.66 24.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 2.49 109.963 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.5 HG21 ' CD1' ' B' ' 47' ' ' LEU . 66.2 mt -93.43 128.14 45.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.19 -0.944 . . . . 1.85 109.85 176.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 21.4 mm -113.28 118.42 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.508 -0.745 . . . . 1.22 109.95 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.3 mp -115.66 134.42 55.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.067 -1.021 . . . . 2.23 110.255 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.577 ' HD2' ' CE1' ' B' ' 39' ' ' TYR . 15.8 ptpt -142.54 161.34 38.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.351 -0.843 . . . . 2.17 110.36 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -56.67 147.59 22.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.186 -0.946 . . . . 2.25 109.893 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.556 ' CZ ' HG21 ' A' ' 9' ' ' VAL . 5.6 t80 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 1.21 110.581 -175.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.437 HD13 HG22 ' A' ' 8' ' ' ILE . 58.5 mt . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 120.962 0.411 . . . . 2.01 109.954 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.62 ' CG1' ' CD2' ' B' ' 50' ' ' TYR . 88.5 t -117.45 144.26 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.014 -1.054 . . . . 1.08 110.875 -175.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.43 ' N ' HG13 ' A' ' 9' ' ' VAL . 69.4 ttt-85 -131.47 162.54 29.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.532 -0.73 . . . . 2.25 109.726 177.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -85.32 148.06 26.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.041 -1.037 . . . . 2.66 110.385 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.549 ' CG2' HD12 ' B' ' 36' ' ' LEU . 3.8 t -82.3 129.8 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.216 -0.928 . . . . 1.09 109.792 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.14 -175.66 5.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.037 -1.039 . . . . 0.55 109.994 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -54.85 -40.69 69.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.083 -1.011 . . . . 2.19 111.68 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.517 HD13 ' NH2' ' B' ' 25' ' ' ARG . 15.4 tp -84.51 -5.82 59.32 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.731 -1.231 . . . . 1.97 111.572 -173.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.477 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.53 46.59 7.28 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.225 -1.464 . . . . 0.22 109.646 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.539 ' CD ' HG21 ' B' ' 19' ' ' VAL . 69.0 mtm180 -114.03 153.74 28.88 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.942 -1.328 . . . . 1.33 110.109 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.528 ' CG1' HD13 ' B' ' 36' ' ' LEU . 16.6 m -124.21 152.99 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 1.08 109.771 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.522 HG23 ' CD ' ' B' ' 17' ' ' ARG . 18.1 t -112.24 134.36 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.983 . . . . 1.05 110.708 -175.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.466 HG21 ' HB2' ' A' ' 24' ' ' LEU . 2.2 mm -82.97 134.13 47.14 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.181 -0.95 . . . . 2.03 109.322 173.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.528 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.5 Cg_endo -58.86 141.57 98.18 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.701 1.369 . . . . 0.4 109.906 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.506 ' HA ' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -55.76 -31.43 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.909 -1.12 . . . . 1.79 110.412 -176.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.467 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 20.1 pt-20 -59.25 -34.67 72.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.024 -1.048 . . . . 2.37 109.732 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.528 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 56.6 mt -80.73 -29.42 36.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 2.3 110.325 176.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.506 ' CD ' ' HA ' ' A' ' 22' ' ' ILE . 73.4 mtt180 -57.1 -44.19 82.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.958 -1.088 . . . . 0.33 109.122 175.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -72.41 -50.45 26.34 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.893 -0.723 . . . . 3.74 110.692 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.1 m -63.53 -31.49 72.66 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 1.44 111.129 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.446 ' CD2' HG13 ' A' ' 30' ' ' ILE . 18.3 tp -87.85 -4.71 58.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.011 -1.055 . . . . 1.64 110.74 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.84 42.04 95.24 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.707 -1.357 . . . . 0.34 109.707 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.446 HG13 ' CD2' ' A' ' 28' ' ' LEU . 32.5 mm -116.41 138.37 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -1.125 . . . . 1.16 110.716 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.63 166.23 25.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.594 -0.691 . . . . 1.08 109.993 -177.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.42 147.0 11.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.024 -1.048 . . . . 1.13 110.584 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 26.6 ttpt 74.39 -4.47 2.31 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.644 -0.66 . . . . 2.33 111.163 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.464 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.8 m-20 -77.79 167.82 20.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.827 -1.17 . . . . 1.1 110.057 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . . . -104.51 131.0 52.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 1.17 110.777 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.496 ' HG ' ' CG2' ' B' ' 12' ' ' VAL . 12.2 mt -108.03 144.3 35.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.381 -0.824 . . . . 1.21 109.461 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.469 ' HG3' HG22 ' B' ' 9' ' ' VAL . 86.0 tt0 -109.5 139.14 44.85 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.812 -1.18 . . . . 1.17 109.614 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.25 132.86 54.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.462 -0.774 . . . . 1.45 110.471 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.554 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 15.8 m-85 -119.19 157.21 28.43 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 116.294 -0.412 . . . . 1.05 109.941 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.1 t -132.14 122.69 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.795 -1.191 . . . . 1.08 110.575 173.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 47.4 p-10 -147.8 149.71 32.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.909 . . . . 1.77 110.602 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 52.7 t0 42.96 44.19 3.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.011 -1.055 . . . . 1.22 111.317 173.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.7 mt-10 57.84 14.46 2.54 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.051 -1.03 . . . . 1.93 110.54 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -114.09 153.32 29.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -0.929 . . . . 2.48 109.984 175.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.504 ' CD1' HD12 ' B' ' 20' ' ' ILE . 66.0 mt -91.82 127.77 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.23 -0.919 . . . . 1.86 109.762 177.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 24.5 mm -112.96 120.07 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.633 -0.667 . . . . 1.24 109.896 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.582 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.1 mp -118.72 134.5 55.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.902 -1.124 . . . . 2.25 110.256 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.533 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 9.8 pttp -141.81 164.49 30.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 2.26 110.451 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -58.68 147.08 34.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 2.12 110.146 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.451 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 7.8 t80 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.833 . . . . 0.96 110.603 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 89.2 t . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.471 0.653 . . . . 1.11 110.919 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.416 ' N ' HG13 ' B' ' 9' ' ' VAL . 69.4 ttt-85 -131.42 162.35 30.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.555 -0.716 . . . . 2.26 109.72 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -85.16 148.01 26.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.083 -1.01 . . . . 2.65 110.393 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.496 ' CG2' ' HG ' ' A' ' 36' ' ' LEU . 3.9 t -82.29 129.85 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.213 -0.929 . . . . 1.06 109.7 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.42 -175.55 5.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.956 . . . . 0.55 110.097 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -54.89 -40.65 69.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 2.19 111.674 -172.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.514 HD23 ' NH1' ' B' ' 17' ' ' ARG . 15.1 tp -84.42 -5.97 59.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.772 -1.205 . . . . 1.99 111.599 -173.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.484 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.18 47.31 7.07 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.558 -1.417 . . . . 0.23 109.558 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.522 ' CD ' HG23 ' A' ' 19' ' ' VAL . 68.7 mtm180 -114.29 153.69 29.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.085 -1.244 . . . . 1.33 110.061 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.468 HG23 HG22 ' A' ' 18' ' ' VAL . 16.4 m -124.12 152.96 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 1.08 109.813 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.539 HG21 ' CD ' ' A' ' 17' ' ' ARG . 18.0 t -112.37 134.36 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 1.07 110.686 -175.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.504 HD12 ' CD1' ' A' ' 45' ' ' ILE . 2.3 mm -82.91 134.02 47.54 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.934 . . . . 1.99 109.409 173.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.525 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.4 Cg_endo -58.96 141.57 98.39 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.807 1.425 . . . . 0.4 109.899 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.526 HG22 HD12 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.95 -31.13 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.068 -1.02 . . . . 1.78 110.409 -176.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . 0.478 ' HG2' ' HB2' ' B' ' 21' ' ' PRO . 20.0 pt-20 -59.16 -35.38 73.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.023 -1.048 . . . . 2.37 109.59 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.525 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 57.3 mt -80.03 -29.83 39.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.484 -0.76 . . . . 2.36 110.334 176.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.517 ' NH2' HD13 ' A' ' 15' ' ' LEU . 73.0 mtt180 -56.83 -44.08 81.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.01 -1.056 . . . . 0.33 109.203 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -72.3 -50.78 24.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.468 -0.77 . . . . 3.75 110.642 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.3 m -63.2 -32.05 73.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.888 . . . . 1.38 110.921 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.442 ' CD2' HG13 ' B' ' 30' ' ' ILE . 18.5 tp -87.39 -4.99 59.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.026 -1.047 . . . . 1.61 110.73 -176.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.31 41.8 94.4 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.603 -1.399 . . . . 0.34 109.603 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.442 HG13 ' CD2' ' B' ' 28' ' ' LEU . 32.1 mm -116.41 138.29 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -1.183 . . . . 1.13 110.616 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.39 166.44 24.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.562 -0.711 . . . . 1.07 110.026 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.48 147.0 11.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.136 -0.978 . . . . 1.13 110.486 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 26.6 ttpt 74.59 -4.76 2.26 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.661 -0.65 . . . . 2.39 111.126 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 89.0 m-20 -77.76 167.54 21.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.825 -1.172 . . . . 1.1 110.107 175.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' B' ' 50' ' ' TYR . . . -104.28 130.98 52.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.184 -0.948 . . . . 1.13 110.803 -176.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.549 HD12 ' CG2' ' A' ' 12' ' ' VAL . 12.2 mt -108.02 144.08 35.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.842 . . . . 1.35 109.551 174.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.466 ' HA ' HG21 ' A' ' 9' ' ' VAL . 85.7 tt0 -109.11 139.09 44.48 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.868 -1.145 . . . . 1.17 109.8 172.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.32 132.84 55.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.363 -0.836 . . . . 1.48 110.427 -172.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.543 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 15.6 m-85 -119.18 157.24 28.35 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 116.231 -0.44 . . . . 1.08 109.874 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.438 HG22 HD13 ' A' ' 24' ' ' LEU . 85.7 t -131.96 123.08 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.958 -1.089 . . . . 1.05 110.441 173.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' B' ' 41' ' ' ASP . 47.6 p-10 -148.35 149.63 32.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.16 -0.962 . . . . 1.77 110.561 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 53.2 t0 42.87 44.48 3.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.129 -0.982 . . . . 1.21 111.287 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.7 mt-10 57.61 14.53 2.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.045 -1.034 . . . . 1.92 110.503 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -114.08 153.49 29.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.292 -0.88 . . . . 2.49 109.989 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 47' ' ' LEU . 65.7 mt -91.95 127.72 44.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.263 -0.898 . . . . 1.85 109.771 177.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 24.7 mm -113.02 120.1 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.513 -0.742 . . . . 1.22 109.903 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.582 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.2 mp -118.66 134.34 55.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.974 -1.079 . . . . 2.23 110.196 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.528 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 10.1 pttp -141.62 164.81 29.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 2.17 110.406 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -58.89 147.04 35.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 2.25 109.953 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.62 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 7.9 t80 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 1.21 110.583 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.1 mm . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 120.979 0.419 . . . . 2.01 110.061 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 95.9 t -115.82 144.85 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.063 -1.023 . . . . 1.08 110.81 -176.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.456 ' N ' HG13 ' A' ' 9' ' ' VAL . 71.0 ttt-85 -131.44 160.27 35.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.515 -0.74 . . . . 2.25 109.704 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -85.58 148.0 26.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.062 -1.024 . . . . 2.66 110.307 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.545 ' CG2' HD13 ' B' ' 36' ' ' LEU . 4.3 t -81.91 130.3 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.268 -0.895 . . . . 1.09 109.855 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.471 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.74 -174.64 5.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.55 110.157 -179.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.42 -41.95 66.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.123 -0.986 . . . . 2.19 111.887 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.529 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.0 tp -87.48 -3.06 59.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.68 -1.262 . . . . 1.97 111.755 -172.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 79.98 46.36 7.75 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.168 -1.491 . . . . 0.22 109.674 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.56 ' CD ' ' CG2' ' B' ' 19' ' ' VAL . 76.9 mtm180 -116.2 154.28 30.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.098 -1.236 . . . . 1.33 109.828 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.53 HG22 ' CD2' ' B' ' 47' ' ' LEU . 27.4 m -125.7 153.14 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 1.08 109.938 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.522 ' CG2' ' CD ' ' B' ' 17' ' ' ARG . 22.7 t -111.55 135.52 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 1.05 110.548 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.482 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.31 134.25 46.01 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.255 -0.903 . . . . 2.03 109.577 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.524 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.4 Cg_endo -57.83 142.81 96.41 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.788 1.415 . . . . 0.4 110.025 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.516 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.37 -32.56 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.034 -1.041 . . . . 1.79 110.378 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.417 ' N ' HG21 ' A' ' 22' ' ' ILE . 84.3 tt0 -57.96 -35.9 71.8 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.143 -0.973 . . . . 2.37 109.9 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.524 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 51.8 mt -81.03 -31.3 34.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 2.3 110.542 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.516 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 72.9 mtt180 -58.17 -43.51 87.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.954 -1.091 . . . . 0.33 109.287 176.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -73.19 -49.66 26.81 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.797 -0.761 . . . . 3.74 110.694 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.5 m -63.9 -31.86 73.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 1.44 111.093 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 tp -88.16 -4.61 58.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.055 -1.028 . . . . 1.64 110.737 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.456 ' O ' HD11 ' A' ' 30' ' ' ILE . . . 65.78 42.35 95.21 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.681 -1.367 . . . . 0.34 109.681 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.456 HD11 ' O ' ' A' ' 29' ' ' GLY . 31.4 mm -116.32 137.79 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.302 -1.116 . . . . 1.16 110.715 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.43 168.65 19.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.589 -0.694 . . . . 1.08 110.061 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.77 145.87 14.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.111 -0.993 . . . . 1.13 110.616 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 41.3 tttp 74.0 -4.35 2.3 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.751 -0.593 . . . . 2.33 111.231 176.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.456 ' O ' HG21 ' B' ' 12' ' ' VAL . 89.1 m-20 -76.84 166.28 23.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.818 -1.176 . . . . 1.1 110.047 174.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -103.7 131.08 51.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.953 . . . . 1.17 110.823 -175.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.488 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 13.2 mt -108.05 144.48 35.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.372 -0.83 . . . . 1.21 109.392 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.481 ' HG3' HG22 ' B' ' 9' ' ' VAL . 86.3 tt0 -108.81 138.28 45.39 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.732 -1.23 . . . . 1.17 109.517 172.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.3 mt -109.09 131.79 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.419 -0.801 . . . . 1.45 110.582 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.581 ' CE1' ' HD2' ' A' ' 48' ' ' LYS . 10.6 m-85 -117.58 159.26 23.18 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.83 -0.433 . . . . 1.05 109.83 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.3 t -133.26 120.93 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.876 -1.14 . . . . 1.08 110.554 172.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 47.2 p-10 -148.4 159.96 43.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.167 -0.958 . . . . 1.77 110.603 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 53.9 t0 42.29 40.35 1.76 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.025 -1.047 . . . . 1.22 111.599 171.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 84.2 tt0 58.87 14.09 3.1 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.844 -1.16 . . . . 1.93 110.567 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.523 ' CE ' HD12 ' A' ' 46' ' ' ILE . 14.0 pttt -127.18 164.45 21.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.96 . . . . 2.48 109.691 174.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.418 HD12 ' CG1' ' B' ' 20' ' ' ILE . 68.9 mt -97.41 134.89 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.137 -0.977 . . . . 1.86 110.322 -176.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 22.3 mm -114.16 119.39 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.674 -0.641 . . . . 1.24 109.857 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.58 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.3 mp -115.95 135.07 54.32 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.021 -1.05 . . . . 2.25 110.226 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.581 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 1.7 ptpm? -141.17 159.08 42.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.439 -0.788 . . . . 2.26 110.389 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -57.75 146.9 29.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.101 -1.0 . . . . 2.12 109.96 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 6.0 t80 . . . . . 0 C--N 1.301 -1.542 0 O-C-N 121.228 -0.92 . . . . 0.96 110.524 -176.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.488 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 96.3 t . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.553 0.692 . . . . 1.11 110.81 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.452 ' N ' HG12 ' B' ' 9' ' ' VAL . 71.1 ttt-85 -131.41 160.16 35.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.501 -0.75 . . . . 2.26 109.736 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -85.6 148.01 26.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.076 -1.015 . . . . 2.65 110.442 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.531 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 4.4 t -81.9 130.38 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 1.06 109.703 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.9 -174.47 5.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.115 -0.991 . . . . 0.55 110.305 -179.35 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -53.66 -41.72 67.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.185 -0.947 . . . . 2.19 111.79 -172.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.525 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.6 tp -87.51 -3.28 59.0 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.695 -1.253 . . . . 1.99 111.665 -172.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.531 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.81 46.93 7.5 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.477 -1.449 . . . . 0.23 109.477 -177.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.525 ' HD3' ' CD2' ' B' ' 15' ' ' LEU . 76.7 mtm180 -116.29 154.31 30.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.132 -1.217 . . . . 1.33 109.864 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.517 HG22 ' CD2' ' A' ' 47' ' ' LEU . 27.2 m -125.68 153.19 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 1.08 109.937 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.56 ' CG2' ' CD ' ' A' ' 17' ' ' ARG . 22.5 t -111.61 135.43 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 1.07 110.559 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -83.15 134.23 46.46 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 1.99 109.608 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.521 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.3 Cg_endo -57.94 142.82 96.73 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.765 1.403 . . . . 0.4 109.992 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.534 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.54 -32.3 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.11 -0.994 . . . . 1.78 110.359 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . 0.413 ' N ' HG22 ' B' ' 22' ' ' ILE . 84.2 tt0 -57.98 -36.41 72.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.074 -1.016 . . . . 2.37 109.794 178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.521 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 52.3 mt -80.34 -31.62 37.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.494 -0.754 . . . . 2.36 110.574 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.534 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 72.3 mtt180 -58.02 -43.46 86.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.896 -1.128 . . . . 0.33 109.246 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -73.17 -49.75 26.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 3.75 110.64 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.0 m -63.74 -32.44 73.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.193 -0.942 . . . . 1.38 110.785 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.424 HD23 HG13 ' B' ' 30' ' ' ILE . 17.5 tp -87.71 -4.87 58.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.098 -1.001 . . . . 1.61 110.709 -176.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.04 42.15 94.77 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.624 -1.391 . . . . 0.34 109.624 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.424 HG13 HD23 ' B' ' 28' ' ' LEU . 31.2 mm -116.24 137.67 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -1.221 . . . . 1.13 110.705 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.16 168.89 18.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.518 -0.739 . . . . 1.07 109.997 -177.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.87 145.9 15.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.163 -0.961 . . . . 1.13 110.493 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.513 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 41.2 tttp 74.13 -4.49 2.28 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.583 -0.698 . . . . 2.39 111.179 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 89.1 m-20 -77.0 166.0 23.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.755 -1.216 . . . . 1.1 109.979 174.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' B' ' 50' ' ' TYR . . . -103.45 131.19 50.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 1.13 110.855 -175.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.545 HD13 ' CG2' ' A' ' 12' ' ' VAL . 13.2 mt -108.2 144.07 36.14 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.328 -0.858 . . . . 1.35 109.448 174.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.469 ' HA ' HG23 ' A' ' 9' ' ' VAL . 86.0 tt0 -108.32 138.22 44.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.851 -1.155 . . . . 1.17 109.729 172.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -109.07 131.87 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.293 -0.879 . . . . 1.48 110.507 -171.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.575 ' CE1' ' HD2' ' B' ' 48' ' ' LYS . 10.6 m-85 -117.52 159.26 23.14 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 116.264 -0.425 . . . . 1.08 109.914 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 74.4 t -133.11 121.37 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.876 -1.14 . . . . 1.05 110.441 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 47.2 p-10 -148.93 159.97 43.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 1.77 110.543 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 54.7 t0 42.09 40.62 1.73 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.126 -0.984 . . . . 1.21 111.577 172.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' B' ' 43' ' ' GLU . 84.1 tt0 58.79 14.03 3.02 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.816 -1.178 . . . . 1.92 110.529 174.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 13.9 pttt -127.19 164.65 21.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.089 -1.007 . . . . 2.49 109.571 174.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.418 HD12 HG12 ' A' ' 20' ' ' ILE . 68.9 mt -97.48 134.73 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 1.85 110.374 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 22.0 mm -114.15 119.45 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.714 -0.616 . . . . 1.22 109.869 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.58 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.4 mp -115.94 134.86 54.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.03 -1.044 . . . . 2.23 110.208 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.575 ' HD2' ' CE1' ' B' ' 39' ' ' TYR . 1.7 ptpm? -140.99 159.3 42.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 2.17 110.316 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -57.9 146.78 30.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.954 . . . . 2.25 109.909 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.53 ' CD2' HG12 ' A' ' 9' ' ' VAL . 6.1 t80 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 1.21 110.415 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.6 mt . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.076 0.465 . . . . 2.01 110.088 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.639 ' CG1' ' CD2' ' B' ' 50' ' ' TYR . 85.9 t -120.04 144.37 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.988 -1.07 . . . . 1.08 110.809 -176.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.426 ' N ' HG11 ' A' ' 9' ' ' VAL . 52.8 ttt85 -131.04 161.21 32.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.525 -0.734 . . . . 2.25 109.69 178.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -85.39 148.09 26.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.133 -0.979 . . . . 2.66 110.34 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.547 ' CG2' HD12 ' B' ' 36' ' ' LEU . 3.6 t -82.93 129.94 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.89 . . . . 1.09 109.831 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.8 -175.82 5.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.106 -0.996 . . . . 0.55 109.923 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.06 -40.38 70.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.104 -0.997 . . . . 2.19 111.677 -173.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.526 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.4 tp -83.25 -6.48 59.49 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.845 -1.159 . . . . 1.97 111.539 -173.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.506 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.74 46.47 7.23 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.243 -1.455 . . . . 0.22 109.652 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.53 ' CD ' HG23 ' B' ' 19' ' ' VAL . 70.7 mtm180 -114.47 154.82 27.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.05 -1.265 . . . . 1.33 110.065 -177.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.533 ' CG1' HD13 ' B' ' 36' ' ' LEU . 19.4 m -123.69 152.56 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.398 -0.814 . . . . 1.08 109.86 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.53 HG21 ' CD ' ' B' ' 17' ' ' ARG . 31.2 t -111.77 134.03 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.179 -0.951 . . . . 1.05 110.69 -175.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.476 HG22 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.63 132.86 50.69 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 2.03 109.437 173.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.53 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.7 Cg_endo -57.47 141.29 95.02 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.699 1.368 . . . . 0.4 109.83 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.482 ' HA ' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -55.75 -31.93 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.107 . . . . 1.79 110.303 -177.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.15 -36.48 70.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.017 . . . . 2.37 109.79 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.53 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 52.8 mt -80.86 -29.04 35.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.262 -0.899 . . . . 2.3 110.487 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.482 ' CD ' ' HA ' ' A' ' 22' ' ' ILE . 75.8 mtt180 -56.85 -43.65 81.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.879 -1.138 . . . . 0.33 109.18 175.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -72.85 -50.67 22.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.557 -0.715 . . . . 3.74 110.755 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.6 m -63.43 -31.3 72.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 1.44 111.117 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.522 ' CD2' HG13 ' A' ' 30' ' ' ILE . 26.3 tp -87.55 -4.93 58.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 1.64 110.782 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.407 ' O ' HD11 ' A' ' 30' ' ' ILE . . . 64.39 42.86 97.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.626 -1.39 . . . . 0.34 109.626 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.522 HG13 ' CD2' ' A' ' 28' ' ' LEU . 29.5 mm -116.12 139.0 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -1.149 . . . . 1.16 110.7 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.5 166.99 23.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.625 -0.672 . . . . 1.08 109.998 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.2 tt0 -53.41 146.31 12.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.966 . . . . 1.13 110.553 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 77.2 tttt 74.86 -4.68 2.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.749 -0.594 . . . . 2.33 111.164 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.461 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.4 m-20 -77.16 166.09 23.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.779 -1.2 . . . . 1.1 110.044 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . . . -104.83 132.57 50.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.941 . . . . 1.17 110.855 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.517 HD12 ' CG1' ' B' ' 18' ' ' VAL . 13.0 mt -109.43 143.65 38.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.397 -0.814 . . . . 1.21 109.555 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.468 ' OE1' ' HE3' ' A' ' 48' ' ' LYS . 85.4 tt0 -108.63 140.29 42.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.836 -1.165 . . . . 1.17 109.824 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.5 mm -111.15 133.18 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.435 -0.79 . . . . 1.45 110.555 -173.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.541 ' OH ' ' CE ' ' A' ' 48' ' ' LYS . 14.4 m-85 -115.16 159.2 21.21 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 120.911 0.386 . . . . 1.05 109.972 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.5 t -130.45 128.92 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.931 -1.106 . . . . 1.08 110.802 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.491 ' CG ' ' CD1' ' A' ' 46' ' ' ILE . 9.7 p-10 -146.54 129.5 16.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.866 . . . . 1.77 110.215 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 48.9 t0 46.12 50.11 11.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.007 -1.058 . . . . 1.22 110.96 175.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.4 mt-10 59.95 12.69 3.24 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.348 -0.845 . . . . 1.93 110.714 176.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 9.6 mtmt -113.12 150.62 31.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 2.48 109.811 175.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.8 mt -101.76 128.84 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.058 -1.026 . . . . 1.86 110.327 -176.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 28.8 mt -112.06 121.47 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.391 -0.818 . . . . 1.24 110.14 176.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.581 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.3 mp -114.52 135.02 54.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.073 -1.017 . . . . 2.25 110.237 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.541 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 10.6 pttp -141.48 165.0 28.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.454 -0.779 . . . . 2.26 110.273 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -58.2 147.5 30.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.978 . . . . 2.12 110.009 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.476 ' CD2' ' CG1' ' B' ' 9' ' ' VAL . 5.9 t80 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.885 . . . . 0.96 110.566 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 85.9 t . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.479 0.656 . . . . 1.11 110.779 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.419 ' N ' HG12 ' B' ' 9' ' ' VAL . 52.8 ttt85 -130.86 161.12 32.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.467 -0.771 . . . . 2.26 109.845 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -85.43 147.98 26.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 2.65 110.404 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.523 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 3.6 t -82.87 129.99 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.918 . . . . 1.06 109.764 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.449 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -83.97 -175.72 5.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.089 -1.007 . . . . 0.55 110.087 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.13 -40.43 70.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.183 -0.948 . . . . 2.19 111.558 -173.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.516 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.9 tp -83.07 -6.7 59.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.856 -1.152 . . . . 1.99 111.563 -173.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.523 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.43 47.2 6.99 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.549 -1.421 . . . . 0.23 109.549 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.53 ' CD ' HG21 ' A' ' 19' ' ' VAL . 70.9 mtm180 -114.67 154.72 27.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.096 -1.238 . . . . 1.33 110.049 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.517 ' CG1' HD12 ' A' ' 36' ' ' LEU . 19.4 m -123.67 152.55 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 1.08 109.858 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.53 HG23 ' CD ' ' A' ' 17' ' ' ARG . 30.8 t -111.76 134.06 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.13 -0.981 . . . . 1.07 110.638 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.48 HG22 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.66 132.83 50.69 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 1.99 109.392 173.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.527 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.7 Cg_endo -57.59 141.23 95.25 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.732 1.385 . . . . 0.4 109.918 177.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.513 HD12 HG21 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.82 -31.71 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.991 -1.068 . . . . 1.78 110.262 -177.345 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.03 -37.19 71.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.022 -1.049 . . . . 2.37 109.649 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.527 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 53.6 mt -80.1 -29.39 39.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.437 -0.789 . . . . 2.36 110.438 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.52 ' NH2' HD13 ' A' ' 15' ' ' LEU . 75.7 mtt180 -56.75 -43.6 80.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.901 -1.124 . . . . 0.33 109.109 175.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -72.72 -51.02 20.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 3.75 110.612 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 48.0 m -63.16 -31.76 72.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -0.869 . . . . 1.38 110.944 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.527 ' CD2' HG13 ' B' ' 30' ' ' ILE . 26.6 tp -87.04 -5.34 59.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.102 -0.999 . . . . 1.61 110.681 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.67 42.74 97.11 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.539 -1.424 . . . . 0.34 109.539 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.527 HG13 ' CD2' ' B' ' 28' ' ' LEU . 29.3 mm -116.02 138.78 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -1.162 . . . . 1.13 110.747 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.18 167.22 22.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.61 -0.681 . . . . 1.07 109.907 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.6 146.42 13.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.942 . . . . 1.13 110.515 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 77.1 tttt 74.99 -4.9 2.27 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.662 -0.648 . . . . 2.39 111.205 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 88.7 m-20 -77.34 165.89 23.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.866 -1.146 . . . . 1.1 110.065 174.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' B' ' 50' ' ' TYR . . . -104.64 132.51 50.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 1.13 110.926 -175.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.547 HD12 ' CG2' ' A' ' 12' ' ' VAL . 12.9 mt -109.46 143.4 39.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.449 -0.782 . . . . 1.35 109.622 175.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.461 ' HA ' HG21 ' A' ' 9' ' ' VAL . 85.3 tt0 -108.4 140.23 41.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.787 -1.195 . . . . 1.17 110.017 173.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 21.5 mm -111.03 133.16 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.315 -0.865 . . . . 1.48 110.549 -173.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.546 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 14.1 m-85 -115.28 159.23 21.28 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 116.308 -0.405 . . . . 1.08 109.956 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 81.4 t -130.24 129.21 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.862 -1.149 . . . . 1.05 110.612 173.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.492 ' CG ' ' CD1' ' B' ' 46' ' ' ILE . 9.8 p-10 -146.86 129.44 15.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 1.77 110.2 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 50.0 t0 46.29 50.13 12.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.012 -1.055 . . . . 1.21 110.959 175.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.4 mt-10 59.85 12.73 3.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.275 -0.891 . . . . 1.92 110.694 176.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 9.6 mtmt -113.13 150.76 31.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 2.49 109.703 175.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.456 HG23 ' CD1' ' B' ' 47' ' ' LEU . 62.3 mt -101.77 128.82 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.01 . . . . 1.85 110.391 -176.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 29.9 mt -112.3 121.41 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.38 -0.825 . . . . 1.22 110.099 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.581 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.4 mp -114.42 134.96 54.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.006 -1.059 . . . . 2.23 110.173 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.532 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 10.8 pttp -141.42 165.19 28.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 2.17 110.222 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -58.18 147.42 30.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 2.25 109.984 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.639 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 6.0 t80 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 1.21 110.598 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.6 mt . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.09 0.471 . . . . 2.01 110.02 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.548 HG23 ' CZ ' ' B' ' 50' ' ' TYR . 88.8 t -115.8 143.92 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.089 -1.007 . . . . 1.08 110.806 -176.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.413 ' N ' HG13 ' A' ' 9' ' ' VAL . 53.4 ttt85 -128.27 159.3 35.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.381 -0.824 . . . . 2.25 109.613 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -84.21 148.08 26.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.041 -1.037 . . . . 2.66 110.317 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.538 ' CG2' HD12 ' B' ' 36' ' ' LEU . 4.3 t -82.96 130.0 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.301 -0.874 . . . . 1.09 109.885 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.47 -174.74 5.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.55 110.025 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.27 -39.5 72.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.009 -1.057 . . . . 2.19 111.739 -172.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.527 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 14.7 tp -85.73 -4.24 59.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.766 -1.209 . . . . 1.97 111.629 -173.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.464 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 79.95 46.45 7.72 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.173 -1.489 . . . . 0.22 109.687 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.554 ' CD ' ' CG2' ' B' ' 19' ' ' VAL . 73.7 mtm180 -116.34 154.98 29.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.055 -1.262 . . . . 1.33 109.945 -177.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.499 ' CG1' HD13 ' B' ' 36' ' ' LEU . 22.4 m -123.49 150.67 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 1.08 109.786 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.538 ' CG2' ' CD ' ' B' ' 17' ' ' ARG . 23.1 t -112.62 134.96 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 1.05 110.578 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.528 ' CD1' HD13 ' B' ' 45' ' ' ILE . 4.5 mm -84.49 134.42 42.6 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 2.03 109.658 176.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.529 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.9 Cg_endo -58.49 143.67 97.74 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.812 1.428 . . . . 0.4 110.089 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.52 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.02 -33.29 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.934 -1.104 . . . . 1.79 110.377 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.493 ' N ' HG21 ' A' ' 22' ' ' ILE . 84.4 tt0 -58.05 -35.72 71.73 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.107 -0.996 . . . . 2.37 109.808 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.529 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 52.3 mt -82.48 -29.95 30.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 2.3 110.591 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.52 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 71.9 mtt180 -57.6 -43.7 84.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.834 -1.166 . . . . 0.33 109.093 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -71.43 -49.44 41.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.568 -0.707 . . . . 3.74 110.724 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.1 m -63.32 -32.01 73.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.23 -0.919 . . . . 1.44 111.114 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.517 ' CD2' HG13 ' A' ' 30' ' ' ILE . 22.1 tp -87.78 -4.82 58.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.084 -1.01 . . . . 1.64 110.75 -177.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.75 42.76 96.99 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.731 -1.348 . . . . 0.34 109.731 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.517 HG13 ' CD2' ' A' ' 28' ' ' LEU . 32.4 mm -116.35 138.91 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -1.183 . . . . 1.16 110.794 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -141.16 167.04 23.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.589 -0.694 . . . . 1.08 109.982 -178.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.37 146.48 12.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.082 -1.011 . . . . 1.13 110.541 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 75.2 tttt 74.46 -4.64 2.28 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.702 -0.623 . . . . 2.33 111.137 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.455 ' O ' HG22 ' B' ' 12' ' ' VAL . 89.6 m-20 -77.41 165.95 23.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.73 -1.231 . . . . 1.1 110.051 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.08 130.69 51.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.2 -0.938 . . . . 1.17 110.715 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.504 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 12.1 mt -107.89 142.21 38.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.375 -0.828 . . . . 1.21 109.367 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.458 ' HA ' HG21 ' B' ' 9' ' ' VAL . 84.8 tt0 -106.25 137.96 43.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.791 -1.193 . . . . 1.17 109.787 173.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.39 132.56 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.522 -0.736 . . . . 1.45 110.44 -174.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.549 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 16.2 m-85 -115.03 158.04 22.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 122.061 -0.399 . . . . 1.05 110.11 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.2 t -129.8 123.97 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.935 -1.103 . . . . 1.08 110.739 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 9.2 p-10 -147.17 139.03 24.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 1.77 110.263 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.3 t0 43.68 47.22 6.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.021 -1.049 . . . . 1.22 111.159 174.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 44.3 tp10 62.4 10.33 3.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.148 -0.97 . . . . 1.93 110.723 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -115.66 148.33 39.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.91 . . . . 2.48 109.995 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.529 HD13 ' CD1' ' B' ' 20' ' ' ILE . 58.5 mt -99.6 129.09 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 1.86 110.103 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.0 mt -109.21 115.84 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.378 -0.826 . . . . 1.24 110.141 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.2 mp -108.75 133.49 52.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.062 -1.024 . . . . 2.25 109.987 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.545 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 13.2 pttp -143.64 165.73 26.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.452 -0.78 . . . . 2.26 110.357 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -56.43 146.99 22.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 2.12 109.937 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.4 t80 . . . . . 0 C--N 1.298 -1.634 0 O-C-N 121.362 -0.836 . . . . 0.96 110.661 -175.733 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.504 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 89.9 t . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.541 0.686 . . . . 1.11 110.76 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.418 ' N ' HG11 ' B' ' 9' ' ' VAL . 53.4 ttt85 -128.28 159.09 36.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.494 -0.754 . . . . 2.26 109.768 177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -84.03 148.03 27.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.042 -1.037 . . . . 2.65 110.403 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.486 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 4.3 t -82.91 130.1 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.33 -0.856 . . . . 1.06 109.804 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.69 -174.47 5.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 0.55 110.152 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . 0.461 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.9 mt-10 -56.5 -39.45 73.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.086 -1.009 . . . . 2.19 111.646 -172.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.517 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.2 tp -85.79 -4.18 59.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.799 -1.188 . . . . 1.99 111.595 -173.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.486 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.56 47.19 7.48 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.514 -1.434 . . . . 0.23 109.514 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.538 ' CD ' ' CG2' ' A' ' 19' ' ' VAL . 73.5 mtm180 -116.46 154.98 29.38 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.039 -1.271 . . . . 1.33 109.982 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.526 HG23 ' CD2' ' A' ' 47' ' ' LEU . 22.4 m -123.54 150.59 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 1.08 109.804 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.554 ' CG2' ' CD ' ' A' ' 17' ' ' ARG . 23.0 t -112.64 134.98 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 1.07 110.505 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.529 ' CD1' HD13 ' A' ' 45' ' ' ILE . 4.5 mm -84.62 134.43 42.26 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 1.99 109.625 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.529 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.9 Cg_endo -58.67 143.69 98.41 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.811 1.427 . . . . 0.4 110.106 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.536 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.2 tp -55.16 -33.08 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.11 -0.993 . . . . 1.78 110.364 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.88 -36.35 72.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.09 -1.006 . . . . 2.37 109.744 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.529 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 52.5 mt -81.74 -30.37 32.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.443 -0.785 . . . . 2.36 110.686 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.536 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 71.2 mtt180 -57.43 -43.59 83.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.877 -1.14 . . . . 0.33 109.087 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -71.25 -49.77 39.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.39 -0.819 . . . . 3.75 110.666 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 51.0 m -63.04 -32.49 73.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.292 -0.88 . . . . 1.38 110.946 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.526 ' CD2' HG13 ' B' ' 30' ' ' ILE . 22.3 tp -87.34 -5.2 58.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 1.61 110.68 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.05 42.65 96.57 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.538 -1.425 . . . . 0.34 109.538 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.526 HG13 ' CD2' ' B' ' 28' ' ' LEU . 31.9 mm -116.27 138.87 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -1.181 . . . . 1.13 110.766 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -140.91 167.09 23.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.498 -0.751 . . . . 1.07 109.968 -178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.43 146.48 12.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 1.13 110.555 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 75.0 tttt 74.63 -4.76 2.27 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.648 -0.657 . . . . 2.39 111.166 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 90.2 m-20 -77.49 165.64 24.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.792 -1.193 . . . . 1.1 110.042 174.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.92 130.65 51.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 1.13 110.836 -176.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.538 HD12 ' CG2' ' A' ' 12' ' ' VAL . 12.0 mt -107.84 142.1 38.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 1.35 109.485 175.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.458 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.7 tt0 -106.08 137.84 43.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.87 -1.144 . . . . 1.17 109.911 173.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 71.0 mt -111.25 132.61 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.388 -0.82 . . . . 1.48 110.383 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.554 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 15.9 m-85 -115.06 157.92 22.85 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 120.896 0.379 . . . . 1.08 110.122 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 94.1 t -129.53 124.3 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.937 -1.102 . . . . 1.05 110.55 173.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.471 ' OD2' HD12 ' B' ' 46' ' ' ILE . 9.4 p-10 -147.66 138.88 23.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.875 . . . . 1.77 110.208 177.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.9 t0 43.99 47.18 7.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.165 -0.959 . . . . 1.21 111.136 174.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 44.2 tp10 62.21 10.36 3.74 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.234 -0.916 . . . . 1.92 110.725 175.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -115.57 148.6 39.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 2.49 109.928 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.528 HD13 ' CD1' ' A' ' 20' ' ' ILE . 58.2 mt -99.76 129.16 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 1.85 110.096 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 21.7 mt -109.39 115.8 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.472 -0.767 . . . . 1.22 110.136 177.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.3 mp -108.55 133.4 52.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.028 -1.045 . . . . 2.23 109.934 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.55 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 13.5 pttp -143.65 165.96 26.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.447 -0.783 . . . . 2.17 110.294 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -56.48 146.94 23.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.95 . . . . 2.25 109.92 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.548 ' CZ ' HG23 ' A' ' 9' ' ' VAL . 6.5 t80 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 1.21 110.529 -175.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.0 mm . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 120.996 0.427 . . . . 2.01 109.947 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.632 ' CG1' ' CD2' ' B' ' 50' ' ' TYR . 87.1 t -116.13 143.91 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.101 -0.999 . . . . 1.08 110.842 -175.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.417 ' N ' HG12 ' A' ' 9' ' ' VAL . 17.4 tpt180 -128.07 157.11 41.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.472 -0.767 . . . . 2.25 109.789 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.413 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 26.0 ttpt -83.14 144.97 29.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.141 -0.974 . . . . 2.66 110.35 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.536 ' CG2' HD13 ' B' ' 36' ' ' LEU . 4.0 t -80.55 128.68 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.337 -0.852 . . . . 1.09 109.762 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.474 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.53 -175.01 5.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.55 110.021 179.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.52 -40.56 68.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.097 -1.002 . . . . 2.19 111.728 -173.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.531 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.8 tp -85.32 -4.18 59.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.798 -1.189 . . . . 1.97 111.611 -173.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.51 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.29 46.18 7.67 Favored Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.133 -1.508 . . . . 0.22 109.68 -177.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.56 ' CD ' ' CG2' ' B' ' 19' ' ' VAL . 73.1 mtm180 -116.15 154.72 29.51 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.012 -1.287 . . . . 1.33 109.818 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.525 ' CG1' HD11 ' B' ' 36' ' ' LEU . 22.5 m -124.49 152.35 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 1.08 110.001 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.548 ' CG2' ' CD ' ' B' ' 17' ' ' ARG . 21.5 t -113.71 133.95 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 1.05 110.571 -175.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.477 HG22 ' HB2' ' A' ' 24' ' ' LEU . 2.5 mm -85.04 138.09 37.21 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.227 -0.921 . . . . 2.03 109.636 175.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.7 Cg_endo -59.68 142.94 99.62 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.71 1.374 . . . . 0.4 109.972 176.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.519 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.22 -32.39 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.962 -1.086 . . . . 1.79 110.478 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.454 ' N ' HG21 ' A' ' 22' ' ' ILE . 48.6 tp10 -58.14 -35.67 71.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.147 -0.971 . . . . 2.37 109.915 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.531 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 63.2 mt -82.21 -30.35 30.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 2.3 110.614 178.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.519 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 74.2 mtt180 -57.77 -43.86 85.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.926 -1.109 . . . . 0.33 109.113 176.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -72.97 -48.48 36.26 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.848 -0.741 . . . . 3.74 110.723 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.6 m -63.72 -31.57 72.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 1.44 111.135 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.413 ' CD2' HG13 ' A' ' 30' ' ' ILE . 19.2 tp -87.94 -4.53 58.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.026 -1.046 . . . . 1.64 110.795 -177.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.09 40.87 95.24 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.714 -1.354 . . . . 0.34 109.714 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 30' ' ' ILE . 36.5 mm -116.54 139.03 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -1.123 . . . . 1.16 110.632 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.0 166.76 23.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.623 -0.673 . . . . 1.08 109.978 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.58 146.54 12.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.102 -0.999 . . . . 1.13 110.534 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 19.9 tttt 74.96 -4.95 2.26 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.733 -0.605 . . . . 2.33 111.12 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.464 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.9 m-20 -78.18 165.81 23.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.902 -1.124 . . . . 1.1 110.054 174.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 50' ' ' TYR . . . -104.61 131.01 52.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 1.17 110.726 -176.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.502 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 13.5 mt -107.87 142.66 37.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.825 . . . . 1.21 109.458 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.449 ' HA ' HG21 ' B' ' 9' ' ' VAL . 84.8 tt0 -106.58 138.88 41.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.805 -1.184 . . . . 1.17 109.685 172.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 68.4 mt -111.37 133.39 57.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.393 -0.817 . . . . 1.45 110.561 -173.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.543 ' OH ' ' CE ' ' A' ' 48' ' ' LYS . 14.9 m-85 -114.81 157.94 22.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.99 -0.374 . . . . 1.05 109.99 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.1 t -130.7 120.43 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.942 -1.098 . . . . 1.08 110.664 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.484 ' CG ' ' CD1' ' A' ' 46' ' ' ILE . 5.9 p-10 -147.35 155.14 41.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 1.77 110.189 177.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 54.0 t0 42.38 41.75 2.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.06 -1.025 . . . . 1.22 111.345 172.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 46.5 tp10 60.81 12.34 3.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.031 -1.043 . . . . 1.93 110.778 174.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 19.3 pttt -128.77 161.29 30.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.114 -0.992 . . . . 2.48 109.848 174.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.529 ' CD1' HD11 ' B' ' 20' ' ' ILE . 56.5 mt -104.04 134.99 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.055 -1.028 . . . . 1.86 110.717 -172.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 25.1 mt -111.33 121.36 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.46 -0.775 . . . . 1.24 110.272 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.4 mp -112.06 133.84 53.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.986 -1.071 . . . . 2.25 110.117 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.543 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 14.0 pttp -141.6 166.08 25.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.45 -0.781 . . . . 2.26 110.359 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -55.94 147.73 18.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.196 -0.94 . . . . 2.12 110.077 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.483 ' CD2' HG13 ' B' ' 9' ' ' VAL . 4.4 t80 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.833 . . . . 0.96 110.73 -175.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 87.1 t . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.527 0.68 . . . . 1.11 110.736 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.416 ' N ' HG11 ' B' ' 9' ' ' VAL . 17.4 tpt180 -128.12 156.82 42.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.743 . . . . 2.26 109.892 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.409 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 26.1 ttpt -82.93 144.85 29.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.102 -0.999 . . . . 2.65 110.414 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.526 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 4.0 t -80.56 128.88 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.367 -0.833 . . . . 1.06 109.642 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -83.79 -174.9 5.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.045 -1.035 . . . . 0.55 110.177 179.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . 0.422 ' HA ' ' CD ' ' A' ' 32' ' ' GLU . 84.6 tt0 -54.65 -40.48 69.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.191 -0.943 . . . . 2.19 111.648 -173.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.52 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 15.4 tp -85.34 -4.22 59.09 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.755 -1.215 . . . . 1.99 111.647 -172.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.526 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.97 46.86 7.45 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.54 -1.424 . . . . 0.23 109.54 -177.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.548 ' CD ' ' CG2' ' A' ' 19' ' ' VAL . 72.6 mtm180 -116.33 154.69 29.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.153 -1.204 . . . . 1.33 109.831 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.453 ' CG1' HD12 ' A' ' 36' ' ' LEU . 22.6 m -124.48 152.33 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.92 . . . . 1.08 110.004 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.56 ' CG2' ' CD ' ' A' ' 17' ' ' ARG . 21.6 t -113.72 133.96 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 1.07 110.542 -175.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.529 HD11 ' CD1' ' A' ' 45' ' ' ILE . 2.5 mm -85.11 138.1 37.04 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.219 -0.925 . . . . 1.99 109.593 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.7 Cg_endo -59.78 142.91 99.54 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.755 1.397 . . . . 0.4 110.043 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.531 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -55.28 -32.25 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.027 -1.046 . . . . 1.78 110.44 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . 0.467 ' N ' HG21 ' B' ' 22' ' ' ILE . 48.5 tp10 -57.99 -36.27 72.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.091 -1.006 . . . . 2.37 109.811 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.526 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 63.2 mt -81.62 -30.76 32.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.401 -0.812 . . . . 2.36 110.601 178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.531 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 73.8 mtt180 -57.54 -43.68 84.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.875 -1.141 . . . . 0.33 109.207 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -72.96 -48.71 34.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.898 . . . . 3.75 110.61 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 52.0 m -63.45 -32.22 73.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.282 -0.886 . . . . 1.38 110.895 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.408 ' CD2' HG13 ' B' ' 30' ' ' ILE . 19.4 tp -87.5 -4.79 58.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 1.61 110.711 -176.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.56 40.64 94.25 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.588 -1.405 . . . . 0.34 109.588 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.408 HG13 ' CD2' ' B' ' 28' ' ' LEU . 36.2 mm -116.52 138.9 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -1.13 . . . . 1.13 110.634 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.73 166.87 23.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.598 -0.689 . . . . 1.07 109.991 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.4 tt0 -53.6 146.72 12.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 1.13 110.421 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 19.8 tttt 75.03 -5.16 2.22 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.622 -0.674 . . . . 2.39 111.123 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 90.6 m-20 -78.19 165.66 23.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.816 -1.178 . . . . 1.1 110.03 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' B' ' 50' ' ' TYR . . . -104.55 130.92 52.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 1.13 110.776 -176.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.536 HD13 ' CG2' ' A' ' 12' ' ' VAL . 13.3 mt -107.9 142.52 37.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.386 -0.821 . . . . 1.35 109.494 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.472 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.7 tt0 -106.42 138.91 41.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.841 -1.162 . . . . 1.17 109.832 172.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 68.5 mt -111.42 133.41 57.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.289 -0.882 . . . . 1.48 110.469 -173.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.544 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 14.4 m-85 -114.77 157.86 22.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 122.096 -0.377 . . . . 1.08 110.07 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 93.7 t -130.42 120.84 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.899 -1.126 . . . . 1.05 110.464 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.489 ' CG ' ' CD1' ' B' ' 46' ' ' ILE . 6.0 p-10 -147.91 155.19 41.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 1.77 110.157 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 54.5 t0 42.19 41.99 2.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.115 -0.991 . . . . 1.21 111.375 173.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 46.3 tp10 60.75 12.3 3.66 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.088 -1.008 . . . . 1.92 110.7 174.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 19.1 pttt -128.78 161.54 29.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.009 . . . . 2.49 109.775 174.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 20' ' ' ILE . 56.8 mt -104.16 135.03 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.061 -1.024 . . . . 1.85 110.665 -172.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 25.8 mt -111.6 121.32 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.455 -0.778 . . . . 1.22 110.181 176.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.5 mp -111.89 133.76 53.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.03 -1.044 . . . . 2.23 110.075 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.536 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 14.2 pttp -141.61 166.36 24.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.429 -0.794 . . . . 2.17 110.27 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -56.09 147.72 19.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 2.25 109.974 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.632 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 4.5 t80 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 1.21 110.646 -175.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.9 mt . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.021 0.439 . . . . 2.01 109.983 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 99.0 t -114.29 144.58 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.025 -1.047 . . . . 1.08 110.915 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.441 ' N ' HG13 ' A' ' 9' ' ' VAL . 71.2 ttt-85 -129.75 160.79 32.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.458 -0.776 . . . . 2.25 109.753 177.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -85.05 148.09 26.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.036 -1.04 . . . . 2.66 110.311 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.546 ' CG2' HD13 ' B' ' 36' ' ' LEU . 6.5 t -81.49 129.73 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.317 -0.865 . . . . 1.09 109.821 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.29 -175.09 5.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.124 -0.985 . . . . 0.55 109.941 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.07 -39.31 71.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 2.19 111.723 -172.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.532 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 14.4 tp -86.01 -5.03 59.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.803 -1.186 . . . . 1.97 111.5 -173.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.492 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.14 46.52 7.56 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.144 -1.503 . . . . 0.22 109.699 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.544 ' CD ' ' CG2' ' B' ' 19' ' ' VAL . 73.8 mtm180 -115.6 154.85 28.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.005 -1.291 . . . . 1.33 110.036 -177.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.509 HG23 ' CD2' ' B' ' 47' ' ' LEU . 24.8 m -124.3 151.72 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 1.08 109.855 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.528 ' CG2' ' CD ' ' B' ' 17' ' ' ARG . 21.2 t -113.22 135.18 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 1.05 110.601 -175.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.496 HG22 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.34 135.12 44.42 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 2.03 109.532 175.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.532 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -58.64 143.34 98.6 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.734 1.386 . . . . 0.4 110.046 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.526 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.1 tp -55.08 -33.32 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.082 -1.012 . . . . 1.79 110.429 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.2 -35.34 71.48 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.17 -0.956 . . . . 2.37 109.893 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.532 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 50.0 mt -82.35 -29.97 30.66 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.35 -0.844 . . . . 2.3 110.65 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.526 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 71.4 mtt180 -57.74 -44.15 85.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.939 -1.1 . . . . 0.33 109.087 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -72.63 -47.81 44.63 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.818 -0.753 . . . . 3.74 110.756 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.1 m -63.68 -31.87 73.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 1.44 111.093 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.518 ' CD2' HG13 ' A' ' 30' ' ' ILE . 20.8 tp -87.69 -4.6 58.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.1 -1.0 . . . . 1.64 110.669 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.436 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.25 41.47 96.77 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.637 -1.385 . . . . 0.34 109.637 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.518 HG13 ' CD2' ' A' ' 28' ' ' LEU . 30.1 mm -116.4 139.75 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -1.144 . . . . 1.16 110.654 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.91 167.19 22.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.567 -0.708 . . . . 1.08 110.025 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.51 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.26 146.79 11.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.058 -1.026 . . . . 1.13 110.54 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 12.9 tttp 74.22 -4.58 2.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.743 -0.598 . . . . 2.33 111.273 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -77.01 166.63 23.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.751 -1.218 . . . . 1.1 109.973 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -103.29 131.6 50.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 1.17 110.757 -175.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.498 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 13.0 mt -108.76 144.3 36.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.342 -0.849 . . . . 1.21 109.307 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.461 ' HG3' HG21 ' B' ' 9' ' ' VAL . 86.6 tt0 -108.37 138.34 44.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.856 -1.152 . . . . 1.17 109.646 173.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.5 mt -107.87 131.31 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.489 -0.757 . . . . 1.45 110.415 -173.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.559 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 21.4 m-85 -118.85 156.79 28.84 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 120.927 0.394 . . . . 1.05 109.963 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.2 t -130.82 126.68 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.848 -1.158 . . . . 1.08 110.642 173.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 41.9 p-10 -147.23 142.23 27.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 1.77 110.607 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 52.3 t0 43.37 45.14 5.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.09 -1.006 . . . . 1.22 111.271 174.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 83.7 tt0 60.81 11.88 3.47 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.104 -0.997 . . . . 1.93 110.608 175.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 54.1 mtmt -114.4 153.92 29.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 2.48 109.628 175.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 47' ' ' LEU . 67.8 mt -94.54 129.95 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.153 -0.967 . . . . 1.86 110.138 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.559 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 24.6 mm -113.15 121.79 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.659 -0.651 . . . . 1.24 109.877 178.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.0 mp -122.55 134.53 54.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.895 -1.128 . . . . 2.25 110.262 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.538 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 14.0 pttp -141.73 162.68 34.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 2.26 110.435 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.4 tttt -58.82 146.89 35.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 2.12 110.011 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 10.3 t80 . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.96 110.586 -176.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.498 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 98.5 t . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.583 0.706 . . . . 1.11 110.898 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.447 ' N ' HG12 ' B' ' 9' ' ' VAL . 71.4 ttt-85 -129.75 160.72 32.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.483 -0.76 . . . . 2.26 109.707 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -85.16 148.02 26.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.962 -1.086 . . . . 2.65 110.331 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.496 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 6.6 t -81.47 129.85 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.369 -0.832 . . . . 1.06 109.734 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.48 -174.83 5.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.148 -0.97 . . . . 0.55 110.136 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . 0.456 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.8 mt-10 -56.28 -39.28 72.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.057 . . . . 2.19 111.569 -172.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.521 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.0 tp -86.05 -4.98 59.29 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.715 -1.241 . . . . 1.99 111.52 -173.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.496 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.63 47.31 7.37 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.592 -1.403 . . . . 0.23 109.592 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.528 ' CD ' ' CG2' ' A' ' 19' ' ' VAL . 73.8 mtm180 -115.79 154.87 28.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.1 -1.235 . . . . 1.33 110.155 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.453 HG23 ' CD2' ' A' ' 47' ' ' LEU . 24.9 m -124.43 151.65 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 1.08 109.814 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.544 ' CG2' ' CD ' ' A' ' 17' ' ' ARG . 21.2 t -113.17 135.17 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 1.07 110.644 -175.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.464 ' CD1' ' N ' ' B' ' 20' ' ' ILE . 1.7 mp -83.33 135.0 44.56 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 1.99 109.588 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.0 Cg_endo -58.71 143.37 98.82 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.749 1.394 . . . . 0.4 110.169 177.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.534 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -55.08 -33.3 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.086 -1.009 . . . . 1.78 110.372 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.97 -36.15 72.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.023 -1.048 . . . . 2.37 109.708 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.526 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 50.4 mt -81.49 -30.42 33.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.519 -0.738 . . . . 2.36 110.668 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.534 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 70.8 mtt180 -57.44 -44.1 84.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.834 -1.166 . . . . 0.33 109.098 176.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -72.56 -48.1 42.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.431 -0.793 . . . . 3.75 110.645 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.5 m -63.36 -32.55 74.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.288 -0.883 . . . . 1.38 110.857 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.518 ' CD2' HG13 ' B' ' 30' ' ' ILE . 20.9 tp -87.09 -5.0 59.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.052 -1.03 . . . . 1.61 110.678 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.57 41.33 96.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.564 -1.414 . . . . 0.34 109.564 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.518 HG13 ' CD2' ' B' ' 28' ' ' LEU . 30.0 mm -116.33 139.57 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -1.182 . . . . 1.13 110.717 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.58 167.3 22.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.471 -0.768 . . . . 1.07 110.057 -177.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.515 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.12 146.74 10.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 1.13 110.572 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 12.9 tttp 74.4 -4.89 2.21 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.657 -0.652 . . . . 2.39 111.198 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 88.2 m-20 -76.98 166.35 23.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.819 -1.176 . . . . 1.1 110.039 174.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' B' ' 50' ' ' TYR . . . -103.04 131.53 49.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 1.13 110.877 -175.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.546 HD13 ' CG2' ' A' ' 12' ' ' VAL . 12.9 mt -108.84 144.11 37.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.428 -0.795 . . . . 1.35 109.362 174.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.462 ' HA ' HG21 ' A' ' 9' ' ' VAL . 86.4 tt0 -108.06 138.34 44.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.854 -1.154 . . . . 1.17 109.847 172.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -107.87 131.37 58.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.405 -0.809 . . . . 1.48 110.354 -173.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.561 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 21.1 m-85 -118.9 156.86 28.77 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.885 -0.413 . . . . 1.08 109.885 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 74.8 t -130.71 127.08 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.854 -1.154 . . . . 1.05 110.471 173.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.479 ' OD1' ' O ' ' B' ' 41' ' ' ASP . 41.9 p-10 -147.69 142.22 26.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.883 . . . . 1.77 110.525 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.0 t0 43.32 45.46 5.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.087 -1.008 . . . . 1.21 111.217 174.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.5 tt0 60.44 12.05 3.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.081 -1.012 . . . . 1.92 110.611 175.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 54.1 mtmt -114.41 154.01 28.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.162 -0.961 . . . . 2.49 109.633 175.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.455 HG21 ' CD1' ' B' ' 47' ' ' LEU . 67.3 mt -94.51 129.72 44.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.108 -0.995 . . . . 1.85 110.227 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 24.6 mm -113.28 121.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.681 -0.637 . . . . 1.22 109.823 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.1 mp -122.44 134.46 54.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.892 -1.13 . . . . 2.23 110.271 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.532 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 14.1 pttp -141.62 162.84 34.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 2.17 110.435 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 43.2 tttt -58.81 146.72 36.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 2.25 110.015 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.475 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 10.5 t80 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 1.21 110.575 -176.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.0 mt . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.083 0.468 . . . . 2.01 109.982 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.598 ' CG1' ' CD2' ' B' ' 50' ' ' TYR . 98.2 t -114.03 144.29 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.048 -1.032 . . . . 1.08 110.871 -176.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.441 ' N ' HG13 ' A' ' 9' ' ' VAL . 28.9 tpt180 -130.03 158.62 39.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.513 -0.742 . . . . 2.25 109.727 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.432 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 66.4 mmtt -85.44 148.18 26.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.006 . . . . 2.66 110.258 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.542 ' CG2' HD13 ' B' ' 36' ' ' LEU . 3.7 t -81.65 128.83 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.274 -0.891 . . . . 1.09 109.778 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.45 -175.09 5.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.087 -1.008 . . . . 0.55 110.061 -179.698 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -54.24 -41.13 68.4 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.114 -0.991 . . . . 2.19 111.7 -173.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.532 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.7 tp -84.83 -5.31 59.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.656 -1.278 . . . . 1.97 111.59 -173.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.508 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.26 46.45 7.53 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.136 -1.507 . . . . 0.22 109.716 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.537 ' CD ' ' CG2' ' B' ' 19' ' ' VAL . 70.2 mtm180 -114.77 153.94 29.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.093 -1.239 . . . . 1.33 110.031 -177.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.514 HG22 ' CD2' ' B' ' 47' ' ' LEU . 22.1 m -123.91 152.21 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 1.08 109.83 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.523 HG21 ' CD ' ' B' ' 17' ' ' ARG . 21.3 t -112.93 133.97 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.947 . . . . 1.05 110.742 -175.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.493 ' CD1' HD13 ' B' ' 45' ' ' ILE . 2.4 mm -84.22 133.04 45.92 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.175 -0.953 . . . . 2.03 109.446 174.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.535 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.8 Cg_endo -57.63 141.39 95.37 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.646 1.34 . . . . 0.4 109.957 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.53 ' HA ' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -55.81 -32.37 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.008 -1.058 . . . . 1.79 110.301 -177.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.27 -36.35 70.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.018 -1.051 . . . . 2.37 109.747 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.535 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 43.4 mt -80.87 -29.22 35.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 2.3 110.449 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.53 ' CD ' ' HA ' ' A' ' 22' ' ' ILE . 73.7 mtt180 -56.79 -44.03 81.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.864 -1.148 . . . . 0.33 108.97 175.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HG2' HD13 ' A' ' 22' ' ' ILE . 42.6 mmt180 -72.49 -47.68 46.69 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.826 -0.749 . . . . 3.74 110.726 -177.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.9 m -63.19 -32.45 73.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.202 -0.937 . . . . 1.44 111.061 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.4 HD21 HG13 ' A' ' 30' ' ' ILE . 20.5 tp -88.56 -4.62 58.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.07 -1.019 . . . . 1.64 110.801 -177.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.98 41.82 95.08 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.732 -1.347 . . . . 0.34 109.732 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.4 HG13 HD21 ' A' ' 28' ' ' LEU . 32.7 mm -116.52 139.49 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.27 -1.135 . . . . 1.16 110.744 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.72 166.46 24.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.619 -0.675 . . . . 1.08 110.006 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.73 146.51 13.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.027 -1.045 . . . . 1.13 110.511 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.513 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 40.3 tttp 74.59 -4.56 2.31 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.684 -0.635 . . . . 2.33 111.114 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.461 ' O ' HG22 ' B' ' 12' ' ' VAL . 88.9 m-20 -76.87 165.87 24.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.782 -1.199 . . . . 1.1 109.966 174.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -104.72 131.19 52.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 1.17 110.771 -176.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.49 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 13.0 mt -108.66 144.1 36.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.33 -0.856 . . . . 1.21 109.341 174.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.463 ' HG3' HG21 ' B' ' 9' ' ' VAL . 85.8 tt0 -106.59 139.02 41.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.744 -1.223 . . . . 1.17 109.491 172.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.49 131.27 59.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.423 -0.798 . . . . 1.45 110.504 -172.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 16.7 m-85 -117.67 157.46 26.41 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 116.263 -0.426 . . . . 1.05 109.915 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.2 t -131.78 120.09 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.903 -1.123 . . . . 1.08 110.617 172.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.481 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 46.7 p-10 -148.32 161.93 40.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.274 -0.891 . . . . 1.77 110.586 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 54.0 t0 42.25 40.57 1.81 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.002 -1.061 . . . . 1.22 111.446 172.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 96.1 mt-10 56.53 16.18 2.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.941 -1.099 . . . . 1.93 110.556 175.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.484 ' CE ' HD13 ' A' ' 46' ' ' ILE . 11.3 pttt -128.98 165.48 21.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 2.48 109.734 174.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.474 ' CD1' ' CD1' ' B' ' 20' ' ' ILE . 67.7 mt -96.71 133.85 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.178 -0.951 . . . . 1.86 110.395 -175.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 23.5 mm -113.46 120.09 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.747 -0.596 . . . . 1.24 109.927 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.577 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.0 mp -118.52 134.34 55.16 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.888 -1.133 . . . . 2.25 110.136 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.538 ' HE2' ' CE1' ' A' ' 39' ' ' TYR . 22.8 pttt -140.52 162.49 35.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.357 -0.839 . . . . 2.26 110.492 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -57.59 147.96 25.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.001 . . . . 2.12 109.902 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.474 ' CD2' HG13 ' B' ' 9' ' ' VAL . 3.5 t80 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.96 110.466 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 98.5 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.526 0.679 . . . . 1.11 110.87 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 29.0 tpt180 -129.96 158.53 39.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.504 -0.747 . . . . 2.26 109.767 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.436 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 66.4 mmtt -85.49 148.09 26.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 2.65 110.319 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.526 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 3.7 t -81.59 128.85 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 1.06 109.79 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.454 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.66 -174.99 5.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.157 -0.964 . . . . 0.55 110.197 -179.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.36 -40.99 68.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.104 -0.997 . . . . 2.19 111.597 -172.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.527 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 15.4 tp -84.82 -5.47 59.33 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.743 -1.223 . . . . 1.99 111.583 -173.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.526 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.93 47.25 7.24 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.529 -1.428 . . . . 0.23 109.529 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.527 ' HD3' ' CD2' ' B' ' 15' ' ' LEU . 70.0 mtm180 -114.99 153.89 29.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.089 -1.242 . . . . 1.33 109.98 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.499 HG23 ' CD2' ' A' ' 47' ' ' LEU . 22.3 m -123.88 152.2 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 1.08 109.807 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.537 ' CG2' ' CD ' ' A' ' 17' ' ' ARG . 21.3 t -112.95 134.04 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.137 -0.977 . . . . 1.07 110.598 -175.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.474 ' CD1' ' CD1' ' A' ' 45' ' ' ILE . 2.5 mm -84.33 133.0 45.72 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 1.99 109.41 174.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.527 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.7 Cg_endo -57.58 141.4 95.26 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.763 1.402 . . . . 0.4 109.963 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.525 HG22 HD11 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -56.04 -32.08 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.994 -1.066 . . . . 1.78 110.316 -177.217 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.19 -37.01 71.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.034 -1.041 . . . . 2.37 109.667 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.527 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 43.4 mt -80.08 -29.6 39.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.516 -0.74 . . . . 2.36 110.48 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.524 ' CD ' ' HA ' ' B' ' 22' ' ' ILE . 73.4 mtt180 -56.67 -43.81 80.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.966 -1.084 . . . . 0.33 109.076 175.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.455 ' HG2' HD13 ' B' ' 22' ' ' ILE . 42.5 mmt180 -72.51 -47.99 44.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 3.75 110.591 -178.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.2 m -62.88 -32.9 74.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.183 -0.948 . . . . 1.38 110.875 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.424 HD22 HG13 ' B' ' 30' ' ' ILE . 20.6 tp -88.16 -5.0 58.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.032 -1.043 . . . . 1.61 110.736 -176.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.41 41.46 94.38 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.656 -1.378 . . . . 0.34 109.656 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.424 HG13 HD22 ' B' ' 28' ' ' LEU . 32.2 mm -116.48 139.36 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -1.153 . . . . 1.13 110.728 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.43 166.6 24.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.632 -0.668 . . . . 1.07 109.985 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.521 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.62 146.45 13.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.102 -0.999 . . . . 1.13 110.55 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 40.3 tttp 74.67 -4.73 2.28 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.579 -0.701 . . . . 2.39 111.194 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 89.0 m-20 -76.93 165.59 24.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.805 -1.184 . . . . 1.1 110.023 174.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' B' ' 50' ' ' TYR . . . -104.53 131.17 52.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 1.13 110.834 -176.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.542 HD13 ' CG2' ' A' ' 12' ' ' VAL . 12.9 mt -108.68 143.71 37.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.37 -0.831 . . . . 1.35 109.481 174.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.475 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.5 tt0 -106.18 138.88 41.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.839 -1.163 . . . . 1.17 109.786 172.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.465 HD13 HG22 ' B' ' 38' ' ' ILE . 69.9 mt -108.4 131.34 59.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.348 -0.845 . . . . 1.48 110.494 -171.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.566 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 16.5 m-85 -117.67 157.45 26.44 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 116.257 -0.428 . . . . 1.08 109.904 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.433 HG22 HD12 ' A' ' 24' ' ' LEU . 75.0 t -131.69 120.51 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.868 -1.145 . . . . 1.05 110.436 172.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 46.6 p-10 -148.96 161.95 40.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.205 -0.934 . . . . 1.77 110.533 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 54.4 t0 42.02 41.0 1.8 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.185 -0.947 . . . . 1.21 111.461 172.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 96.1 mt-10 56.32 16.12 2.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.926 -1.109 . . . . 1.92 110.584 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 11.2 pttt -128.96 165.67 20.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 2.49 109.666 174.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.493 HD13 ' CD1' ' A' ' 20' ' ' ILE . 68.0 mt -96.82 133.83 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 1.85 110.363 -175.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 23.1 mm -113.53 120.17 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.739 -0.601 . . . . 1.22 109.865 177.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.577 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.1 mp -118.46 134.14 55.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.899 -1.125 . . . . 2.23 110.174 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.533 ' HE2' ' CE1' ' B' ' 39' ' ' TYR . 23.3 pttt -140.41 162.55 35.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 2.17 110.371 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -57.47 147.82 25.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.977 . . . . 2.25 109.871 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.598 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 3.6 t80 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.908 . . . . 1.21 110.551 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.7 mt . . . . . 0 N--CA 1.494 1.775 0 N-CA-C 109.636 -0.505 . . . . 2.01 109.636 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 98.5 t -113.51 143.75 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.911 -1.118 . . . . 1.08 111.348 -171.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.422 ' NE ' ' HB ' ' A' ' 19' ' ' VAL . 59.5 ttm-85 -123.82 161.17 25.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.539 -0.725 . . . . 2.25 109.621 176.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' B' ' 33' ' ' LYS . 82.1 tttt -82.54 145.01 29.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.138 -0.976 . . . . 2.66 110.563 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.525 ' CG2' HD12 ' B' ' 36' ' ' LEU . 4.1 t -82.97 129.38 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.412 -0.805 . . . . 1.09 109.881 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.11 -175.06 5.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.55 109.901 179.309 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.94 -39.28 74.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.991 -1.068 . . . . 2.19 111.61 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.529 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.2 tp -83.47 -6.23 59.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.755 -1.215 . . . . 1.97 111.542 -174.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.472 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 79.98 46.46 7.69 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.193 -1.479 . . . . 0.22 109.648 -177.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.529 ' HD3' ' CD2' ' A' ' 15' ' ' LEU . 68.4 mtm180 -114.12 156.15 24.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.076 -1.249 . . . . 1.33 110.019 -177.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.524 HG21 ' CD2' ' B' ' 47' ' ' LEU . 16.8 m -124.53 153.35 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 1.08 109.805 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.529 HG22 ' CD ' ' B' ' 17' ' ' ARG . 35.2 t -111.06 134.47 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 1.05 110.536 -176.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.506 HG21 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.39 133.38 50.32 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.314 -0.867 . . . . 2.03 109.433 174.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.535 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.1 Cg_endo -57.18 142.86 94.54 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.761 1.401 . . . . 0.4 110.018 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.526 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.28 -32.69 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.977 -1.077 . . . . 1.79 110.357 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.22 -35.93 72.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.096 -1.002 . . . . 2.37 109.839 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.535 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 48.7 mt -80.41 -31.4 37.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.818 . . . . 2.3 110.537 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.526 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 72.3 mtt180 -58.09 -43.38 87.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.883 -1.136 . . . . 0.33 109.243 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -73.57 -49.95 23.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.767 . . . . 3.74 110.804 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m -64.42 -30.97 72.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.24 -0.912 . . . . 1.44 111.16 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.52 ' CD2' HG13 ' A' ' 30' ' ' ILE . 19.7 tp -87.14 -4.64 59.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.02 -1.05 . . . . 1.64 110.656 -177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.403 ' O ' HD11 ' A' ' 30' ' ' ILE . . . 64.63 43.73 96.02 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.673 -1.371 . . . . 0.34 109.673 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.52 HG13 ' CD2' ' A' ' 28' ' ' LEU . 29.6 mm -114.74 138.07 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -1.152 . . . . 1.16 110.664 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -141.22 166.57 24.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.548 -0.72 . . . . 1.08 109.986 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.3 145.99 12.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.068 -1.02 . . . . 1.13 110.51 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 45.6 tttp 74.91 -4.7 2.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.653 -0.654 . . . . 2.33 111.084 177.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.466 ' O ' HG23 ' B' ' 12' ' ' VAL . 92.0 m-20 -78.04 167.73 20.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.812 -1.18 . . . . 1.1 110.018 174.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -105.98 131.74 52.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.166 -0.959 . . . . 1.17 110.762 -176.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.529 HD13 ' CG2' ' B' ' 12' ' ' VAL . 10.3 mt -106.75 141.36 38.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.392 -0.817 . . . . 1.21 109.319 175.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.462 ' OE1' ' HE3' ' A' ' 48' ' ' LYS . 85.6 tt0 -103.88 138.17 40.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.794 -1.191 . . . . 1.17 109.892 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 74.5 mt -112.25 133.11 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.54 -0.725 . . . . 1.45 110.575 -174.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.561 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 17.3 m-85 -115.17 158.32 22.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 122.045 -0.41 . . . . 1.05 110.076 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.3 t -129.44 124.29 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.016 -1.053 . . . . 1.08 110.707 173.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.465 ' OD2' HD13 ' A' ' 46' ' ' ILE . 9.1 p-10 -146.93 136.32 22.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 1.77 110.233 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 56.0 t0 44.05 49.84 7.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.017 -1.052 . . . . 1.22 111.071 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.3 mt-10 59.1 13.6 3.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.202 -0.936 . . . . 1.93 110.636 175.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -117.24 147.6 42.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 2.48 110.036 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 61.3 mt -99.65 129.16 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.148 -0.97 . . . . 1.86 110.183 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 23.3 mt -109.1 116.42 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.341 -0.849 . . . . 1.24 110.043 176.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.581 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.1 mp -111.05 134.76 52.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.029 -1.044 . . . . 2.25 110.113 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.538 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 14.0 pttp -142.66 163.14 33.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.5 -0.75 . . . . 2.26 110.347 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -58.05 147.12 30.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.114 -0.991 . . . . 2.12 109.93 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 14.6 t80 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.96 110.616 -176.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 98.7 t . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.572 0.701 . . . . 1.11 111.29 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.41 ' NE ' ' HB ' ' B' ' 19' ' ' VAL . 59.5 ttm-85 -123.76 160.98 26.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.579 -0.701 . . . . 2.26 109.776 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 33' ' ' LYS . 81.9 tttt -82.53 144.9 30.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.072 -1.017 . . . . 2.65 110.616 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.529 ' CG2' HD13 ' A' ' 36' ' ' LEU . 4.1 t -82.87 129.6 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.804 . . . . 1.06 109.78 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.36 -174.89 5.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.129 -0.982 . . . . 0.55 110.023 179.079 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . 0.456 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.8 mt-10 -56.96 -39.28 74.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.065 -1.022 . . . . 2.19 111.552 -172.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.528 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.6 tp -83.56 -6.26 59.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.767 -1.208 . . . . 1.99 111.568 -174.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.479 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.63 47.15 7.46 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.484 -1.447 . . . . 0.23 109.484 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.529 ' CD ' HG22 ' A' ' 19' ' ' VAL . 68.6 mtm180 -114.23 156.11 24.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.974 -1.309 . . . . 1.33 110.058 -177.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.515 HG21 ' CD2' ' A' ' 47' ' ' LEU . 16.6 m -124.5 153.34 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.431 -0.793 . . . . 1.08 109.846 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.523 HG21 ' CD ' ' A' ' 17' ' ' ARG . 35.4 t -111.06 134.5 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 1.07 110.527 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.476 HG22 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.31 133.33 50.65 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.329 -0.857 . . . . 1.99 109.493 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.533 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.3 Cg_endo -57.4 142.84 95.18 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.675 1.355 . . . . 0.4 110.036 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.534 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.4 tp -55.39 -32.53 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.062 -1.024 . . . . 1.78 110.343 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . 0.49 ' N ' HG23 ' B' ' 22' ' ' ILE . 84.3 tt0 -58.03 -36.64 73.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.02 -1.05 . . . . 2.37 109.714 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.533 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 48.0 mt -79.68 -31.75 41.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.483 -0.76 . . . . 2.36 110.514 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.534 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 71.9 mtt180 -57.93 -43.3 86.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.925 -1.11 . . . . 0.33 109.28 176.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -73.54 -50.21 22.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.327 -0.858 . . . . 3.75 110.653 -177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 55.4 m -64.17 -31.56 72.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 1.38 110.86 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.514 ' CD2' HG13 ' B' ' 30' ' ' ILE . 20.0 tp -86.64 -5.09 59.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.124 -0.985 . . . . 1.61 110.63 -176.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.91 43.68 95.66 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.49 -1.444 . . . . 0.34 109.49 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.514 HG13 ' CD2' ' B' ' 28' ' ' LEU . 29.4 mm -114.66 137.97 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -1.168 . . . . 1.13 110.699 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.459 ' HB1' ' OD2' ' B' ' 34' ' ' ASP . . . -140.98 166.66 24.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.509 -0.745 . . . . 1.07 109.99 -178.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.27 146.03 12.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.138 -0.976 . . . . 1.13 110.536 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 45.5 tttp 75.0 -4.94 2.27 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.706 -0.621 . . . . 2.39 111.16 177.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.459 ' OD2' ' HB1' ' B' ' 31' ' ' ALA . 92.5 m-20 -78.03 167.56 21.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.914 -1.116 . . . . 1.1 110.045 174.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.449 ' HB1' HG13 ' A' ' 9' ' ' VAL . . . -105.88 131.66 52.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.961 . . . . 1.13 110.807 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.525 HD12 ' CG2' ' A' ' 12' ' ' VAL . 10.1 mt -106.72 141.16 38.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.887 . . . . 1.35 109.421 175.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.462 ' OE1' ' HE3' ' B' ' 48' ' ' LYS . 85.5 tt0 -103.75 138.22 40.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.86 -1.15 . . . . 1.17 109.975 173.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 74.5 mt -112.13 133.2 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.459 -0.775 . . . . 1.48 110.507 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.564 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 17.2 m-85 -115.32 158.27 22.64 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 120.914 0.387 . . . . 1.08 109.962 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 83.9 t -129.2 124.66 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.99 -1.069 . . . . 1.05 110.61 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.466 ' OD2' HD12 ' B' ' 46' ' ' ILE . 9.2 p-10 -147.32 136.26 22.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -0.838 . . . . 1.77 110.151 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 56.7 t0 44.26 49.85 7.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.119 -0.988 . . . . 1.21 111.012 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.3 mt-10 58.95 13.63 2.91 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.229 -0.919 . . . . 1.92 110.607 176.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -117.23 147.87 42.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.945 . . . . 2.49 109.94 175.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.473 HG21 ' CD1' ' B' ' 47' ' ' LEU . 61.0 mt -99.83 129.15 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.102 -0.999 . . . . 1.85 110.153 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 23.8 mt -109.29 116.42 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.463 -0.773 . . . . 1.22 110.019 176.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' B' ' 47' ' ' LEU . 4.2 mp -110.91 134.7 52.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.004 -1.06 . . . . 2.23 110.097 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.535 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 14.2 pttp -142.52 163.37 33.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.443 -0.785 . . . . 2.17 110.29 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -58.13 147.1 31.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 2.25 109.885 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' B' ' 35' ' ' ALA . 14.8 t80 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.18 -0.95 . . . . 1.21 110.667 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.1 mt . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.043 0.449 . . . . 2.01 109.967 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.647 ' CG1' ' CD2' ' B' ' 50' ' ' TYR . 90.0 t -116.15 144.46 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.019 -1.051 . . . . 1.08 110.989 -175.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.437 ' N ' HG12 ' A' ' 9' ' ' VAL . 57.5 ttm-85 -129.61 159.66 35.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.513 -0.742 . . . . 2.25 109.736 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -86.49 148.03 25.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.2 -0.938 . . . . 2.66 110.328 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.533 ' CG2' HD11 ' B' ' 36' ' ' LEU . 3.7 t -82.58 129.29 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.266 -0.896 . . . . 1.09 109.945 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.471 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.18 -174.7 5.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.051 -1.031 . . . . 0.55 109.995 179.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -56.1 -39.93 72.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.025 -1.047 . . . . 2.19 111.718 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.52 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.1 tp -85.41 -4.53 59.19 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.751 -1.218 . . . . 1.97 111.674 -173.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.474 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.07 46.34 7.71 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.176 -1.488 . . . . 0.22 109.662 -177.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.547 ' CD ' ' CG2' ' B' ' 19' ' ' VAL . 73.8 mtm180 -115.75 154.62 29.27 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.054 -1.262 . . . . 1.33 109.995 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.514 HG13 ' CD1' ' B' ' 36' ' ' LEU . 22.7 m -123.81 151.76 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 1.08 109.868 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.541 ' CG2' ' CD ' ' B' ' 17' ' ' ARG . 22.4 t -112.35 135.13 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.152 -0.968 . . . . 1.05 110.54 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.493 HG22 ' HB2' ' A' ' 24' ' ' LEU . 3.0 mm -83.64 133.29 46.94 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 2.03 109.606 175.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.2 Cg_endo -58.04 143.62 96.07 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.778 1.409 . . . . 0.4 110.061 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.518 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.1 tp -54.85 -33.12 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.991 -1.068 . . . . 1.79 110.347 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.03 -35.6 71.52 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.154 -0.966 . . . . 2.37 109.833 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.531 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 51.4 mt -83.8 -28.81 27.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.335 -0.853 . . . . 2.3 110.789 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.518 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 71.5 mtt180 -57.44 -43.9 84.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.752 -1.218 . . . . 0.33 108.957 175.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -71.49 -49.75 38.2 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.092 -0.643 . . . . 3.74 110.714 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.8 m -63.59 -31.4 72.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.177 -0.952 . . . . 1.44 111.15 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.528 ' CD2' HG13 ' A' ' 30' ' ' ILE . 23.8 tp -87.35 -5.03 59.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.061 -1.024 . . . . 1.64 110.729 -177.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.08 41.4 98.51 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.701 -1.36 . . . . 0.34 109.701 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.528 HG13 ' CD2' ' A' ' 28' ' ' LEU . 34.3 mm -116.41 139.73 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -1.15 . . . . 1.16 110.759 -178.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -139.89 167.46 22.05 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.654 -0.654 . . . . 1.08 110.082 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.609 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 83.3 tt0 -52.41 150.87 4.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.047 -1.033 . . . . 1.13 110.549 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.609 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 74.5 mttt 67.16 -3.32 1.01 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.857 -0.527 . . . . 2.33 112.234 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.464 ' O ' HG21 ' B' ' 12' ' ' VAL . 90.1 m-20 -76.07 165.44 24.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.579 -1.326 . . . . 1.1 109.952 174.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . . . -103.87 130.98 51.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 1.17 110.785 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.514 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 13.5 mt -109.14 142.36 40.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.388 -0.82 . . . . 1.21 109.54 175.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.459 ' HG3' HG22 ' B' ' 9' ' ' VAL . 85.4 tt0 -107.4 140.35 40.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.795 -1.191 . . . . 1.17 109.739 172.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.6 mt -111.57 135.41 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.345 -0.847 . . . . 1.45 110.564 -172.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.545 ' CE1' ' HD3' ' A' ' 48' ' ' LYS . 12.4 m-85 -114.6 158.55 21.55 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 120.934 0.397 . . . . 1.05 110.078 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.7 t -130.89 128.39 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.924 -1.11 . . . . 1.08 110.62 172.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.489 ' CG ' ' CD1' ' A' ' 46' ' ' ILE . 8.9 p-10 -146.62 128.34 15.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.86 . . . . 1.77 110.249 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 48.1 t0 46.57 49.11 13.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.022 -1.048 . . . . 1.22 110.948 175.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.1 tt0 62.53 10.35 4.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.337 -0.852 . . . . 1.93 110.696 176.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 9.0 mtmm -110.59 148.38 32.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 2.48 109.868 176.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.463 HD13 HD12 ' B' ' 20' ' ' ILE . 58.0 mt -101.92 127.98 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 1.86 110.331 -176.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 29.6 mt -114.99 123.33 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.343 -0.848 . . . . 1.24 110.233 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.576 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 4.2 mp -114.11 136.74 52.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.961 -1.087 . . . . 2.25 110.167 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.545 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 25.2 pttt -140.92 165.61 27.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.449 -0.782 . . . . 2.26 110.132 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -56.06 149.07 16.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.109 -0.995 . . . . 2.12 109.819 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.518 ' CD2' ' CG1' ' B' ' 9' ' ' VAL . 2.2 t80 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.29 -0.881 . . . . 0.96 110.655 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.518 ' CG1' ' CD2' ' A' ' 50' ' ' TYR . 90.1 t . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.515 0.674 . . . . 1.11 110.959 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.429 ' N ' HG13 ' B' ' 9' ' ' VAL . 57.4 ttm-85 -129.44 159.5 36.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.488 -0.757 . . . . 2.26 109.809 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -86.49 147.95 25.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.027 -1.046 . . . . 2.65 110.434 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.492 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 3.7 t -82.45 129.3 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.265 -0.897 . . . . 1.06 109.823 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.3 -174.49 5.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.085 -1.009 . . . . 0.55 110.171 179.359 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . 0.465 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.5 mt-10 -56.24 -39.85 73.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.095 -1.003 . . . . 2.19 111.679 -172.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.512 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.5 tp -85.54 -4.55 59.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.723 -1.235 . . . . 1.99 111.624 -173.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.492 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.82 46.99 7.45 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.485 -1.446 . . . . 0.23 109.485 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.541 ' CD ' ' CG2' ' A' ' 19' ' ' VAL . 73.7 mtm180 -115.9 154.66 29.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.102 -1.234 . . . . 1.33 109.936 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.469 ' CG1' HD12 ' A' ' 36' ' ' LEU . 22.6 m -123.91 151.7 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.822 . . . . 1.08 109.866 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.547 ' CG2' ' CD ' ' A' ' 17' ' ' ARG . 22.6 t -112.37 135.09 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 1.07 110.576 -175.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.464 HG21 ' HB2' ' B' ' 24' ' ' LEU . 3.0 mm -83.64 133.24 47.03 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 1.99 109.594 175.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.522 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.2 Cg_endo -58.15 143.6 96.51 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.721 1.38 . . . . 0.4 110.063 177.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.534 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -54.9 -33.04 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.043 -1.036 . . . . 1.78 110.315 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.79 -36.34 72.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.152 -0.968 . . . . 2.37 109.724 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.522 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 51.4 mt -83.03 -29.28 28.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.496 -0.753 . . . . 2.36 110.752 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.534 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 71.0 mtt180 -57.22 -43.8 83.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.816 -1.178 . . . . 0.33 108.987 175.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -71.32 -50.15 35.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.452 -0.78 . . . . 3.75 110.543 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.4 m -63.3 -31.92 73.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.258 -0.901 . . . . 1.38 110.931 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.52 ' CD2' HG13 ' B' ' 30' ' ' ILE . 24.0 tp -86.84 -5.41 59.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.052 -1.03 . . . . 1.61 110.723 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.401 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.4 41.31 98.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.625 -1.39 . . . . 0.34 109.625 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.52 HG13 ' CD2' ' B' ' 28' ' ' LEU . 33.6 mm -116.43 139.65 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.177 -1.19 . . . . 1.13 110.707 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -139.69 167.62 21.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.516 -0.74 . . . . 1.07 109.975 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' B' ' 33' ' ' LYS . 83.2 tt0 -52.33 151.07 4.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.129 -0.982 . . . . 1.13 110.467 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.564 ' HB2' ' O ' ' B' ' 32' ' ' GLU . 74.0 mttt 66.57 -2.74 0.99 Allowed 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 112.363 0.505 . . . . 2.39 112.363 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 90.4 m-20 -76.55 165.31 24.96 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.506 -1.371 . . . . 1.1 109.965 173.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' B' ' 50' ' ' TYR . . . -103.63 131.02 51.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 1.13 110.802 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.537 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 13.3 mt -109.23 142.18 40.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.383 -0.823 . . . . 1.35 109.558 175.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.472 ' HA ' HG23 ' A' ' 9' ' ' VAL . 85.2 tt0 -107.26 140.32 40.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.842 -1.161 . . . . 1.17 109.824 172.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.8 mt -111.61 135.36 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.284 -0.885 . . . . 1.48 110.58 -172.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 12.1 m-85 -114.4 158.57 21.35 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 120.946 0.403 . . . . 1.08 110.09 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 78.6 t -130.72 128.61 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.903 -1.123 . . . . 1.05 110.476 172.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.478 ' CG ' ' CD1' ' B' ' 46' ' ' ILE . 9.0 p-10 -146.91 128.24 14.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 1.77 110.241 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 49.0 t0 46.77 49.08 14.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.093 -1.005 . . . . 1.21 110.934 175.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.0 tt0 62.4 10.4 3.92 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.224 -0.923 . . . . 1.92 110.691 176.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 9.0 mtmm -110.61 148.66 31.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.942 . . . . 2.49 109.705 176.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.435 HD12 HD22 ' A' ' 28' ' ' LEU . 58.0 mt -102.08 128.0 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.981 . . . . 1.85 110.365 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 30.4 mt -115.17 123.4 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.415 -0.803 . . . . 1.22 110.146 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' B' ' 47' ' ' LEU . 4.2 mp -114.05 136.63 52.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.981 -1.074 . . . . 2.23 110.145 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.537 ' HD3' ' CE1' ' B' ' 39' ' ' TYR . 25.2 pttt -140.78 165.84 26.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.44 -0.788 . . . . 2.17 110.079 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -56.3 148.87 17.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.992 -1.067 . . . . 2.25 109.754 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.647 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 2.2 t80 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 1.21 110.667 -175.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.5 mt . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 121.053 0.454 . . . . 2.01 110.014 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 86.8 t -114.0 144.12 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.027 -1.046 . . . . 1.08 110.871 -175.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.429 ' N ' HG11 ' A' ' 9' ' ' VAL . 58.2 ttt85 -126.29 157.88 37.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.398 -0.814 . . . . 2.25 109.71 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.443 ' CE ' ' HA ' ' B' ' 33' ' ' LYS . 55.2 tttt -83.58 145.04 29.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.137 -0.977 . . . . 2.66 110.396 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.538 ' CG2' HD13 ' B' ' 36' ' ' LEU . 3.9 t -81.77 130.31 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.351 -0.843 . . . . 1.09 109.929 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.38 -174.58 5.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.177 -0.952 . . . . 0.55 110.131 -179.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.46 -39.74 73.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.07 -1.019 . . . . 2.19 111.779 -172.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.518 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.3 tp -84.76 -4.33 59.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.765 -1.209 . . . . 1.97 111.6 -173.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.469 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.06 46.23 7.79 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.172 -1.49 . . . . 0.22 109.715 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.561 ' CD ' ' CG2' ' B' ' 19' ' ' VAL . 74.9 mtm180 -116.16 155.12 28.82 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.069 -1.254 . . . . 1.33 110.05 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.517 ' CG1' HD11 ' B' ' 36' ' ' LEU . 21.9 m -122.23 148.4 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 1.08 109.758 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.546 ' CG2' ' CD ' ' B' ' 17' ' ' ARG . 28.5 t -112.82 133.79 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 1.05 110.623 -175.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 24' ' ' LEU . 2.2 mm -84.75 130.86 51.31 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.294 -0.878 . . . . 2.03 109.461 175.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.52 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -57.29 142.34 94.79 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.668 1.352 . . . . 0.4 109.849 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.527 ' HA ' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -55.46 -32.39 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.952 -1.093 . . . . 1.79 110.289 -177.624 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.54 -36.38 71.55 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.16 -0.963 . . . . 2.37 109.747 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.52 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 52.9 mt -82.1 -27.59 32.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 2.3 110.471 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.527 ' CD ' ' HA ' ' A' ' 22' ' ' ILE . 73.0 mtt180 -56.97 -43.93 82.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.833 -1.167 . . . . 0.33 108.966 174.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 61.0 ttm-85 -71.66 -49.31 40.96 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.956 -0.698 . . . . 3.74 110.765 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.9 m -63.21 -31.84 73.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.186 -0.946 . . . . 1.44 111.078 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.526 ' CD2' HG13 ' A' ' 30' ' ' ILE . 23.2 tp -88.09 -5.01 58.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.093 -1.004 . . . . 1.64 110.758 -177.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.52 41.57 97.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.651 -1.38 . . . . 0.34 109.651 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.526 HG13 ' CD2' ' A' ' 28' ' ' LEU . 33.6 mm -116.53 139.1 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -1.169 . . . . 1.16 110.732 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -141.32 166.65 24.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.645 -0.659 . . . . 1.08 109.984 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.2 tt0 -53.29 146.39 12.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.056 -1.027 . . . . 1.13 110.592 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 28.5 tttt 74.52 -4.63 2.28 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.674 -0.642 . . . . 2.33 111.166 176.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.455 ' O ' HG22 ' B' ' 12' ' ' VAL . 90.6 m-20 -77.3 165.95 23.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.788 -1.195 . . . . 1.1 110.03 174.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.21 130.14 53.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 1.17 110.629 -176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.515 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 11.6 mt -106.25 141.64 37.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 1.21 109.387 174.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.464 ' OE1' ' HE3' ' A' ' 48' ' ' LYS . 85.3 tt0 -104.65 139.01 40.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.758 -1.214 . . . . 1.17 109.882 173.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.7 mt -109.82 132.67 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.514 -0.741 . . . . 1.45 110.374 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.544 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 14.2 m-85 -114.65 157.54 22.96 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.929 -0.397 . . . . 1.05 109.929 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.9 t -129.59 126.29 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.942 -1.099 . . . . 1.08 110.746 174.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.467 ' CG ' ' CD1' ' A' ' 46' ' ' ILE . 9.4 p-10 -146.71 131.91 18.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 1.77 110.178 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 47.7 t0 46.09 48.19 12.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.952 -1.092 . . . . 1.22 111.008 175.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.0 tt0 62.02 10.98 3.95 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.202 -0.936 . . . . 1.93 110.609 175.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 32.7 mtmt -113.07 150.98 31.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.072 -1.017 . . . . 2.48 109.873 176.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.457 ' CD1' HD12 ' B' ' 20' ' ' ILE . 56.7 mt -101.9 129.58 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 1.86 110.284 -176.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.9 mt -112.5 120.83 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 1.24 110.193 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.583 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.2 mp -112.39 134.08 54.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.984 -1.073 . . . . 2.25 110.133 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.543 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 10.5 pttp -141.52 164.8 29.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.478 -0.764 . . . . 2.26 110.394 178.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.517 ' HD3' ' CD1' ' A' ' 30' ' ' ILE . 18.3 tptp -56.97 146.04 28.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.133 -0.979 . . . . 2.12 109.938 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.9 t80 . . . . . 0 C--N 1.299 -1.619 0 O-C-N 121.331 -0.855 . . . . 0.96 110.646 -176.25 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 88.3 t . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.503 0.668 . . . . 1.11 110.911 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.425 ' N ' HG13 ' B' ' 9' ' ' VAL . 58.2 ttt85 -126.29 157.6 37.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.456 -0.777 . . . . 2.26 109.833 177.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -83.53 144.95 29.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.983 . . . . 2.65 110.453 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.478 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 4.0 t -81.72 130.49 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.354 -0.841 . . . . 1.06 109.812 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.6 -174.4 5.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.103 -0.998 . . . . 0.55 110.3 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . 0.457 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -56.63 -39.62 73.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.103 -0.998 . . . . 2.19 111.65 -172.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.52 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 15.0 tp -84.87 -4.39 59.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.741 -1.225 . . . . 1.99 111.527 -173.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.478 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.75 47.04 7.46 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.495 -1.442 . . . . 0.23 109.495 -177.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.546 ' CD ' ' CG2' ' A' ' 19' ' ' VAL . 74.8 mtm180 -116.44 155.1 29.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.001 -1.293 . . . . 1.33 109.969 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.43 HG22 ' O ' ' B' ' 18' ' ' VAL . 22.0 m -122.3 148.35 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 1.08 109.756 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.561 ' CG2' ' CD ' ' A' ' 17' ' ' ARG . 28.4 t -112.75 133.76 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.948 . . . . 1.07 110.636 -175.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.495 HG22 ' HB2' ' B' ' 24' ' ' LEU . 2.2 mm -84.76 130.86 51.28 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 1.99 109.416 175.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.516 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.0 Cg_endo -57.42 142.28 95.11 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.771 1.406 . . . . 0.4 109.888 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.522 ' HA ' ' CD ' ' B' ' 25' ' ' ARG . 0.0 OUTLIER -55.52 -32.17 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.994 -1.066 . . . . 1.78 110.291 -177.375 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.45 -37.05 72.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.103 -0.998 . . . . 2.37 109.643 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.516 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 52.5 mt -81.42 -27.88 34.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 2.36 110.502 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.522 ' CD ' ' HA ' ' B' ' 22' ' ' ILE . 72.7 mtt180 -56.79 -43.8 81.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.912 -1.118 . . . . 0.33 109.046 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 61.0 ttm-85 -71.56 -49.78 37.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.463 -0.773 . . . . 3.75 110.578 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 48.1 m -62.8 -32.43 73.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.3 -0.875 . . . . 1.38 110.893 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.527 ' CD2' HG13 ' B' ' 30' ' ' ILE . 23.4 tp -87.55 -5.42 58.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.058 -1.027 . . . . 1.61 110.661 -176.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.86 41.33 97.52 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.605 -1.398 . . . . 0.34 109.605 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.527 HG13 ' CD2' ' B' ' 28' ' ' LEU . 33.4 mm -116.45 138.93 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -1.199 . . . . 1.13 110.725 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.439 ' HB3' ' OD2' ' B' ' 34' ' ' ASP . . . -140.99 166.78 23.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.59 -0.694 . . . . 1.07 110.053 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.51 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.31 146.48 12.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.132 -0.98 . . . . 1.13 110.516 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 28.5 tttt 74.54 -4.78 2.25 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.673 -0.642 . . . . 2.39 111.225 176.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' B' ' 31' ' ' ALA . 90.7 m-20 -77.39 165.57 24.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.849 -1.157 . . . . 1.1 110.05 175.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.95 130.1 53.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 1.13 110.69 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.538 HD13 ' CG2' ' A' ' 12' ' ' VAL . 11.4 mt -106.26 141.5 37.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.396 -0.815 . . . . 1.35 109.426 174.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.464 ' HA ' HG21 ' A' ' 9' ' ' VAL . 85.2 tt0 -104.55 138.95 40.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.84 -1.163 . . . . 1.17 110.008 173.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 72.0 mt -109.76 132.59 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.395 -0.816 . . . . 1.48 110.329 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.543 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 13.9 m-85 -114.59 157.55 22.89 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.901 -0.407 . . . . 1.08 109.901 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.7 t -129.41 126.6 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.958 -1.089 . . . . 1.05 110.584 174.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.47 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.4 p-10 -146.99 131.83 18.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.354 -0.841 . . . . 1.77 110.14 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 48.7 t0 46.3 48.21 13.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.107 -0.996 . . . . 1.21 110.968 175.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 82.8 tt0 61.82 11.04 3.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.238 -0.914 . . . . 1.92 110.617 175.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 32.7 mtmt -113.08 151.2 31.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.178 -0.951 . . . . 2.49 109.791 176.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.456 HD11 HD13 ' A' ' 20' ' ' ILE . 56.3 mt -102.01 129.67 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.174 -0.954 . . . . 1.85 110.294 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 22.3 mt -112.71 120.83 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 1.22 110.075 176.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.583 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.2 mp -112.28 134.02 54.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.077 -1.014 . . . . 2.23 110.053 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.536 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 10.7 pttp -141.5 165.02 28.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 2.17 110.248 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.518 ' HD3' ' CD1' ' B' ' 30' ' ' ILE . 18.3 tptp -57.06 145.96 28.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 2.25 109.878 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . . . . . . . . . 10.1 t80 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 1.21 110.599 -176.23 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.0 mm . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 121.107 0.479 . . . . 2.01 110.157 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.639 ' CG1' ' CD2' ' B' ' 50' ' ' TYR . 98.9 t -115.28 144.46 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.996 -1.065 . . . . 1.08 110.893 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.459 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 14.8 tpt180 -130.22 160.62 33.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.514 -0.741 . . . . 2.25 109.687 177.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 66.7 mttm -85.76 148.5 25.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.106 -0.996 . . . . 2.66 110.344 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.541 ' CG2' HD12 ' B' ' 36' ' ' LEU . 6.3 t -82.05 128.75 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.216 -0.927 . . . . 1.09 109.816 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.37 -174.82 5.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.209 -0.932 . . . . 0.55 110.164 -179.299 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -53.24 -41.99 65.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.087 -1.008 . . . . 2.19 111.687 -173.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.53 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 16.3 tp -85.97 -4.89 59.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.717 -1.239 . . . . 1.97 111.685 -172.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.502 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.23 46.44 7.55 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.094 -1.527 . . . . 0.22 109.695 -177.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.535 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.2 mtm180 -114.78 154.63 28.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.079 -1.248 . . . . 1.33 110.088 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.452 HG12 HD13 ' B' ' 36' ' ' LEU . 20.9 m -124.85 152.7 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 1.08 109.819 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.526 HG21 ' CD ' ' B' ' 17' ' ' ARG . 21.4 t -112.61 134.91 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 1.05 110.637 -175.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.487 HD11 ' N ' ' A' ' 20' ' ' ILE . 1.7 mp -82.95 132.11 52.02 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.279 -0.888 . . . . 2.03 109.539 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.533 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.1 Cg_endo -57.28 141.23 94.6 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.729 1.384 . . . . 0.4 109.947 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.524 HD11 ' NE ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -55.66 -31.7 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.023 -1.048 . . . . 1.79 110.371 -177.56 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.73 -35.33 72.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.071 -1.018 . . . . 2.37 109.824 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.533 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 46.7 mt -81.39 -28.22 34.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.282 -0.887 . . . . 2.3 110.394 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.521 ' CD ' ' HA ' ' A' ' 22' ' ' ILE . 72.4 mtt180 -56.98 -44.72 82.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.897 -1.127 . . . . 0.33 109.092 175.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.524 ' NE ' HD11 ' A' ' 22' ' ' ILE . 98.1 mtt180 -72.14 -47.83 48.05 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.775 -0.77 . . . . 3.74 110.839 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.3 m -63.26 -32.19 73.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.158 -0.964 . . . . 1.44 111.018 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.514 ' CD2' HG13 ' A' ' 30' ' ' ILE . 21.3 tp -88.62 -4.71 58.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.1 -1.0 . . . . 1.64 110.734 -177.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.412 ' O ' HD11 ' A' ' 30' ' ' ILE . . . 65.05 41.81 97.01 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.718 -1.353 . . . . 0.34 109.718 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.514 HG13 ' CD2' ' A' ' 28' ' ' LEU . 32.0 mm -116.48 139.24 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.313 -1.11 . . . . 1.16 110.777 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -141.57 166.12 25.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.677 -0.64 . . . . 1.08 109.987 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.24 147.09 10.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.081 -1.012 . . . . 1.13 110.492 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 33.1 tttp 74.78 -4.97 2.24 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.77 -0.581 . . . . 2.33 111.118 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.413 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.4 m-20 -77.38 166.52 23.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.79 -1.194 . . . . 1.1 109.989 174.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -105.2 132.81 50.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 1.17 110.842 -175.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.517 HD11 ' CG2' ' B' ' 12' ' ' VAL . 13.0 mt -110.11 144.82 38.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.376 -0.828 . . . . 1.21 109.509 175.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.462 ' HG3' HG21 ' B' ' 9' ' ' VAL . 86.6 tt0 -108.81 139.79 43.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.726 -1.234 . . . . 1.17 109.685 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.2 mt -109.04 131.17 60.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.434 -0.791 . . . . 1.45 110.56 -172.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.557 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 16.7 m-85 -117.73 157.74 25.98 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 116.296 -0.411 . . . . 1.05 110.02 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.7 t -131.79 125.17 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.891 -1.131 . . . . 1.08 110.571 172.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.477 ' OD1' HG12 ' A' ' 46' ' ' ILE . 43.5 p-10 -147.49 144.84 28.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.106 -0.996 . . . . 1.77 110.768 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 52.8 t0 43.02 44.27 4.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.982 -1.074 . . . . 1.22 111.285 173.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 84.1 tt0 60.87 11.34 3.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.108 -0.995 . . . . 1.93 110.679 176.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -111.07 153.53 25.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 2.48 110.057 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' B' ' 47' ' ' LEU . 66.0 mt -93.51 128.8 44.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.279 -0.888 . . . . 1.86 109.846 177.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 23.9 mm -112.97 119.55 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.629 -0.669 . . . . 1.24 110.004 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.576 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.2 mp -117.96 134.79 54.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 2.25 110.202 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HE2' ' CE1' ' A' ' 39' ' ' TYR . 22.7 pttt -141.28 162.42 35.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.377 -0.827 . . . . 2.26 110.326 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -57.79 147.17 28.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.147 -0.971 . . . . 2.12 110.023 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.463 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 5.3 t80 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.96 110.575 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 99.4 t . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.464 0.65 . . . . 1.11 110.837 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.462 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 14.8 tpt180 -130.23 160.51 33.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.573 -0.705 . . . . 2.26 109.792 177.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.462 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 66.7 mttm -85.76 148.49 25.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.062 -1.024 . . . . 2.65 110.331 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.517 ' CG2' HD11 ' A' ' 36' ' ' LEU . 6.4 t -82.11 128.76 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.281 -0.887 . . . . 1.06 109.728 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -85.52 -174.6 5.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.55 110.217 -179.395 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . 0.465 ' OE1' ' OE2' ' A' ' 32' ' ' GLU . 47.2 tp10 -53.41 -41.86 66.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 2.19 111.689 -173.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.528 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 15.9 tp -85.97 -4.93 59.28 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.781 -1.2 . . . . 1.99 111.732 -172.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.504 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.88 47.27 7.26 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.439 -1.464 . . . . 0.23 109.439 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.528 ' HD3' ' CD2' ' B' ' 15' ' ' LEU . 69.2 mtm180 -114.94 154.64 28.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.057 -1.26 . . . . 1.33 110.043 -177.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 47' ' ' LEU . 21.0 m -124.93 152.71 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.367 -0.833 . . . . 1.08 109.852 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.535 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.4 t -112.62 134.83 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 1.07 110.666 -175.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.491 HD12 ' N ' ' B' ' 20' ' ' ILE . 1.7 mp -82.98 132.1 51.95 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.92 . . . . 1.99 109.528 174.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.529 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.1 Cg_endo -57.45 141.26 94.97 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.73 1.384 . . . . 0.4 109.964 177.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.525 HD11 ' NE ' ' B' ' 26' ' ' ARG . 0.0 OUTLIER -55.9 -31.24 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.982 . . . . 1.78 110.367 -177.216 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.83 -35.91 73.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.04 -1.038 . . . . 2.37 109.633 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.529 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 47.1 mt -80.73 -28.5 36.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.44 -0.788 . . . . 2.36 110.438 176.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.522 ' CD ' ' HA ' ' B' ' 22' ' ' ILE . 72.1 mtt180 -56.93 -44.59 82.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.876 -1.14 . . . . 0.33 109.037 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.525 ' NE ' HD11 ' B' ' 22' ' ' ILE . 98.1 mtt180 -72.1 -48.08 46.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.403 -0.811 . . . . 3.75 110.698 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.3 m -63.0 -32.66 74.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.244 -0.91 . . . . 1.38 110.816 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.524 ' CD2' HG13 ' B' ' 30' ' ' ILE . 21.4 tp -88.12 -5.15 58.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.997 -1.064 . . . . 1.61 110.636 -177.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.436 ' O ' HD12 ' B' ' 30' ' ' ILE . . . 65.44 41.69 96.25 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.519 -1.433 . . . . 0.34 109.519 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.524 HG13 ' CD2' ' B' ' 28' ' ' LEU . 31.7 mm -116.49 139.24 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.14 -1.212 . . . . 1.13 110.731 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.34 166.24 25.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.663 -0.648 . . . . 1.07 109.948 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.19 147.1 10.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.028 -1.045 . . . . 1.13 110.525 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 33.1 tttp 74.76 -5.0 2.22 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.737 -0.602 . . . . 2.39 111.132 177.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 88.7 m-20 -77.43 166.4 23.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.795 -1.19 . . . . 1.1 109.992 174.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' B' ' 50' ' ' TYR . . . -105.14 132.79 50.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 1.13 110.902 -175.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.541 HD12 ' CG2' ' A' ' 12' ' ' VAL . 12.7 mt -110.24 144.54 38.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.355 -0.841 . . . . 1.35 109.533 175.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.467 ' OE1' ' HE2' ' B' ' 48' ' ' LYS . 86.4 tt0 -108.44 139.81 42.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.744 -1.223 . . . . 1.17 109.832 172.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -109.01 131.26 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.353 -0.842 . . . . 1.48 110.42 -172.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.55 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 16.5 m-85 -117.82 157.64 26.23 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 120.964 0.411 . . . . 1.08 109.97 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 80.9 t -131.59 125.5 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.864 -1.148 . . . . 1.05 110.427 172.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.481 ' OD1' HG12 ' B' ' 46' ' ' ILE . 43.4 p-10 -147.88 144.85 28.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 1.77 110.743 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.4 t0 43.02 44.44 4.08 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.059 -1.026 . . . . 1.21 111.237 174.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 84.1 tt0 60.65 11.44 3.1 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.027 -1.046 . . . . 1.92 110.613 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -111.09 153.78 25.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.111 -0.993 . . . . 2.49 109.895 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.462 HD13 HG12 ' A' ' 20' ' ' ILE . 65.2 mt -93.69 128.6 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.198 -0.939 . . . . 1.85 109.967 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 23.4 mm -112.95 119.65 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.697 -0.627 . . . . 1.22 109.873 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.576 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.3 mp -117.89 134.68 54.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.007 -1.058 . . . . 2.23 110.147 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.524 ' HE2' ' CE1' ' B' ' 39' ' ' TYR . 23.1 pttt -141.16 162.61 35.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.352 -0.843 . . . . 2.17 110.276 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -57.8 147.09 29.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.947 . . . . 2.25 109.997 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.639 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 5.5 t80 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 1.21 110.516 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 57.9 mt . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.058 0.456 . . . . 2.01 109.991 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 92.6 t -112.65 143.71 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.975 -1.078 . . . . 1.08 110.782 -176.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.42 ' N ' HG12 ' A' ' 9' ' ' VAL . 29.7 tpt180 -125.98 157.83 36.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.539 -0.726 . . . . 2.25 109.832 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' B' ' 33' ' ' LYS . 33.2 tttp -82.81 143.82 30.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.915 . . . . 2.66 110.172 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.535 ' CG2' HD12 ' B' ' 36' ' ' LEU . 15.0 t -80.4 126.93 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.888 . . . . 1.09 109.855 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.99 -174.93 5.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.975 . . . . 0.55 110.013 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.34 -39.55 73.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.011 -1.056 . . . . 2.19 111.689 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.534 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.1 tp -84.67 -6.17 59.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.728 -1.233 . . . . 1.97 111.574 -173.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.32 46.69 7.35 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.108 -1.52 . . . . 0.22 109.641 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.537 ' CD ' HG23 ' B' ' 19' ' ' VAL . 70.8 mtm180 -114.06 153.99 28.48 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.033 -1.275 . . . . 1.33 110.078 -177.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.532 ' CG1' HD13 ' B' ' 36' ' ' LEU . 20.9 m -124.28 153.39 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.343 -0.848 . . . . 1.08 109.789 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.52 HG22 ' CD ' ' B' ' 17' ' ' ARG . 17.0 t -113.42 133.66 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 1.05 110.703 -175.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.46 HG22 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.42 136.19 43.11 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.163 -0.961 . . . . 2.03 109.443 174.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.5 Cg_endo -58.56 141.12 97.14 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.702 1.369 . . . . 0.4 109.893 176.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.524 ' HA ' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -55.89 -31.31 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.94 -1.1 . . . . 1.79 110.382 -177.55 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.59 -35.38 72.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.049 -1.032 . . . . 2.37 109.854 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.531 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 52.8 mt -81.02 -29.46 35.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 2.3 110.455 176.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.524 ' CD ' ' HA ' ' A' ' 22' ' ' ILE . 73.9 mtt180 -57.13 -44.02 82.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.969 -1.082 . . . . 0.33 109.05 175.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -72.64 -50.12 27.29 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.539 -0.726 . . . . 3.74 110.708 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m -63.56 -31.25 72.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.195 -0.941 . . . . 1.44 111.09 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.431 HD22 HG13 ' A' ' 30' ' ' ILE . 18.2 tp -87.59 -4.37 58.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 1.64 110.759 -177.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.442 ' O ' HD12 ' A' ' 30' ' ' ILE . . . 67.01 40.94 93.37 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.712 -1.355 . . . . 0.34 109.712 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 29' ' ' GLY . 31.2 mm -116.51 139.07 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.328 -1.101 . . . . 1.16 110.674 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.83 166.53 24.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.529 -0.732 . . . . 1.08 110.032 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.503 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.24 146.53 11.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 1.13 110.602 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 56.2 tttt 74.7 -4.58 2.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.678 -0.639 . . . . 2.33 111.139 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -76.75 168.09 20.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.189 . . . . 1.1 110.034 174.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -106.23 131.69 53.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 1.17 110.726 -175.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.527 ' CD1' HG23 ' B' ' 12' ' ' VAL . 13.0 mt -109.04 144.55 36.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.425 -0.797 . . . . 1.21 109.457 175.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.477 ' HG3' HG21 ' B' ' 9' ' ' VAL . 86.0 tt0 -109.65 138.67 45.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.74 -1.225 . . . . 1.17 109.491 172.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.51 133.33 55.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.336 -0.853 . . . . 1.45 110.607 -171.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.579 ' CE1' ' HD2' ' A' ' 48' ' ' LYS . 9.5 m-85 -118.3 161.48 19.86 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.905 -0.405 . . . . 1.05 109.905 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.4 t -133.8 120.53 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.854 -1.154 . . . . 1.08 110.599 172.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 45.4 p-10 -148.25 160.99 42.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 1.77 110.55 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 53.0 t0 42.21 39.51 1.44 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.009 -1.057 . . . . 1.22 111.493 172.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 84.2 tt0 59.05 14.07 3.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.898 -1.127 . . . . 1.93 110.567 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 11.2 pttt -127.66 166.25 18.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.147 -0.971 . . . . 2.48 109.696 174.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.515 HD13 ' CG1' ' B' ' 20' ' ' ILE . 66.8 mt -97.95 134.37 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 1.86 110.388 -175.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 20.3 mm -113.95 120.13 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.643 -0.661 . . . . 1.24 109.959 178.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.586 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.5 mp -115.83 135.63 53.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.965 -1.085 . . . . 2.25 110.227 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.579 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 13.5 ptpt -141.28 158.64 43.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 2.26 110.368 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -58.42 146.75 33.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 2.12 109.934 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.453 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 8.5 t80 . . . . . 0 C--N 1.301 -1.537 0 O-C-N 121.318 -0.864 . . . . 0.96 110.602 -175.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 92.7 t . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.556 0.693 . . . . 1.11 110.789 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.424 ' N ' HG12 ' B' ' 9' ' ' VAL . 29.7 tpt180 -125.96 157.69 37.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.463 -0.773 . . . . 2.26 109.912 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.409 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 33.0 tttp -82.78 143.67 30.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 2.65 110.173 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 36' ' ' LEU . 15.1 t -80.23 127.08 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 1.06 109.78 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -86.15 -174.79 5.25 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.082 -1.011 . . . . 0.55 110.14 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . 0.463 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.8 mt-10 -56.46 -39.51 73.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.017 -1.052 . . . . 2.19 111.609 -172.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.528 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.7 tp -84.69 -6.21 59.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.733 -1.229 . . . . 1.99 111.599 -173.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.88 47.65 7.03 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.474 -1.45 . . . . 0.23 109.474 -177.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.528 ' HD3' ' CD2' ' B' ' 15' ' ' LEU . 70.6 mtm180 -114.39 154.05 28.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.037 -1.272 . . . . 1.33 109.974 -177.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.455 HG23 HD22 ' A' ' 47' ' ' LEU . 20.6 m -124.35 153.49 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 1.08 109.864 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.537 HG23 ' CD ' ' A' ' 17' ' ' ARG . 16.9 t -113.53 133.68 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 1.07 110.672 -175.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.515 ' CG1' HD13 ' A' ' 45' ' ' ILE . 1.7 mp -83.41 136.21 43.13 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.201 -0.937 . . . . 1.99 109.475 174.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.4 Cg_endo -58.74 141.01 97.38 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.716 1.377 . . . . 0.4 109.896 176.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.525 HG22 HD11 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -56.03 -31.01 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 1.78 110.415 -177.268 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.56 -35.96 73.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.994 -1.066 . . . . 2.37 109.714 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.526 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 52.6 mt -80.32 -29.83 38.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.416 -0.802 . . . . 2.36 110.435 176.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.519 ' NH2' HD12 ' A' ' 15' ' ' LEU . 73.3 mtt180 -56.98 -44.0 82.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.903 -1.123 . . . . 0.33 109.036 175.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -72.4 -50.44 26.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 3.75 110.715 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 55.5 m -63.29 -31.78 73.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.33 -0.856 . . . . 1.38 110.878 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.403 HD21 HG13 ' B' ' 30' ' ' ILE . 18.3 tp -87.16 -4.57 59.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.007 -1.058 . . . . 1.61 110.71 -176.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.34 40.73 91.81 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.597 -1.401 . . . . 0.34 109.597 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.403 HG13 HD21 ' B' ' 28' ' ' LEU . 30.6 mm -116.53 139.05 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -1.175 . . . . 1.13 110.586 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.62 166.53 24.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.545 -0.722 . . . . 1.07 110.06 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.33 146.64 11.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.944 . . . . 1.13 110.511 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 56.1 tttt 74.71 -4.69 2.29 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.592 -0.693 . . . . 2.39 111.264 177.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 87.7 m-20 -76.75 167.74 21.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.8 -1.187 . . . . 1.1 110.021 174.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' B' ' 50' ' ' TYR . . . -105.94 131.67 52.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 1.13 110.856 -175.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.535 HD12 ' CG2' ' A' ' 12' ' ' VAL . 12.8 mt -109.03 144.26 37.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.858 . . . . 1.35 109.626 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.461 ' HA ' HG23 ' A' ' 9' ' ' VAL . 85.7 tt0 -109.27 138.69 45.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.759 -1.213 . . . . 1.17 109.734 172.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.3 mt -109.5 133.38 54.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.336 -0.853 . . . . 1.48 110.531 -171.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.573 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 9.3 m-85 -118.33 161.31 20.15 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.954 -0.387 . . . . 1.08 109.954 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.412 ' CG2' HD12 ' A' ' 24' ' ' LEU . 78.9 t -133.5 121.01 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.861 -1.15 . . . . 1.05 110.473 172.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' B' ' 41' ' ' ASP . 45.3 p-10 -148.86 160.95 42.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.98 . . . . 1.77 110.49 178.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 53.4 t0 41.99 39.82 1.42 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.204 -0.935 . . . . 1.21 111.481 172.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' B' ' 43' ' ' GLU . 84.2 tt0 58.89 14.04 3.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.91 -1.119 . . . . 1.92 110.528 174.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 11.2 pttt -127.55 166.41 18.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 2.49 109.699 174.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.406 ' HB ' ' HB2' ' A' ' 47' ' ' LEU . 66.7 mt -98.09 134.32 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 1.85 110.399 -175.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 20.7 mm -113.94 120.09 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.683 -0.636 . . . . 1.22 109.975 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.586 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.6 mp -115.76 135.5 53.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.069 -1.019 . . . . 2.23 110.192 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.569 ' HD2' ' CE1' ' B' ' 39' ' ' TYR . 13.5 ptpt -141.14 158.88 43.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.375 -0.828 . . . . 2.17 110.295 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -58.54 146.75 34.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.213 -0.929 . . . . 2.25 109.908 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' B' ' 35' ' ' ALA . 8.8 t80 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 1.21 110.69 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.6 mt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.075 0.464 . . . . 2.01 110.085 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.534 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 90.7 t -117.41 144.49 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.056 -1.027 . . . . 1.08 110.82 -176.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.427 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 23.9 tpt180 -129.77 158.95 38.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -0.793 . . . . 2.25 109.798 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.427 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 35.5 ttpt -82.71 145.52 29.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.127 -0.983 . . . . 2.66 110.335 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.548 ' CG2' HD13 ' B' ' 36' ' ' LEU . 3.7 t -81.76 128.69 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.385 -0.822 . . . . 1.09 109.807 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.55 -177.29 6.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.072 -1.017 . . . . 0.55 109.997 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.99 -40.5 73.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.049 -1.032 . . . . 2.19 111.539 -174.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.57 ' CD1' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -76.83 -13.81 59.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.873 -1.142 . . . . 1.97 110.542 -174.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.81 46.66 5.9 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.401 -1.479 . . . . 0.22 109.401 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.542 ' CD ' HG21 ' B' ' 19' ' ' VAL . 70.5 mtm180 -114.41 155.04 27.06 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.024 -1.28 . . . . 1.33 110.095 -176.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.529 ' CG1' HD11 ' B' ' 36' ' ' LEU . 13.1 m -122.91 152.46 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.318 -0.864 . . . . 1.08 109.769 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.525 HG21 ' CD ' ' B' ' 17' ' ' ARG . 15.0 t -112.8 134.08 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 1.05 110.659 -174.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.473 HG21 ' HB2' ' A' ' 24' ' ' LEU . 2.5 mm -84.3 137.24 39.68 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 2.03 109.367 174.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.523 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.8 Cg_endo -58.63 140.77 96.24 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.718 1.378 . . . . 0.4 109.785 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.523 ' HA ' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -55.63 -32.21 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.862 -1.149 . . . . 1.79 110.313 -177.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -58.73 -35.27 72.42 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.16 -0.962 . . . . 2.37 109.763 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.523 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 41.3 mt -82.65 -27.62 31.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 2.3 110.517 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.523 ' CD ' ' HA ' ' A' ' 22' ' ' ILE . 71.2 mtt180 -56.85 -44.51 82.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.798 -1.189 . . . . 0.33 108.84 175.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . 0.463 ' HG2' HD11 ' A' ' 22' ' ' ILE . 31.5 mmt180 -72.77 -47.81 43.59 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.938 -0.705 . . . . 3.74 110.657 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.4 m -63.69 -31.32 72.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.191 -0.943 . . . . 1.44 111.069 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.454 ' CD2' HG13 ' A' ' 30' ' ' ILE . 20.9 tp -87.39 -4.65 59.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 1.64 110.683 -177.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.05 41.49 95.11 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.662 -1.375 . . . . 0.34 109.662 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.454 HG13 ' CD2' ' A' ' 28' ' ' LEU . 33.3 mm -116.43 138.79 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.344 -1.092 . . . . 1.16 110.675 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.64 166.07 25.76 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.55 -0.719 . . . . 1.08 109.981 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.73 146.51 13.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.094 -1.004 . . . . 1.13 110.533 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 43.5 tttm 75.02 -4.63 2.34 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.744 -0.598 . . . . 2.33 111.068 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.472 ' O ' HG22 ' B' ' 12' ' ' VAL . 89.9 m-20 -77.21 167.19 22.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.73 -1.231 . . . . 1.1 110.05 174.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -105.49 130.74 53.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 1.17 110.744 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.505 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 13.4 mt -107.58 143.9 35.36 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.336 -0.852 . . . . 1.21 109.388 175.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.46 ' HG3' HG22 ' B' ' 9' ' ' VAL . 85.3 tt0 -108.77 139.22 43.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.809 -1.182 . . . . 1.17 109.694 172.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.3 mt -109.84 133.1 56.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.425 -0.797 . . . . 1.45 110.541 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.575 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 17.2 m-85 -119.45 158.85 25.38 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 116.262 -0.426 . . . . 1.05 109.894 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.44 HG22 ' CD1' ' B' ' 24' ' ' LEU . 85.3 t -132.01 123.32 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.833 -1.167 . . . . 1.08 110.66 173.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.478 ' OD1' HG12 ' A' ' 46' ' ' ILE . 47.8 p-10 -147.69 149.12 31.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 1.77 110.632 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 52.7 t0 42.95 44.64 4.07 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.001 -1.062 . . . . 1.22 111.256 173.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 75.6 mm-40 57.67 14.55 2.45 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.053 -1.03 . . . . 1.93 110.567 176.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -115.84 153.94 30.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 2.48 109.955 175.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.457 ' CG2' HD13 ' B' ' 20' ' ' ILE . 67.7 mt -92.92 129.05 44.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.253 -0.904 . . . . 1.86 109.954 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.586 ' CD1' ' CD1' ' B' ' 46' ' ' ILE . 21.0 mm -111.91 119.36 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.561 -0.712 . . . . 1.24 109.907 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.2 mp -118.81 134.36 55.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.924 -1.11 . . . . 2.25 110.281 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 12.1 pttp -141.99 163.69 32.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.451 -0.781 . . . . 2.26 110.478 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -59.26 147.02 37.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 2.12 110.14 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 10.3 t80 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.96 110.67 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.505 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 89.4 t . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.514 0.673 . . . . 1.11 110.804 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.433 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 24.0 tpt180 -129.75 158.85 38.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.545 -0.722 . . . . 2.26 109.907 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.433 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 35.5 ttpt -82.72 145.38 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.059 -1.026 . . . . 2.65 110.4 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.493 ' CG2' ' HG ' ' A' ' 36' ' ' LEU . 3.7 t -81.67 128.79 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.256 -0.903 . . . . 1.06 109.704 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.76 -177.4 6.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.093 -1.005 . . . . 0.55 110.073 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.97 -40.41 73.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.073 -1.017 . . . . 2.19 111.489 -173.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.567 ' CD1' ' O ' ' B' ' 15' ' ' LEU . 0.1 OUTLIER -76.49 -14.26 60.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.894 -1.129 . . . . 1.99 110.647 -174.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.63 47.32 5.69 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.319 -1.512 . . . . 0.23 109.319 -177.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.525 ' CD ' HG21 ' A' ' 19' ' ' VAL . 70.5 mtm180 -114.61 154.95 27.44 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.155 -1.203 . . . . 1.33 110.058 -176.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.522 HG23 ' CD2' ' A' ' 47' ' ' LEU . 13.2 m -122.93 152.48 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 1.08 109.74 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.542 HG21 ' CD ' ' A' ' 17' ' ' ARG . 14.9 t -112.84 134.1 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 1.07 110.678 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.47 HG21 ' HB2' ' B' ' 24' ' ' LEU . 2.5 mm -84.29 137.21 39.72 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.924 . . . . 1.99 109.388 174.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.53 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.8 Cg_endo -58.74 140.77 96.39 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.656 1.345 . . . . 0.4 109.837 176.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.514 ' HA ' ' CD ' ' B' ' 25' ' ' ARG . 0.0 OUTLIER -55.78 -31.99 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.998 -1.064 . . . . 1.78 110.294 -177.374 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -58.74 -35.85 73.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.024 -1.047 . . . . 2.37 109.609 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.53 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 41.8 mt -81.89 -28.01 33.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.431 -0.793 . . . . 2.36 110.566 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.514 ' CD ' ' HA ' ' B' ' 22' ' ' ILE . 70.7 mtt180 -56.78 -44.27 81.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.901 -1.124 . . . . 0.33 108.957 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . 0.441 ' HG2' HD12 ' B' ' 22' ' ' ILE . 31.4 mmt180 -72.74 -47.96 42.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.484 -0.76 . . . . 3.75 110.642 -178.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.3 m -63.45 -31.96 73.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.226 -0.921 . . . . 1.38 110.84 -177.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.458 ' CD2' HG13 ' B' ' 30' ' ' ILE . 21.0 tp -86.83 -4.99 59.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.132 -0.98 . . . . 1.61 110.66 -177.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.48 41.17 94.41 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.603 -1.399 . . . . 0.34 109.603 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.458 HG13 ' CD2' ' B' ' 28' ' ' LEU . 32.6 mm -116.34 138.65 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -1.199 . . . . 1.13 110.667 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.33 166.24 25.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.633 -0.667 . . . . 1.07 110.001 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.4 tt0 -53.74 146.6 13.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 1.13 110.475 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 43.6 tttm 75.07 -4.87 2.28 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.621 -0.675 . . . . 2.39 111.169 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 90.1 m-20 -77.37 166.99 22.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.91 -1.119 . . . . 1.1 110.041 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' B' ' 50' ' ' TYR . . . -105.27 130.78 53.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 1.13 110.816 -176.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.548 HD13 ' CG2' ' A' ' 12' ' ' VAL . 13.1 mt -107.7 143.56 36.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.375 -0.828 . . . . 1.35 109.495 175.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.47 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.2 tt0 -108.43 139.18 43.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.932 -1.105 . . . . 1.17 109.85 172.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.5 mt -109.85 133.01 56.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.39 -0.819 . . . . 1.48 110.489 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.581 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 17.1 m-85 -119.43 158.85 25.37 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 116.244 -0.435 . . . . 1.08 109.94 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.426 HG22 ' CD1' ' A' ' 24' ' ' LEU . 86.5 t -131.82 123.65 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.863 -1.148 . . . . 1.05 110.515 173.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' B' ' 41' ' ' ASP . 47.9 p-10 -148.18 149.14 31.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 1.77 110.613 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 53.2 t0 42.83 44.94 4.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.101 -0.999 . . . . 1.21 111.188 174.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 75.6 mm-40 57.42 14.65 2.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.071 -1.018 . . . . 1.92 110.562 176.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -115.87 154.18 30.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 2.49 109.896 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.486 HG23 ' CD1' ' B' ' 47' ' ' LEU . 67.6 mt -93.07 128.84 44.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.187 -0.946 . . . . 1.85 109.945 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.586 ' CD1' ' CD1' ' A' ' 46' ' ' ILE . 21.0 mm -111.93 119.51 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.572 -0.705 . . . . 1.22 109.946 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.4 mp -118.78 134.23 55.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.892 -1.13 . . . . 2.23 110.15 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.542 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 12.3 pttp -141.85 163.89 31.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 2.17 110.371 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -59.24 146.91 37.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.135 -0.978 . . . . 2.25 110.1 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.501 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 10.5 t80 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 1.21 110.542 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.5 mm . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 121.026 0.441 . . . . 2.01 109.811 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.643 ' CG1' ' CD2' ' B' ' 50' ' ' TYR . 85.7 t -118.84 144.75 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.969 -1.082 . . . . 1.08 110.904 -174.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.487 ' CZ ' HG21 ' A' ' 19' ' ' VAL . 70.6 ttt-85 -129.94 159.26 37.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.455 -0.778 . . . . 2.25 109.83 177.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -82.87 146.03 29.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 2.66 110.265 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.537 ' CG2' HD12 ' B' ' 36' ' ' LEU . 3.4 t -80.42 129.28 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.357 -0.839 . . . . 1.09 109.866 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.469 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.84 -175.35 5.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.179 -0.951 . . . . 0.55 110.039 179.337 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -54.56 -40.82 69.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.069 -1.019 . . . . 2.19 111.788 -173.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.529 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.9 tp -84.99 -5.41 59.35 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.758 -1.214 . . . . 1.97 111.595 -173.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.44 46.52 7.38 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 119.178 -1.486 . . . . 0.22 109.687 -177.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.532 ' CD ' HG21 ' B' ' 19' ' ' VAL . 71.1 mtm180 -114.83 154.51 28.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.031 -1.276 . . . . 1.33 110.004 -177.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.518 HG22 ' CD2' ' B' ' 47' ' ' LEU . 18.8 m -124.47 153.15 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 1.08 109.809 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.524 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.4 t -111.19 135.38 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 1.05 110.569 -176.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.69 134.6 47.18 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 2.03 109.524 175.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.524 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.3 Cg_endo -58.27 143.45 97.19 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.756 1.398 . . . . 0.4 110.092 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.52 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.28 -31.81 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.934 -1.104 . . . . 1.79 110.416 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.42 -34.95 73.11 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.15 -0.969 . . . . 2.37 109.907 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.524 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 61.5 mt -81.96 -30.66 31.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.326 -0.858 . . . . 2.3 110.589 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.52 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 73.7 mtt180 -57.69 -43.92 85.45 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.044 -1.062 . . . . 0.33 109.212 175.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -72.5 -50.51 25.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.559 -0.713 . . . . 3.74 110.706 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.0 m -63.7 -31.21 72.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.144 -0.972 . . . . 1.44 111.086 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.528 ' CD2' HG13 ' A' ' 30' ' ' ILE . 22.9 tp -87.56 -4.78 58.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.088 -1.007 . . . . 1.64 110.698 -177.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.72 43.47 96.26 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.614 -1.395 . . . . 0.34 109.614 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.528 HG13 ' CD2' ' A' ' 28' ' ' LEU . 30.8 mm -115.69 139.08 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.272 -1.134 . . . . 1.16 110.65 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -140.81 167.49 22.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.555 -0.716 . . . . 1.08 110.003 -178.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.608 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 83.4 tt0 -52.48 150.44 4.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 1.13 110.468 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 39.9 mttp 67.01 -2.97 1.02 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 112.294 0.479 . . . . 2.33 112.294 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.466 ' O ' HG21 ' B' ' 12' ' ' VAL . 88.3 m-20 -75.55 166.89 22.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.526 -1.359 . . . . 1.1 109.922 173.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 50' ' ' TYR . . . -103.83 130.23 51.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 1.17 110.769 -175.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.528 HD13 ' CG2' ' B' ' 12' ' ' VAL . 13.7 mt -108.3 140.67 41.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 1.21 109.49 175.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -105.4 140.1 39.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.834 -1.166 . . . . 1.17 109.731 173.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.2 mt -111.49 133.88 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.44 -0.788 . . . . 1.45 110.478 -173.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.571 ' CE1' ' HD2' ' A' ' 48' ' ' LYS . 8.6 m-85 -115.2 160.4 19.77 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 120.904 0.383 . . . . 1.05 110.09 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.0 t -133.58 123.13 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.132 -0.98 . . . . 1.08 110.857 173.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.472 ' OD2' HD12 ' A' ' 46' ' ' ILE . 9.1 p-10 -147.3 141.61 26.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 1.77 110.22 177.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 53.4 t0 43.47 47.86 6.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.074 -1.016 . . . . 1.22 111.096 174.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.7 mt-10 58.74 13.77 2.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.186 -0.946 . . . . 1.93 110.711 176.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -114.52 148.19 38.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 2.48 110.07 175.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.48 HD12 ' CG1' ' B' ' 20' ' ' ILE . 61.2 mt -99.6 127.6 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 1.86 110.095 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 34.2 mt -111.87 118.15 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.331 -0.856 . . . . 1.24 110.275 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.2 mp -107.95 135.59 49.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 2.25 110.122 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.571 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 16.2 ptpt -142.45 164.22 30.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.516 -0.74 . . . . 2.26 110.125 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -55.77 147.95 17.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.116 -0.99 . . . . 2.12 109.721 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.476 ' CD2' ' CG1' ' B' ' 9' ' ' VAL . 1.7 t80 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.96 110.644 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.498 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 86.3 t . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.456 0.645 . . . . 1.11 110.935 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.466 ' CZ ' HG23 ' B' ' 19' ' ' VAL . 70.6 ttt-85 -129.93 159.08 37.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.468 -0.77 . . . . 2.26 109.924 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -82.84 145.93 29.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 2.65 110.395 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.528 ' CG2' HD13 ' A' ' 36' ' ' LEU . 3.4 t -80.26 129.46 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.917 . . . . 1.06 109.756 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.09 -175.29 5.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.122 -0.986 . . . . 0.55 110.069 179.154 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.67 -40.78 69.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.177 -0.952 . . . . 2.19 111.678 -173.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.526 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 15.2 tp -85.04 -5.43 59.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.764 -1.21 . . . . 1.99 111.572 -173.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.526 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.11 47.24 7.15 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.523 -1.431 . . . . 0.23 109.523 -177.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.526 ' HD3' ' CD2' ' B' ' 15' ' ' LEU . 70.9 mtm180 -115.06 154.49 28.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.05 -1.265 . . . . 1.33 109.932 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.516 ' CG1' HD11 ' A' ' 36' ' ' LEU . 18.8 m -124.49 153.07 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 1.08 109.822 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.532 HG21 ' CD ' ' A' ' 17' ' ' ARG . 21.4 t -111.23 135.3 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -0.956 . . . . 1.07 110.605 -175.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.501 HG21 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.62 134.52 47.52 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.26 -0.9 . . . . 1.99 109.545 175.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.522 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.3 Cg_endo -58.28 143.4 97.29 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.851 1.448 . . . . 0.4 110.111 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.533 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.36 -31.66 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.098 -1.001 . . . . 1.78 110.408 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.26 -35.63 74.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.121 -0.987 . . . . 2.37 109.808 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.522 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 62.2 mt -81.23 -30.96 34.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.386 -0.822 . . . . 2.36 110.619 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.533 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 73.2 mtt180 -57.57 -43.86 84.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.883 -1.135 . . . . 0.33 109.208 176.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -72.45 -50.81 23.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 3.75 110.599 -177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.7 m -63.35 -31.8 73.05 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 1.38 110.88 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.518 ' CD2' HG13 ' B' ' 30' ' ' ILE . 23.1 tp -87.0 -5.21 59.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.042 -1.036 . . . . 1.61 110.651 -176.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.417 ' O ' HD11 ' B' ' 30' ' ' ILE . . . 65.01 43.25 96.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.55 -1.42 . . . . 0.34 109.55 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.518 HG13 ' CD2' ' B' ' 28' ' ' LEU . 30.5 mm -115.53 138.97 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.213 -1.169 . . . . 1.13 110.727 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -140.6 167.64 21.69 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.676 -0.64 . . . . 1.07 110.003 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.569 ' O ' ' HB2' ' B' ' 33' ' ' LYS . 83.5 tt0 -52.59 150.69 4.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 1.13 110.454 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' B' ' 32' ' ' GLU . 40.5 mttp 66.52 -2.51 1.03 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 112.4 0.518 . . . . 2.39 112.4 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 88.5 m-20 -75.86 166.78 23.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.599 -1.313 . . . . 1.1 109.895 173.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' B' ' 50' ' ' TYR . . . -103.64 130.14 51.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -0.91 . . . . 1.13 110.807 -175.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.537 HD12 ' CG2' ' A' ' 12' ' ' VAL . 13.6 mt -108.28 140.5 41.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.866 . . . . 1.35 109.513 175.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.476 ' HA ' HG21 ' A' ' 9' ' ' VAL . 84.8 tt0 -105.24 139.98 39.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.827 -1.171 . . . . 1.17 109.86 173.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . 0.448 HG23 HD11 ' B' ' 38' ' ' ILE . 71.4 mt -111.41 133.99 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.362 -0.836 . . . . 1.48 110.455 -173.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.578 ' CD1' ' HE3' ' B' ' 48' ' ' LYS . 8.5 m-85 -115.2 160.38 19.8 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 120.972 0.415 . . . . 1.08 110.18 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 94.3 t -133.31 123.45 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.922 -1.112 . . . . 1.05 110.686 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.458 ' OD2' HD13 ' B' ' 46' ' ' ILE . 9.1 p-10 -147.69 141.55 25.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 1.77 110.197 176.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 54.1 t0 43.56 48.0 6.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.098 -1.001 . . . . 1.21 111.045 174.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.7 mt-10 58.55 13.85 2.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.132 -0.98 . . . . 1.92 110.666 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -114.44 148.39 37.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 2.49 110.007 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 60.9 mt -99.71 127.61 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.909 . . . . 1.85 110.145 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 35.5 mt -112.03 118.16 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.428 -0.795 . . . . 1.22 110.216 178.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.3 mp -107.83 135.48 49.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 2.23 110.009 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.578 ' HE3' ' CD1' ' B' ' 39' ' ' TYR . 16.2 ptpt -142.29 164.28 30.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.517 -0.739 . . . . 2.17 110.153 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -55.83 147.84 18.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.083 -1.011 . . . . 2.25 109.764 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.643 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 1.7 t80 . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 1.21 110.616 -175.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.476 HG21 HD13 ' A' ' 8' ' ' ILE . 58.4 mt . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 109.633 -0.506 . . . . 2.01 109.633 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.581 HG21 ' CZ ' ' B' ' 50' ' ' TYR . 78.5 t -113.14 144.52 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.815 -1.178 . . . . 1.08 111.347 -170.404 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.449 ' HG2' ' NH1' ' A' ' 10' ' ' ARG . 57.4 ttp85 -129.19 167.08 18.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.536 -0.727 . . . . 2.25 109.455 175.057 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -84.42 146.45 27.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.02 -1.05 . . . . 2.66 110.443 -178.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.542 ' CG2' HD11 ' B' ' 36' ' ' LEU . 3.9 t -82.47 131.8 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -0.839 . . . . 1.09 109.758 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.466 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.14 -175.55 5.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.55 110.058 -179.038 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.406 ' HG2' ' OE2' ' B' ' 32' ' ' GLU . 97.0 mt-10 -57.03 -39.34 74.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.064 -1.022 . . . . 2.19 111.754 -172.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.527 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 14.7 tp -84.29 -5.96 59.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.734 -1.229 . . . . 1.97 111.606 -173.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA2' HG13 ' A' ' 12' ' ' VAL . . . 79.99 46.9 7.41 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.161 -1.495 . . . . 0.22 109.694 -177.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.527 ' HD3' ' CD2' ' A' ' 15' ' ' LEU . 69.5 mtm180 -114.58 154.5 28.21 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.954 -1.321 . . . . 1.33 110.127 -177.221 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.461 HG22 ' CD2' ' B' ' 47' ' ' LEU . 15.5 m -123.26 150.69 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.311 -0.868 . . . . 1.08 109.802 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.53 HG22 ' CD ' ' B' ' 17' ' ' ARG . 34.1 t -111.69 134.16 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.915 . . . . 1.05 110.632 -175.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.496 HG21 ' HB2' ' A' ' 24' ' ' LEU . 2.9 mm -83.89 134.78 43.51 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 2.03 109.507 174.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.534 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.3 Cg_endo -58.17 143.42 96.86 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.749 1.394 . . . . 0.4 110.061 177.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.522 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.1 tp -54.92 -33.47 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.014 -1.054 . . . . 1.79 110.429 -178.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.06 -35.51 71.44 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.094 -1.003 . . . . 2.37 109.816 178.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.534 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 48.2 mt -83.28 -29.17 28.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.39 -0.819 . . . . 2.3 110.636 178.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.522 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 71.4 mtt180 -57.71 -44.24 85.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.834 -1.166 . . . . 0.33 109.069 175.451 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -72.97 -48.62 35.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.54 -0.725 . . . . 3.74 110.719 -177.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.0 m -63.48 -32.06 73.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.153 -0.967 . . . . 1.44 111.081 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.1 tp -88.28 -4.4 58.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.088 -1.008 . . . . 1.64 110.766 -176.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.31 42.05 94.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.818 -1.313 . . . . 0.34 109.818 178.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.526 ' CD1' ' HD3' ' A' ' 49' ' ' LYS . 34.1 mm -116.49 137.76 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -1.156 . . . . 1.16 110.682 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.14 166.5 24.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.594 -0.691 . . . . 1.08 110.04 -178.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.51 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.2 146.68 11.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 1.13 110.599 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 44.7 tttm 74.25 -4.52 2.28 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.666 -0.646 . . . . 2.33 111.143 176.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.465 ' O ' HG21 ' B' ' 12' ' ' VAL . 91.2 m-20 -77.54 168.46 19.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.859 -1.151 . . . . 1.1 110.064 175.147 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.34 130.56 52.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 1.17 110.694 -176.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.529 ' HG ' ' CG2' ' B' ' 12' ' ' VAL . 9.1 mt -107.09 142.69 36.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.314 -0.866 . . . . 1.21 109.312 174.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.454 ' OE1' ' HE3' ' A' ' 48' ' ' LYS . 86.1 tt0 -105.76 137.75 43.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.775 -1.203 . . . . 1.17 109.585 172.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.0 mt -108.0 131.37 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -0.784 . . . . 1.45 110.536 -172.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.571 ' CE1' ' HE3' ' A' ' 48' ' ' LYS . 23.3 m-85 -120.16 155.81 32.35 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.849 -0.426 . . . . 1.05 109.849 -178.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . 0.494 HG22 ' CD1' ' B' ' 24' ' ' LEU . 71.3 t -131.23 120.75 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.88 -1.137 . . . . 1.08 110.586 172.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 47.9 p-10 -148.25 160.86 42.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 1.77 110.583 178.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 54.8 t0 42.13 41.23 1.96 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.065 -1.022 . . . . 1.22 111.575 172.03 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 96.0 mt-10 56.57 15.99 2.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.984 -1.072 . . . . 1.93 110.541 175.491 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 27.3 pttt -129.54 164.77 23.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.96 . . . . 2.48 109.738 174.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.527 ' CD1' HD13 ' B' ' 20' ' ' ILE . 64.7 mt -97.66 134.18 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 1.86 110.381 -174.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.587 ' CD1' ' CD1' ' B' ' 46' ' ' ILE . 21.6 mm -113.21 121.29 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.679 -0.638 . . . . 1.24 109.969 177.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 3.9 mp -120.77 133.78 55.32 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.915 -1.116 . . . . 2.25 110.021 178.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 12.9 pttp -143.62 165.53 27.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.232 -0.918 . . . . 2.26 110.631 -179.224 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.526 ' HD3' ' CD1' ' A' ' 30' ' ' ILE . 14.3 tptt -57.6 146.94 28.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 2.12 110.127 177.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.509 ' CZ ' HG21 ' B' ' 9' ' ' VAL . 11.2 t80 . . . . . 0 C--N 1.3 -1.568 0 O-C-N 121.324 -0.86 . . . . 0.96 110.693 -176.632 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 77.3 t . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.585 0.707 . . . . 1.11 111.356 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.444 ' NH1' ' HG2' ' B' ' 10' ' ' ARG . 57.4 ttp85 -129.07 166.99 18.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.519 -0.738 . . . . 2.26 109.537 175.076 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -84.46 146.37 27.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.052 . . . . 2.65 110.551 -178.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.529 ' CG2' ' HG ' ' A' ' 36' ' ' LEU . 3.9 t -82.48 131.75 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.379 -0.826 . . . . 1.06 109.699 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.08 -175.49 5.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.084 -1.01 . . . . 0.55 110.212 -179.219 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . 0.47 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -57.17 -39.24 74.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.143 -0.973 . . . . 2.19 111.639 -172.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.521 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.4 tp -84.34 -5.96 59.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.811 -1.181 . . . . 1.99 111.61 -173.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.53 47.8 7.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.533 -1.427 . . . . 0.23 109.533 -177.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.53 ' CD ' HG22 ' A' ' 19' ' ' VAL . 69.5 mtm180 -114.88 154.48 28.59 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.091 -1.24 . . . . 1.33 110.046 -177.539 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.498 HG21 ' CD2' ' A' ' 47' ' ' LEU . 15.5 m -123.27 150.65 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.326 -0.859 . . . . 1.08 109.874 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.527 HG21 ' CD ' ' A' ' 17' ' ' ARG . 33.6 t -111.78 134.12 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 1.07 110.56 -175.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.527 HD13 ' CD1' ' A' ' 45' ' ' ILE . 2.9 mm -83.81 134.75 43.77 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.22 -0.925 . . . . 1.99 109.617 174.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.523 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.2 Cg_endo -58.24 143.35 97.2 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.727 1.383 . . . . 0.4 110.066 177.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.535 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -55.07 -33.35 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.997 -1.065 . . . . 1.78 110.334 -178.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . 0.403 ' N ' HG21 ' B' ' 22' ' ' ILE . 84.1 tt0 -57.83 -36.22 71.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.042 -1.036 . . . . 2.37 109.709 178.498 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.523 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 48.5 mt -82.47 -29.58 30.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.388 -0.82 . . . . 2.36 110.654 178.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.535 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 70.6 mtt180 -57.59 -44.08 85.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.817 -1.177 . . . . 0.33 109.046 175.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -73.0 -48.83 32.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.863 . . . . 3.75 110.566 -177.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.4 m -63.23 -32.54 73.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.254 -0.904 . . . . 1.38 110.909 -178.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 18.2 tp -87.77 -4.91 58.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.045 -1.035 . . . . 1.61 110.667 -176.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.83 41.83 93.32 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.659 -1.377 . . . . 0.34 109.659 178.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.529 ' CD1' ' HD3' ' B' ' 49' ' ' LYS . 33.7 mm -116.48 137.66 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -1.162 . . . . 1.13 110.644 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.96 166.55 24.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.602 -0.686 . . . . 1.07 110.081 -178.27 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.13 146.72 10.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 1.13 110.582 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 44.6 tttm 74.27 -4.56 2.27 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.645 -0.659 . . . . 2.39 111.198 176.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.464 ' O ' HG22 ' A' ' 12' ' ' VAL . 91.1 m-20 -77.67 168.19 20.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.792 -1.192 . . . . 1.1 110.031 175.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.12 130.69 51.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 1.13 110.819 -176.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.542 HD11 ' CG2' ' A' ' 12' ' ' VAL . 9.1 mt -107.26 142.5 36.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 1.35 109.318 174.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.47 ' HA ' HG23 ' A' ' 9' ' ' VAL . 86.0 tt0 -105.55 137.71 42.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.929 -1.107 . . . . 1.17 109.721 172.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 71.5 mt -108.02 131.41 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.349 -0.844 . . . . 1.48 110.538 -172.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.571 ' CE1' ' HE3' ' B' ' 48' ' ' LYS . 23.0 m-85 -120.1 155.85 32.19 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 116.294 -0.412 . . . . 1.08 109.948 -178.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . 0.419 HG21 HD12 ' A' ' 24' ' ' LEU . 72.1 t -131.1 121.15 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.836 -1.165 . . . . 1.05 110.402 172.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.499 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 47.9 p-10 -148.82 160.92 42.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -0.933 . . . . 1.77 110.519 178.461 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 55.2 t0 41.76 41.72 1.88 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.172 -0.955 . . . . 1.21 111.554 172.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 96.0 mt-10 56.26 16.11 2.2 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.881 -1.137 . . . . 1.92 110.552 175.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 27.2 pttt -129.63 164.9 22.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 2.49 109.604 174.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.472 ' CD1' HD13 ' A' ' 20' ' ' ILE . 64.6 mt -97.67 134.08 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 1.85 110.416 -174.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.587 ' CD1' ' CD1' ' A' ' 46' ' ' ILE . 21.6 mm -113.21 121.47 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.748 -0.595 . . . . 1.22 109.914 177.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.0 mp -120.73 133.5 55.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.931 -1.106 . . . . 2.23 109.958 179.005 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 13.2 pttp -143.47 165.72 26.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.962 . . . . 2.17 110.657 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.529 ' HD3' ' CD1' ' B' ' 30' ' ' ILE . 14.4 tptt -57.6 146.87 28.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 2.25 110.012 177.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.581 ' CZ ' HG21 ' A' ' 9' ' ' VAL . 11.4 t80 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 1.21 110.643 -176.643 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.1 mm . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 109.669 -0.493 . . . . 2.01 109.669 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.539 HG22 ' CE1' ' B' ' 50' ' ' TYR . 78.4 t -109.85 143.48 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.86 -1.15 . . . . 1.08 111.281 -171.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ARG . . . . . 0.457 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 15.5 tpt180 -121.27 161.62 21.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.571 -0.706 . . . . 2.25 109.666 177.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' B' ' 33' ' ' LYS . 6.4 tptm -82.8 142.42 31.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.169 -0.957 . . . . 2.66 110.364 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.529 ' CG2' HD12 ' B' ' 36' ' ' LEU . 8.9 t -82.97 130.39 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.329 -0.857 . . . . 1.09 109.886 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -83.96 -175.28 5.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.099 -1.001 . . . . 0.55 110.036 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.44 ' HG2' ' OE2' ' B' ' 32' ' ' GLU . 97.0 mt-10 -56.66 -39.71 74.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.998 -1.064 . . . . 2.19 111.756 -172.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.519 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.4 tp -84.68 -5.73 59.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.794 -1.191 . . . . 1.97 111.523 -173.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.472 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.19 46.7 7.42 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.228 -1.463 . . . . 0.22 109.643 -177.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.523 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.0 mtm180 -114.36 155.03 27.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.071 -1.252 . . . . 1.33 110.024 -177.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.532 ' CG1' HD13 ' B' ' 36' ' ' LEU . 17.1 m -123.87 152.43 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.365 -0.834 . . . . 1.08 109.817 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.517 HG22 ' CD ' ' B' ' 17' ' ' ARG . 33.6 t -110.03 135.82 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 1.05 110.446 -176.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.518 HG21 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -80.63 130.46 64.43 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 2.03 109.465 174.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -56.79 143.63 90.03 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.817 1.43 . . . . 0.4 110.059 178.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.526 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.14 -32.54 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.005 -1.06 . . . . 1.79 110.293 -178.18 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -57.68 -36.48 71.98 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.055 -1.028 . . . . 2.37 109.891 178.025 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.531 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 51.7 mt -82.07 -30.04 31.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.346 -0.847 . . . . 2.3 110.63 178.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.526 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 73.9 mtt180 -57.91 -43.61 86.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.923 -1.111 . . . . 0.33 109.172 175.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -74.2 -51.7 14.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.469 -0.769 . . . . 3.74 110.651 -177.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.6 m -64.04 -31.22 72.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 1.44 111.182 -178.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . 0.521 ' CD2' HG13 ' A' ' 30' ' ' ILE . 16.7 tp -88.6 -4.89 58.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.09 -1.006 . . . . 1.64 110.808 -176.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.69 43.97 95.59 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.738 -1.345 . . . . 0.34 109.738 179.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.521 HG13 ' CD2' ' A' ' 28' ' ' LEU . 31.3 mm -115.82 136.94 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.266 -1.137 . . . . 1.16 110.75 -178.082 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -144.43 167.12 23.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.62 -0.675 . . . . 1.08 110.019 -177.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.22 146.05 12.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.037 -1.039 . . . . 1.13 110.623 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 68.3 tttt 74.34 -4.24 2.36 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.665 . . . . 2.33 111.144 176.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.464 ' O ' HG22 ' B' ' 12' ' ' VAL . 89.2 m-20 -77.22 168.97 19.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.866 -1.146 . . . . 1.1 110.06 174.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.05 130.97 54.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 1.17 110.612 -177.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.533 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 9.2 mt -107.06 141.97 37.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 1.21 109.235 174.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.462 ' OE1' ' HE3' ' A' ' 48' ' ' LYS . 86.1 tt0 -104.3 137.6 41.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.769 -1.207 . . . . 1.17 109.712 174.08 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.0 mt -108.73 132.57 56.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.456 -0.778 . . . . 1.45 110.605 -172.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' TYR . . . . . 0.579 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 22.5 m-85 -121.07 157.25 30.45 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.868 -0.419 . . . . 1.05 109.868 -178.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.2 t -131.56 125.91 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.811 -1.18 . . . . 1.08 110.715 173.498 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 38.7 p-10 -147.48 140.87 25.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.92 . . . . 1.77 110.733 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.8 t0 43.32 46.74 5.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.001 -1.062 . . . . 1.22 111.449 173.336 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.8 tt0 61.3 10.87 3.28 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.132 -0.98 . . . . 1.93 110.707 175.479 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -111.44 151.09 28.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 2.48 109.885 175.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.415 HG23 ' CD1' ' A' ' 47' ' ' LEU . 67.2 mt -92.9 128.22 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.308 -0.87 . . . . 1.86 109.779 177.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.583 ' CD1' ' CD1' ' B' ' 46' ' ' ILE . 23.5 mm -111.45 118.29 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.543 -0.723 . . . . 1.24 109.91 178.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.579 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 3.9 mp -119.27 134.18 55.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.867 -1.146 . . . . 2.25 110.164 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.561 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 13.0 pttp -143.26 163.26 33.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 2.26 110.44 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -58.18 147.52 29.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 2.12 109.94 177.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.553 ' CG ' HG22 ' B' ' 9' ' ' VAL . 15.5 t80 . . . . . 0 C--N 1.3 -1.566 0 O-C-N 121.368 -0.833 . . . . 0.96 110.688 -175.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 9' ' ' VAL . . . . . 0.553 HG22 ' CG ' ' A' ' 50' ' ' TYR . 78.0 t . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.601 0.715 . . . . 1.11 111.244 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 10' ' ' ARG . . . . . 0.466 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 15.5 tpt180 -121.28 161.5 21.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.589 -0.695 . . . . 2.26 109.753 177.619 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 11' ' ' LYS . . . . . 0.466 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 6.4 tptm -82.83 142.26 31.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.994 . . . . 2.65 110.37 -178.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . 0.479 ' CG2' ' HG ' ' A' ' 36' ' ' LEU . 8.9 t -82.88 130.56 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.24 -0.913 . . . . 1.06 109.855 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.01 -175.05 5.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.983 . . . . 0.55 110.227 179.674 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' B' B ' 14' ' ' GLU . . . . . 0.474 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -56.91 -39.63 74.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.132 -0.98 . . . . 2.19 111.634 -172.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 15' ' ' LEU . . . . . 0.526 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 15.3 tp -84.65 -5.89 59.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.786 -1.196 . . . . 1.99 111.546 -173.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 16' ' ' GLY . . . . . 0.473 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.93 47.32 7.2 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.531 -1.428 . . . . 0.23 109.531 -177.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 17' ' ' ARG . . . . . 0.526 ' HD3' ' CD2' ' B' ' 15' ' ' LEU . 70.0 mtm180 -114.43 154.99 27.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.089 -1.242 . . . . 1.33 110.042 -177.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 18' ' ' VAL . . . . . 0.421 ' O ' HG22 ' B' ' 18' ' ' VAL . 17.1 m -123.96 152.42 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.887 . . . . 1.08 109.775 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 19' ' ' VAL . . . . . 0.523 HG22 ' CD ' ' A' ' 17' ' ' ARG . 34.2 t -110.06 135.72 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.146 -0.971 . . . . 1.07 110.506 -176.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 20' ' ' ILE . . . . . 0.473 HG22 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -80.57 130.45 64.65 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 1.99 109.537 174.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 21' ' ' PRO . . . . . 0.529 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.1 Cg_endo -56.82 143.66 90.23 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.773 1.407 . . . . 0.4 110.115 178.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 22' ' ' ILE . . . . . 0.52 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.27 -32.39 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.155 -0.966 . . . . 1.78 110.281 -177.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -57.49 -37.18 72.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.046 -1.034 . . . . 2.37 109.808 177.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 24' ' ' LEU . . . . . 0.529 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 51.1 mt -81.32 -30.52 33.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.468 -0.77 . . . . 2.36 110.561 178.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 25' ' ' ARG . . . . . 0.52 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 73.7 mtt180 -57.69 -43.43 85.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.9 -1.125 . . . . 0.33 109.285 176.008 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -74.26 -51.82 14.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 3.75 110.571 -177.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.3 m -63.85 -31.85 73.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 1.38 110.855 -178.107 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 28' ' ' LEU . . . . . 0.511 ' CD2' HG13 ' B' ' 30' ' ' ILE . 16.8 tp -88.07 -5.25 58.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.971 -1.081 . . . . 1.61 110.691 -176.356 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 29' ' ' GLY . . . . . 0.448 ' O ' HD12 ' B' ' 30' ' ' ILE . . . 64.91 43.89 95.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.646 -1.382 . . . . 0.34 109.646 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 30' ' ' ILE . . . . . 0.511 HG13 ' CD2' ' B' ' 28' ' ' LEU . 31.3 mm -115.68 136.79 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -1.162 . . . . 1.13 110.797 -178.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 31' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -144.12 167.18 23.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.574 -0.704 . . . . 1.07 109.951 -177.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 32' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.05 146.04 11.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.143 -0.973 . . . . 1.13 110.634 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 33' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 68.1 tttt 74.34 -4.29 2.35 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.713 -0.617 . . . . 2.39 111.168 176.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 34' ' ' ASP . . . . . 0.467 ' O ' HG22 ' A' ' 12' ' ' VAL . 89.8 m-20 -77.42 168.76 19.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.846 -1.158 . . . . 1.1 109.979 174.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.81 130.93 54.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 1.13 110.726 -177.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 36' ' ' LEU . . . . . 0.532 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 9.1 mt -107.08 141.79 37.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.265 -0.897 . . . . 1.35 109.319 174.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 37' ' ' GLU . . . . . 0.474 ' HA ' HG21 ' A' ' 9' ' ' VAL . 86.0 tt0 -103.99 137.57 41.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.78 -1.2 . . . . 1.17 109.881 174.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.2 mt -108.73 132.61 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 1.48 110.493 -172.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 39' ' ' TYR . . . . . 0.566 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 22.0 m-85 -121.05 157.2 30.55 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 116.208 -0.451 . . . . 1.08 109.886 -178.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 75.6 t -131.36 126.27 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.861 -1.149 . . . . 1.05 110.545 173.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 41' ' ' ASP . . . . . 0.479 ' OD1' ' O ' ' B' ' 41' ' ' ASP . 38.5 p-10 -147.99 140.77 24.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.333 -0.854 . . . . 1.77 110.638 179.005 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 42' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 54.3 t0 43.44 46.88 5.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.072 -1.018 . . . . 1.21 111.317 173.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.6 tt0 61.1 10.88 3.12 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.053 -1.029 . . . . 1.92 110.71 175.504 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -111.38 151.3 28.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 2.49 109.913 175.062 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 45' ' ' ILE . . . . . 0.455 HG23 HD13 ' B' ' 47' ' ' LEU . 66.8 mt -93.01 128.07 44.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.253 -0.904 . . . . 1.85 109.876 177.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 46' ' ' ILE . . . . . 0.583 ' CD1' ' CD1' ' A' ' 46' ' ' ILE . 23.2 mm -111.55 118.42 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.611 -0.681 . . . . 1.22 109.886 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 47' ' ' LEU . . . . . 0.579 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.0 mp -119.2 134.07 55.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.957 -1.089 . . . . 2.23 110.13 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 48' ' ' LYS . . . . . 0.566 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 13.3 pttp -143.2 163.33 33.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.206 -0.934 . . . . 2.17 110.455 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -58.1 147.43 29.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.908 . . . . 2.25 109.917 177.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' B' B ' 50' ' ' TYR . . . . . 0.539 ' CE1' HG22 ' A' ' 9' ' ' VAL . 15.6 t80 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.214 -0.929 . . . . 1.21 110.605 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.2 t80 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.213 0.53 . . . . 11.69 110.22 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.6 mtp -128.38 160.65 31.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 9.04 110.185 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -88.49 140.15 29.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.919 . . . . 9.15 110.124 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.553 ' CB ' ' CD2' ' B' ' 39' ' ' TYR . 82.7 p -146.27 165.53 28.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 4.5 110.237 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.503 HG21 ' CG2' ' B' ' 40' ' ' VAL . 80.4 p -62.34 -34.11 76.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 4.26 110.181 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.18 46.32 43.71 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.737 -1.345 . . . . 1.24 109.737 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.412 HD11 HG21 ' A' ' 8' ' ' ILE . 59.9 mt -114.83 134.5 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.083 -1.245 . . . . 2.01 109.993 179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 90.3 t -116.68 144.06 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.041 -1.037 . . . . 1.08 110.961 -175.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.437 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 27.7 tpt180 -128.15 159.21 35.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.464 -0.773 . . . . 2.25 109.711 177.279 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.437 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 70.3 mttt -85.74 147.67 26.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.103 -0.998 . . . . 2.66 110.401 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.536 ' CG2' HD12 ' B' ' 36' ' ' LEU . 3.7 t -84.06 129.0 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.292 -0.88 . . . . 1.09 109.942 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.68 -175.29 5.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.55 110.08 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -54.24 -40.91 68.16 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.151 -0.968 . . . . 2.19 111.671 -173.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.525 HD21 ' CZ ' ' A' ' 17' ' ' ARG . 14.3 tp -84.12 -5.64 59.28 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.739 -1.225 . . . . 1.97 111.581 -173.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.499 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.38 46.31 7.54 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.191 -1.48 . . . . 0.22 109.657 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.535 ' CD ' HG22 ' B' ' 19' ' ' VAL . 72.6 mtm180 -114.74 154.05 29.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.099 -1.236 . . . . 1.33 109.968 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.521 ' CG1' HD13 ' B' ' 36' ' ' LEU . 19.8 m -123.99 153.11 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 1.08 109.866 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.526 HG22 ' CD ' ' B' ' 17' ' ' ARG . 24.3 t -111.35 134.77 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 1.05 110.632 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.507 HD13 ' CD1' ' B' ' 45' ' ' ILE . 6.4 mt -82.53 135.14 46.81 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 2.03 109.487 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.528 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.2 Cg_endo -58.13 142.98 97.39 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.771 1.406 . . . . 0.4 110.044 177.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.522 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.14 -32.78 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.962 -1.086 . . . . 1.79 110.373 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -58.07 -35.64 71.66 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.113 -0.992 . . . . 2.37 109.861 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.528 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 54.9 mt -82.75 -29.78 29.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.382 -0.824 . . . . 2.3 110.627 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.522 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 72.8 mtt180 -57.56 -44.13 85.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.898 -1.126 . . . . 0.33 109.146 175.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -73.37 -49.14 28.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.537 -0.727 . . . . 3.74 110.742 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.0 m -63.94 -31.24 72.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.189 -0.944 . . . . 1.44 111.085 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.528 ' CD2' HG13 ' A' ' 30' ' ' ILE . 22.2 tp -87.57 -4.79 58.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.027 -1.046 . . . . 1.64 110.711 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.75 43.74 95.82 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.663 -1.375 . . . . 0.34 109.663 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.528 HG13 ' CD2' ' A' ' 28' ' ' LEU . 31.6 mm -115.28 138.99 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.241 -1.152 . . . . 1.16 110.699 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.79 167.11 22.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.631 -0.668 . . . . 1.08 109.945 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.515 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.52 146.02 13.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.047 -1.033 . . . . 1.13 110.554 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 40.7 tttt 74.81 -4.57 2.33 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.757 -0.589 . . . . 2.33 111.103 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.458 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.9 m-20 -76.93 165.54 24.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.773 -1.204 . . . . 1.1 110.028 174.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.451 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -106.26 132.52 52.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 1.17 110.734 -176.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.512 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 12.6 mt -108.9 142.74 39.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 1.21 109.49 175.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.453 ' OE1' ' HE2' ' A' ' 48' ' ' LYS . 85.8 tt0 -107.88 139.8 41.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.869 -1.144 . . . . 1.17 109.793 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 72.1 mt -112.61 136.85 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.393 -0.817 . . . . 1.45 110.68 -172.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.565 ' CE1' ' HD3' ' A' ' 48' ' ' LYS . 14.6 m-85 -114.16 158.61 21.08 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.977 -0.379 . . . . 1.05 109.977 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.523 ' CG2' HG22 ' B' ' 6' ' ' THR . 83.9 t -130.66 121.92 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.973 -1.079 . . . . 1.08 110.739 172.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.476 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.9 p-10 -147.17 140.51 25.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 1.77 110.216 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.469 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 52.4 t0 43.56 48.39 6.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.02 -1.05 . . . . 1.22 111.154 175.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.8 mt-10 58.55 14.05 2.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.134 -0.979 . . . . 1.93 110.656 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -117.12 147.11 42.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 2.48 110.024 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.519 ' CD1' HD13 ' B' ' 20' ' ' ILE . 60.4 mt -99.98 128.17 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 1.86 110.093 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.533 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 24.1 mt -111.52 118.62 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.352 -0.843 . . . . 1.24 110.209 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.577 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 4.2 mp -108.04 136.54 47.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.067 -1.021 . . . . 2.25 110.093 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.565 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 27.2 pttt -138.64 162.23 35.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.501 -0.749 . . . . 2.26 110.189 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -58.84 146.55 36.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.09 -1.006 . . . . 2.12 109.965 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 9.1 t80 -105.95 119.23 38.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.96 110.726 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.82 122.84 49.62 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.359 -0.838 . . . . 3.58 109.307 171.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -63.05 145.12 93.92 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.74 1.389 . . . . 0.48 110.299 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.03 -0.986 . . . . 2.9 110.258 -179.878 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.184 0.516 . . . . 12.33 110.183 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 50.9 ttm -89.48 126.09 35.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 8.85 110.183 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -99.65 144.27 28.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 9.64 110.363 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.536 ' OG ' ' CD2' ' A' ' 39' ' ' TYR . 25.9 t -119.47 145.51 46.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.882 . . . . 5.64 109.971 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.523 HG22 ' CG2' ' A' ' 40' ' ' VAL . 79.7 p -62.62 -34.33 76.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.134 -0.979 . . . . 3.35 110.166 -178.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.01 46.73 42.35 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.642 -1.383 . . . . 1.53 109.642 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.4 mt -114.88 134.38 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.118 -1.225 . . . . 1.97 109.978 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.512 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 90.7 t -116.72 144.09 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.928 -1.107 . . . . 1.11 110.937 -175.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.434 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 27.8 tpt180 -128.16 159.03 36.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.49 -0.756 . . . . 2.26 109.793 177.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.434 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 70.4 mttt -85.65 147.6 26.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.013 . . . . 2.65 110.419 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.515 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 3.8 t -83.98 129.11 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.891 . . . . 1.06 109.844 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.93 -175.16 5.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.116 -0.99 . . . . 0.55 110.126 179.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . 0.422 ' OE1' ' CD ' ' A' ' 32' ' ' GLU . 46.9 tp10 -54.37 -40.84 68.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.147 -0.971 . . . . 2.19 111.599 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.513 HD22 ' CZ ' ' B' ' 17' ' ' ARG . 14.0 tp -84.12 -5.74 59.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.76 -1.213 . . . . 1.99 111.568 -173.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.515 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.05 47.02 7.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.521 -1.432 . . . . 0.23 109.521 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.526 ' CD ' HG22 ' A' ' 19' ' ' VAL . 72.7 mtm180 -114.93 154.08 29.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.102 -1.234 . . . . 1.33 109.94 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.526 HG23 ' CD2' ' A' ' 47' ' ' LEU . 19.7 m -124.04 153.09 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 1.08 109.891 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.535 HG22 ' CD ' ' A' ' 17' ' ' ARG . 24.3 t -111.4 134.76 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 1.07 110.619 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.519 HD13 ' CD1' ' A' ' 45' ' ' ILE . 6.4 mt -82.57 135.16 46.67 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 1.99 109.472 174.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.521 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.2 Cg_endo -58.21 143.0 97.63 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.797 1.419 . . . . 0.4 110.049 177.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.534 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.3 -32.59 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.135 -0.978 . . . . 1.78 110.336 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -57.86 -36.4 72.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.091 -1.006 . . . . 2.37 109.774 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.521 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 54.7 mt -81.97 -30.16 31.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.478 -0.764 . . . . 2.36 110.605 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.534 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 72.2 mtt180 -57.44 -43.92 84.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.89 -1.131 . . . . 0.33 109.204 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -73.37 -49.32 27.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 3.75 110.621 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 61.0 m -63.81 -31.73 73.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.177 -0.952 . . . . 1.38 110.862 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.512 ' CD2' HG13 ' B' ' 30' ' ' ILE . 22.4 tp -87.1 -5.17 59.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.053 -1.03 . . . . 1.61 110.701 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.07 43.65 95.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.578 -1.409 . . . . 0.34 109.578 179.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.512 HG13 ' CD2' ' B' ' 28' ' ' LEU . 31.1 mm -115.27 138.81 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -1.176 . . . . 1.13 110.725 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.48 167.27 22.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.628 -0.67 . . . . 1.07 109.935 -178.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.515 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.55 146.12 13.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.988 . . . . 1.13 110.554 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 40.6 tttt 74.84 -4.77 2.29 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.688 -0.633 . . . . 2.39 111.164 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 90.0 m-20 -76.98 165.21 24.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.791 -1.193 . . . . 1.1 110.014 174.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.455 ' O ' ' HB3' ' B' ' 50' ' ' TYR . . . -105.93 132.48 51.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 1.13 110.833 -176.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.536 HD12 ' CG2' ' A' ' 12' ' ' VAL . 12.5 mt -108.93 142.61 39.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.397 -0.815 . . . . 1.35 109.531 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.47 ' HA ' HG23 ' A' ' 9' ' ' VAL . 85.6 tt0 -107.7 139.79 41.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.902 -1.124 . . . . 1.17 109.92 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.416 HD11 HG22 ' B' ' 38' ' ' ILE . 72.1 mt -112.6 136.79 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.299 -0.876 . . . . 1.48 110.651 -172.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.567 ' CE1' ' HD3' ' B' ' 48' ' ' LYS . 14.3 m-85 -114.0 158.63 20.92 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 116.35 -0.386 . . . . 1.08 109.993 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.503 ' CG2' HG21 ' A' ' 6' ' ' THR . 83.8 t -130.52 122.26 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.907 -1.121 . . . . 1.05 110.502 172.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.472 ' OD2' HD13 ' B' ' 46' ' ' ILE . 9.9 p-10 -147.6 140.5 24.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 1.77 110.176 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 53.3 t0 43.69 48.46 6.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.134 -0.979 . . . . 1.21 111.059 175.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.7 mt-10 58.41 14.01 2.74 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.199 -0.938 . . . . 1.92 110.679 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -117.0 147.37 42.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 2.49 109.959 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.507 ' CD1' HD13 ' A' ' 20' ' ' ILE . 60.2 mt -100.23 128.22 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -0.928 . . . . 1.85 110.102 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 25.0 mt -111.7 118.61 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 1.22 110.148 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.581 ' CD1' ' N ' ' B' ' 47' ' ' LEU . 4.3 mp -107.9 136.45 47.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 2.23 110.124 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.567 ' HD3' ' CE1' ' B' ' 39' ' ' TYR . 27.3 pttt -138.57 162.43 34.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.489 -0.757 . . . . 2.17 110.07 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -58.82 146.44 37.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.124 -0.985 . . . . 2.25 109.93 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.572 ' CZ ' ' HG3' ' B' ' 52' ' ' PRO . 9.3 t80 -106.03 114.54 28.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 1.21 110.644 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.89 85.53 50.3 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.176 -0.953 . . . . 4.73 110.295 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.572 ' HG3' ' CZ ' ' B' ' 50' ' ' TYR . 35.8 Cg_exo -55.48 144.99 71.15 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.977 1.514 . . . . 4.2 110.296 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.958 -1.02 . . . . 6.56 110.169 -179.949 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.312 0.577 . . . . 11.69 110.206 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.4 mtm -121.65 152.67 39.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.184 -0.947 . . . . 9.04 110.169 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -80.98 132.71 35.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 9.15 110.314 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 85.1 p -142.48 159.61 41.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 4.5 110.185 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.456 ' HB ' HD11 ' A' ' 8' ' ' ILE . 55.8 p -63.07 -40.46 97.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.258 -0.901 . . . . 4.26 110.171 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.22 45.68 90.34 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.582 -1.407 . . . . 1.24 109.582 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.456 HD11 ' HB ' ' A' ' 6' ' ' THR . 59.5 mt -118.08 134.09 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.11 -1.23 . . . . 2.01 110.115 179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 93.0 t -115.95 144.35 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.001 -1.062 . . . . 1.08 110.916 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.44 ' N ' HG13 ' A' ' 9' ' ' VAL . 61.1 ttm-85 -129.23 160.66 32.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.494 -0.753 . . . . 2.25 109.679 177.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -85.25 147.7 26.44 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.067 -1.021 . . . . 2.66 110.385 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.546 ' CG2' HD13 ' B' ' 36' ' ' LEU . 4.0 t -83.09 129.94 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 1.09 109.88 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.461 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.36 -175.18 5.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.96 . . . . 0.55 110.082 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.74 -39.51 74.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.073 -1.017 . . . . 2.19 111.652 -172.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.532 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.2 tp -83.25 -6.61 59.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.831 -1.168 . . . . 1.97 111.499 -174.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.457 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.36 46.76 7.28 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.259 -1.448 . . . . 0.22 109.615 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.536 ' CD ' HG21 ' B' ' 19' ' ' VAL . 70.1 mtm180 -114.33 154.73 27.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.079 -1.247 . . . . 1.33 110.078 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.525 ' CG1' HD11 ' B' ' 36' ' ' LEU . 17.9 m -123.87 152.37 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 1.08 109.763 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.523 HG21 ' CD ' ' B' ' 17' ' ' ARG . 19.9 t -112.97 135.32 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.138 -0.976 . . . . 1.05 110.643 -174.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.513 ' CD1' ' CD1' ' B' ' 45' ' ' ILE . 19.5 mt -81.57 135.96 49.15 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.255 -0.903 . . . . 2.03 109.763 174.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 11.0 Cg_endo -60.02 143.65 99.55 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.754 1.397 . . . . 0.4 109.942 176.027 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.52 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.12 -33.15 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.952 -1.093 . . . . 1.79 110.348 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.431 ' N ' HG22 ' A' ' 22' ' ' ILE . 48.6 tp10 -58.04 -35.41 71.29 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.181 -0.95 . . . . 2.37 109.884 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.531 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 59.6 mt -84.5 -28.25 26.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 2.3 110.664 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.52 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 70.8 mtt180 -57.44 -44.38 84.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.843 -1.161 . . . . 0.33 109.065 175.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.5 mmm180 -73.58 -49.12 27.88 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.862 -0.735 . . . . 3.74 110.671 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.8 m -63.96 -30.96 72.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.141 -0.974 . . . . 1.44 111.121 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.524 ' CD2' HG13 ' A' ' 30' ' ' ILE . 23.0 tp -87.59 -4.93 58.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.069 -1.019 . . . . 1.64 110.769 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.84 41.75 97.35 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.724 -1.35 . . . . 0.34 109.724 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.524 HG13 ' CD2' ' A' ' 28' ' ' LEU . 38.3 mm -116.38 138.45 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -1.17 . . . . 1.16 110.629 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.99 166.88 23.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.575 -0.703 . . . . 1.08 110.002 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.511 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.41 146.25 12.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.055 -1.028 . . . . 1.13 110.61 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.511 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 31.8 ttpt 74.35 -4.35 2.33 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.687 -0.633 . . . . 2.33 111.177 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.462 ' O ' HG23 ' B' ' 12' ' ' VAL . 90.1 m-20 -77.23 166.52 23.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.75 -1.219 . . . . 1.1 110.029 174.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.05 130.09 51.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.159 -0.963 . . . . 1.17 110.77 -176.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.508 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 12.4 mt -106.41 142.54 35.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.349 -0.845 . . . . 1.21 109.403 174.501 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.481 ' HG3' HG21 ' B' ' 9' ' ' VAL . 86.4 tt0 -106.33 138.45 42.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.773 -1.204 . . . . 1.17 109.564 173.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.2 mt -108.28 132.06 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.404 -0.81 . . . . 1.45 110.537 -171.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.569 ' CE1' ' HD2' ' A' ' 48' ' ' LYS . 10.0 m-85 -118.22 159.45 23.3 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 116.259 -0.428 . . . . 1.05 110.001 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.525 HG22 ' CG2' ' B' ' 6' ' ' THR . 72.2 t -133.49 125.9 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.919 -1.113 . . . . 1.08 110.637 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 42.3 p-10 -147.41 143.22 27.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 1.77 110.499 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 51.8 t0 43.44 43.95 4.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.014 -1.054 . . . . 1.22 111.149 174.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 83.7 tt0 60.82 11.76 3.41 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.121 -0.987 . . . . 1.93 110.616 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 53.0 mtmt -111.54 154.64 24.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 2.48 109.779 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.587 ' CD1' ' CD1' ' B' ' 20' ' ' ILE . 66.1 mt -95.16 129.27 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 1.86 109.968 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 22.9 mm -115.12 120.65 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.719 . . . . 1.24 109.915 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.2 mp -117.63 135.17 54.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.981 -1.075 . . . . 2.25 110.25 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.569 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 8.2 ptpt -142.74 162.21 36.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.384 -0.823 . . . . 2.26 110.418 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.517 ' HD3' ' CD1' ' A' ' 30' ' ' ILE . 22.8 tptm -55.63 147.46 18.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.037 -1.039 . . . . 2.12 109.789 176.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -100.3 119.72 38.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -0.843 . . . . 0.96 110.524 -176.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 51' ' ' LYS . 13.7 pttt -99.31 123.15 49.57 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.395 -0.816 . . . . 3.58 109.71 174.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.11 145.96 90.06 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.766 1.403 . . . . 0.48 110.34 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.0 t30 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.008 -0.996 . . . . 2.9 110.267 179.477 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 67.5 t80 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.185 0.517 . . . . 12.33 110.103 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 87.5 mtp -125.0 161.52 26.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 8.85 110.234 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.462 ' HD3' ' OE2' ' A' ' 37' ' ' GLU . 98.4 mttt -88.31 144.8 26.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 9.64 110.147 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 66.2 m -71.92 -93.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 5.64 110.418 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.525 ' CG2' HG22 ' A' ' 40' ' ' VAL . 54.9 p -73.85 -40.6 63.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.015 -1.053 . . . . 3.35 110.269 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.98 46.03 90.53 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.564 -1.414 . . . . 1.53 109.564 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.437 HD13 ' HB ' ' B' ' 6' ' ' THR . 60.0 mt -118.19 133.92 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.053 -1.263 . . . . 1.97 110.085 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.508 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 91.7 t -115.93 144.35 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.971 -1.08 . . . . 1.11 110.925 -176.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.429 ' N ' HG13 ' B' ' 9' ' ' VAL . 61.2 ttm-85 -129.19 160.45 32.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.457 -0.777 . . . . 2.26 109.759 177.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -85.19 147.59 26.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.038 -1.039 . . . . 2.65 110.425 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.487 ' CG2' ' HG ' ' A' ' 36' ' ' LEU . 4.0 t -82.95 129.97 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.4 -0.813 . . . . 1.06 109.894 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.449 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.61 -175.04 5.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.153 -0.967 . . . . 0.55 110.135 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . 0.47 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -56.87 -39.44 74.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.081 -1.012 . . . . 2.19 111.496 -172.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.526 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 15.1 tp -83.27 -6.56 59.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.787 -1.196 . . . . 1.99 111.527 -174.196 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.471 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.9 47.5 7.12 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.54 -1.424 . . . . 0.23 109.54 -177.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.526 ' HD3' ' CD2' ' B' ' 15' ' ' LEU . 70.0 mtm180 -114.5 154.67 27.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.028 -1.278 . . . . 1.33 110.131 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.503 HG23 ' CD2' ' A' ' 47' ' ' LEU . 17.8 m -123.93 152.31 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 1.08 109.737 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.536 HG21 ' CD ' ' A' ' 17' ' ' ARG . 19.8 t -113.0 135.26 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 1.07 110.712 -174.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.587 ' CD1' ' CD1' ' A' ' 45' ' ' ILE . 19.2 mt -81.5 135.96 49.36 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 1.99 109.734 174.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 11.0 Cg_endo -60.15 143.53 99.53 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.801 1.422 . . . . 0.4 110.036 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.533 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.2 tp -55.13 -32.92 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.018 -1.051 . . . . 1.78 110.399 -178.496 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -57.93 -36.12 72.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.058 -1.026 . . . . 2.37 109.777 178.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.526 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 60.1 mt -83.74 -28.55 28.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.532 -0.73 . . . . 2.36 110.628 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.533 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 70.2 mtt180 -57.35 -44.32 84.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.792 -1.193 . . . . 0.33 109.044 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.405 ' HA ' ' HD2' ' B' ' 26' ' ' ARG . 32.5 mmm180 -73.49 -49.31 27.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.357 -0.84 . . . . 3.75 110.664 -177.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.1 m -63.68 -31.64 72.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.896 . . . . 1.38 110.919 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.517 ' CD2' HG13 ' B' ' 30' ' ' ILE . 23.2 tp -87.01 -5.33 59.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.032 -1.042 . . . . 1.61 110.731 -176.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.24 41.53 96.75 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.562 -1.415 . . . . 0.34 109.562 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.527 ' CD1' ' HD3' ' B' ' 49' ' ' LYS . 37.9 mm -116.27 138.39 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -1.182 . . . . 1.13 110.694 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.78 167.04 23.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.612 -0.68 . . . . 1.07 109.987 -177.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.517 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.41 146.39 12.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.141 -0.975 . . . . 1.13 110.523 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.517 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 31.7 ttpt 74.42 -4.64 2.27 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.699 -0.626 . . . . 2.39 111.174 176.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 90.4 m-20 -77.21 166.26 23.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.853 -1.154 . . . . 1.1 110.067 174.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.97 130.09 51.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 1.13 110.753 -176.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.546 HD13 ' CG2' ' A' ' 12' ' ' VAL . 12.2 mt -106.47 142.25 36.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 1.35 109.471 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.472 ' HA ' HG21 ' A' ' 9' ' ' VAL . 86.1 tt0 -106.06 138.44 42.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.825 -1.172 . . . . 1.17 109.72 173.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.22 132.06 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.367 -0.833 . . . . 1.48 110.486 -171.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.58 ' CE1' ' HD2' ' B' ' 48' ' ' LYS . 10.0 m-85 -118.31 159.34 23.56 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 116.261 -0.427 . . . . 1.08 110.001 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.436 HG21 HG23 ' A' ' 6' ' ' THR . 72.4 t -133.22 126.27 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.936 -1.102 . . . . 1.05 110.466 172.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' B' ' 41' ' ' ASP . 42.5 p-10 -147.81 143.22 27.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 1.77 110.466 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 52.4 t0 43.47 44.04 4.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.934 . . . . 1.21 111.108 174.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.5 tt0 60.67 11.87 3.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.028 -1.045 . . . . 1.92 110.571 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 53.0 mtmt -111.56 154.76 24.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.185 -0.947 . . . . 2.49 109.71 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.513 ' CD1' ' CD1' ' A' ' 20' ' ' ILE . 66.2 mt -95.26 129.14 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 1.85 110.0 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 22.6 mm -115.15 120.7 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 1.22 109.817 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.3 mp -117.46 135.05 54.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.014 -1.054 . . . . 2.23 110.294 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.58 ' HD2' ' CE1' ' B' ' 39' ' ' TYR . 8.1 ptpt -142.65 162.39 35.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.843 . . . . 2.17 110.392 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.527 ' HD3' ' CD1' ' B' ' 30' ' ' ILE . 22.8 tptm -55.63 147.3 18.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.114 -0.992 . . . . 2.25 109.83 176.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.517 ' CZ ' HG22 ' A' ' 9' ' ' VAL . 5.3 t80 -100.29 115.99 31.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 1.21 110.525 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.69 93.27 38.05 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.366 -0.834 . . . . 4.73 110.181 179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.48 143.55 87.25 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.861 1.453 . . . . 4.2 110.396 -178.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 118.019 -0.991 . . . . 6.56 110.201 -179.159 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.4 t80 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.342 0.592 . . . . 11.69 110.172 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.8 mtm -85.83 159.42 19.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.174 -0.954 . . . . 9.04 110.316 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -79.52 157.1 27.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.867 . . . . 9.15 110.368 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.3 m -58.52 158.68 7.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.856 . . . . 4.5 110.323 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.505 HG21 ' CG2' ' B' ' 40' ' ' VAL . 59.1 p -62.37 -37.11 84.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.326 -0.859 . . . . 4.26 110.288 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.56 46.22 71.0 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.493 -1.443 . . . . 1.24 109.493 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.4 mt -118.16 136.06 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.169 -1.195 . . . . 2.01 110.087 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.646 ' CG1' ' CD2' ' B' ' 50' ' ' TYR . 92.7 t -115.1 144.34 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.033 -1.042 . . . . 1.08 110.856 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.527 ' CZ ' HG21 ' A' ' 19' ' ' VAL . 68.9 ttt-85 -129.91 160.07 34.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.48 -0.762 . . . . 2.25 109.684 177.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -86.44 149.03 25.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.103 -0.998 . . . . 2.66 110.466 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.544 ' CG2' HD13 ' B' ' 36' ' ' LEU . 3.9 t -82.99 129.64 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.241 -0.912 . . . . 1.09 109.873 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.19 -174.67 5.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.145 -0.972 . . . . 0.55 110.182 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -53.62 -41.81 67.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.18 -0.95 . . . . 2.19 111.783 -173.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.531 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.2 tp -85.79 -4.26 59.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.709 -1.244 . . . . 1.97 111.619 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.508 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.09 46.31 7.72 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.184 -1.484 . . . . 0.22 109.645 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.55 ' CD ' ' CG2' ' B' ' 19' ' ' VAL . 74.6 mtm180 -115.56 154.35 29.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.15 -1.206 . . . . 1.33 109.933 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.523 HG23 ' CD2' ' B' ' 47' ' ' LEU . 16.6 m -124.61 152.23 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 1.08 109.898 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.535 ' CG2' ' CD ' ' B' ' 17' ' ' ARG . 21.9 t -112.25 135.44 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.932 . . . . 1.05 110.514 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.491 HG22 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.04 134.57 46.11 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 2.03 109.577 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.9 Cg_endo -58.73 143.8 98.54 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.793 1.417 . . . . 0.4 110.104 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.518 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.19 -32.08 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.988 -1.07 . . . . 1.79 110.386 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.29 -34.88 72.82 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.118 -0.989 . . . . 2.37 109.901 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.526 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 62.4 mt -83.19 -29.68 28.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 2.3 110.57 178.416 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.518 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 73.6 mtt180 -57.55 -43.96 84.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.877 -1.139 . . . . 0.33 109.107 175.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -71.64 -50.11 33.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.518 -0.739 . . . . 3.74 110.707 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.0 m -63.38 -32.02 73.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.218 -0.926 . . . . 1.44 111.088 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.519 ' CD2' HG13 ' A' ' 30' ' ' ILE . 21.0 tp -88.39 -4.86 58.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.064 -1.022 . . . . 1.64 110.751 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.42 42.82 97.46 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.667 -1.373 . . . . 0.34 109.667 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.519 HG13 ' CD2' ' A' ' 28' ' ' LEU . 35.3 mm -116.36 138.75 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.242 -1.152 . . . . 1.16 110.74 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.06 167.26 22.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.617 -0.677 . . . . 1.08 110.092 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.2 tt0 -53.26 147.09 10.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.075 -1.016 . . . . 1.13 110.542 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 29.3 tttt 74.65 -4.92 2.23 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.781 -0.574 . . . . 2.33 111.123 177.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.458 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.9 m-20 -77.49 165.36 24.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.81 -1.181 . . . . 1.1 110.019 174.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . . . -104.69 131.61 51.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.209 -0.932 . . . . 1.17 110.74 -176.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.495 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 13.6 mt -109.57 140.63 43.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 1.21 109.575 175.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.448 ' HA ' HG23 ' B' ' 9' ' ' VAL . 84.8 tt0 -103.67 138.56 40.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.823 -1.173 . . . . 1.17 109.528 171.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.6 mt -111.47 133.27 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.369 -0.832 . . . . 1.45 110.512 -173.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.574 ' CE1' ' HD2' ' A' ' 48' ' ' LYS . 8.5 m-85 -114.53 160.76 18.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 122.068 -0.395 . . . . 1.05 110.218 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.569 ' CG2' ' CG2' ' B' ' 6' ' ' THR . 94.1 t -133.9 117.69 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 1.08 110.83 173.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.486 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 6.2 p-10 -147.69 160.23 42.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 1.77 110.031 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 22.5 t70 42.47 41.46 2.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.097 . . . . 1.22 111.332 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 75.5 mm-40 57.4 15.71 2.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.07 -1.019 . . . . 1.93 110.651 175.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.486 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 56.1 pttt -130.78 163.21 27.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.156 -0.965 . . . . 2.48 109.887 175.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.453 HD13 HG13 ' B' ' 20' ' ' ILE . 61.2 mt -104.21 134.74 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.046 -1.034 . . . . 1.86 110.516 -173.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.51 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 26.7 mt -112.96 119.27 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -0.833 . . . . 1.24 110.249 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.583 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 4.1 mp -108.12 134.84 50.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.932 . . . . 2.25 109.987 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.574 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 1.8 ptpm? -140.79 163.5 32.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.417 -0.802 . . . . 2.26 110.296 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.7 tttp -55.12 148.08 14.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.109 -0.995 . . . . 2.12 109.776 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.46 ' CD2' ' CG1' ' B' ' 9' ' ' VAL . 1.7 t80 -101.21 122.48 43.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.96 110.565 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -99.38 123.2 49.27 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 3.58 109.796 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.447 ' O ' ' OXT' ' A' ' 53' ' ' ASN . 15.8 Cg_endo -62.98 146.0 94.6 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.733 1.386 . . . . 0.48 110.22 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.447 ' OXT' ' O ' ' A' ' 52' ' ' PRO . 37.3 p-10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.019 -0.991 . . . . 2.9 110.267 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 65.0 t80 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.277 0.561 . . . . 12.33 110.149 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 64.3 mtt -104.32 143.9 32.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 8.85 110.168 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -100.76 135.8 41.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 9.64 110.407 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 86.3 p -142.78 155.2 44.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 5.64 109.852 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.569 ' CG2' ' CG2' ' A' ' 40' ' ' VAL . 58.6 p -68.66 -37.35 79.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 3.35 110.231 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.36 46.52 69.95 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.393 -1.483 . . . . 1.53 109.393 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.466 HD12 HG23 ' B' ' 8' ' ' ILE . 61.8 mt -118.14 136.03 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.168 -1.195 . . . . 1.97 110.134 -179.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 91.1 t -115.17 144.32 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.028 -1.045 . . . . 1.11 110.855 -176.492 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.507 ' CZ ' HG23 ' B' ' 19' ' ' VAL . 68.8 ttt-85 -129.85 159.89 35.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.479 -0.763 . . . . 2.26 109.782 177.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -86.32 148.88 25.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 2.65 110.472 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.528 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 3.9 t -82.83 129.73 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.265 -0.897 . . . . 1.06 109.867 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.454 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -85.46 -174.49 5.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.105 -0.997 . . . . 0.55 110.239 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . 0.462 ' OE1' ' OE2' ' A' ' 32' ' ' GLU . 47.5 tp10 -53.82 -41.61 67.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.17 -0.956 . . . . 2.19 111.765 -173.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.525 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.9 tp -85.99 -4.14 59.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.722 -1.236 . . . . 1.99 111.592 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.528 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.72 46.97 7.52 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.524 -1.431 . . . . 0.23 109.524 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.535 ' CD ' ' CG2' ' A' ' 19' ' ' VAL . 74.2 mtm180 -115.76 154.28 29.89 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.083 -1.245 . . . . 1.33 109.96 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.477 HG22 ' CD2' ' A' ' 47' ' ' LEU . 16.6 m -124.6 152.25 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 1.08 109.899 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.55 ' CG2' ' CD ' ' A' ' 17' ' ' ARG . 21.9 t -112.34 135.38 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.93 . . . . 1.07 110.505 -175.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.49 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.99 134.49 46.44 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 1.99 109.554 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.522 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.8 Cg_endo -58.83 143.84 98.92 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.803 1.423 . . . . 0.4 110.053 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.533 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.28 -31.86 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.042 -1.036 . . . . 1.78 110.446 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.18 -35.57 73.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.057 -1.027 . . . . 2.37 109.758 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.522 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 62.7 mt -82.49 -30.06 30.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.408 -0.808 . . . . 2.36 110.602 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.533 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 73.1 mtt180 -57.34 -43.85 83.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.877 -1.139 . . . . 0.33 109.106 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -71.53 -50.54 30.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.418 -0.801 . . . . 3.75 110.614 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 60.8 m -62.98 -32.58 73.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.342 -0.849 . . . . 1.38 110.948 -177.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.526 ' CD2' HG13 ' B' ' 30' ' ' ILE . 21.2 tp -87.84 -5.32 58.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.981 -1.074 . . . . 1.61 110.759 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.79 42.64 97.0 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.575 -1.41 . . . . 0.34 109.575 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.526 HG13 ' CD2' ' B' ' 28' ' ' LEU . 34.8 mm -116.2 138.63 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -1.199 . . . . 1.13 110.816 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.82 167.43 22.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.605 -0.685 . . . . 1.07 109.97 -178.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.25 147.18 10.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 1.13 110.515 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.513 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 29.2 tttt 74.69 -5.01 2.21 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.733 -0.604 . . . . 2.39 111.206 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 89.5 m-20 -77.63 164.98 24.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.821 -1.174 . . . . 1.1 109.998 174.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.45 ' HB3' ' HB3' ' B' ' 50' ' ' TYR . . . -104.41 131.58 51.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 1.13 110.833 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.544 HD13 ' CG2' ' A' ' 12' ' ' VAL . 13.4 mt -109.62 140.42 43.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 1.35 109.632 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.473 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.7 tt0 -103.43 138.56 39.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.829 -1.169 . . . . 1.17 109.749 171.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.8 mt -111.4 133.19 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.882 . . . . 1.48 110.524 -172.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.568 ' CE1' ' HD2' ' B' ' 48' ' ' LYS . 8.4 m-85 -114.48 160.7 18.9 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 120.958 0.409 . . . . 1.08 110.275 -177.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.505 ' CG2' HG21 ' A' ' 6' ' ' THR . 94.8 t -133.64 118.14 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.986 -1.071 . . . . 1.05 110.559 173.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.489 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 6.3 p-10 -148.29 160.2 43.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 1.77 110.033 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 22.7 t70 42.46 41.7 2.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -0.985 . . . . 1.21 111.225 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 75.5 mm-40 57.23 15.61 2.62 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.079 -1.013 . . . . 1.92 110.71 175.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 56.1 pttt -130.58 163.45 27.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.955 . . . . 2.49 109.866 174.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.422 HD11 HG13 ' A' ' 20' ' ' ILE . 60.5 mt -104.31 134.67 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.153 -0.967 . . . . 1.85 110.616 -173.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 27.5 mt -113.05 119.31 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 1.22 110.21 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' B' ' 47' ' ' LEU . 4.2 mp -108.04 134.75 50.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.214 -0.929 . . . . 2.23 109.978 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.568 ' HD2' ' CE1' ' B' ' 39' ' ' TYR . 1.8 ptpm? -140.69 163.63 32.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.422 -0.798 . . . . 2.17 110.288 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -55.12 147.93 15.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 2.25 109.696 176.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.646 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 1.7 t80 -101.25 120.92 40.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 1.21 110.587 -175.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.561 ' CB ' ' HD3' ' B' ' 52' ' ' PRO . 0.0 OUTLIER -97.01 -56.25 0.2 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 4.73 110.776 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.585 ' O ' ' CZ ' ' B' ' 50' ' ' TYR . 26.5 Cg_exo -54.59 154.42 20.24 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.491 1.258 . . . . 4.2 110.373 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.972 -1.013 . . . . 6.56 110.225 -178.462 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.203 0.525 . . . . 11.69 110.272 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.5 mtt -118.66 147.96 43.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.345 -0.847 . . . . 9.04 110.125 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -102.99 137.06 41.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 9.15 110.392 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -137.55 144.97 42.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 4.5 110.031 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.443 HG21 HG21 ' B' ' 40' ' ' VAL . 72.5 p -63.1 -39.4 94.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.076 -1.015 . . . . 4.26 110.064 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.08 46.1 67.83 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.711 -1.356 . . . . 1.24 109.711 176.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.1 mm -113.77 132.32 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.021 -1.282 . . . . 2.01 110.016 179.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 87.0 t -117.91 144.03 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.024 -1.048 . . . . 1.08 110.94 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.461 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 27.7 tpt180 -128.57 160.56 32.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.549 -0.72 . . . . 2.25 109.65 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.461 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 94.8 mttt -84.92 146.87 27.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 2.66 110.297 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.546 ' CG2' HD13 ' B' ' 36' ' ' LEU . 4.1 t -82.27 127.49 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 1.09 109.757 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.27 -175.07 5.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.128 -0.983 . . . . 0.55 109.985 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.8 -39.14 73.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.998 -1.064 . . . . 2.19 111.596 -172.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.531 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 16.4 tp -83.0 -6.62 59.56 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.805 -1.185 . . . . 1.97 111.531 -174.408 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.48 46.62 7.3 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.173 -1.489 . . . . 0.22 109.654 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.535 ' CD ' HG23 ' B' ' 19' ' ' VAL . 69.1 mtm180 -114.07 154.44 27.72 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.018 -1.283 . . . . 1.33 110.007 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.531 ' CG1' HD11 ' B' ' 36' ' ' LEU . 17.7 m -123.56 151.97 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 1.08 109.799 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.525 HG21 ' CD ' ' B' ' 17' ' ' ARG . 17.1 t -113.61 133.56 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 1.05 110.762 -174.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.523 ' CD1' HD12 ' B' ' 45' ' ' ILE . 2.5 mm -85.28 136.97 37.23 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.908 . . . . 2.03 109.483 174.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.53 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -58.85 141.18 97.76 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.676 1.356 . . . . 0.4 109.965 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.525 ' HA ' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -55.83 -32.03 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.946 -1.096 . . . . 1.79 110.407 -177.641 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.64 -35.31 72.31 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.034 -1.041 . . . . 2.37 109.77 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.53 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 45.3 mt -81.4 -28.97 34.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 2.3 110.52 176.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.525 ' CD ' ' HA ' ' A' ' 22' ' ' ILE . 72.6 mtt180 -56.93 -44.25 82.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.916 -1.115 . . . . 0.33 108.942 175.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -72.03 -49.26 38.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.574 -0.704 . . . . 3.74 110.735 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.7 m -63.55 -31.22 72.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 1.44 111.119 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.479 ' CD2' HG13 ' A' ' 30' ' ' ILE . 21.4 tp -87.24 -4.66 59.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.004 -1.06 . . . . 1.64 110.712 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.18 40.92 95.09 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.721 -1.352 . . . . 0.34 109.721 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.479 HG13 ' CD2' ' A' ' 28' ' ' LEU . 35.4 mm -116.33 139.09 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.309 -1.112 . . . . 1.16 110.623 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -141.55 166.5 24.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.546 -0.721 . . . . 1.08 110.124 -177.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.515 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.47 146.65 12.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.973 . . . . 1.13 110.591 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 15.1 tptt 74.83 -4.62 2.32 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.759 -0.588 . . . . 2.33 111.092 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.469 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.8 m-20 -77.42 166.74 22.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.792 -1.193 . . . . 1.1 110.021 174.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.53 131.94 52.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 1.17 110.748 -176.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.511 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 13.9 mt -109.03 142.05 40.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.422 -0.799 . . . . 1.21 109.519 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.452 ' HA ' HG23 ' B' ' 9' ' ' VAL . 85.0 tt0 -108.29 139.89 42.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.879 -1.138 . . . . 1.17 109.784 173.043 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.0 mm -111.86 133.98 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.332 -0.855 . . . . 1.45 110.553 -173.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.576 ' CE1' ' HD2' ' A' ' 48' ' ' LYS . 8.2 m-85 -115.34 162.03 17.69 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 120.955 0.407 . . . . 1.05 110.045 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.513 HG21 ' CG2' ' B' ' 6' ' ' THR . 92.2 t -133.48 121.79 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.926 -1.108 . . . . 1.08 110.92 173.085 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.514 ' O ' ' CG ' ' A' ' 44' ' ' LYS . 6.3 p-10 -147.31 152.53 38.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 1.77 110.129 176.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 53.7 t0 43.02 45.34 4.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.122 -0.986 . . . . 1.22 111.32 173.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 96.0 mt-10 56.99 16.91 3.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.028 -1.045 . . . . 1.93 110.548 175.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' A' ' 41' ' ' ASP . 16.2 ptpt -129.73 159.61 35.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 2.48 109.872 176.114 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.487 ' CD1' ' CD1' ' B' ' 20' ' ' ILE . 57.8 mt -104.33 133.48 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 1.86 110.607 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.507 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 33.4 mt -112.11 120.53 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.507 -0.745 . . . . 1.24 110.283 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.5 mp -109.74 135.38 50.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.11 -0.994 . . . . 2.25 110.015 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.576 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 1.8 ptpm? -141.09 162.83 34.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 2.26 110.3 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -57.94 146.54 31.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.171 -0.956 . . . . 2.12 110.03 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 8.1 t80 -105.94 120.12 40.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.307 -0.871 . . . . 0.96 110.655 -176.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -99.64 122.71 50.43 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.275 -0.891 . . . . 3.58 109.47 172.462 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.04 146.62 87.74 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.743 1.391 . . . . 0.48 110.291 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.958 -1.02 . . . . 2.9 110.206 179.884 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 66.5 t80 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.248 0.547 . . . . 12.33 110.19 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 87.9 mtp -96.1 148.8 22.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.319 -0.863 . . . . 8.85 110.139 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -87.38 142.32 27.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 9.64 110.396 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 51.1 m -121.9 153.57 38.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.342 -0.849 . . . . 5.64 110.047 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.513 ' CG2' HG21 ' A' ' 40' ' ' VAL . 72.7 p -55.42 -39.3 70.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 3.35 110.019 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.89 46.44 66.92 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.652 -1.379 . . . . 1.53 109.652 176.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 19.0 mm -113.88 132.32 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.093 -1.239 . . . . 1.97 109.962 179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 86.7 t -118.03 144.0 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.014 -1.054 . . . . 1.11 110.925 -175.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.461 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 27.6 tpt180 -128.49 160.36 32.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.552 -0.717 . . . . 2.26 109.76 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.461 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 94.8 mttt -84.82 146.8 27.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.038 -1.039 . . . . 2.65 110.283 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.475 ' CG2' HD13 ' A' ' 36' ' ' LEU . 4.1 t -82.29 127.52 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 1.06 109.767 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.458 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -85.35 -174.86 5.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.18 -0.95 . . . . 0.55 110.111 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . 0.465 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.9 mt-10 -57.07 -38.91 73.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.099 -1.001 . . . . 2.19 111.554 -172.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.525 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 15.8 tp -83.09 -6.74 59.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.796 -1.19 . . . . 1.99 111.51 -174.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.18 47.31 7.07 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.508 -1.437 . . . . 0.23 109.508 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.525 ' HD3' ' CD2' ' B' ' 15' ' ' LEU . 69.2 mtm180 -114.17 154.35 27.99 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.082 -1.246 . . . . 1.33 110.074 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.521 HG22 ' CD2' ' A' ' 47' ' ' LEU . 17.7 m -123.52 152.0 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.86 . . . . 1.08 109.794 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.535 HG23 ' CD ' ' A' ' 17' ' ' ARG . 16.8 t -113.57 133.57 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.158 -0.963 . . . . 1.07 110.748 -174.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.487 ' CD1' ' CD1' ' A' ' 45' ' ' ILE . 2.6 mm -85.3 136.96 37.21 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 1.99 109.526 174.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.527 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.0 Cg_endo -58.94 141.19 97.96 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.547 1.288 . . . . 0.4 110.023 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.524 HD12 HG23 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -56.08 -31.7 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.09 -1.006 . . . . 1.78 110.373 -177.368 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.58 -35.94 73.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.051 -1.03 . . . . 2.37 109.661 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.527 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 45.4 mt -80.65 -29.35 36.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.448 -0.782 . . . . 2.36 110.526 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.517 ' CD ' ' HA ' ' B' ' 22' ' ' ILE . 72.1 mtt180 -56.81 -44.06 81.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.836 -1.165 . . . . 0.33 109.001 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -71.98 -49.56 36.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.542 -0.723 . . . . 3.75 110.628 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.0 m -63.22 -31.8 73.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.286 -0.884 . . . . 1.38 110.898 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.472 ' CD2' HG13 ' B' ' 30' ' ' ILE . 21.7 tp -86.72 -5.02 59.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.122 -0.986 . . . . 1.61 110.69 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.58 40.69 94.22 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.613 -1.395 . . . . 0.34 109.613 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.472 HG13 ' CD2' ' B' ' 28' ' ' LEU . 34.8 mm -116.39 139.03 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -1.123 . . . . 1.13 110.604 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.34 166.6 24.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.559 -0.713 . . . . 1.07 110.071 -177.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.521 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.43 146.71 11.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 1.13 110.508 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 15.1 tptt 74.88 -4.91 2.26 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.695 -0.628 . . . . 2.39 111.184 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 89.1 m-20 -77.4 166.48 23.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.769 -1.207 . . . . 1.1 110.094 174.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.401 ' HB2' ' HB3' ' B' ' 50' ' ' TYR . . . -105.32 131.86 52.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.134 -0.979 . . . . 1.13 110.781 -176.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.546 HD13 ' CG2' ' A' ' 12' ' ' VAL . 13.7 mt -109.1 141.77 40.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 1.35 109.6 175.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.471 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.9 tt0 -107.97 139.9 41.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.932 -1.105 . . . . 1.17 109.892 173.011 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.409 HD11 ' O ' ' B' ' 37' ' ' GLU . 21.9 mm -111.95 134.14 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.352 -0.842 . . . . 1.48 110.443 -173.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.572 ' CE1' ' HD2' ' B' ' 48' ' ' LYS . 8.0 m-85 -115.43 162.0 17.77 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 116.315 -0.402 . . . . 1.08 110.078 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.443 HG21 HG21 ' A' ' 6' ' ' THR . 92.2 t -133.23 122.21 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.931 -1.106 . . . . 1.05 110.633 173.162 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.523 ' O ' ' CG ' ' B' ' 44' ' ' LYS . 6.5 p-10 -147.84 152.56 37.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 1.77 110.114 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 54.2 t0 42.98 45.54 4.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.164 -0.96 . . . . 1.21 111.258 173.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.9 mt-10 56.85 16.89 2.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.983 -1.073 . . . . 1.92 110.594 175.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' B' ' 41' ' ' ASP . 16.2 ptpt -129.67 159.88 35.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 2.49 109.763 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.523 HD12 ' CD1' ' A' ' 20' ' ' ILE . 57.3 mt -104.39 133.51 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.124 -0.985 . . . . 1.85 110.687 -173.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.531 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 34.7 mt -112.34 120.57 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.389 -0.819 . . . . 1.22 110.181 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.6 mp -109.63 135.24 50.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.196 -0.94 . . . . 2.23 110.071 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.572 ' HD2' ' CE1' ' B' ' 39' ' ' TYR . 1.8 ptpm? -140.99 163.03 34.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.454 -0.778 . . . . 2.17 110.248 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -57.93 146.55 31.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 2.25 109.988 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.424 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 8.3 t80 -106.18 117.28 33.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 1.21 110.596 -176.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.41 106.79 54.1 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.17 -0.956 . . . . 4.73 110.205 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -55.57 145.33 70.3 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.977 1.514 . . . . 4.2 110.308 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.009 -0.996 . . . . 6.56 110.144 -179.78 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.1 t80 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.264 0.554 . . . . 11.69 110.142 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.7 mmm -88.98 165.95 14.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 9.04 110.225 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -68.75 170.89 8.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.331 -0.855 . . . . 9.15 110.17 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.534 ' O ' ' CG2' ' A' ' 6' ' ' THR . 36.8 m -53.46 153.07 4.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.176 -0.952 . . . . 4.5 110.154 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 5' ' ' SER . 0.8 OUTLIER -170.24 64.4 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.852 . . . . 4.26 109.966 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.09 49.73 4.63 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.359 -1.4 . . . . 1.24 110.045 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.401 HD12 HG22 ' A' ' 8' ' ' ILE . 61.8 mt -103.76 136.2 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.998 -1.295 . . . . 2.01 109.594 179.229 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 75.1 t -110.94 143.87 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.791 -1.193 . . . . 1.08 111.394 -170.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.489 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 28.7 tpt180 -125.85 163.11 23.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.645 -0.659 . . . . 2.25 109.527 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.489 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 56.6 mttm -84.98 146.54 27.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.986 -1.071 . . . . 2.66 110.453 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.549 ' CG2' HD12 ' B' ' 36' ' ' LEU . 3.9 t -83.51 130.29 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.385 -0.822 . . . . 1.09 109.876 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.74 -175.54 5.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.048 -1.032 . . . . 0.55 110.03 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.85 -39.33 74.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.998 -1.064 . . . . 2.19 111.677 -172.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.527 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.1 tp -83.26 -6.67 59.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.735 -1.228 . . . . 1.97 111.524 -174.008 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.45 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.47 46.58 7.32 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.176 -1.488 . . . . 0.22 109.715 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.532 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.5 mtm180 -113.88 154.73 27.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.953 -1.322 . . . . 1.33 110.043 -177.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.524 ' CG1' HD13 ' B' ' 36' ' ' LEU . 15.4 m -123.84 152.72 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 1.08 109.755 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.529 HG23 ' CD ' ' B' ' 17' ' ' ARG . 21.4 t -111.28 135.12 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 1.05 110.671 -175.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.53 ' CD1' HD13 ' B' ' 45' ' ' ILE . 16.2 mt -81.63 135.05 49.8 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.274 -0.891 . . . . 2.03 109.675 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.529 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.4 Cg_endo -58.32 142.61 97.68 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.67 1.352 . . . . 0.4 109.954 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.517 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.18 -32.16 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.899 -1.126 . . . . 1.79 110.389 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.39 -34.87 72.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.055 -1.028 . . . . 2.37 109.888 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.529 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 52.3 mt -81.86 -30.72 31.89 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.277 -0.889 . . . . 2.3 110.532 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.517 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 72.1 mtt180 -57.94 -44.19 86.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.95 -1.093 . . . . 0.33 109.2 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -73.82 -49.9 23.03 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.831 -0.748 . . . . 3.74 110.653 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.6 m -64.12 -31.15 72.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.201 -0.937 . . . . 1.44 111.11 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.44 HD23 HG13 ' A' ' 30' ' ' ILE . 18.7 tp -87.82 -4.68 58.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.039 -1.038 . . . . 1.64 110.739 -176.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.07 43.28 93.68 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.685 -1.366 . . . . 0.34 109.685 178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.44 HG13 HD23 ' A' ' 28' ' ' LEU . 32.8 mm -115.96 138.19 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -1.162 . . . . 1.16 110.671 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.78 167.0 23.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.579 -0.7 . . . . 1.08 110.049 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.58 145.79 14.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 1.13 110.601 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 69.1 tttt 74.43 -4.34 2.34 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.708 -0.62 . . . . 2.33 111.073 176.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.469 ' O ' HG21 ' B' ' 12' ' ' VAL . 89.7 m-20 -76.97 168.29 20.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.816 -1.177 . . . . 1.1 109.962 174.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.82 131.37 53.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.937 . . . . 1.17 110.798 -176.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.526 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 9.5 mt -107.61 144.23 34.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.369 -0.832 . . . . 1.21 109.267 174.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.455 ' HA ' HG23 ' B' ' 9' ' ' VAL . 86.4 tt0 -108.35 137.93 45.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.696 -1.253 . . . . 1.17 109.648 173.514 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.5 mt -108.42 133.29 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.452 -0.78 . . . . 1.45 110.571 -172.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.573 ' CE1' ' HD2' ' A' ' 48' ' ' LYS . 10.3 m-85 -119.38 159.98 23.16 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 116.319 -0.401 . . . . 1.05 110.001 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.523 ' CG2' ' OG ' ' B' ' 5' ' ' SER . 76.8 t -133.22 127.25 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.98 -1.075 . . . . 1.08 110.564 173.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.472 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 39.1 p-10 -147.23 137.99 23.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 1.77 110.658 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.472 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.7 t0 43.74 47.36 6.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.043 -1.035 . . . . 1.22 111.306 174.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.5 tt0 61.02 11.8 3.57 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.193 -0.942 . . . . 1.93 110.622 175.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 35.4 mtmt -113.07 151.91 30.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 2.48 109.71 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.523 ' CD1' HD13 ' B' ' 20' ' ' ILE . 65.9 mt -94.73 129.78 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 1.86 109.977 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 27.6 mm -114.95 120.93 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.465 -0.772 . . . . 1.24 109.928 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.588 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.4 mp -118.34 136.04 53.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.973 -1.079 . . . . 2.25 110.257 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.573 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 5.0 ptpt -142.67 158.24 43.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.339 -0.85 . . . . 2.26 110.333 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -57.88 146.59 31.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -0.958 . . . . 2.12 109.934 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.436 ' CZ ' HG21 ' B' ' 9' ' ' VAL . 14.5 t80 -103.24 119.87 39.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.96 110.729 -175.566 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -99.63 122.54 51.0 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.198 -0.938 . . . . 3.58 109.415 171.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.58 147.0 86.04 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.797 1.419 . . . . 0.48 110.297 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.029 -0.986 . . . . 2.9 110.241 179.627 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 49.7 p90 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.235 0.541 . . . . 12.33 110.211 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' MET . . . . . 0.407 ' SD ' ' OE2' ' B' ' 23' ' ' GLU . 50.3 ttm -111.18 91.32 3.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 8.85 110.162 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -135.22 146.0 48.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.338 -0.851 . . . . 9.64 110.056 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.551 ' O ' ' CG2' ' B' ' 6' ' ' THR . 54.4 p -58.98 153.61 17.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.22 -0.925 . . . . 5.64 110.057 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.551 ' CG2' ' O ' ' B' ' 5' ' ' SER . 0.7 OUTLIER -170.84 64.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.407 -0.808 . . . . 3.35 110.071 -176.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.36 51.1 4.25 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.861 -1.296 . . . . 1.53 109.861 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.416 HD12 HG23 ' B' ' 8' ' ' ILE . 61.9 mt -104.14 135.93 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.992 -1.299 . . . . 1.97 109.725 178.647 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 74.0 t -110.94 143.77 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.741 -1.225 . . . . 1.11 111.375 -170.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.502 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 28.8 tpt180 -125.69 162.96 23.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.527 -0.733 . . . . 2.26 109.596 175.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.502 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 56.7 mttm -84.97 146.52 27.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.071 -1.018 . . . . 2.65 110.484 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.497 ' CG2' ' HG ' ' A' ' 36' ' ' LEU . 4.0 t -83.5 130.38 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.35 -0.844 . . . . 1.06 109.763 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.0 -175.33 5.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.076 -1.015 . . . . 0.55 110.054 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . 0.466 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -57.11 -39.19 74.59 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.028 -1.045 . . . . 2.19 111.554 -172.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.527 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.9 tp -83.23 -6.83 59.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.737 -1.227 . . . . 1.99 111.589 -174.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.457 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.12 47.38 7.06 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.483 -1.447 . . . . 0.23 109.483 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.529 ' CD ' HG23 ' A' ' 19' ' ' VAL . 69.6 mtm180 -114.08 154.67 27.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.026 -1.279 . . . . 1.33 110.059 -177.75 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.443 HG13 ' CD1' ' A' ' 36' ' ' LEU . 15.1 m -123.73 152.74 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 1.08 109.803 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.532 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.4 t -111.41 135.12 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 1.07 110.655 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.523 HD13 ' CD1' ' A' ' 45' ' ' ILE . 15.9 mt -81.64 135.03 49.78 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.326 -0.859 . . . . 1.99 109.602 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.52 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.5 Cg_endo -58.38 142.64 97.87 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.773 1.407 . . . . 0.4 110.045 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.529 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.42 -31.79 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.06 -1.025 . . . . 1.78 110.357 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . 0.407 ' OE2' ' SD ' ' B' ' 3' ' ' MET . 96.8 mt-10 -59.31 -35.59 74.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.019 -1.051 . . . . 2.37 109.787 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.52 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 51.9 mt -81.15 -31.02 34.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 2.36 110.569 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.529 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 71.7 mtt180 -57.85 -43.93 86.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.848 -1.157 . . . . 0.33 109.319 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -73.82 -50.1 22.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 3.75 110.62 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.5 m -63.81 -31.78 73.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.304 -0.872 . . . . 1.38 110.854 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.449 HD21 HG13 ' B' ' 30' ' ' ILE . 18.8 tp -87.35 -4.95 59.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.124 -0.985 . . . . 1.61 110.732 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.4 43.12 93.3 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.626 -1.39 . . . . 0.34 109.626 178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.449 HG13 HD21 ' B' ' 28' ' ' LEU . 32.5 mm -115.96 138.11 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -1.144 . . . . 1.13 110.64 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.418 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.55 167.11 22.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.478 -0.764 . . . . 1.07 109.999 -177.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.64 145.93 14.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 1.13 110.565 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 69.2 tttt 74.49 -4.58 2.29 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.656 -0.653 . . . . 2.39 111.128 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.446 ' O ' HG22 ' A' ' 12' ' ' VAL . 89.9 m-20 -76.97 168.07 20.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.83 -1.169 . . . . 1.1 110.013 174.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.66 131.36 53.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 1.13 110.805 -176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.549 HD12 ' CG2' ' A' ' 12' ' ' VAL . 9.4 mt -107.71 144.04 35.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.391 -0.818 . . . . 1.35 109.291 174.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.45 ' HA ' HG21 ' A' ' 9' ' ' VAL . 86.3 tt0 -108.15 137.81 45.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.764 -1.21 . . . . 1.17 109.881 173.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -108.32 133.35 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.322 -0.861 . . . . 1.48 110.508 -172.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.573 ' CE1' ' HD2' ' B' ' 48' ' ' LYS . 10.3 m-85 -119.41 159.98 23.18 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 116.276 -0.42 . . . . 1.08 110.03 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 76.7 t -133.12 127.56 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.945 -1.097 . . . . 1.05 110.454 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.474 ' OD1' ' O ' ' B' ' 41' ' ' ASP . 39.2 p-10 -147.6 137.98 23.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.34 -0.85 . . . . 1.77 110.58 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 54.4 t0 43.89 47.42 6.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.136 -0.977 . . . . 1.21 111.278 174.318 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.3 tt0 60.85 11.74 3.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.133 -0.979 . . . . 1.92 110.636 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 35.3 mtmt -113.02 152.06 29.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.176 -0.952 . . . . 2.49 109.683 175.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.53 HD13 ' CD1' ' A' ' 20' ' ' ILE . 65.6 mt -94.81 129.57 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 1.85 110.108 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 27.2 mm -114.84 120.94 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.581 -0.699 . . . . 1.22 109.962 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.588 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.4 mp -118.2 135.88 53.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.999 -1.063 . . . . 2.23 110.235 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.573 ' HD2' ' CE1' ' B' ' 39' ' ' TYR . 5.0 ptpt -142.53 158.41 43.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 2.17 110.346 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -57.83 146.47 31.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 2.25 109.955 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.512 ' CZ ' HG22 ' A' ' 9' ' ' VAL . 15.0 t80 -103.34 116.1 31.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 1.21 110.697 -175.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.456 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -110.99 108.57 57.55 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 4.73 110.111 176.396 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -55.83 145.0 74.89 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.011 1.532 . . . . 4.2 110.337 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.993 -1.003 . . . . 6.56 110.205 -179.877 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.233 0.54 . . . . 11.69 110.133 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 71.0 mtm -47.12 -39.91 14.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.146 -0.971 . . . . 9.04 111.3 -174.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -86.36 138.75 31.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.748 -1.22 . . . . 9.15 110.362 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.9 p -75.99 163.47 27.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -0.861 . . . . 4.5 110.145 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 47.6 p -62.52 -38.89 91.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 4.26 110.152 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.22 45.38 70.95 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.72 -1.352 . . . . 1.24 109.72 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.408 HG21 HD12 ' A' ' 8' ' ' ILE . 59.5 mt -118.51 133.7 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.059 -1.26 . . . . 2.01 110.018 178.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.556 HG21 ' CZ ' ' B' ' 50' ' ' TYR . 89.2 t -115.71 144.25 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.013 -1.054 . . . . 1.08 110.855 -176.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.439 ' N ' HG11 ' A' ' 9' ' ' VAL . 69.8 ttt-85 -129.85 160.38 33.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.522 -0.736 . . . . 2.25 109.658 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -85.62 147.73 26.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.029 -1.044 . . . . 2.66 110.33 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.548 ' CG2' HD13 ' B' ' 36' ' ' LEU . 3.8 t -82.33 130.78 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -0.864 . . . . 1.09 109.825 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.469 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.8 -175.55 5.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.128 -0.982 . . . . 0.55 110.02 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.9 -40.77 70.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.134 -0.979 . . . . 2.19 111.733 -173.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.507 HD12 ' NH2' ' B' ' 25' ' ' ARG . 14.1 tp -84.09 -5.51 59.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.746 -1.221 . . . . 1.97 111.493 -173.28 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.516 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.34 46.37 7.53 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.193 -1.479 . . . . 0.22 109.704 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.533 ' CD ' HG23 ' B' ' 19' ' ' VAL . 70.0 mtm180 -114.93 154.53 28.57 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.028 -1.277 . . . . 1.33 109.994 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.516 ' CG1' HD11 ' B' ' 36' ' ' LEU . 16.6 m -123.86 152.01 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 1.08 109.768 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.525 HG22 ' CD ' ' B' ' 17' ' ' ARG . 36.0 t -111.23 134.87 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 1.05 110.724 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.484 HG21 ' HB2' ' A' ' 24' ' ' LEU . 19.0 mt -81.36 133.28 53.7 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.277 -0.89 . . . . 2.03 109.632 174.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.532 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.2 Cg_endo -58.85 143.32 99.34 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.701 1.369 . . . . 0.4 109.985 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.519 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.07 -32.82 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.934 -1.104 . . . . 1.79 110.33 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.11 -35.66 71.77 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.111 -0.993 . . . . 2.37 109.852 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.532 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 57.2 mt -82.83 -29.8 29.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.429 -0.795 . . . . 2.3 110.645 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.519 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 72.0 mtt180 -57.54 -43.88 84.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.887 -1.133 . . . . 0.33 109.166 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -73.06 -50.97 19.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.542 -0.724 . . . . 3.74 110.645 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.3 m -63.53 -31.32 72.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.259 -0.9 . . . . 1.44 111.195 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.519 ' CD2' HG13 ' A' ' 30' ' ' ILE . 20.8 tp -87.71 -4.8 58.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.037 -1.039 . . . . 1.64 110.783 -177.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.15 41.72 96.83 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.624 -1.391 . . . . 0.34 109.624 179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.519 HG13 ' CD2' ' A' ' 28' ' ' LEU . 34.9 mm -116.4 138.05 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.228 -1.16 . . . . 1.16 110.633 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.68 166.74 23.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.652 -0.655 . . . . 1.08 110.005 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.513 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.53 146.56 12.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.065 -1.022 . . . . 1.13 110.532 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.513 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 28.6 tttm 74.57 -4.62 2.29 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.699 -0.626 . . . . 2.33 111.097 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.458 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.3 m-20 -77.65 166.74 22.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.81 -1.182 . . . . 1.1 110.078 174.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.14 130.69 51.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 1.17 110.747 -176.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.499 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 12.3 mt -107.3 143.21 35.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.351 -0.843 . . . . 1.21 109.424 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.474 ' HG3' HG23 ' B' ' 9' ' ' VAL . 86.5 tt0 -107.27 137.85 44.56 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.839 -1.163 . . . . 1.17 109.577 173.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.6 mt -108.6 133.44 53.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.361 -0.837 . . . . 1.45 110.583 -171.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.573 ' CE1' ' HD2' ' A' ' 48' ' ' LYS . 10.7 m-85 -120.13 159.44 24.85 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 116.309 -0.405 . . . . 1.05 110.014 -178.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.522 HG23 ' CG2' ' B' ' 6' ' ' THR . 80.8 t -133.16 124.55 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.85 -1.156 . . . . 1.08 110.666 172.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.474 ' OD1' HG12 ' A' ' 46' ' ' ILE . 42.3 p-10 -147.54 145.08 28.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 1.77 110.577 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.472 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.1 t0 43.08 43.9 3.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.998 -1.064 . . . . 1.22 111.283 174.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.472 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 45.2 tp10 61.74 10.6 3.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.128 -0.983 . . . . 1.93 110.676 175.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -109.77 153.44 24.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 2.48 110.034 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.519 ' CD1' HD12 ' B' ' 20' ' ' ILE . 66.6 mt -93.32 128.34 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 1.86 109.752 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.57 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.0 mm -113.35 118.43 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.602 -0.687 . . . . 1.24 109.941 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.2 mp -115.84 134.67 54.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.944 -1.097 . . . . 2.25 110.284 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.573 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 15.9 ptpt -142.78 161.14 38.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.793 . . . . 2.26 110.317 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -56.59 147.67 21.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.042 -1.037 . . . . 2.12 109.882 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 5.5 t80 -102.39 120.15 40.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.96 110.653 -175.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -99.37 123.42 48.5 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.383 -0.823 . . . . 3.58 109.718 173.936 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.61 144.44 99.53 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.647 1.34 . . . . 0.48 110.273 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.989 -1.005 . . . . 2.9 110.204 -179.691 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 47.0 p90 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.284 0.564 . . . . 12.33 110.169 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 87.3 mtp -124.49 154.64 40.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 8.85 110.202 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.526 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 67.0 mttm -94.5 142.36 27.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 9.64 110.195 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.58 -94.59 0.22 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 5.64 110.176 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.522 ' CG2' HG23 ' A' ' 40' ' ' VAL . 46.9 p -68.82 -39.07 80.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.022 . . . . 3.35 110.155 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.26 45.43 70.3 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.772 -1.331 . . . . 1.53 109.772 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.1 mt -118.49 133.55 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.062 -1.257 . . . . 1.97 109.99 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 87.2 t -115.7 144.24 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.019 -1.051 . . . . 1.11 110.951 -176.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.437 ' N ' HG13 ' B' ' 9' ' ' VAL . 69.8 ttt-85 -129.79 160.16 34.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.53 -0.731 . . . . 2.26 109.709 177.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -85.53 147.59 26.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.101 -1.0 . . . . 2.65 110.413 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.524 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 3.8 t -82.25 130.75 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.874 . . . . 1.06 109.743 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -83.95 -175.59 5.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.049 -1.032 . . . . 0.55 110.119 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.02 -40.62 70.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.133 -0.98 . . . . 2.19 111.649 -172.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.502 HD23 ' NH1' ' B' ' 17' ' ' ARG . 13.9 tp -84.1 -5.52 59.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.766 -1.209 . . . . 1.99 111.602 -173.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.524 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.92 47.12 7.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.606 -1.397 . . . . 0.23 109.606 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.525 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.0 mtm180 -115.09 154.57 28.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.071 -1.253 . . . . 1.33 109.996 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.516 HG23 ' CD2' ' A' ' 47' ' ' LEU . 16.6 m -123.96 152.01 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 1.08 109.823 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.533 HG23 ' CD ' ' A' ' 17' ' ' ARG . 35.9 t -111.29 134.85 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.935 . . . . 1.07 110.714 -175.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.519 HD12 ' CD1' ' A' ' 45' ' ' ILE . 18.5 mt -81.41 133.23 53.62 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.253 -0.904 . . . . 1.99 109.609 174.207 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.528 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.1 Cg_endo -58.96 143.25 99.76 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.735 1.387 . . . . 0.4 109.98 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.534 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.2 tp -55.09 -32.63 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.002 -1.061 . . . . 1.78 110.412 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.98 -36.39 72.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.11 -0.994 . . . . 2.37 109.747 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.528 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 57.6 mt -82.13 -30.01 31.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.494 -0.754 . . . . 2.36 110.638 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.534 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 71.6 mtt180 -57.56 -43.71 84.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.847 -1.158 . . . . 0.33 109.076 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -72.97 -51.21 19.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.482 -0.761 . . . . 3.75 110.6 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.2 m -63.29 -31.87 73.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.261 -0.899 . . . . 1.38 110.953 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.519 ' CD2' HG13 ' B' ' 30' ' ' ILE . 20.9 tp -87.12 -5.22 59.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.042 -1.036 . . . . 1.61 110.73 -176.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.46 41.54 96.29 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.563 -1.415 . . . . 0.34 109.563 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.519 HG13 ' CD2' ' B' ' 28' ' ' LEU . 34.2 mm -116.37 137.94 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -1.199 . . . . 1.13 110.598 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.41 166.86 23.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.624 -0.672 . . . . 1.07 109.965 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.51 146.61 12.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 1.13 110.48 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 28.5 tttm 74.66 -4.78 2.27 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.671 -0.643 . . . . 2.39 111.17 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.423 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 89.9 m-20 -77.73 166.5 22.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.789 -1.194 . . . . 1.1 110.092 175.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.06 130.63 51.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 1.13 110.837 -176.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.548 HD13 ' CG2' ' A' ' 12' ' ' VAL . 12.1 mt -107.27 143.06 36.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 1.35 109.48 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.465 ' HA ' HG23 ' A' ' 9' ' ' VAL . 86.4 tt0 -107.05 137.85 44.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.763 -1.21 . . . . 1.17 109.688 172.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.474 HD13 HG21 ' B' ' 38' ' ' ILE . 70.8 mt -108.72 133.53 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.292 -0.88 . . . . 1.48 110.516 -171.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.577 ' CE1' ' HD2' ' B' ' 48' ' ' LYS . 10.7 m-85 -120.16 159.44 24.88 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 116.225 -0.443 . . . . 1.08 109.978 -178.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 81.5 t -133.03 125.02 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.885 -1.134 . . . . 1.05 110.451 172.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' B' ' 41' ' ' ASP . 42.1 p-10 -148.03 145.06 28.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 1.77 110.556 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.7 t0 43.25 43.91 4.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.077 -1.014 . . . . 1.21 111.242 174.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 45.0 tp10 61.61 10.61 3.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.147 -0.971 . . . . 1.92 110.703 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -109.87 153.66 24.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 2.49 109.963 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.5 HG21 ' CD1' ' B' ' 47' ' ' LEU . 66.2 mt -93.43 128.14 45.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.19 -0.944 . . . . 1.85 109.85 176.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 21.4 mm -113.28 118.42 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.508 -0.745 . . . . 1.22 109.95 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.3 mp -115.66 134.42 55.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.067 -1.021 . . . . 2.23 110.255 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.577 ' HD2' ' CE1' ' B' ' 39' ' ' TYR . 15.8 ptpt -142.54 161.34 38.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.351 -0.843 . . . . 2.17 110.36 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -56.67 147.59 22.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.186 -0.946 . . . . 2.25 109.893 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.556 ' CZ ' HG21 ' A' ' 9' ' ' VAL . 5.6 t80 -102.36 116.77 33.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 1.21 110.581 -175.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.08 80.28 72.47 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 4.73 110.144 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.09 144.64 94.62 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.009 1.531 . . . . 4.2 110.378 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.045 -0.979 . . . . 6.56 110.19 -179.764 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.201 0.524 . . . . 11.69 110.264 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.2 mmm -87.11 138.82 31.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 9.04 110.21 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -78.1 134.13 37.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -0.885 . . . . 9.15 110.184 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.503 ' OG ' ' CD2' ' B' ' 39' ' ' TYR . 35.7 m -121.16 147.77 45.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 4.5 110.275 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.0 p -64.67 -34.71 78.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -0.986 . . . . 4.26 110.027 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.92 45.45 51.35 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.852 -1.299 . . . . 1.24 109.852 177.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.437 HD13 HG22 ' A' ' 8' ' ' ILE . 58.5 mt -116.82 132.79 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.254 . . . . 2.01 109.954 178.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.62 ' CG1' ' CD2' ' B' ' 50' ' ' TYR . 88.5 t -117.45 144.26 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.014 -1.054 . . . . 1.08 110.875 -175.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.43 ' N ' HG13 ' A' ' 9' ' ' VAL . 69.4 ttt-85 -131.47 162.54 29.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.532 -0.73 . . . . 2.25 109.726 177.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -85.32 148.06 26.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.041 -1.037 . . . . 2.66 110.385 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.549 ' CG2' HD12 ' B' ' 36' ' ' LEU . 3.8 t -82.3 129.8 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.216 -0.928 . . . . 1.09 109.792 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.14 -175.66 5.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.037 -1.039 . . . . 0.55 109.994 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -54.85 -40.69 69.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.083 -1.011 . . . . 2.19 111.68 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.517 HD13 ' NH2' ' B' ' 25' ' ' ARG . 15.4 tp -84.51 -5.82 59.32 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.731 -1.231 . . . . 1.97 111.572 -173.195 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.477 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.53 46.59 7.28 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.225 -1.464 . . . . 0.22 109.646 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.539 ' CD ' HG21 ' B' ' 19' ' ' VAL . 69.0 mtm180 -114.03 153.74 28.88 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.942 -1.328 . . . . 1.33 110.109 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.528 ' CG1' HD13 ' B' ' 36' ' ' LEU . 16.6 m -124.21 152.99 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 1.08 109.771 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.522 HG23 ' CD ' ' B' ' 17' ' ' ARG . 18.1 t -112.24 134.36 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.983 . . . . 1.05 110.708 -175.032 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.466 HG21 ' HB2' ' A' ' 24' ' ' LEU . 2.2 mm -82.97 134.13 47.14 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.181 -0.95 . . . . 2.03 109.322 173.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.528 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.5 Cg_endo -58.86 141.57 98.18 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.701 1.369 . . . . 0.4 109.906 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.506 ' HA ' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -55.76 -31.43 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.909 -1.12 . . . . 1.79 110.412 -176.556 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.467 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 20.1 pt-20 -59.25 -34.67 72.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.024 -1.048 . . . . 2.37 109.732 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.528 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 56.6 mt -80.73 -29.42 36.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 2.3 110.325 176.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.506 ' CD ' ' HA ' ' A' ' 22' ' ' ILE . 73.4 mtt180 -57.1 -44.19 82.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.958 -1.088 . . . . 0.33 109.122 175.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -72.41 -50.45 26.34 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.893 -0.723 . . . . 3.74 110.692 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.1 m -63.53 -31.49 72.66 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 1.44 111.129 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.446 ' CD2' HG13 ' A' ' 30' ' ' ILE . 18.3 tp -87.85 -4.71 58.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.011 -1.055 . . . . 1.64 110.74 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.84 42.04 95.24 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.707 -1.357 . . . . 0.34 109.707 178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.446 HG13 ' CD2' ' A' ' 28' ' ' LEU . 32.5 mm -116.41 138.37 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -1.125 . . . . 1.16 110.716 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.63 166.23 25.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.594 -0.691 . . . . 1.08 109.993 -177.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.42 147.0 11.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.024 -1.048 . . . . 1.13 110.584 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 26.6 ttpt 74.39 -4.47 2.31 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.644 -0.66 . . . . 2.33 111.163 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.464 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.8 m-20 -77.79 167.82 20.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.827 -1.17 . . . . 1.1 110.057 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' A' ' 50' ' ' TYR . . . -104.51 131.0 52.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 1.17 110.777 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.496 ' HG ' ' CG2' ' B' ' 12' ' ' VAL . 12.2 mt -108.03 144.3 35.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.381 -0.824 . . . . 1.21 109.461 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.469 ' HG3' HG22 ' B' ' 9' ' ' VAL . 86.0 tt0 -109.5 139.14 44.85 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.812 -1.18 . . . . 1.17 109.614 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.25 132.86 54.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.462 -0.774 . . . . 1.45 110.471 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.58 ' CD2' ' OG ' ' B' ' 5' ' ' SER . 15.8 m-85 -119.19 157.21 28.43 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 116.294 -0.412 . . . . 1.05 109.941 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.464 HG21 ' CG2' ' B' ' 6' ' ' THR . 84.1 t -132.14 122.69 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.795 -1.191 . . . . 1.08 110.575 173.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 47.4 p-10 -147.8 149.71 32.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.909 . . . . 1.77 110.602 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 52.7 t0 42.96 44.19 3.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.011 -1.055 . . . . 1.22 111.317 173.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.7 mt-10 57.84 14.46 2.54 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.051 -1.03 . . . . 1.93 110.54 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -114.09 153.32 29.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -0.929 . . . . 2.48 109.984 175.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.504 ' CD1' HD12 ' B' ' 20' ' ' ILE . 66.0 mt -91.82 127.77 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.23 -0.919 . . . . 1.86 109.762 177.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 24.5 mm -112.96 120.07 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.633 -0.667 . . . . 1.24 109.896 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.582 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.1 mp -118.72 134.5 55.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.902 -1.124 . . . . 2.25 110.256 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.533 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 9.8 pttp -141.81 164.49 30.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 2.26 110.451 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -58.68 147.08 34.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 2.12 110.146 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.451 ' HB3' ' HB3' ' A' ' 35' ' ' ALA . 7.8 t80 -104.13 120.13 40.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.833 . . . . 0.96 110.603 -176.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -99.38 123.01 49.94 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 3.58 109.459 171.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -58.42 145.71 93.03 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.797 1.419 . . . . 0.48 110.424 -178.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.959 -1.02 . . . . 2.9 110.238 -179.745 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.218 0.532 . . . . 12.33 110.187 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 94.5 mmm -100.91 146.06 27.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.342 -0.849 . . . . 8.85 110.171 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -88.44 143.01 27.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 9.64 110.272 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.58 ' OG ' ' CD2' ' A' ' 39' ' ' TYR . 47.3 t -123.8 145.1 49.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.864 . . . . 5.64 110.2 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.464 ' CG2' HG21 ' A' ' 40' ' ' VAL . 71.5 p -63.8 -34.77 78.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.934 . . . . 3.35 109.961 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.94 45.6 50.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.74 -1.344 . . . . 1.53 109.74 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 59.0 mt -116.85 132.72 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.095 -1.238 . . . . 1.97 109.97 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.495 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 89.2 t -117.46 144.25 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.977 -1.077 . . . . 1.11 110.919 -175.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.416 ' N ' HG13 ' B' ' 9' ' ' VAL . 69.4 ttt-85 -131.42 162.35 30.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.555 -0.716 . . . . 2.26 109.72 177.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -85.16 148.01 26.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.083 -1.01 . . . . 2.65 110.393 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.496 ' CG2' ' HG ' ' A' ' 36' ' ' LEU . 3.9 t -82.29 129.85 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.213 -0.929 . . . . 1.06 109.7 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.42 -175.55 5.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.956 . . . . 0.55 110.097 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -54.89 -40.65 69.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 2.19 111.674 -172.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.514 HD23 ' NH1' ' B' ' 17' ' ' ARG . 15.1 tp -84.42 -5.97 59.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.772 -1.205 . . . . 1.99 111.599 -173.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.484 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.18 47.31 7.07 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.558 -1.417 . . . . 0.23 109.558 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.522 ' CD ' HG23 ' A' ' 19' ' ' VAL . 68.7 mtm180 -114.29 153.69 29.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.085 -1.244 . . . . 1.33 110.061 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.468 HG23 HG22 ' A' ' 18' ' ' VAL . 16.4 m -124.12 152.96 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 1.08 109.813 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.539 HG21 ' CD ' ' A' ' 17' ' ' ARG . 18.0 t -112.37 134.36 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 1.07 110.686 -175.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.504 HD12 ' CD1' ' A' ' 45' ' ' ILE . 2.3 mm -82.91 134.02 47.54 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.934 . . . . 1.99 109.409 173.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.525 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.4 Cg_endo -58.96 141.57 98.39 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.807 1.425 . . . . 0.4 109.899 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.526 HG22 HD12 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.95 -31.13 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.068 -1.02 . . . . 1.78 110.409 -176.266 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . 0.478 ' HG2' ' HB2' ' B' ' 21' ' ' PRO . 20.0 pt-20 -59.16 -35.38 73.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.023 -1.048 . . . . 2.37 109.59 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.525 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 57.3 mt -80.03 -29.83 39.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.484 -0.76 . . . . 2.36 110.334 176.419 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.517 ' NH2' HD13 ' A' ' 15' ' ' LEU . 73.0 mtt180 -56.83 -44.08 81.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.01 -1.056 . . . . 0.33 109.203 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -72.3 -50.78 24.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.468 -0.77 . . . . 3.75 110.642 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.3 m -63.2 -32.05 73.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.888 . . . . 1.38 110.921 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.442 ' CD2' HG13 ' B' ' 30' ' ' ILE . 18.5 tp -87.39 -4.99 59.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.026 -1.047 . . . . 1.61 110.73 -176.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.31 41.8 94.4 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.603 -1.399 . . . . 0.34 109.603 178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.442 HG13 ' CD2' ' B' ' 28' ' ' LEU . 32.1 mm -116.41 138.29 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -1.183 . . . . 1.13 110.616 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.39 166.44 24.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.562 -0.711 . . . . 1.07 110.026 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.48 147.0 11.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.136 -0.978 . . . . 1.13 110.486 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 26.6 ttpt 74.59 -4.76 2.26 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.661 -0.65 . . . . 2.39 111.126 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.417 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 89.0 m-20 -77.76 167.54 21.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.825 -1.172 . . . . 1.1 110.107 175.209 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' B' ' 50' ' ' TYR . . . -104.28 130.98 52.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.184 -0.948 . . . . 1.13 110.803 -176.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.549 HD12 ' CG2' ' A' ' 12' ' ' VAL . 12.2 mt -108.02 144.08 35.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.842 . . . . 1.35 109.551 174.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.466 ' HA ' HG21 ' A' ' 9' ' ' VAL . 85.7 tt0 -109.11 139.09 44.48 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.868 -1.145 . . . . 1.17 109.8 172.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.32 132.84 55.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.363 -0.836 . . . . 1.48 110.427 -172.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.543 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 15.6 m-85 -119.18 157.24 28.35 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 116.231 -0.44 . . . . 1.08 109.874 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.438 HG22 HD13 ' A' ' 24' ' ' LEU . 85.7 t -131.96 123.08 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.958 -1.089 . . . . 1.05 110.441 173.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' B' ' 41' ' ' ASP . 47.6 p-10 -148.35 149.63 32.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.16 -0.962 . . . . 1.77 110.561 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 53.2 t0 42.87 44.48 3.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.129 -0.982 . . . . 1.21 111.287 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.7 mt-10 57.61 14.53 2.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.045 -1.034 . . . . 1.92 110.503 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -114.08 153.49 29.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.292 -0.88 . . . . 2.49 109.989 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.439 ' HB ' ' HB2' ' A' ' 47' ' ' LEU . 65.7 mt -91.95 127.72 44.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.263 -0.898 . . . . 1.85 109.771 177.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 24.7 mm -113.02 120.1 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.513 -0.742 . . . . 1.22 109.903 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.582 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.2 mp -118.66 134.34 55.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.974 -1.079 . . . . 2.23 110.196 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.528 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 10.1 pttp -141.62 164.81 29.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 2.17 110.406 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -58.89 147.04 35.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 2.25 109.953 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.62 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 7.9 t80 -104.16 113.33 26.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 1.21 110.583 -176.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.16 78.78 75.55 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 4.73 110.266 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -58.64 143.98 98.04 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.004 1.528 . . . . 4.2 110.302 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.026 -0.988 . . . . 6.56 110.226 -179.765 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.201 0.524 . . . . 11.69 110.204 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 88.4 mtp -78.09 139.51 39.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 9.04 110.103 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -49.09 -45.88 43.93 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.18 -0.95 . . . . 9.15 111.156 -174.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.2 m -122.47 152.76 39.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.837 -1.164 . . . . 4.5 110.192 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.525 HG23 ' CG2' ' B' ' 40' ' ' VAL . 64.1 p -59.15 -38.78 80.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 4.26 109.943 178.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.454 ' O ' HD11 ' A' ' 8' ' ' ILE . . . 65.72 45.9 86.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.665 -1.374 . . . . 1.24 109.665 177.161 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.454 HD11 ' O ' ' A' ' 7' ' ' GLY . 25.1 mm -114.98 132.55 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.134 -1.215 . . . . 2.01 110.061 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 95.9 t -115.82 144.85 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.063 -1.023 . . . . 1.08 110.81 -176.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.456 ' N ' HG13 ' A' ' 9' ' ' VAL . 71.0 ttt-85 -131.44 160.27 35.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.515 -0.74 . . . . 2.25 109.704 177.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -85.58 148.0 26.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.062 -1.024 . . . . 2.66 110.307 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.545 ' CG2' HD13 ' B' ' 36' ' ' LEU . 4.3 t -81.91 130.3 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.268 -0.895 . . . . 1.09 109.855 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.471 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.74 -174.64 5.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.55 110.157 -179.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.42 -41.95 66.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.123 -0.986 . . . . 2.19 111.887 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.529 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.0 tp -87.48 -3.06 59.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.68 -1.262 . . . . 1.97 111.755 -172.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 79.98 46.36 7.75 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.168 -1.491 . . . . 0.22 109.674 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.56 ' CD ' ' CG2' ' B' ' 19' ' ' VAL . 76.9 mtm180 -116.2 154.28 30.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.098 -1.236 . . . . 1.33 109.828 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.53 HG22 ' CD2' ' B' ' 47' ' ' LEU . 27.4 m -125.7 153.14 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 1.08 109.938 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.522 ' CG2' ' CD ' ' B' ' 17' ' ' ARG . 22.7 t -111.55 135.52 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 1.05 110.548 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.482 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.31 134.25 46.01 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.255 -0.903 . . . . 2.03 109.577 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.524 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.4 Cg_endo -57.83 142.81 96.41 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.788 1.415 . . . . 0.4 110.025 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.516 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.37 -32.56 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.034 -1.041 . . . . 1.79 110.378 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.417 ' N ' HG21 ' A' ' 22' ' ' ILE . 84.3 tt0 -57.96 -35.9 71.8 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.143 -0.973 . . . . 2.37 109.9 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.524 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 51.8 mt -81.03 -31.3 34.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 2.3 110.542 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.516 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 72.9 mtt180 -58.17 -43.51 87.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.954 -1.091 . . . . 0.33 109.287 176.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -73.19 -49.66 26.81 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.797 -0.761 . . . . 3.74 110.694 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.5 m -63.9 -31.86 73.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 1.44 111.093 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 17.4 tp -88.16 -4.61 58.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.055 -1.028 . . . . 1.64 110.737 -176.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.456 ' O ' HD11 ' A' ' 30' ' ' ILE . . . 65.78 42.35 95.21 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.681 -1.367 . . . . 0.34 109.681 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.456 HD11 ' O ' ' A' ' 29' ' ' GLY . 31.4 mm -116.32 137.79 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.302 -1.116 . . . . 1.16 110.715 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.43 168.65 19.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.589 -0.694 . . . . 1.08 110.061 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.77 145.87 14.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.111 -0.993 . . . . 1.13 110.616 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.507 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 41.3 tttp 74.0 -4.35 2.3 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.751 -0.593 . . . . 2.33 111.231 176.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.456 ' O ' HG21 ' B' ' 12' ' ' VAL . 89.1 m-20 -76.84 166.28 23.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.818 -1.176 . . . . 1.1 110.047 174.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.465 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -103.7 131.08 51.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.953 . . . . 1.17 110.823 -175.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.488 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 13.2 mt -108.05 144.48 35.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.372 -0.83 . . . . 1.21 109.392 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.481 ' HG3' HG22 ' B' ' 9' ' ' VAL . 86.3 tt0 -108.81 138.28 45.39 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.732 -1.23 . . . . 1.17 109.517 172.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.3 mt -109.09 131.79 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.419 -0.801 . . . . 1.45 110.582 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.581 ' CE1' ' HD2' ' A' ' 48' ' ' LYS . 10.6 m-85 -117.58 159.26 23.18 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.83 -0.433 . . . . 1.05 109.83 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.417 ' CG2' HG23 ' B' ' 6' ' ' THR . 73.3 t -133.26 120.93 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.876 -1.14 . . . . 1.08 110.554 172.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 47.2 p-10 -148.4 159.96 43.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.167 -0.958 . . . . 1.77 110.603 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 53.9 t0 42.29 40.35 1.76 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.025 -1.047 . . . . 1.22 111.599 171.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 84.2 tt0 58.87 14.09 3.1 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.844 -1.16 . . . . 1.93 110.567 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.523 ' CE ' HD12 ' A' ' 46' ' ' ILE . 14.0 pttt -127.18 164.45 21.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.96 . . . . 2.48 109.691 174.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.418 HD12 ' CG1' ' B' ' 20' ' ' ILE . 68.9 mt -97.41 134.89 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.137 -0.977 . . . . 1.86 110.322 -176.059 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 22.3 mm -114.16 119.39 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.674 -0.641 . . . . 1.24 109.857 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.58 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.3 mp -115.95 135.07 54.32 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.021 -1.05 . . . . 2.25 110.226 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.581 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 1.7 ptpm? -141.17 159.08 42.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.439 -0.788 . . . . 2.26 110.389 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -57.75 146.9 29.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.101 -1.0 . . . . 2.12 109.96 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.465 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 6.0 t80 -103.72 120.07 40.19 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.228 -0.92 . . . . 0.96 110.524 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -99.77 122.84 49.75 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.419 -0.8 . . . . 3.58 109.427 173.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.89 146.15 91.19 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.826 1.435 . . . . 0.48 110.341 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.461 ' O ' ' OD1' ' A' ' 53' ' ' ASN . 37.4 p-10 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.003 -0.998 . . . . 2.9 110.26 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.258 0.551 . . . . 12.33 110.246 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 86.9 mtp -128.05 164.1 23.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 8.85 110.288 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.466 ' HD3' ' OE2' ' A' ' 37' ' ' GLU . 45.7 mttt -85.49 142.3 29.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 9.64 110.152 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 68.8 m -73.87 -93.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.153 -0.967 . . . . 5.64 110.327 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.417 HG23 ' CG2' ' A' ' 40' ' ' VAL . 60.0 p -75.56 -38.94 58.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.061 -1.025 . . . . 3.35 110.147 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . 0.467 ' O ' HD13 ' B' ' 8' ' ' ILE . . . 65.6 46.16 85.79 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.642 -1.383 . . . . 1.53 109.642 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.467 HD13 ' O ' ' B' ' 7' ' ' GLY . 25.2 mm -115.03 132.48 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.097 -1.237 . . . . 1.97 110.053 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.488 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 96.3 t -115.81 144.86 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.065 -1.022 . . . . 1.11 110.81 -176.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.452 ' N ' HG12 ' B' ' 9' ' ' VAL . 71.1 ttt-85 -131.41 160.16 35.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.501 -0.75 . . . . 2.26 109.736 177.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -85.6 148.01 26.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.076 -1.015 . . . . 2.65 110.442 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.531 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 4.4 t -81.9 130.38 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 1.06 109.703 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.9 -174.47 5.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.115 -0.991 . . . . 0.55 110.305 -179.35 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -53.66 -41.72 67.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.185 -0.947 . . . . 2.19 111.79 -172.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.525 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.6 tp -87.51 -3.28 59.0 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.695 -1.253 . . . . 1.99 111.665 -172.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.531 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.81 46.93 7.5 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.477 -1.449 . . . . 0.23 109.477 -177.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.525 ' HD3' ' CD2' ' B' ' 15' ' ' LEU . 76.7 mtm180 -116.29 154.31 30.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.132 -1.217 . . . . 1.33 109.864 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.517 HG22 ' CD2' ' A' ' 47' ' ' LEU . 27.2 m -125.68 153.19 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 1.08 109.937 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.56 ' CG2' ' CD ' ' A' ' 17' ' ' ARG . 22.5 t -111.61 135.43 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 1.07 110.559 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -83.15 134.23 46.46 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 1.99 109.608 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.521 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.3 Cg_endo -57.94 142.82 96.73 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.765 1.403 . . . . 0.4 109.992 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.534 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.54 -32.3 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.11 -0.994 . . . . 1.78 110.359 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . 0.413 ' N ' HG22 ' B' ' 22' ' ' ILE . 84.2 tt0 -57.98 -36.41 72.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.074 -1.016 . . . . 2.37 109.794 178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.521 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 52.3 mt -80.34 -31.62 37.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.494 -0.754 . . . . 2.36 110.574 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.534 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 72.3 mtt180 -58.02 -43.46 86.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.896 -1.128 . . . . 0.33 109.246 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -73.17 -49.75 26.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 3.75 110.64 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.0 m -63.74 -32.44 73.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.193 -0.942 . . . . 1.38 110.785 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.424 HD23 HG13 ' B' ' 30' ' ' ILE . 17.5 tp -87.71 -4.87 58.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.098 -1.001 . . . . 1.61 110.709 -176.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.04 42.15 94.77 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.624 -1.391 . . . . 0.34 109.624 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.424 HG13 HD23 ' B' ' 28' ' ' LEU . 31.2 mm -116.24 137.67 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -1.221 . . . . 1.13 110.705 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.16 168.89 18.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.518 -0.739 . . . . 1.07 109.997 -177.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.87 145.9 15.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.163 -0.961 . . . . 1.13 110.493 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.513 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 41.2 tttp 74.13 -4.49 2.28 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.583 -0.698 . . . . 2.39 111.179 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 89.1 m-20 -77.0 166.0 23.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.755 -1.216 . . . . 1.1 109.979 174.814 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.459 ' O ' ' HB3' ' B' ' 50' ' ' TYR . . . -103.45 131.19 50.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 1.13 110.855 -175.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.545 HD13 ' CG2' ' A' ' 12' ' ' VAL . 13.2 mt -108.2 144.07 36.14 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.328 -0.858 . . . . 1.35 109.448 174.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.469 ' HA ' HG23 ' A' ' 9' ' ' VAL . 86.0 tt0 -108.32 138.22 44.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.851 -1.155 . . . . 1.17 109.729 172.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -109.07 131.87 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.293 -0.879 . . . . 1.48 110.507 -171.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.575 ' CE1' ' HD2' ' B' ' 48' ' ' LYS . 10.6 m-85 -117.52 159.26 23.14 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 116.264 -0.425 . . . . 1.08 109.914 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.525 ' CG2' HG23 ' A' ' 6' ' ' THR . 74.4 t -133.11 121.37 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.876 -1.14 . . . . 1.05 110.441 172.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 47.2 p-10 -148.93 159.97 43.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 1.77 110.543 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 54.7 t0 42.09 40.62 1.73 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.126 -0.984 . . . . 1.21 111.577 172.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.47 ' O ' ' HG2' ' B' ' 43' ' ' GLU . 84.1 tt0 58.79 14.03 3.02 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.816 -1.178 . . . . 1.92 110.529 174.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 13.9 pttt -127.19 164.65 21.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.089 -1.007 . . . . 2.49 109.571 174.195 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.418 HD12 HG12 ' A' ' 20' ' ' ILE . 68.9 mt -97.48 134.73 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 1.85 110.374 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.574 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 22.0 mm -114.15 119.45 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.714 -0.616 . . . . 1.22 109.869 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.58 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.4 mp -115.94 134.86 54.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.03 -1.044 . . . . 2.23 110.208 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.575 ' HD2' ' CE1' ' B' ' 39' ' ' TYR . 1.7 ptpm? -140.99 159.3 42.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 2.17 110.316 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -57.9 146.78 30.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.954 . . . . 2.25 109.909 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.578 ' CZ ' ' HG3' ' B' ' 52' ' ' PRO . 6.1 t80 -103.72 114.7 29.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 1.21 110.415 -176.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.04 81.68 28.18 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.295 -0.878 . . . . 4.73 110.43 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.578 ' HG3' ' CZ ' ' B' ' 50' ' ' TYR . 27.9 Cg_exo -56.61 142.27 90.68 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.123 1.591 . . . . 4.2 110.183 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' B' ' 52' ' ' PRO . 37.6 t30 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 117.994 -1.003 . . . . 6.56 110.223 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.197 0.522 . . . . 11.69 110.304 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.9 mtm -91.9 126.19 36.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 9.04 110.245 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -51.59 -50.2 60.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.167 -0.958 . . . . 9.15 111.142 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.9 p -147.3 164.59 32.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.86 -1.15 . . . . 4.5 110.2 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.4 p -62.47 -42.31 99.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 4.26 110.103 178.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.99 46.58 71.85 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.665 -1.374 . . . . 1.24 109.665 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.6 mt -114.0 134.37 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.09 -1.241 . . . . 2.01 110.088 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.639 ' CG1' ' CD2' ' B' ' 50' ' ' TYR . 85.9 t -120.04 144.37 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.988 -1.07 . . . . 1.08 110.809 -176.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.426 ' N ' HG11 ' A' ' 9' ' ' VAL . 52.8 ttt85 -131.04 161.21 32.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.525 -0.734 . . . . 2.25 109.69 178.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -85.39 148.09 26.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.133 -0.979 . . . . 2.66 110.34 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.547 ' CG2' HD12 ' B' ' 36' ' ' LEU . 3.6 t -82.93 129.94 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.89 . . . . 1.09 109.831 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.8 -175.82 5.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.106 -0.996 . . . . 0.55 109.923 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.06 -40.38 70.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.104 -0.997 . . . . 2.19 111.677 -173.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.526 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.4 tp -83.25 -6.48 59.49 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.845 -1.159 . . . . 1.97 111.539 -173.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.74 46.47 7.23 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.243 -1.455 . . . . 0.22 109.652 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.53 ' CD ' HG23 ' B' ' 19' ' ' VAL . 70.7 mtm180 -114.47 154.82 27.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.05 -1.265 . . . . 1.33 110.065 -177.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.533 ' CG1' HD13 ' B' ' 36' ' ' LEU . 19.4 m -123.69 152.56 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.398 -0.814 . . . . 1.08 109.86 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.53 HG21 ' CD ' ' B' ' 17' ' ' ARG . 31.2 t -111.77 134.03 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.179 -0.951 . . . . 1.05 110.69 -175.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.476 HG22 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.63 132.86 50.69 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 2.03 109.437 173.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.53 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.7 Cg_endo -57.47 141.29 95.02 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.699 1.368 . . . . 0.4 109.83 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.482 ' HA ' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -55.75 -31.93 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.107 . . . . 1.79 110.303 -177.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.15 -36.48 70.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.017 . . . . 2.37 109.79 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.53 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 52.8 mt -80.86 -29.04 35.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.262 -0.899 . . . . 2.3 110.487 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.482 ' CD ' ' HA ' ' A' ' 22' ' ' ILE . 75.8 mtt180 -56.85 -43.65 81.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.879 -1.138 . . . . 0.33 109.18 175.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -72.85 -50.67 22.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.557 -0.715 . . . . 3.74 110.755 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.6 m -63.43 -31.3 72.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 1.44 111.117 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.522 ' CD2' HG13 ' A' ' 30' ' ' ILE . 26.3 tp -87.55 -4.93 58.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 1.64 110.782 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.407 ' O ' HD11 ' A' ' 30' ' ' ILE . . . 64.39 42.86 97.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.626 -1.39 . . . . 0.34 109.626 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.522 HG13 ' CD2' ' A' ' 28' ' ' LEU . 29.5 mm -116.12 139.0 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -1.149 . . . . 1.16 110.7 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.5 166.99 23.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.625 -0.672 . . . . 1.08 109.998 -178.059 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.2 tt0 -53.41 146.31 12.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.966 . . . . 1.13 110.553 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 77.2 tttt 74.86 -4.68 2.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.749 -0.594 . . . . 2.33 111.164 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.461 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.4 m-20 -77.16 166.09 23.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.779 -1.2 . . . . 1.1 110.044 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.456 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . . . -104.83 132.57 50.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.941 . . . . 1.17 110.855 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.517 HD12 ' CG1' ' B' ' 18' ' ' VAL . 13.0 mt -109.43 143.65 38.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.397 -0.814 . . . . 1.21 109.555 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.468 ' OE1' ' HE3' ' A' ' 48' ' ' LYS . 85.4 tt0 -108.63 140.29 42.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.836 -1.165 . . . . 1.17 109.824 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.5 mm -111.15 133.18 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.435 -0.79 . . . . 1.45 110.555 -173.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.578 ' CE2' ' HE3' ' B' ' 4' ' ' LYS . 14.4 m-85 -115.16 159.2 21.21 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 120.911 0.386 . . . . 1.05 109.972 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.499 ' CG2' HG23 ' B' ' 6' ' ' THR . 79.5 t -130.45 128.92 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.931 -1.106 . . . . 1.08 110.802 173.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.491 ' CG ' ' CD1' ' A' ' 46' ' ' ILE . 9.7 p-10 -146.54 129.5 16.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.866 . . . . 1.77 110.215 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 48.9 t0 46.12 50.11 11.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.007 -1.058 . . . . 1.22 110.96 175.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.4 mt-10 59.95 12.69 3.24 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.348 -0.845 . . . . 1.93 110.714 176.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.452 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 9.6 mtmt -113.12 150.62 31.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 2.48 109.811 175.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 62.8 mt -101.76 128.84 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.058 -1.026 . . . . 1.86 110.327 -176.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.538 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 28.8 mt -112.06 121.47 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.391 -0.818 . . . . 1.24 110.14 176.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.581 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.3 mp -114.52 135.02 54.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.073 -1.017 . . . . 2.25 110.237 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.541 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 10.6 pttp -141.48 165.0 28.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.454 -0.779 . . . . 2.26 110.273 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -58.2 147.5 30.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.978 . . . . 2.12 110.009 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.476 ' CD2' ' CG1' ' B' ' 9' ' ' VAL . 5.9 t80 -104.07 123.16 46.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.885 . . . . 0.96 110.566 -175.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -99.73 122.79 49.99 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 3.58 109.393 173.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.18 146.47 90.56 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.749 1.394 . . . . 0.48 110.44 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.886 -1.054 . . . . 2.9 110.278 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 67.6 t80 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.248 0.547 . . . . 12.33 110.105 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 70.2 mtm -105.17 145.73 30.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 8.85 110.221 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.578 ' HE3' ' CE2' ' A' ' 39' ' ' TYR . 22.2 tptm -76.35 131.76 39.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 9.64 110.211 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 40' ' ' VAL . 53.5 m -46.96 -53.03 13.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.209 -0.932 . . . . 5.64 110.724 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.499 HG23 ' CG2' ' A' ' 40' ' ' VAL . 71.0 p -147.68 -42.68 0.17 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.931 -1.106 . . . . 3.35 109.993 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.85 47.07 68.78 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.586 -1.405 . . . . 1.53 109.586 177.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.453 HD13 ' HB ' ' B' ' 6' ' ' THR . 60.3 mt -114.23 134.31 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.074 -1.251 . . . . 1.97 110.029 -179.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 85.9 t -120.07 144.29 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.055 -1.028 . . . . 1.11 110.779 -176.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.419 ' N ' HG12 ' B' ' 9' ' ' VAL . 52.8 ttt85 -130.86 161.12 32.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.467 -0.771 . . . . 2.26 109.845 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -85.43 147.98 26.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 2.65 110.404 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.523 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 3.6 t -82.87 129.99 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.918 . . . . 1.06 109.764 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.449 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -83.97 -175.72 5.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.089 -1.007 . . . . 0.55 110.087 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.13 -40.43 70.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.183 -0.948 . . . . 2.19 111.558 -173.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.516 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.9 tp -83.07 -6.7 59.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.856 -1.152 . . . . 1.99 111.563 -173.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.523 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.43 47.2 6.99 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.549 -1.421 . . . . 0.23 109.549 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.53 ' CD ' HG21 ' A' ' 19' ' ' VAL . 70.9 mtm180 -114.67 154.72 27.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.096 -1.238 . . . . 1.33 110.049 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.517 ' CG1' HD12 ' A' ' 36' ' ' LEU . 19.4 m -123.67 152.55 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 1.08 109.858 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.53 HG23 ' CD ' ' A' ' 17' ' ' ARG . 30.8 t -111.76 134.06 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.13 -0.981 . . . . 1.07 110.638 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.48 HG22 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.66 132.83 50.69 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 1.99 109.392 173.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.527 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.7 Cg_endo -57.59 141.23 95.25 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.732 1.385 . . . . 0.4 109.918 177.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.513 HD12 HG21 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.82 -31.71 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.991 -1.068 . . . . 1.78 110.262 -177.345 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.03 -37.19 71.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.022 -1.049 . . . . 2.37 109.649 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.527 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 53.6 mt -80.1 -29.39 39.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.437 -0.789 . . . . 2.36 110.438 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.52 ' NH2' HD13 ' A' ' 15' ' ' LEU . 75.7 mtt180 -56.75 -43.6 80.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.901 -1.124 . . . . 0.33 109.109 175.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -72.72 -51.02 20.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 3.75 110.612 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 48.0 m -63.16 -31.76 72.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -0.869 . . . . 1.38 110.944 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.527 ' CD2' HG13 ' B' ' 30' ' ' ILE . 26.6 tp -87.04 -5.34 59.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.102 -0.999 . . . . 1.61 110.681 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.67 42.74 97.11 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.539 -1.424 . . . . 0.34 109.539 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.527 HG13 ' CD2' ' B' ' 28' ' ' LEU . 29.3 mm -116.02 138.78 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -1.162 . . . . 1.13 110.747 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.18 167.22 22.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.61 -0.681 . . . . 1.07 109.907 -178.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.6 146.42 13.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.942 . . . . 1.13 110.515 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 77.1 tttt 74.99 -4.9 2.27 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.662 -0.648 . . . . 2.39 111.205 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.409 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 88.7 m-20 -77.34 165.89 23.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.866 -1.146 . . . . 1.1 110.065 174.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.455 ' HB2' ' HB3' ' B' ' 50' ' ' TYR . . . -104.64 132.51 50.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 1.13 110.926 -175.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.547 HD12 ' CG2' ' A' ' 12' ' ' VAL . 12.9 mt -109.46 143.4 39.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.449 -0.782 . . . . 1.35 109.622 175.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.461 ' HA ' HG21 ' A' ' 9' ' ' VAL . 85.3 tt0 -108.4 140.23 41.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.787 -1.195 . . . . 1.17 110.017 173.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 21.5 mm -111.03 133.16 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.315 -0.865 . . . . 1.48 110.549 -173.302 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.546 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 14.1 m-85 -115.28 159.23 21.28 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 116.308 -0.405 . . . . 1.08 109.956 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 81.4 t -130.24 129.21 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.862 -1.149 . . . . 1.05 110.612 173.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.492 ' CG ' ' CD1' ' B' ' 46' ' ' ILE . 9.8 p-10 -146.86 129.44 15.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 1.77 110.2 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 50.0 t0 46.29 50.13 12.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.012 -1.055 . . . . 1.21 110.959 175.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.4 mt-10 59.85 12.73 3.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.275 -0.891 . . . . 1.92 110.694 176.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 9.6 mtmt -113.13 150.76 31.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 2.49 109.703 175.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.456 HG23 ' CD1' ' B' ' 47' ' ' LEU . 62.3 mt -101.77 128.82 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.01 . . . . 1.85 110.391 -176.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.546 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 29.9 mt -112.3 121.41 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.38 -0.825 . . . . 1.22 110.099 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.581 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.4 mp -114.42 134.96 54.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.006 -1.059 . . . . 2.23 110.173 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.532 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 10.8 pttp -141.42 165.19 28.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 2.17 110.222 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -58.18 147.42 30.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 2.25 109.984 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.639 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 6.0 t80 -104.29 121.71 43.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 1.21 110.598 -176.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' B' ' 51' ' ' LYS . 3.9 pttt -119.74 75.67 19.68 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.043 -1.036 . . . . 4.73 110.26 176.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.533 ' HB3' ' CZ ' ' B' ' 50' ' ' TYR . 11.8 Cg_endo -60.6 147.23 95.29 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.097 1.577 . . . . 4.2 110.348 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.016 -0.992 . . . . 6.56 110.163 179.718 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.2 t80 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.207 0.527 . . . . 11.69 110.169 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.0 ttp -105.69 140.5 38.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 9.04 110.221 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -122.08 132.64 54.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 9.15 110.166 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.2 m -121.29 150.69 41.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 4.5 110.343 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.463 HG21 ' CG2' ' B' ' 40' ' ' VAL . 58.2 p -62.19 -35.58 79.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.941 . . . . 4.26 110.228 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.2 45.95 59.66 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.642 -1.383 . . . . 1.24 109.642 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.408 HD12 ' HB ' ' A' ' 6' ' ' THR . 60.6 mt -117.76 135.93 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.204 -1.174 . . . . 2.01 110.02 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.548 HG23 ' CZ ' ' B' ' 50' ' ' TYR . 88.8 t -115.8 143.92 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.089 -1.007 . . . . 1.08 110.806 -176.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.413 ' N ' HG13 ' A' ' 9' ' ' VAL . 53.4 ttt85 -128.27 159.3 35.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.381 -0.824 . . . . 2.25 109.613 177.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -84.21 148.08 26.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.041 -1.037 . . . . 2.66 110.317 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.538 ' CG2' HD12 ' B' ' 36' ' ' LEU . 4.3 t -82.96 130.0 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.301 -0.874 . . . . 1.09 109.885 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.47 -174.74 5.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.55 110.025 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.27 -39.5 72.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.009 -1.057 . . . . 2.19 111.739 -172.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.527 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 14.7 tp -85.73 -4.24 59.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.766 -1.209 . . . . 1.97 111.629 -173.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.464 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 79.95 46.45 7.72 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.173 -1.489 . . . . 0.22 109.687 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.554 ' CD ' ' CG2' ' B' ' 19' ' ' VAL . 73.7 mtm180 -116.34 154.98 29.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.055 -1.262 . . . . 1.33 109.945 -177.539 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.499 ' CG1' HD13 ' B' ' 36' ' ' LEU . 22.4 m -123.49 150.67 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 1.08 109.786 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.538 ' CG2' ' CD ' ' B' ' 17' ' ' ARG . 23.1 t -112.62 134.96 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 1.05 110.578 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.528 ' CD1' HD13 ' B' ' 45' ' ' ILE . 4.5 mm -84.49 134.42 42.6 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 2.03 109.658 176.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.529 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.9 Cg_endo -58.49 143.67 97.74 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.812 1.428 . . . . 0.4 110.089 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.52 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.02 -33.29 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.934 -1.104 . . . . 1.79 110.377 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.493 ' N ' HG21 ' A' ' 22' ' ' ILE . 84.4 tt0 -58.05 -35.72 71.73 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.107 -0.996 . . . . 2.37 109.808 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.529 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 52.3 mt -82.48 -29.95 30.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 2.3 110.591 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.52 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 71.9 mtt180 -57.6 -43.7 84.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.834 -1.166 . . . . 0.33 109.093 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -71.43 -49.44 41.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.568 -0.707 . . . . 3.74 110.724 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.1 m -63.32 -32.01 73.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.23 -0.919 . . . . 1.44 111.114 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.517 ' CD2' HG13 ' A' ' 30' ' ' ILE . 22.1 tp -87.78 -4.82 58.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.084 -1.01 . . . . 1.64 110.75 -177.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.75 42.76 96.99 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.731 -1.348 . . . . 0.34 109.731 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.517 HG13 ' CD2' ' A' ' 28' ' ' LEU . 32.4 mm -116.35 138.91 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -1.183 . . . . 1.16 110.794 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -141.16 167.04 23.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.589 -0.694 . . . . 1.08 109.982 -178.336 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.516 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.37 146.48 12.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.082 -1.011 . . . . 1.13 110.541 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.516 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 75.2 tttt 74.46 -4.64 2.28 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.702 -0.623 . . . . 2.33 111.137 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.455 ' O ' HG22 ' B' ' 12' ' ' VAL . 89.6 m-20 -77.41 165.95 23.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.73 -1.231 . . . . 1.1 110.051 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.08 130.69 51.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.2 -0.938 . . . . 1.17 110.715 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.504 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 12.1 mt -107.89 142.21 38.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.375 -0.828 . . . . 1.21 109.367 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.458 ' HA ' HG21 ' B' ' 9' ' ' VAL . 84.8 tt0 -106.25 137.96 43.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.791 -1.193 . . . . 1.17 109.787 173.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.39 132.56 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.522 -0.736 . . . . 1.45 110.44 -174.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.549 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 16.2 m-85 -115.03 158.04 22.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 122.061 -0.399 . . . . 1.05 110.11 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.526 ' CG2' HG23 ' B' ' 6' ' ' THR . 93.2 t -129.8 123.97 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.935 -1.103 . . . . 1.08 110.739 173.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 9.2 p-10 -147.17 139.03 24.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 1.77 110.263 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.3 t0 43.68 47.22 6.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.021 -1.049 . . . . 1.22 111.159 174.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 44.3 tp10 62.4 10.33 3.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.148 -0.97 . . . . 1.93 110.723 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -115.66 148.33 39.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.91 . . . . 2.48 109.995 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.529 HD13 ' CD1' ' B' ' 20' ' ' ILE . 58.5 mt -99.6 129.09 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 1.86 110.103 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.0 mt -109.21 115.84 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.378 -0.826 . . . . 1.24 110.141 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.2 mp -108.75 133.49 52.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.062 -1.024 . . . . 2.25 109.987 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.545 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 13.2 pttp -143.64 165.73 26.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.452 -0.78 . . . . 2.26 110.357 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -56.43 146.99 22.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 2.12 109.937 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -102.43 120.02 39.8 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.362 -0.836 . . . . 0.96 110.661 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.55 123.11 49.26 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.366 -0.834 . . . . 3.58 109.571 173.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -61.98 144.75 96.68 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.787 1.414 . . . . 0.48 110.311 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.993 -1.003 . . . . 2.9 110.229 -179.871 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.23 0.538 . . . . 12.33 110.244 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 65.0 mtt -48.38 -42.25 31.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -0.929 . . . . 8.85 111.332 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -107.3 138.38 43.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.788 -1.195 . . . . 9.64 110.447 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 84.2 p -145.22 159.12 43.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.359 -0.838 . . . . 5.64 109.971 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.526 HG23 ' CG2' ' A' ' 40' ' ' VAL . 58.4 p -65.87 -35.62 81.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.164 -0.96 . . . . 3.35 110.225 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.93 46.32 60.17 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.534 -1.426 . . . . 1.53 109.534 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.452 HD13 ' HB ' ' B' ' 6' ' ' THR . 61.1 mt -117.82 135.82 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.209 -1.171 . . . . 1.97 110.084 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.504 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 89.9 t -115.81 143.86 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.048 -1.033 . . . . 1.11 110.76 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.418 ' N ' HG11 ' B' ' 9' ' ' VAL . 53.4 ttt85 -128.28 159.09 36.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.494 -0.754 . . . . 2.26 109.768 177.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -84.03 148.03 27.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.042 -1.037 . . . . 2.65 110.403 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.486 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 4.3 t -82.91 130.1 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.33 -0.856 . . . . 1.06 109.804 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.69 -174.47 5.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 0.55 110.152 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . 0.461 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.9 mt-10 -56.5 -39.45 73.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.086 -1.009 . . . . 2.19 111.646 -172.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.517 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.2 tp -85.79 -4.18 59.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.799 -1.188 . . . . 1.99 111.595 -173.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.486 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.56 47.19 7.48 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.514 -1.434 . . . . 0.23 109.514 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.538 ' CD ' ' CG2' ' A' ' 19' ' ' VAL . 73.5 mtm180 -116.46 154.98 29.38 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.039 -1.271 . . . . 1.33 109.982 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.526 HG23 ' CD2' ' A' ' 47' ' ' LEU . 22.4 m -123.54 150.59 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 1.08 109.804 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.554 ' CG2' ' CD ' ' A' ' 17' ' ' ARG . 23.0 t -112.64 134.98 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 1.07 110.505 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.529 ' CD1' HD13 ' A' ' 45' ' ' ILE . 4.5 mm -84.62 134.43 42.26 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 1.99 109.625 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.529 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.9 Cg_endo -58.67 143.69 98.41 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.811 1.427 . . . . 0.4 110.106 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.536 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.2 tp -55.16 -33.08 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.11 -0.993 . . . . 1.78 110.364 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.88 -36.35 72.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.09 -1.006 . . . . 2.37 109.744 178.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.529 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 52.5 mt -81.74 -30.37 32.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.443 -0.785 . . . . 2.36 110.686 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.536 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 71.2 mtt180 -57.43 -43.59 83.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.877 -1.14 . . . . 0.33 109.087 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -71.25 -49.77 39.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.39 -0.819 . . . . 3.75 110.666 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 51.0 m -63.04 -32.49 73.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.292 -0.88 . . . . 1.38 110.946 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.526 ' CD2' HG13 ' B' ' 30' ' ' ILE . 22.3 tp -87.34 -5.2 58.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 1.61 110.68 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.05 42.65 96.57 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.538 -1.425 . . . . 0.34 109.538 179.057 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.526 HG13 ' CD2' ' B' ' 28' ' ' LEU . 31.9 mm -116.27 138.87 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -1.181 . . . . 1.13 110.766 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -140.91 167.09 23.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.498 -0.751 . . . . 1.07 109.968 -178.383 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.512 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.43 146.48 12.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 1.13 110.555 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 75.0 tttt 74.63 -4.76 2.27 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.648 -0.657 . . . . 2.39 111.166 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.405 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 90.2 m-20 -77.49 165.64 24.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.792 -1.193 . . . . 1.1 110.042 174.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . . . . . . . . . . . -103.92 130.65 51.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 1.13 110.836 -176.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.538 HD12 ' CG2' ' A' ' 12' ' ' VAL . 12.0 mt -107.84 142.1 38.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 1.35 109.485 175.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.458 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.7 tt0 -106.08 137.84 43.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.87 -1.144 . . . . 1.17 109.911 173.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 71.0 mt -111.25 132.61 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.388 -0.82 . . . . 1.48 110.383 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.554 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 15.9 m-85 -115.06 157.92 22.85 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 120.896 0.379 . . . . 1.08 110.122 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.463 ' CG2' HG21 ' A' ' 6' ' ' THR . 94.1 t -129.53 124.3 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.937 -1.102 . . . . 1.05 110.55 173.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.471 ' OD2' HD12 ' B' ' 46' ' ' ILE . 9.4 p-10 -147.66 138.88 23.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.875 . . . . 1.77 110.208 177.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.485 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.9 t0 43.99 47.18 7.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.165 -0.959 . . . . 1.21 111.136 174.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 44.2 tp10 62.21 10.36 3.74 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.234 -0.916 . . . . 1.92 110.725 175.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -115.57 148.6 39.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 2.49 109.928 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.528 HD13 ' CD1' ' A' ' 20' ' ' ILE . 58.2 mt -99.76 129.16 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 1.85 110.096 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 21.7 mt -109.39 115.8 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.472 -0.767 . . . . 1.22 110.136 177.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.3 mp -108.55 133.4 52.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.028 -1.045 . . . . 2.23 109.934 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.55 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 13.5 pttp -143.65 165.96 26.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.447 -0.783 . . . . 2.17 110.294 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -56.48 146.94 23.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.95 . . . . 2.25 109.92 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.568 ' CZ ' ' HG3' ' B' ' 52' ' ' PRO . 6.5 t80 -102.59 117.12 33.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 1.21 110.529 -175.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -122.6 85.14 48.68 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 4.73 110.26 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.568 ' HG3' ' CZ ' ' B' ' 50' ' ' TYR . 34.5 Cg_exo -55.65 145.25 71.6 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.964 1.507 . . . . 4.2 110.306 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 51.4 t30 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.992 -1.004 . . . . 6.56 110.167 -179.904 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.145 0.498 . . . . 11.69 110.207 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.6 mtm -126.45 142.12 51.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.868 . . . . 9.04 110.133 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 43.4 tttt -101.7 43.15 1.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.211 -0.931 . . . . 9.15 110.602 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.584 ' CB ' ' CD2' ' B' ' 39' ' ' TYR . 54.6 p -157.65 163.49 38.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.987 -1.071 . . . . 4.5 110.444 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.482 HG21 ' CG2' ' B' ' 40' ' ' VAL . 70.0 p -68.54 -31.38 70.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 4.26 110.046 175.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.406 ' O ' HD13 ' A' ' 8' ' ' ILE . . . 71.12 45.87 47.05 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.691 -1.364 . . . . 1.24 109.691 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.406 HD13 ' O ' ' A' ' 7' ' ' GLY . 26.0 mm -115.3 133.73 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.189 -1.183 . . . . 2.01 109.947 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.632 ' CG1' ' CD2' ' B' ' 50' ' ' TYR . 87.1 t -116.13 143.91 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.101 -0.999 . . . . 1.08 110.842 -175.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.417 ' N ' HG12 ' A' ' 9' ' ' VAL . 17.4 tpt180 -128.07 157.11 41.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.472 -0.767 . . . . 2.25 109.789 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.413 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 26.0 ttpt -83.14 144.97 29.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.141 -0.974 . . . . 2.66 110.35 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.536 ' CG2' HD13 ' B' ' 36' ' ' LEU . 4.0 t -80.55 128.68 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.337 -0.852 . . . . 1.09 109.762 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.474 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.53 -175.01 5.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.55 110.021 179.71 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.52 -40.56 68.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.097 -1.002 . . . . 2.19 111.728 -173.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.531 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.8 tp -85.32 -4.18 59.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.798 -1.189 . . . . 1.97 111.611 -173.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.51 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.29 46.18 7.67 Favored Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.133 -1.508 . . . . 0.22 109.68 -177.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.56 ' CD ' ' CG2' ' B' ' 19' ' ' VAL . 73.1 mtm180 -116.15 154.72 29.51 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.012 -1.287 . . . . 1.33 109.818 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.525 ' CG1' HD11 ' B' ' 36' ' ' LEU . 22.5 m -124.49 152.35 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 1.08 110.001 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.548 ' CG2' ' CD ' ' B' ' 17' ' ' ARG . 21.5 t -113.71 133.95 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 1.05 110.571 -175.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.477 HG22 ' HB2' ' A' ' 24' ' ' LEU . 2.5 mm -85.04 138.09 37.21 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.227 -0.921 . . . . 2.03 109.636 175.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.7 Cg_endo -59.68 142.94 99.62 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.71 1.374 . . . . 0.4 109.972 176.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.519 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.22 -32.39 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.962 -1.086 . . . . 1.79 110.478 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.454 ' N ' HG21 ' A' ' 22' ' ' ILE . 48.6 tp10 -58.14 -35.67 71.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.147 -0.971 . . . . 2.37 109.915 179.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.531 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 63.2 mt -82.21 -30.35 30.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 2.3 110.614 178.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.519 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 74.2 mtt180 -57.77 -43.86 85.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.926 -1.109 . . . . 0.33 109.113 176.031 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -72.97 -48.48 36.26 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.848 -0.741 . . . . 3.74 110.723 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.6 m -63.72 -31.57 72.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 1.44 111.135 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.413 ' CD2' HG13 ' A' ' 30' ' ' ILE . 19.2 tp -87.94 -4.53 58.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.026 -1.046 . . . . 1.64 110.795 -177.066 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.09 40.87 95.24 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.714 -1.354 . . . . 0.34 109.714 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.422 HD13 HG21 ' A' ' 30' ' ' ILE . 36.5 mm -116.54 139.03 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -1.123 . . . . 1.16 110.632 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.0 166.76 23.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.623 -0.673 . . . . 1.08 109.978 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.514 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.58 146.54 12.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.102 -0.999 . . . . 1.13 110.534 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.514 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 19.9 tttt 74.96 -4.95 2.26 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.733 -0.605 . . . . 2.33 111.12 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.464 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.9 m-20 -78.18 165.81 23.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.902 -1.124 . . . . 1.1 110.054 174.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.422 ' HB1' ' HB3' ' A' ' 50' ' ' TYR . . . -104.61 131.01 52.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 1.17 110.726 -176.463 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.502 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 13.5 mt -107.87 142.66 37.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.825 . . . . 1.21 109.458 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.449 ' HA ' HG21 ' B' ' 9' ' ' VAL . 84.8 tt0 -106.58 138.88 41.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.805 -1.184 . . . . 1.17 109.685 172.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 68.4 mt -111.37 133.39 57.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.393 -0.817 . . . . 1.45 110.561 -173.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.543 ' OH ' ' CE ' ' A' ' 48' ' ' LYS . 14.9 m-85 -114.81 157.94 22.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.99 -0.374 . . . . 1.05 109.99 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.525 ' CG2' HG22 ' B' ' 6' ' ' THR . 93.1 t -130.7 120.43 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.942 -1.098 . . . . 1.08 110.664 172.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.484 ' CG ' ' CD1' ' A' ' 46' ' ' ILE . 5.9 p-10 -147.35 155.14 41.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 1.77 110.189 177.151 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 54.0 t0 42.38 41.75 2.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.06 -1.025 . . . . 1.22 111.345 172.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.477 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 46.5 tp10 60.81 12.34 3.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.031 -1.043 . . . . 1.93 110.778 174.433 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 19.3 pttt -128.77 161.29 30.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.114 -0.992 . . . . 2.48 109.848 174.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.529 ' CD1' HD11 ' B' ' 20' ' ' ILE . 56.5 mt -104.04 134.99 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.055 -1.028 . . . . 1.86 110.717 -172.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.534 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 25.1 mt -111.33 121.36 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.46 -0.775 . . . . 1.24 110.272 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.4 mp -112.06 133.84 53.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.986 -1.071 . . . . 2.25 110.117 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.543 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 14.0 pttp -141.6 166.08 25.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.45 -0.781 . . . . 2.26 110.359 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -55.94 147.73 18.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.196 -0.94 . . . . 2.12 110.077 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.483 ' CD2' HG13 ' B' ' 9' ' ' VAL . 4.4 t80 -103.25 126.52 50.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.833 . . . . 0.96 110.73 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -99.2 122.84 50.87 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.366 -0.834 . . . . 3.58 109.398 172.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -59.42 145.57 97.52 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.794 1.418 . . . . 0.48 110.417 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.044 -0.979 . . . . 2.9 110.219 -179.952 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.199 0.523 . . . . 12.33 110.299 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 96.2 mmm -109.67 139.19 45.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 8.85 110.286 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -128.43 148.89 50.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 9.64 110.146 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 54.2 p -68.47 159.0 32.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 5.64 110.099 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.525 HG22 ' CG2' ' A' ' 40' ' ' VAL . 69.6 p -69.28 -31.36 69.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 3.35 110.173 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . 0.472 ' O ' HD13 ' B' ' 8' ' ' ILE . . . 70.93 46.17 46.65 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.647 -1.381 . . . . 1.53 109.647 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.472 HD13 ' O ' ' B' ' 7' ' ' GLY . 26.2 mm -115.26 133.66 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.091 -1.241 . . . . 1.97 109.931 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 87.1 t -116.18 143.87 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.956 -1.09 . . . . 1.11 110.736 -175.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.416 ' N ' HG11 ' B' ' 9' ' ' VAL . 17.4 tpt180 -128.12 156.82 42.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.743 . . . . 2.26 109.892 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.409 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 26.1 ttpt -82.93 144.85 29.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.102 -0.999 . . . . 2.65 110.414 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.526 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 4.0 t -80.56 128.88 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.367 -0.833 . . . . 1.06 109.642 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -83.79 -174.9 5.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.045 -1.035 . . . . 0.55 110.177 179.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . 0.422 ' HA ' ' CD ' ' A' ' 32' ' ' GLU . 84.6 tt0 -54.65 -40.48 69.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.191 -0.943 . . . . 2.19 111.648 -173.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.52 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 15.4 tp -85.34 -4.22 59.09 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.755 -1.215 . . . . 1.99 111.647 -172.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.526 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.97 46.86 7.45 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.54 -1.424 . . . . 0.23 109.54 -177.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.548 ' CD ' ' CG2' ' A' ' 19' ' ' VAL . 72.6 mtm180 -116.33 154.69 29.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.153 -1.204 . . . . 1.33 109.831 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.453 ' CG1' HD12 ' A' ' 36' ' ' LEU . 22.6 m -124.48 152.33 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.92 . . . . 1.08 110.004 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.56 ' CG2' ' CD ' ' A' ' 17' ' ' ARG . 21.6 t -113.72 133.96 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 1.07 110.542 -175.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.529 HD11 ' CD1' ' A' ' 45' ' ' ILE . 2.5 mm -85.11 138.1 37.04 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.219 -0.925 . . . . 1.99 109.593 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.7 Cg_endo -59.78 142.91 99.54 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.755 1.397 . . . . 0.4 110.043 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.531 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -55.28 -32.25 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.027 -1.046 . . . . 1.78 110.44 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . 0.467 ' N ' HG21 ' B' ' 22' ' ' ILE . 48.5 tp10 -57.99 -36.27 72.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.091 -1.006 . . . . 2.37 109.811 178.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.526 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 63.2 mt -81.62 -30.76 32.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.401 -0.812 . . . . 2.36 110.601 178.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.531 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 73.8 mtt180 -57.54 -43.68 84.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.875 -1.141 . . . . 0.33 109.207 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -72.96 -48.71 34.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.898 . . . . 3.75 110.61 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 52.0 m -63.45 -32.22 73.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.282 -0.886 . . . . 1.38 110.895 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.408 ' CD2' HG13 ' B' ' 30' ' ' ILE . 19.4 tp -87.5 -4.79 58.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 1.61 110.711 -176.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.56 40.64 94.25 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.588 -1.405 . . . . 0.34 109.588 178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.408 HG13 ' CD2' ' B' ' 28' ' ' LEU . 36.2 mm -116.52 138.9 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -1.13 . . . . 1.13 110.634 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.73 166.87 23.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.598 -0.689 . . . . 1.07 109.991 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.4 tt0 -53.6 146.72 12.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 1.13 110.421 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 19.8 tttt 75.03 -5.16 2.22 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.622 -0.674 . . . . 2.39 111.123 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 90.6 m-20 -78.19 165.66 23.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.816 -1.178 . . . . 1.1 110.03 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.446 ' HB3' ' HB3' ' B' ' 50' ' ' TYR . . . -104.55 130.92 52.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 1.13 110.776 -176.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.536 HD13 ' CG2' ' A' ' 12' ' ' VAL . 13.3 mt -107.9 142.52 37.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.386 -0.821 . . . . 1.35 109.494 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.472 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.7 tt0 -106.42 138.91 41.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.841 -1.162 . . . . 1.17 109.832 172.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 68.5 mt -111.42 133.41 57.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.289 -0.882 . . . . 1.48 110.469 -173.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.584 ' CD2' ' CB ' ' A' ' 5' ' ' SER . 14.4 m-85 -114.77 157.86 22.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 122.096 -0.377 . . . . 1.08 110.07 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.482 ' CG2' HG21 ' A' ' 6' ' ' THR . 93.7 t -130.42 120.84 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.899 -1.126 . . . . 1.05 110.464 172.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.489 ' CG ' ' CD1' ' B' ' 46' ' ' ILE . 6.0 p-10 -147.91 155.19 41.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 1.77 110.157 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 54.5 t0 42.19 41.99 2.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.115 -0.991 . . . . 1.21 111.375 173.025 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 46.3 tp10 60.75 12.3 3.66 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.088 -1.008 . . . . 1.92 110.7 174.403 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.485 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 19.1 pttt -128.78 161.54 29.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.009 . . . . 2.49 109.775 174.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.463 HD12 HD12 ' A' ' 20' ' ' ILE . 56.8 mt -104.16 135.03 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.061 -1.024 . . . . 1.85 110.665 -172.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 25.8 mt -111.6 121.32 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.455 -0.778 . . . . 1.22 110.181 176.418 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.5 mp -111.89 133.76 53.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.03 -1.044 . . . . 2.23 110.075 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.536 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 14.2 pttp -141.61 166.36 24.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.429 -0.794 . . . . 2.17 110.27 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -56.09 147.72 19.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 2.25 109.974 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.632 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 4.5 t80 -103.35 122.19 44.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 1.21 110.646 -175.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.42 81.49 53.29 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.176 -0.953 . . . . 4.73 110.229 177.612 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -57.72 144.14 93.76 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.901 1.474 . . . . 4.2 110.238 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.002 -0.999 . . . . 6.56 110.261 -179.42 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.0 p90 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.218 0.532 . . . . 11.69 110.217 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.8 mtp -135.55 163.14 30.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.309 -0.869 . . . . 9.04 110.204 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -87.68 149.27 24.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 9.15 110.185 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.569 ' CB ' ' CD2' ' B' ' 39' ' ' TYR . 55.4 p -66.55 162.8 20.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 4.5 110.312 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.467 HG23 ' CG2' ' B' ' 40' ' ' VAL . 68.9 p -62.11 -35.96 80.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.942 . . . . 4.26 110.181 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.13 45.58 55.36 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.655 -1.378 . . . . 1.24 109.655 177.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.9 mt -118.16 134.43 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.153 -1.204 . . . . 2.01 109.983 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 99.0 t -114.29 144.58 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.025 -1.047 . . . . 1.08 110.915 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.441 ' N ' HG13 ' A' ' 9' ' ' VAL . 71.2 ttt-85 -129.75 160.79 32.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.458 -0.776 . . . . 2.25 109.753 177.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -85.05 148.09 26.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.036 -1.04 . . . . 2.66 110.311 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.546 ' CG2' HD13 ' B' ' 36' ' ' LEU . 6.5 t -81.49 129.73 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.317 -0.865 . . . . 1.09 109.821 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.29 -175.09 5.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.124 -0.985 . . . . 0.55 109.941 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.07 -39.31 71.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 2.19 111.723 -172.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.532 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 14.4 tp -86.01 -5.03 59.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.803 -1.186 . . . . 1.97 111.5 -173.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.492 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.14 46.52 7.56 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.144 -1.503 . . . . 0.22 109.699 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.544 ' CD ' ' CG2' ' B' ' 19' ' ' VAL . 73.8 mtm180 -115.6 154.85 28.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.005 -1.291 . . . . 1.33 110.036 -177.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.509 HG23 ' CD2' ' B' ' 47' ' ' LEU . 24.8 m -124.3 151.72 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 1.08 109.855 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.528 ' CG2' ' CD ' ' B' ' 17' ' ' ARG . 21.2 t -113.22 135.18 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 1.05 110.601 -175.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.496 HG22 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.34 135.12 44.42 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 2.03 109.532 175.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.532 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -58.64 143.34 98.6 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.734 1.386 . . . . 0.4 110.046 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.526 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.1 tp -55.08 -33.32 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.082 -1.012 . . . . 1.79 110.429 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.2 -35.34 71.48 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.17 -0.956 . . . . 2.37 109.893 178.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.532 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 50.0 mt -82.35 -29.97 30.66 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.35 -0.844 . . . . 2.3 110.65 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.526 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 71.4 mtt180 -57.74 -44.15 85.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.939 -1.1 . . . . 0.33 109.087 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -72.63 -47.81 44.63 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.818 -0.753 . . . . 3.74 110.756 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.1 m -63.68 -31.87 73.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 1.44 111.093 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.518 ' CD2' HG13 ' A' ' 30' ' ' ILE . 20.8 tp -87.69 -4.6 58.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.1 -1.0 . . . . 1.64 110.669 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.436 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.25 41.47 96.77 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.637 -1.385 . . . . 0.34 109.637 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.518 HG13 ' CD2' ' A' ' 28' ' ' LEU . 30.1 mm -116.4 139.75 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -1.144 . . . . 1.16 110.654 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.91 167.19 22.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.567 -0.708 . . . . 1.08 110.025 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.51 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.26 146.79 11.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.058 -1.026 . . . . 1.13 110.54 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 12.9 tttp 74.22 -4.58 2.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.743 -0.598 . . . . 2.33 111.273 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 87.8 m-20 -77.01 166.63 23.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.751 -1.218 . . . . 1.1 109.973 174.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -103.29 131.6 50.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 1.17 110.757 -175.712 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.498 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 13.0 mt -108.76 144.3 36.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.342 -0.849 . . . . 1.21 109.307 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.461 ' HG3' HG21 ' B' ' 9' ' ' VAL . 86.6 tt0 -108.37 138.34 44.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.856 -1.152 . . . . 1.17 109.646 173.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.5 mt -107.87 131.31 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.489 -0.757 . . . . 1.45 110.415 -173.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.559 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 21.4 m-85 -118.85 156.79 28.84 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 120.927 0.394 . . . . 1.05 109.963 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.473 HG23 ' CG2' ' B' ' 6' ' ' THR . 74.2 t -130.82 126.68 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.848 -1.158 . . . . 1.08 110.642 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 41.9 p-10 -147.23 142.23 27.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 1.77 110.607 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 52.3 t0 43.37 45.14 5.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.09 -1.006 . . . . 1.22 111.271 174.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 83.7 tt0 60.81 11.88 3.47 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.104 -0.997 . . . . 1.93 110.608 175.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.463 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 54.1 mtmt -114.4 153.92 29.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 2.48 109.628 175.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.418 HG22 HD12 ' A' ' 47' ' ' LEU . 67.8 mt -94.54 129.95 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.153 -0.967 . . . . 1.86 110.138 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.559 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 24.6 mm -113.15 121.79 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.659 -0.651 . . . . 1.24 109.877 178.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.0 mp -122.55 134.53 54.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.895 -1.128 . . . . 2.25 110.262 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.538 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 14.0 pttp -141.73 162.68 34.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 2.26 110.435 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.4 tttt -58.82 146.89 35.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 2.12 110.011 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.466 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 10.3 t80 -105.13 115.07 29.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.96 110.586 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 ttmt -99.74 122.76 50.07 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.884 . . . . 3.58 109.508 173.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.57 144.7 90.64 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.798 1.42 . . . . 0.48 110.2 -179.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.051 -0.976 . . . . 2.9 110.186 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 56.3 t80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.219 0.533 . . . . 12.33 110.004 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 89.4 mmm -116.11 144.18 44.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.913 . . . . 8.85 110.131 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -126.06 149.35 48.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.2 -0.938 . . . . 9.64 110.195 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 54.3 p -67.78 161.07 26.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.205 -0.934 . . . . 5.64 110.066 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.473 ' CG2' HG23 ' A' ' 40' ' ' VAL . 69.0 p -65.2 -36.08 83.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 3.35 110.229 -178.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.16 45.63 54.92 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.644 -1.382 . . . . 1.53 109.644 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.7 mt -118.16 134.32 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.124 -1.221 . . . . 1.97 109.927 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.498 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 98.5 t -114.28 144.62 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.04 -1.038 . . . . 1.11 110.898 -175.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.447 ' N ' HG12 ' B' ' 9' ' ' VAL . 71.4 ttt-85 -129.75 160.72 32.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.483 -0.76 . . . . 2.26 109.707 177.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -85.16 148.02 26.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.962 -1.086 . . . . 2.65 110.331 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.496 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 6.6 t -81.47 129.85 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.369 -0.832 . . . . 1.06 109.734 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.48 -174.83 5.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.148 -0.97 . . . . 0.55 110.136 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . 0.456 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.8 mt-10 -56.28 -39.28 72.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.057 . . . . 2.19 111.569 -172.178 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.521 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.0 tp -86.05 -4.98 59.29 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.715 -1.241 . . . . 1.99 111.52 -173.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.496 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.63 47.31 7.37 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.592 -1.403 . . . . 0.23 109.592 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.528 ' CD ' ' CG2' ' A' ' 19' ' ' VAL . 73.8 mtm180 -115.79 154.87 28.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.1 -1.235 . . . . 1.33 110.155 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.453 HG23 ' CD2' ' A' ' 47' ' ' LEU . 24.9 m -124.43 151.65 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 1.08 109.814 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.544 ' CG2' ' CD ' ' A' ' 17' ' ' ARG . 21.2 t -113.17 135.17 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 1.07 110.644 -175.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.464 ' CD1' ' N ' ' B' ' 20' ' ' ILE . 1.7 mp -83.33 135.0 44.56 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 1.99 109.588 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.0 Cg_endo -58.71 143.37 98.82 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.749 1.394 . . . . 0.4 110.169 177.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.534 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -55.08 -33.3 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.086 -1.009 . . . . 1.78 110.372 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.97 -36.15 72.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.023 -1.048 . . . . 2.37 109.708 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.526 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 50.4 mt -81.49 -30.42 33.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.519 -0.738 . . . . 2.36 110.668 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.534 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 70.8 mtt180 -57.44 -44.1 84.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.834 -1.166 . . . . 0.33 109.098 176.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -72.56 -48.1 42.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.431 -0.793 . . . . 3.75 110.645 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.5 m -63.36 -32.55 74.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.288 -0.883 . . . . 1.38 110.857 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.518 ' CD2' HG13 ' B' ' 30' ' ' ILE . 20.9 tp -87.09 -5.0 59.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.052 -1.03 . . . . 1.61 110.678 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.57 41.33 96.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.564 -1.414 . . . . 0.34 109.564 179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.518 HG13 ' CD2' ' B' ' 28' ' ' LEU . 30.0 mm -116.33 139.57 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -1.182 . . . . 1.13 110.717 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.58 167.3 22.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.471 -0.768 . . . . 1.07 110.057 -177.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.515 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.12 146.74 10.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 1.13 110.572 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.515 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 12.9 tttp 74.4 -4.89 2.21 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.657 -0.652 . . . . 2.39 111.198 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 88.2 m-20 -76.98 166.35 23.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.819 -1.176 . . . . 1.1 110.039 174.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.47 ' O ' ' HB3' ' B' ' 50' ' ' TYR . . . -103.04 131.53 49.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 1.13 110.877 -175.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.546 HD13 ' CG2' ' A' ' 12' ' ' VAL . 12.9 mt -108.84 144.11 37.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.428 -0.795 . . . . 1.35 109.362 174.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.462 ' HA ' HG21 ' A' ' 9' ' ' VAL . 86.4 tt0 -108.06 138.34 44.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.854 -1.154 . . . . 1.17 109.847 172.994 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -107.87 131.37 58.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.405 -0.809 . . . . 1.48 110.354 -173.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.569 ' CD2' ' CB ' ' A' ' 5' ' ' SER . 21.1 m-85 -118.9 156.86 28.77 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.885 -0.413 . . . . 1.08 109.885 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.467 ' CG2' HG23 ' A' ' 6' ' ' THR . 74.8 t -130.71 127.08 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.854 -1.154 . . . . 1.05 110.471 173.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.479 ' OD1' ' O ' ' B' ' 41' ' ' ASP . 41.9 p-10 -147.69 142.22 26.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.883 . . . . 1.77 110.525 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.0 t0 43.32 45.46 5.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.087 -1.008 . . . . 1.21 111.217 174.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.5 tt0 60.44 12.05 3.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.081 -1.012 . . . . 1.92 110.611 175.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 54.1 mtmt -114.41 154.01 28.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.162 -0.961 . . . . 2.49 109.633 175.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.455 HG21 ' CD1' ' B' ' 47' ' ' LEU . 67.3 mt -94.51 129.72 44.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.108 -0.995 . . . . 1.85 110.227 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 24.6 mm -113.28 121.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.681 -0.637 . . . . 1.22 109.823 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.584 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.1 mp -122.44 134.46 54.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.892 -1.13 . . . . 2.23 110.271 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.532 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 14.1 pttp -141.62 162.84 34.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 2.17 110.435 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 43.2 tttt -58.81 146.72 36.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 2.25 110.015 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.475 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 10.5 t80 -105.12 111.86 24.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 1.21 110.575 -176.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 15.6 pttt -127.08 77.23 75.56 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 4.73 110.27 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -60.68 144.61 99.56 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.957 1.504 . . . . 4.2 110.426 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 118.064 -0.97 . . . . 6.56 110.16 179.436 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 48.1 p90 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.259 0.552 . . . . 11.69 110.103 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.3 mtm -93.76 -89.38 0.22 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.281 -0.887 . . . . 9.04 110.412 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -117.97 148.52 42.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.154 -0.966 . . . . 9.15 110.314 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.1 p -119.58 157.37 28.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 4.5 110.093 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.489 ' CG2' HG23 ' B' ' 40' ' ' VAL . 74.3 p -61.83 -38.69 89.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 4.26 110.054 -179.413 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.26 45.87 76.46 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.739 -1.344 . . . . 1.24 109.739 176.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.0 mt -117.02 133.02 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.093 -1.239 . . . . 2.01 109.982 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.598 ' CG1' ' CD2' ' B' ' 50' ' ' TYR . 98.2 t -114.03 144.29 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.048 -1.032 . . . . 1.08 110.871 -176.063 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.441 ' N ' HG13 ' A' ' 9' ' ' VAL . 28.9 tpt180 -130.03 158.62 39.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.513 -0.742 . . . . 2.25 109.727 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.432 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 66.4 mmtt -85.44 148.18 26.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.006 . . . . 2.66 110.258 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.542 ' CG2' HD13 ' B' ' 36' ' ' LEU . 3.7 t -81.65 128.83 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.274 -0.891 . . . . 1.09 109.778 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.45 -175.09 5.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.087 -1.008 . . . . 0.55 110.061 -179.698 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -54.24 -41.13 68.4 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.114 -0.991 . . . . 2.19 111.7 -173.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.532 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.7 tp -84.83 -5.31 59.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.656 -1.278 . . . . 1.97 111.59 -173.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.508 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.26 46.45 7.53 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.136 -1.507 . . . . 0.22 109.716 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.537 ' CD ' ' CG2' ' B' ' 19' ' ' VAL . 70.2 mtm180 -114.77 153.94 29.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.093 -1.239 . . . . 1.33 110.031 -177.351 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.514 HG22 ' CD2' ' B' ' 47' ' ' LEU . 22.1 m -123.91 152.21 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 1.08 109.83 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.523 HG21 ' CD ' ' B' ' 17' ' ' ARG . 21.3 t -112.93 133.97 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.947 . . . . 1.05 110.742 -175.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.493 ' CD1' HD13 ' B' ' 45' ' ' ILE . 2.4 mm -84.22 133.04 45.92 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.175 -0.953 . . . . 2.03 109.446 174.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.535 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.8 Cg_endo -57.63 141.39 95.37 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.646 1.34 . . . . 0.4 109.957 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.53 ' HA ' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -55.81 -32.37 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.008 -1.058 . . . . 1.79 110.301 -177.395 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.27 -36.35 70.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.018 -1.051 . . . . 2.37 109.747 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.535 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 43.4 mt -80.87 -29.22 35.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 2.3 110.449 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.53 ' CD ' ' HA ' ' A' ' 22' ' ' ILE . 73.7 mtt180 -56.79 -44.03 81.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.864 -1.148 . . . . 0.33 108.97 175.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.453 ' HG2' HD13 ' A' ' 22' ' ' ILE . 42.6 mmt180 -72.49 -47.68 46.69 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.826 -0.749 . . . . 3.74 110.726 -177.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.9 m -63.19 -32.45 73.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.202 -0.937 . . . . 1.44 111.061 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.4 HD21 HG13 ' A' ' 30' ' ' ILE . 20.5 tp -88.56 -4.62 58.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.07 -1.019 . . . . 1.64 110.801 -177.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.98 41.82 95.08 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.732 -1.347 . . . . 0.34 109.732 178.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.4 HG13 HD21 ' A' ' 28' ' ' LEU . 32.7 mm -116.52 139.49 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.27 -1.135 . . . . 1.16 110.744 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.72 166.46 24.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.619 -0.675 . . . . 1.08 110.006 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.513 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.73 146.51 13.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.027 -1.045 . . . . 1.13 110.511 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.513 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 40.3 tttp 74.59 -4.56 2.31 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.684 -0.635 . . . . 2.33 111.114 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.461 ' O ' HG22 ' B' ' 12' ' ' VAL . 88.9 m-20 -76.87 165.87 24.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.782 -1.199 . . . . 1.1 109.966 174.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.462 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -104.72 131.19 52.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 1.17 110.771 -176.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.49 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 13.0 mt -108.66 144.1 36.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.33 -0.856 . . . . 1.21 109.341 174.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.463 ' HG3' HG21 ' B' ' 9' ' ' VAL . 85.8 tt0 -106.59 139.02 41.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.744 -1.223 . . . . 1.17 109.491 172.334 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.49 131.27 59.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.423 -0.798 . . . . 1.45 110.504 -172.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.563 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 16.7 m-85 -117.67 157.46 26.41 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 116.263 -0.426 . . . . 1.05 109.915 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.502 ' CG2' HG21 ' B' ' 6' ' ' THR . 74.2 t -131.78 120.09 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.903 -1.123 . . . . 1.08 110.617 172.773 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.481 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 46.7 p-10 -148.32 161.93 40.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.274 -0.891 . . . . 1.77 110.586 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 54.0 t0 42.25 40.57 1.81 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.002 -1.061 . . . . 1.22 111.446 172.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 96.1 mt-10 56.53 16.18 2.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.941 -1.099 . . . . 1.93 110.556 175.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.484 ' CE ' HD13 ' A' ' 46' ' ' ILE . 11.3 pttt -128.98 165.48 21.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 2.48 109.734 174.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.474 ' CD1' ' CD1' ' B' ' 20' ' ' ILE . 67.7 mt -96.71 133.85 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.178 -0.951 . . . . 1.86 110.395 -175.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 23.5 mm -113.46 120.09 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.747 -0.596 . . . . 1.24 109.927 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.577 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.0 mp -118.52 134.34 55.16 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.888 -1.133 . . . . 2.25 110.136 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.538 ' HE2' ' CE1' ' A' ' 39' ' ' TYR . 22.8 pttt -140.52 162.49 35.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.357 -0.839 . . . . 2.26 110.492 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -57.59 147.96 25.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.001 . . . . 2.12 109.902 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.474 ' CD2' HG13 ' B' ' 9' ' ' VAL . 3.5 t80 -102.63 119.55 39.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.96 110.466 -176.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.432 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -99.67 122.98 49.47 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.44 -0.787 . . . . 3.58 109.633 175.625 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 53' ' ' ASN . 17.8 Cg_endo -65.38 151.0 86.5 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.841 1.442 . . . . 0.48 110.276 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 52' ' ' PRO . 30.1 t30 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.969 -1.015 . . . . 2.9 110.301 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 65.6 t80 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.261 0.553 . . . . 12.33 110.162 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 88.4 mtp -82.76 134.31 35.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -0.936 . . . . 8.85 110.158 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -117.82 141.76 48.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 9.64 110.358 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 29.9 t -137.07 149.23 47.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.309 -0.87 . . . . 5.64 110.063 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.502 HG21 ' CG2' ' A' ' 40' ' ' VAL . 76.1 p -60.69 -38.78 86.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 3.35 109.983 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.18 46.15 74.64 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.67 -1.372 . . . . 1.53 109.67 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 59.4 mt -117.07 132.93 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.068 -1.254 . . . . 1.97 109.966 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.49 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 98.5 t -114.14 144.25 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.994 -1.066 . . . . 1.11 110.87 -176.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.436 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 29.0 tpt180 -129.96 158.53 39.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.504 -0.747 . . . . 2.26 109.767 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.436 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 66.4 mmtt -85.49 148.09 26.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 2.65 110.319 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.526 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 3.7 t -81.59 128.85 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 1.06 109.79 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.454 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.66 -174.99 5.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.157 -0.964 . . . . 0.55 110.197 -179.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.36 -40.99 68.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.104 -0.997 . . . . 2.19 111.597 -172.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.527 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 15.4 tp -84.82 -5.47 59.33 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.743 -1.223 . . . . 1.99 111.583 -173.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.526 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.93 47.25 7.24 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.529 -1.428 . . . . 0.23 109.529 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.527 ' HD3' ' CD2' ' B' ' 15' ' ' LEU . 70.0 mtm180 -114.99 153.89 29.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.089 -1.242 . . . . 1.33 109.98 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.499 HG23 ' CD2' ' A' ' 47' ' ' LEU . 22.3 m -123.88 152.2 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 1.08 109.807 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.537 ' CG2' ' CD ' ' A' ' 17' ' ' ARG . 21.3 t -112.95 134.04 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.137 -0.977 . . . . 1.07 110.598 -175.058 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.474 ' CD1' ' CD1' ' A' ' 45' ' ' ILE . 2.5 mm -84.33 133.0 45.72 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 1.99 109.41 174.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.527 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.7 Cg_endo -57.58 141.4 95.26 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.763 1.402 . . . . 0.4 109.963 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.525 HG22 HD11 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -56.04 -32.08 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.994 -1.066 . . . . 1.78 110.316 -177.217 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.19 -37.01 71.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.034 -1.041 . . . . 2.37 109.667 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.527 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 43.4 mt -80.08 -29.6 39.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.516 -0.74 . . . . 2.36 110.48 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.524 ' CD ' ' HA ' ' B' ' 22' ' ' ILE . 73.4 mtt180 -56.67 -43.81 80.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.966 -1.084 . . . . 0.33 109.076 175.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.455 ' HG2' HD13 ' B' ' 22' ' ' ILE . 42.5 mmt180 -72.51 -47.99 44.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 3.75 110.591 -178.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.2 m -62.88 -32.9 74.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.183 -0.948 . . . . 1.38 110.875 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.424 HD22 HG13 ' B' ' 30' ' ' ILE . 20.6 tp -88.16 -5.0 58.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.032 -1.043 . . . . 1.61 110.736 -176.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.41 41.46 94.38 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.656 -1.378 . . . . 0.34 109.656 178.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.424 HG13 HD22 ' B' ' 28' ' ' LEU . 32.2 mm -116.48 139.36 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -1.153 . . . . 1.13 110.728 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.43 166.6 24.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.632 -0.668 . . . . 1.07 109.985 -178.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.521 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.62 146.45 13.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.102 -0.999 . . . . 1.13 110.55 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 40.3 tttp 74.67 -4.73 2.28 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.579 -0.701 . . . . 2.39 111.194 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.407 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 89.0 m-20 -76.93 165.59 24.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.805 -1.184 . . . . 1.1 110.023 174.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' B' ' 50' ' ' TYR . . . -104.53 131.17 52.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 1.13 110.834 -176.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.542 HD13 ' CG2' ' A' ' 12' ' ' VAL . 12.9 mt -108.68 143.71 37.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.37 -0.831 . . . . 1.35 109.481 174.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.475 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.5 tt0 -106.18 138.88 41.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.839 -1.163 . . . . 1.17 109.786 172.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.465 HD13 HG22 ' B' ' 38' ' ' ILE . 69.9 mt -108.4 131.34 59.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.348 -0.845 . . . . 1.48 110.494 -171.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.566 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 16.5 m-85 -117.67 157.45 26.44 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 116.257 -0.428 . . . . 1.08 109.904 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.489 HG23 ' CG2' ' A' ' 6' ' ' THR . 75.0 t -131.69 120.51 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.868 -1.145 . . . . 1.05 110.436 172.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 46.6 p-10 -148.96 161.95 40.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.205 -0.934 . . . . 1.77 110.533 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 54.4 t0 42.02 41.0 1.8 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.185 -0.947 . . . . 1.21 111.461 172.48 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 96.1 mt-10 56.32 16.12 2.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.926 -1.109 . . . . 1.92 110.584 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 11.2 pttt -128.96 165.67 20.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 2.49 109.666 174.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.493 HD13 ' CD1' ' A' ' 20' ' ' ILE . 68.0 mt -96.82 133.83 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 1.85 110.363 -175.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 23.1 mm -113.53 120.17 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.739 -0.601 . . . . 1.22 109.865 177.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.577 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.1 mp -118.46 134.14 55.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.899 -1.125 . . . . 2.23 110.174 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.533 ' HE2' ' CE1' ' B' ' 39' ' ' TYR . 23.3 pttt -140.41 162.55 35.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 2.17 110.371 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -57.47 147.82 25.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.977 . . . . 2.25 109.871 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.598 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 3.6 t80 -102.77 118.96 37.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.908 . . . . 1.21 110.551 -176.22 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -122.29 78.86 44.52 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.123 -0.986 . . . . 4.73 110.237 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.22 145.6 97.26 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.064 1.56 . . . . 4.2 110.323 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.008 -0.996 . . . . 6.56 110.225 -179.83 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.565 ' CZ ' ' OE2' ' A' ' 23' ' ' GLU . 63.0 t80 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.206 0.527 . . . . 11.69 110.136 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.471 ' O ' ' OE2' ' A' ' 23' ' ' GLU . 93.2 mmm -122.4 143.24 49.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 9.04 110.112 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -92.0 146.29 23.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.106 -0.996 . . . . 9.15 110.277 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.558 ' O ' ' CG2' ' A' ' 6' ' ' THR . 52.9 p -67.16 158.38 31.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.946 . . . . 4.5 109.864 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.558 ' CG2' ' O ' ' A' ' 5' ' ' SER . 0.8 OUTLIER -170.8 63.58 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.445 -0.784 . . . . 4.26 110.076 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.35 49.97 4.99 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.208 -1.472 . . . . 1.24 109.979 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.7 mt -99.52 135.29 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.975 -1.309 . . . . 2.01 109.636 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 98.5 t -113.51 143.75 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.911 -1.118 . . . . 1.08 111.348 -171.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.422 ' NE ' ' HB ' ' A' ' 19' ' ' VAL . 59.5 ttm-85 -123.82 161.17 25.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.539 -0.725 . . . . 2.25 109.621 176.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HE2' ' HA ' ' B' ' 33' ' ' LYS . 82.1 tttt -82.54 145.01 29.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.138 -0.976 . . . . 2.66 110.563 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.525 ' CG2' HD12 ' B' ' 36' ' ' LEU . 4.1 t -82.97 129.38 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.412 -0.805 . . . . 1.09 109.881 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.11 -175.06 5.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.55 109.901 179.309 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.94 -39.28 74.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.991 -1.068 . . . . 2.19 111.61 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.529 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.2 tp -83.47 -6.23 59.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.755 -1.215 . . . . 1.97 111.542 -174.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.472 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 79.98 46.46 7.69 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.193 -1.479 . . . . 0.22 109.648 -177.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.529 ' HD3' ' CD2' ' A' ' 15' ' ' LEU . 68.4 mtm180 -114.12 156.15 24.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.076 -1.249 . . . . 1.33 110.019 -177.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.524 HG21 ' CD2' ' B' ' 47' ' ' LEU . 16.8 m -124.53 153.35 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 1.08 109.805 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.529 HG22 ' CD ' ' B' ' 17' ' ' ARG . 35.2 t -111.06 134.47 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 1.05 110.536 -176.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.506 HG21 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.39 133.38 50.32 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.314 -0.867 . . . . 2.03 109.433 174.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.535 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.1 Cg_endo -57.18 142.86 94.54 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.761 1.401 . . . . 0.4 110.018 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.526 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.28 -32.69 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.977 -1.077 . . . . 1.79 110.357 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.565 ' OE2' ' CZ ' ' A' ' 2' ' ' PHE . 84.4 tt0 -58.22 -35.93 72.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.096 -1.002 . . . . 2.37 109.839 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.535 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 48.7 mt -80.41 -31.4 37.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.818 . . . . 2.3 110.537 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.526 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 72.3 mtt180 -58.09 -43.38 87.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.883 -1.136 . . . . 0.33 109.243 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -73.57 -49.95 23.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.767 . . . . 3.74 110.804 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m -64.42 -30.97 72.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.24 -0.912 . . . . 1.44 111.16 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.52 ' CD2' HG13 ' A' ' 30' ' ' ILE . 19.7 tp -87.14 -4.64 59.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.02 -1.05 . . . . 1.64 110.656 -177.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.403 ' O ' HD11 ' A' ' 30' ' ' ILE . . . 64.63 43.73 96.02 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.673 -1.371 . . . . 0.34 109.673 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.52 HG13 ' CD2' ' A' ' 28' ' ' LEU . 29.6 mm -114.74 138.07 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -1.152 . . . . 1.16 110.664 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.408 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -141.22 166.57 24.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.548 -0.72 . . . . 1.08 109.986 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.3 145.99 12.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.068 -1.02 . . . . 1.13 110.51 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 45.6 tttp 74.91 -4.7 2.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.653 -0.654 . . . . 2.33 111.084 177.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.466 ' O ' HG23 ' B' ' 12' ' ' VAL . 92.0 m-20 -78.04 167.73 20.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.812 -1.18 . . . . 1.1 110.018 174.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.42 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -105.98 131.74 52.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.166 -0.959 . . . . 1.17 110.762 -176.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.529 HD13 ' CG2' ' B' ' 12' ' ' VAL . 10.3 mt -106.75 141.36 38.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.392 -0.817 . . . . 1.21 109.319 175.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.462 ' OE1' ' HE3' ' A' ' 48' ' ' LYS . 85.6 tt0 -103.88 138.17 40.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.794 -1.191 . . . . 1.17 109.892 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 74.5 mt -112.25 133.11 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.54 -0.725 . . . . 1.45 110.575 -174.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.561 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 17.3 m-85 -115.17 158.32 22.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 122.045 -0.41 . . . . 1.05 110.076 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.419 HG21 ' CB ' ' B' ' 5' ' ' SER . 82.3 t -129.44 124.29 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.016 -1.053 . . . . 1.08 110.707 173.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.465 ' OD2' HD13 ' A' ' 46' ' ' ILE . 9.1 p-10 -146.93 136.32 22.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 1.77 110.233 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 56.0 t0 44.05 49.84 7.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.017 -1.052 . . . . 1.22 111.071 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.3 mt-10 59.1 13.6 3.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.202 -0.936 . . . . 1.93 110.636 175.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -117.24 147.6 42.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 2.48 110.036 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 61.3 mt -99.65 129.16 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.148 -0.97 . . . . 1.86 110.183 -179.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 23.3 mt -109.1 116.42 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.341 -0.849 . . . . 1.24 110.043 176.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.581 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.1 mp -111.05 134.76 52.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.029 -1.044 . . . . 2.25 110.113 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.538 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 14.0 pttp -142.66 163.14 33.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.5 -0.75 . . . . 2.26 110.347 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -58.05 147.12 30.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.114 -0.991 . . . . 2.12 109.93 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.42 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 14.6 t80 -104.71 112.26 25.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.96 110.616 -176.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -100.16 122.67 49.54 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.459 -0.776 . . . . 3.58 109.385 172.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.29 144.07 99.5 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.753 1.396 . . . . 0.48 110.104 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 21.4 m120 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.051 -0.976 . . . . 2.9 110.231 -179.922 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.241 0.543 . . . . 12.33 110.151 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' MET . . . . . 0.41 ' HB3' ' HE2' ' B' ' 3' ' ' MET . 87.6 mtp -97.09 43.68 1.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 8.85 110.515 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -93.41 152.96 18.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.158 -0.963 . . . . 9.64 110.283 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.518 ' O ' ' CG2' ' B' ' 6' ' ' THR . 50.5 m -59.79 154.12 19.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.23 -0.919 . . . . 5.64 110.275 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.518 ' CG2' ' O ' ' B' ' 5' ' ' SER . 0.8 OUTLIER -168.72 63.55 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.27 -0.894 . . . . 3.35 110.243 -179.232 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.5 51.59 4.55 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.697 -1.361 . . . . 1.53 109.697 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.413 HD11 ' HA ' ' B' ' 5' ' ' SER . 61.9 mt -100.01 135.14 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.039 -1.271 . . . . 1.97 109.707 179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 98.7 t -113.5 143.71 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.869 -1.145 . . . . 1.11 111.29 -171.314 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.41 ' NE ' ' HB ' ' B' ' 19' ' ' VAL . 59.5 ttm-85 -123.76 160.98 26.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.579 -0.701 . . . . 2.26 109.776 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.43 ' HE2' ' HA ' ' A' ' 33' ' ' LYS . 81.9 tttt -82.53 144.9 30.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.072 -1.017 . . . . 2.65 110.616 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.529 ' CG2' HD13 ' A' ' 36' ' ' LEU . 4.1 t -82.87 129.6 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.804 . . . . 1.06 109.78 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.36 -174.89 5.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.129 -0.982 . . . . 0.55 110.023 179.079 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . 0.456 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.8 mt-10 -56.96 -39.28 74.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.065 -1.022 . . . . 2.19 111.552 -172.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.528 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.6 tp -83.56 -6.26 59.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.767 -1.208 . . . . 1.99 111.568 -174.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.479 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.63 47.15 7.46 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.484 -1.447 . . . . 0.23 109.484 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.529 ' CD ' HG22 ' A' ' 19' ' ' VAL . 68.6 mtm180 -114.23 156.11 24.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.974 -1.309 . . . . 1.33 110.058 -177.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.515 HG21 ' CD2' ' A' ' 47' ' ' LEU . 16.6 m -124.5 153.34 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.431 -0.793 . . . . 1.08 109.846 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.523 HG21 ' CD ' ' A' ' 17' ' ' ARG . 35.4 t -111.06 134.5 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 1.07 110.527 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.476 HG22 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.31 133.33 50.65 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.329 -0.857 . . . . 1.99 109.493 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.533 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.3 Cg_endo -57.4 142.84 95.18 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.675 1.355 . . . . 0.4 110.036 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.534 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.4 tp -55.39 -32.53 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.062 -1.024 . . . . 1.78 110.343 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . 0.49 ' N ' HG23 ' B' ' 22' ' ' ILE . 84.3 tt0 -58.03 -36.64 73.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.02 -1.05 . . . . 2.37 109.714 178.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.533 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 48.0 mt -79.68 -31.75 41.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.483 -0.76 . . . . 2.36 110.514 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.534 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 71.9 mtt180 -57.93 -43.3 86.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.925 -1.11 . . . . 0.33 109.28 176.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -73.54 -50.21 22.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.327 -0.858 . . . . 3.75 110.653 -177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 55.4 m -64.17 -31.56 72.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 1.38 110.86 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.514 ' CD2' HG13 ' B' ' 30' ' ' ILE . 20.0 tp -86.64 -5.09 59.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.124 -0.985 . . . . 1.61 110.63 -176.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.91 43.68 95.66 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.49 -1.444 . . . . 0.34 109.49 179.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.514 HG13 ' CD2' ' B' ' 28' ' ' LEU . 29.4 mm -114.66 137.97 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -1.168 . . . . 1.13 110.699 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.459 ' HB1' ' OD2' ' B' ' 34' ' ' ASP . . . -140.98 166.66 24.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.509 -0.745 . . . . 1.07 109.99 -178.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.517 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.27 146.03 12.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.138 -0.976 . . . . 1.13 110.536 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.517 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 45.5 tttp 75.0 -4.94 2.27 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.706 -0.621 . . . . 2.39 111.16 177.114 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.459 ' OD2' ' HB1' ' B' ' 31' ' ' ALA . 92.5 m-20 -78.03 167.56 21.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.914 -1.116 . . . . 1.1 110.045 174.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.449 ' HB1' HG13 ' A' ' 9' ' ' VAL . . . -105.88 131.66 52.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.961 . . . . 1.13 110.807 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.525 HD12 ' CG2' ' A' ' 12' ' ' VAL . 10.1 mt -106.72 141.16 38.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.887 . . . . 1.35 109.421 175.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.462 ' OE1' ' HE3' ' B' ' 48' ' ' LYS . 85.5 tt0 -103.75 138.22 40.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.86 -1.15 . . . . 1.17 109.975 173.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 74.5 mt -112.13 133.2 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.459 -0.775 . . . . 1.48 110.507 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.564 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 17.2 m-85 -115.32 158.27 22.64 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 120.914 0.387 . . . . 1.08 109.962 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.53 ' CG2' ' OG ' ' A' ' 5' ' ' SER . 83.9 t -129.2 124.66 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.99 -1.069 . . . . 1.05 110.61 173.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.466 ' OD2' HD12 ' B' ' 46' ' ' ILE . 9.2 p-10 -147.32 136.26 22.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -0.838 . . . . 1.77 110.151 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.486 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 56.7 t0 44.26 49.85 7.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.119 -0.988 . . . . 1.21 111.012 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.3 mt-10 58.95 13.63 2.91 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.229 -0.919 . . . . 1.92 110.607 176.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -117.23 147.87 42.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.945 . . . . 2.49 109.94 175.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.473 HG21 ' CD1' ' B' ' 47' ' ' LEU . 61.0 mt -99.83 129.15 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.102 -0.999 . . . . 1.85 110.153 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 23.8 mt -109.29 116.42 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.463 -0.773 . . . . 1.22 110.019 176.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.586 ' CD1' ' N ' ' B' ' 47' ' ' LEU . 4.2 mp -110.91 134.7 52.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.004 -1.06 . . . . 2.23 110.097 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.535 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 14.2 pttp -142.52 163.37 33.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.443 -0.785 . . . . 2.17 110.29 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -58.13 147.1 31.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 2.25 109.885 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.433 ' HB3' ' O ' ' B' ' 35' ' ' ALA . 14.8 t80 -104.94 111.99 24.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.18 -0.95 . . . . 1.21 110.667 -176.006 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -123.35 79.44 53.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.078 -1.014 . . . . 4.73 110.142 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.429 ' HG3' ' CE2' ' B' ' 50' ' ' TYR . 12.0 Cg_endo -60.4 146.24 97.1 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.075 1.566 . . . . 4.2 110.358 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 39.1 p-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.069 -0.967 . . . . 6.56 110.27 179.496 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.221 0.534 . . . . 11.69 110.227 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.443 ' SD ' ' HB2' ' B' ' 41' ' ' ASP . 70.2 mtm -120.92 149.33 42.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 9.04 110.159 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' B' ' 40' ' ' VAL . 16.2 tttp -83.88 134.62 34.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.305 -0.872 . . . . 9.15 110.331 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.0 m -119.1 147.38 44.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 4.5 110.097 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.485 HG22 ' CG2' ' B' ' 40' ' ' VAL . 64.1 p -66.49 -32.31 73.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 4.26 110.285 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.1 46.18 52.46 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.567 -1.413 . . . . 1.24 109.567 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.1 mt -116.87 135.38 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.161 -1.199 . . . . 2.01 109.967 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.647 ' CG1' ' CD2' ' B' ' 50' ' ' TYR . 90.0 t -116.15 144.46 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.019 -1.051 . . . . 1.08 110.989 -175.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.437 ' N ' HG12 ' A' ' 9' ' ' VAL . 57.5 ttm-85 -129.61 159.66 35.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.513 -0.742 . . . . 2.25 109.736 177.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -86.49 148.03 25.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.2 -0.938 . . . . 2.66 110.328 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.533 ' CG2' HD11 ' B' ' 36' ' ' LEU . 3.7 t -82.58 129.29 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.266 -0.896 . . . . 1.09 109.945 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.471 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.18 -174.7 5.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.051 -1.031 . . . . 0.55 109.995 179.614 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -56.1 -39.93 72.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.025 -1.047 . . . . 2.19 111.718 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.52 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.1 tp -85.41 -4.53 59.19 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.751 -1.218 . . . . 1.97 111.674 -173.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.474 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.07 46.34 7.71 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.176 -1.488 . . . . 0.22 109.662 -177.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.547 ' CD ' ' CG2' ' B' ' 19' ' ' VAL . 73.8 mtm180 -115.75 154.62 29.27 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.054 -1.262 . . . . 1.33 109.995 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.514 HG13 ' CD1' ' B' ' 36' ' ' LEU . 22.7 m -123.81 151.76 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 1.08 109.868 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.541 ' CG2' ' CD ' ' B' ' 17' ' ' ARG . 22.4 t -112.35 135.13 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.152 -0.968 . . . . 1.05 110.54 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.493 HG22 ' HB2' ' A' ' 24' ' ' LEU . 3.0 mm -83.64 133.29 46.94 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 2.03 109.606 175.371 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.2 Cg_endo -58.04 143.62 96.07 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.778 1.409 . . . . 0.4 110.061 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.518 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.1 tp -54.85 -33.12 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.991 -1.068 . . . . 1.79 110.347 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.03 -35.6 71.52 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.154 -0.966 . . . . 2.37 109.833 178.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.531 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 51.4 mt -83.8 -28.81 27.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.335 -0.853 . . . . 2.3 110.789 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.518 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 71.5 mtt180 -57.44 -43.9 84.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.752 -1.218 . . . . 0.33 108.957 175.011 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -71.49 -49.75 38.2 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.092 -0.643 . . . . 3.74 110.714 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.8 m -63.59 -31.4 72.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.177 -0.952 . . . . 1.44 111.15 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.528 ' CD2' HG13 ' A' ' 30' ' ' ILE . 23.8 tp -87.35 -5.03 59.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.061 -1.024 . . . . 1.64 110.729 -177.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.08 41.4 98.51 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.701 -1.36 . . . . 0.34 109.701 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.528 HG13 ' CD2' ' A' ' 28' ' ' LEU . 34.3 mm -116.41 139.73 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -1.15 . . . . 1.16 110.759 -178.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -139.89 167.46 22.05 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.654 -0.654 . . . . 1.08 110.082 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.609 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 83.3 tt0 -52.41 150.87 4.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.047 -1.033 . . . . 1.13 110.549 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.609 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 74.5 mttt 67.16 -3.32 1.01 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.857 -0.527 . . . . 2.33 112.234 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.464 ' O ' HG21 ' B' ' 12' ' ' VAL . 90.1 m-20 -76.07 165.44 24.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.579 -1.326 . . . . 1.1 109.952 174.152 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.451 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . . . -103.87 130.98 51.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 1.17 110.785 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.514 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 13.5 mt -109.14 142.36 40.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.388 -0.82 . . . . 1.21 109.54 175.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.459 ' HG3' HG22 ' B' ' 9' ' ' VAL . 85.4 tt0 -107.4 140.35 40.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.795 -1.191 . . . . 1.17 109.739 172.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.6 mt -111.57 135.41 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.345 -0.847 . . . . 1.45 110.564 -172.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.545 ' CE1' ' HD3' ' A' ' 48' ' ' LYS . 12.4 m-85 -114.6 158.55 21.55 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 120.934 0.397 . . . . 1.05 110.078 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.527 ' CG2' HG22 ' B' ' 6' ' ' THR . 77.7 t -130.89 128.39 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.924 -1.11 . . . . 1.08 110.62 172.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.489 ' CG ' ' CD1' ' A' ' 46' ' ' ILE . 8.9 p-10 -146.62 128.34 15.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.86 . . . . 1.77 110.249 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.492 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 48.1 t0 46.57 49.11 13.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.022 -1.048 . . . . 1.22 110.948 175.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.492 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.1 tt0 62.53 10.35 4.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.337 -0.852 . . . . 1.93 110.696 176.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 9.0 mtmm -110.59 148.38 32.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 2.48 109.868 176.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.463 HD13 HD12 ' B' ' 20' ' ' ILE . 58.0 mt -101.92 127.98 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 1.86 110.331 -176.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.54 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 29.6 mt -114.99 123.33 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.343 -0.848 . . . . 1.24 110.233 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.576 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 4.2 mp -114.11 136.74 52.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.961 -1.087 . . . . 2.25 110.167 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.545 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 25.2 pttt -140.92 165.61 27.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.449 -0.782 . . . . 2.26 110.132 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -56.06 149.07 16.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.109 -0.995 . . . . 2.12 109.819 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.518 ' CD2' ' CG1' ' B' ' 9' ' ' VAL . 2.2 t80 -100.43 126.53 46.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.29 -0.881 . . . . 0.96 110.655 -175.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -99.28 123.24 49.32 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.311 -0.868 . . . . 3.58 109.605 174.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -57.43 144.89 90.57 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.846 1.446 . . . . 0.48 110.367 -178.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.011 -0.995 . . . . 2.9 110.225 -179.889 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.282 0.563 . . . . 12.33 110.216 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 70.7 mtm -117.57 148.11 42.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -0.923 . . . . 8.85 110.22 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -81.39 133.28 35.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 9.64 110.242 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.45 ' HB2' ' HA ' ' A' ' 39' ' ' TYR . 97.3 p -139.05 159.32 42.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.9 . . . . 5.64 110.222 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.527 HG22 ' CG2' ' A' ' 40' ' ' VAL . 63.4 p -65.18 -32.37 74.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 3.35 110.256 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.94 46.48 52.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.55 -1.42 . . . . 1.53 109.55 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.6 mt -116.84 135.32 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.218 -1.166 . . . . 1.97 110.052 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.518 ' CG1' ' CD2' ' A' ' 50' ' ' TYR . 90.1 t -116.23 144.45 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.974 -1.079 . . . . 1.11 110.959 -175.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.429 ' N ' HG13 ' B' ' 9' ' ' VAL . 57.4 ttm-85 -129.44 159.5 36.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.488 -0.757 . . . . 2.26 109.809 177.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -86.49 147.95 25.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.027 -1.046 . . . . 2.65 110.434 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.492 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 3.7 t -82.45 129.3 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.265 -0.897 . . . . 1.06 109.823 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.3 -174.49 5.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.085 -1.009 . . . . 0.55 110.171 179.359 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . 0.465 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.5 mt-10 -56.24 -39.85 73.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.095 -1.003 . . . . 2.19 111.679 -172.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.512 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.5 tp -85.54 -4.55 59.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.723 -1.235 . . . . 1.99 111.624 -173.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.492 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.82 46.99 7.45 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.485 -1.446 . . . . 0.23 109.485 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.541 ' CD ' ' CG2' ' A' ' 19' ' ' VAL . 73.7 mtm180 -115.9 154.66 29.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.102 -1.234 . . . . 1.33 109.936 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.469 ' CG1' HD12 ' A' ' 36' ' ' LEU . 22.6 m -123.91 151.7 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.822 . . . . 1.08 109.866 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.547 ' CG2' ' CD ' ' A' ' 17' ' ' ARG . 22.6 t -112.37 135.09 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 1.07 110.576 -175.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.464 HG21 ' HB2' ' B' ' 24' ' ' LEU . 3.0 mm -83.64 133.24 47.03 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 1.99 109.594 175.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.522 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.2 Cg_endo -58.15 143.6 96.51 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.721 1.38 . . . . 0.4 110.063 177.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.534 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -54.9 -33.04 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.043 -1.036 . . . . 1.78 110.315 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.79 -36.34 72.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.152 -0.968 . . . . 2.37 109.724 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.522 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 51.4 mt -83.03 -29.28 28.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.496 -0.753 . . . . 2.36 110.752 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.534 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 71.0 mtt180 -57.22 -43.8 83.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.816 -1.178 . . . . 0.33 108.987 175.402 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -71.32 -50.15 35.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.452 -0.78 . . . . 3.75 110.543 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.4 m -63.3 -31.92 73.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.258 -0.901 . . . . 1.38 110.931 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.52 ' CD2' HG13 ' B' ' 30' ' ' ILE . 24.0 tp -86.84 -5.41 59.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.052 -1.03 . . . . 1.61 110.723 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.401 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.4 41.31 98.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.625 -1.39 . . . . 0.34 109.625 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.52 HG13 ' CD2' ' B' ' 28' ' ' LEU . 33.6 mm -116.43 139.65 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.177 -1.19 . . . . 1.13 110.707 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -139.69 167.62 21.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.516 -0.74 . . . . 1.07 109.975 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.564 ' O ' ' HB2' ' B' ' 33' ' ' LYS . 83.2 tt0 -52.33 151.07 4.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.129 -0.982 . . . . 1.13 110.467 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.564 ' HB2' ' O ' ' B' ' 32' ' ' GLU . 74.0 mttt 66.57 -2.74 0.99 Allowed 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 112.363 0.505 . . . . 2.39 112.363 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 90.4 m-20 -76.55 165.31 24.96 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.506 -1.371 . . . . 1.1 109.965 173.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.459 ' HB3' ' HB3' ' B' ' 50' ' ' TYR . . . -103.63 131.02 51.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 1.13 110.802 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.537 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 13.3 mt -109.23 142.18 40.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.383 -0.823 . . . . 1.35 109.558 175.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.472 ' HA ' HG23 ' A' ' 9' ' ' VAL . 85.2 tt0 -107.26 140.32 40.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.842 -1.161 . . . . 1.17 109.824 172.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.8 mt -111.61 135.36 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.284 -0.885 . . . . 1.48 110.58 -172.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.537 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 12.1 m-85 -114.4 158.57 21.35 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 120.946 0.403 . . . . 1.08 110.09 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.485 ' CG2' HG22 ' A' ' 6' ' ' THR . 78.6 t -130.72 128.61 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.903 -1.123 . . . . 1.05 110.476 172.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.478 ' CG ' ' CD1' ' B' ' 46' ' ' ILE . 9.0 p-10 -146.91 128.24 14.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 1.77 110.241 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 49.0 t0 46.77 49.08 14.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.093 -1.005 . . . . 1.21 110.934 175.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.0 tt0 62.4 10.4 3.92 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.224 -0.923 . . . . 1.92 110.691 176.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.437 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 9.0 mtmm -110.61 148.66 31.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.942 . . . . 2.49 109.705 176.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.435 HD12 HD22 ' A' ' 28' ' ' LEU . 58.0 mt -102.08 128.0 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.981 . . . . 1.85 110.365 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 30.4 mt -115.17 123.4 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.415 -0.803 . . . . 1.22 110.146 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.579 ' CD1' ' N ' ' B' ' 47' ' ' LEU . 4.2 mp -114.05 136.63 52.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.981 -1.074 . . . . 2.23 110.145 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.537 ' HD3' ' CE1' ' B' ' 39' ' ' TYR . 25.2 pttt -140.78 165.84 26.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.44 -0.788 . . . . 2.17 110.079 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -56.3 148.87 17.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.992 -1.067 . . . . 2.25 109.754 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.647 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 2.2 t80 -100.46 122.33 43.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 1.21 110.667 -175.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.543 ' CB ' ' HD3' ' B' ' 52' ' ' PRO . 0.0 OUTLIER -97.03 -56.6 0.2 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.932 . . . . 4.73 110.952 179.719 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.585 ' O ' ' CZ ' ' B' ' 50' ' ' TYR . 36.6 Cg_exo -52.75 155.35 10.77 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.505 1.266 . . . . 4.2 110.604 -177.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 17.7 m120 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.997 -1.001 . . . . 6.56 110.181 -178.561 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.0 t80 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.301 0.572 . . . . 11.69 110.227 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.3 mmm -98.4 138.9 34.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 9.04 110.229 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -49.36 -39.68 32.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.269 -0.895 . . . . 9.15 111.412 -174.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.8 m -110.63 159.13 17.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.737 -1.227 . . . . 4.5 110.235 -177.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.517 HG21 ' CG2' ' B' ' 40' ' ' VAL . 70.2 p -60.76 -35.19 75.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.139 -0.976 . . . . 4.26 110.194 -177.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.91 46.7 43.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.703 -1.359 . . . . 1.24 109.703 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.5 mt -114.57 134.58 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.039 -1.271 . . . . 2.01 110.014 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 86.8 t -114.0 144.12 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.027 -1.046 . . . . 1.08 110.871 -175.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.429 ' N ' HG11 ' A' ' 9' ' ' VAL . 58.2 ttt85 -126.29 157.88 37.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.398 -0.814 . . . . 2.25 109.71 177.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.443 ' CE ' ' HA ' ' B' ' 33' ' ' LYS . 55.2 tttt -83.58 145.04 29.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.137 -0.977 . . . . 2.66 110.396 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.538 ' CG2' HD13 ' B' ' 36' ' ' LEU . 3.9 t -81.77 130.31 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.351 -0.843 . . . . 1.09 109.929 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.472 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.38 -174.58 5.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.177 -0.952 . . . . 0.55 110.131 -179.606 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.46 -39.74 73.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.07 -1.019 . . . . 2.19 111.779 -172.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.518 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.3 tp -84.76 -4.33 59.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.765 -1.209 . . . . 1.97 111.6 -173.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.469 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.06 46.23 7.79 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.172 -1.49 . . . . 0.22 109.715 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.561 ' CD ' ' CG2' ' B' ' 19' ' ' VAL . 74.9 mtm180 -116.16 155.12 28.82 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.069 -1.254 . . . . 1.33 110.05 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.517 ' CG1' HD11 ' B' ' 36' ' ' LEU . 21.9 m -122.23 148.4 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 1.08 109.758 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.546 ' CG2' ' CD ' ' B' ' 17' ' ' ARG . 28.5 t -112.82 133.79 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 1.05 110.623 -175.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.478 HG23 ' HB2' ' A' ' 24' ' ' LEU . 2.2 mm -84.75 130.86 51.31 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.294 -0.878 . . . . 2.03 109.461 175.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.52 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -57.29 142.34 94.79 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.668 1.352 . . . . 0.4 109.849 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.527 ' HA ' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -55.46 -32.39 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.952 -1.093 . . . . 1.79 110.289 -177.624 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.54 -36.38 71.55 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.16 -0.963 . . . . 2.37 109.747 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.52 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 52.9 mt -82.1 -27.59 32.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 2.3 110.471 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.527 ' CD ' ' HA ' ' A' ' 22' ' ' ILE . 73.0 mtt180 -56.97 -43.93 82.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.833 -1.167 . . . . 0.33 108.966 174.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 61.0 ttm-85 -71.66 -49.31 40.96 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.956 -0.698 . . . . 3.74 110.765 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.9 m -63.21 -31.84 73.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.186 -0.946 . . . . 1.44 111.078 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.526 ' CD2' HG13 ' A' ' 30' ' ' ILE . 23.2 tp -88.09 -5.01 58.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.093 -1.004 . . . . 1.64 110.758 -177.254 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.52 41.57 97.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.651 -1.38 . . . . 0.34 109.651 179.022 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.526 HG13 ' CD2' ' A' ' 28' ' ' LEU . 33.6 mm -116.53 139.1 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -1.169 . . . . 1.16 110.732 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -141.32 166.65 24.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.645 -0.659 . . . . 1.08 109.984 -178.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 33' ' ' LYS . 84.2 tt0 -53.29 146.39 12.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.056 -1.027 . . . . 1.13 110.592 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.519 ' CB ' ' O ' ' A' ' 32' ' ' GLU . 28.5 tttt 74.52 -4.63 2.28 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.674 -0.642 . . . . 2.33 111.166 176.944 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.455 ' O ' HG22 ' B' ' 12' ' ' VAL . 90.6 m-20 -77.3 165.95 23.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.788 -1.195 . . . . 1.1 110.03 174.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -105.21 130.14 53.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 1.17 110.629 -176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.515 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 11.6 mt -106.25 141.64 37.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 1.21 109.387 174.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.464 ' OE1' ' HE3' ' A' ' 48' ' ' LYS . 85.3 tt0 -104.65 139.01 40.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.758 -1.214 . . . . 1.17 109.882 173.66 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.7 mt -109.82 132.67 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.514 -0.741 . . . . 1.45 110.374 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.544 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 14.2 m-85 -114.65 157.54 22.96 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.929 -0.397 . . . . 1.05 109.929 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.466 HG22 HG22 ' B' ' 6' ' ' THR . 79.9 t -129.59 126.29 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.942 -1.099 . . . . 1.08 110.746 174.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.467 ' CG ' ' CD1' ' A' ' 46' ' ' ILE . 9.4 p-10 -146.71 131.91 18.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 1.77 110.178 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 47.7 t0 46.09 48.19 12.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.952 -1.092 . . . . 1.22 111.008 175.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.0 tt0 62.02 10.98 3.95 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.202 -0.936 . . . . 1.93 110.609 175.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.436 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 32.7 mtmt -113.07 150.98 31.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.072 -1.017 . . . . 2.48 109.873 176.42 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.457 ' CD1' HD12 ' B' ' 20' ' ' ILE . 56.7 mt -101.9 129.58 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 1.86 110.284 -176.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.9 mt -112.5 120.83 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 1.24 110.193 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.583 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.2 mp -112.39 134.08 54.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.984 -1.073 . . . . 2.25 110.133 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.543 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 10.5 pttp -141.52 164.8 29.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.478 -0.764 . . . . 2.26 110.394 178.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.517 ' HD3' ' CD1' ' A' ' 30' ' ' ILE . 18.3 tptp -56.97 146.04 28.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.133 -0.979 . . . . 2.12 109.938 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 9.9 t80 -101.9 114.03 27.76 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.331 -0.855 . . . . 0.96 110.646 -176.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.52 123.0 49.7 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.309 -0.869 . . . . 3.58 109.606 174.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -60.09 147.04 94.7 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.763 1.402 . . . . 0.48 110.214 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.8 m120 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.046 -0.978 . . . . 2.9 110.21 -179.382 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 68.2 t80 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.274 0.559 . . . . 12.33 110.28 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 64.7 mtt -89.13 140.65 29.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 8.85 110.224 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -133.14 165.4 24.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -0.866 . . . . 9.64 110.217 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 40.7 m -62.81 156.29 24.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 5.64 110.209 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.466 HG22 HG22 ' A' ' 40' ' ' VAL . 70.4 p -63.77 -35.16 79.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 3.35 110.217 -179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.65 47.28 42.02 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.581 -1.408 . . . . 1.53 109.581 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.454 HD11 ' HB ' ' B' ' 6' ' ' THR . 60.0 mt -114.68 134.47 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.136 -1.214 . . . . 1.97 110.037 -179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.515 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 88.3 t -114.03 144.11 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.079 -1.013 . . . . 1.11 110.911 -175.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.425 ' N ' HG13 ' B' ' 9' ' ' VAL . 58.2 ttt85 -126.29 157.6 37.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.456 -0.777 . . . . 2.26 109.833 177.486 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -83.53 144.95 29.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.983 . . . . 2.65 110.453 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.478 ' CG1' ' HA2' ' B' ' 16' ' ' GLY . 4.0 t -81.72 130.49 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.354 -0.841 . . . . 1.06 109.812 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.6 -174.4 5.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.103 -0.998 . . . . 0.55 110.3 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . 0.457 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -56.63 -39.62 73.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.103 -0.998 . . . . 2.19 111.65 -172.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.52 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 15.0 tp -84.87 -4.39 59.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.741 -1.225 . . . . 1.99 111.527 -173.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.478 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.75 47.04 7.46 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.495 -1.442 . . . . 0.23 109.495 -177.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.546 ' CD ' ' CG2' ' A' ' 19' ' ' VAL . 74.8 mtm180 -116.44 155.1 29.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.001 -1.293 . . . . 1.33 109.969 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.43 HG22 ' O ' ' B' ' 18' ' ' VAL . 22.0 m -122.3 148.35 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 1.08 109.756 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.561 ' CG2' ' CD ' ' A' ' 17' ' ' ARG . 28.4 t -112.75 133.76 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.948 . . . . 1.07 110.636 -175.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.495 HG22 ' HB2' ' B' ' 24' ' ' LEU . 2.2 mm -84.76 130.86 51.28 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 1.99 109.416 175.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.516 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.0 Cg_endo -57.42 142.28 95.11 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.771 1.406 . . . . 0.4 109.888 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.522 ' HA ' ' CD ' ' B' ' 25' ' ' ARG . 0.0 OUTLIER -55.52 -32.17 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.994 -1.066 . . . . 1.78 110.291 -177.375 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.45 -37.05 72.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.103 -0.998 . . . . 2.37 109.643 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.516 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 52.5 mt -81.42 -27.88 34.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 2.36 110.502 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.522 ' CD ' ' HA ' ' B' ' 22' ' ' ILE . 72.7 mtt180 -56.79 -43.8 81.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.912 -1.118 . . . . 0.33 109.046 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 61.0 ttm-85 -71.56 -49.78 37.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.463 -0.773 . . . . 3.75 110.578 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 48.1 m -62.8 -32.43 73.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.3 -0.875 . . . . 1.38 110.893 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.527 ' CD2' HG13 ' B' ' 30' ' ' ILE . 23.4 tp -87.55 -5.42 58.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.058 -1.027 . . . . 1.61 110.661 -176.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.86 41.33 97.52 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.605 -1.398 . . . . 0.34 109.605 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.527 HG13 ' CD2' ' B' ' 28' ' ' LEU . 33.4 mm -116.45 138.93 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -1.199 . . . . 1.13 110.725 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.439 ' HB3' ' OD2' ' B' ' 34' ' ' ASP . . . -140.99 166.78 23.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.59 -0.694 . . . . 1.07 110.053 -178.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.51 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.31 146.48 12.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.132 -0.98 . . . . 1.13 110.516 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.51 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 28.5 tttt 74.54 -4.78 2.25 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.673 -0.642 . . . . 2.39 111.225 176.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' B' ' 31' ' ' ALA . 90.7 m-20 -77.39 165.57 24.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.849 -1.157 . . . . 1.1 110.05 175.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.95 130.1 53.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 1.13 110.69 -176.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.538 HD13 ' CG2' ' A' ' 12' ' ' VAL . 11.4 mt -106.26 141.5 37.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.396 -0.815 . . . . 1.35 109.426 174.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.464 ' HA ' HG21 ' A' ' 9' ' ' VAL . 85.2 tt0 -104.55 138.95 40.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.84 -1.163 . . . . 1.17 110.008 173.624 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 72.0 mt -109.76 132.59 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.395 -0.816 . . . . 1.48 110.329 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.543 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 13.9 m-85 -114.59 157.55 22.89 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.901 -0.407 . . . . 1.08 109.901 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.517 ' CG2' HG21 ' A' ' 6' ' ' THR . 79.7 t -129.41 126.6 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.958 -1.089 . . . . 1.05 110.584 174.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.47 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.4 p-10 -146.99 131.83 18.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.354 -0.841 . . . . 1.77 110.14 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 48.7 t0 46.3 48.21 13.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.107 -0.996 . . . . 1.21 110.968 175.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 82.8 tt0 61.82 11.04 3.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.238 -0.914 . . . . 1.92 110.617 175.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 32.7 mtmt -113.08 151.2 31.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.178 -0.951 . . . . 2.49 109.791 176.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.456 HD11 HD13 ' A' ' 20' ' ' ILE . 56.3 mt -102.01 129.67 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.174 -0.954 . . . . 1.85 110.294 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.543 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 22.3 mt -112.71 120.83 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 1.22 110.075 176.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.583 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.2 mp -112.28 134.02 54.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.077 -1.014 . . . . 2.23 110.053 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.536 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 10.7 pttp -141.5 165.02 28.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 2.17 110.248 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.518 ' HD3' ' CD1' ' B' ' 30' ' ' ILE . 18.3 tptp -57.06 145.96 28.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 2.25 109.878 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.508 ' CD1' ' HD3' ' B' ' 52' ' ' PRO . 10.1 t80 -102.01 112.14 24.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 1.21 110.599 -176.23 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.42 76.74 77.18 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.881 . . . . 4.73 110.067 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.508 ' HD3' ' CD1' ' B' ' 50' ' ' TYR . 10.6 Cg_endo -58.71 144.62 97.82 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.998 1.525 . . . . 4.2 110.367 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.961 -1.019 . . . . 6.56 110.267 -179.934 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.205 0.526 . . . . 11.69 110.203 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.9 mtt -96.92 131.12 44.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.246 -0.908 . . . . 9.04 110.203 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -51.37 -42.15 61.14 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.225 -0.922 . . . . 9.15 111.5 -174.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.0 t -110.86 148.86 31.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.668 -1.27 . . . . 4.5 110.331 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.4 p -60.84 -39.32 88.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 4.26 110.181 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.95 46.51 81.16 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.63 -1.388 . . . . 1.24 109.63 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.0 mm -115.05 133.75 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.138 -1.213 . . . . 2.01 110.157 -178.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.639 ' CG1' ' CD2' ' B' ' 50' ' ' TYR . 98.9 t -115.28 144.46 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.996 -1.065 . . . . 1.08 110.893 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.459 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 14.8 tpt180 -130.22 160.62 33.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.514 -0.741 . . . . 2.25 109.687 177.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.459 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 66.7 mttm -85.76 148.5 25.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.106 -0.996 . . . . 2.66 110.344 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.541 ' CG2' HD12 ' B' ' 36' ' ' LEU . 6.3 t -82.05 128.75 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.216 -0.927 . . . . 1.09 109.816 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.37 -174.82 5.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.209 -0.932 . . . . 0.55 110.164 -179.299 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -53.24 -41.99 65.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.087 -1.008 . . . . 2.19 111.687 -173.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.53 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 16.3 tp -85.97 -4.89 59.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.717 -1.239 . . . . 1.97 111.685 -172.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.502 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.23 46.44 7.55 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.094 -1.527 . . . . 0.22 109.695 -177.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.535 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.2 mtm180 -114.78 154.63 28.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.079 -1.248 . . . . 1.33 110.088 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.452 HG12 HD13 ' B' ' 36' ' ' LEU . 20.9 m -124.85 152.7 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 1.08 109.819 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.526 HG21 ' CD ' ' B' ' 17' ' ' ARG . 21.4 t -112.61 134.91 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 1.05 110.637 -175.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.487 HD11 ' N ' ' A' ' 20' ' ' ILE . 1.7 mp -82.95 132.11 52.02 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.279 -0.888 . . . . 2.03 109.539 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.533 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.1 Cg_endo -57.28 141.23 94.6 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.729 1.384 . . . . 0.4 109.947 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.524 HD11 ' NE ' ' A' ' 26' ' ' ARG . 0.0 OUTLIER -55.66 -31.7 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.023 -1.048 . . . . 1.79 110.371 -177.56 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.73 -35.33 72.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.071 -1.018 . . . . 2.37 109.824 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.533 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 46.7 mt -81.39 -28.22 34.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.282 -0.887 . . . . 2.3 110.394 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.521 ' CD ' ' HA ' ' A' ' 22' ' ' ILE . 72.4 mtt180 -56.98 -44.72 82.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.897 -1.127 . . . . 0.33 109.092 175.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.524 ' NE ' HD11 ' A' ' 22' ' ' ILE . 98.1 mtt180 -72.14 -47.83 48.05 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.775 -0.77 . . . . 3.74 110.839 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.3 m -63.26 -32.19 73.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.158 -0.964 . . . . 1.44 111.018 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.514 ' CD2' HG13 ' A' ' 30' ' ' ILE . 21.3 tp -88.62 -4.71 58.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.1 -1.0 . . . . 1.64 110.734 -177.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.412 ' O ' HD11 ' A' ' 30' ' ' ILE . . . 65.05 41.81 97.01 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.718 -1.353 . . . . 0.34 109.718 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.514 HG13 ' CD2' ' A' ' 28' ' ' LEU . 32.0 mm -116.48 139.24 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.313 -1.11 . . . . 1.16 110.777 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -141.57 166.12 25.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.677 -0.64 . . . . 1.08 109.987 -178.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.24 147.09 10.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.081 -1.012 . . . . 1.13 110.492 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 33.1 tttp 74.78 -4.97 2.24 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.77 -0.581 . . . . 2.33 111.118 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.413 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.4 m-20 -77.38 166.52 23.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.79 -1.194 . . . . 1.1 109.989 174.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -105.2 132.81 50.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 1.17 110.842 -175.655 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.517 HD11 ' CG2' ' B' ' 12' ' ' VAL . 13.0 mt -110.11 144.82 38.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.376 -0.828 . . . . 1.21 109.509 175.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.462 ' HG3' HG21 ' B' ' 9' ' ' VAL . 86.6 tt0 -108.81 139.79 43.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.726 -1.234 . . . . 1.17 109.685 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.2 mt -109.04 131.17 60.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.434 -0.791 . . . . 1.45 110.56 -172.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.557 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 16.7 m-85 -117.73 157.74 25.98 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 116.296 -0.411 . . . . 1.05 110.02 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.449 HG21 HG22 ' B' ' 6' ' ' THR . 80.7 t -131.79 125.17 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.891 -1.131 . . . . 1.08 110.571 172.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.477 ' OD1' HG12 ' A' ' 46' ' ' ILE . 43.5 p-10 -147.49 144.84 28.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.106 -0.996 . . . . 1.77 110.768 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 52.8 t0 43.02 44.27 4.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.982 -1.074 . . . . 1.22 111.285 173.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.466 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 84.1 tt0 60.87 11.34 3.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.108 -0.995 . . . . 1.93 110.679 176.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -111.07 153.53 25.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 2.48 110.057 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.41 ' HB ' ' HB2' ' B' ' 47' ' ' LEU . 66.0 mt -93.51 128.8 44.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.279 -0.888 . . . . 1.86 109.846 177.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.557 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 23.9 mm -112.97 119.55 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.629 -0.669 . . . . 1.24 110.004 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.576 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.2 mp -117.96 134.79 54.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 2.25 110.202 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.527 ' HE2' ' CE1' ' A' ' 39' ' ' TYR . 22.7 pttt -141.28 162.42 35.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.377 -0.827 . . . . 2.26 110.326 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -57.79 147.17 28.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.147 -0.971 . . . . 2.12 110.023 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.463 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 5.3 t80 -102.8 124.71 48.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.96 110.575 -176.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -99.5 122.94 49.94 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.38 -0.825 . . . . 3.58 109.379 172.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -62.13 145.1 96.51 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.742 1.391 . . . . 0.48 110.352 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 m120 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.02 -0.991 . . . . 2.9 110.233 -179.659 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.232 0.539 . . . . 12.33 110.238 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 69.0 mtm -134.95 157.55 46.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.289 -0.882 . . . . 8.85 110.344 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -131.66 129.98 41.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 9.64 109.988 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 72.3 m -107.59 -100.14 0.36 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 5.64 110.444 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.449 HG22 HG21 ' A' ' 40' ' ' VAL . 52.5 p -70.02 -39.59 75.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.939 -1.101 . . . . 3.35 110.317 -176.896 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . 0.447 ' O ' HD13 ' B' ' 8' ' ' ILE . . . 65.56 47.18 80.27 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.495 -1.442 . . . . 1.53 109.495 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.447 HD13 ' O ' ' B' ' 7' ' ' GLY . 20.8 mm -115.22 133.63 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.192 -1.181 . . . . 1.97 110.222 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.502 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 99.4 t -115.22 144.51 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.03 -1.044 . . . . 1.11 110.837 -176.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.462 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 14.8 tpt180 -130.23 160.51 33.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.573 -0.705 . . . . 2.26 109.792 177.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.462 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 66.7 mttm -85.76 148.49 25.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.062 -1.024 . . . . 2.65 110.331 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.517 ' CG2' HD11 ' A' ' 36' ' ' LEU . 6.4 t -82.11 128.76 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.281 -0.887 . . . . 1.06 109.728 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -85.52 -174.6 5.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.55 110.217 -179.395 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . 0.465 ' OE1' ' OE2' ' A' ' 32' ' ' GLU . 47.2 tp10 -53.41 -41.86 66.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 2.19 111.689 -173.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.528 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 15.9 tp -85.97 -4.93 59.28 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.781 -1.2 . . . . 1.99 111.732 -172.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.504 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.88 47.27 7.26 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.439 -1.464 . . . . 0.23 109.439 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.528 ' HD3' ' CD2' ' B' ' 15' ' ' LEU . 69.2 mtm180 -114.94 154.64 28.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.057 -1.26 . . . . 1.33 110.043 -177.392 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.516 HG21 ' CD2' ' A' ' 47' ' ' LEU . 21.0 m -124.93 152.71 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.367 -0.833 . . . . 1.08 109.852 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.535 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.4 t -112.62 134.83 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 1.07 110.666 -175.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.491 HD12 ' N ' ' B' ' 20' ' ' ILE . 1.7 mp -82.98 132.1 51.95 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.92 . . . . 1.99 109.528 174.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.529 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.1 Cg_endo -57.45 141.26 94.97 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.73 1.384 . . . . 0.4 109.964 177.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.525 HD11 ' NE ' ' B' ' 26' ' ' ARG . 0.0 OUTLIER -55.9 -31.24 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.982 . . . . 1.78 110.367 -177.216 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.83 -35.91 73.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.04 -1.038 . . . . 2.37 109.633 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.529 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 47.1 mt -80.73 -28.5 36.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.44 -0.788 . . . . 2.36 110.438 176.78 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.522 ' CD ' ' HA ' ' B' ' 22' ' ' ILE . 72.1 mtt180 -56.93 -44.59 82.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.876 -1.14 . . . . 0.33 109.037 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.525 ' NE ' HD11 ' B' ' 22' ' ' ILE . 98.1 mtt180 -72.1 -48.08 46.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.403 -0.811 . . . . 3.75 110.698 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.3 m -63.0 -32.66 74.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.244 -0.91 . . . . 1.38 110.816 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.524 ' CD2' HG13 ' B' ' 30' ' ' ILE . 21.4 tp -88.12 -5.15 58.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.997 -1.064 . . . . 1.61 110.636 -177.021 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.436 ' O ' HD12 ' B' ' 30' ' ' ILE . . . 65.44 41.69 96.25 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.519 -1.433 . . . . 0.34 109.519 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.524 HG13 ' CD2' ' B' ' 28' ' ' LEU . 31.7 mm -116.49 139.24 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.14 -1.212 . . . . 1.13 110.731 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.34 166.24 25.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.663 -0.648 . . . . 1.07 109.948 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.52 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.19 147.1 10.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.028 -1.045 . . . . 1.13 110.525 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.52 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 33.1 tttp 74.76 -5.0 2.22 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.737 -0.602 . . . . 2.39 111.132 177.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 88.7 m-20 -77.43 166.4 23.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.795 -1.19 . . . . 1.1 109.992 174.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.463 ' O ' ' HB3' ' B' ' 50' ' ' TYR . . . -105.14 132.79 50.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 1.13 110.902 -175.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.541 HD12 ' CG2' ' A' ' 12' ' ' VAL . 12.7 mt -110.24 144.54 38.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.355 -0.841 . . . . 1.35 109.533 175.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.467 ' OE1' ' HE2' ' B' ' 48' ' ' LYS . 86.4 tt0 -108.44 139.81 42.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.744 -1.223 . . . . 1.17 109.832 172.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -109.01 131.26 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.353 -0.842 . . . . 1.48 110.42 -172.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.55 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 16.5 m-85 -117.82 157.64 26.23 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 120.964 0.411 . . . . 1.08 109.97 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 80.9 t -131.59 125.5 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.864 -1.148 . . . . 1.05 110.427 172.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.481 ' OD1' HG12 ' B' ' 46' ' ' ILE . 43.4 p-10 -147.88 144.85 28.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 1.77 110.743 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.4 t0 43.02 44.44 4.08 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.059 -1.026 . . . . 1.21 111.237 174.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 84.1 tt0 60.65 11.44 3.1 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.027 -1.046 . . . . 1.92 110.613 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -111.09 153.78 25.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.111 -0.993 . . . . 2.49 109.895 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.462 HD13 HG12 ' A' ' 20' ' ' ILE . 65.2 mt -93.69 128.6 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.198 -0.939 . . . . 1.85 109.967 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 23.4 mm -112.95 119.65 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.697 -0.627 . . . . 1.22 109.873 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.576 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.3 mp -117.89 134.68 54.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.007 -1.058 . . . . 2.23 110.147 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.524 ' HE2' ' CE1' ' B' ' 39' ' ' TYR . 23.1 pttt -141.16 162.61 35.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.352 -0.843 . . . . 2.17 110.276 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -57.8 147.09 29.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.947 . . . . 2.25 109.997 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.639 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 5.5 t80 -102.91 120.3 40.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 1.21 110.516 -176.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.47 78.07 19.92 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 4.73 110.327 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -60.21 144.67 99.48 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.161 1.611 . . . . 4.2 110.28 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.004 -0.998 . . . . 6.56 110.239 -179.867 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.1 t80 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.268 0.556 . . . . 11.69 110.272 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.6 mtm -104.53 142.02 35.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.283 -0.886 . . . . 9.04 110.261 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -49.27 -54.34 17.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.15 -0.969 . . . . 9.15 110.643 -176.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.0 p -80.45 161.55 24.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.945 -1.097 . . . . 4.5 109.958 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 63.5 p -63.6 -37.32 86.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.112 -0.993 . . . . 4.26 110.051 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.28 45.53 60.76 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.715 -1.354 . . . . 1.24 109.715 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 57.9 mt -117.79 132.77 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.142 -1.211 . . . . 2.01 109.991 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.53 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 92.6 t -112.65 143.71 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.975 -1.078 . . . . 1.08 110.782 -176.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.42 ' N ' HG12 ' A' ' 9' ' ' VAL . 29.7 tpt180 -125.98 157.83 36.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.539 -0.726 . . . . 2.25 109.832 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HE3' ' HA ' ' B' ' 33' ' ' LYS . 33.2 tttp -82.81 143.82 30.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.915 . . . . 2.66 110.172 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.535 ' CG2' HD12 ' B' ' 36' ' ' LEU . 15.0 t -80.4 126.93 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.888 . . . . 1.09 109.855 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.99 -174.93 5.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.975 . . . . 0.55 110.013 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.34 -39.55 73.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.011 -1.056 . . . . 2.19 111.689 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.534 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.1 tp -84.67 -6.17 59.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.728 -1.233 . . . . 1.97 111.574 -173.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.32 46.69 7.35 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.108 -1.52 . . . . 0.22 109.641 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.537 ' CD ' HG23 ' B' ' 19' ' ' VAL . 70.8 mtm180 -114.06 153.99 28.48 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.033 -1.275 . . . . 1.33 110.078 -177.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.532 ' CG1' HD13 ' B' ' 36' ' ' LEU . 20.9 m -124.28 153.39 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.343 -0.848 . . . . 1.08 109.789 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.52 HG22 ' CD ' ' B' ' 17' ' ' ARG . 17.0 t -113.42 133.66 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 1.05 110.703 -175.337 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.46 HG22 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.42 136.19 43.11 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.163 -0.961 . . . . 2.03 109.443 174.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.5 Cg_endo -58.56 141.12 97.14 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.702 1.369 . . . . 0.4 109.893 176.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.524 ' HA ' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -55.89 -31.31 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.94 -1.1 . . . . 1.79 110.382 -177.55 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.59 -35.38 72.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.049 -1.032 . . . . 2.37 109.854 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.531 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 52.8 mt -81.02 -29.46 35.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 2.3 110.455 176.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.524 ' CD ' ' HA ' ' A' ' 22' ' ' ILE . 73.9 mtt180 -57.13 -44.02 82.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.969 -1.082 . . . . 0.33 109.05 175.547 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -72.64 -50.12 27.29 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.539 -0.726 . . . . 3.74 110.708 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m -63.56 -31.25 72.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.195 -0.941 . . . . 1.44 111.09 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.431 HD22 HG13 ' A' ' 30' ' ' ILE . 18.2 tp -87.59 -4.37 58.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 1.64 110.759 -177.092 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.442 ' O ' HD12 ' A' ' 30' ' ' ILE . . . 67.01 40.94 93.37 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.712 -1.355 . . . . 0.34 109.712 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.442 HD12 ' O ' ' A' ' 29' ' ' GLY . 31.2 mm -116.51 139.07 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.328 -1.101 . . . . 1.16 110.674 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.83 166.53 24.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.529 -0.732 . . . . 1.08 110.032 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.503 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.24 146.53 11.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 1.13 110.602 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.503 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 56.2 tttt 74.7 -4.58 2.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.678 -0.639 . . . . 2.33 111.139 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -76.75 168.09 20.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.189 . . . . 1.1 110.034 174.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.453 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -106.23 131.69 53.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 1.17 110.726 -175.818 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.527 ' CD1' HG23 ' B' ' 12' ' ' VAL . 13.0 mt -109.04 144.55 36.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.425 -0.797 . . . . 1.21 109.457 175.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.477 ' HG3' HG21 ' B' ' 9' ' ' VAL . 86.0 tt0 -109.65 138.67 45.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.74 -1.225 . . . . 1.17 109.491 172.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.51 133.33 55.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.336 -0.853 . . . . 1.45 110.607 -171.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.579 ' CE1' ' HD2' ' A' ' 48' ' ' LYS . 9.5 m-85 -118.3 161.48 19.86 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.905 -0.405 . . . . 1.05 109.905 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.504 HG22 ' CG2' ' B' ' 6' ' ' THR . 77.4 t -133.8 120.53 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.854 -1.154 . . . . 1.08 110.599 172.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 45.4 p-10 -148.25 160.99 42.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 1.77 110.55 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 53.0 t0 42.21 39.51 1.44 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.009 -1.057 . . . . 1.22 111.493 172.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 84.2 tt0 59.05 14.07 3.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.898 -1.127 . . . . 1.93 110.567 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 11.2 pttt -127.66 166.25 18.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.147 -0.971 . . . . 2.48 109.696 174.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.515 HD13 ' CG1' ' B' ' 20' ' ' ILE . 66.8 mt -97.95 134.37 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 1.86 110.388 -175.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.547 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 20.3 mm -113.95 120.13 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.643 -0.661 . . . . 1.24 109.959 178.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.586 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.5 mp -115.83 135.63 53.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.965 -1.085 . . . . 2.25 110.227 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.579 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 13.5 ptpt -141.28 158.64 43.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 2.26 110.368 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -58.42 146.75 33.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 2.12 109.934 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.453 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 8.5 t80 -104.05 119.6 39.28 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.318 -0.864 . . . . 0.96 110.602 -175.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -100.32 122.61 49.44 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.618 -0.677 . . . . 3.58 109.383 173.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_exo -62.28 145.44 96.03 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.723 1.381 . . . . 0.48 110.207 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.018 -0.991 . . . . 2.9 110.163 179.79 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 66.1 t80 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.148 0.499 . . . . 12.33 110.153 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 88.3 mtp -45.81 -41.58 11.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.218 -0.926 . . . . 8.85 111.03 -175.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -78.1 132.48 37.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.745 -1.222 . . . . 9.64 110.192 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 55.8 p -69.52 165.03 21.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 5.64 110.107 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.504 ' CG2' HG22 ' A' ' 40' ' ' VAL . 64.4 p -57.9 -37.27 73.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 3.35 109.984 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.4 45.53 60.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.609 -1.396 . . . . 1.53 109.609 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 58.6 mt -117.67 132.73 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.144 -1.21 . . . . 1.97 109.964 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.503 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 92.7 t -112.74 143.68 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.07 -1.019 . . . . 1.11 110.789 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.424 ' N ' HG12 ' B' ' 9' ' ' VAL . 29.7 tpt180 -125.96 157.69 37.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.463 -0.773 . . . . 2.26 109.912 178.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.409 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 33.0 tttp -82.78 143.67 30.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 2.65 110.173 -179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.527 HG23 ' CD1' ' A' ' 36' ' ' LEU . 15.1 t -80.23 127.08 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 1.06 109.78 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -86.15 -174.79 5.25 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.082 -1.011 . . . . 0.55 110.14 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . 0.463 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.8 mt-10 -56.46 -39.51 73.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.017 -1.052 . . . . 2.19 111.609 -172.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.528 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.7 tp -84.69 -6.21 59.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.733 -1.229 . . . . 1.99 111.599 -173.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.88 47.65 7.03 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.474 -1.45 . . . . 0.23 109.474 -177.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.528 ' HD3' ' CD2' ' B' ' 15' ' ' LEU . 70.6 mtm180 -114.39 154.05 28.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.037 -1.272 . . . . 1.33 109.974 -177.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.455 HG23 HD22 ' A' ' 47' ' ' LEU . 20.6 m -124.35 153.49 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 1.08 109.864 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.537 HG23 ' CD ' ' A' ' 17' ' ' ARG . 16.9 t -113.53 133.68 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 1.07 110.672 -175.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.515 ' CG1' HD13 ' A' ' 45' ' ' ILE . 1.7 mp -83.41 136.21 43.13 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.201 -0.937 . . . . 1.99 109.475 174.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.4 Cg_endo -58.74 141.01 97.38 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.716 1.377 . . . . 0.4 109.896 176.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.525 HG22 HD11 ' B' ' 22' ' ' ILE . 0.0 OUTLIER -56.03 -31.01 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 1.78 110.415 -177.268 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.56 -35.96 73.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.994 -1.066 . . . . 2.37 109.714 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.526 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 52.6 mt -80.32 -29.83 38.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.416 -0.802 . . . . 2.36 110.435 176.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.519 ' NH2' HD12 ' A' ' 15' ' ' LEU . 73.3 mtt180 -56.98 -44.0 82.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.903 -1.123 . . . . 0.33 109.036 175.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -72.4 -50.44 26.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 3.75 110.715 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 55.5 m -63.29 -31.78 73.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.33 -0.856 . . . . 1.38 110.878 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.403 HD21 HG13 ' B' ' 30' ' ' ILE . 18.3 tp -87.16 -4.57 59.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.007 -1.058 . . . . 1.61 110.71 -176.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 67.34 40.73 91.81 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.597 -1.401 . . . . 0.34 109.597 178.631 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.403 HG13 HD21 ' B' ' 28' ' ' LEU . 30.6 mm -116.53 139.05 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -1.175 . . . . 1.13 110.586 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.62 166.53 24.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.545 -0.722 . . . . 1.07 110.06 -177.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.33 146.64 11.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.944 . . . . 1.13 110.511 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 56.1 tttt 74.71 -4.69 2.29 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.592 -0.693 . . . . 2.39 111.264 177.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.4 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 87.7 m-20 -76.75 167.74 21.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.8 -1.187 . . . . 1.1 110.021 174.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.45 ' O ' ' HB3' ' B' ' 50' ' ' TYR . . . -105.94 131.67 52.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 1.13 110.856 -175.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.535 HD12 ' CG2' ' A' ' 12' ' ' VAL . 12.8 mt -109.03 144.26 37.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.858 . . . . 1.35 109.626 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.461 ' HA ' HG23 ' A' ' 9' ' ' VAL . 85.7 tt0 -109.27 138.69 45.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.759 -1.213 . . . . 1.17 109.734 172.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.3 mt -109.5 133.38 54.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.336 -0.853 . . . . 1.48 110.531 -171.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.573 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 9.3 m-85 -118.33 161.31 20.15 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.954 -0.387 . . . . 1.08 109.954 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.412 ' CG2' HD12 ' A' ' 24' ' ' LEU . 78.9 t -133.5 121.01 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.861 -1.15 . . . . 1.05 110.473 172.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' B' ' 41' ' ' ASP . 45.3 p-10 -148.86 160.95 42.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.98 . . . . 1.77 110.49 178.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 53.4 t0 41.99 39.82 1.42 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.204 -0.935 . . . . 1.21 111.481 172.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.468 ' O ' ' HG2' ' B' ' 43' ' ' GLU . 84.2 tt0 58.89 14.04 3.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.91 -1.119 . . . . 1.92 110.528 174.915 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 11.2 pttt -127.55 166.41 18.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 2.49 109.699 174.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.406 ' HB ' ' HB2' ' A' ' 47' ' ' LEU . 66.7 mt -98.09 134.32 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 1.85 110.399 -175.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.573 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 20.7 mm -113.94 120.09 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.683 -0.636 . . . . 1.22 109.975 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.586 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.6 mp -115.76 135.5 53.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.069 -1.019 . . . . 2.23 110.192 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.569 ' HD2' ' CE1' ' B' ' 39' ' ' TYR . 13.5 ptpt -141.14 158.88 43.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.375 -0.828 . . . . 2.17 110.295 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -58.54 146.75 34.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.213 -0.929 . . . . 2.25 109.908 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.45 ' HB3' ' O ' ' B' ' 35' ' ' ALA . 8.8 t80 -104.25 119.34 38.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 1.21 110.69 -175.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -109.08 77.1 0.81 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 4.73 110.315 176.186 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -61.21 147.14 96.42 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.082 1.569 . . . . 4.2 110.431 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.998 -1.001 . . . . 6.56 110.21 179.693 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.201 0.524 . . . . 11.69 110.223 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.8 mtt -107.39 147.13 30.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 9.04 110.234 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -94.1 148.29 22.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.211 -0.93 . . . . 9.15 110.28 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.5 p -122.53 159.04 28.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -0.866 . . . . 4.5 110.107 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.436 ' CG2' HG23 ' B' ' 40' ' ' VAL . 56.7 p -60.86 -38.25 84.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.25 -0.906 . . . . 4.26 110.003 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.72 45.4 84.59 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.697 -1.361 . . . . 1.24 109.697 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.6 mt -117.81 133.95 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.128 -1.219 . . . . 2.01 110.085 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.534 ' CG1' ' O ' ' B' ' 36' ' ' LEU . 90.7 t -117.41 144.49 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.056 -1.027 . . . . 1.08 110.82 -176.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.427 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 23.9 tpt180 -129.77 158.95 38.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -0.793 . . . . 2.25 109.798 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.427 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 35.5 ttpt -82.71 145.52 29.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.127 -0.983 . . . . 2.66 110.335 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.548 ' CG2' HD13 ' B' ' 36' ' ' LEU . 3.7 t -81.76 128.69 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.385 -0.822 . . . . 1.09 109.807 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.55 -177.29 6.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.072 -1.017 . . . . 0.55 109.997 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.99 -40.5 73.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.049 -1.032 . . . . 2.19 111.539 -174.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.57 ' CD1' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -76.83 -13.81 59.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.873 -1.142 . . . . 1.97 110.542 -174.458 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.81 46.66 5.9 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.401 -1.479 . . . . 0.22 109.401 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.542 ' CD ' HG21 ' B' ' 19' ' ' VAL . 70.5 mtm180 -114.41 155.04 27.06 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.024 -1.28 . . . . 1.33 110.095 -176.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.529 ' CG1' HD11 ' B' ' 36' ' ' LEU . 13.1 m -122.91 152.46 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.318 -0.864 . . . . 1.08 109.769 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.525 HG21 ' CD ' ' B' ' 17' ' ' ARG . 15.0 t -112.8 134.08 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 1.05 110.659 -174.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.473 HG21 ' HB2' ' A' ' 24' ' ' LEU . 2.5 mm -84.3 137.24 39.68 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 2.03 109.367 174.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.523 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.8 Cg_endo -58.63 140.77 96.24 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.718 1.378 . . . . 0.4 109.785 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.523 ' HA ' ' CD ' ' A' ' 25' ' ' ARG . 0.0 OUTLIER -55.63 -32.21 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.862 -1.149 . . . . 1.79 110.313 -177.679 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -58.73 -35.27 72.42 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.16 -0.962 . . . . 2.37 109.763 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.523 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 41.3 mt -82.65 -27.62 31.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 2.3 110.517 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.523 ' CD ' ' HA ' ' A' ' 22' ' ' ILE . 71.2 mtt180 -56.85 -44.51 82.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.798 -1.189 . . . . 0.33 108.84 175.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . 0.463 ' HG2' HD11 ' A' ' 22' ' ' ILE . 31.5 mmt180 -72.77 -47.81 43.59 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.938 -0.705 . . . . 3.74 110.657 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.4 m -63.69 -31.32 72.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.191 -0.943 . . . . 1.44 111.069 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.454 ' CD2' HG13 ' A' ' 30' ' ' ILE . 20.9 tp -87.39 -4.65 59.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 1.64 110.683 -177.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.05 41.49 95.11 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.662 -1.375 . . . . 0.34 109.662 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.454 HG13 ' CD2' ' A' ' 28' ' ' LEU . 33.3 mm -116.43 138.79 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.344 -1.092 . . . . 1.16 110.675 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.64 166.07 25.76 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.55 -0.719 . . . . 1.08 109.981 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.508 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.73 146.51 13.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.094 -1.004 . . . . 1.13 110.533 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.508 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 43.5 tttm 75.02 -4.63 2.34 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.744 -0.598 . . . . 2.33 111.068 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.472 ' O ' HG22 ' B' ' 12' ' ' VAL . 89.9 m-20 -77.21 167.19 22.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.73 -1.231 . . . . 1.1 110.05 174.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -105.49 130.74 53.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 1.17 110.744 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.505 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 13.4 mt -107.58 143.9 35.36 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.336 -0.852 . . . . 1.21 109.388 175.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.46 ' HG3' HG22 ' B' ' 9' ' ' VAL . 85.3 tt0 -108.77 139.22 43.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.809 -1.182 . . . . 1.17 109.694 172.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.3 mt -109.84 133.1 56.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.425 -0.797 . . . . 1.45 110.541 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.575 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 17.2 m-85 -119.45 158.85 25.38 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 116.262 -0.426 . . . . 1.05 109.894 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.531 ' CG2' ' CG2' ' B' ' 6' ' ' THR . 85.3 t -132.01 123.32 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.833 -1.167 . . . . 1.08 110.66 173.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.478 ' OD1' HG12 ' A' ' 46' ' ' ILE . 47.8 p-10 -147.69 149.12 31.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 1.77 110.632 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.474 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 52.7 t0 42.95 44.64 4.07 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.001 -1.062 . . . . 1.22 111.256 173.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 75.6 mm-40 57.67 14.55 2.45 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.053 -1.03 . . . . 1.93 110.567 176.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -115.84 153.94 30.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 2.48 109.955 175.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.457 ' CG2' HD13 ' B' ' 20' ' ' ILE . 67.7 mt -92.92 129.05 44.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.253 -0.904 . . . . 1.86 109.954 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.586 ' CD1' ' CD1' ' B' ' 46' ' ' ILE . 21.0 mm -111.91 119.36 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.561 -0.712 . . . . 1.24 109.907 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.2 mp -118.81 134.36 55.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.924 -1.11 . . . . 2.25 110.281 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.534 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 12.1 pttp -141.99 163.69 32.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.451 -0.781 . . . . 2.26 110.478 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -59.26 147.02 37.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 2.12 110.14 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.46 ' HB3' ' O ' ' A' ' 35' ' ' ALA . 10.3 t80 -105.32 118.82 37.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.96 110.67 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.3 tttp -99.45 123.12 49.39 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 3.58 109.447 171.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -60.85 144.27 99.53 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.764 1.402 . . . . 0.48 110.418 -177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.2 t30 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.023 -0.989 . . . . 2.9 110.223 -179.954 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.187 0.518 . . . . 12.33 110.207 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 71.1 mtm -46.73 -42.24 16.42 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.164 -0.96 . . . . 8.85 111.103 -175.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . 0.459 ' HD2' ' OH ' ' A' ' 39' ' ' TYR . 25.1 mmtm -96.86 142.07 29.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.802 -1.186 . . . . 9.64 110.129 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 25.8 t -66.29 -99.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 5.64 110.245 -179.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.531 ' CG2' ' CG2' ' A' ' 40' ' ' VAL . 56.2 p -75.35 -38.35 60.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.948 -1.095 . . . . 3.35 109.995 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.65 45.6 83.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.636 -1.386 . . . . 1.53 109.636 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.4 mt -117.84 133.82 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.15 -1.206 . . . . 1.97 110.08 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.505 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 89.4 t -117.34 144.45 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.009 -1.057 . . . . 1.11 110.804 -176.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.433 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 24.0 tpt180 -129.75 158.85 38.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.545 -0.722 . . . . 2.26 109.907 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.433 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 35.5 ttpt -82.72 145.38 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.059 -1.026 . . . . 2.65 110.4 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.493 ' CG2' ' HG ' ' A' ' 36' ' ' LEU . 3.7 t -81.67 128.79 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.256 -0.903 . . . . 1.06 109.704 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.76 -177.4 6.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.093 -1.005 . . . . 0.55 110.073 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.97 -40.41 73.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.073 -1.017 . . . . 2.19 111.489 -173.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.567 ' CD1' ' O ' ' B' ' 15' ' ' LEU . 0.1 OUTLIER -76.49 -14.26 60.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.894 -1.129 . . . . 1.99 110.647 -174.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.63 47.32 5.69 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.319 -1.512 . . . . 0.23 109.319 -177.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.525 ' CD ' HG21 ' A' ' 19' ' ' VAL . 70.5 mtm180 -114.61 154.95 27.44 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.155 -1.203 . . . . 1.33 110.058 -176.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.522 HG23 ' CD2' ' A' ' 47' ' ' LEU . 13.2 m -122.93 152.48 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 1.08 109.74 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.542 HG21 ' CD ' ' A' ' 17' ' ' ARG . 14.9 t -112.84 134.1 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 1.07 110.678 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.47 HG21 ' HB2' ' B' ' 24' ' ' LEU . 2.5 mm -84.29 137.21 39.72 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.924 . . . . 1.99 109.388 174.259 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.53 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.8 Cg_endo -58.74 140.77 96.39 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.656 1.345 . . . . 0.4 109.837 176.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.514 ' HA ' ' CD ' ' B' ' 25' ' ' ARG . 0.0 OUTLIER -55.78 -31.99 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.998 -1.064 . . . . 1.78 110.294 -177.374 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -58.74 -35.85 73.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.024 -1.047 . . . . 2.37 109.609 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.53 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 41.8 mt -81.89 -28.01 33.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.431 -0.793 . . . . 2.36 110.566 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.514 ' CD ' ' HA ' ' B' ' 22' ' ' ILE . 70.7 mtt180 -56.78 -44.27 81.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.901 -1.124 . . . . 0.33 108.957 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . 0.441 ' HG2' HD12 ' B' ' 22' ' ' ILE . 31.4 mmt180 -72.74 -47.96 42.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.484 -0.76 . . . . 3.75 110.642 -178.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.3 m -63.45 -31.96 73.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.226 -0.921 . . . . 1.38 110.84 -177.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.458 ' CD2' HG13 ' B' ' 30' ' ' ILE . 21.0 tp -86.83 -4.99 59.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.132 -0.98 . . . . 1.61 110.66 -177.11 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.48 41.17 94.41 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.603 -1.399 . . . . 0.34 109.603 178.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.458 HG13 ' CD2' ' B' ' 28' ' ' LEU . 32.6 mm -116.34 138.65 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -1.199 . . . . 1.13 110.667 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.33 166.24 25.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.633 -0.667 . . . . 1.07 110.001 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.525 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.4 tt0 -53.74 146.6 13.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 1.13 110.475 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 43.6 tttm 75.07 -4.87 2.28 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.621 -0.675 . . . . 2.39 111.169 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 90.1 m-20 -77.37 166.99 22.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.91 -1.119 . . . . 1.1 110.041 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.458 ' O ' ' HB3' ' B' ' 50' ' ' TYR . . . -105.27 130.78 53.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 1.13 110.816 -176.629 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.548 HD13 ' CG2' ' A' ' 12' ' ' VAL . 13.1 mt -107.7 143.56 36.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.375 -0.828 . . . . 1.35 109.495 175.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.47 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.2 tt0 -108.43 139.18 43.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.932 -1.105 . . . . 1.17 109.85 172.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.5 mt -109.85 133.01 56.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.39 -0.819 . . . . 1.48 110.489 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.581 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 17.1 m-85 -119.43 158.85 25.37 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 116.244 -0.435 . . . . 1.08 109.94 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.436 HG23 ' CG2' ' A' ' 6' ' ' THR . 86.5 t -131.82 123.65 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.863 -1.148 . . . . 1.05 110.515 173.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.478 ' OD1' ' O ' ' B' ' 41' ' ' ASP . 47.9 p-10 -148.18 149.14 31.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 1.77 110.613 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.461 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 53.2 t0 42.83 44.94 4.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.101 -0.999 . . . . 1.21 111.188 174.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 75.6 mm-40 57.42 14.65 2.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.071 -1.018 . . . . 1.92 110.562 176.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -115.87 154.18 30.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 2.49 109.896 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.486 HG23 ' CD1' ' B' ' 47' ' ' LEU . 67.6 mt -93.07 128.84 44.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.187 -0.946 . . . . 1.85 109.945 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.586 ' CD1' ' CD1' ' A' ' 46' ' ' ILE . 21.0 mm -111.93 119.51 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.572 -0.705 . . . . 1.22 109.946 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.59 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.4 mp -118.78 134.23 55.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.892 -1.13 . . . . 2.23 110.15 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.542 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 12.3 pttp -141.85 163.89 31.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 2.17 110.371 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -59.24 146.91 37.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.135 -0.978 . . . . 2.25 110.1 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.501 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 10.5 t80 -105.35 112.15 25.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 1.21 110.542 -176.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.451 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 14.5 pttt -130.01 76.3 78.28 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.173 -0.954 . . . . 4.73 110.303 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.419 ' HD3' ' CD1' ' B' ' 50' ' ' TYR . 11.7 Cg_endo -60.4 145.05 99.44 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.989 1.521 . . . . 4.2 110.321 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.001 -1.0 . . . . 6.56 110.226 -179.986 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.219 0.533 . . . . 11.69 110.196 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.4 mtm -114.49 149.96 35.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.31 -0.869 . . . . 9.04 110.15 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.1 pttm -133.23 169.02 17.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 9.15 110.245 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.1 m -117.41 151.89 36.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.897 . . . . 4.5 110.023 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.528 HG23 ' CG2' ' B' ' 40' ' ' VAL . 81.1 p -60.97 -36.38 79.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 4.26 110.02 -179.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.419 ' C ' HD12 ' A' ' 8' ' ' ILE . . . 71.05 46.23 45.37 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.814 -1.315 . . . . 1.24 109.814 176.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.419 HD12 ' C ' ' A' ' 7' ' ' GLY . 18.5 mm -113.48 131.57 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.165 -1.197 . . . . 2.01 109.811 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.643 ' CG1' ' CD2' ' B' ' 50' ' ' TYR . 85.7 t -118.84 144.75 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.969 -1.082 . . . . 1.08 110.904 -174.615 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.487 ' CZ ' HG21 ' A' ' 19' ' ' VAL . 70.6 ttt-85 -129.94 159.26 37.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.455 -0.778 . . . . 2.25 109.83 177.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -82.87 146.03 29.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 2.66 110.265 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.537 ' CG2' HD12 ' B' ' 36' ' ' LEU . 3.4 t -80.42 129.28 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.357 -0.839 . . . . 1.09 109.866 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.469 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.84 -175.35 5.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.179 -0.951 . . . . 0.55 110.039 179.337 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -54.56 -40.82 69.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.069 -1.019 . . . . 2.19 111.788 -173.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.529 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.9 tp -84.99 -5.41 59.35 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.758 -1.214 . . . . 1.97 111.595 -173.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.44 46.52 7.38 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 119.178 -1.486 . . . . 0.22 109.687 -177.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.532 ' CD ' HG21 ' B' ' 19' ' ' VAL . 71.1 mtm180 -114.83 154.51 28.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.031 -1.276 . . . . 1.33 110.004 -177.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.518 HG22 ' CD2' ' B' ' 47' ' ' LEU . 18.8 m -124.47 153.15 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 1.08 109.809 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.524 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.4 t -111.19 135.38 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 1.05 110.569 -176.007 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.474 HG21 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.69 134.6 47.18 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 2.03 109.524 175.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.524 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.3 Cg_endo -58.27 143.45 97.19 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.756 1.398 . . . . 0.4 110.092 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.52 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.28 -31.81 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.934 -1.104 . . . . 1.79 110.416 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.42 -34.95 73.11 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.15 -0.969 . . . . 2.37 109.907 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.524 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 61.5 mt -81.96 -30.66 31.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.326 -0.858 . . . . 2.3 110.589 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.52 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 73.7 mtt180 -57.69 -43.92 85.45 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.044 -1.062 . . . . 0.33 109.212 175.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -72.5 -50.51 25.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.559 -0.713 . . . . 3.74 110.706 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.0 m -63.7 -31.21 72.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.144 -0.972 . . . . 1.44 111.086 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.528 ' CD2' HG13 ' A' ' 30' ' ' ILE . 22.9 tp -87.56 -4.78 58.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.088 -1.007 . . . . 1.64 110.698 -177.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.72 43.47 96.26 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.614 -1.395 . . . . 0.34 109.614 179.043 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.528 HG13 ' CD2' ' A' ' 28' ' ' LEU . 30.8 mm -115.69 139.08 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.272 -1.134 . . . . 1.16 110.65 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -140.81 167.49 22.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.555 -0.716 . . . . 1.08 110.003 -178.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.608 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 83.4 tt0 -52.48 150.44 4.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 1.13 110.468 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.608 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 39.9 mttp 67.01 -2.97 1.02 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 112.294 0.479 . . . . 2.33 112.294 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.466 ' O ' HG21 ' B' ' 12' ' ' VAL . 88.3 m-20 -75.55 166.89 22.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.526 -1.359 . . . . 1.1 109.922 173.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.45 ' HB1' ' HB3' ' A' ' 50' ' ' TYR . . . -103.83 130.23 51.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 1.17 110.769 -175.72 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.528 HD13 ' CG2' ' B' ' 12' ' ' VAL . 13.7 mt -108.3 140.67 41.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 1.21 109.49 175.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -105.4 140.1 39.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.834 -1.166 . . . . 1.17 109.731 173.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.2 mt -111.49 133.88 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.44 -0.788 . . . . 1.45 110.478 -173.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.571 ' CE1' ' HD2' ' A' ' 48' ' ' LYS . 8.6 m-85 -115.2 160.4 19.77 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 120.904 0.383 . . . . 1.05 110.09 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.514 ' CG2' HG22 ' B' ' 6' ' ' THR . 94.0 t -133.58 123.13 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.132 -0.98 . . . . 1.08 110.857 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.508 ' OD2' ' CE2' ' B' ' 2' ' ' PHE . 9.1 p-10 -147.3 141.61 26.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 1.77 110.22 177.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 53.4 t0 43.47 47.86 6.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.074 -1.016 . . . . 1.22 111.096 174.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.7 mt-10 58.74 13.77 2.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.186 -0.946 . . . . 1.93 110.711 176.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -114.52 148.19 38.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 2.48 110.07 175.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.48 HD12 ' CG1' ' B' ' 20' ' ' ILE . 61.2 mt -99.6 127.6 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 1.86 110.095 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.53 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 34.2 mt -111.87 118.15 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.331 -0.856 . . . . 1.24 110.275 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 4.2 mp -107.95 135.59 49.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 2.25 110.122 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.571 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 16.2 ptpt -142.45 164.22 30.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.516 -0.74 . . . . 2.26 110.125 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -55.77 147.95 17.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.116 -0.99 . . . . 2.12 109.721 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.476 ' CD2' ' CG1' ' B' ' 9' ' ' VAL . 1.7 t80 -100.56 123.68 45.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.96 110.644 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.08 123.25 49.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.357 -0.839 . . . . 3.58 109.753 175.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 53' ' ' ASN . 24.2 Cg_exo -58.63 145.26 96.08 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.799 1.421 . . . . 0.48 110.292 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 52' ' ' PRO . 84.7 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.939 -1.029 . . . . 2.9 110.223 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . 0.508 ' CE2' ' OD2' ' A' ' 41' ' ' ASP . 97.8 m-85 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.203 0.525 . . . . 12.33 110.267 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 94.9 mmm -48.87 -40.5 29.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.18 -0.95 . . . . 8.85 111.424 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -91.51 135.09 34.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.757 -1.214 . . . . 9.64 110.46 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.4 ' OG ' ' CD2' ' A' ' 39' ' ' TYR . 27.9 t -149.96 152.61 35.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.329 -0.857 . . . . 5.64 110.007 178.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.514 HG22 ' CG2' ' A' ' 40' ' ' VAL . 80.9 p -61.28 -36.42 80.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.141 -0.974 . . . . 3.35 110.059 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.78 46.58 45.15 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.786 -1.326 . . . . 1.53 109.786 176.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 18.5 mm -113.53 131.41 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.133 -1.216 . . . . 1.97 109.879 178.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.498 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 86.3 t -118.81 144.69 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.005 -1.059 . . . . 1.11 110.935 -174.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.466 ' CZ ' HG23 ' B' ' 19' ' ' VAL . 70.6 ttt-85 -129.93 159.08 37.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.468 -0.77 . . . . 2.26 109.924 177.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -82.84 145.93 29.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 2.65 110.395 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.528 ' CG2' HD13 ' A' ' 36' ' ' LEU . 3.4 t -80.26 129.46 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.917 . . . . 1.06 109.756 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.09 -175.29 5.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.122 -0.986 . . . . 0.55 110.069 179.154 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.67 -40.78 69.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.177 -0.952 . . . . 2.19 111.678 -173.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.526 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 15.2 tp -85.04 -5.43 59.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.764 -1.21 . . . . 1.99 111.572 -173.144 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.526 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.11 47.24 7.15 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.523 -1.431 . . . . 0.23 109.523 -177.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.526 ' HD3' ' CD2' ' B' ' 15' ' ' LEU . 70.9 mtm180 -115.06 154.49 28.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.05 -1.265 . . . . 1.33 109.932 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.516 ' CG1' HD11 ' A' ' 36' ' ' LEU . 18.8 m -124.49 153.07 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 1.08 109.822 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.532 HG21 ' CD ' ' A' ' 17' ' ' ARG . 21.4 t -111.23 135.3 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -0.956 . . . . 1.07 110.605 -175.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.501 HG21 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.62 134.52 47.52 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.26 -0.9 . . . . 1.99 109.545 175.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.522 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.3 Cg_endo -58.28 143.4 97.29 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.851 1.448 . . . . 0.4 110.111 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.533 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.36 -31.66 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.098 -1.001 . . . . 1.78 110.408 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.26 -35.63 74.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.121 -0.987 . . . . 2.37 109.808 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.522 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 62.2 mt -81.23 -30.96 34.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.386 -0.822 . . . . 2.36 110.619 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.533 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 73.2 mtt180 -57.57 -43.86 84.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.883 -1.135 . . . . 0.33 109.208 176.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -72.45 -50.81 23.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 3.75 110.599 -177.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.7 m -63.35 -31.8 73.05 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 1.38 110.88 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.518 ' CD2' HG13 ' B' ' 30' ' ' ILE . 23.1 tp -87.0 -5.21 59.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.042 -1.036 . . . . 1.61 110.651 -176.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.417 ' O ' HD11 ' B' ' 30' ' ' ILE . . . 65.01 43.25 96.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.55 -1.42 . . . . 0.34 109.55 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.518 HG13 ' CD2' ' B' ' 28' ' ' LEU . 30.5 mm -115.53 138.97 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.213 -1.169 . . . . 1.13 110.727 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.42 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -140.6 167.64 21.69 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.676 -0.64 . . . . 1.07 110.003 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.569 ' O ' ' HB2' ' B' ' 33' ' ' LYS . 83.5 tt0 -52.59 150.69 4.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 1.13 110.454 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' B' ' 32' ' ' GLU . 40.5 mttp 66.52 -2.51 1.03 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 112.4 0.518 . . . . 2.39 112.4 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' B' ' 31' ' ' ALA . 88.5 m-20 -75.86 166.78 23.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.599 -1.313 . . . . 1.1 109.895 173.492 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . 0.443 ' HB3' ' HB3' ' B' ' 50' ' ' TYR . . . -103.64 130.14 51.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -0.91 . . . . 1.13 110.807 -175.763 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.537 HD12 ' CG2' ' A' ' 12' ' ' VAL . 13.6 mt -108.28 140.5 41.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.866 . . . . 1.35 109.513 175.065 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.476 ' HA ' HG21 ' A' ' 9' ' ' VAL . 84.8 tt0 -105.24 139.98 39.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.827 -1.171 . . . . 1.17 109.86 173.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . 0.448 HG23 HD11 ' B' ' 38' ' ' ILE . 71.4 mt -111.41 133.99 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.362 -0.836 . . . . 1.48 110.455 -173.404 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.578 ' CD1' ' HE3' ' B' ' 48' ' ' LYS . 8.5 m-85 -115.2 160.38 19.8 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 120.972 0.415 . . . . 1.08 110.18 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.528 ' CG2' HG23 ' A' ' 6' ' ' THR . 94.3 t -133.31 123.45 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.922 -1.112 . . . . 1.05 110.686 173.565 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.458 ' OD2' HD13 ' B' ' 46' ' ' ILE . 9.1 p-10 -147.69 141.55 25.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 1.77 110.197 176.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 54.1 t0 43.56 48.0 6.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.098 -1.001 . . . . 1.21 111.045 174.642 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.7 mt-10 58.55 13.85 2.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.132 -0.98 . . . . 1.92 110.666 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -114.44 148.39 37.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 2.49 110.007 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 60.9 mt -99.71 127.61 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.909 . . . . 1.85 110.145 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 35.5 mt -112.03 118.16 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.428 -0.795 . . . . 1.22 110.216 178.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.3 mp -107.83 135.48 49.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 2.23 110.009 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.578 ' HE3' ' CD1' ' B' ' 39' ' ' TYR . 16.2 ptpt -142.29 164.28 30.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.517 -0.739 . . . . 2.17 110.153 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -55.83 147.84 18.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.083 -1.011 . . . . 2.25 109.764 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.643 ' CD2' ' CG1' ' A' ' 9' ' ' VAL . 1.7 t80 -100.53 120.07 39.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 1.21 110.616 -175.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . 0.546 ' CB ' ' HD3' ' B' ' 52' ' ' PRO . 0.1 OUTLIER -100.44 -54.81 0.16 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 4.73 110.885 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.582 ' O ' ' CZ ' ' B' ' 50' ' ' TYR . 38.0 Cg_exo -54.87 154.7 20.41 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.54 1.284 . . . . 4.2 110.501 -178.107 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.037 -0.982 . . . . 6.56 110.21 -178.425 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.269 0.557 . . . . 11.69 110.246 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.457 ' O ' ' OE1' ' A' ' 23' ' ' GLU . 69.8 mtm -126.77 161.54 27.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 9.04 110.222 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -91.36 150.25 21.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 9.15 110.196 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.549 ' O ' ' CG2' ' A' ' 6' ' ' THR . 28.4 t -87.08 135.62 33.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 4.5 110.011 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.549 ' CG2' ' O ' ' A' ' 5' ' ' SER . 0.7 OUTLIER -171.0 62.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.436 -0.79 . . . . 4.26 110.121 -178.268 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.51 49.61 5.72 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.267 -1.444 . . . . 1.24 109.991 178.658 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.476 HG21 HD13 ' A' ' 8' ' ' ILE . 58.4 mt -96.83 133.24 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.011 -1.288 . . . . 2.01 109.633 179.569 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.581 HG21 ' CZ ' ' B' ' 50' ' ' TYR . 78.5 t -113.14 144.52 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.815 -1.178 . . . . 1.08 111.347 -170.404 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.449 ' HG2' ' NH1' ' A' ' 10' ' ' ARG . 57.4 ttp85 -129.19 167.08 18.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.536 -0.727 . . . . 2.25 109.455 175.057 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -84.42 146.45 27.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.02 -1.05 . . . . 2.66 110.443 -178.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.542 ' CG2' HD11 ' B' ' 36' ' ' LEU . 3.9 t -82.47 131.8 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -0.839 . . . . 1.09 109.758 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.14 -175.55 5.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.55 110.058 -179.038 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.406 ' HG2' ' OE2' ' B' ' 32' ' ' GLU . 97.0 mt-10 -57.03 -39.34 74.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.064 -1.022 . . . . 2.19 111.754 -172.675 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.527 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 14.7 tp -84.29 -5.96 59.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.734 -1.229 . . . . 1.97 111.606 -173.616 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.4 ' HA2' HG13 ' A' ' 12' ' ' VAL . . . 79.99 46.9 7.41 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.161 -1.495 . . . . 0.22 109.694 -177.744 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.527 ' HD3' ' CD2' ' A' ' 15' ' ' LEU . 69.5 mtm180 -114.58 154.5 28.21 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.954 -1.321 . . . . 1.33 110.127 -177.221 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.461 HG22 ' CD2' ' B' ' 47' ' ' LEU . 15.5 m -123.26 150.69 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.311 -0.868 . . . . 1.08 109.802 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.53 HG22 ' CD ' ' B' ' 17' ' ' ARG . 34.1 t -111.69 134.16 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.915 . . . . 1.05 110.632 -175.571 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.496 HG21 ' HB2' ' A' ' 24' ' ' LEU . 2.9 mm -83.89 134.78 43.51 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 2.03 109.507 174.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.534 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.3 Cg_endo -58.17 143.42 96.86 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.749 1.394 . . . . 0.4 110.061 177.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.522 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.1 tp -54.92 -33.47 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.014 -1.054 . . . . 1.79 110.429 -178.802 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 3' ' ' MET . 84.2 tt0 -58.06 -35.51 71.44 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.094 -1.003 . . . . 2.37 109.816 178.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.534 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 48.2 mt -83.28 -29.17 28.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.39 -0.819 . . . . 2.3 110.636 178.865 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.522 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 71.4 mtt180 -57.71 -44.24 85.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.834 -1.166 . . . . 0.33 109.069 175.451 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -72.97 -48.62 35.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.54 -0.725 . . . . 3.74 110.719 -177.878 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.0 m -63.48 -32.06 73.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.153 -0.967 . . . . 1.44 111.081 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 18.1 tp -88.28 -4.4 58.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.088 -1.008 . . . . 1.64 110.766 -176.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.31 42.05 94.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.818 -1.313 . . . . 0.34 109.818 178.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.526 ' CD1' ' HD3' ' A' ' 49' ' ' LYS . 34.1 mm -116.49 137.76 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -1.156 . . . . 1.16 110.682 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.14 166.5 24.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.594 -0.691 . . . . 1.08 110.04 -178.149 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.51 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.2 146.68 11.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 1.13 110.599 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.51 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 44.7 tttm 74.25 -4.52 2.28 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.666 -0.646 . . . . 2.33 111.143 176.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.465 ' O ' HG21 ' B' ' 12' ' ' VAL . 91.2 m-20 -77.54 168.46 19.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.859 -1.151 . . . . 1.1 110.064 175.147 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.34 130.56 52.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 1.17 110.694 -176.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.529 ' HG ' ' CG2' ' B' ' 12' ' ' VAL . 9.1 mt -107.09 142.69 36.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.314 -0.866 . . . . 1.21 109.312 174.618 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.454 ' OE1' ' HE3' ' A' ' 48' ' ' LYS . 86.1 tt0 -105.76 137.75 43.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.775 -1.203 . . . . 1.17 109.585 172.915 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.0 mt -108.0 131.37 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -0.784 . . . . 1.45 110.536 -172.441 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.571 ' CE1' ' HE3' ' A' ' 48' ' ' LYS . 23.3 m-85 -120.16 155.81 32.35 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.849 -0.426 . . . . 1.05 109.849 -178.925 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.494 HG22 ' CD1' ' B' ' 24' ' ' LEU . 71.3 t -131.23 120.75 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.88 -1.137 . . . . 1.08 110.586 172.77 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 47.9 p-10 -148.25 160.86 42.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 1.77 110.583 178.659 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.465 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 54.8 t0 42.13 41.23 1.96 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.065 -1.022 . . . . 1.22 111.575 172.03 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.465 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 96.0 mt-10 56.57 15.99 2.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.984 -1.072 . . . . 1.93 110.541 175.491 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 27.3 pttt -129.54 164.77 23.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.96 . . . . 2.48 109.738 174.564 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.527 ' CD1' HD13 ' B' ' 20' ' ' ILE . 64.7 mt -97.66 134.18 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 1.86 110.381 -174.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.587 ' CD1' ' CD1' ' B' ' 46' ' ' ILE . 21.6 mm -113.21 121.29 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.679 -0.638 . . . . 1.24 109.969 177.475 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 3.9 mp -120.77 133.78 55.32 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.915 -1.116 . . . . 2.25 110.021 178.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 12.9 pttp -143.62 165.53 27.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.232 -0.918 . . . . 2.26 110.631 -179.224 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.526 ' HD3' ' CD1' ' A' ' 30' ' ' ILE . 14.3 tptt -57.6 146.94 28.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 2.12 110.127 177.301 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.509 ' CZ ' HG21 ' B' ' 9' ' ' VAL . 11.2 t80 -102.73 120.93 41.43 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.324 -0.86 . . . . 0.96 110.693 -176.632 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -99.59 122.81 50.18 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.296 -0.877 . . . . 3.58 109.47 172.384 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -60.14 145.04 99.36 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.763 1.402 . . . . 0.48 110.254 -178.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.017 -0.992 . . . . 2.9 110.225 179.893 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.215 0.531 . . . . 12.33 110.28 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 69.0 mtm -47.13 -43.02 20.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.088 -1.008 . . . . 8.85 111.083 -174.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -78.34 -84.59 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.729 -1.232 . . . . 9.64 110.256 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.536 ' O ' ' CG2' ' B' ' 6' ' ' THR . 83.5 p -148.13 150.1 33.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.068 -1.02 . . . . 5.64 110.017 176.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.536 ' CG2' ' O ' ' B' ' 5' ' ' SER . 0.7 OUTLIER -170.49 62.39 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.332 -0.855 . . . . 3.35 110.23 179.764 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.84 51.06 5.28 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.711 -1.355 . . . . 1.53 109.711 178.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 59.0 mt -97.29 133.02 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.068 -1.254 . . . . 1.97 109.691 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 36' ' ' LEU . 77.3 t -113.18 144.44 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.842 -1.161 . . . . 1.11 111.356 -170.465 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.444 ' NH1' ' HG2' ' B' ' 10' ' ' ARG . 57.4 ttp85 -129.07 166.99 18.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.519 -0.738 . . . . 2.26 109.537 175.076 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -84.46 146.37 27.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.052 . . . . 2.65 110.551 -178.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.529 ' CG2' ' HG ' ' A' ' 36' ' ' LEU . 3.9 t -82.48 131.75 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.379 -0.826 . . . . 1.06 109.699 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.08 -175.49 5.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.084 -1.01 . . . . 0.55 110.212 -179.219 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . 0.47 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -57.17 -39.24 74.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.143 -0.973 . . . . 2.19 111.639 -172.358 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.521 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 14.4 tp -84.34 -5.96 59.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.811 -1.181 . . . . 1.99 111.61 -173.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.53 47.8 7.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.533 -1.427 . . . . 0.23 109.533 -177.83 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.53 ' CD ' HG22 ' A' ' 19' ' ' VAL . 69.5 mtm180 -114.88 154.48 28.59 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.091 -1.24 . . . . 1.33 110.046 -177.539 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.498 HG21 ' CD2' ' A' ' 47' ' ' LEU . 15.5 m -123.27 150.65 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.326 -0.859 . . . . 1.08 109.874 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.527 HG21 ' CD ' ' A' ' 17' ' ' ARG . 33.6 t -111.78 134.12 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 1.07 110.56 -175.494 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.527 HD13 ' CD1' ' A' ' 45' ' ' ILE . 2.9 mm -83.81 134.75 43.77 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.22 -0.925 . . . . 1.99 109.617 174.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.523 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.2 Cg_endo -58.24 143.35 97.2 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.727 1.383 . . . . 0.4 110.066 177.517 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.535 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -55.07 -33.35 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.997 -1.065 . . . . 1.78 110.334 -178.511 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . 0.403 ' N ' HG21 ' B' ' 22' ' ' ILE . 84.1 tt0 -57.83 -36.22 71.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.042 -1.036 . . . . 2.37 109.709 178.498 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.523 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 48.5 mt -82.47 -29.58 30.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.388 -0.82 . . . . 2.36 110.654 178.877 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.535 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 70.6 mtt180 -57.59 -44.08 85.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.817 -1.177 . . . . 0.33 109.046 175.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -73.0 -48.83 32.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.863 . . . . 3.75 110.566 -177.924 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.4 m -63.23 -32.54 73.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.254 -0.904 . . . . 1.38 110.909 -178.177 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . . . . . . . . . 18.2 tp -87.77 -4.91 58.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.045 -1.035 . . . . 1.61 110.667 -176.724 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.83 41.83 93.32 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.659 -1.377 . . . . 0.34 109.659 178.525 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.529 ' CD1' ' HD3' ' B' ' 49' ' ' LYS . 33.7 mm -116.48 137.66 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -1.162 . . . . 1.13 110.644 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.96 166.55 24.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.602 -0.686 . . . . 1.07 110.081 -178.27 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.518 ' O ' ' CB ' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.13 146.72 10.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 1.13 110.582 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.518 ' CB ' ' O ' ' B' ' 32' ' ' GLU . 44.6 tttm 74.27 -4.56 2.27 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.645 -0.659 . . . . 2.39 111.198 176.868 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.464 ' O ' HG22 ' A' ' 12' ' ' VAL . 91.1 m-20 -77.67 168.19 20.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.792 -1.192 . . . . 1.1 110.031 175.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . . . . . . . . . . . -104.12 130.69 51.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 1.13 110.819 -176.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.542 HD11 ' CG2' ' A' ' 12' ' ' VAL . 9.1 mt -107.26 142.5 36.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 1.35 109.318 174.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.47 ' HA ' HG23 ' A' ' 9' ' ' VAL . 86.0 tt0 -105.55 137.71 42.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.929 -1.107 . . . . 1.17 109.721 172.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 71.5 mt -108.02 131.41 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.349 -0.844 . . . . 1.48 110.538 -172.367 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.571 ' CE1' ' HE3' ' B' ' 48' ' ' LYS . 23.0 m-85 -120.1 155.85 32.19 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 116.294 -0.412 . . . . 1.08 109.948 -178.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . 0.419 HG21 HD12 ' A' ' 24' ' ' LEU . 72.1 t -131.1 121.15 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.836 -1.165 . . . . 1.05 110.402 172.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.499 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 47.9 p-10 -148.82 160.92 42.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -0.933 . . . . 1.77 110.519 178.461 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 55.2 t0 41.76 41.72 1.88 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.172 -0.955 . . . . 1.21 111.554 172.374 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 96.0 mt-10 56.26 16.11 2.2 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.881 -1.137 . . . . 1.92 110.552 175.446 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . 0.499 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 27.2 pttt -129.63 164.9 22.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 2.49 109.604 174.466 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.472 ' CD1' HD13 ' A' ' 20' ' ' ILE . 64.6 mt -97.67 134.08 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 1.85 110.416 -174.684 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.587 ' CD1' ' CD1' ' A' ' 46' ' ' ILE . 21.6 mm -113.21 121.47 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.748 -0.595 . . . . 1.22 109.914 177.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.585 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.0 mp -120.73 133.5 55.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.931 -1.106 . . . . 2.23 109.958 179.005 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 13.2 pttp -143.47 165.72 26.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.962 . . . . 2.17 110.657 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.529 ' HD3' ' CD1' ' B' ' 30' ' ' ILE . 14.4 tptt -57.6 146.87 28.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 2.25 110.012 177.364 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.581 ' CZ ' HG21 ' A' ' 9' ' ' VAL . 11.4 t80 -102.87 117.23 34.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 1.21 110.643 -176.643 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.99 79.38 69.11 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.94 . . . . 4.73 110.215 177.157 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.418 ' HB3' ' OH ' ' B' ' 50' ' ' TYR . 10.6 Cg_endo -58.84 145.02 98.12 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.066 1.561 . . . . 4.2 110.281 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.979 -1.01 . . . . 6.56 110.209 -179.829 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.467 ' HB2' ' OG ' ' A' ' 5' ' ' SER . 96.5 m-85 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.127 0.489 . . . . 11.69 110.078 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 95.6 mmm -64.74 -77.05 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.213 -0.93 . . . . 9.04 110.387 -177.493 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.432 ' HD2' ' CD ' ' A' ' 23' ' ' GLU . 90.7 mttt -52.7 -43.47 65.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.15 -0.969 . . . . 9.15 111.55 -173.828 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.557 ' O ' ' CG2' ' A' ' 6' ' ' THR . 12.1 p -87.35 121.5 29.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.49 -1.381 . . . . 4.5 110.067 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.557 ' CG2' ' O ' ' A' ' 5' ' ' SER . 0.8 OUTLIER -172.44 62.88 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.624 -0.672 . . . . 4.26 110.03 -179.314 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.53 49.17 6.31 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.34 -1.409 . . . . 1.24 110.011 178.946 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.1 mm -103.42 134.7 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.009 -1.289 . . . . 2.01 109.669 179.331 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.539 HG22 ' CE1' ' B' ' 50' ' ' TYR . 78.4 t -109.85 143.48 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.86 -1.15 . . . . 1.08 111.281 -171.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . 0.457 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 15.5 tpt180 -121.27 161.62 21.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.571 -0.706 . . . . 2.25 109.666 177.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' B' ' 33' ' ' LYS . 6.4 tptm -82.8 142.42 31.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.169 -0.957 . . . . 2.66 110.364 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.529 ' CG2' HD12 ' B' ' 36' ' ' LEU . 8.9 t -82.97 130.39 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.329 -0.857 . . . . 1.09 109.886 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.47 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -83.96 -175.28 5.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.099 -1.001 . . . . 0.55 110.036 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.44 ' HG2' ' OE2' ' B' ' 32' ' ' GLU . 97.0 mt-10 -56.66 -39.71 74.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.998 -1.064 . . . . 2.19 111.756 -172.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.519 ' CD2' ' HD3' ' A' ' 17' ' ' ARG . 15.4 tp -84.68 -5.73 59.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.794 -1.191 . . . . 1.97 111.523 -173.831 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.472 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.19 46.7 7.42 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.228 -1.463 . . . . 0.22 109.643 -177.72 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.523 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.0 mtm180 -114.36 155.03 27.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.071 -1.252 . . . . 1.33 110.024 -177.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.532 ' CG1' HD13 ' B' ' 36' ' ' LEU . 17.1 m -123.87 152.43 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.365 -0.834 . . . . 1.08 109.817 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.517 HG22 ' CD ' ' B' ' 17' ' ' ARG . 33.6 t -110.03 135.82 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 1.05 110.446 -176.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.518 HG21 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -80.63 130.46 64.43 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 2.03 109.465 174.905 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.531 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -56.79 143.63 90.03 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.817 1.43 . . . . 0.4 110.059 178.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.526 ' CD1' ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.14 -32.54 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.005 -1.06 . . . . 1.79 110.293 -178.18 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.432 ' CD ' ' HD2' ' A' ' 4' ' ' LYS . 83.8 tt0 -57.68 -36.48 71.98 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.055 -1.028 . . . . 2.37 109.891 178.025 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.531 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 51.7 mt -82.07 -30.04 31.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.346 -0.847 . . . . 2.3 110.63 178.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.526 ' HD2' ' CD1' ' A' ' 22' ' ' ILE . 73.9 mtt180 -57.91 -43.61 86.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.923 -1.111 . . . . 0.33 109.172 175.631 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -74.2 -51.7 14.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.469 -0.769 . . . . 3.74 110.651 -177.08 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.6 m -64.04 -31.22 72.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 1.44 111.182 -178.379 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . 0.521 ' CD2' HG13 ' A' ' 30' ' ' ILE . 16.7 tp -88.6 -4.89 58.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.09 -1.006 . . . . 1.64 110.808 -176.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.69 43.97 95.59 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.738 -1.345 . . . . 0.34 109.738 179.166 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.521 HG13 ' CD2' ' A' ' 28' ' ' LEU . 31.3 mm -115.82 136.94 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.266 -1.137 . . . . 1.16 110.75 -178.082 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -144.43 167.12 23.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.62 -0.675 . . . . 1.08 110.019 -177.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.515 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.22 146.05 12.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.037 -1.039 . . . . 1.13 110.623 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 68.3 tttt 74.34 -4.24 2.36 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.665 . . . . 2.33 111.144 176.921 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.464 ' O ' HG22 ' B' ' 12' ' ' VAL . 89.2 m-20 -77.22 168.97 19.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.866 -1.146 . . . . 1.1 110.06 174.736 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.05 130.97 54.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 1.17 110.612 -177.205 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.533 ' O ' ' CG1' ' B' ' 9' ' ' VAL . 9.2 mt -107.06 141.97 37.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 1.21 109.235 174.993 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.462 ' OE1' ' HE3' ' A' ' 48' ' ' LYS . 86.1 tt0 -104.3 137.6 41.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.769 -1.207 . . . . 1.17 109.712 174.08 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.0 mt -108.73 132.57 56.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.456 -0.778 . . . . 1.45 110.605 -172.656 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' TYR . . . . . 0.579 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 22.5 m-85 -121.07 157.25 30.45 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.868 -0.419 . . . . 1.05 109.868 -178.775 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . 0.417 HG21 ' CB ' ' B' ' 5' ' ' SER . 75.2 t -131.56 125.91 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.811 -1.18 . . . . 1.08 110.715 173.498 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.473 ' OD1' ' O ' ' A' ' 41' ' ' ASP . 38.7 p-10 -147.48 140.87 25.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.92 . . . . 1.77 110.733 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.479 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.8 t0 43.32 46.74 5.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.001 -1.062 . . . . 1.22 111.449 173.336 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.8 tt0 61.3 10.87 3.28 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.132 -0.98 . . . . 1.93 110.707 175.479 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -111.44 151.09 28.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 2.48 109.885 175.179 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.415 HG23 ' CD1' ' A' ' 47' ' ' LEU . 67.2 mt -92.9 128.22 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.308 -0.87 . . . . 1.86 109.779 177.713 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.583 ' CD1' ' CD1' ' B' ' 46' ' ' ILE . 23.5 mm -111.45 118.29 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.543 -0.723 . . . . 1.24 109.91 178.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.579 ' CD1' ' CD1' ' B' ' 47' ' ' LEU . 3.9 mp -119.27 134.18 55.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.867 -1.146 . . . . 2.25 110.164 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.561 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 13.0 pttp -143.26 163.26 33.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 2.26 110.44 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -58.18 147.52 29.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 2.12 109.94 177.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.553 ' CG ' HG22 ' B' ' 9' ' ' VAL . 15.5 t80 -101.73 118.22 36.49 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.368 -0.833 . . . . 0.96 110.688 -175.912 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 51' ' ' LYS . 18.2 pttm -99.89 122.86 49.46 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.37 -0.831 . . . . 3.58 109.399 172.139 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.3 144.77 92.14 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.761 1.401 . . . . 0.48 110.259 -178.823 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.7 m120 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.971 -1.014 . . . . 2.9 110.182 -179.976 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 46.3 p90 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.203 0.525 . . . . 12.33 110.145 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 69.8 mtm -111.03 147.22 35.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.915 . . . . 8.85 110.207 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -89.71 146.57 24.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 9.64 110.101 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 5' ' ' SER . . . . . 0.534 ' O ' ' CG2' ' B' ' 6' ' ' THR . 41.1 m -59.84 148.43 34.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 5.64 109.996 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 6' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' B' ' 5' ' ' SER . 0.7 OUTLIER -169.23 62.8 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 3.35 110.259 -179.037 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.89 50.49 5.89 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.733 -1.347 . . . . 1.53 109.733 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 20.0 mm -103.8 134.58 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.082 -1.246 . . . . 1.97 109.757 178.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 9' ' ' VAL . . . . . 0.553 HG22 ' CG ' ' A' ' 50' ' ' TYR . 78.0 t -109.88 143.44 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.823 -1.173 . . . . 1.11 111.244 -171.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 10' ' ' ARG . . . . . 0.466 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 15.5 tpt180 -121.28 161.5 21.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.589 -0.695 . . . . 2.26 109.753 177.619 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 11' ' ' LYS . . . . . 0.466 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 6.4 tptm -82.83 142.26 31.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.994 . . . . 2.65 110.37 -178.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . 0.479 ' CG2' ' HG ' ' A' ' 36' ' ' LEU . 8.9 t -82.88 130.56 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.24 -0.913 . . . . 1.06 109.855 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.01 -175.05 5.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.983 . . . . 0.55 110.227 179.674 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' B' B ' 14' ' ' GLU . . . . . 0.474 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -56.91 -39.63 74.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.132 -0.98 . . . . 2.19 111.634 -172.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 15' ' ' LEU . . . . . 0.526 ' CD2' ' HD3' ' B' ' 17' ' ' ARG . 15.3 tp -84.65 -5.89 59.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.786 -1.196 . . . . 1.99 111.546 -173.802 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 16' ' ' GLY . . . . . 0.473 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.93 47.32 7.2 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.531 -1.428 . . . . 0.23 109.531 -177.727 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 17' ' ' ARG . . . . . 0.526 ' HD3' ' CD2' ' B' ' 15' ' ' LEU . 70.0 mtm180 -114.43 154.99 27.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.089 -1.242 . . . . 1.33 110.042 -177.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 18' ' ' VAL . . . . . 0.421 ' O ' HG22 ' B' ' 18' ' ' VAL . 17.1 m -123.96 152.42 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.887 . . . . 1.08 109.775 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 19' ' ' VAL . . . . . 0.523 HG22 ' CD ' ' A' ' 17' ' ' ARG . 34.2 t -110.06 135.72 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.146 -0.971 . . . . 1.07 110.506 -176.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 20' ' ' ILE . . . . . 0.473 HG22 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -80.57 130.45 64.65 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 1.99 109.537 174.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 21' ' ' PRO . . . . . 0.529 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.1 Cg_endo -56.82 143.66 90.23 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.773 1.407 . . . . 0.4 110.115 178.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 22' ' ' ILE . . . . . 0.52 ' CD1' ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.27 -32.39 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.155 -0.966 . . . . 1.78 110.281 -177.991 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -57.49 -37.18 72.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.046 -1.034 . . . . 2.37 109.808 177.736 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 24' ' ' LEU . . . . . 0.529 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 51.1 mt -81.32 -30.52 33.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.468 -0.77 . . . . 2.36 110.561 178.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 25' ' ' ARG . . . . . 0.52 ' HD2' ' CD1' ' B' ' 22' ' ' ILE . 73.7 mtt180 -57.69 -43.43 85.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.9 -1.125 . . . . 0.33 109.285 176.008 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -74.26 -51.82 14.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 3.75 110.571 -177.218 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.3 m -63.85 -31.85 73.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 1.38 110.855 -178.107 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 28' ' ' LEU . . . . . 0.511 ' CD2' HG13 ' B' ' 30' ' ' ILE . 16.8 tp -88.07 -5.25 58.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.971 -1.081 . . . . 1.61 110.691 -176.356 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 29' ' ' GLY . . . . . 0.448 ' O ' HD12 ' B' ' 30' ' ' ILE . . . 64.91 43.89 95.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.646 -1.382 . . . . 0.34 109.646 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 30' ' ' ILE . . . . . 0.511 HG13 ' CD2' ' B' ' 28' ' ' LEU . 31.3 mm -115.68 136.79 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -1.162 . . . . 1.13 110.797 -178.122 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 31' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -144.12 167.18 23.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.574 -0.704 . . . . 1.07 109.951 -177.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 32' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.05 146.04 11.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.143 -0.973 . . . . 1.13 110.634 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 33' ' ' LYS . . . . . 0.512 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 68.1 tttt 74.34 -4.29 2.35 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.713 -0.617 . . . . 2.39 111.168 176.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 34' ' ' ASP . . . . . 0.467 ' O ' HG22 ' A' ' 12' ' ' VAL . 89.8 m-20 -77.42 168.76 19.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.846 -1.158 . . . . 1.1 109.979 174.869 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 35' ' ' ALA . . . . . . . . . . . . . . . -106.81 130.93 54.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 1.13 110.726 -177.256 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 36' ' ' LEU . . . . . 0.532 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 9.1 mt -107.08 141.79 37.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.265 -0.897 . . . . 1.35 109.319 174.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 37' ' ' GLU . . . . . 0.474 ' HA ' HG21 ' A' ' 9' ' ' VAL . 86.0 tt0 -103.99 137.57 41.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.78 -1.2 . . . . 1.17 109.881 174.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.2 mt -108.73 132.61 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 1.48 110.493 -172.588 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 39' ' ' TYR . . . . . 0.566 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 22.0 m-85 -121.05 157.2 30.55 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 116.208 -0.451 . . . . 1.08 109.886 -178.857 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 75.6 t -131.36 126.27 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.861 -1.149 . . . . 1.05 110.545 173.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 41' ' ' ASP . . . . . 0.479 ' OD1' ' O ' ' B' ' 41' ' ' ASP . 38.5 p-10 -147.99 140.77 24.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.333 -0.854 . . . . 1.77 110.638 179.005 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 42' ' ' ASP . . . . . 0.482 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 54.3 t0 43.44 46.88 5.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.072 -1.018 . . . . 1.21 111.317 173.346 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.482 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.6 tt0 61.1 10.88 3.12 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.053 -1.029 . . . . 1.92 110.71 175.504 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -111.38 151.3 28.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 2.49 109.913 175.062 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.455 HG23 HD13 ' B' ' 47' ' ' LEU . 66.8 mt -93.01 128.07 44.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.253 -0.904 . . . . 1.85 109.876 177.699 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 46' ' ' ILE . . . . . 0.583 ' CD1' ' CD1' ' A' ' 46' ' ' ILE . 23.2 mm -111.55 118.42 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.611 -0.681 . . . . 1.22 109.886 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 47' ' ' LEU . . . . . 0.579 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 4.0 mp -119.2 134.07 55.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.957 -1.089 . . . . 2.23 110.13 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 48' ' ' LYS . . . . . 0.566 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 13.3 pttp -143.2 163.33 33.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.206 -0.934 . . . . 2.17 110.455 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -58.1 147.43 29.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.908 . . . . 2.25 109.917 177.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' B' B ' 50' ' ' TYR . . . . . 0.58 ' CE2' ' HG3' ' B' ' 52' ' ' PRO . 15.6 t80 -101.9 113.44 26.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.214 -0.929 . . . . 1.21 110.605 -175.946 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.57 88.56 46.67 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 4.73 110.339 178.37 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 52' ' ' PRO . . . . . 0.58 ' HG3' ' CE2' ' B' ' 50' ' ' TYR . 35.9 Cg_exo -55.64 145.44 70.46 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.007 1.53 . . . . 4.2 110.347 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.973 -1.013 . . . . 6.56 110.176 179.815 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.9 mt . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.014 0.435 . . . . 1.3600000000000001 109.993 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.931 HG13 ' O ' ' B' ' 36' ' ' LEU . 90.3 t -116.68 144.06 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.041 -1.037 . . . . 0.37 110.961 -175.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 27.7 tpt180 -128.15 159.21 35.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.464 -0.773 . . . . 1.9099999999999999 109.711 177.279 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.425 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 70.3 mttt -85.74 147.67 26.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.103 -0.998 . . . . 2.21 110.401 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.938 HG22 HD11 ' B' ' 36' ' ' LEU . 3.7 t -84.06 129.0 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.292 -0.88 . . . . 0.28000000000000003 109.942 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.68 -175.29 5.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.55000000000000004 110.08 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -54.24 -40.91 68.16 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.151 -0.968 . . . . 2.1899999999999999 111.671 -173.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.851 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.3 tp -84.12 -5.64 59.28 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.739 -1.225 . . . . 1.3799999999999999 111.581 -173.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.506 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.38 46.31 7.54 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.191 -1.48 . . . . 0.20999999999999999 109.657 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.919 ' CD ' HG22 ' B' ' 19' ' ' VAL . 72.6 mtm180 -114.74 154.05 29.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.099 -1.236 . . . . 1.1499999999999999 109.968 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.71 HG12 HD13 ' B' ' 36' ' ' LEU . 19.8 m -123.99 153.11 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.28000000000000003 109.866 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.928 HG22 ' CD ' ' B' ' 17' ' ' ARG . 24.3 t -111.35 134.77 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.23999999999999999 110.632 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.585 HG23 ' HB2' ' A' ' 24' ' ' LEU . 6.4 mt -82.53 135.14 46.81 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 1.3799999999999999 109.487 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.2 Cg_endo -58.13 142.98 97.39 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.771 1.406 . . . . 0.34999999999999998 110.044 177.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.885 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.14 -32.78 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.962 -1.086 . . . . 1.1100000000000001 110.373 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -58.07 -35.64 71.66 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.113 -0.992 . . . . 2.3700000000000001 109.861 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.585 ' HB2' HG23 ' A' ' 20' ' ' ILE . 54.9 mt -82.75 -29.78 29.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.382 -0.824 . . . . 1.75 110.627 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.885 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.8 mtt180 -57.56 -44.13 85.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.898 -1.126 . . . . 0.29999999999999999 109.146 175.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -73.37 -49.14 28.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.537 -0.727 . . . . 3.2599999999999998 110.742 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.0 m -63.94 -31.24 72.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.189 -0.944 . . . . 0.77000000000000002 111.085 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.929 HD23 HG13 ' A' ' 30' ' ' ILE . 22.2 tp -87.57 -4.79 58.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.027 -1.046 . . . . 1.05 110.711 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.416 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.75 43.74 95.82 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.663 -1.375 . . . . 0.32000000000000001 109.663 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.929 HG13 HD23 ' A' ' 28' ' ' LEU . 31.6 mm -115.28 138.99 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.241 -1.152 . . . . 0.40999999999999998 110.699 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.79 167.11 22.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.631 -0.668 . . . . 0.23000000000000001 109.945 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.52 146.02 13.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.047 -1.033 . . . . 1.1299999999999999 110.554 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 40.7 tttt 74.81 -4.57 2.33 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.757 -0.589 . . . . 1.8799999999999999 111.103 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.729 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.9 m-20 -76.93 165.54 24.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.773 -1.204 . . . . 1.1000000000000001 110.028 174.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -106.26 132.52 52.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 0.35999999999999999 110.734 -176.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.925 ' O ' HG13 ' B' ' 9' ' ' VAL . 12.6 mt -108.9 142.74 39.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.56000000000000005 109.49 175.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.625 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.8 tt0 -107.88 139.8 41.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.869 -1.144 . . . . 1.1699999999999999 109.793 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 72.1 mt -112.61 136.85 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.393 -0.817 . . . . 0.83999999999999997 110.68 -172.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.577 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 14.6 m-85 -114.16 158.61 21.08 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.977 -0.379 . . . . 0.45000000000000001 109.977 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.9 t -130.66 121.92 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.973 -1.079 . . . . 0.27000000000000002 110.739 172.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.576 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.9 p-10 -147.17 140.51 25.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 1.77 110.216 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 52.4 t0 43.56 48.39 6.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.02 -1.05 . . . . 1.22 111.154 175.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.8 mt-10 58.55 14.05 2.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.134 -0.979 . . . . 1.9299999999999999 110.656 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -117.12 147.11 42.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 2.0099999999999998 110.024 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.577 ' CD1' HD11 ' B' ' 20' ' ' ILE . 60.4 mt -99.98 128.17 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 1.25 110.093 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 24.1 mt -111.52 118.62 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.352 -0.843 . . . . 0.5 110.209 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.837 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -108.04 136.54 47.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.067 -1.021 . . . . 1.6599999999999999 110.093 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.548 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 27.2 pttt -138.64 162.23 35.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.501 -0.749 . . . . 1.74 110.189 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -58.84 146.55 36.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.09 -1.006 . . . . 1.6499999999999999 109.965 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.588 ' CD2' HG11 ' B' ' 9' ' ' VAL . 9.1 t80 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.34999999999999998 110.726 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.925 HG13 ' O ' ' A' ' 36' ' ' LEU . 90.7 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.483 0.658 . . . . 0.37 110.937 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 27.8 tpt180 -128.16 159.03 36.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.49 -0.756 . . . . 1.9199999999999999 109.793 177.292 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.421 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 70.4 mttt -85.65 147.6 26.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.013 . . . . 2.21 110.419 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.921 HG22 HD11 ' A' ' 36' ' ' LEU . 3.8 t -83.98 129.11 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.891 . . . . 0.28999999999999998 109.844 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.449 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.93 -175.16 5.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.116 -0.99 . . . . 0.55000000000000004 110.126 179.411 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.422 ' OE1' ' CD ' ' A' ' 32' ' ' GLU . 46.9 tp10 -54.37 -40.84 68.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.147 -0.971 . . . . 2.1899999999999999 111.599 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.868 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.0 tp -84.12 -5.74 59.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.76 -1.213 . . . . 1.3899999999999999 111.568 -173.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.519 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.05 47.02 7.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.521 -1.432 . . . . 0.20999999999999999 109.521 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.928 ' CD ' HG22 ' A' ' 19' ' ' VAL . 72.7 mtm180 -114.93 154.08 29.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.102 -1.234 . . . . 1.1399999999999999 109.94 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.703 HG12 HD13 ' A' ' 36' ' ' LEU . 19.7 m -124.04 153.09 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.28000000000000003 109.891 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.919 HG22 ' CD ' ' A' ' 17' ' ' ARG . 24.3 t -111.4 134.76 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.23999999999999999 110.619 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.597 HG23 ' HB2' ' B' ' 24' ' ' LEU . 6.4 mt -82.57 135.16 46.67 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 1.3799999999999999 109.472 174.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.538 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.2 Cg_endo -58.21 143.0 97.63 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.797 1.419 . . . . 0.35999999999999999 110.049 177.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.879 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.3 -32.59 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.135 -0.978 . . . . 1.1100000000000001 110.336 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -57.86 -36.4 72.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.091 -1.006 . . . . 2.3700000000000001 109.774 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.597 ' HB2' HG23 ' B' ' 20' ' ' ILE . 54.7 mt -81.97 -30.16 31.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.478 -0.764 . . . . 1.75 110.605 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.879 ' HD2' HD12 ' B' ' 22' ' ' ILE . 72.2 mtt180 -57.44 -43.92 84.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.89 -1.131 . . . . 0.29999999999999999 109.204 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -73.37 -49.32 27.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 3.27 110.621 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 61.0 m -63.81 -31.73 73.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.177 -0.952 . . . . 0.77000000000000002 110.862 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.934 HD23 HG13 ' B' ' 30' ' ' ILE . 22.4 tp -87.1 -5.17 59.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.053 -1.03 . . . . 1.05 110.701 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.415 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.07 43.65 95.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.578 -1.409 . . . . 0.32000000000000001 109.578 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.934 HG13 HD23 ' B' ' 28' ' ' LEU . 31.1 mm -115.27 138.81 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -1.176 . . . . 0.40999999999999998 110.725 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.48 167.27 22.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.628 -0.67 . . . . 0.23000000000000001 109.935 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.527 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.55 146.12 13.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.988 . . . . 1.1299999999999999 110.554 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 40.6 tttt 74.84 -4.77 2.29 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.688 -0.633 . . . . 1.8799999999999999 111.164 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.649 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.0 m-20 -76.98 165.21 24.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.791 -1.193 . . . . 1.1000000000000001 110.014 174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.594 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.93 132.48 51.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.35999999999999999 110.833 -176.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.938 HD11 HG22 ' A' ' 12' ' ' VAL . 12.5 mt -108.93 142.61 39.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.397 -0.815 . . . . 0.56000000000000005 109.531 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.61 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.6 tt0 -107.7 139.79 41.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.902 -1.124 . . . . 1.1699999999999999 109.92 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 72.1 mt -112.6 136.79 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.299 -0.876 . . . . 0.83999999999999997 110.651 -172.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 14.3 m-85 -114.0 158.63 20.92 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 116.35 -0.386 . . . . 0.45000000000000001 109.993 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 83.8 t -130.52 122.26 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.907 -1.121 . . . . 0.26000000000000001 110.502 172.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.572 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.9 p-10 -147.6 140.5 24.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 1.77 110.176 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 53.3 t0 43.69 48.46 6.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.134 -0.979 . . . . 1.21 111.059 175.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.7 mt-10 58.41 14.01 2.74 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.199 -0.938 . . . . 1.9199999999999999 110.679 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -117.0 147.37 42.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 2.0 109.959 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.575 ' CD1' HD11 ' A' ' 20' ' ' ILE . 60.2 mt -100.23 128.22 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -0.928 . . . . 1.24 110.102 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 25.0 mt -111.7 118.61 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.5 110.148 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.822 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.3 mp -107.9 136.45 47.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 1.6599999999999999 110.124 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.552 ' HD3' ' CE1' ' B' ' 39' ' ' TYR . 27.3 pttt -138.57 162.43 34.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.489 -0.757 . . . . 1.74 110.07 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -58.82 146.44 37.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.124 -0.985 . . . . 1.6499999999999999 109.93 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.71 ' CD2' HG11 ' A' ' 9' ' ' VAL . 9.3 t80 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.65000000000000002 110.644 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.5 mt . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.089 0.471 . . . . 1.3600000000000001 110.115 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.935 HG13 ' O ' ' B' ' 36' ' ' LEU . 93.0 t -115.95 144.35 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.001 -1.062 . . . . 0.37 110.916 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -129.23 160.66 32.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.494 -0.753 . . . . 1.9099999999999999 109.679 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -85.25 147.7 26.44 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.067 -1.021 . . . . 2.21 110.385 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.899 HG22 HD11 ' B' ' 36' ' ' LEU . 4.0 t -83.09 129.94 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.28000000000000003 109.88 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.36 -175.18 5.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.96 . . . . 0.55000000000000004 110.082 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.74 -39.51 74.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.073 -1.017 . . . . 2.1899999999999999 111.652 -172.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.891 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.2 tp -83.25 -6.61 59.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.831 -1.168 . . . . 1.3799999999999999 111.499 -174.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.36 46.76 7.28 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.259 -1.448 . . . . 0.20999999999999999 109.615 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.898 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.1 mtm180 -114.33 154.73 27.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.079 -1.247 . . . . 1.1499999999999999 110.078 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.818 HG12 HD13 ' B' ' 36' ' ' LEU . 17.9 m -123.87 152.37 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.28000000000000003 109.763 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.91 HG22 ' CD ' ' B' ' 17' ' ' ARG . 19.9 t -112.97 135.32 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.138 -0.976 . . . . 0.23999999999999999 110.643 -174.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.715 HD11 ' CD1' ' B' ' 45' ' ' ILE . 19.5 mt -81.57 135.96 49.15 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.255 -0.903 . . . . 1.3799999999999999 109.763 174.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HG2' HD12 ' A' ' 24' ' ' LEU . 11.0 Cg_endo -60.02 143.65 99.55 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.754 1.397 . . . . 0.34999999999999998 109.942 176.027 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.874 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.12 -33.15 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.952 -1.093 . . . . 1.1100000000000001 110.348 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.404 ' N ' HG23 ' A' ' 22' ' ' ILE . 48.6 tp10 -58.04 -35.41 71.29 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.181 -0.95 . . . . 2.3700000000000001 109.884 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.561 HD12 ' HG2' ' A' ' 21' ' ' PRO . 59.6 mt -84.5 -28.25 26.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 1.75 110.664 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.874 ' HD2' HD12 ' A' ' 22' ' ' ILE . 70.8 mtt180 -57.44 -44.38 84.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.843 -1.161 . . . . 0.29999999999999999 109.065 175.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.5 mmm180 -73.58 -49.12 27.88 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.862 -0.735 . . . . 3.2599999999999998 110.671 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.8 m -63.96 -30.96 72.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.141 -0.974 . . . . 0.77000000000000002 111.121 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.831 HD23 HG13 ' A' ' 30' ' ' ILE . 23.0 tp -87.59 -4.93 58.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.069 -1.019 . . . . 1.05 110.769 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.84 41.75 97.35 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.724 -1.35 . . . . 0.32000000000000001 109.724 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.831 HG13 HD23 ' A' ' 28' ' ' LEU . 38.3 mm -116.38 138.45 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -1.17 . . . . 0.40999999999999998 110.629 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.99 166.88 23.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.575 -0.703 . . . . 0.23000000000000001 110.002 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.41 146.25 12.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.055 -1.028 . . . . 1.1299999999999999 110.61 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 31.8 ttpt 74.35 -4.35 2.33 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.687 -0.633 . . . . 1.8799999999999999 111.177 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.732 ' O ' HG23 ' B' ' 12' ' ' VAL . 90.1 m-20 -77.23 166.52 23.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.75 -1.219 . . . . 1.1000000000000001 110.029 174.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.659 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.05 130.09 51.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.159 -0.963 . . . . 0.35999999999999999 110.77 -176.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.951 HD11 HG22 ' B' ' 12' ' ' VAL . 12.4 mt -106.41 142.54 35.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.349 -0.845 . . . . 0.56000000000000005 109.403 174.501 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.707 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.4 tt0 -106.33 138.45 42.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.773 -1.204 . . . . 1.1699999999999999 109.564 173.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.2 mt -108.28 132.06 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.404 -0.81 . . . . 0.83999999999999997 110.537 -171.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.606 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.0 m-85 -118.22 159.45 23.3 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 116.259 -0.428 . . . . 0.45000000000000001 110.001 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.2 t -133.49 125.9 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.919 -1.113 . . . . 0.27000000000000002 110.637 172.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.479 ' OD1' HG12 ' A' ' 46' ' ' ILE . 42.3 p-10 -147.41 143.22 27.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 1.77 110.499 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 51.8 t0 43.44 43.95 4.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.014 -1.054 . . . . 1.22 111.149 174.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.7 tt0 60.82 11.76 3.41 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.121 -0.987 . . . . 1.9299999999999999 110.616 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 53.0 mtmt -111.54 154.64 24.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 2.0099999999999998 109.779 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.759 ' CD1' HD11 ' B' ' 20' ' ' ILE . 66.1 mt -95.16 129.27 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 1.25 109.968 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.606 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 22.9 mm -115.12 120.65 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.719 . . . . 0.5 109.915 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.882 ' CD2' HG21 ' B' ' 18' ' ' VAL . 4.2 mp -117.63 135.17 54.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.981 -1.075 . . . . 1.6599999999999999 110.25 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.567 ' HE3' ' CD1' ' A' ' 39' ' ' TYR . 8.2 ptpt -142.74 162.21 36.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.384 -0.823 . . . . 1.74 110.418 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.566 ' HD3' HD11 ' A' ' 30' ' ' ILE . 22.8 tptm -55.63 147.46 18.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.037 -1.039 . . . . 1.6499999999999999 109.789 176.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.733 ' CD2' HG11 ' B' ' 9' ' ' VAL . 5.2 t80 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.35 -0.843 . . . . 0.34999999999999998 110.524 -176.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.946 HG13 ' O ' ' A' ' 36' ' ' LEU . 91.7 t . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.538 0.685 . . . . 0.37 110.925 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -129.19 160.45 32.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.457 -0.777 . . . . 1.9199999999999999 109.759 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -85.19 147.59 26.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.038 -1.039 . . . . 2.21 110.425 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.951 HG22 HD11 ' A' ' 36' ' ' LEU . 4.0 t -82.95 129.97 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.4 -0.813 . . . . 0.28999999999999998 109.894 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.61 -175.04 5.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.153 -0.967 . . . . 0.55000000000000004 110.135 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.489 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -56.87 -39.44 74.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.081 -1.012 . . . . 2.1899999999999999 111.496 -172.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.1 tp -83.27 -6.56 59.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.787 -1.196 . . . . 1.3899999999999999 111.527 -174.196 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.475 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.9 47.5 7.12 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.54 -1.424 . . . . 0.20999999999999999 109.54 -177.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.91 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.0 mtm180 -114.5 154.67 27.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.028 -1.278 . . . . 1.1399999999999999 110.131 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.882 HG21 ' CD2' ' A' ' 47' ' ' LEU . 17.8 m -123.93 152.31 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.28000000000000003 109.737 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.898 HG22 ' CD ' ' A' ' 17' ' ' ARG . 19.8 t -113.0 135.26 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.23999999999999999 110.712 -174.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.759 HD11 ' CD1' ' A' ' 45' ' ' ILE . 19.2 mt -81.5 135.96 49.36 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 1.3799999999999999 109.734 174.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 11.0 Cg_endo -60.15 143.53 99.53 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.801 1.422 . . . . 0.35999999999999999 110.036 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.87 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.2 tp -55.13 -32.92 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.018 -1.051 . . . . 1.1100000000000001 110.399 -178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' GLU . . . . . 0.403 ' N ' HG23 ' B' ' 22' ' ' ILE . 48.4 tp10 -57.93 -36.12 72.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.058 -1.026 . . . . 2.3700000000000001 109.777 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.571 ' HB2' HG23 ' B' ' 20' ' ' ILE . 60.1 mt -83.74 -28.55 28.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.532 -0.73 . . . . 1.75 110.628 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.87 ' HD2' HD12 ' B' ' 22' ' ' ILE . 70.2 mtt180 -57.35 -44.32 84.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.792 -1.193 . . . . 0.29999999999999999 109.044 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 32.5 mmm180 -73.49 -49.31 27.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.357 -0.84 . . . . 3.27 110.664 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.1 m -63.68 -31.64 72.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.896 . . . . 0.77000000000000002 110.919 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.867 HD23 HG13 ' B' ' 30' ' ' ILE . 23.2 tp -87.01 -5.33 59.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.032 -1.042 . . . . 1.05 110.731 -176.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.24 41.53 96.75 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.562 -1.415 . . . . 0.32000000000000001 109.562 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.867 HG13 HD23 ' B' ' 28' ' ' LEU . 37.9 mm -116.27 138.39 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -1.182 . . . . 0.40999999999999998 110.694 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.78 167.04 23.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.612 -0.68 . . . . 0.23000000000000001 109.987 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.41 146.39 12.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.141 -0.975 . . . . 1.1299999999999999 110.523 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 31.7 ttpt 74.42 -4.64 2.27 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.699 -0.626 . . . . 1.8799999999999999 111.174 176.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.4 m-20 -77.21 166.26 23.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.853 -1.154 . . . . 1.1000000000000001 110.067 174.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.641 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.97 130.09 51.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.35999999999999999 110.753 -176.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.935 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.2 mt -106.47 142.25 36.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 0.56000000000000005 109.471 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.688 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.1 tt0 -106.06 138.44 42.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.825 -1.172 . . . . 1.1699999999999999 109.72 173.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.22 132.06 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.367 -0.833 . . . . 0.83999999999999997 110.486 -171.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.597 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 10.0 m-85 -118.31 159.34 23.56 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 116.261 -0.427 . . . . 0.45000000000000001 110.001 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 72.4 t -133.22 126.27 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.936 -1.102 . . . . 0.26000000000000001 110.466 172.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.487 ' OD1' HG12 ' B' ' 46' ' ' ILE . 42.5 p-10 -147.81 143.22 27.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 1.77 110.466 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 52.4 t0 43.47 44.04 4.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.934 . . . . 1.21 111.108 174.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.5 tt0 60.67 11.87 3.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.028 -1.045 . . . . 1.9199999999999999 110.571 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 53.0 mtmt -111.56 154.76 24.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.185 -0.947 . . . . 2.0 109.71 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.754 HG22 HD11 ' B' ' 47' ' ' LEU . 66.2 mt -95.26 129.14 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 1.24 110.0 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.602 HD12 HD12 ' A' ' 46' ' ' ILE . 22.6 mm -115.15 120.7 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.5 109.817 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.823 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.3 mp -117.46 135.05 54.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.014 -1.054 . . . . 1.6599999999999999 110.294 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.572 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 8.1 ptpt -142.65 162.39 35.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.843 . . . . 1.74 110.392 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.551 ' HD3' ' CD1' ' B' ' 30' ' ' ILE . 22.8 tptm -55.63 147.3 18.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.114 -0.992 . . . . 1.6499999999999999 109.83 176.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.886 ' CD2' HG11 ' A' ' 9' ' ' VAL . 5.3 t80 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.65000000000000002 110.525 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 121.139 0.495 . . . . 1.3600000000000001 110.087 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.081 HG11 ' CD2' ' B' ' 50' ' ' TYR . 92.7 t -115.1 144.34 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.033 -1.042 . . . . 0.37 110.856 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.9 ttt-85 -129.91 160.07 34.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.48 -0.762 . . . . 1.9099999999999999 109.684 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -86.44 149.03 25.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.103 -0.998 . . . . 2.21 110.466 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.99 HG22 HD11 ' B' ' 36' ' ' LEU . 3.9 t -82.99 129.64 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.241 -0.912 . . . . 0.28000000000000003 109.873 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.466 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.19 -174.67 5.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.145 -0.972 . . . . 0.55000000000000004 110.182 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -53.62 -41.81 67.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.18 -0.95 . . . . 2.1899999999999999 111.783 -173.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.88 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.2 tp -85.79 -4.26 59.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.709 -1.244 . . . . 1.3799999999999999 111.619 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.514 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.09 46.31 7.72 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.184 -1.484 . . . . 0.20999999999999999 109.645 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.918 ' CD ' HG22 ' B' ' 19' ' ' VAL . 74.6 mtm180 -115.56 154.35 29.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.15 -1.206 . . . . 1.1499999999999999 109.933 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.732 HG21 ' CD2' ' B' ' 47' ' ' LEU . 16.6 m -124.61 152.23 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 0.28000000000000003 109.898 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.943 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.9 t -112.25 135.44 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.932 . . . . 0.23999999999999999 110.514 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.593 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.04 134.57 46.11 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 1.3799999999999999 109.577 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.54 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.9 Cg_endo -58.73 143.8 98.54 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.793 1.417 . . . . 0.34999999999999998 110.104 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.886 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.19 -32.08 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.988 -1.07 . . . . 1.1100000000000001 110.386 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.29 -34.88 72.82 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.118 -0.989 . . . . 2.3700000000000001 109.901 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.593 ' HB2' HG23 ' A' ' 20' ' ' ILE . 62.4 mt -83.19 -29.68 28.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 1.75 110.57 178.416 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.886 ' HD2' HD12 ' A' ' 22' ' ' ILE . 73.6 mtt180 -57.55 -43.96 84.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.877 -1.139 . . . . 0.29999999999999999 109.107 175.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -71.64 -50.11 33.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.518 -0.739 . . . . 3.2599999999999998 110.707 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.0 m -63.38 -32.02 73.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.218 -0.926 . . . . 0.77000000000000002 111.088 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.894 HD23 HG13 ' A' ' 30' ' ' ILE . 21.0 tp -88.39 -4.86 58.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.064 -1.022 . . . . 1.05 110.751 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.42 42.82 97.46 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.667 -1.373 . . . . 0.32000000000000001 109.667 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.894 HG13 HD23 ' A' ' 28' ' ' LEU . 35.3 mm -116.36 138.75 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.242 -1.152 . . . . 0.40999999999999998 110.74 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.06 167.26 22.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.617 -0.677 . . . . 0.23000000000000001 110.092 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.2 tt0 -53.26 147.09 10.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.075 -1.016 . . . . 1.1299999999999999 110.542 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 29.3 tttt 74.65 -4.92 2.23 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.781 -0.574 . . . . 1.8799999999999999 111.123 177.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.71 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.9 m-20 -77.49 165.36 24.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.81 -1.181 . . . . 1.1000000000000001 110.019 174.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.785 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.69 131.61 51.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.209 -0.932 . . . . 0.35999999999999999 110.74 -176.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.968 HD11 HG22 ' B' ' 12' ' ' VAL . 13.6 mt -109.57 140.63 43.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 0.56000000000000005 109.575 175.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.764 ' HA ' HG22 ' B' ' 9' ' ' VAL . 84.8 tt0 -103.67 138.56 40.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.823 -1.173 . . . . 1.1699999999999999 109.528 171.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.6 mt -111.47 133.27 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.369 -0.832 . . . . 0.83999999999999997 110.512 -173.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.587 ' CE2' ' HE3' ' A' ' 48' ' ' LYS . 8.5 m-85 -114.53 160.76 18.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 122.068 -0.395 . . . . 0.45000000000000001 110.218 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.1 t -133.9 117.69 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 0.27000000000000002 110.83 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.547 ' OD2' HD11 ' A' ' 46' ' ' ILE . 6.2 p-10 -147.69 160.23 42.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 1.77 110.031 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 22.5 t70 42.47 41.46 2.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.097 . . . . 1.22 111.332 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 75.5 mm-40 57.4 15.71 2.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.07 -1.019 . . . . 1.9299999999999999 110.651 175.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 56.1 pttt -130.78 163.21 27.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.156 -0.965 . . . . 2.0099999999999998 109.887 175.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.601 HD13 HG13 ' B' ' 20' ' ' ILE . 61.2 mt -104.21 134.74 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.046 -1.034 . . . . 1.25 110.516 -173.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 26.7 mt -112.96 119.27 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -0.833 . . . . 0.5 110.249 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.84 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.1 mp -108.12 134.84 50.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.932 . . . . 1.6599999999999999 109.987 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.587 ' HE3' ' CE2' ' A' ' 39' ' ' TYR . 1.8 ptpm? -140.79 163.5 32.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.417 -0.802 . . . . 1.74 110.296 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.7 tttp -55.12 148.08 14.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.109 -0.995 . . . . 1.6499999999999999 109.776 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.92 ' CD2' HG11 ' B' ' 9' ' ' VAL . 1.7 t80 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.34999999999999998 110.565 -175.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.934 HG13 ' O ' ' A' ' 36' ' ' LEU . 91.1 t . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.479 0.657 . . . . 0.37 110.855 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -129.85 159.89 35.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.479 -0.763 . . . . 1.9199999999999999 109.782 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -86.32 148.88 25.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 2.21 110.472 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.968 HG22 HD11 ' A' ' 36' ' ' LEU . 3.9 t -82.83 129.73 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.265 -0.897 . . . . 0.28999999999999998 109.867 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -85.46 -174.49 5.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.105 -0.997 . . . . 0.55000000000000004 110.239 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.462 ' OE1' ' OE2' ' A' ' 32' ' ' GLU . 47.5 tp10 -53.82 -41.61 67.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.17 -0.956 . . . . 2.1899999999999999 111.765 -173.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.9 tp -85.99 -4.14 59.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.722 -1.236 . . . . 1.3899999999999999 111.592 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.534 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.72 46.97 7.52 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.524 -1.431 . . . . 0.20999999999999999 109.524 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.943 ' CD ' HG22 ' A' ' 19' ' ' VAL . 74.2 mtm180 -115.76 154.28 29.89 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.083 -1.245 . . . . 1.1399999999999999 109.96 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.836 HG21 ' CD2' ' A' ' 47' ' ' LEU . 16.6 m -124.6 152.25 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.28000000000000003 109.899 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.918 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.9 t -112.34 135.38 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.93 . . . . 0.23999999999999999 110.505 -175.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.612 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.99 134.49 46.44 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 1.3799999999999999 109.554 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.536 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.8 Cg_endo -58.83 143.84 98.92 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.803 1.423 . . . . 0.35999999999999999 110.053 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.884 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.28 -31.86 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.042 -1.036 . . . . 1.1100000000000001 110.446 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.18 -35.57 73.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.057 -1.027 . . . . 2.3700000000000001 109.758 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.612 ' HB2' HG23 ' B' ' 20' ' ' ILE . 62.7 mt -82.49 -30.06 30.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.408 -0.808 . . . . 1.75 110.602 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.884 ' HD2' HD12 ' B' ' 22' ' ' ILE . 73.1 mtt180 -57.34 -43.85 83.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.877 -1.139 . . . . 0.29999999999999999 109.106 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -71.53 -50.54 30.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.418 -0.801 . . . . 3.27 110.614 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 60.8 m -62.98 -32.58 73.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.342 -0.849 . . . . 0.77000000000000002 110.948 -177.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.894 HD23 HG13 ' B' ' 30' ' ' ILE . 21.2 tp -87.84 -5.32 58.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.981 -1.074 . . . . 1.05 110.759 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.4 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.79 42.64 97.0 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.575 -1.41 . . . . 0.32000000000000001 109.575 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.894 HG13 HD23 ' B' ' 28' ' ' LEU . 34.8 mm -116.2 138.63 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -1.199 . . . . 0.40999999999999998 110.816 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.82 167.43 22.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.605 -0.685 . . . . 0.23000000000000001 109.97 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.25 147.18 10.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 1.1299999999999999 110.515 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 29.2 tttt 74.69 -5.01 2.21 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.733 -0.604 . . . . 1.8799999999999999 111.206 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.605 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.5 m-20 -77.63 164.98 24.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.821 -1.174 . . . . 1.1000000000000001 109.998 174.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.753 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.41 131.58 51.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.35999999999999999 110.833 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.99 HD11 HG22 ' A' ' 12' ' ' VAL . 13.4 mt -109.62 140.42 43.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 0.56000000000000005 109.632 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.743 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.7 tt0 -103.43 138.56 39.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.829 -1.169 . . . . 1.1699999999999999 109.749 171.859 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.8 mt -111.4 133.19 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.882 . . . . 0.83999999999999997 110.524 -172.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.575 ' CZ ' ' HE3' ' B' ' 48' ' ' LYS . 8.4 m-85 -114.48 160.7 18.9 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 120.958 0.409 . . . . 0.45000000000000001 110.275 -177.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 94.8 t -133.64 118.14 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.986 -1.071 . . . . 0.26000000000000001 110.559 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.54 ' OD2' HD11 ' B' ' 46' ' ' ILE . 6.3 p-10 -148.29 160.2 43.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 1.77 110.033 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 22.7 t70 42.46 41.7 2.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -0.985 . . . . 1.21 111.225 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 75.5 mm-40 57.23 15.61 2.62 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.079 -1.013 . . . . 1.9199999999999999 110.71 175.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 56.1 pttt -130.58 163.45 27.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.955 . . . . 2.0 109.866 174.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.453 HD13 HG13 ' A' ' 20' ' ' ILE . 60.5 mt -104.31 134.67 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.153 -0.967 . . . . 1.24 110.616 -173.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 27.5 mt -113.05 119.31 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.5 110.21 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.822 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.2 mp -108.04 134.75 50.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.214 -0.929 . . . . 1.6599999999999999 109.978 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.575 ' HE3' ' CZ ' ' B' ' 39' ' ' TYR . 1.8 ptpm? -140.69 163.63 32.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.422 -0.798 . . . . 1.74 110.288 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -55.12 147.93 15.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 1.6499999999999999 109.696 176.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 1.081 ' CD2' HG11 ' A' ' 9' ' ' VAL . 1.7 t80 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.65000000000000002 110.587 -175.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.1 mm . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 120.978 0.418 . . . . 1.3600000000000001 110.016 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.932 HG13 ' O ' ' B' ' 36' ' ' LEU . 87.0 t -117.91 144.03 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.024 -1.048 . . . . 0.37 110.94 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.449 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 27.7 tpt180 -128.57 160.56 32.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.549 -0.72 . . . . 1.9099999999999999 109.65 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 94.8 mttt -84.92 146.87 27.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 2.21 110.297 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.916 HG22 HD11 ' B' ' 36' ' ' LEU . 4.1 t -82.27 127.49 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.28000000000000003 109.757 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.27 -175.07 5.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.128 -0.983 . . . . 0.55000000000000004 109.985 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.8 -39.14 73.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.998 -1.064 . . . . 2.1899999999999999 111.596 -172.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.89 HD23 ' HD3' ' A' ' 17' ' ' ARG . 16.4 tp -83.0 -6.62 59.56 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.805 -1.185 . . . . 1.3799999999999999 111.531 -174.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.48 46.62 7.3 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.173 -1.489 . . . . 0.20999999999999999 109.654 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.896 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.1 mtm180 -114.07 154.44 27.72 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.018 -1.283 . . . . 1.1499999999999999 110.007 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.866 HG12 HD13 ' B' ' 36' ' ' LEU . 17.7 m -123.56 151.97 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.28000000000000003 109.799 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.909 HG22 ' CD ' ' B' ' 17' ' ' ARG . 17.1 t -113.61 133.56 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.23999999999999999 110.762 -174.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.945 HD11 HD13 ' B' ' 45' ' ' ILE . 2.5 mm -85.28 136.97 37.23 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.908 . . . . 1.3799999999999999 109.483 174.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.55 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -58.85 141.18 97.76 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.676 1.356 . . . . 0.34999999999999998 109.965 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.949 ' O ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.83 -32.03 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.946 -1.096 . . . . 1.1100000000000001 110.407 -177.641 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.64 -35.31 72.31 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.034 -1.041 . . . . 2.3700000000000001 109.77 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.55 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 45.3 mt -81.4 -28.97 34.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 1.75 110.52 176.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.663 HH22 HD11 ' B' ' 15' ' ' LEU . 72.6 mtt180 -56.93 -44.25 82.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.916 -1.115 . . . . 0.29999999999999999 108.942 175.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -72.03 -49.26 38.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.574 -0.704 . . . . 3.2599999999999998 110.735 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.7 m -63.55 -31.22 72.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 0.77000000000000002 111.119 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.832 HD23 HG13 ' A' ' 30' ' ' ILE . 21.4 tp -87.24 -4.66 59.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.004 -1.06 . . . . 1.05 110.712 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.18 40.92 95.09 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.721 -1.352 . . . . 0.32000000000000001 109.721 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.832 HG13 HD23 ' A' ' 28' ' ' LEU . 35.4 mm -116.33 139.09 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.309 -1.112 . . . . 0.40999999999999998 110.623 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.55 166.5 24.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.546 -0.721 . . . . 0.23000000000000001 110.124 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.47 146.65 12.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.973 . . . . 1.1299999999999999 110.591 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 15.1 tptt 74.83 -4.62 2.32 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.759 -0.588 . . . . 1.8799999999999999 111.092 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.75 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.8 m-20 -77.42 166.74 22.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.792 -1.193 . . . . 1.1000000000000001 110.021 174.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.684 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.53 131.94 52.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.35999999999999999 110.748 -176.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.932 HD11 HG22 ' B' ' 12' ' ' VAL . 13.9 mt -109.03 142.05 40.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.422 -0.799 . . . . 0.56000000000000005 109.519 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.651 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.0 tt0 -108.29 139.89 42.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.879 -1.138 . . . . 1.1699999999999999 109.784 173.043 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.425 HD13 ' O ' ' A' ' 37' ' ' GLU . 22.0 mm -111.86 133.98 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.332 -0.855 . . . . 0.83999999999999997 110.553 -173.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.593 ' CE2' ' HE3' ' A' ' 48' ' ' LYS . 8.2 m-85 -115.34 162.03 17.69 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 120.955 0.407 . . . . 0.45000000000000001 110.045 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.2 t -133.48 121.79 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.926 -1.108 . . . . 0.27000000000000002 110.92 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.605 ' CG ' HD11 ' A' ' 46' ' ' ILE . 6.3 p-10 -147.31 152.53 38.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 1.77 110.129 176.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 53.7 t0 43.02 45.34 4.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.122 -0.986 . . . . 1.22 111.32 173.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 96.0 mt-10 56.99 16.91 3.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.028 -1.045 . . . . 1.9299999999999999 110.548 175.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' A' ' 41' ' ' ASP . 16.2 ptpt -129.73 159.61 35.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 2.0099999999999998 109.872 176.114 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 1.059 HD13 HD11 ' B' ' 20' ' ' ILE . 57.8 mt -104.33 133.48 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 1.25 110.607 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.605 HD11 ' CG ' ' A' ' 41' ' ' ASP . 33.4 mt -112.11 120.53 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.507 -0.745 . . . . 0.5 110.283 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.845 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.5 mp -109.74 135.38 50.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.11 -0.994 . . . . 1.6599999999999999 110.015 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.593 ' HE3' ' CE2' ' A' ' 39' ' ' TYR . 1.8 ptpm? -141.09 162.83 34.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 1.74 110.3 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -57.94 146.54 31.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.171 -0.956 . . . . 1.6499999999999999 110.03 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.745 ' CD2' HG11 ' B' ' 9' ' ' VAL . 8.1 t80 . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.307 -0.871 . . . . 0.34999999999999998 110.655 -176.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 36' ' ' LEU . 86.7 t . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.453 0.644 . . . . 0.37 110.925 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.454 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 27.6 tpt180 -128.49 160.36 32.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.552 -0.717 . . . . 1.9199999999999999 109.76 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.454 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 94.8 mttt -84.82 146.8 27.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.038 -1.039 . . . . 2.21 110.283 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.932 HG22 HD11 ' A' ' 36' ' ' LEU . 4.1 t -82.29 127.52 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.28999999999999998 109.767 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -85.35 -174.86 5.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.18 -0.95 . . . . 0.55000000000000004 110.111 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.485 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.9 mt-10 -57.07 -38.91 73.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.099 -1.001 . . . . 2.1899999999999999 111.554 -172.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.8 tp -83.09 -6.74 59.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.796 -1.19 . . . . 1.3899999999999999 111.51 -174.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.18 47.31 7.07 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.508 -1.437 . . . . 0.20999999999999999 109.508 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.909 ' CD ' HG22 ' A' ' 19' ' ' VAL . 69.2 mtm180 -114.17 154.35 27.99 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.082 -1.246 . . . . 1.1399999999999999 110.074 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.892 HG12 HD13 ' A' ' 36' ' ' LEU . 17.7 m -123.52 152.0 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.86 . . . . 0.28000000000000003 109.794 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.896 HG22 ' CD ' ' A' ' 17' ' ' ARG . 16.8 t -113.57 133.57 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.158 -0.963 . . . . 0.23999999999999999 110.748 -174.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 1.059 HD11 HD13 ' A' ' 45' ' ' ILE . 2.6 mm -85.3 136.96 37.21 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 1.3799999999999999 109.526 174.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.0 Cg_endo -58.94 141.19 97.96 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.547 1.288 . . . . 0.35999999999999999 110.023 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.948 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -56.08 -31.7 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.09 -1.006 . . . . 1.1100000000000001 110.373 -177.368 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.58 -35.94 73.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.051 -1.03 . . . . 2.3700000000000001 109.661 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.556 ' HB2' HG23 ' B' ' 20' ' ' ILE . 45.4 mt -80.65 -29.35 36.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.448 -0.782 . . . . 1.75 110.526 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.61 HH22 HD11 ' A' ' 15' ' ' LEU . 72.1 mtt180 -56.81 -44.06 81.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.836 -1.165 . . . . 0.29999999999999999 109.001 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -71.98 -49.56 36.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.542 -0.723 . . . . 3.27 110.628 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.0 m -63.22 -31.8 73.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.286 -0.884 . . . . 0.77000000000000002 110.898 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.854 HD23 HG13 ' B' ' 30' ' ' ILE . 21.7 tp -86.72 -5.02 59.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.122 -0.986 . . . . 1.05 110.69 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.58 40.69 94.22 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.613 -1.395 . . . . 0.32000000000000001 109.613 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.854 HG13 HD23 ' B' ' 28' ' ' LEU . 34.8 mm -116.39 139.03 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -1.123 . . . . 0.40999999999999998 110.604 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.34 166.6 24.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.559 -0.713 . . . . 0.23000000000000001 110.071 -177.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.43 146.71 11.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 1.1299999999999999 110.508 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 15.1 tptt 74.88 -4.91 2.26 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.695 -0.628 . . . . 1.8799999999999999 111.184 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.665 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.1 m-20 -77.4 166.48 23.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.769 -1.207 . . . . 1.1000000000000001 110.094 174.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.7 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.32 131.86 52.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.134 -0.979 . . . . 0.35999999999999999 110.781 -176.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.932 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.7 mt -109.1 141.77 40.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.56000000000000005 109.6 175.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.625 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.9 tt0 -107.97 139.9 41.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.932 -1.105 . . . . 1.1699999999999999 109.892 173.011 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.429 HD13 ' O ' ' B' ' 37' ' ' GLU . 21.9 mm -111.95 134.14 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.352 -0.842 . . . . 0.83999999999999997 110.443 -173.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.583 ' CE2' ' HE3' ' B' ' 48' ' ' LYS . 8.0 m-85 -115.43 162.0 17.77 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 116.315 -0.402 . . . . 0.45000000000000001 110.078 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 92.2 t -133.23 122.21 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.931 -1.106 . . . . 0.26000000000000001 110.633 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.597 ' OD2' HD11 ' B' ' 46' ' ' ILE . 6.5 p-10 -147.84 152.56 37.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 1.77 110.114 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' B' ' 42' ' ' ASP . 54.2 t0 42.98 45.54 4.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.164 -0.96 . . . . 1.21 111.258 173.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.9 mt-10 56.85 16.89 2.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.983 -1.073 . . . . 1.9199999999999999 110.594 175.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' B' ' 41' ' ' ASP . 16.2 ptpt -129.67 159.88 35.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 2.0 109.763 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.945 HD13 HD11 ' A' ' 20' ' ' ILE . 57.3 mt -104.39 133.51 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.124 -0.985 . . . . 1.24 110.687 -173.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.597 HD11 ' OD2' ' B' ' 41' ' ' ASP . 34.7 mt -112.34 120.57 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.389 -0.819 . . . . 0.5 110.181 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.835 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.6 mp -109.63 135.24 50.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.196 -0.94 . . . . 1.6599999999999999 110.071 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.583 ' HE3' ' CE2' ' B' ' 39' ' ' TYR . 1.8 ptpm? -140.99 163.03 34.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.454 -0.778 . . . . 1.74 110.248 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -57.93 146.55 31.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 1.6499999999999999 109.988 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.881 ' CD2' HG11 ' A' ' 9' ' ' VAL . 8.3 t80 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.65000000000000002 110.596 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.8 mt . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 109.594 -0.521 . . . . 1.3600000000000001 109.594 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.906 HG13 ' O ' ' B' ' 36' ' ' LEU . 75.1 t -110.94 143.87 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.791 -1.193 . . . . 0.37 111.394 -170.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.489 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 28.7 tpt180 -125.85 163.11 23.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.645 -0.659 . . . . 1.9099999999999999 109.527 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.489 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 56.6 mttm -84.98 146.54 27.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.986 -1.071 . . . . 2.21 110.453 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.896 HG22 HD11 ' B' ' 36' ' ' LEU . 3.9 t -83.51 130.29 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.385 -0.822 . . . . 0.28000000000000003 109.876 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.74 -175.54 5.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.048 -1.032 . . . . 0.55000000000000004 110.03 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.85 -39.33 74.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.998 -1.064 . . . . 2.1899999999999999 111.677 -172.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.895 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.1 tp -83.26 -6.67 59.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.735 -1.228 . . . . 1.3799999999999999 111.524 -174.008 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.457 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.47 46.58 7.32 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.176 -1.488 . . . . 0.20999999999999999 109.715 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.911 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.5 mtm180 -113.88 154.73 27.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.953 -1.322 . . . . 1.1499999999999999 110.043 -177.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.905 HG12 HD13 ' B' ' 36' ' ' LEU . 15.4 m -123.84 152.72 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.28000000000000003 109.755 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.917 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.4 t -111.28 135.12 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.23999999999999999 110.671 -175.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.6 HD11 ' CD1' ' B' ' 45' ' ' ILE . 16.2 mt -81.63 135.05 49.8 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.274 -0.891 . . . . 1.3799999999999999 109.675 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.4 Cg_endo -58.32 142.61 97.68 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.67 1.352 . . . . 0.34999999999999998 109.954 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.884 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.18 -32.16 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.899 -1.126 . . . . 1.1100000000000001 110.389 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.39 -34.87 72.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.055 -1.028 . . . . 2.3700000000000001 109.888 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.546 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 52.3 mt -81.86 -30.72 31.89 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.277 -0.889 . . . . 1.75 110.532 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.884 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.1 mtt180 -57.94 -44.19 86.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.95 -1.093 . . . . 0.29999999999999999 109.2 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -73.82 -49.9 23.03 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.831 -0.748 . . . . 3.2599999999999998 110.653 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.6 m -64.12 -31.15 72.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.201 -0.937 . . . . 0.77000000000000002 111.11 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.862 HD23 HG13 ' A' ' 30' ' ' ILE . 18.7 tp -87.82 -4.68 58.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.039 -1.038 . . . . 1.05 110.739 -176.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 66.07 43.28 93.68 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.685 -1.366 . . . . 0.32000000000000001 109.685 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.862 HG13 HD23 ' A' ' 28' ' ' LEU . 32.8 mm -115.96 138.19 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -1.162 . . . . 0.40999999999999998 110.671 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.405 ' HB3' ' OD2' ' A' ' 34' ' ' ASP . . . -142.78 167.0 23.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.579 -0.7 . . . . 0.23000000000000001 110.049 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.58 145.79 14.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 1.1299999999999999 110.601 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 69.1 tttt 74.43 -4.34 2.34 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.708 -0.62 . . . . 1.8799999999999999 111.073 176.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.767 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.7 m-20 -76.97 168.29 20.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.816 -1.177 . . . . 1.1000000000000001 109.962 174.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.82 131.37 53.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.937 . . . . 0.35999999999999999 110.798 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.93 ' O ' HG13 ' B' ' 9' ' ' VAL . 9.5 mt -107.61 144.23 34.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.369 -0.832 . . . . 0.56000000000000005 109.267 174.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.532 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.4 tt0 -108.35 137.93 45.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.696 -1.253 . . . . 1.1699999999999999 109.648 173.514 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.5 mt -108.42 133.29 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.452 -0.78 . . . . 0.83999999999999997 110.571 -172.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.595 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.3 m-85 -119.38 159.98 23.16 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 116.319 -0.401 . . . . 0.45000000000000001 110.001 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.8 t -133.22 127.25 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.98 -1.075 . . . . 0.27000000000000002 110.564 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.478 ' OD1' HG12 ' A' ' 46' ' ' ILE . 39.1 p-10 -147.23 137.99 23.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 1.77 110.658 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.7 t0 43.74 47.36 6.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.043 -1.035 . . . . 1.22 111.306 174.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.5 tt0 61.02 11.8 3.57 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.193 -0.942 . . . . 1.9299999999999999 110.622 175.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 35.4 mtmt -113.07 151.91 30.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 2.0099999999999998 109.71 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.809 HG22 HD11 ' A' ' 47' ' ' LEU . 65.9 mt -94.73 129.78 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 1.25 109.977 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 27.6 mm -114.95 120.93 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.465 -0.772 . . . . 0.5 109.928 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.845 HD13 ' CD1' ' B' ' 47' ' ' LEU . 4.4 mp -118.34 136.04 53.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.973 -1.079 . . . . 1.6599999999999999 110.257 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.559 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 5.0 ptpt -142.67 158.24 43.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.339 -0.85 . . . . 1.74 110.333 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -57.88 146.59 31.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -0.958 . . . . 1.6499999999999999 109.934 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.631 ' CD2' HG11 ' B' ' 9' ' ' VAL . 14.5 t80 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.34999999999999998 110.729 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 36' ' ' LEU . 74.0 t . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.643 0.735 . . . . 0.37 111.375 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 28.8 tpt180 -125.69 162.96 23.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.527 -0.733 . . . . 1.9199999999999999 109.596 175.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.49 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 56.7 mttm -84.97 146.52 27.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.071 -1.018 . . . . 2.21 110.484 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.914 HG22 ' CD1' ' A' ' 36' ' ' LEU . 4.0 t -83.5 130.38 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.35 -0.844 . . . . 0.28999999999999998 109.763 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.0 -175.33 5.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.076 -1.015 . . . . 0.55000000000000004 110.054 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.486 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -57.11 -39.19 74.59 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.028 -1.045 . . . . 2.1899999999999999 111.554 -172.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.901 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.9 tp -83.23 -6.83 59.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.737 -1.227 . . . . 1.3899999999999999 111.589 -174.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.461 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.12 47.38 7.06 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.483 -1.447 . . . . 0.20999999999999999 109.483 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.917 ' CD ' HG22 ' A' ' 19' ' ' VAL . 69.6 mtm180 -114.08 154.67 27.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.026 -1.279 . . . . 1.1399999999999999 110.059 -177.75 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.922 HG12 HD13 ' A' ' 36' ' ' LEU . 15.1 m -123.73 152.74 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.28000000000000003 109.803 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.911 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.4 t -111.41 135.12 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.23999999999999999 110.655 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.635 HD11 ' CD1' ' A' ' 45' ' ' ILE . 15.9 mt -81.64 135.03 49.78 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.326 -0.859 . . . . 1.3799999999999999 109.602 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.538 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.5 Cg_endo -58.38 142.64 97.87 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.773 1.407 . . . . 0.35999999999999999 110.045 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.881 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.42 -31.79 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.06 -1.025 . . . . 1.1100000000000001 110.357 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.31 -35.59 74.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.019 -1.051 . . . . 2.3700000000000001 109.787 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.545 ' HB2' HG23 ' B' ' 20' ' ' ILE . 51.9 mt -81.15 -31.02 34.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 1.75 110.569 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.881 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.7 mtt180 -57.85 -43.93 86.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.848 -1.157 . . . . 0.29999999999999999 109.319 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -73.82 -50.1 22.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 3.27 110.62 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.5 m -63.81 -31.78 73.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.304 -0.872 . . . . 0.77000000000000002 110.854 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.875 HD23 HG13 ' B' ' 30' ' ' ILE . 18.8 tp -87.35 -4.95 59.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.124 -0.985 . . . . 1.05 110.732 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.446 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.4 43.12 93.3 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.626 -1.39 . . . . 0.32000000000000001 109.626 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.875 HG13 HD23 ' B' ' 28' ' ' LEU . 32.5 mm -115.96 138.11 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -1.144 . . . . 0.40999999999999998 110.64 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.55 167.11 22.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.478 -0.764 . . . . 0.23000000000000001 109.999 -177.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.64 145.93 14.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 1.1299999999999999 110.565 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 69.2 tttt 74.49 -4.58 2.29 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.656 -0.653 . . . . 1.8799999999999999 111.128 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.723 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.9 m-20 -76.97 168.07 20.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.83 -1.169 . . . . 1.1000000000000001 110.013 174.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.499 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.66 131.36 53.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 0.35999999999999999 110.805 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.906 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.4 mt -107.71 144.04 35.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.391 -0.818 . . . . 0.56000000000000005 109.291 174.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.473 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.3 tt0 -108.15 137.81 45.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.764 -1.21 . . . . 1.1699999999999999 109.881 173.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -108.32 133.35 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.322 -0.861 . . . . 0.83999999999999997 110.508 -172.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.602 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 10.3 m-85 -119.41 159.98 23.18 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 116.276 -0.42 . . . . 0.45000000000000001 110.03 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 76.7 t -133.12 127.56 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.945 -1.097 . . . . 0.26000000000000001 110.454 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.489 ' OD1' HG12 ' B' ' 46' ' ' ILE . 39.2 p-10 -147.6 137.98 23.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.34 -0.85 . . . . 1.77 110.58 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 54.4 t0 43.89 47.42 6.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.136 -0.977 . . . . 1.21 111.278 174.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.3 tt0 60.85 11.74 3.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.133 -0.979 . . . . 1.9199999999999999 110.636 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 35.3 mtmt -113.02 152.06 29.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.176 -0.952 . . . . 2.0 109.683 175.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.803 HG22 HD11 ' B' ' 47' ' ' LEU . 65.6 mt -94.81 129.57 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 1.24 110.108 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 27.2 mm -114.84 120.94 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.581 -0.699 . . . . 0.5 109.962 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.845 ' CD1' HD13 ' A' ' 47' ' ' LEU . 4.4 mp -118.2 135.88 53.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.999 -1.063 . . . . 1.6599999999999999 110.235 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.558 ' HD2' ' CE1' ' B' ' 39' ' ' TYR . 5.0 ptpt -142.53 158.41 43.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 1.74 110.346 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -57.83 146.47 31.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 1.6499999999999999 109.955 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.699 ' CD2' HG11 ' A' ' 9' ' ' VAL . 15.0 t80 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.65000000000000002 110.697 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.5 mt . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.047 0.451 . . . . 1.3600000000000001 110.018 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.93 HG13 ' O ' ' B' ' 36' ' ' LEU . 89.2 t -115.71 144.25 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.013 -1.054 . . . . 0.37 110.855 -176.223 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -129.85 160.38 33.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.522 -0.736 . . . . 1.9099999999999999 109.658 177.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -85.62 147.73 26.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.029 -1.044 . . . . 2.21 110.33 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.93 HG22 HD11 ' B' ' 36' ' ' LEU . 3.8 t -82.33 130.78 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -0.864 . . . . 0.28000000000000003 109.825 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.8 -175.55 5.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.128 -0.982 . . . . 0.55000000000000004 110.02 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.9 -40.77 70.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.134 -0.979 . . . . 2.1899999999999999 111.733 -173.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.843 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.1 tp -84.09 -5.51 59.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.746 -1.221 . . . . 1.3799999999999999 111.493 -173.28 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.523 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.34 46.37 7.53 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.193 -1.479 . . . . 0.20999999999999999 109.704 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.919 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.0 mtm180 -114.93 154.53 28.57 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.028 -1.277 . . . . 1.1499999999999999 109.994 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.769 HG12 HD13 ' B' ' 36' ' ' LEU . 16.6 m -123.86 152.01 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.28000000000000003 109.768 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.929 HG22 ' CD ' ' B' ' 17' ' ' ARG . 36.0 t -111.23 134.87 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.23999999999999999 110.724 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.53 HG23 ' HB2' ' A' ' 24' ' ' LEU . 19.0 mt -81.36 133.28 53.7 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.277 -0.89 . . . . 1.3799999999999999 109.632 174.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' HD12 ' A' ' 24' ' ' LEU . 10.2 Cg_endo -58.85 143.32 99.34 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.701 1.369 . . . . 0.34999999999999998 109.985 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.883 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.07 -32.82 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.934 -1.104 . . . . 1.1100000000000001 110.33 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.11 -35.66 71.77 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.111 -0.993 . . . . 2.3700000000000001 109.852 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.552 HD12 ' HG2' ' A' ' 21' ' ' PRO . 57.2 mt -82.83 -29.8 29.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.429 -0.795 . . . . 1.75 110.645 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.883 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.0 mtt180 -57.54 -43.88 84.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.887 -1.133 . . . . 0.29999999999999999 109.166 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -73.06 -50.97 19.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.542 -0.724 . . . . 3.2599999999999998 110.645 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.3 m -63.53 -31.32 72.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.259 -0.9 . . . . 0.77000000000000002 111.195 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.886 HD23 HG13 ' A' ' 30' ' ' ILE . 20.8 tp -87.71 -4.8 58.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.037 -1.039 . . . . 1.05 110.783 -177.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.15 41.72 96.83 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.624 -1.391 . . . . 0.32000000000000001 109.624 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.886 HG13 HD23 ' A' ' 28' ' ' LEU . 34.9 mm -116.4 138.05 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.228 -1.16 . . . . 0.40999999999999998 110.633 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.68 166.74 23.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.652 -0.655 . . . . 0.23000000000000001 110.005 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.53 146.56 12.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.065 -1.022 . . . . 1.1299999999999999 110.532 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 28.6 tttm 74.57 -4.62 2.29 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.699 -0.626 . . . . 1.8799999999999999 111.097 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.715 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.3 m-20 -77.65 166.74 22.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.81 -1.182 . . . . 1.1000000000000001 110.078 174.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.14 130.69 51.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.35999999999999999 110.747 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.978 HD11 HG22 ' B' ' 12' ' ' VAL . 12.3 mt -107.3 143.21 35.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.351 -0.843 . . . . 0.56000000000000005 109.424 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.663 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.5 tt0 -107.27 137.85 44.56 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.839 -1.163 . . . . 1.1699999999999999 109.577 173.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.6 mt -108.6 133.44 53.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.361 -0.837 . . . . 0.83999999999999997 110.583 -171.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.625 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.7 m-85 -120.13 159.44 24.85 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 116.309 -0.405 . . . . 0.45000000000000001 110.014 -178.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.8 t -133.16 124.55 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.85 -1.156 . . . . 0.27000000000000002 110.666 172.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.495 ' OD1' HG12 ' A' ' 46' ' ' ILE . 42.3 p-10 -147.54 145.08 28.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 1.77 110.577 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.1 t0 43.08 43.9 3.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.998 -1.064 . . . . 1.22 111.283 174.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 45.2 tp10 61.74 10.6 3.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.128 -0.983 . . . . 1.9299999999999999 110.676 175.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -109.77 153.44 24.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 2.0099999999999998 110.034 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.76 HG22 HD11 ' A' ' 47' ' ' LEU . 66.6 mt -93.32 128.34 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 1.25 109.752 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.0 mm -113.35 118.43 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.602 -0.687 . . . . 0.5 109.941 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.83 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -115.84 134.67 54.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.944 -1.097 . . . . 1.6599999999999999 110.284 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.57 ' HE3' ' CD1' ' A' ' 39' ' ' TYR . 15.9 ptpt -142.78 161.14 38.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.793 . . . . 1.74 110.317 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -56.59 147.67 21.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.042 -1.037 . . . . 1.6499999999999999 109.882 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.768 ' CD2' HG11 ' B' ' 9' ' ' VAL . 5.5 t80 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.34999999999999998 110.653 -175.578 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.942 HG13 ' O ' ' A' ' 36' ' ' LEU . 87.2 t . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.504 0.669 . . . . 0.37 110.951 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -129.79 160.16 34.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.53 -0.731 . . . . 1.9199999999999999 109.709 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -85.53 147.59 26.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.101 -1.0 . . . . 2.21 110.413 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.978 HG22 HD11 ' A' ' 36' ' ' LEU . 3.8 t -82.25 130.75 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.874 . . . . 0.28999999999999998 109.743 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -83.95 -175.59 5.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.049 -1.032 . . . . 0.55000000000000004 110.119 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.02 -40.62 70.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.133 -0.98 . . . . 2.1899999999999999 111.649 -172.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.865 HD23 ' HD3' ' B' ' 17' ' ' ARG . 13.9 tp -84.1 -5.52 59.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.766 -1.209 . . . . 1.3899999999999999 111.602 -173.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.529 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.92 47.12 7.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.606 -1.397 . . . . 0.20999999999999999 109.606 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.929 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.0 mtm180 -115.09 154.57 28.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.071 -1.253 . . . . 1.1399999999999999 109.996 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.801 HG12 HD13 ' A' ' 36' ' ' LEU . 16.6 m -123.96 152.01 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 0.28000000000000003 109.823 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.919 HG22 ' CD ' ' A' ' 17' ' ' ARG . 35.9 t -111.29 134.85 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.935 . . . . 0.23999999999999999 110.714 -175.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.532 HD11 ' CD1' ' A' ' 45' ' ' ILE . 18.5 mt -81.41 133.23 53.62 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.253 -0.904 . . . . 1.3799999999999999 109.609 174.207 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.544 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.1 Cg_endo -58.96 143.25 99.76 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.735 1.387 . . . . 0.35999999999999999 109.98 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.877 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.2 tp -55.09 -32.63 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.002 -1.061 . . . . 1.1100000000000001 110.412 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.98 -36.39 72.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.11 -0.994 . . . . 2.3700000000000001 109.747 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.544 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 57.6 mt -82.13 -30.01 31.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.494 -0.754 . . . . 1.75 110.638 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.877 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.6 mtt180 -57.56 -43.71 84.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.847 -1.158 . . . . 0.29999999999999999 109.076 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -72.97 -51.21 19.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.482 -0.761 . . . . 3.27 110.6 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.2 m -63.29 -31.87 73.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.261 -0.899 . . . . 0.77000000000000002 110.953 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.895 HD23 HG13 ' B' ' 30' ' ' ILE . 20.9 tp -87.12 -5.22 59.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.042 -1.036 . . . . 1.05 110.73 -176.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.429 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.46 41.54 96.29 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.563 -1.415 . . . . 0.32000000000000001 109.563 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.895 HG13 HD23 ' B' ' 28' ' ' LEU . 34.2 mm -116.37 137.94 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -1.199 . . . . 0.40999999999999998 110.598 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.41 166.86 23.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.624 -0.672 . . . . 0.23000000000000001 109.965 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.51 146.61 12.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 1.1299999999999999 110.48 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 28.5 tttm 74.66 -4.78 2.27 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.671 -0.643 . . . . 1.8799999999999999 111.17 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.622 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.9 m-20 -77.73 166.5 22.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.789 -1.194 . . . . 1.1000000000000001 110.092 175.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.693 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.06 130.63 51.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 0.35999999999999999 110.837 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.93 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.1 mt -107.27 143.06 36.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 0.56000000000000005 109.48 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.649 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.4 tt0 -107.05 137.85 44.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.763 -1.21 . . . . 1.1699999999999999 109.688 172.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.8 mt -108.72 133.53 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.292 -0.88 . . . . 0.83999999999999997 110.516 -171.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.616 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 10.7 m-85 -120.16 159.44 24.88 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 116.225 -0.443 . . . . 0.45000000000000001 109.978 -178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 81.5 t -133.03 125.02 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.885 -1.134 . . . . 0.26000000000000001 110.451 172.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.491 ' OD1' HG12 ' B' ' 46' ' ' ILE . 42.1 p-10 -148.03 145.06 28.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 1.77 110.556 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.7 t0 43.25 43.91 4.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.077 -1.014 . . . . 1.21 111.242 174.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 45.0 tp10 61.61 10.61 3.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.147 -0.971 . . . . 1.9199999999999999 110.703 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -109.87 153.66 24.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 2.0 109.963 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.759 HG22 HD11 ' B' ' 47' ' ' LEU . 66.2 mt -93.43 128.14 45.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.19 -0.944 . . . . 1.24 109.85 176.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 21.4 mm -113.28 118.42 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.508 -0.745 . . . . 0.5 109.95 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.821 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.3 mp -115.66 134.42 55.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.067 -1.021 . . . . 1.6599999999999999 110.255 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.57 ' HE3' ' CD1' ' B' ' 39' ' ' TYR . 15.8 ptpt -142.54 161.34 38.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.351 -0.843 . . . . 1.74 110.36 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -56.67 147.59 22.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.186 -0.946 . . . . 1.6499999999999999 109.893 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.929 ' CD2' HG11 ' A' ' 9' ' ' VAL . 5.6 t80 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.65000000000000002 110.581 -175.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.5 mt . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 120.962 0.411 . . . . 1.3600000000000001 109.954 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.05 HG11 ' CD2' ' B' ' 50' ' ' TYR . 88.5 t -117.45 144.26 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.014 -1.054 . . . . 0.37 110.875 -175.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -131.47 162.54 29.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.532 -0.73 . . . . 1.9099999999999999 109.726 177.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -85.32 148.06 26.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.041 -1.037 . . . . 2.21 110.385 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.916 HG22 HD11 ' B' ' 36' ' ' LEU . 3.8 t -82.3 129.8 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.216 -0.928 . . . . 0.28000000000000003 109.792 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.14 -175.66 5.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.037 -1.039 . . . . 0.55000000000000004 109.994 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -54.85 -40.69 69.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.083 -1.011 . . . . 2.1899999999999999 111.68 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.831 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.4 tp -84.51 -5.82 59.32 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.731 -1.231 . . . . 1.3799999999999999 111.572 -173.195 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.486 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.53 46.59 7.28 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.225 -1.464 . . . . 0.20999999999999999 109.646 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.898 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.0 mtm180 -114.03 153.74 28.88 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.942 -1.328 . . . . 1.1499999999999999 110.109 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.902 HG12 HD13 ' B' ' 36' ' ' LEU . 16.6 m -124.21 152.99 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.28000000000000003 109.771 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.9 HG22 ' CD ' ' B' ' 17' ' ' ARG . 18.1 t -112.24 134.36 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.983 . . . . 0.23999999999999999 110.708 -175.032 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.668 HD11 HG21 ' B' ' 45' ' ' ILE . 2.2 mm -82.97 134.13 47.14 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.181 -0.95 . . . . 1.3799999999999999 109.322 173.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.5 Cg_endo -58.86 141.57 98.18 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.701 1.369 . . . . 0.34999999999999998 109.906 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.962 ' O ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.76 -31.43 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.909 -1.12 . . . . 1.1100000000000001 110.412 -176.556 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.473 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 20.1 pt-20 -59.25 -34.67 72.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.024 -1.048 . . . . 2.3700000000000001 109.732 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.584 ' HB2' HG23 ' A' ' 20' ' ' ILE . 56.6 mt -80.73 -29.42 36.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 1.75 110.325 176.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.701 HH22 HD11 ' B' ' 15' ' ' LEU . 73.4 mtt180 -57.1 -44.19 82.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.958 -1.088 . . . . 0.29999999999999999 109.122 175.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -72.41 -50.45 26.34 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.893 -0.723 . . . . 3.2599999999999998 110.692 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.1 m -63.53 -31.49 72.66 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.77000000000000002 111.129 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.863 HD23 HG13 ' A' ' 30' ' ' ILE . 18.3 tp -87.85 -4.71 58.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.011 -1.055 . . . . 1.05 110.74 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.444 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.84 42.04 95.24 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.707 -1.357 . . . . 0.32000000000000001 109.707 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.863 HG13 HD23 ' A' ' 28' ' ' LEU . 32.5 mm -116.41 138.37 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -1.125 . . . . 0.40999999999999998 110.716 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.63 166.23 25.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.594 -0.691 . . . . 0.23000000000000001 109.993 -177.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.42 147.0 11.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.024 -1.048 . . . . 1.1299999999999999 110.584 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 26.6 ttpt 74.39 -4.47 2.31 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.644 -0.66 . . . . 1.8799999999999999 111.163 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.754 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.8 m-20 -77.79 167.82 20.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.827 -1.17 . . . . 1.1000000000000001 110.057 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.51 131.0 52.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 0.35999999999999999 110.777 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.935 ' CD1' HG22 ' B' ' 12' ' ' VAL . 12.2 mt -108.03 144.3 35.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.381 -0.824 . . . . 0.56000000000000005 109.461 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.63 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.0 tt0 -109.5 139.14 44.85 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.812 -1.18 . . . . 1.1699999999999999 109.614 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.25 132.86 54.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.462 -0.774 . . . . 0.83999999999999997 110.471 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.601 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 15.8 m-85 -119.19 157.21 28.43 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 116.294 -0.412 . . . . 0.45000000000000001 109.941 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.1 t -132.14 122.69 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.795 -1.191 . . . . 0.27000000000000002 110.575 173.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.49 ' OD1' HG12 ' A' ' 46' ' ' ILE . 47.4 p-10 -147.8 149.71 32.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.909 . . . . 1.77 110.602 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 52.7 t0 42.96 44.19 3.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.011 -1.055 . . . . 1.22 111.317 173.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.7 mt-10 57.84 14.46 2.54 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.051 -1.03 . . . . 1.9299999999999999 110.54 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -114.09 153.32 29.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -0.929 . . . . 2.0099999999999998 109.984 175.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.835 HG22 HD11 ' A' ' 47' ' ' LEU . 66.0 mt -91.82 127.77 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.23 -0.919 . . . . 1.25 109.762 177.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 24.5 mm -112.96 120.07 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.633 -0.667 . . . . 0.5 109.896 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.843 ' CD2' HG21 ' B' ' 18' ' ' VAL . 4.1 mp -118.72 134.5 55.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.902 -1.124 . . . . 1.6599999999999999 110.256 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.533 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 9.8 pttp -141.81 164.49 30.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 1.74 110.451 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -58.68 147.08 34.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 1.6499999999999999 110.146 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.884 ' CD2' HG11 ' B' ' 9' ' ' VAL . 7.8 t80 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.833 . . . . 0.34999999999999998 110.603 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.931 HG13 ' O ' ' A' ' 36' ' ' LEU . 89.2 t . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.471 0.653 . . . . 0.37 110.919 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -131.42 162.35 30.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.555 -0.716 . . . . 1.9199999999999999 109.72 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -85.16 148.01 26.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.083 -1.01 . . . . 2.21 110.393 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.935 HG22 ' CD1' ' A' ' 36' ' ' LEU . 3.9 t -82.29 129.85 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.213 -0.929 . . . . 0.28999999999999998 109.7 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.42 -175.55 5.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.956 . . . . 0.55000000000000004 110.097 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -54.89 -40.65 69.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 2.1899999999999999 111.674 -172.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.845 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.1 tp -84.42 -5.97 59.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.772 -1.205 . . . . 1.3899999999999999 111.599 -173.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.489 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.18 47.31 7.07 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.558 -1.417 . . . . 0.20999999999999999 109.558 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.9 ' CD ' HG22 ' A' ' 19' ' ' VAL . 68.7 mtm180 -114.29 153.69 29.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.085 -1.244 . . . . 1.1399999999999999 110.061 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.923 HG12 HD13 ' A' ' 36' ' ' LEU . 16.4 m -124.12 152.96 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 0.28000000000000003 109.813 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.898 HG22 ' CD ' ' A' ' 17' ' ' ARG . 18.0 t -112.37 134.36 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.23999999999999999 110.686 -175.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.696 HD11 HG21 ' A' ' 45' ' ' ILE . 2.3 mm -82.91 134.02 47.54 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.934 . . . . 1.3799999999999999 109.409 173.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.4 Cg_endo -58.96 141.57 98.39 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.807 1.425 . . . . 0.35999999999999999 109.899 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.956 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.95 -31.13 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.068 -1.02 . . . . 1.1100000000000001 110.409 -176.266 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 23' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' B' ' 21' ' ' PRO . 20.0 pt-20 -59.16 -35.38 73.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.023 -1.048 . . . . 2.3700000000000001 109.59 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.596 ' HB2' HG23 ' B' ' 20' ' ' ILE . 57.3 mt -80.03 -29.83 39.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.484 -0.76 . . . . 1.75 110.334 176.419 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.64 HH22 HD11 ' A' ' 15' ' ' LEU . 73.0 mtt180 -56.83 -44.08 81.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.01 -1.056 . . . . 0.29999999999999999 109.203 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -72.3 -50.78 24.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.468 -0.77 . . . . 3.27 110.642 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.3 m -63.2 -32.05 73.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.888 . . . . 0.77000000000000002 110.921 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.864 HD23 HG13 ' B' ' 30' ' ' ILE . 18.5 tp -87.39 -4.99 59.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.026 -1.047 . . . . 1.05 110.73 -176.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.447 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.31 41.8 94.4 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.603 -1.399 . . . . 0.32000000000000001 109.603 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.864 HG13 HD23 ' B' ' 28' ' ' LEU . 32.1 mm -116.41 138.29 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -1.183 . . . . 0.40999999999999998 110.616 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.39 166.44 24.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.562 -0.711 . . . . 0.23000000000000001 110.026 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.48 147.0 11.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.136 -0.978 . . . . 1.1299999999999999 110.486 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 26.6 ttpt 74.59 -4.76 2.26 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.661 -0.65 . . . . 1.8799999999999999 111.126 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.657 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.0 m-20 -77.76 167.54 21.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.825 -1.172 . . . . 1.1000000000000001 110.107 175.209 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.758 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.28 130.98 52.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.184 -0.948 . . . . 0.35999999999999999 110.803 -176.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.932 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.2 mt -108.02 144.08 35.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.842 . . . . 0.56000000000000005 109.551 174.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.617 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.7 tt0 -109.11 139.09 44.48 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.868 -1.145 . . . . 1.1699999999999999 109.8 172.754 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.32 132.84 55.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.363 -0.836 . . . . 0.83999999999999997 110.427 -172.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.591 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 15.6 m-85 -119.18 157.24 28.35 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 116.231 -0.44 . . . . 0.45000000000000001 109.874 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 85.7 t -131.96 123.08 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.958 -1.089 . . . . 0.26000000000000001 110.441 173.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.484 ' OD1' HG12 ' B' ' 46' ' ' ILE . 47.6 p-10 -148.35 149.63 32.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.16 -0.962 . . . . 1.77 110.561 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' B' ' 42' ' ' ASP . 53.2 t0 42.87 44.48 3.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.129 -0.982 . . . . 1.21 111.287 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.7 mt-10 57.61 14.53 2.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.045 -1.034 . . . . 1.9199999999999999 110.503 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -114.08 153.49 29.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.292 -0.88 . . . . 2.0 109.989 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.832 HG22 HD11 ' B' ' 47' ' ' LEU . 65.7 mt -91.95 127.72 44.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.263 -0.898 . . . . 1.24 109.771 177.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.591 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 24.7 mm -113.02 120.1 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.513 -0.742 . . . . 0.5 109.903 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.832 HD11 HG22 ' B' ' 45' ' ' ILE . 4.2 mp -118.66 134.34 55.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.974 -1.079 . . . . 1.6599999999999999 110.196 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.535 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 10.1 pttp -141.62 164.81 29.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 1.74 110.406 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -58.89 147.04 35.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 1.6499999999999999 109.953 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 1.05 ' CD2' HG11 ' A' ' 9' ' ' VAL . 7.9 t80 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.65000000000000002 110.583 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.1 mm . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 120.979 0.419 . . . . 1.3600000000000001 110.061 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.943 HG13 ' O ' ' B' ' 36' ' ' LEU . 95.9 t -115.82 144.85 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.063 -1.023 . . . . 0.37 110.81 -176.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -131.44 160.27 35.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.515 -0.74 . . . . 1.9099999999999999 109.704 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -85.58 148.0 26.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.062 -1.024 . . . . 2.21 110.307 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.932 HG22 HD11 ' B' ' 36' ' ' LEU . 4.3 t -81.91 130.3 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.268 -0.895 . . . . 0.28000000000000003 109.855 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.74 -174.64 5.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.55000000000000004 110.157 -179.124 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.42 -41.95 66.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.123 -0.986 . . . . 2.1899999999999999 111.887 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.901 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.0 tp -87.48 -3.06 59.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.68 -1.262 . . . . 1.3799999999999999 111.755 -172.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.528 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 79.98 46.36 7.75 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.168 -1.491 . . . . 0.20999999999999999 109.674 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.935 ' CD ' HG22 ' B' ' 19' ' ' VAL . 76.9 mtm180 -116.2 154.28 30.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.098 -1.236 . . . . 1.1499999999999999 109.828 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.645 HG12 HD13 ' B' ' 36' ' ' LEU . 27.4 m -125.7 153.14 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 0.28000000000000003 109.938 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.935 HG22 ' CD ' ' B' ' 17' ' ' ARG . 22.7 t -111.55 135.52 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.23999999999999999 110.548 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.31 134.25 46.01 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.255 -0.903 . . . . 1.3799999999999999 109.577 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.54 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.4 Cg_endo -57.83 142.81 96.41 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.788 1.415 . . . . 0.34999999999999998 110.025 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.893 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.37 -32.56 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.034 -1.041 . . . . 1.1100000000000001 110.378 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.96 -35.9 71.8 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.143 -0.973 . . . . 2.3700000000000001 109.9 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.543 ' HB2' HG23 ' A' ' 20' ' ' ILE . 51.8 mt -81.03 -31.3 34.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 1.75 110.542 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.893 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.9 mtt180 -58.17 -43.51 87.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.954 -1.091 . . . . 0.29999999999999999 109.287 176.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -73.19 -49.66 26.81 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.797 -0.761 . . . . 3.2599999999999998 110.694 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.5 m -63.9 -31.86 73.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.77000000000000002 111.093 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.823 HD23 HG13 ' A' ' 30' ' ' ILE . 17.4 tp -88.16 -4.61 58.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.055 -1.028 . . . . 1.05 110.737 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.48 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.78 42.35 95.21 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.681 -1.367 . . . . 0.32000000000000001 109.681 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.823 HG13 HD23 ' A' ' 28' ' ' LEU . 31.4 mm -116.32 137.79 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.302 -1.116 . . . . 0.40999999999999998 110.715 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.43 168.65 19.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.589 -0.694 . . . . 0.23000000000000001 110.061 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.77 145.87 14.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.111 -0.993 . . . . 1.1299999999999999 110.616 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 41.3 tttp 74.0 -4.35 2.3 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.751 -0.593 . . . . 1.8799999999999999 111.231 176.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.718 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.1 m-20 -76.84 166.28 23.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.818 -1.176 . . . . 1.1000000000000001 110.047 174.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.727 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -103.7 131.08 51.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.953 . . . . 0.35999999999999999 110.823 -175.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.992 HD11 HG22 ' B' ' 12' ' ' VAL . 13.2 mt -108.05 144.48 35.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.372 -0.83 . . . . 0.56000000000000005 109.392 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.684 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.3 tt0 -108.81 138.28 45.39 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.732 -1.23 . . . . 1.1699999999999999 109.517 172.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.3 mt -109.09 131.79 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.419 -0.801 . . . . 0.83999999999999997 110.582 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.614 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.6 m-85 -117.58 159.26 23.18 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.83 -0.433 . . . . 0.45000000000000001 109.83 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.3 t -133.26 120.93 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.876 -1.14 . . . . 0.27000000000000002 110.554 172.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 47.2 p-10 -148.4 159.96 43.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.167 -0.958 . . . . 1.77 110.603 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 53.9 t0 42.29 40.35 1.76 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.025 -1.047 . . . . 1.22 111.599 171.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 84.2 tt0 58.87 14.09 3.1 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.844 -1.16 . . . . 1.9299999999999999 110.567 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.529 ' CE ' HD11 ' A' ' 46' ' ' ILE . 14.0 pttt -127.18 164.45 21.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.96 . . . . 2.0099999999999998 109.691 174.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.595 HG22 HD11 ' A' ' 47' ' ' LEU . 68.9 mt -97.41 134.89 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.137 -0.977 . . . . 1.25 110.322 -176.059 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.614 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 22.3 mm -114.16 119.39 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.674 -0.641 . . . . 0.5 109.857 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.829 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.3 mp -115.95 135.07 54.32 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.021 -1.05 . . . . 1.6599999999999999 110.226 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.594 ' HE3' ' CE2' ' A' ' 39' ' ' TYR . 1.7 ptpm? -141.17 159.08 42.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.439 -0.788 . . . . 1.74 110.389 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -57.75 146.9 29.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.101 -1.0 . . . . 1.6499999999999999 109.96 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.727 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 6.0 t80 . . . . . 0 C--N 1.301 -1.542 0 O-C-N 121.228 -0.92 . . . . 0.34999999999999998 110.524 -176.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 36' ' ' LEU . 96.3 t . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.553 0.692 . . . . 0.37 110.81 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -131.41 160.16 35.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.501 -0.75 . . . . 1.9199999999999999 109.736 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -85.6 148.01 26.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.076 -1.015 . . . . 2.21 110.442 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.992 HG22 HD11 ' A' ' 36' ' ' LEU . 4.4 t -81.9 130.38 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.28999999999999998 109.703 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.9 -174.47 5.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.115 -0.991 . . . . 0.55000000000000004 110.305 -179.35 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -53.66 -41.72 67.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.185 -0.947 . . . . 2.1899999999999999 111.79 -172.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.898 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.6 tp -87.51 -3.28 59.0 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.695 -1.253 . . . . 1.3899999999999999 111.665 -172.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.54 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.81 46.93 7.5 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.477 -1.449 . . . . 0.20999999999999999 109.477 -177.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.935 ' CD ' HG22 ' A' ' 19' ' ' VAL . 76.7 mtm180 -116.29 154.31 30.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.132 -1.217 . . . . 1.1399999999999999 109.864 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.646 HG12 HD13 ' A' ' 36' ' ' LEU . 27.2 m -125.68 153.19 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.28000000000000003 109.937 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.935 HG22 ' CD ' ' A' ' 17' ' ' ARG . 22.5 t -111.61 135.43 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 0.23999999999999999 110.559 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.557 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -83.15 134.23 46.46 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 1.3799999999999999 109.608 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.537 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.3 Cg_endo -57.94 142.82 96.73 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.765 1.403 . . . . 0.35999999999999999 109.992 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.89 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.54 -32.3 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.11 -0.994 . . . . 1.1100000000000001 110.359 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.98 -36.41 72.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.074 -1.016 . . . . 2.3700000000000001 109.794 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.557 ' HB2' HG23 ' B' ' 20' ' ' ILE . 52.3 mt -80.34 -31.62 37.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.494 -0.754 . . . . 1.75 110.574 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.89 ' HD2' HD12 ' B' ' 22' ' ' ILE . 72.3 mtt180 -58.02 -43.46 86.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.896 -1.128 . . . . 0.29999999999999999 109.246 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -73.17 -49.75 26.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 3.27 110.64 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.0 m -63.74 -32.44 73.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.193 -0.942 . . . . 0.77000000000000002 110.785 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.832 HD23 HG13 ' B' ' 30' ' ' ILE . 17.5 tp -87.71 -4.87 58.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.098 -1.001 . . . . 1.05 110.709 -176.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.482 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.04 42.15 94.77 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.624 -1.391 . . . . 0.32000000000000001 109.624 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.832 HG13 HD23 ' B' ' 28' ' ' LEU . 31.2 mm -116.24 137.67 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -1.221 . . . . 0.40999999999999998 110.705 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.16 168.89 18.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.518 -0.739 . . . . 0.23000000000000001 109.997 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.87 145.9 15.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.163 -0.961 . . . . 1.1299999999999999 110.493 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 41.2 tttp 74.13 -4.49 2.28 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.583 -0.698 . . . . 1.8799999999999999 111.179 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.611 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.1 m-20 -77.0 166.0 23.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.755 -1.216 . . . . 1.1000000000000001 109.979 174.814 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.738 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.45 131.19 50.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.35999999999999999 110.855 -175.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.943 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.2 mt -108.2 144.07 36.14 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.328 -0.858 . . . . 0.56000000000000005 109.448 174.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.662 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.0 tt0 -108.32 138.22 44.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.851 -1.155 . . . . 1.1699999999999999 109.729 172.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -109.07 131.87 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.293 -0.879 . . . . 0.83999999999999997 110.507 -171.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.624 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 10.6 m-85 -117.52 159.26 23.14 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 116.264 -0.425 . . . . 0.45000000000000001 109.914 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 74.4 t -133.11 121.37 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.876 -1.14 . . . . 0.26000000000000001 110.441 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 47.2 p-10 -148.93 159.97 43.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 1.77 110.543 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' B' ' 42' ' ' ASP . 54.7 t0 42.09 40.62 1.73 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.126 -0.984 . . . . 1.21 111.577 172.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' B' ' 43' ' ' GLU . 84.1 tt0 58.79 14.03 3.02 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.816 -1.178 . . . . 1.9199999999999999 110.529 174.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.534 ' CE ' HD11 ' B' ' 46' ' ' ILE . 13.9 pttt -127.19 164.65 21.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.089 -1.007 . . . . 2.0 109.571 174.195 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.633 HG22 HD11 ' B' ' 47' ' ' LEU . 68.9 mt -97.48 134.73 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 1.24 110.374 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 22.0 mm -114.15 119.45 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.714 -0.616 . . . . 0.5 109.869 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.818 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.4 mp -115.94 134.86 54.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.03 -1.044 . . . . 1.6599999999999999 110.208 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.58 ' HE3' ' CE2' ' B' ' 39' ' ' TYR . 1.7 ptpm? -140.99 159.3 42.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 1.74 110.316 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -57.9 146.78 30.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.954 . . . . 1.6499999999999999 109.909 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.927 ' CD2' HG11 ' A' ' 9' ' ' VAL . 6.1 t80 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.65000000000000002 110.415 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.6 mt . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.076 0.465 . . . . 1.3600000000000001 110.088 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.076 HG11 ' CD2' ' B' ' 50' ' ' TYR . 85.9 t -120.04 144.37 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.988 -1.07 . . . . 0.37 110.809 -176.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -131.04 161.21 32.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.525 -0.734 . . . . 1.9099999999999999 109.69 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -85.39 148.09 26.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.133 -0.979 . . . . 2.21 110.34 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.908 HG22 HD11 ' B' ' 36' ' ' LEU . 3.6 t -82.93 129.94 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.89 . . . . 0.28000000000000003 109.831 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.8 -175.82 5.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.106 -0.996 . . . . 0.55000000000000004 109.923 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.06 -40.38 70.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.104 -0.997 . . . . 2.1899999999999999 111.677 -173.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.878 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.4 tp -83.25 -6.48 59.49 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.845 -1.159 . . . . 1.3799999999999999 111.539 -173.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.515 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.74 46.47 7.23 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.243 -1.455 . . . . 0.20999999999999999 109.652 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.908 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.7 mtm180 -114.47 154.82 27.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.05 -1.265 . . . . 1.1499999999999999 110.065 -177.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.815 HG12 HD13 ' B' ' 36' ' ' LEU . 19.4 m -123.69 152.56 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.398 -0.814 . . . . 0.28000000000000003 109.86 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.933 HG22 ' CD ' ' B' ' 17' ' ' ARG . 31.2 t -111.77 134.03 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.179 -0.951 . . . . 0.23999999999999999 110.69 -175.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.578 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.63 132.86 50.69 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 1.3799999999999999 109.437 173.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.547 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.7 Cg_endo -57.47 141.29 95.02 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.699 1.368 . . . . 0.34999999999999998 109.83 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.947 ' O ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.75 -31.93 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.107 . . . . 1.1100000000000001 110.303 -177.622 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.15 -36.48 70.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.017 . . . . 2.3700000000000001 109.79 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.578 ' HB2' HG23 ' A' ' 20' ' ' ILE . 52.8 mt -80.86 -29.04 35.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.262 -0.899 . . . . 1.75 110.487 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.71 HH22 HD11 ' B' ' 15' ' ' LEU . 75.8 mtt180 -56.85 -43.65 81.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.879 -1.138 . . . . 0.29999999999999999 109.18 175.34 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -72.85 -50.67 22.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.557 -0.715 . . . . 3.2599999999999998 110.755 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.6 m -63.43 -31.3 72.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.77000000000000002 111.117 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.846 HD23 HG13 ' A' ' 30' ' ' ILE . 26.3 tp -87.55 -4.93 58.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 1.05 110.782 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.464 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.39 42.86 97.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.626 -1.39 . . . . 0.32000000000000001 109.626 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.846 HG13 HD23 ' A' ' 28' ' ' LEU . 29.5 mm -116.12 139.0 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -1.149 . . . . 0.40999999999999998 110.7 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.5 166.99 23.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.625 -0.672 . . . . 0.23000000000000001 109.998 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.2 tt0 -53.41 146.31 12.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.966 . . . . 1.1299999999999999 110.553 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 77.2 tttt 74.86 -4.68 2.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.749 -0.594 . . . . 1.8799999999999999 111.164 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.748 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.4 m-20 -77.16 166.09 23.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.779 -1.2 . . . . 1.1000000000000001 110.044 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.755 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.83 132.57 50.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.941 . . . . 0.35999999999999999 110.855 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.96 HD11 HG22 ' B' ' 12' ' ' VAL . 13.0 mt -109.43 143.65 38.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.397 -0.814 . . . . 0.56000000000000005 109.555 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.667 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.4 tt0 -108.63 140.29 42.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.836 -1.165 . . . . 1.1699999999999999 109.824 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.414 HD13 ' O ' ' A' ' 37' ' ' GLU . 21.5 mm -111.15 133.18 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.435 -0.79 . . . . 0.83999999999999997 110.555 -173.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.582 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 14.4 m-85 -115.16 159.2 21.21 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 120.911 0.386 . . . . 0.45000000000000001 109.972 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.5 t -130.45 128.92 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.931 -1.106 . . . . 0.27000000000000002 110.802 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.663 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.7 p-10 -146.54 129.5 16.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.866 . . . . 1.77 110.215 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 48.9 t0 46.12 50.11 11.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.007 -1.058 . . . . 1.22 110.96 175.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.4 mt-10 59.95 12.69 3.24 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.348 -0.845 . . . . 1.9299999999999999 110.714 176.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 9.6 mtmt -113.12 150.62 31.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 2.0099999999999998 109.811 175.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.634 HG22 HD11 ' A' ' 47' ' ' LEU . 62.8 mt -101.76 128.84 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.058 -1.026 . . . . 1.25 110.327 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.663 HD11 ' OD2' ' A' ' 41' ' ' ASP . 28.8 mt -112.06 121.47 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.391 -0.818 . . . . 0.5 110.14 176.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.843 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.3 mp -114.52 135.02 54.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.073 -1.017 . . . . 1.6599999999999999 110.237 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.541 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 10.6 pttp -141.48 165.0 28.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.454 -0.779 . . . . 1.74 110.273 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -58.2 147.5 30.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.978 . . . . 1.6499999999999999 110.009 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.934 ' CD2' HG11 ' B' ' 9' ' ' VAL . 5.9 t80 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.885 . . . . 0.34999999999999998 110.566 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.943 HG13 ' O ' ' A' ' 36' ' ' LEU . 85.9 t . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.479 0.656 . . . . 0.37 110.779 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -130.86 161.12 32.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.467 -0.771 . . . . 1.9199999999999999 109.845 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -85.43 147.98 26.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 2.21 110.404 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.96 HG22 HD11 ' A' ' 36' ' ' LEU . 3.6 t -82.87 129.99 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.918 . . . . 0.28999999999999998 109.764 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.449 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -83.97 -175.72 5.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.089 -1.007 . . . . 0.55000000000000004 110.087 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.13 -40.43 70.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.183 -0.948 . . . . 2.1899999999999999 111.558 -173.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.891 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.9 tp -83.07 -6.7 59.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.856 -1.152 . . . . 1.3899999999999999 111.563 -173.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.528 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.43 47.2 6.99 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.549 -1.421 . . . . 0.20999999999999999 109.549 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.933 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.9 mtm180 -114.67 154.72 27.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.096 -1.238 . . . . 1.1399999999999999 110.049 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.832 HG12 HD13 ' A' ' 36' ' ' LEU . 19.4 m -123.67 152.55 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.28000000000000003 109.858 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.908 HG22 ' CD ' ' A' ' 17' ' ' ARG . 30.8 t -111.76 134.06 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.13 -0.981 . . . . 0.23999999999999999 110.638 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.598 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.66 132.83 50.69 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 1.3799999999999999 109.392 173.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.7 Cg_endo -57.59 141.23 95.25 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.732 1.385 . . . . 0.35999999999999999 109.918 177.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.945 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.82 -31.71 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.991 -1.068 . . . . 1.1100000000000001 110.262 -177.345 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.03 -37.19 71.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.022 -1.049 . . . . 2.3700000000000001 109.649 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.598 ' HB2' HG23 ' B' ' 20' ' ' ILE . 53.6 mt -80.1 -29.39 39.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.437 -0.789 . . . . 1.75 110.438 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.642 HH22 HD11 ' A' ' 15' ' ' LEU . 75.7 mtt180 -56.75 -43.6 80.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.901 -1.124 . . . . 0.29999999999999999 109.109 175.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -72.72 -51.02 20.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 3.27 110.612 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 48.0 m -63.16 -31.76 72.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -0.869 . . . . 0.77000000000000002 110.944 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.851 HD23 HG13 ' B' ' 30' ' ' ILE . 26.6 tp -87.04 -5.34 59.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.102 -0.999 . . . . 1.05 110.681 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.464 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.67 42.74 97.11 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.539 -1.424 . . . . 0.32000000000000001 109.539 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.851 HG13 HD23 ' B' ' 28' ' ' LEU . 29.3 mm -116.02 138.78 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -1.162 . . . . 0.40999999999999998 110.747 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.18 167.22 22.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.61 -0.681 . . . . 0.23000000000000001 109.907 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.6 146.42 13.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.942 . . . . 1.1299999999999999 110.515 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 77.1 tttt 74.99 -4.9 2.27 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.662 -0.648 . . . . 1.8799999999999999 111.205 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.658 ' O ' HG23 ' A' ' 12' ' ' VAL . 88.7 m-20 -77.34 165.89 23.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.866 -1.146 . . . . 1.1000000000000001 110.065 174.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.755 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.64 132.51 50.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.35999999999999999 110.926 -175.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.937 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.9 mt -109.46 143.4 39.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.449 -0.782 . . . . 0.56000000000000005 109.622 175.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.651 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.3 tt0 -108.4 140.23 41.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.787 -1.195 . . . . 1.1699999999999999 110.017 173.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ILE . . . . . 0.416 HD13 ' O ' ' B' ' 37' ' ' GLU . 21.5 mm -111.03 133.16 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.315 -0.865 . . . . 0.83999999999999997 110.549 -173.302 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.593 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 14.1 m-85 -115.28 159.23 21.28 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 116.308 -0.405 . . . . 0.45000000000000001 109.956 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 81.4 t -130.24 129.21 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.862 -1.149 . . . . 0.26000000000000001 110.612 173.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.662 ' CG ' HD11 ' B' ' 46' ' ' ILE . 9.8 p-10 -146.86 129.44 15.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 1.77 110.2 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 50.0 t0 46.29 50.13 12.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.012 -1.055 . . . . 1.21 110.959 175.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.4 mt-10 59.85 12.73 3.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.275 -0.891 . . . . 1.9199999999999999 110.694 176.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 9.6 mtmt -113.13 150.76 31.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 2.0 109.703 175.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.651 HG22 HD11 ' B' ' 47' ' ' LEU . 62.3 mt -101.77 128.82 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.01 . . . . 1.24 110.391 -176.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.662 HD11 ' CG ' ' B' ' 41' ' ' ASP . 29.9 mt -112.3 121.41 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.38 -0.825 . . . . 0.5 110.099 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.836 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.4 mp -114.42 134.96 54.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.006 -1.059 . . . . 1.6599999999999999 110.173 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.532 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 10.8 pttp -141.42 165.19 28.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 1.74 110.222 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -58.18 147.42 30.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 1.6499999999999999 109.984 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 1.076 ' CD2' HG11 ' A' ' 9' ' ' VAL . 6.0 t80 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.65000000000000002 110.598 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.6 mt . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.09 0.471 . . . . 1.3600000000000001 110.02 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.934 HG11 ' CD2' ' B' ' 50' ' ' TYR . 88.8 t -115.8 143.92 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.089 -1.007 . . . . 0.37 110.806 -176.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -128.27 159.3 35.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.381 -0.824 . . . . 1.9099999999999999 109.613 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -84.21 148.08 26.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.041 -1.037 . . . . 2.21 110.317 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.96 HG22 HD11 ' B' ' 36' ' ' LEU . 4.3 t -82.96 130.0 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.301 -0.874 . . . . 0.28000000000000003 109.885 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.47 -174.74 5.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.55000000000000004 110.025 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.27 -39.5 72.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.009 -1.057 . . . . 2.1899999999999999 111.739 -172.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.853 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.7 tp -85.73 -4.24 59.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.766 -1.209 . . . . 1.3799999999999999 111.629 -173.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.472 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 79.95 46.45 7.72 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.173 -1.489 . . . . 0.20999999999999999 109.687 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.923 ' CD ' HG22 ' B' ' 19' ' ' VAL . 73.7 mtm180 -116.34 154.98 29.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.055 -1.262 . . . . 1.1499999999999999 109.945 -177.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.681 HG12 HD13 ' B' ' 36' ' ' LEU . 22.4 m -123.49 150.67 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.28000000000000003 109.786 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.946 HG22 ' CD ' ' B' ' 17' ' ' ARG . 23.1 t -112.62 134.96 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.23999999999999999 110.578 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.928 HD11 HD13 ' B' ' 45' ' ' ILE . 4.5 mm -84.49 134.42 42.6 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 1.3799999999999999 109.658 176.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.551 ' HG2' HD12 ' A' ' 24' ' ' LEU . 9.9 Cg_endo -58.49 143.67 97.74 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.812 1.428 . . . . 0.34999999999999998 110.089 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.89 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.02 -33.29 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.934 -1.104 . . . . 1.1100000000000001 110.377 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' N ' HG23 ' A' ' 22' ' ' ILE . 84.4 tt0 -58.05 -35.72 71.73 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.107 -0.996 . . . . 2.3700000000000001 109.808 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.574 ' HB2' HG23 ' A' ' 20' ' ' ILE . 52.3 mt -82.48 -29.95 30.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 1.75 110.591 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.89 ' HD2' HD12 ' A' ' 22' ' ' ILE . 71.9 mtt180 -57.6 -43.7 84.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.834 -1.166 . . . . 0.29999999999999999 109.093 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -71.43 -49.44 41.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.568 -0.707 . . . . 3.2599999999999998 110.724 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.1 m -63.32 -32.01 73.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.23 -0.919 . . . . 0.77000000000000002 111.114 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.885 HD23 HG13 ' A' ' 30' ' ' ILE . 22.1 tp -87.78 -4.82 58.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.084 -1.01 . . . . 1.05 110.75 -177.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.437 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.75 42.76 96.99 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.731 -1.348 . . . . 0.32000000000000001 109.731 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.885 HG13 HD23 ' A' ' 28' ' ' LEU . 32.4 mm -116.35 138.91 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -1.183 . . . . 0.40999999999999998 110.794 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.16 167.04 23.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.589 -0.694 . . . . 0.23000000000000001 109.982 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.37 146.48 12.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.082 -1.011 . . . . 1.1299999999999999 110.541 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 75.2 tttt 74.46 -4.64 2.28 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.702 -0.623 . . . . 1.8799999999999999 111.137 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.741 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.6 m-20 -77.41 165.95 23.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.73 -1.231 . . . . 1.1000000000000001 110.051 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.66 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.08 130.69 51.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.2 -0.938 . . . . 0.35999999999999999 110.715 -176.539 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.97 HD11 HG22 ' B' ' 12' ' ' VAL . 12.1 mt -107.89 142.21 38.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.375 -0.828 . . . . 0.56000000000000005 109.367 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.662 ' HA ' HG22 ' B' ' 9' ' ' VAL . 84.8 tt0 -106.25 137.96 43.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.791 -1.193 . . . . 1.1699999999999999 109.787 173.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.39 132.56 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.522 -0.736 . . . . 0.83999999999999997 110.44 -174.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.592 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 16.2 m-85 -115.03 158.04 22.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 122.061 -0.399 . . . . 0.45000000000000001 110.11 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.2 t -129.8 123.97 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.935 -1.103 . . . . 0.27000000000000002 110.739 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.59 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.2 p-10 -147.17 139.03 24.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 1.77 110.263 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.3 t0 43.68 47.22 6.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.021 -1.049 . . . . 1.22 111.159 174.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 44.3 tp10 62.4 10.33 3.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.148 -0.97 . . . . 1.9299999999999999 110.723 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -115.66 148.33 39.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.91 . . . . 2.0099999999999998 109.995 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 1.011 HD13 HD11 ' B' ' 20' ' ' ILE . 58.5 mt -99.6 129.09 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 1.25 110.103 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.0 mt -109.21 115.84 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.378 -0.826 . . . . 0.5 110.141 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.842 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -108.75 133.49 52.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.062 -1.024 . . . . 1.6599999999999999 109.987 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.568 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 13.2 pttp -143.64 165.73 26.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.452 -0.78 . . . . 1.74 110.357 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -56.43 146.99 22.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 1.6499999999999999 109.937 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.801 ' CD2' HG11 ' B' ' 9' ' ' VAL . 6.4 t80 . . . . . 0 C--N 1.298 -1.634 0 O-C-N 121.362 -0.836 . . . . 0.34999999999999998 110.661 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.948 HG13 ' O ' ' A' ' 36' ' ' LEU . 89.9 t . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.541 0.686 . . . . 0.37 110.76 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -128.28 159.09 36.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.494 -0.754 . . . . 1.9199999999999999 109.768 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -84.03 148.03 27.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.042 -1.037 . . . . 2.21 110.403 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.97 HG22 HD11 ' A' ' 36' ' ' LEU . 4.3 t -82.91 130.1 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.33 -0.856 . . . . 0.28999999999999998 109.804 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.69 -174.47 5.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 0.55000000000000004 110.152 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.48 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.9 mt-10 -56.5 -39.45 73.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.086 -1.009 . . . . 2.1899999999999999 111.646 -172.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.891 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.2 tp -85.79 -4.18 59.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.799 -1.188 . . . . 1.3899999999999999 111.595 -173.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.491 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.56 47.19 7.48 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.514 -1.434 . . . . 0.20999999999999999 109.514 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.946 ' CD ' HG22 ' A' ' 19' ' ' VAL . 73.5 mtm180 -116.46 154.98 29.38 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.039 -1.271 . . . . 1.1399999999999999 109.982 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.687 HG12 HD13 ' A' ' 36' ' ' LEU . 22.4 m -123.54 150.59 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 0.28000000000000003 109.804 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.923 HG22 ' CD ' ' A' ' 17' ' ' ARG . 23.0 t -112.64 134.98 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.23999999999999999 110.505 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 1.011 HD11 HD13 ' A' ' 45' ' ' ILE . 4.5 mm -84.62 134.43 42.26 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 1.3799999999999999 109.625 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.547 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.9 Cg_endo -58.67 143.69 98.41 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.811 1.427 . . . . 0.35999999999999999 110.106 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.888 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.2 tp -55.16 -33.08 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.11 -0.993 . . . . 1.1100000000000001 110.364 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' GLU . . . . . 0.409 ' N ' HG23 ' B' ' 22' ' ' ILE . 84.3 tt0 -57.88 -36.35 72.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.09 -1.006 . . . . 2.3700000000000001 109.744 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.568 ' HB2' HG23 ' B' ' 20' ' ' ILE . 52.5 mt -81.74 -30.37 32.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.443 -0.785 . . . . 1.75 110.686 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.888 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.2 mtt180 -57.43 -43.59 83.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.877 -1.14 . . . . 0.29999999999999999 109.087 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -71.25 -49.77 39.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.39 -0.819 . . . . 3.27 110.666 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 51.0 m -63.04 -32.49 73.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.292 -0.88 . . . . 0.77000000000000002 110.946 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.886 HD23 HG13 ' B' ' 30' ' ' ILE . 22.3 tp -87.34 -5.2 58.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 1.05 110.68 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.442 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.05 42.65 96.57 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.538 -1.425 . . . . 0.32000000000000001 109.538 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.886 HG13 HD23 ' B' ' 28' ' ' LEU . 31.9 mm -116.27 138.87 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -1.181 . . . . 0.40999999999999998 110.766 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.91 167.09 23.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.498 -0.751 . . . . 0.23000000000000001 109.968 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.527 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.43 146.48 12.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 1.1299999999999999 110.555 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 75.0 tttt 74.63 -4.76 2.27 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.648 -0.657 . . . . 1.8799999999999999 111.166 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.64 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.2 m-20 -77.49 165.64 24.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.792 -1.193 . . . . 1.1000000000000001 110.042 174.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.638 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.92 130.65 51.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.35999999999999999 110.836 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.96 HD11 HG22 ' A' ' 12' ' ' VAL . 12.0 mt -107.84 142.1 38.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.56000000000000005 109.485 175.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.656 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.7 tt0 -106.08 137.84 43.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.87 -1.144 . . . . 1.1699999999999999 109.911 173.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 71.0 mt -111.25 132.61 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.388 -0.82 . . . . 0.83999999999999997 110.383 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.6 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 15.9 m-85 -115.06 157.92 22.85 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 120.896 0.379 . . . . 0.45000000000000001 110.122 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 94.1 t -129.53 124.3 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.937 -1.102 . . . . 0.26000000000000001 110.55 173.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.601 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.4 p-10 -147.66 138.88 23.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.875 . . . . 1.77 110.208 177.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.9 t0 43.99 47.18 7.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.165 -0.959 . . . . 1.21 111.136 174.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 44.2 tp10 62.21 10.36 3.74 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.234 -0.916 . . . . 1.9199999999999999 110.725 175.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -115.57 148.6 39.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 2.0 109.928 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.928 HD13 HD11 ' A' ' 20' ' ' ILE . 58.2 mt -99.76 129.16 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 1.24 110.096 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.601 HD11 ' OD2' ' B' ' 41' ' ' ASP . 21.7 mt -109.39 115.8 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.472 -0.767 . . . . 0.5 110.136 177.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.842 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.3 mp -108.55 133.4 52.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.028 -1.045 . . . . 1.6599999999999999 109.934 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.572 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 13.5 pttp -143.65 165.96 26.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.447 -0.783 . . . . 1.74 110.294 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -56.48 146.94 23.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.95 . . . . 1.6499999999999999 109.92 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.934 ' CD2' HG11 ' A' ' 9' ' ' VAL . 6.5 t80 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.65000000000000002 110.529 -175.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.0 mm . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 120.996 0.427 . . . . 1.3600000000000001 109.947 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.102 HG11 ' CD2' ' B' ' 50' ' ' TYR . 87.1 t -116.13 143.91 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.101 -0.999 . . . . 0.37 110.842 -175.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.401 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 17.4 tpt180 -128.07 157.11 41.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.472 -0.767 . . . . 1.9099999999999999 109.789 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 26.0 ttpt -83.14 144.97 29.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.141 -0.974 . . . . 2.21 110.35 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.984 HG22 HD11 ' B' ' 36' ' ' LEU . 4.0 t -80.55 128.68 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.337 -0.852 . . . . 0.28000000000000003 109.762 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.53 -175.01 5.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.55000000000000004 110.021 179.71 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.52 -40.56 68.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.097 -1.002 . . . . 2.1899999999999999 111.728 -173.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.872 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.8 tp -85.32 -4.18 59.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.798 -1.189 . . . . 1.3799999999999999 111.611 -173.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.29 46.18 7.67 Favored Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.133 -1.508 . . . . 0.20999999999999999 109.68 -177.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.931 ' CD ' HG22 ' B' ' 19' ' ' VAL . 73.1 mtm180 -116.15 154.72 29.51 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.012 -1.287 . . . . 1.1499999999999999 109.818 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.674 HG12 ' CD1' ' B' ' 36' ' ' LEU . 22.5 m -124.49 152.35 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.28000000000000003 110.001 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.953 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.5 t -113.71 133.95 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.23999999999999999 110.571 -175.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.653 HD11 HD13 ' B' ' 45' ' ' ILE . 2.5 mm -85.04 138.09 37.21 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.227 -0.921 . . . . 1.3799999999999999 109.636 175.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.7 Cg_endo -59.68 142.94 99.62 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.71 1.374 . . . . 0.34999999999999998 109.972 176.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.918 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.22 -32.39 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.962 -1.086 . . . . 1.1100000000000001 110.478 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -58.14 -35.67 71.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.147 -0.971 . . . . 2.3700000000000001 109.915 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.612 ' HB2' HG23 ' A' ' 20' ' ' ILE . 63.2 mt -82.21 -30.35 30.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 1.75 110.614 178.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.918 ' HD2' HD12 ' A' ' 22' ' ' ILE . 74.2 mtt180 -57.77 -43.86 85.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.926 -1.109 . . . . 0.29999999999999999 109.113 176.031 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -72.97 -48.48 36.26 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.848 -0.741 . . . . 3.2599999999999998 110.723 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.6 m -63.72 -31.57 72.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 0.77000000000000002 111.135 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.815 HD23 HG13 ' A' ' 30' ' ' ILE . 19.2 tp -87.94 -4.53 58.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.026 -1.046 . . . . 1.05 110.795 -177.066 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.09 40.87 95.24 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.714 -1.354 . . . . 0.32000000000000001 109.714 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.815 HG13 HD23 ' A' ' 28' ' ' LEU . 36.5 mm -116.54 139.03 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -1.123 . . . . 0.40999999999999998 110.632 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.0 166.76 23.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.623 -0.673 . . . . 0.23000000000000001 109.978 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.58 146.54 12.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.102 -0.999 . . . . 1.1299999999999999 110.534 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 19.9 tttt 74.96 -4.95 2.26 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.733 -0.605 . . . . 1.8799999999999999 111.12 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.712 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.9 m-20 -78.18 165.81 23.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.902 -1.124 . . . . 1.1000000000000001 110.054 174.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.745 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.61 131.01 52.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.35999999999999999 110.726 -176.463 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.932 ' O ' HG13 ' B' ' 9' ' ' VAL . 13.5 mt -107.87 142.66 37.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.825 . . . . 0.56000000000000005 109.458 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.687 ' HA ' HG22 ' B' ' 9' ' ' VAL . 84.8 tt0 -106.58 138.88 41.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.805 -1.184 . . . . 1.1699999999999999 109.685 172.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 68.4 mt -111.37 133.39 57.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.393 -0.817 . . . . 0.83999999999999997 110.561 -173.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.576 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 14.9 m-85 -114.81 157.94 22.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.99 -0.374 . . . . 0.45000000000000001 109.99 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.1 t -130.7 120.43 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.942 -1.098 . . . . 0.27000000000000002 110.664 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.549 ' OD2' HD11 ' A' ' 46' ' ' ILE . 5.9 p-10 -147.35 155.14 41.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 1.77 110.189 177.151 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 54.0 t0 42.38 41.75 2.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.06 -1.025 . . . . 1.22 111.345 172.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 46.5 tp10 60.81 12.34 3.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.031 -1.043 . . . . 1.9299999999999999 110.778 174.433 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 19.3 pttt -128.77 161.29 30.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.114 -0.992 . . . . 2.0099999999999998 109.848 174.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.816 HD13 HD11 ' B' ' 20' ' ' ILE . 56.5 mt -104.04 134.99 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.055 -1.028 . . . . 1.25 110.717 -172.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 25.1 mt -111.33 121.36 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.46 -0.775 . . . . 0.5 110.272 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.846 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.4 mp -112.06 133.84 53.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.986 -1.071 . . . . 1.6599999999999999 110.117 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.543 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 14.0 pttp -141.6 166.08 25.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.45 -0.781 . . . . 1.74 110.359 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -55.94 147.73 18.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.196 -0.94 . . . . 1.6499999999999999 110.077 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.95 ' CD2' HG11 ' B' ' 9' ' ' VAL . 4.4 t80 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.833 . . . . 0.34999999999999998 110.73 -175.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.95 HG11 ' CD2' ' A' ' 50' ' ' TYR . 87.1 t . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.527 0.68 . . . . 0.37 110.736 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 17.4 tpt180 -128.12 156.82 42.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.743 . . . . 1.9199999999999999 109.892 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.4 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 26.1 ttpt -82.93 144.85 29.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.102 -0.999 . . . . 2.21 110.414 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.927 HG22 HD11 ' A' ' 36' ' ' LEU . 4.0 t -80.56 128.88 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.367 -0.833 . . . . 0.28999999999999998 109.642 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -83.79 -174.9 5.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.045 -1.035 . . . . 0.55000000000000004 110.177 179.613 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.65 -40.48 69.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.191 -0.943 . . . . 2.1899999999999999 111.648 -173.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.898 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.4 tp -85.34 -4.22 59.09 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.755 -1.215 . . . . 1.3899999999999999 111.647 -172.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.53 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.97 46.86 7.45 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.54 -1.424 . . . . 0.20999999999999999 109.54 -177.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.953 ' CD ' HG22 ' A' ' 19' ' ' VAL . 72.6 mtm180 -116.33 154.69 29.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.153 -1.204 . . . . 1.1399999999999999 109.831 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.673 HG12 ' CD1' ' A' ' 36' ' ' LEU . 22.6 m -124.48 152.33 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.92 . . . . 0.28000000000000003 110.004 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.931 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.6 t -113.72 133.96 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.23999999999999999 110.542 -175.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.816 HD11 HD13 ' A' ' 45' ' ' ILE . 2.5 mm -85.11 138.1 37.04 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.219 -0.925 . . . . 1.3799999999999999 109.593 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.7 Cg_endo -59.78 142.91 99.54 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.755 1.397 . . . . 0.35999999999999999 110.043 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.919 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -55.28 -32.25 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.027 -1.046 . . . . 1.1100000000000001 110.44 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -57.99 -36.27 72.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.091 -1.006 . . . . 2.3700000000000001 109.811 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.598 ' HB2' HG23 ' B' ' 20' ' ' ILE . 63.2 mt -81.62 -30.76 32.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.401 -0.812 . . . . 1.75 110.601 178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.919 ' HD2' HD12 ' B' ' 22' ' ' ILE . 73.8 mtt180 -57.54 -43.68 84.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.875 -1.141 . . . . 0.29999999999999999 109.207 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -72.96 -48.71 34.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.898 . . . . 3.27 110.61 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 52.0 m -63.45 -32.22 73.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.282 -0.886 . . . . 0.77000000000000002 110.895 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.815 HD23 HG13 ' B' ' 30' ' ' ILE . 19.4 tp -87.5 -4.79 58.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 1.05 110.711 -176.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.404 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.56 40.64 94.25 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.588 -1.405 . . . . 0.32000000000000001 109.588 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.815 HG13 HD23 ' B' ' 28' ' ' LEU . 36.2 mm -116.52 138.9 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -1.13 . . . . 0.40999999999999998 110.634 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.73 166.87 23.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.598 -0.689 . . . . 0.23000000000000001 109.991 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.4 tt0 -53.6 146.72 12.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 1.1299999999999999 110.421 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 19.8 tttt 75.03 -5.16 2.22 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.622 -0.674 . . . . 1.8799999999999999 111.123 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.617 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.6 m-20 -78.19 165.66 23.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.816 -1.178 . . . . 1.1000000000000001 110.03 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.751 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.55 130.92 52.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.35999999999999999 110.776 -176.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.984 HD11 HG22 ' A' ' 12' ' ' VAL . 13.3 mt -107.9 142.52 37.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.386 -0.821 . . . . 0.56000000000000005 109.494 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.666 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.7 tt0 -106.42 138.91 41.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.841 -1.162 . . . . 1.1699999999999999 109.832 172.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 68.5 mt -111.42 133.41 57.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.289 -0.882 . . . . 0.83999999999999997 110.469 -173.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.589 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 14.4 m-85 -114.77 157.86 22.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 122.096 -0.377 . . . . 0.45000000000000001 110.07 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 93.7 t -130.42 120.84 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.899 -1.126 . . . . 0.26000000000000001 110.464 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.549 ' OD2' HD11 ' B' ' 46' ' ' ILE . 6.0 p-10 -147.91 155.19 41.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 1.77 110.157 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 54.5 t0 42.19 41.99 2.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.115 -0.991 . . . . 1.21 111.375 173.025 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 46.3 tp10 60.75 12.3 3.66 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.088 -1.008 . . . . 1.9199999999999999 110.7 174.403 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 19.1 pttt -128.78 161.54 29.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.009 . . . . 2.0 109.775 174.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.653 HD13 HD11 ' A' ' 20' ' ' ILE . 56.8 mt -104.16 135.03 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.061 -1.024 . . . . 1.24 110.665 -172.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 25.8 mt -111.6 121.32 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.455 -0.778 . . . . 0.5 110.181 176.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.842 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.5 mp -111.89 133.76 53.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.03 -1.044 . . . . 1.6599999999999999 110.075 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.536 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 14.2 pttp -141.61 166.36 24.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.429 -0.794 . . . . 1.74 110.27 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -56.09 147.72 19.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 1.6499999999999999 109.974 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 1.102 ' CD2' HG11 ' A' ' 9' ' ' VAL . 4.5 t80 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.65000000000000002 110.646 -175.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.9 mt . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.021 0.439 . . . . 1.3600000000000001 109.983 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.935 HG13 ' O ' ' B' ' 36' ' ' LEU . 99.0 t -114.29 144.58 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.025 -1.047 . . . . 0.37 110.915 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -129.75 160.79 32.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.458 -0.776 . . . . 1.9099999999999999 109.753 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -85.05 148.09 26.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.036 -1.04 . . . . 2.21 110.311 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.978 HG22 HD11 ' B' ' 36' ' ' LEU . 6.5 t -81.49 129.73 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.317 -0.865 . . . . 0.28000000000000003 109.821 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.29 -175.09 5.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.124 -0.985 . . . . 0.55000000000000004 109.941 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.07 -39.31 71.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 2.1899999999999999 111.723 -172.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.863 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.4 tp -86.01 -5.03 59.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.803 -1.186 . . . . 1.3799999999999999 111.5 -173.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.499 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.14 46.52 7.56 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.144 -1.503 . . . . 0.20999999999999999 109.699 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.906 ' CD ' HG22 ' B' ' 19' ' ' VAL . 73.8 mtm180 -115.6 154.85 28.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.005 -1.291 . . . . 1.1499999999999999 110.036 -177.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.749 HG12 HD13 ' B' ' 36' ' ' LEU . 24.8 m -124.3 151.72 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 0.28000000000000003 109.855 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.923 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.2 t -113.22 135.18 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 0.23999999999999999 110.601 -175.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.34 135.12 44.42 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 1.3799999999999999 109.532 175.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.555 ' HG2' HD12 ' A' ' 24' ' ' LEU . 10.0 Cg_endo -58.64 143.34 98.6 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.734 1.386 . . . . 0.34999999999999998 110.046 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.905 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.1 tp -55.08 -33.32 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.082 -1.012 . . . . 1.1100000000000001 110.429 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 22' ' ' ILE . 84.4 tt0 -58.2 -35.34 71.48 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.17 -0.956 . . . . 2.3700000000000001 109.893 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.555 HD12 ' HG2' ' A' ' 21' ' ' PRO . 50.0 mt -82.35 -29.97 30.66 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.35 -0.844 . . . . 1.75 110.65 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.905 ' HD2' HD12 ' A' ' 22' ' ' ILE . 71.4 mtt180 -57.74 -44.15 85.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.939 -1.1 . . . . 0.29999999999999999 109.087 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -72.63 -47.81 44.63 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.818 -0.753 . . . . 3.2599999999999998 110.756 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.1 m -63.68 -31.87 73.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.77000000000000002 111.093 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.875 HD23 HG13 ' A' ' 30' ' ' ILE . 20.8 tp -87.69 -4.6 58.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.1 -1.0 . . . . 1.05 110.669 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.453 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.25 41.47 96.77 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.637 -1.385 . . . . 0.32000000000000001 109.637 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.875 HG13 HD23 ' A' ' 28' ' ' LEU . 30.1 mm -116.4 139.75 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -1.144 . . . . 0.40999999999999998 110.654 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.91 167.19 22.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.567 -0.708 . . . . 0.23000000000000001 110.025 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.26 146.79 11.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.058 -1.026 . . . . 1.1299999999999999 110.54 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 12.9 tttp 74.22 -4.58 2.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.743 -0.598 . . . . 1.8799999999999999 111.273 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.716 ' O ' HG23 ' B' ' 12' ' ' VAL . 87.8 m-20 -77.01 166.63 23.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.751 -1.218 . . . . 1.1000000000000001 109.973 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.706 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -103.29 131.6 50.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 0.35999999999999999 110.757 -175.712 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 1.014 HD11 HG22 ' B' ' 12' ' ' VAL . 13.0 mt -108.76 144.3 36.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.342 -0.849 . . . . 0.56000000000000005 109.307 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.642 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.6 tt0 -108.37 138.34 44.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.856 -1.152 . . . . 1.1699999999999999 109.646 173.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.5 mt -107.87 131.31 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.489 -0.757 . . . . 0.83999999999999997 110.415 -173.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.605 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 21.4 m-85 -118.85 156.79 28.84 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 120.927 0.394 . . . . 0.45000000000000001 109.963 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.2 t -130.82 126.68 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.848 -1.158 . . . . 0.27000000000000002 110.642 173.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.487 ' OD1' HG12 ' A' ' 46' ' ' ILE . 41.9 p-10 -147.23 142.23 27.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 1.77 110.607 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 52.3 t0 43.37 45.14 5.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.09 -1.006 . . . . 1.22 111.271 174.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.7 tt0 60.81 11.88 3.47 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.104 -0.997 . . . . 1.9299999999999999 110.608 175.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 54.1 mtmt -114.4 153.92 29.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 2.0099999999999998 109.628 175.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.929 HG22 HD11 ' A' ' 47' ' ' LEU . 67.8 mt -94.54 129.95 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.153 -0.967 . . . . 1.25 110.138 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.605 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 24.6 mm -113.15 121.79 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.659 -0.651 . . . . 0.5 109.877 178.141 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.929 HD11 HG22 ' A' ' 45' ' ' ILE . 4.0 mp -122.55 134.53 54.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.895 -1.128 . . . . 1.6599999999999999 110.262 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.538 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 14.0 pttp -141.73 162.68 34.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 1.74 110.435 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.4 tttt -58.82 146.89 35.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 1.6499999999999999 110.011 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.738 ' CD2' HG11 ' B' ' 9' ' ' VAL . 10.3 t80 . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.34999999999999998 110.586 -176.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.943 HG13 ' O ' ' A' ' 36' ' ' LEU . 98.5 t . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.583 0.706 . . . . 0.37 110.898 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -129.75 160.72 32.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.483 -0.76 . . . . 1.9199999999999999 109.707 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -85.16 148.02 26.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.962 -1.086 . . . . 2.21 110.331 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 1.014 HG22 HD11 ' A' ' 36' ' ' LEU . 6.6 t -81.47 129.85 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.369 -0.832 . . . . 0.28999999999999998 109.734 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.48 -174.83 5.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.148 -0.97 . . . . 0.55000000000000004 110.136 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.475 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.8 mt-10 -56.28 -39.28 72.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.057 . . . . 2.1899999999999999 111.569 -172.178 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.904 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.0 tp -86.05 -4.98 59.29 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.715 -1.241 . . . . 1.3899999999999999 111.52 -173.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.5 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.63 47.31 7.37 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.592 -1.403 . . . . 0.20999999999999999 109.592 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.923 ' CD ' HG22 ' A' ' 19' ' ' VAL . 73.8 mtm180 -115.79 154.87 28.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.1 -1.235 . . . . 1.1399999999999999 110.155 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.741 HG12 HD13 ' A' ' 36' ' ' LEU . 24.9 m -124.43 151.65 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.28000000000000003 109.814 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.906 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.2 t -113.17 135.17 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.23999999999999999 110.644 -175.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -83.33 135.0 44.56 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 1.3799999999999999 109.588 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.544 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.0 Cg_endo -58.71 143.37 98.82 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.749 1.394 . . . . 0.35999999999999999 110.169 177.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.903 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -55.08 -33.3 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.086 -1.009 . . . . 1.1100000000000001 110.372 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 23' ' ' GLU . . . . . 0.409 ' N ' HG23 ' B' ' 22' ' ' ILE . 84.4 tt0 -57.97 -36.15 72.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.023 -1.048 . . . . 2.3700000000000001 109.708 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.55 ' HB2' HG23 ' B' ' 20' ' ' ILE . 50.4 mt -81.49 -30.42 33.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.519 -0.738 . . . . 1.75 110.668 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.903 ' HD2' HD12 ' B' ' 22' ' ' ILE . 70.8 mtt180 -57.44 -44.1 84.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.834 -1.166 . . . . 0.29999999999999999 109.098 176.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -72.56 -48.1 42.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.431 -0.793 . . . . 3.27 110.645 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.5 m -63.36 -32.55 74.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.288 -0.883 . . . . 0.77000000000000002 110.857 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.892 HD23 HG13 ' B' ' 30' ' ' ILE . 20.9 tp -87.09 -5.0 59.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.052 -1.03 . . . . 1.05 110.678 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.46 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.57 41.33 96.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.564 -1.414 . . . . 0.32000000000000001 109.564 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.892 HG13 HD23 ' B' ' 28' ' ' LEU . 30.0 mm -116.33 139.57 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -1.182 . . . . 0.40999999999999998 110.717 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.58 167.3 22.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.471 -0.768 . . . . 0.23000000000000001 110.057 -177.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.12 146.74 10.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 1.1299999999999999 110.572 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 12.9 tttp 74.4 -4.89 2.21 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.657 -0.652 . . . . 1.8799999999999999 111.198 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.615 ' O ' HG23 ' A' ' 12' ' ' VAL . 88.2 m-20 -76.98 166.35 23.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.819 -1.176 . . . . 1.1000000000000001 110.039 174.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.719 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.04 131.53 49.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.35999999999999999 110.877 -175.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.978 HD11 HG22 ' A' ' 12' ' ' VAL . 12.9 mt -108.84 144.11 37.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.428 -0.795 . . . . 0.56000000000000005 109.362 174.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.624 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.4 tt0 -108.06 138.34 44.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.854 -1.154 . . . . 1.1699999999999999 109.847 172.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -107.87 131.37 58.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.405 -0.809 . . . . 0.83999999999999997 110.354 -173.031 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.608 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 21.1 m-85 -118.9 156.86 28.77 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.885 -0.413 . . . . 0.45000000000000001 109.885 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 74.8 t -130.71 127.08 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.854 -1.154 . . . . 0.26000000000000001 110.471 173.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.496 ' OD1' HG12 ' B' ' 46' ' ' ILE . 41.9 p-10 -147.69 142.22 26.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.883 . . . . 1.77 110.525 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.0 t0 43.32 45.46 5.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.087 -1.008 . . . . 1.21 111.217 174.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.5 tt0 60.44 12.05 3.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.081 -1.012 . . . . 1.9199999999999999 110.611 175.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 54.1 mtmt -114.41 154.01 28.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.162 -0.961 . . . . 2.0 109.633 175.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.927 HG22 HD11 ' B' ' 47' ' ' LEU . 67.3 mt -94.51 129.72 44.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.108 -0.995 . . . . 1.24 110.227 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.608 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 24.6 mm -113.28 121.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.681 -0.637 . . . . 0.5 109.823 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.927 HD11 HG22 ' B' ' 45' ' ' ILE . 4.1 mp -122.44 134.46 54.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.892 -1.13 . . . . 1.6599999999999999 110.271 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.542 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 14.1 pttp -141.62 162.84 34.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 1.74 110.435 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 43.2 tttt -58.81 146.72 36.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 1.6499999999999999 110.015 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.901 ' CD2' HG11 ' A' ' 9' ' ' VAL . 10.5 t80 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.65000000000000002 110.575 -176.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.0 mt . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.083 0.468 . . . . 1.3600000000000001 109.982 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.016 HG11 ' CD2' ' B' ' 50' ' ' TYR . 98.2 t -114.03 144.29 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.048 -1.032 . . . . 0.37 110.871 -176.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 28.9 tpt180 -130.03 158.62 39.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.513 -0.742 . . . . 1.9099999999999999 109.727 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.422 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 66.4 mmtt -85.44 148.18 26.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.006 . . . . 2.21 110.258 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.97 HG22 HD11 ' B' ' 36' ' ' LEU . 3.7 t -81.65 128.83 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.274 -0.891 . . . . 0.28000000000000003 109.778 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.45 -175.09 5.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.087 -1.008 . . . . 0.55000000000000004 110.061 -179.698 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -54.24 -41.13 68.4 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.114 -0.991 . . . . 2.1899999999999999 111.7 -173.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.886 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.7 tp -84.83 -5.31 59.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.656 -1.278 . . . . 1.3799999999999999 111.59 -173.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.516 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.26 46.45 7.53 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.136 -1.507 . . . . 0.20999999999999999 109.716 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.906 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.2 mtm180 -114.77 153.94 29.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.093 -1.239 . . . . 1.1499999999999999 110.031 -177.351 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.672 HG12 HD13 ' B' ' 36' ' ' LEU . 22.1 m -123.91 152.21 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.28000000000000003 109.83 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.921 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.3 t -112.93 133.97 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.947 . . . . 0.23999999999999999 110.742 -175.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.671 HD11 HD13 ' B' ' 45' ' ' ILE . 2.4 mm -84.22 133.04 45.92 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.175 -0.953 . . . . 1.3799999999999999 109.446 174.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.8 Cg_endo -57.63 141.39 95.37 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.646 1.34 . . . . 0.34999999999999998 109.957 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.93 ' O ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.81 -32.37 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.008 -1.058 . . . . 1.1100000000000001 110.301 -177.395 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.27 -36.35 70.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.018 -1.051 . . . . 2.3700000000000001 109.747 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.559 ' HB2' HG23 ' A' ' 20' ' ' ILE . 43.4 mt -80.87 -29.22 35.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 1.75 110.449 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.706 HH22 HD11 ' B' ' 15' ' ' LEU . 73.7 mtt180 -56.79 -44.03 81.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.864 -1.148 . . . . 0.29999999999999999 108.97 175.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.6 mmt180 -72.49 -47.68 46.69 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.826 -0.749 . . . . 3.2599999999999998 110.726 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.9 m -63.19 -32.45 73.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.202 -0.937 . . . . 0.77000000000000002 111.061 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.778 HD23 HG13 ' A' ' 30' ' ' ILE . 20.5 tp -88.56 -4.62 58.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.07 -1.019 . . . . 1.05 110.801 -177.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.415 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.98 41.82 95.08 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.732 -1.347 . . . . 0.32000000000000001 109.732 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.778 HG13 HD23 ' A' ' 28' ' ' LEU . 32.7 mm -116.52 139.49 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.27 -1.135 . . . . 0.40999999999999998 110.744 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.72 166.46 24.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.619 -0.675 . . . . 0.23000000000000001 110.006 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.73 146.51 13.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.027 -1.045 . . . . 1.1299999999999999 110.511 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 40.3 tttp 74.59 -4.56 2.31 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.684 -0.635 . . . . 1.8799999999999999 111.114 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.702 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.9 m-20 -76.87 165.87 24.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.782 -1.199 . . . . 1.1000000000000001 109.966 174.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.767 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.72 131.19 52.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.35999999999999999 110.771 -176.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.964 HD11 HG22 ' B' ' 12' ' ' VAL . 13.0 mt -108.66 144.1 36.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.33 -0.856 . . . . 0.56000000000000005 109.341 174.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.691 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.8 tt0 -106.59 139.02 41.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.744 -1.223 . . . . 1.1699999999999999 109.491 172.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.49 131.27 59.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.423 -0.798 . . . . 0.83999999999999997 110.504 -172.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.612 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 16.7 m-85 -117.67 157.46 26.41 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 116.263 -0.426 . . . . 0.45000000000000001 109.915 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.2 t -131.78 120.09 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.903 -1.123 . . . . 0.27000000000000002 110.617 172.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 46.7 p-10 -148.32 161.93 40.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.274 -0.891 . . . . 1.77 110.586 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 54.0 t0 42.25 40.57 1.81 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.002 -1.061 . . . . 1.22 111.446 172.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 96.1 mt-10 56.53 16.18 2.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.941 -1.099 . . . . 1.9299999999999999 110.556 175.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 11.3 pttt -128.98 165.48 21.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 2.0099999999999998 109.734 174.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.818 HD13 HD11 ' B' ' 20' ' ' ILE . 67.7 mt -96.71 133.85 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.178 -0.951 . . . . 1.25 110.395 -175.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.612 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 23.5 mm -113.46 120.09 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.747 -0.596 . . . . 0.5 109.927 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.829 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.0 mp -118.52 134.34 55.16 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.888 -1.133 . . . . 1.6599999999999999 110.136 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.522 ' HE2' ' CE1' ' A' ' 39' ' ' TYR . 22.8 pttt -140.52 162.49 35.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.357 -0.839 . . . . 1.74 110.492 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -57.59 147.96 25.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.001 . . . . 1.6499999999999999 109.902 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.815 ' CD2' HG11 ' B' ' 9' ' ' VAL . 3.5 t80 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.34999999999999998 110.466 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 36' ' ' LEU . 98.5 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.526 0.679 . . . . 0.37 110.87 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 29.0 tpt180 -129.96 158.53 39.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.504 -0.747 . . . . 1.9199999999999999 109.767 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.422 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 66.4 mmtt -85.49 148.09 26.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 2.21 110.319 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.964 HG22 HD11 ' A' ' 36' ' ' LEU . 3.7 t -81.59 128.85 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 0.28999999999999998 109.79 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.66 -174.99 5.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.157 -0.964 . . . . 0.55000000000000004 110.197 -179.795 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.36 -40.99 68.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.104 -0.997 . . . . 2.1899999999999999 111.597 -172.841 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.912 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.4 tp -84.82 -5.47 59.33 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.743 -1.223 . . . . 1.3899999999999999 111.583 -173.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.532 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.93 47.25 7.24 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.529 -1.428 . . . . 0.20999999999999999 109.529 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.921 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.0 mtm180 -114.99 153.89 29.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.089 -1.242 . . . . 1.1399999999999999 109.98 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.732 HG21 ' CD2' ' A' ' 47' ' ' LEU . 22.3 m -123.88 152.2 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 0.28000000000000003 109.807 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.906 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.3 t -112.95 134.04 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.137 -0.977 . . . . 0.23999999999999999 110.598 -175.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.818 HD11 HD13 ' A' ' 45' ' ' ILE . 2.5 mm -84.33 133.0 45.72 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 1.3799999999999999 109.41 174.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.7 Cg_endo -57.58 141.4 95.26 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.763 1.402 . . . . 0.35999999999999999 109.963 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.939 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -56.04 -32.08 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.994 -1.066 . . . . 1.1100000000000001 110.316 -177.217 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.19 -37.01 71.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.034 -1.041 . . . . 2.3700000000000001 109.667 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.553 ' HB2' HG23 ' B' ' 20' ' ' ILE . 43.4 mt -80.08 -29.6 39.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.516 -0.74 . . . . 1.75 110.48 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.607 HH22 HD11 ' A' ' 15' ' ' LEU . 73.4 mtt180 -56.67 -43.81 80.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.966 -1.084 . . . . 0.29999999999999999 109.076 175.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -72.51 -47.99 44.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 3.27 110.591 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.2 m -62.88 -32.9 74.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.183 -0.948 . . . . 0.77000000000000002 110.875 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.781 HD23 HG13 ' B' ' 30' ' ' ILE . 20.6 tp -88.16 -5.0 58.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.032 -1.043 . . . . 1.05 110.736 -176.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.423 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.41 41.46 94.38 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.656 -1.378 . . . . 0.32000000000000001 109.656 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.781 HG13 HD23 ' B' ' 28' ' ' LEU . 32.2 mm -116.48 139.36 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -1.153 . . . . 0.40999999999999998 110.728 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.43 166.6 24.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.632 -0.668 . . . . 0.23000000000000001 109.985 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.62 146.45 13.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.102 -0.999 . . . . 1.1299999999999999 110.55 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 40.3 tttp 74.67 -4.73 2.28 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.579 -0.701 . . . . 1.8799999999999999 111.194 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.586 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.0 m-20 -76.93 165.59 24.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.805 -1.184 . . . . 1.1000000000000001 110.023 174.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.747 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.53 131.17 52.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.35999999999999999 110.834 -176.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.97 HD11 HG22 ' A' ' 12' ' ' VAL . 12.9 mt -108.68 143.71 37.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.37 -0.831 . . . . 0.56000000000000005 109.481 174.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.663 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.5 tt0 -106.18 138.88 41.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.839 -1.163 . . . . 1.1699999999999999 109.786 172.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.4 131.34 59.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.348 -0.845 . . . . 0.83999999999999997 110.494 -171.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.613 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 16.5 m-85 -117.67 157.45 26.44 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 116.257 -0.428 . . . . 0.45000000000000001 109.904 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 75.0 t -131.69 120.51 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.868 -1.145 . . . . 0.26000000000000001 110.436 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.498 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 46.6 p-10 -148.96 161.95 40.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.205 -0.934 . . . . 1.77 110.533 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' B' ' 42' ' ' ASP . 54.4 t0 42.02 41.0 1.8 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.185 -0.947 . . . . 1.21 111.461 172.48 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 96.1 mt-10 56.32 16.12 2.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.926 -1.109 . . . . 1.9199999999999999 110.584 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 11.2 pttt -128.96 165.67 20.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 2.0 109.666 174.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.735 HG22 HD11 ' B' ' 47' ' ' LEU . 68.0 mt -96.82 133.83 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 1.24 110.363 -175.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 23.1 mm -113.53 120.17 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.739 -0.601 . . . . 0.5 109.865 177.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.833 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.1 mp -118.46 134.14 55.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.899 -1.125 . . . . 1.6599999999999999 110.174 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.516 ' HE2' ' CE1' ' B' ' 39' ' ' TYR . 23.3 pttt -140.41 162.55 35.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 1.74 110.371 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -57.47 147.82 25.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.977 . . . . 1.6499999999999999 109.871 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 1.016 ' CD2' HG11 ' A' ' 9' ' ' VAL . 3.6 t80 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.908 . . . . 0.65000000000000002 110.551 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.7 mt . . . . . 0 N--CA 1.494 1.775 0 N-CA-C 109.636 -0.505 . . . . 1.3600000000000001 109.636 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.906 HG13 ' O ' ' B' ' 36' ' ' LEU . 98.5 t -113.51 143.75 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.911 -1.118 . . . . 0.37 111.348 -171.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.43 ' NE ' ' HB ' ' A' ' 19' ' ' VAL . 59.5 ttm-85 -123.82 161.17 25.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.539 -0.725 . . . . 1.9099999999999999 109.621 176.809 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' B' ' 33' ' ' LYS . 82.1 tttt -82.54 145.01 29.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.138 -0.976 . . . . 2.21 110.563 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.908 HG22 HD11 ' B' ' 36' ' ' LEU . 4.1 t -82.97 129.38 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.412 -0.805 . . . . 0.28000000000000003 109.881 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.11 -175.06 5.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.55000000000000004 109.901 179.309 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.94 -39.28 74.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.991 -1.068 . . . . 2.1899999999999999 111.61 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.903 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.2 tp -83.47 -6.23 59.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.755 -1.215 . . . . 1.3799999999999999 111.542 -174.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.479 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 79.98 46.46 7.69 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.193 -1.479 . . . . 0.20999999999999999 109.648 -177.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.908 ' CD ' HG22 ' B' ' 19' ' ' VAL . 68.4 mtm180 -114.12 156.15 24.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.076 -1.249 . . . . 1.1499999999999999 110.019 -177.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.856 HG12 HD13 ' B' ' 36' ' ' LEU . 16.8 m -124.53 153.35 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.28000000000000003 109.805 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.938 HG22 ' CD ' ' B' ' 17' ' ' ARG . 35.2 t -111.06 134.47 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.23999999999999999 110.536 -176.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.39 133.38 50.32 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.314 -0.867 . . . . 1.3799999999999999 109.433 174.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.1 Cg_endo -57.18 142.86 94.54 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.761 1.401 . . . . 0.34999999999999998 110.018 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.861 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.28 -32.69 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.977 -1.077 . . . . 1.1100000000000001 110.357 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.22 -35.93 72.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.096 -1.002 . . . . 2.3700000000000001 109.839 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.563 ' HB2' HG23 ' A' ' 20' ' ' ILE . 48.7 mt -80.41 -31.4 37.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.818 . . . . 1.75 110.537 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.861 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.3 mtt180 -58.09 -43.38 87.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.883 -1.136 . . . . 0.29999999999999999 109.243 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -73.57 -49.95 23.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.767 . . . . 3.2599999999999998 110.804 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m -64.42 -30.97 72.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.24 -0.912 . . . . 0.77000000000000002 111.16 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.922 HD23 HG13 ' A' ' 30' ' ' ILE . 19.7 tp -87.14 -4.64 59.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.02 -1.05 . . . . 1.05 110.656 -177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.63 43.73 96.02 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.673 -1.371 . . . . 0.32000000000000001 109.673 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.922 HG13 HD23 ' A' ' 28' ' ' LEU . 29.6 mm -114.74 138.07 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -1.152 . . . . 0.40999999999999998 110.664 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.406 ' HB3' ' OD2' ' A' ' 34' ' ' ASP . . . -141.22 166.57 24.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.548 -0.72 . . . . 0.23000000000000001 109.986 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.3 145.99 12.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.068 -1.02 . . . . 1.1299999999999999 110.51 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 45.6 tttp 74.91 -4.7 2.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.653 -0.654 . . . . 1.8799999999999999 111.084 177.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.772 ' O ' HG23 ' B' ' 12' ' ' VAL . 92.0 m-20 -78.04 167.73 20.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.812 -1.18 . . . . 1.1000000000000001 110.018 174.551 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -105.98 131.74 52.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.166 -0.959 . . . . 0.35999999999999999 110.762 -176.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.927 ' O ' HG13 ' B' ' 9' ' ' VAL . 10.3 mt -106.75 141.36 38.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.392 -0.817 . . . . 0.56000000000000005 109.319 175.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.678 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.6 tt0 -103.88 138.17 40.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.794 -1.191 . . . . 1.1699999999999999 109.892 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 74.5 mt -112.25 133.11 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.54 -0.725 . . . . 0.83999999999999997 110.575 -174.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.606 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 17.3 m-85 -115.17 158.32 22.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 122.045 -0.41 . . . . 0.45000000000000001 110.076 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.3 t -129.44 124.29 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.016 -1.053 . . . . 0.27000000000000002 110.707 173.183 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.623 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.1 p-10 -146.93 136.32 22.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 1.77 110.233 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 56.0 t0 44.05 49.84 7.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.017 -1.052 . . . . 1.22 111.071 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.3 mt-10 59.1 13.6 3.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.202 -0.936 . . . . 1.9299999999999999 110.636 175.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -117.24 147.6 42.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 2.0099999999999998 110.036 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.597 HG22 HD11 ' A' ' 47' ' ' LEU . 61.3 mt -99.65 129.16 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.148 -0.97 . . . . 1.25 110.183 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.623 HD11 ' OD2' ' A' ' 41' ' ' ASP . 23.3 mt -109.1 116.42 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.341 -0.849 . . . . 0.5 110.043 176.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.839 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.1 mp -111.05 134.76 52.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.029 -1.044 . . . . 1.6599999999999999 110.113 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.538 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 14.0 pttp -142.66 163.14 33.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.5 -0.75 . . . . 1.74 110.347 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -58.05 147.12 30.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.114 -0.991 . . . . 1.6499999999999999 109.93 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.491 ' CD2' HG11 ' B' ' 9' ' ' VAL . 14.6 t80 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.34999999999999998 110.616 -176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 36' ' ' LEU . 98.7 t . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.572 0.701 . . . . 0.37 111.29 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.419 ' NE ' ' HB ' ' B' ' 19' ' ' VAL . 59.5 ttm-85 -123.76 160.98 26.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.579 -0.701 . . . . 1.9199999999999999 109.776 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 33' ' ' LYS . 81.9 tttt -82.53 144.9 30.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.072 -1.017 . . . . 2.21 110.616 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.902 HG22 ' CD1' ' A' ' 36' ' ' LEU . 4.1 t -82.87 129.6 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.804 . . . . 0.28999999999999998 109.78 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.36 -174.89 5.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.129 -0.982 . . . . 0.55000000000000004 110.023 179.079 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.477 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.8 mt-10 -56.96 -39.28 74.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.065 -1.022 . . . . 2.1899999999999999 111.552 -172.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.905 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.6 tp -83.56 -6.26 59.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.767 -1.208 . . . . 1.3899999999999999 111.568 -174.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.482 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.63 47.15 7.46 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.484 -1.447 . . . . 0.20999999999999999 109.484 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.938 ' CD ' HG22 ' A' ' 19' ' ' VAL . 68.6 mtm180 -114.23 156.11 24.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.974 -1.309 . . . . 1.1399999999999999 110.058 -177.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.823 HG12 HD13 ' A' ' 36' ' ' LEU . 16.6 m -124.5 153.34 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.431 -0.793 . . . . 0.28000000000000003 109.846 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.908 HG22 ' CD ' ' A' ' 17' ' ' ARG . 35.4 t -111.06 134.5 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.23999999999999999 110.527 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.577 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.31 133.33 50.65 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.329 -0.857 . . . . 1.3799999999999999 109.493 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.551 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.3 Cg_endo -57.4 142.84 95.18 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.675 1.355 . . . . 0.35999999999999999 110.036 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.858 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.4 tp -55.39 -32.53 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.062 -1.024 . . . . 1.1100000000000001 110.343 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.03 -36.64 73.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.02 -1.05 . . . . 2.3700000000000001 109.714 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.577 ' HB2' HG23 ' B' ' 20' ' ' ILE . 48.0 mt -79.68 -31.75 41.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.483 -0.76 . . . . 1.75 110.514 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.858 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.9 mtt180 -57.93 -43.3 86.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.925 -1.11 . . . . 0.29999999999999999 109.28 176.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -73.54 -50.21 22.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.327 -0.858 . . . . 3.27 110.653 -177.443 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 55.4 m -64.17 -31.56 72.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.77000000000000002 110.86 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.971 HD23 HG13 ' B' ' 30' ' ' ILE . 20.0 tp -86.64 -5.09 59.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.124 -0.985 . . . . 1.05 110.63 -176.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.442 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.91 43.68 95.66 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.49 -1.444 . . . . 0.32000000000000001 109.49 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.971 HG13 HD23 ' B' ' 28' ' ' LEU . 29.4 mm -114.66 137.97 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -1.168 . . . . 0.40999999999999998 110.699 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.401 ' HB3' ' OD2' ' B' ' 34' ' ' ASP . . . -140.98 166.66 24.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.509 -0.745 . . . . 0.23000000000000001 109.99 -178.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.27 146.03 12.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.138 -0.976 . . . . 1.1299999999999999 110.536 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 45.5 tttp 75.0 -4.94 2.27 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.706 -0.621 . . . . 1.8799999999999999 111.16 177.114 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.724 ' O ' HG23 ' A' ' 12' ' ' VAL . 92.5 m-20 -78.03 167.56 21.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.914 -1.116 . . . . 1.1000000000000001 110.045 174.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.46 ' HB1' HG11 ' A' ' 9' ' ' VAL . . . -105.88 131.66 52.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.961 . . . . 0.35999999999999999 110.807 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.908 HD11 HG22 ' A' ' 12' ' ' VAL . 10.1 mt -106.72 141.16 38.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.887 . . . . 0.56000000000000005 109.421 175.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.635 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.5 tt0 -103.75 138.22 40.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.86 -1.15 . . . . 1.1699999999999999 109.975 173.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 74.5 mt -112.13 133.2 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.459 -0.775 . . . . 0.83999999999999997 110.507 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.61 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 17.2 m-85 -115.32 158.27 22.64 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 120.914 0.387 . . . . 0.45000000000000001 109.962 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 83.9 t -129.2 124.66 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.99 -1.069 . . . . 0.26000000000000001 110.61 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.627 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.2 p-10 -147.32 136.26 22.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -0.838 . . . . 1.77 110.151 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 56.7 t0 44.26 49.85 7.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.119 -0.988 . . . . 1.21 111.012 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.3 mt-10 58.95 13.63 2.91 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.229 -0.919 . . . . 1.9199999999999999 110.607 176.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -117.23 147.87 42.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.945 . . . . 2.0 109.94 175.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.578 HG22 HD11 ' B' ' 47' ' ' LEU . 61.0 mt -99.83 129.15 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.102 -0.999 . . . . 1.24 110.153 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.627 HD11 ' OD2' ' B' ' 41' ' ' ASP . 23.8 mt -109.29 116.42 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.463 -0.773 . . . . 0.5 110.019 176.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.842 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.2 mp -110.91 134.7 52.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.004 -1.06 . . . . 1.6599999999999999 110.097 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.535 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 14.2 pttp -142.52 163.37 33.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.443 -0.785 . . . . 1.74 110.29 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -58.13 147.1 31.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 1.6499999999999999 109.885 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.548 ' CD2' HG11 ' A' ' 9' ' ' VAL . 14.8 t80 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.18 -0.95 . . . . 0.65000000000000002 110.667 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.1 mt . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.043 0.449 . . . . 1.3600000000000001 109.967 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.093 HG11 ' CD2' ' B' ' 50' ' ' TYR . 90.0 t -116.15 144.46 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.019 -1.051 . . . . 0.37 110.989 -175.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 57.5 ttm-85 -129.61 159.66 35.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.513 -0.742 . . . . 1.9099999999999999 109.736 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -86.49 148.03 25.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.2 -0.938 . . . . 2.21 110.328 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.987 HG22 HD11 ' B' ' 36' ' ' LEU . 3.7 t -82.58 129.29 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.266 -0.896 . . . . 0.28000000000000003 109.945 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.18 -174.7 5.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.051 -1.031 . . . . 0.55000000000000004 109.995 179.614 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -56.1 -39.93 72.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.025 -1.047 . . . . 2.1899999999999999 111.718 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.861 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.1 tp -85.41 -4.53 59.19 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.751 -1.218 . . . . 1.3799999999999999 111.674 -173.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.482 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.07 46.34 7.71 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.176 -1.488 . . . . 0.20999999999999999 109.662 -177.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.919 ' CD ' HG22 ' B' ' 19' ' ' VAL . 73.8 mtm180 -115.75 154.62 29.27 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.054 -1.262 . . . . 1.1499999999999999 109.995 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.54 HG12 HD13 ' B' ' 36' ' ' LEU . 22.7 m -123.81 151.76 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.28000000000000003 109.868 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.95 HG22 ' CD ' ' B' ' 17' ' ' ARG . 22.4 t -112.35 135.13 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.152 -0.968 . . . . 0.23999999999999999 110.54 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.569 HG23 ' HB2' ' A' ' 24' ' ' LEU . 3.0 mm -83.64 133.29 46.94 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 1.3799999999999999 109.606 175.371 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' HD12 ' A' ' 24' ' ' LEU . 9.2 Cg_endo -58.04 143.62 96.07 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.778 1.409 . . . . 0.34999999999999998 110.061 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.878 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.1 tp -54.85 -33.12 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.991 -1.068 . . . . 1.1100000000000001 110.347 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.409 ' N ' HG23 ' A' ' 22' ' ' ILE . 84.3 tt0 -58.03 -35.6 71.52 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.154 -0.966 . . . . 2.3700000000000001 109.833 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.569 ' HB2' HG23 ' A' ' 20' ' ' ILE . 51.4 mt -83.8 -28.81 27.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.335 -0.853 . . . . 1.75 110.789 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.878 ' HD2' HD12 ' A' ' 22' ' ' ILE . 71.5 mtt180 -57.44 -43.9 84.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.752 -1.218 . . . . 0.29999999999999999 108.957 175.011 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -71.49 -49.75 38.2 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.092 -0.643 . . . . 3.2599999999999998 110.714 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.8 m -63.59 -31.4 72.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.177 -0.952 . . . . 0.77000000000000002 111.15 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.805 HD23 HG13 ' A' ' 30' ' ' ILE . 23.8 tp -87.35 -5.03 59.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.061 -1.024 . . . . 1.05 110.729 -177.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.08 41.4 98.51 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.701 -1.36 . . . . 0.32000000000000001 109.701 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.805 HG13 HD23 ' A' ' 28' ' ' LEU . 34.3 mm -116.41 139.73 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -1.15 . . . . 0.40999999999999998 110.759 -178.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -139.89 167.46 22.05 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.654 -0.654 . . . . 0.23000000000000001 110.082 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 83.3 tt0 -52.41 150.87 4.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.047 -1.033 . . . . 1.1299999999999999 110.549 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 74.5 mttt 67.16 -3.32 1.01 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.857 -0.527 . . . . 1.8799999999999999 112.234 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.745 ' O ' HG23 ' B' ' 12' ' ' VAL . 90.1 m-20 -76.07 165.44 24.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.579 -1.326 . . . . 1.1000000000000001 109.952 174.152 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.799 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -103.87 130.98 51.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.35999999999999999 110.785 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.974 HD11 HG22 ' B' ' 12' ' ' VAL . 13.5 mt -109.14 142.36 40.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.388 -0.82 . . . . 0.56000000000000005 109.54 175.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.678 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.4 tt0 -107.4 140.35 40.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.795 -1.191 . . . . 1.1699999999999999 109.739 172.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.6 mt -111.57 135.41 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.345 -0.847 . . . . 0.83999999999999997 110.564 -172.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.588 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 12.4 m-85 -114.6 158.55 21.55 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 120.934 0.397 . . . . 0.45000000000000001 110.078 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.7 t -130.89 128.39 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.924 -1.11 . . . . 0.27000000000000002 110.62 172.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.643 ' CG ' HD11 ' A' ' 46' ' ' ILE . 8.9 p-10 -146.62 128.34 15.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.86 . . . . 1.77 110.249 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 48.1 t0 46.57 49.11 13.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.022 -1.048 . . . . 1.22 110.948 175.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.1 tt0 62.53 10.35 4.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.337 -0.852 . . . . 1.9299999999999999 110.696 176.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 9.0 mtmm -110.59 148.38 32.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 2.0099999999999998 109.868 176.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.669 HD13 HD11 ' B' ' 20' ' ' ILE . 58.0 mt -101.92 127.98 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 1.25 110.331 -176.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.643 HD11 ' CG ' ' A' ' 41' ' ' ASP . 29.6 mt -114.99 123.33 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.343 -0.848 . . . . 0.5 110.233 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.822 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -114.11 136.74 52.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.961 -1.087 . . . . 1.6599999999999999 110.167 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 25.2 pttt -140.92 165.61 27.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.449 -0.782 . . . . 1.74 110.132 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -56.06 149.07 16.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.109 -0.995 . . . . 1.6499999999999999 109.819 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.971 ' CD2' HG11 ' B' ' 9' ' ' VAL . 2.2 t80 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.29 -0.881 . . . . 0.34999999999999998 110.655 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.971 HG11 ' CD2' ' A' ' 50' ' ' TYR . 90.1 t . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.515 0.674 . . . . 0.37 110.959 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 57.4 ttm-85 -129.44 159.5 36.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.488 -0.757 . . . . 1.9199999999999999 109.809 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -86.49 147.95 25.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.027 -1.046 . . . . 2.21 110.434 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.974 HG22 HD11 ' A' ' 36' ' ' LEU . 3.7 t -82.45 129.3 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.265 -0.897 . . . . 0.28999999999999998 109.823 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.3 -174.49 5.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.085 -1.009 . . . . 0.55000000000000004 110.171 179.359 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.485 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.5 mt-10 -56.24 -39.85 73.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.095 -1.003 . . . . 2.1899999999999999 111.679 -172.407 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.892 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.5 tp -85.54 -4.55 59.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.723 -1.235 . . . . 1.3899999999999999 111.624 -173.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.498 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.82 46.99 7.45 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.485 -1.446 . . . . 0.20999999999999999 109.485 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.95 ' CD ' HG22 ' A' ' 19' ' ' VAL . 73.7 mtm180 -115.9 154.66 29.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.102 -1.234 . . . . 1.1399999999999999 109.936 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 47' ' ' LEU . 22.6 m -123.91 151.7 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.822 . . . . 0.28000000000000003 109.866 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.919 HG22 ' CD ' ' A' ' 17' ' ' ARG . 22.6 t -112.37 135.09 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.23999999999999999 110.576 -175.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.669 HD11 HD13 ' A' ' 45' ' ' ILE . 3.0 mm -83.64 133.24 47.03 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 1.3799999999999999 109.594 175.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.539 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.2 Cg_endo -58.15 143.6 96.51 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.721 1.38 . . . . 0.35999999999999999 110.063 177.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.874 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -54.9 -33.04 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.043 -1.036 . . . . 1.1100000000000001 110.315 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' GLU . . . . . 0.41 ' N ' HG23 ' B' ' 22' ' ' ILE . 84.2 tt0 -57.79 -36.34 72.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.152 -0.968 . . . . 2.3700000000000001 109.724 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.562 ' HB2' HG23 ' B' ' 20' ' ' ILE . 51.4 mt -83.03 -29.28 28.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.496 -0.753 . . . . 1.75 110.752 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.874 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.0 mtt180 -57.22 -43.8 83.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.816 -1.178 . . . . 0.29999999999999999 108.987 175.402 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -71.32 -50.15 35.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.452 -0.78 . . . . 3.27 110.543 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.4 m -63.3 -31.92 73.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.258 -0.901 . . . . 0.77000000000000002 110.931 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.81 HD23 HG13 ' B' ' 30' ' ' ILE . 24.0 tp -86.84 -5.41 59.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.052 -1.03 . . . . 1.05 110.723 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.401 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.4 41.31 98.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.625 -1.39 . . . . 0.32000000000000001 109.625 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.81 HG13 HD23 ' B' ' 28' ' ' LEU . 33.6 mm -116.43 139.65 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.177 -1.19 . . . . 0.40999999999999998 110.707 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -139.69 167.62 21.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.516 -0.74 . . . . 0.23000000000000001 109.975 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' B' ' 33' ' ' LYS . 83.2 tt0 -52.33 151.07 4.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.129 -0.982 . . . . 1.1299999999999999 110.467 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' B' ' 32' ' ' GLU . 74.0 mttt 66.57 -2.74 0.99 Allowed 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 112.363 0.505 . . . . 1.8799999999999999 112.363 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.647 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.4 m-20 -76.55 165.31 24.96 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.506 -1.371 . . . . 1.1000000000000001 109.965 173.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.764 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.63 131.02 51.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.35999999999999999 110.802 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.987 HD11 HG22 ' A' ' 12' ' ' VAL . 13.3 mt -109.23 142.18 40.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.383 -0.823 . . . . 0.56000000000000005 109.558 175.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.655 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.2 tt0 -107.26 140.32 40.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.842 -1.161 . . . . 1.1699999999999999 109.824 172.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.8 mt -111.61 135.36 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.284 -0.885 . . . . 0.83999999999999997 110.58 -172.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.583 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 12.1 m-85 -114.4 158.57 21.35 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 120.946 0.403 . . . . 0.45000000000000001 110.09 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 78.6 t -130.72 128.61 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.903 -1.123 . . . . 0.26000000000000001 110.476 172.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.641 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.0 p-10 -146.91 128.24 14.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 1.77 110.241 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 49.0 t0 46.77 49.08 14.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.093 -1.005 . . . . 1.21 110.934 175.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.0 tt0 62.4 10.4 3.92 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.224 -0.923 . . . . 1.9199999999999999 110.691 176.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 9.0 mtmm -110.61 148.66 31.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.942 . . . . 2.0 109.705 176.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.553 HG21 HD11 ' A' ' 20' ' ' ILE . 58.0 mt -102.08 128.0 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.981 . . . . 1.24 110.365 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.641 HD11 ' OD2' ' B' ' 41' ' ' ASP . 30.4 mt -115.17 123.4 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.415 -0.803 . . . . 0.5 110.146 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.817 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.2 mp -114.05 136.63 52.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.981 -1.074 . . . . 1.6599999999999999 110.145 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.523 ' HD3' ' CE1' ' B' ' 39' ' ' TYR . 25.2 pttt -140.78 165.84 26.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.44 -0.788 . . . . 1.74 110.079 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -56.3 148.87 17.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.992 -1.067 . . . . 1.6499999999999999 109.754 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 1.093 ' CD2' HG11 ' A' ' 9' ' ' VAL . 2.2 t80 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.65000000000000002 110.667 -175.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.5 mt . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 121.053 0.454 . . . . 1.3600000000000001 110.014 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.92 HG13 ' O ' ' B' ' 36' ' ' LEU . 86.8 t -114.0 144.12 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.027 -1.046 . . . . 0.37 110.871 -175.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -126.29 157.88 37.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.398 -0.814 . . . . 1.9099999999999999 109.71 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' B' ' 33' ' ' LYS . 55.2 tttt -83.58 145.04 29.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.137 -0.977 . . . . 2.21 110.396 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.925 HG22 HD11 ' B' ' 36' ' ' LEU . 3.9 t -81.77 130.31 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.351 -0.843 . . . . 0.28000000000000003 109.929 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.38 -174.58 5.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.177 -0.952 . . . . 0.55000000000000004 110.131 -179.606 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.46 -39.74 73.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.07 -1.019 . . . . 2.1899999999999999 111.779 -172.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.864 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.3 tp -84.76 -4.33 59.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.765 -1.209 . . . . 1.3799999999999999 111.6 -173.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.474 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.06 46.23 7.79 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.172 -1.49 . . . . 0.20999999999999999 109.715 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.934 ' CD ' HG22 ' B' ' 19' ' ' VAL . 74.9 mtm180 -116.16 155.12 28.82 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.069 -1.254 . . . . 1.1499999999999999 110.05 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.697 HG12 HD13 ' B' ' 36' ' ' LEU . 21.9 m -122.23 148.4 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.28000000000000003 109.758 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.945 HG22 ' CD ' ' B' ' 17' ' ' ARG . 28.5 t -112.82 133.79 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.23999999999999999 110.623 -175.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.622 HD11 HD13 ' B' ' 45' ' ' ILE . 2.2 mm -84.75 130.86 51.31 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.294 -0.878 . . . . 1.3799999999999999 109.461 175.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.54 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -57.29 142.34 94.79 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.668 1.352 . . . . 0.34999999999999998 109.849 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.926 ' O ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.46 -32.39 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.952 -1.093 . . . . 1.1100000000000001 110.289 -177.624 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.54 -36.38 71.55 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.16 -0.963 . . . . 2.3700000000000001 109.747 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.595 ' HB2' HG23 ' A' ' 20' ' ' ILE . 52.9 mt -82.1 -27.59 32.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 1.75 110.471 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.68 HH22 HD11 ' B' ' 15' ' ' LEU . 73.0 mtt180 -56.97 -43.93 82.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.833 -1.167 . . . . 0.29999999999999999 108.966 174.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 61.0 ttm-85 -71.66 -49.31 40.96 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.956 -0.698 . . . . 3.2599999999999998 110.765 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.9 m -63.21 -31.84 73.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.186 -0.946 . . . . 0.77000000000000002 111.078 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.8 HD23 HG13 ' A' ' 30' ' ' ILE . 23.2 tp -88.09 -5.01 58.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.093 -1.004 . . . . 1.05 110.758 -177.254 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.414 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.52 41.57 97.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.651 -1.38 . . . . 0.32000000000000001 109.651 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.8 HG13 HD23 ' A' ' 28' ' ' LEU . 33.6 mm -116.53 139.1 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -1.169 . . . . 0.40999999999999998 110.732 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.32 166.65 24.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.645 -0.659 . . . . 0.23000000000000001 109.984 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.2 tt0 -53.29 146.39 12.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.056 -1.027 . . . . 1.1299999999999999 110.592 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 28.5 tttt 74.52 -4.63 2.28 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.674 -0.642 . . . . 1.8799999999999999 111.166 176.944 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.728 ' O ' HG23 ' B' ' 12' ' ' VAL . 90.6 m-20 -77.3 165.95 23.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.788 -1.195 . . . . 1.1000000000000001 110.03 174.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.21 130.14 53.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.35999999999999999 110.629 -176.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.949 ' O ' HG13 ' B' ' 9' ' ' VAL . 11.6 mt -106.25 141.64 37.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 0.56000000000000005 109.387 174.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.682 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.3 tt0 -104.65 139.01 40.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.758 -1.214 . . . . 1.1699999999999999 109.882 173.66 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.7 mt -109.82 132.67 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.514 -0.741 . . . . 0.83999999999999997 110.374 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.588 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 14.2 m-85 -114.65 157.54 22.96 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.929 -0.397 . . . . 0.45000000000000001 109.929 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.9 t -129.59 126.29 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.942 -1.099 . . . . 0.27000000000000002 110.746 174.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.638 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.4 p-10 -146.71 131.91 18.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 1.77 110.178 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.497 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 47.7 t0 46.09 48.19 12.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.952 -1.092 . . . . 1.22 111.008 175.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.0 tt0 62.02 10.98 3.95 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.202 -0.936 . . . . 1.9299999999999999 110.609 175.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 32.7 mtmt -113.07 150.98 31.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.072 -1.017 . . . . 2.0099999999999998 109.873 176.42 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.706 HD13 HD11 ' B' ' 20' ' ' ILE . 56.7 mt -101.9 129.58 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 1.25 110.284 -176.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.638 HD11 ' OD2' ' A' ' 41' ' ' ASP . 21.9 mt -112.5 120.83 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.5 110.193 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.849 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -112.39 134.08 54.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.984 -1.073 . . . . 1.6599999999999999 110.133 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.543 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 10.5 pttp -141.52 164.8 29.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.478 -0.764 . . . . 1.74 110.394 178.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.543 ' HD3' ' CD1' ' A' ' 30' ' ' ILE . 18.3 tptp -56.97 146.04 28.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.133 -0.979 . . . . 1.6499999999999999 109.938 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.595 ' CD2' HG11 ' B' ' 9' ' ' VAL . 9.9 t80 . . . . . 0 C--N 1.299 -1.619 0 O-C-N 121.331 -0.855 . . . . 0.34999999999999998 110.646 -176.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.949 HG13 ' O ' ' A' ' 36' ' ' LEU . 88.3 t . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.503 0.668 . . . . 0.37 110.911 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -126.29 157.6 37.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.456 -0.777 . . . . 1.9199999999999999 109.833 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -83.53 144.95 29.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.983 . . . . 2.21 110.453 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.911 HG22 HD11 ' A' ' 36' ' ' LEU . 4.0 t -81.72 130.49 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.354 -0.841 . . . . 0.28999999999999998 109.812 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.454 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.6 -174.4 5.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.103 -0.998 . . . . 0.55000000000000004 110.3 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.474 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -56.63 -39.62 73.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.103 -0.998 . . . . 2.1899999999999999 111.65 -172.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.892 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.0 tp -84.87 -4.39 59.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.741 -1.225 . . . . 1.3899999999999999 111.527 -173.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.481 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.75 47.04 7.46 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.495 -1.442 . . . . 0.20999999999999999 109.495 -177.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.945 ' CD ' HG22 ' A' ' 19' ' ' VAL . 74.8 mtm180 -116.44 155.1 29.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.001 -1.293 . . . . 1.1399999999999999 109.969 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.7 HG12 HD13 ' A' ' 36' ' ' LEU . 22.0 m -122.3 148.35 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.28000000000000003 109.756 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.934 HG22 ' CD ' ' A' ' 17' ' ' ARG . 28.4 t -112.75 133.76 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.948 . . . . 0.23999999999999999 110.636 -175.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.706 HD11 HD13 ' A' ' 45' ' ' ILE . 2.2 mm -84.76 130.86 51.28 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 1.3799999999999999 109.416 175.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.532 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.0 Cg_endo -57.42 142.28 95.11 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.771 1.406 . . . . 0.35999999999999999 109.888 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.948 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.52 -32.17 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.994 -1.066 . . . . 1.1100000000000001 110.291 -177.375 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.45 -37.05 72.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.103 -0.998 . . . . 2.3700000000000001 109.643 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.579 ' HB2' HG23 ' B' ' 20' ' ' ILE . 52.5 mt -81.42 -27.88 34.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 1.75 110.502 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.638 HH22 HD11 ' A' ' 15' ' ' LEU . 72.7 mtt180 -56.79 -43.8 81.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.912 -1.118 . . . . 0.29999999999999999 109.046 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 61.0 ttm-85 -71.56 -49.78 37.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.463 -0.773 . . . . 3.27 110.578 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 48.1 m -62.8 -32.43 73.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.3 -0.875 . . . . 0.77000000000000002 110.893 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.835 HD23 HG13 ' B' ' 30' ' ' ILE . 23.4 tp -87.55 -5.42 58.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.058 -1.027 . . . . 1.05 110.661 -176.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.419 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.86 41.33 97.52 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.605 -1.398 . . . . 0.32000000000000001 109.605 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.835 HG13 HD23 ' B' ' 28' ' ' LEU . 33.4 mm -116.45 138.93 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -1.199 . . . . 0.40999999999999998 110.725 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.99 166.78 23.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.59 -0.694 . . . . 0.23000000000000001 110.053 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.527 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.31 146.48 12.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.132 -0.98 . . . . 1.1299999999999999 110.516 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 28.5 tttt 74.54 -4.78 2.25 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.673 -0.642 . . . . 1.8799999999999999 111.225 176.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.666 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.7 m-20 -77.39 165.57 24.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.849 -1.157 . . . . 1.1000000000000001 110.05 175.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.95 130.1 53.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.35999999999999999 110.69 -176.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.925 HD11 HG22 ' A' ' 12' ' ' VAL . 11.4 mt -106.26 141.5 37.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.396 -0.815 . . . . 0.56000000000000005 109.426 174.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.669 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.2 tt0 -104.55 138.95 40.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.84 -1.163 . . . . 1.1699999999999999 110.008 173.624 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 72.0 mt -109.76 132.59 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.395 -0.816 . . . . 0.83999999999999997 110.329 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.591 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 13.9 m-85 -114.59 157.55 22.89 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.901 -0.407 . . . . 0.45000000000000001 109.901 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.7 t -129.41 126.6 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.958 -1.089 . . . . 0.26000000000000001 110.584 174.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.618 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.4 p-10 -146.99 131.83 18.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.354 -0.841 . . . . 1.77 110.14 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 48.7 t0 46.3 48.21 13.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.107 -0.996 . . . . 1.21 110.968 175.889 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 82.8 tt0 61.82 11.04 3.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.238 -0.914 . . . . 1.9199999999999999 110.617 175.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 32.7 mtmt -113.08 151.2 31.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.178 -0.951 . . . . 2.0 109.791 176.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.622 HD13 HD11 ' A' ' 20' ' ' ILE . 56.3 mt -102.01 129.67 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.174 -0.954 . . . . 1.24 110.294 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.618 HD11 ' OD2' ' B' ' 41' ' ' ASP . 22.3 mt -112.71 120.83 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.5 110.075 176.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.838 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.2 mp -112.28 134.02 54.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.077 -1.014 . . . . 1.6599999999999999 110.053 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.536 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 10.7 pttp -141.5 165.02 28.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 1.74 110.248 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.544 ' HD3' ' CD1' ' B' ' 30' ' ' ILE . 18.3 tptp -57.06 145.96 28.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 1.6499999999999999 109.878 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.692 ' CD2' HG11 ' A' ' 9' ' ' VAL . 10.1 t80 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.65000000000000002 110.599 -176.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.0 mm . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 121.107 0.479 . . . . 1.3600000000000001 110.157 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.069 HG11 ' CD2' ' B' ' 50' ' ' TYR . 98.9 t -115.28 144.46 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.996 -1.065 . . . . 0.37 110.893 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.447 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 14.8 tpt180 -130.22 160.62 33.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.514 -0.741 . . . . 1.9099999999999999 109.687 177.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.447 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 66.7 mttm -85.76 148.5 25.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.106 -0.996 . . . . 2.21 110.344 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.924 HG22 HD11 ' B' ' 36' ' ' LEU . 6.3 t -82.05 128.75 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.216 -0.927 . . . . 0.28000000000000003 109.816 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.464 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.37 -174.82 5.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.209 -0.932 . . . . 0.55000000000000004 110.164 -179.299 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -53.24 -41.99 65.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.087 -1.008 . . . . 2.1899999999999999 111.687 -173.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.918 HD23 ' HD3' ' A' ' 17' ' ' ARG . 16.3 tp -85.97 -4.89 59.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.717 -1.239 . . . . 1.3799999999999999 111.685 -172.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.51 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.23 46.44 7.55 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.094 -1.527 . . . . 0.20999999999999999 109.695 -177.723 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.918 ' HD3' HD23 ' A' ' 15' ' ' LEU . 69.2 mtm180 -114.78 154.63 28.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.079 -1.248 . . . . 1.1499999999999999 110.088 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.697 HG12 HD13 ' B' ' 36' ' ' LEU . 20.9 m -124.85 152.7 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.28000000000000003 109.819 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.914 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.4 t -112.61 134.91 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.23999999999999999 110.637 -175.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.547 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.95 132.11 52.02 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.279 -0.888 . . . . 1.3799999999999999 109.539 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.1 Cg_endo -57.28 141.23 94.6 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.729 1.384 . . . . 0.34999999999999998 109.947 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.925 ' O ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.66 -31.7 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.023 -1.048 . . . . 1.1100000000000001 110.371 -177.56 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.73 -35.33 72.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.071 -1.018 . . . . 2.3700000000000001 109.824 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.548 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 46.7 mt -81.39 -28.22 34.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.282 -0.887 . . . . 1.75 110.394 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.725 HH22 HD11 ' B' ' 15' ' ' LEU . 72.4 mtt180 -56.98 -44.72 82.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.897 -1.127 . . . . 0.29999999999999999 109.092 175.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.466 ' NE ' HD11 ' A' ' 22' ' ' ILE . 98.1 mtt180 -72.14 -47.83 48.05 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.775 -0.77 . . . . 3.2599999999999998 110.839 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.3 m -63.26 -32.19 73.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.158 -0.964 . . . . 0.77000000000000002 111.018 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.879 HD23 HG13 ' A' ' 30' ' ' ILE . 21.3 tp -88.62 -4.71 58.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.1 -1.0 . . . . 1.05 110.734 -177.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.439 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.05 41.81 97.01 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.718 -1.353 . . . . 0.32000000000000001 109.718 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.879 HG13 HD23 ' A' ' 28' ' ' LEU . 32.0 mm -116.48 139.24 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.313 -1.11 . . . . 0.40999999999999998 110.777 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.57 166.12 25.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.677 -0.64 . . . . 0.23000000000000001 109.987 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.24 147.09 10.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.081 -1.012 . . . . 1.1299999999999999 110.492 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 33.1 tttp 74.78 -4.97 2.24 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.77 -0.581 . . . . 1.8799999999999999 111.118 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.731 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.4 m-20 -77.38 166.52 23.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.79 -1.194 . . . . 1.1000000000000001 109.989 174.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.779 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.2 132.81 50.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 0.35999999999999999 110.842 -175.655 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.991 HD11 HG22 ' B' ' 12' ' ' VAL . 13.0 mt -110.11 144.82 38.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.376 -0.828 . . . . 0.56000000000000005 109.509 175.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.646 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.6 tt0 -108.81 139.79 43.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.726 -1.234 . . . . 1.1699999999999999 109.685 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.2 mt -109.04 131.17 60.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.434 -0.791 . . . . 0.83999999999999997 110.56 -172.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.607 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 16.7 m-85 -117.73 157.74 25.98 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 116.296 -0.411 . . . . 0.45000000000000001 110.02 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.7 t -131.79 125.17 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.891 -1.131 . . . . 0.27000000000000002 110.571 172.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.498 ' OD1' HG12 ' A' ' 46' ' ' ILE . 43.5 p-10 -147.49 144.84 28.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.106 -0.996 . . . . 1.77 110.768 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 52.8 t0 43.02 44.27 4.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.982 -1.074 . . . . 1.22 111.285 173.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 84.1 tt0 60.87 11.34 3.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.108 -0.995 . . . . 1.9299999999999999 110.679 176.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -111.07 153.53 25.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 2.0099999999999998 110.057 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.831 HG22 HD11 ' A' ' 47' ' ' LEU . 66.0 mt -93.51 128.8 44.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.279 -0.888 . . . . 1.25 109.846 177.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 23.9 mm -112.97 119.55 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.629 -0.669 . . . . 0.5 110.004 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.833 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -117.96 134.79 54.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 1.6599999999999999 110.202 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.514 ' HE2' ' CE1' ' A' ' 39' ' ' TYR . 22.7 pttt -141.28 162.42 35.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.377 -0.827 . . . . 1.74 110.326 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -57.79 147.17 28.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.147 -0.971 . . . . 1.6499999999999999 110.023 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.895 ' CD2' HG11 ' B' ' 9' ' ' VAL . 5.3 t80 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.34999999999999998 110.575 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 36' ' ' LEU . 99.4 t . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.464 0.65 . . . . 0.37 110.837 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 14.8 tpt180 -130.23 160.51 33.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.573 -0.705 . . . . 1.9199999999999999 109.792 177.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.451 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 66.7 mttm -85.76 148.49 25.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.062 -1.024 . . . . 2.21 110.331 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.991 HG22 HD11 ' A' ' 36' ' ' LEU . 6.4 t -82.11 128.76 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.281 -0.887 . . . . 0.28999999999999998 109.728 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -85.52 -174.6 5.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.55000000000000004 110.217 -179.395 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.465 ' OE1' ' OE2' ' A' ' 32' ' ' GLU . 47.2 tp10 -53.41 -41.86 66.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 2.1899999999999999 111.689 -173.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.9 tp -85.97 -4.93 59.28 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.781 -1.2 . . . . 1.3899999999999999 111.732 -172.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.511 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.88 47.27 7.26 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.439 -1.464 . . . . 0.20999999999999999 109.439 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.914 ' CD ' HG22 ' A' ' 19' ' ' VAL . 69.2 mtm180 -114.94 154.64 28.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.057 -1.26 . . . . 1.1399999999999999 110.043 -177.392 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.712 HG12 HD13 ' A' ' 36' ' ' LEU . 21.0 m -124.93 152.71 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.367 -0.833 . . . . 0.28000000000000003 109.852 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.908 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.4 t -112.62 134.83 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 0.23999999999999999 110.666 -175.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.98 132.1 51.95 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.92 . . . . 1.3799999999999999 109.528 174.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.1 Cg_endo -57.45 141.26 94.97 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.73 1.384 . . . . 0.35999999999999999 109.964 177.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.922 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.9 -31.24 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.982 . . . . 1.1100000000000001 110.367 -177.216 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.83 -35.91 73.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.04 -1.038 . . . . 2.3700000000000001 109.633 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.55 ' HB2' HG23 ' B' ' 20' ' ' ILE . 47.1 mt -80.73 -28.5 36.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.44 -0.788 . . . . 1.75 110.438 176.78 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.659 HH22 HD11 ' A' ' 15' ' ' LEU . 72.1 mtt180 -56.93 -44.59 82.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.876 -1.14 . . . . 0.29999999999999999 109.037 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.471 ' NE ' HD11 ' B' ' 22' ' ' ILE . 98.1 mtt180 -72.1 -48.08 46.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.403 -0.811 . . . . 3.27 110.698 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.3 m -63.0 -32.66 74.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.244 -0.91 . . . . 0.77000000000000002 110.816 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.886 HD23 HG13 ' B' ' 30' ' ' ILE . 21.4 tp -88.12 -5.15 58.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.997 -1.064 . . . . 1.05 110.636 -177.021 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.446 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.44 41.69 96.25 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.519 -1.433 . . . . 0.32000000000000001 109.519 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.886 HG13 HD23 ' B' ' 28' ' ' LEU . 31.7 mm -116.49 139.24 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.14 -1.212 . . . . 0.40999999999999998 110.731 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.34 166.24 25.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.663 -0.648 . . . . 0.23000000000000001 109.948 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.19 147.1 10.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.028 -1.045 . . . . 1.1299999999999999 110.525 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 33.1 tttp 74.76 -5.0 2.22 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.737 -0.602 . . . . 1.8799999999999999 111.132 177.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.629 ' O ' HG23 ' A' ' 12' ' ' VAL . 88.7 m-20 -77.43 166.4 23.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.795 -1.19 . . . . 1.1000000000000001 109.992 174.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.14 132.79 50.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.35999999999999999 110.902 -175.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.942 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.7 mt -110.24 144.54 38.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.355 -0.841 . . . . 0.56000000000000005 109.533 175.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.63 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.4 tt0 -108.44 139.81 42.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.744 -1.223 . . . . 1.1699999999999999 109.832 172.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -109.01 131.26 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.353 -0.842 . . . . 0.83999999999999997 110.42 -172.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 16.5 m-85 -117.82 157.64 26.23 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 120.964 0.411 . . . . 0.45000000000000001 109.97 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 80.9 t -131.59 125.5 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.864 -1.148 . . . . 0.26000000000000001 110.427 172.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.501 ' OD1' HG12 ' B' ' 46' ' ' ILE . 43.4 p-10 -147.88 144.85 28.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 1.77 110.743 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.4 t0 43.02 44.44 4.08 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.059 -1.026 . . . . 1.21 111.237 174.112 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 84.1 tt0 60.65 11.44 3.1 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.027 -1.046 . . . . 1.9199999999999999 110.613 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -111.09 153.78 25.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.111 -0.993 . . . . 2.0 109.895 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.828 HG22 HD11 ' B' ' 47' ' ' LEU . 65.2 mt -93.69 128.6 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.198 -0.939 . . . . 1.24 109.967 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 23.4 mm -112.95 119.65 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.697 -0.627 . . . . 0.5 109.873 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.829 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.3 mp -117.89 134.68 54.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.007 -1.058 . . . . 1.6599999999999999 110.147 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.509 ' HE2' ' CE1' ' B' ' 39' ' ' TYR . 23.1 pttt -141.16 162.61 35.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.352 -0.843 . . . . 1.74 110.276 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -57.8 147.09 29.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.947 . . . . 1.6499999999999999 109.997 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 1.069 ' CD2' HG11 ' A' ' 9' ' ' VAL . 5.5 t80 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.65000000000000002 110.516 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 57.9 mt . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.058 0.456 . . . . 1.3600000000000001 109.991 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.929 HG13 ' O ' ' B' ' 36' ' ' LEU . 92.6 t -112.65 143.71 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.975 -1.078 . . . . 0.37 110.782 -176.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 29.7 tpt180 -125.98 157.83 36.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.539 -0.726 . . . . 1.9099999999999999 109.832 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.461 ' HE3' ' HA ' ' B' ' 33' ' ' LYS . 33.2 tttp -82.81 143.82 30.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.915 . . . . 2.21 110.172 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.924 HG22 HD11 ' B' ' 36' ' ' LEU . 15.0 t -80.4 126.93 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.888 . . . . 0.28000000000000003 109.855 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.99 -174.93 5.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.975 . . . . 0.55000000000000004 110.013 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.34 -39.55 73.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.011 -1.056 . . . . 2.1899999999999999 111.689 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.914 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.1 tp -84.67 -6.17 59.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.728 -1.233 . . . . 1.3799999999999999 111.574 -173.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.32 46.69 7.35 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.108 -1.52 . . . . 0.20999999999999999 109.641 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.914 ' HD3' HD23 ' A' ' 15' ' ' LEU . 70.8 mtm180 -114.06 153.99 28.48 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.033 -1.275 . . . . 1.1499999999999999 110.078 -177.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.862 HG12 HD13 ' B' ' 36' ' ' LEU . 20.9 m -124.28 153.39 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.343 -0.848 . . . . 0.28000000000000003 109.789 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.903 HG22 ' CD ' ' B' ' 17' ' ' ARG . 17.0 t -113.42 133.66 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.23999999999999999 110.703 -175.337 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.594 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.42 136.19 43.11 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.163 -0.961 . . . . 1.3799999999999999 109.443 174.27 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.5 Cg_endo -58.56 141.12 97.14 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.702 1.369 . . . . 0.34999999999999998 109.893 176.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.954 ' O ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.89 -31.31 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.94 -1.1 . . . . 1.1100000000000001 110.382 -177.55 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.59 -35.38 72.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.049 -1.032 . . . . 2.3700000000000001 109.854 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.594 ' HB2' HG23 ' A' ' 20' ' ' ILE . 52.8 mt -81.02 -29.46 35.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 1.75 110.455 176.918 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.705 HH22 HD11 ' B' ' 15' ' ' LEU . 73.9 mtt180 -57.13 -44.02 82.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.969 -1.082 . . . . 0.29999999999999999 109.05 175.547 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -72.64 -50.12 27.29 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.539 -0.726 . . . . 3.2599999999999998 110.708 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m -63.56 -31.25 72.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.195 -0.941 . . . . 0.77000000000000002 111.09 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.722 HD23 HG13 ' A' ' 30' ' ' ILE . 18.2 tp -87.59 -4.37 58.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 1.05 110.759 -177.092 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.454 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 67.01 40.94 93.37 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.712 -1.355 . . . . 0.32000000000000001 109.712 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.722 HG13 HD23 ' A' ' 28' ' ' LEU . 31.2 mm -116.51 139.07 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.328 -1.101 . . . . 0.40999999999999998 110.674 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.83 166.53 24.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.529 -0.732 . . . . 0.23000000000000001 110.032 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.524 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.24 146.53 11.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 1.1299999999999999 110.602 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 56.2 tttt 74.7 -4.58 2.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.678 -0.639 . . . . 1.8799999999999999 111.139 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.764 ' O ' HG23 ' B' ' 12' ' ' VAL . 87.3 m-20 -76.75 168.09 20.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.189 . . . . 1.1000000000000001 110.034 174.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.681 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -106.23 131.69 53.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.35999999999999999 110.726 -175.818 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.925 ' O ' HG13 ' B' ' 9' ' ' VAL . 13.0 mt -109.04 144.55 36.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.425 -0.797 . . . . 0.56000000000000005 109.457 175.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.567 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.0 tt0 -109.65 138.67 45.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.74 -1.225 . . . . 1.1699999999999999 109.491 172.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.51 133.33 55.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.336 -0.853 . . . . 0.83999999999999997 110.607 -171.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.596 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 9.5 m-85 -118.3 161.48 19.86 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.905 -0.405 . . . . 0.45000000000000001 109.905 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.464 HG21 HD11 ' B' ' 24' ' ' LEU . 77.4 t -133.8 120.53 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.854 -1.154 . . . . 0.27000000000000002 110.599 172.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 45.4 p-10 -148.25 160.99 42.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 1.77 110.55 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 53.0 t0 42.21 39.51 1.44 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.009 -1.057 . . . . 1.22 111.493 172.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 84.2 tt0 59.05 14.07 3.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.898 -1.127 . . . . 1.9299999999999999 110.567 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.558 ' CE ' HD11 ' A' ' 46' ' ' ILE . 11.2 pttt -127.66 166.25 18.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.147 -0.971 . . . . 2.0099999999999998 109.696 174.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.68 HG22 HD11 ' A' ' 47' ' ' LEU . 66.8 mt -97.95 134.37 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 1.25 110.388 -175.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.596 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 20.3 mm -113.95 120.13 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.643 -0.661 . . . . 0.5 109.959 178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.838 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.5 mp -115.83 135.63 53.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.965 -1.085 . . . . 1.6599999999999999 110.227 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.577 ' HE3' ' CD1' ' A' ' 39' ' ' TYR . 13.5 ptpt -141.28 158.64 43.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 1.74 110.368 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -58.42 146.75 33.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 1.6499999999999999 109.934 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.681 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 8.5 t80 . . . . . 0 C--N 1.301 -1.537 0 O-C-N 121.318 -0.864 . . . . 0.34999999999999998 110.602 -175.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.925 HG13 ' O ' ' A' ' 36' ' ' LEU . 92.7 t . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.556 0.693 . . . . 0.37 110.789 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -125.96 157.69 37.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.463 -0.773 . . . . 1.9199999999999999 109.912 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -82.78 143.67 30.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 2.21 110.173 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.914 HG22 HD11 ' A' ' 36' ' ' LEU . 15.1 t -80.23 127.08 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 0.28999999999999998 109.78 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -86.15 -174.79 5.25 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.082 -1.011 . . . . 0.55000000000000004 110.14 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.479 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.8 mt-10 -56.46 -39.51 73.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.017 -1.052 . . . . 2.1899999999999999 111.609 -172.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.901 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.7 tp -84.69 -6.21 59.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.733 -1.229 . . . . 1.3899999999999999 111.599 -173.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.88 47.65 7.03 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.474 -1.45 . . . . 0.20999999999999999 109.474 -177.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.903 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.6 mtm180 -114.39 154.05 28.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.037 -1.272 . . . . 1.1399999999999999 109.974 -177.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.858 HG12 HD13 ' A' ' 36' ' ' LEU . 20.6 m -124.35 153.49 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.28000000000000003 109.864 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.907 HG22 ' CD ' ' A' ' 17' ' ' ARG . 16.9 t -113.53 133.68 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.23999999999999999 110.672 -175.307 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.594 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -83.41 136.21 43.13 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.201 -0.937 . . . . 1.3799999999999999 109.475 174.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.542 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.4 Cg_endo -58.74 141.01 97.38 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.716 1.377 . . . . 0.35999999999999999 109.896 176.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.954 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -56.03 -31.01 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 1.1100000000000001 110.415 -177.268 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.56 -35.96 73.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.994 -1.066 . . . . 2.3700000000000001 109.714 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.594 ' HB2' HG23 ' B' ' 20' ' ' ILE . 52.6 mt -80.32 -29.83 38.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.416 -0.802 . . . . 1.75 110.435 176.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.647 HH22 HD11 ' A' ' 15' ' ' LEU . 73.3 mtt180 -56.98 -44.0 82.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.903 -1.123 . . . . 0.29999999999999999 109.036 175.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -72.4 -50.44 26.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 3.27 110.715 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 55.5 m -63.29 -31.78 73.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.33 -0.856 . . . . 0.77000000000000002 110.878 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.722 HD23 HG13 ' B' ' 30' ' ' ILE . 18.3 tp -87.16 -4.57 59.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.007 -1.058 . . . . 1.05 110.71 -176.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.459 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 67.34 40.73 91.81 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.597 -1.401 . . . . 0.32000000000000001 109.597 178.631 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.722 HG13 HD23 ' B' ' 28' ' ' LEU . 30.6 mm -116.53 139.05 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -1.175 . . . . 0.40999999999999998 110.586 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.62 166.53 24.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.545 -0.722 . . . . 0.23000000000000001 110.06 -177.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.33 146.64 11.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.944 . . . . 1.1299999999999999 110.511 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 56.1 tttt 74.71 -4.69 2.29 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.592 -0.693 . . . . 1.8799999999999999 111.264 177.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.698 ' O ' HG23 ' A' ' 12' ' ' VAL . 87.7 m-20 -76.75 167.74 21.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.8 -1.187 . . . . 1.1000000000000001 110.021 174.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.691 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.94 131.67 52.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 0.35999999999999999 110.856 -175.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.929 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.8 mt -109.03 144.26 37.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.858 . . . . 0.56000000000000005 109.626 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.55 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.7 tt0 -109.27 138.69 45.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.759 -1.213 . . . . 1.1699999999999999 109.734 172.229 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.3 mt -109.5 133.38 54.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.336 -0.853 . . . . 0.83999999999999997 110.531 -171.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.622 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 9.3 m-85 -118.33 161.31 20.15 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.954 -0.387 . . . . 0.45000000000000001 109.954 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 24' ' ' LEU . 78.9 t -133.5 121.01 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.861 -1.15 . . . . 0.26000000000000001 110.473 172.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 45.3 p-10 -148.86 160.95 42.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.98 . . . . 1.77 110.49 178.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.4 t0 41.99 39.82 1.42 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.204 -0.935 . . . . 1.21 111.481 172.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' B' ' 43' ' ' GLU . 84.2 tt0 58.89 14.04 3.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.91 -1.119 . . . . 1.9199999999999999 110.528 174.915 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.56 ' CE ' HD11 ' B' ' 46' ' ' ILE . 11.2 pttt -127.55 166.41 18.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 2.0 109.699 174.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.681 HG22 HD11 ' B' ' 47' ' ' LEU . 66.7 mt -98.09 134.32 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 1.24 110.399 -175.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 20.7 mm -113.94 120.09 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.683 -0.636 . . . . 0.5 109.975 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.83 ' CD1' HD13 ' A' ' 47' ' ' LEU . 4.6 mp -115.76 135.5 53.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.069 -1.019 . . . . 1.6599999999999999 110.192 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.574 ' HE3' ' CD1' ' B' ' 39' ' ' TYR . 13.5 ptpt -141.14 158.88 43.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.375 -0.828 . . . . 1.74 110.295 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -58.54 146.75 34.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.213 -0.929 . . . . 1.6499999999999999 109.908 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.771 ' CD2' HG11 ' A' ' 9' ' ' VAL . 8.8 t80 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.65000000000000002 110.69 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.6 mt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.075 0.464 . . . . 1.3600000000000001 110.085 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.967 HG11 ' CD2' ' B' ' 50' ' ' TYR . 90.7 t -117.41 144.49 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.056 -1.027 . . . . 0.37 110.82 -176.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.417 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 23.9 tpt180 -129.77 158.95 38.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -0.793 . . . . 1.9099999999999999 109.798 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.417 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 35.5 ttpt -82.71 145.52 29.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.127 -0.983 . . . . 2.21 110.335 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.916 HG22 HD11 ' B' ' 36' ' ' LEU . 3.7 t -81.76 128.69 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.385 -0.822 . . . . 0.28000000000000003 109.807 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.55 -177.29 6.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.072 -1.017 . . . . 0.55000000000000004 109.997 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.99 -40.5 73.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.049 -1.032 . . . . 2.1899999999999999 111.539 -174.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.57 ' O ' ' CD1' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -76.83 -13.81 59.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.873 -1.142 . . . . 1.3799999999999999 110.542 -174.458 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.81 46.66 5.9 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.401 -1.479 . . . . 0.20999999999999999 109.401 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.893 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.5 mtm180 -114.41 155.04 27.06 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.024 -1.28 . . . . 1.1499999999999999 110.095 -176.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.952 HG12 HD13 ' B' ' 36' ' ' LEU . 13.1 m -122.91 152.46 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.318 -0.864 . . . . 0.28000000000000003 109.769 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.889 HG22 ' CD ' ' B' ' 17' ' ' ARG . 15.0 t -112.8 134.08 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.23999999999999999 110.659 -174.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.552 HD11 ' CG2' ' B' ' 45' ' ' ILE . 2.5 mm -84.3 137.24 39.68 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 1.3799999999999999 109.367 174.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.55 ' HG2' HD12 ' A' ' 24' ' ' LEU . 9.8 Cg_endo -58.63 140.77 96.24 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.718 1.378 . . . . 0.34999999999999998 109.785 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.954 ' O ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.63 -32.21 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.862 -1.149 . . . . 1.1100000000000001 110.313 -177.679 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -58.73 -35.27 72.42 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.16 -0.962 . . . . 2.3700000000000001 109.763 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.55 HD12 ' HG2' ' A' ' 21' ' ' PRO . 41.3 mt -82.65 -27.62 31.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 1.75 110.517 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.523 ' CG ' ' HA ' ' A' ' 22' ' ' ILE . 71.2 mtt180 -56.85 -44.51 82.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.798 -1.189 . . . . 0.29999999999999999 108.84 175.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ARG . . . . . 0.463 ' HE ' HD11 ' A' ' 22' ' ' ILE . 31.5 mmt180 -72.77 -47.81 43.59 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.938 -0.705 . . . . 3.2599999999999998 110.657 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.4 m -63.69 -31.32 72.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.191 -0.943 . . . . 0.77000000000000002 111.069 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.84 HD23 HG13 ' A' ' 30' ' ' ILE . 20.9 tp -87.39 -4.65 59.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 1.05 110.683 -177.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.413 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 66.05 41.49 95.11 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.662 -1.375 . . . . 0.32000000000000001 109.662 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.84 HG13 HD23 ' A' ' 28' ' ' LEU . 33.3 mm -116.43 138.79 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.344 -1.092 . . . . 0.40999999999999998 110.675 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.64 166.07 25.76 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.55 -0.719 . . . . 0.23000000000000001 109.981 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.73 146.51 13.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.094 -1.004 . . . . 1.1299999999999999 110.533 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 43.5 tttm 75.02 -4.63 2.34 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.744 -0.598 . . . . 1.8799999999999999 111.068 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.743 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.9 m-20 -77.21 167.19 22.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.73 -1.231 . . . . 1.1000000000000001 110.05 174.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.718 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.49 130.74 53.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.35999999999999999 110.744 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.969 HD13 HG12 ' B' ' 18' ' ' VAL . 13.4 mt -107.58 143.9 35.36 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.336 -0.852 . . . . 0.56000000000000005 109.388 175.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.647 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.3 tt0 -108.77 139.22 43.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.809 -1.182 . . . . 1.1699999999999999 109.694 172.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.3 mt -109.84 133.1 56.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.425 -0.797 . . . . 0.83999999999999997 110.541 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.622 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 17.2 m-85 -119.45 158.85 25.38 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 116.262 -0.426 . . . . 0.45000000000000001 109.894 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.511 HG21 HD11 ' B' ' 24' ' ' LEU . 85.3 t -132.01 123.32 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.833 -1.167 . . . . 0.27000000000000002 110.66 173.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.502 ' OD1' HG12 ' A' ' 46' ' ' ILE . 47.8 p-10 -147.69 149.12 31.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 1.77 110.632 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 52.7 t0 42.95 44.64 4.07 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.001 -1.062 . . . . 1.22 111.256 173.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 75.6 mm-40 57.67 14.55 2.45 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.053 -1.03 . . . . 1.9299999999999999 110.567 176.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -115.84 153.94 30.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 2.0099999999999998 109.955 175.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.901 HG22 HD11 ' A' ' 47' ' ' LEU . 67.7 mt -92.92 129.05 44.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.253 -0.904 . . . . 1.25 109.954 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.0 mm -111.91 119.36 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.561 -0.712 . . . . 0.5 109.907 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.901 HD11 HG22 ' A' ' 45' ' ' ILE . 4.2 mp -118.81 134.36 55.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.924 -1.11 . . . . 1.6599999999999999 110.281 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.556 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 12.1 pttp -141.99 163.69 32.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.451 -0.781 . . . . 1.74 110.478 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -59.26 147.02 37.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 1.6499999999999999 110.14 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.799 ' CD2' HG11 ' B' ' 9' ' ' VAL . 10.3 t80 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.34999999999999998 110.67 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 36' ' ' LEU . 89.4 t . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.514 0.673 . . . . 0.37 110.804 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 24.0 tpt180 -129.75 158.85 38.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.545 -0.722 . . . . 1.9199999999999999 109.907 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.421 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 35.5 ttpt -82.72 145.38 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.059 -1.026 . . . . 2.21 110.4 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.921 HG22 ' CD1' ' A' ' 36' ' ' LEU . 3.7 t -81.67 128.79 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.256 -0.903 . . . . 0.28999999999999998 109.704 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.76 -177.4 6.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.093 -1.005 . . . . 0.55000000000000004 110.073 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.97 -40.41 73.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.073 -1.017 . . . . 2.1899999999999999 111.489 -173.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.567 ' O ' ' CD1' ' B' ' 15' ' ' LEU . 0.1 OUTLIER -76.49 -14.26 60.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.894 -1.129 . . . . 1.3899999999999999 110.647 -174.69 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.63 47.32 5.69 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.319 -1.512 . . . . 0.20999999999999999 109.319 -177.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.889 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.5 mtm180 -114.61 154.95 27.44 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.155 -1.203 . . . . 1.1399999999999999 110.058 -176.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.969 HG12 HD13 ' A' ' 36' ' ' LEU . 13.2 m -122.93 152.48 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.28000000000000003 109.74 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.893 HG22 ' CD ' ' A' ' 17' ' ' ARG . 14.9 t -112.84 134.1 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.23999999999999999 110.678 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.589 HD11 ' CG2' ' A' ' 45' ' ' ILE . 2.5 mm -84.29 137.21 39.72 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.924 . . . . 1.3799999999999999 109.388 174.259 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.57 ' HG2' HD12 ' B' ' 24' ' ' LEU . 9.8 Cg_endo -58.74 140.77 96.39 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.656 1.345 . . . . 0.35999999999999999 109.837 176.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.941 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.78 -31.99 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.998 -1.064 . . . . 1.1100000000000001 110.294 -177.374 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -58.74 -35.85 73.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.024 -1.047 . . . . 2.3700000000000001 109.609 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.57 HD12 ' HG2' ' B' ' 21' ' ' PRO . 41.8 mt -81.89 -28.01 33.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.431 -0.793 . . . . 1.75 110.566 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.534 ' CG ' ' HA ' ' B' ' 22' ' ' ILE . 70.7 mtt180 -56.78 -44.27 81.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.901 -1.124 . . . . 0.29999999999999999 108.957 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 26' ' ' ARG . . . . . 0.467 ' HE ' HD11 ' B' ' 22' ' ' ILE . 31.4 mmt180 -72.74 -47.96 42.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.484 -0.76 . . . . 3.27 110.642 -178.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.3 m -63.45 -31.96 73.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.226 -0.921 . . . . 0.77000000000000002 110.84 -177.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.845 HD23 HG13 ' B' ' 30' ' ' ILE . 21.0 tp -86.83 -4.99 59.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.132 -0.98 . . . . 1.05 110.66 -177.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.419 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.48 41.17 94.41 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.603 -1.399 . . . . 0.32000000000000001 109.603 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.845 HG13 HD23 ' B' ' 28' ' ' LEU . 32.6 mm -116.34 138.65 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -1.199 . . . . 0.40999999999999998 110.667 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.33 166.24 25.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.633 -0.667 . . . . 0.23000000000000001 110.001 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.4 tt0 -53.74 146.6 13.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 1.1299999999999999 110.475 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 43.6 tttm 75.07 -4.87 2.28 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.621 -0.675 . . . . 1.8799999999999999 111.169 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.1 m-20 -77.37 166.99 22.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.91 -1.119 . . . . 1.1000000000000001 110.041 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.722 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.27 130.78 53.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 0.35999999999999999 110.816 -176.629 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.952 HD13 HG12 ' A' ' 18' ' ' VAL . 13.1 mt -107.7 143.56 36.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.375 -0.828 . . . . 0.56000000000000005 109.495 175.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.625 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.2 tt0 -108.43 139.18 43.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.932 -1.105 . . . . 1.1699999999999999 109.85 172.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.5 mt -109.85 133.01 56.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.39 -0.819 . . . . 0.83999999999999997 110.489 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.631 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 17.1 m-85 -119.43 158.85 25.37 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 116.244 -0.435 . . . . 0.45000000000000001 109.94 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.432 HG21 HD11 ' A' ' 24' ' ' LEU . 86.5 t -131.82 123.65 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.863 -1.148 . . . . 0.26000000000000001 110.515 173.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.5 ' OD1' HG12 ' B' ' 46' ' ' ILE . 47.9 p-10 -148.18 149.14 31.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 1.77 110.613 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' B' ' 42' ' ' ASP . 53.2 t0 42.83 44.94 4.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.101 -0.999 . . . . 1.21 111.188 174.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 75.6 mm-40 57.42 14.65 2.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.071 -1.018 . . . . 1.9199999999999999 110.562 176.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -115.87 154.18 30.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 2.0 109.896 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.894 HG22 HD11 ' B' ' 47' ' ' LEU . 67.6 mt -93.07 128.84 44.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.187 -0.946 . . . . 1.24 109.945 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 21.0 mm -111.93 119.51 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.572 -0.705 . . . . 0.5 109.946 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.894 HD11 HG22 ' B' ' 45' ' ' ILE . 4.4 mp -118.78 134.23 55.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.892 -1.13 . . . . 1.6599999999999999 110.15 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.563 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 12.3 pttp -141.85 163.89 31.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 1.74 110.371 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -59.24 146.91 37.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.135 -0.978 . . . . 1.6499999999999999 110.1 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.967 ' CD2' HG11 ' A' ' 9' ' ' VAL . 10.5 t80 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.65000000000000002 110.542 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.5 mm . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 121.026 0.441 . . . . 1.3600000000000001 109.811 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.07 HG11 ' CD2' ' B' ' 50' ' ' TYR . 85.7 t -118.84 144.75 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.969 -1.082 . . . . 0.37 110.904 -174.615 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -129.94 159.26 37.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.455 -0.778 . . . . 1.9099999999999999 109.83 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -82.87 146.03 29.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 2.21 110.265 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.924 HG22 HD11 ' B' ' 36' ' ' LEU . 3.4 t -80.42 129.28 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.357 -0.839 . . . . 0.28000000000000003 109.866 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.84 -175.35 5.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.179 -0.951 . . . . 0.55000000000000004 110.039 179.337 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -54.56 -40.82 69.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.069 -1.019 . . . . 2.1899999999999999 111.788 -173.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.884 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.9 tp -84.99 -5.41 59.35 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.758 -1.214 . . . . 1.3799999999999999 111.595 -173.168 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.526 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.44 46.52 7.38 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 119.178 -1.486 . . . . 0.20999999999999999 109.687 -177.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.917 ' CD ' HG22 ' B' ' 19' ' ' VAL . 71.1 mtm180 -114.83 154.51 28.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.031 -1.276 . . . . 1.1499999999999999 110.004 -177.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.838 HG21 ' CD2' ' B' ' 47' ' ' LEU . 18.8 m -124.47 153.15 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.28000000000000003 109.809 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.928 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.4 t -111.19 135.38 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.23999999999999999 110.569 -176.007 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.599 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.69 134.6 47.18 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 1.3799999999999999 109.524 175.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.542 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.3 Cg_endo -58.27 143.45 97.19 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.756 1.398 . . . . 0.34999999999999998 110.092 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.892 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.28 -31.81 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.934 -1.104 . . . . 1.1100000000000001 110.416 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.42 -34.95 73.11 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.15 -0.969 . . . . 2.3700000000000001 109.907 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.599 ' HB2' HG23 ' A' ' 20' ' ' ILE . 61.5 mt -81.96 -30.66 31.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.326 -0.858 . . . . 1.75 110.589 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.892 ' HD2' HD12 ' A' ' 22' ' ' ILE . 73.7 mtt180 -57.69 -43.92 85.45 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.044 -1.062 . . . . 0.29999999999999999 109.212 175.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -72.5 -50.51 25.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.559 -0.713 . . . . 3.2599999999999998 110.706 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.0 m -63.7 -31.21 72.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.144 -0.972 . . . . 0.77000000000000002 111.086 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.916 HD23 HG13 ' A' ' 30' ' ' ILE . 22.9 tp -87.56 -4.78 58.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.088 -1.007 . . . . 1.05 110.698 -177.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.442 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.72 43.47 96.26 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.614 -1.395 . . . . 0.32000000000000001 109.614 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.916 HG13 HD23 ' A' ' 28' ' ' LEU . 30.8 mm -115.69 139.08 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.272 -1.134 . . . . 0.40999999999999998 110.65 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -140.81 167.49 22.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.555 -0.716 . . . . 0.23000000000000001 110.003 -178.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 83.4 tt0 -52.48 150.44 4.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 1.1299999999999999 110.468 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.604 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 39.9 mttp 67.01 -2.97 1.02 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 112.294 0.479 . . . . 1.8799999999999999 112.294 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.77 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.3 m-20 -75.55 166.89 22.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.526 -1.359 . . . . 1.1000000000000001 109.922 173.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.79 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -103.83 130.23 51.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.35999999999999999 110.769 -175.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.934 ' O ' HG13 ' B' ' 9' ' ' VAL . 13.7 mt -108.3 140.67 41.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.56000000000000005 109.49 175.084 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.745 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.1 tt0 -105.4 140.1 39.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.834 -1.166 . . . . 1.1699999999999999 109.731 173.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.2 mt -111.49 133.88 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.44 -0.788 . . . . 0.83999999999999997 110.478 -173.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.58 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 8.6 m-85 -115.2 160.4 19.77 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 120.904 0.383 . . . . 0.45000000000000001 110.09 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.0 t -133.58 123.13 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.132 -0.98 . . . . 0.27000000000000002 110.857 173.53 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.609 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.1 p-10 -147.3 141.61 26.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 1.77 110.22 177.184 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 53.4 t0 43.47 47.86 6.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.074 -1.016 . . . . 1.22 111.096 174.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.7 mt-10 58.74 13.77 2.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.186 -0.946 . . . . 1.9299999999999999 110.711 176.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -114.52 148.19 38.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 2.0099999999999998 110.07 175.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.586 HD13 HG13 ' B' ' 20' ' ' ILE . 61.2 mt -99.6 127.6 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 1.25 110.095 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.609 HD11 ' OD2' ' A' ' 41' ' ' ASP . 34.2 mt -111.87 118.15 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.331 -0.856 . . . . 0.5 110.275 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.94 ' CD2' HG21 ' B' ' 18' ' ' VAL . 4.2 mp -107.95 135.59 49.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 1.6599999999999999 110.122 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.575 ' HE3' ' CD1' ' A' ' 39' ' ' TYR . 16.2 ptpt -142.45 164.22 30.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.516 -0.74 . . . . 1.74 110.125 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -55.77 147.95 17.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.116 -0.99 . . . . 1.6499999999999999 109.721 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.924 ' CD2' HG11 ' B' ' 9' ' ' VAL . 1.7 t80 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.34999999999999998 110.644 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.934 HG13 ' O ' ' A' ' 36' ' ' LEU . 86.3 t . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.456 0.645 . . . . 0.37 110.935 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -129.93 159.08 37.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.468 -0.77 . . . . 1.9199999999999999 109.924 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -82.84 145.93 29.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 2.21 110.395 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.927 HG22 ' CD1' ' A' ' 36' ' ' LEU . 3.4 t -80.26 129.46 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.917 . . . . 0.28999999999999998 109.756 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.09 -175.29 5.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.122 -0.986 . . . . 0.55000000000000004 110.069 179.154 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.67 -40.78 69.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.177 -0.952 . . . . 2.1899999999999999 111.678 -173.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.904 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.2 tp -85.04 -5.43 59.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.764 -1.21 . . . . 1.3899999999999999 111.572 -173.144 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.531 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.11 47.24 7.15 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.523 -1.431 . . . . 0.20999999999999999 109.523 -177.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.928 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.9 mtm180 -115.06 154.49 28.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.05 -1.265 . . . . 1.1399999999999999 109.932 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.94 HG21 ' CD2' ' A' ' 47' ' ' LEU . 18.8 m -124.49 153.07 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.28000000000000003 109.822 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.917 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.4 t -111.23 135.3 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -0.956 . . . . 0.23999999999999999 110.605 -175.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.603 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.62 134.52 47.52 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.26 -0.9 . . . . 1.3799999999999999 109.545 175.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.541 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.3 Cg_endo -58.28 143.4 97.29 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.851 1.448 . . . . 0.35999999999999999 110.111 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.888 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.36 -31.66 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.098 -1.001 . . . . 1.1100000000000001 110.408 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.26 -35.63 74.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.121 -0.987 . . . . 2.3700000000000001 109.808 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.603 ' HB2' HG23 ' B' ' 20' ' ' ILE . 62.2 mt -81.23 -30.96 34.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.386 -0.822 . . . . 1.75 110.619 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.888 ' HD2' HD12 ' B' ' 22' ' ' ILE . 73.2 mtt180 -57.57 -43.86 84.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.883 -1.135 . . . . 0.29999999999999999 109.208 176.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -72.45 -50.81 23.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 3.27 110.599 -177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.7 m -63.35 -31.8 73.05 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.77000000000000002 110.88 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.915 HD23 HG13 ' B' ' 30' ' ' ILE . 23.1 tp -87.0 -5.21 59.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.042 -1.036 . . . . 1.05 110.651 -176.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.445 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.01 43.25 96.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.55 -1.42 . . . . 0.32000000000000001 109.55 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.915 HG13 HD23 ' B' ' 28' ' ' LEU . 30.5 mm -115.53 138.97 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.213 -1.169 . . . . 0.40999999999999998 110.727 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -140.6 167.64 21.69 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.676 -0.64 . . . . 0.23000000000000001 110.003 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' B' ' 33' ' ' LYS . 83.5 tt0 -52.59 150.69 4.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 1.1299999999999999 110.454 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' B' ' 32' ' ' GLU . 40.5 mttp 66.52 -2.51 1.03 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 112.4 0.518 . . . . 1.8799999999999999 112.4 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.654 ' O ' HG23 ' A' ' 12' ' ' VAL . 88.5 m-20 -75.86 166.78 23.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.599 -1.313 . . . . 1.1000000000000001 109.895 173.492 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.762 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.64 130.14 51.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -0.91 . . . . 0.35999999999999999 110.807 -175.763 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.937 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.6 mt -108.28 140.5 41.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.866 . . . . 0.56000000000000005 109.513 175.065 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.722 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.8 tt0 -105.24 139.98 39.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.827 -1.171 . . . . 1.1699999999999999 109.86 173.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 71.4 mt -111.41 133.99 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.362 -0.836 . . . . 0.83999999999999997 110.455 -173.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.578 ' CD1' ' HE3' ' B' ' 48' ' ' LYS . 8.5 m-85 -115.2 160.38 19.8 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 120.972 0.415 . . . . 0.45000000000000001 110.18 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 94.3 t -133.31 123.45 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.922 -1.112 . . . . 0.26000000000000001 110.686 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.612 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.1 p-10 -147.69 141.55 25.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 1.77 110.197 176.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 54.1 t0 43.56 48.0 6.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.098 -1.001 . . . . 1.21 111.045 174.642 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.7 mt-10 58.55 13.85 2.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.132 -0.98 . . . . 1.9199999999999999 110.666 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -114.44 148.39 37.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 2.0 110.007 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.459 HD13 ' CG1' ' A' ' 20' ' ' ILE . 60.9 mt -99.71 127.61 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.909 . . . . 1.24 110.145 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.612 HD11 ' OD2' ' B' ' 41' ' ' ASP . 35.5 mt -112.03 118.16 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.428 -0.795 . . . . 0.5 110.216 178.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.838 ' CD2' HG21 ' A' ' 18' ' ' VAL . 4.3 mp -107.83 135.48 49.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 1.6599999999999999 110.009 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.578 ' HE3' ' CD1' ' B' ' 39' ' ' TYR . 16.2 ptpt -142.29 164.28 30.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.517 -0.739 . . . . 1.74 110.153 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -55.83 147.84 18.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.083 -1.011 . . . . 1.6499999999999999 109.764 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 1.07 ' CD2' HG11 ' A' ' 9' ' ' VAL . 1.7 t80 . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.65000000000000002 110.616 -175.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.4 mt . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 109.633 -0.506 . . . . 1.3600000000000001 109.633 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.91 HG13 ' O ' ' B' ' 36' ' ' LEU . 78.5 t -113.14 144.52 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.815 -1.178 . . . . 0.37 111.347 -170.404 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.444 ' NH1' ' HG2' ' A' ' 10' ' ' ARG . 57.4 ttp85 -129.19 167.08 18.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.536 -0.727 . . . . 1.9099999999999999 109.455 175.057 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -84.42 146.45 27.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.02 -1.05 . . . . 2.21 110.443 -178.233 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.907 HG22 ' CD1' ' B' ' 36' ' ' LEU . 3.9 t -82.47 131.8 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -0.839 . . . . 0.28000000000000003 109.758 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.46 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.14 -175.55 5.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.55000000000000004 110.058 -179.038 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.424 ' HG2' ' OE2' ' B' ' 32' ' ' GLU . 97.0 mt-10 -57.03 -39.34 74.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.064 -1.022 . . . . 2.1899999999999999 111.754 -172.675 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.882 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.7 tp -84.29 -5.96 59.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.734 -1.229 . . . . 1.3799999999999999 111.606 -173.616 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.413 ' HA2' HG12 ' A' ' 12' ' ' VAL . . . 79.99 46.9 7.41 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.161 -1.495 . . . . 0.20999999999999999 109.694 -177.744 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.915 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.5 mtm180 -114.58 154.5 28.21 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.954 -1.321 . . . . 1.1499999999999999 110.127 -177.221 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.853 HG12 HD13 ' B' ' 36' ' ' LEU . 15.5 m -123.26 150.69 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.311 -0.868 . . . . 0.28000000000000003 109.802 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.928 HG22 ' CD ' ' B' ' 17' ' ' ARG . 34.1 t -111.69 134.16 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.915 . . . . 0.23999999999999999 110.632 -175.571 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.714 HD11 HG21 ' B' ' 45' ' ' ILE . 2.9 mm -83.89 134.78 43.51 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 1.3799999999999999 109.507 174.959 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.555 ' HG2' HD12 ' A' ' 24' ' ' LEU . 9.3 Cg_endo -58.17 143.42 96.86 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.749 1.394 . . . . 0.34999999999999998 110.061 177.394 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.903 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.1 tp -54.92 -33.47 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.014 -1.054 . . . . 1.1100000000000001 110.429 -178.802 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.416 ' N ' HG23 ' A' ' 22' ' ' ILE . 84.2 tt0 -58.06 -35.51 71.44 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.094 -1.003 . . . . 2.3700000000000001 109.816 178.769 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.562 ' HB2' HG23 ' A' ' 20' ' ' ILE . 48.2 mt -83.28 -29.17 28.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.39 -0.819 . . . . 1.75 110.636 178.865 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.903 ' HD2' HD12 ' A' ' 22' ' ' ILE . 71.4 mtt180 -57.71 -44.24 85.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.834 -1.166 . . . . 0.29999999999999999 109.069 175.451 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -72.97 -48.62 35.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.54 -0.725 . . . . 3.2599999999999998 110.719 -177.878 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.0 m -63.48 -32.06 73.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.153 -0.967 . . . . 0.77000000000000002 111.081 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.772 HD23 HG13 ' A' ' 30' ' ' ILE . 18.1 tp -88.28 -4.4 58.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.088 -1.008 . . . . 1.05 110.766 -176.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.42 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 66.31 42.05 94.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.818 -1.313 . . . . 0.32000000000000001 109.818 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.772 HG13 HD23 ' A' ' 28' ' ' LEU . 34.1 mm -116.49 137.76 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -1.156 . . . . 0.40999999999999998 110.682 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.4 ' HB3' ' OD2' ' A' ' 34' ' ' ASP . . . -142.14 166.5 24.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.594 -0.691 . . . . 0.23000000000000001 110.04 -178.149 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.2 146.68 11.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 1.1299999999999999 110.599 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 44.7 tttm 74.25 -4.52 2.28 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.666 -0.646 . . . . 1.8799999999999999 111.143 176.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.781 ' O ' HG23 ' B' ' 12' ' ' VAL . 91.2 m-20 -77.54 168.46 19.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.859 -1.151 . . . . 1.1000000000000001 110.064 175.147 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.605 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.34 130.56 52.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.35999999999999999 110.694 -176.754 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.961 ' CD1' HG22 ' B' ' 12' ' ' VAL . 9.1 mt -107.09 142.69 36.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.314 -0.866 . . . . 0.56000000000000005 109.312 174.618 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.699 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.1 tt0 -105.76 137.75 43.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.775 -1.203 . . . . 1.1699999999999999 109.585 172.915 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.0 mt -108.0 131.37 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -0.784 . . . . 0.83999999999999997 110.536 -172.441 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.609 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 23.3 m-85 -120.16 155.81 32.35 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.849 -0.426 . . . . 0.45000000000000001 109.849 -178.925 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' VAL . . . . . 0.551 HG21 HD11 ' B' ' 24' ' ' LEU . 71.3 t -131.23 120.75 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.88 -1.137 . . . . 0.27000000000000002 110.586 172.77 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 47.9 p-10 -148.25 160.86 42.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 1.77 110.583 178.659 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 54.8 t0 42.13 41.23 1.96 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.065 -1.022 . . . . 1.22 111.575 172.03 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 96.0 mt-10 56.57 15.99 2.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.984 -1.072 . . . . 1.9299999999999999 110.541 175.491 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 27.3 pttt -129.54 164.77 23.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.96 . . . . 2.0099999999999998 109.738 174.564 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.725 HG21 HD11 ' B' ' 20' ' ' ILE . 64.7 mt -97.66 134.18 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 1.25 110.381 -174.67 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.609 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.6 mm -113.21 121.29 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.679 -0.638 . . . . 0.5 109.969 177.475 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.834 ' N ' HD12 ' A' ' 47' ' ' LEU . 3.9 mp -120.77 133.78 55.32 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.915 -1.116 . . . . 1.6599999999999999 110.021 178.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.595 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 12.9 pttp -143.62 165.53 27.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.232 -0.918 . . . . 1.74 110.631 -179.224 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.552 ' HD3' ' CD1' ' A' ' 30' ' ' ILE . 14.3 tptt -57.6 146.94 28.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 1.6499999999999999 110.127 177.301 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.853 ' CD2' HG11 ' B' ' 9' ' ' VAL . 11.2 t80 . . . . . 0 C--N 1.3 -1.568 0 O-C-N 121.324 -0.86 . . . . 0.34999999999999998 110.693 -176.632 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.943 HG13 ' O ' ' A' ' 36' ' ' LEU . 77.3 t . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.585 0.707 . . . . 0.37 111.356 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.442 ' NH1' ' HG2' ' B' ' 10' ' ' ARG . 57.4 ttp85 -129.07 166.99 18.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.519 -0.738 . . . . 1.9199999999999999 109.537 175.076 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -84.46 146.37 27.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.052 . . . . 2.21 110.551 -178.152 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.961 HG22 ' CD1' ' A' ' 36' ' ' LEU . 3.9 t -82.48 131.75 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.379 -0.826 . . . . 0.28999999999999998 109.699 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.08 -175.49 5.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.084 -1.01 . . . . 0.55000000000000004 110.212 -179.219 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.49 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -57.17 -39.24 74.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.143 -0.973 . . . . 2.1899999999999999 111.639 -172.358 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.901 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.4 tp -84.34 -5.96 59.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.811 -1.181 . . . . 1.3899999999999999 111.61 -173.637 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.411 ' HA2' HG12 ' B' ' 12' ' ' VAL . . . 79.53 47.8 7.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.533 -1.427 . . . . 0.20999999999999999 109.533 -177.83 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.928 ' CD ' HG22 ' A' ' 19' ' ' VAL . 69.5 mtm180 -114.88 154.48 28.59 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.091 -1.24 . . . . 1.1399999999999999 110.046 -177.539 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.877 HG12 HD13 ' A' ' 36' ' ' LEU . 15.5 m -123.27 150.65 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.326 -0.859 . . . . 0.28000000000000003 109.874 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.915 HG22 ' CD ' ' A' ' 17' ' ' ARG . 33.6 t -111.78 134.12 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.23999999999999999 110.56 -175.494 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.725 HD11 HG21 ' A' ' 45' ' ' ILE . 2.9 mm -83.81 134.75 43.77 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.22 -0.925 . . . . 1.3799999999999999 109.617 174.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.2 Cg_endo -58.24 143.35 97.2 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.727 1.383 . . . . 0.35999999999999999 110.066 177.517 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.898 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -55.07 -33.35 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.997 -1.065 . . . . 1.1100000000000001 110.334 -178.511 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 23' ' ' GLU . . . . . 0.412 ' N ' HG23 ' B' ' 22' ' ' ILE . 84.1 tt0 -57.83 -36.22 71.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.042 -1.036 . . . . 2.3700000000000001 109.709 178.498 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.565 ' HB2' HG23 ' B' ' 20' ' ' ILE . 48.5 mt -82.47 -29.58 30.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.388 -0.82 . . . . 1.75 110.654 178.877 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.898 ' HD2' HD12 ' B' ' 22' ' ' ILE . 70.6 mtt180 -57.59 -44.08 85.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.817 -1.177 . . . . 0.29999999999999999 109.046 175.913 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -73.0 -48.83 32.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.863 . . . . 3.27 110.566 -177.924 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.4 m -63.23 -32.54 73.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.254 -0.904 . . . . 0.77000000000000002 110.909 -178.177 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.774 HD23 HG13 ' B' ' 30' ' ' ILE . 18.2 tp -87.77 -4.91 58.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.045 -1.035 . . . . 1.05 110.667 -176.724 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.423 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.83 41.83 93.32 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.659 -1.377 . . . . 0.32000000000000001 109.659 178.525 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.774 HG13 HD23 ' B' ' 28' ' ' LEU . 33.7 mm -116.48 137.66 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -1.162 . . . . 0.40999999999999998 110.644 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 31' ' ' ALA . . . . . 0.4 ' HB3' ' OD2' ' B' ' 34' ' ' ASP . . . -141.96 166.55 24.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.602 -0.686 . . . . 0.23000000000000001 110.081 -178.27 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.13 146.72 10.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 1.1299999999999999 110.582 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 44.6 tttm 74.27 -4.56 2.27 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.645 -0.659 . . . . 1.8799999999999999 111.198 176.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.751 ' O ' HG23 ' A' ' 12' ' ' VAL . 91.1 m-20 -77.67 168.19 20.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.792 -1.192 . . . . 1.1000000000000001 110.031 175.204 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.597 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.12 130.69 51.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.35999999999999999 110.819 -176.868 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.91 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.1 mt -107.26 142.5 36.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.56000000000000005 109.318 174.68 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.653 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.0 tt0 -105.55 137.71 42.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.929 -1.107 . . . . 1.1699999999999999 109.721 172.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 71.5 mt -108.02 131.41 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.349 -0.844 . . . . 0.83999999999999997 110.538 -172.367 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.617 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 23.0 m-85 -120.1 155.85 32.19 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 116.294 -0.412 . . . . 0.45000000000000001 109.948 -178.965 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 40' ' ' VAL . . . . . 0.527 HG21 HD11 ' A' ' 24' ' ' LEU . 72.1 t -131.1 121.15 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.836 -1.165 . . . . 0.26000000000000001 110.402 172.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 47.9 p-10 -148.82 160.92 42.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -0.933 . . . . 1.77 110.519 178.461 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' B' ' 42' ' ' ASP . 55.2 t0 41.76 41.72 1.88 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.172 -0.955 . . . . 1.21 111.554 172.374 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 96.0 mt-10 56.26 16.11 2.2 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.881 -1.137 . . . . 1.9199999999999999 110.552 175.446 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 44' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 27.2 pttt -129.63 164.9 22.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 2.0 109.604 174.466 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.742 HG22 HD11 ' B' ' 47' ' ' LEU . 64.6 mt -97.67 134.08 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 1.24 110.416 -174.684 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 21.6 mm -113.21 121.47 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.748 -0.595 . . . . 0.5 109.914 177.497 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.833 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.0 mp -120.73 133.5 55.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.931 -1.106 . . . . 1.6599999999999999 109.958 179.005 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.592 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 13.2 pttp -143.47 165.72 26.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.962 . . . . 1.74 110.657 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.557 ' HD3' ' CD1' ' B' ' 30' ' ' ILE . 14.4 tptt -57.6 146.87 28.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 1.6499999999999999 110.012 177.364 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.889 ' CD2' HG11 ' A' ' 9' ' ' VAL . 11.4 t80 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 0.65000000000000002 110.643 -176.643 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.1 mm . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 109.669 -0.493 . . . . 1.3600000000000001 109.669 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.899 HG13 ' O ' ' B' ' 36' ' ' LEU . 78.4 t -109.85 143.48 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.86 -1.15 . . . . 0.37 111.281 -171.281 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ARG . . . . . 0.449 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 15.5 tpt180 -121.27 161.62 21.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.571 -0.706 . . . . 1.9099999999999999 109.666 177.691 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' B' ' 33' ' ' LYS . 6.4 tptm -82.8 142.42 31.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.169 -0.957 . . . . 2.21 110.364 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.904 HG22 HD11 ' B' ' 36' ' ' LEU . 8.9 t -82.97 130.39 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.329 -0.857 . . . . 0.28000000000000003 109.886 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -83.96 -175.28 5.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.099 -1.001 . . . . 0.55000000000000004 110.036 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HG2' ' OE2' ' B' ' 32' ' ' GLU . 97.0 mt-10 -56.66 -39.71 74.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.998 -1.064 . . . . 2.1899999999999999 111.756 -172.514 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.4 tp -84.68 -5.73 59.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.794 -1.191 . . . . 1.3799999999999999 111.523 -173.831 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLY . . . . . 0.479 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.19 46.7 7.42 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.228 -1.463 . . . . 0.20999999999999999 109.643 -177.72 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.916 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.0 mtm180 -114.36 155.03 27.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.071 -1.252 . . . . 1.1499999999999999 110.024 -177.647 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.847 HG12 HD13 ' B' ' 36' ' ' LEU . 17.1 m -123.87 152.43 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.365 -0.834 . . . . 0.28000000000000003 109.817 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.925 HG22 ' CD ' ' B' ' 17' ' ' ARG . 33.6 t -110.03 135.82 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.23999999999999999 110.446 -176.931 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -80.63 130.46 64.43 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 1.3799999999999999 109.465 174.905 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -56.79 143.63 90.03 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.817 1.43 . . . . 0.34999999999999998 110.059 178.562 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.838 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.14 -32.54 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.005 -1.06 . . . . 1.1100000000000001 110.293 -178.18 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -57.68 -36.48 71.98 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.055 -1.028 . . . . 2.3700000000000001 109.891 178.025 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.563 ' HB2' HG23 ' A' ' 20' ' ' ILE . 51.7 mt -82.07 -30.04 31.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.346 -0.847 . . . . 1.75 110.63 178.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.838 ' HD2' HD12 ' A' ' 22' ' ' ILE . 73.9 mtt180 -57.91 -43.61 86.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.923 -1.111 . . . . 0.29999999999999999 109.172 175.631 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -74.2 -51.7 14.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.469 -0.769 . . . . 3.2599999999999998 110.651 -177.08 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.6 m -64.04 -31.22 72.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.77000000000000002 111.182 -178.379 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.951 HD23 HG13 ' A' ' 30' ' ' ILE . 16.7 tp -88.6 -4.89 58.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.09 -1.006 . . . . 1.05 110.808 -176.742 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.471 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.69 43.97 95.59 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.738 -1.345 . . . . 0.32000000000000001 109.738 179.166 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.951 HG13 HD23 ' A' ' 28' ' ' LEU . 31.3 mm -115.82 136.94 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.266 -1.137 . . . . 0.40999999999999998 110.75 -178.082 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.43 167.12 23.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.62 -0.675 . . . . 0.23000000000000001 110.019 -177.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.22 146.05 12.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.037 -1.039 . . . . 1.1299999999999999 110.623 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 68.3 tttt 74.34 -4.24 2.36 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.665 . . . . 1.8799999999999999 111.144 176.921 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.792 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.2 m-20 -77.22 168.97 19.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.866 -1.146 . . . . 1.1000000000000001 110.06 174.736 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.05 130.97 54.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.35999999999999999 110.612 -177.205 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.924 ' O ' HG13 ' B' ' 9' ' ' VAL . 9.2 mt -107.06 141.97 37.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 0.56000000000000005 109.235 174.993 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.583 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.1 tt0 -104.3 137.6 41.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.769 -1.207 . . . . 1.1699999999999999 109.712 174.08 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.0 mt -108.73 132.57 56.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.456 -0.778 . . . . 0.83999999999999997 110.605 -172.656 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' TYR . . . . . 0.631 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 22.5 m-85 -121.07 157.25 30.45 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.868 -0.419 . . . . 0.45000000000000001 109.868 -178.775 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.2 t -131.56 125.91 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.811 -1.18 . . . . 0.27000000000000002 110.715 173.498 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.486 ' OD1' HG12 ' A' ' 46' ' ' ILE . 38.7 p-10 -147.48 140.87 25.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.92 . . . . 1.77 110.733 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.8 t0 43.32 46.74 5.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.001 -1.062 . . . . 1.22 111.449 173.336 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.8 tt0 61.3 10.87 3.28 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.132 -0.98 . . . . 1.9299999999999999 110.707 175.479 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -111.44 151.09 28.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 2.0099999999999998 109.885 175.179 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.874 HG22 HD11 ' A' ' 47' ' ' LEU . 67.2 mt -92.9 128.22 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.308 -0.87 . . . . 1.25 109.779 177.713 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 23.5 mm -111.45 118.29 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.543 -0.723 . . . . 0.5 109.91 178.817 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.874 HD11 HG22 ' A' ' 45' ' ' ILE . 3.9 mp -119.27 134.18 55.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.867 -1.146 . . . . 1.6599999999999999 110.164 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.586 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 13.0 pttp -143.26 163.26 33.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 1.74 110.44 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -58.18 147.52 29.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 1.6499999999999999 109.94 177.798 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.57 ' CD2' HG11 ' B' ' 9' ' ' VAL . 15.5 t80 . . . . . 0 C--N 1.3 -1.566 0 O-C-N 121.368 -0.833 . . . . 0.34999999999999998 110.688 -175.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 9' ' ' VAL . . . . . 0.924 HG13 ' O ' ' A' ' 36' ' ' LEU . 78.0 t . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.601 0.715 . . . . 0.37 111.244 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 10' ' ' ARG . . . . . 0.457 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 15.5 tpt180 -121.28 161.5 21.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.589 -0.695 . . . . 1.9199999999999999 109.753 177.619 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 11' ' ' LYS . . . . . 0.457 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 6.4 tptm -82.83 142.26 31.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.994 . . . . 2.21 110.37 -178.643 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.887 HG22 HD11 ' A' ' 36' ' ' LEU . 8.9 t -82.88 130.56 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.24 -0.913 . . . . 0.28999999999999998 109.855 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.01 -175.05 5.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.983 . . . . 0.55000000000000004 110.227 179.674 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' B' B ' 14' ' ' GLU . . . . . 0.492 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -56.91 -39.63 74.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.132 -0.98 . . . . 2.1899999999999999 111.634 -172.189 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 15' ' ' LEU . . . . . 0.9 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.3 tp -84.65 -5.89 59.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.786 -1.196 . . . . 1.3899999999999999 111.546 -173.802 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 16' ' ' GLY . . . . . 0.478 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.93 47.32 7.2 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.531 -1.428 . . . . 0.20999999999999999 109.531 -177.727 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 17' ' ' ARG . . . . . 0.925 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.0 mtm180 -114.43 154.99 27.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.089 -1.242 . . . . 1.1399999999999999 110.042 -177.884 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 18' ' ' VAL . . . . . 0.847 HG12 HD13 ' A' ' 36' ' ' LEU . 17.1 m -123.96 152.42 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.887 . . . . 0.28000000000000003 109.775 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 19' ' ' VAL . . . . . 0.916 HG22 ' CD ' ' A' ' 17' ' ' ARG . 34.2 t -110.06 135.72 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.146 -0.971 . . . . 0.23999999999999999 110.506 -176.9 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 20' ' ' ILE . . . . . 0.556 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -80.57 130.45 64.65 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 1.3799999999999999 109.537 174.978 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.1 Cg_endo -56.82 143.66 90.23 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.773 1.407 . . . . 0.35999999999999999 110.115 178.643 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 22' ' ' ILE . . . . . 0.866 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.27 -32.39 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.155 -0.966 . . . . 1.1100000000000001 110.281 -177.991 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -57.49 -37.18 72.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.046 -1.034 . . . . 2.3700000000000001 109.808 177.736 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 24' ' ' LEU . . . . . 0.556 ' HB2' HG23 ' B' ' 20' ' ' ILE . 51.1 mt -81.32 -30.52 33.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.468 -0.77 . . . . 1.75 110.561 178.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 25' ' ' ARG . . . . . 0.866 ' HD2' HD12 ' B' ' 22' ' ' ILE . 73.7 mtt180 -57.69 -43.43 85.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.9 -1.125 . . . . 0.29999999999999999 109.285 176.008 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -74.26 -51.82 14.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 3.27 110.571 -177.218 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.3 m -63.85 -31.85 73.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.77000000000000002 110.855 -178.107 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 28' ' ' LEU . . . . . 0.984 HD23 HG13 ' B' ' 30' ' ' ILE . 16.8 tp -88.07 -5.25 58.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.971 -1.081 . . . . 1.05 110.691 -176.356 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 29' ' ' GLY . . . . . 0.454 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.91 43.89 95.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.646 -1.382 . . . . 0.32000000000000001 109.646 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 30' ' ' ILE . . . . . 0.984 HG13 HD23 ' B' ' 28' ' ' LEU . 31.3 mm -115.68 136.79 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -1.162 . . . . 0.40999999999999998 110.797 -178.122 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.12 167.18 23.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.574 -0.704 . . . . 0.23000000000000001 109.951 -177.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 32' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.05 146.04 11.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.143 -0.973 . . . . 1.1299999999999999 110.634 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 33' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 68.1 tttt 74.34 -4.29 2.35 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.713 -0.617 . . . . 1.8799999999999999 111.168 176.924 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 34' ' ' ASP . . . . . 0.787 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.8 m-20 -77.42 168.76 19.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.846 -1.158 . . . . 1.1000000000000001 109.979 174.869 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 35' ' ' ALA . . . . . 0.449 ' HB1' HG11 ' A' ' 9' ' ' VAL . . . -106.81 130.93 54.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.35999999999999999 110.726 -177.256 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 36' ' ' LEU . . . . . 0.904 HD11 HG22 ' A' ' 12' ' ' VAL . 9.1 mt -107.08 141.79 37.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.265 -0.897 . . . . 0.56000000000000005 109.319 174.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 37' ' ' GLU . . . . . 0.565 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.0 tt0 -103.99 137.57 41.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.78 -1.2 . . . . 1.1699999999999999 109.881 174.06 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.2 mt -108.73 132.61 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.83999999999999997 110.493 -172.588 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 39' ' ' TYR . . . . . 0.616 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 22.0 m-85 -121.05 157.2 30.55 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 116.208 -0.451 . . . . 0.45000000000000001 109.886 -178.857 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 75.6 t -131.36 126.27 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.861 -1.149 . . . . 0.26000000000000001 110.545 173.536 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 41' ' ' ASP . . . . . 0.495 ' OD1' HG12 ' B' ' 46' ' ' ILE . 38.5 p-10 -147.99 140.77 24.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.333 -0.854 . . . . 1.77 110.638 179.005 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 42' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 54.3 t0 43.44 46.88 5.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.072 -1.018 . . . . 1.21 111.317 173.346 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.6 tt0 61.1 10.88 3.12 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.053 -1.029 . . . . 1.9199999999999999 110.71 175.504 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -111.38 151.3 28.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 2.0 109.913 175.062 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 45' ' ' ILE . . . . . 0.868 HG22 HD11 ' B' ' 47' ' ' LEU . 66.8 mt -93.01 128.07 44.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.253 -0.904 . . . . 1.24 109.876 177.699 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 46' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 23.2 mm -111.55 118.42 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.611 -0.681 . . . . 0.5 109.886 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 47' ' ' LEU . . . . . 0.868 HD11 HG22 ' B' ' 45' ' ' ILE . 4.0 mp -119.2 134.07 55.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.957 -1.089 . . . . 1.6599999999999999 110.13 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 48' ' ' LYS . . . . . 0.589 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 13.3 pttp -143.2 163.33 33.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.206 -0.934 . . . . 1.74 110.455 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -58.1 147.43 29.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.908 . . . . 1.6499999999999999 109.917 177.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' B' B ' 50' ' ' TYR . . . . . 0.599 ' CD2' HG11 ' A' ' 9' ' ' VAL . 15.6 t80 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.214 -0.929 . . . . 0.65000000000000002 110.605 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.2 t80 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.213 0.53 . . . . 10.99 110.22 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.6 mtp -128.38 160.65 31.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 8.7599999999999998 110.185 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -88.49 140.15 29.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.919 . . . . 8.8499999999999996 110.124 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.553 ' CB ' ' CD2' ' B' ' 39' ' ' TYR . 82.7 p -146.27 165.53 28.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 4.2000000000000002 110.237 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.418 HG23 ' HB ' ' B' ' 40' ' ' VAL . 80.4 p -62.34 -34.11 76.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 3.77 110.181 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.18 46.32 43.71 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.737 -1.345 . . . . 0.82999999999999996 109.737 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.9 mt -114.83 134.5 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.083 -1.245 . . . . 1.3600000000000001 109.993 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.931 HG13 ' O ' ' B' ' 36' ' ' LEU . 90.3 t -116.68 144.06 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.041 -1.037 . . . . 0.37 110.961 -175.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 27.7 tpt180 -128.15 159.21 35.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.464 -0.773 . . . . 1.9099999999999999 109.711 177.279 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.425 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 70.3 mttt -85.74 147.67 26.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.103 -0.998 . . . . 2.21 110.401 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.938 HG22 HD11 ' B' ' 36' ' ' LEU . 3.7 t -84.06 129.0 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.292 -0.88 . . . . 0.28000000000000003 109.942 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.68 -175.29 5.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.55000000000000004 110.08 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -54.24 -40.91 68.16 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.151 -0.968 . . . . 2.1899999999999999 111.671 -173.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.851 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.3 tp -84.12 -5.64 59.28 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.739 -1.225 . . . . 1.3799999999999999 111.581 -173.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.38 46.31 7.54 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.191 -1.48 . . . . 0.20999999999999999 109.657 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.919 ' CD ' HG22 ' B' ' 19' ' ' VAL . 72.6 mtm180 -114.74 154.05 29.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.099 -1.236 . . . . 1.1499999999999999 109.968 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.71 HG12 HD13 ' B' ' 36' ' ' LEU . 19.8 m -123.99 153.11 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.28000000000000003 109.866 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.928 HG22 ' CD ' ' B' ' 17' ' ' ARG . 24.3 t -111.35 134.77 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.23999999999999999 110.632 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.585 HG23 ' HB2' ' A' ' 24' ' ' LEU . 6.4 mt -82.53 135.14 46.81 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 1.3799999999999999 109.487 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.2 Cg_endo -58.13 142.98 97.39 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.771 1.406 . . . . 0.34999999999999998 110.044 177.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.885 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.14 -32.78 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.962 -1.086 . . . . 1.1100000000000001 110.373 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -58.07 -35.64 71.66 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.113 -0.992 . . . . 2.3700000000000001 109.861 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.585 ' HB2' HG23 ' A' ' 20' ' ' ILE . 54.9 mt -82.75 -29.78 29.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.382 -0.824 . . . . 1.75 110.627 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.885 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.8 mtt180 -57.56 -44.13 85.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.898 -1.126 . . . . 0.29999999999999999 109.146 175.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -73.37 -49.14 28.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.537 -0.727 . . . . 3.2599999999999998 110.742 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.0 m -63.94 -31.24 72.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.189 -0.944 . . . . 0.77000000000000002 111.085 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.929 HD23 HG13 ' A' ' 30' ' ' ILE . 22.2 tp -87.57 -4.79 58.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.027 -1.046 . . . . 1.05 110.711 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.416 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.75 43.74 95.82 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.663 -1.375 . . . . 0.32000000000000001 109.663 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.929 HG13 HD23 ' A' ' 28' ' ' LEU . 31.6 mm -115.28 138.99 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.241 -1.152 . . . . 0.40999999999999998 110.699 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.79 167.11 22.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.631 -0.668 . . . . 0.23000000000000001 109.945 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.52 146.02 13.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.047 -1.033 . . . . 1.1299999999999999 110.554 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 40.7 tttt 74.81 -4.57 2.33 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.757 -0.589 . . . . 1.8799999999999999 111.103 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.729 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.9 m-20 -76.93 165.54 24.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.773 -1.204 . . . . 1.1000000000000001 110.028 174.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -106.26 132.52 52.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 0.35999999999999999 110.734 -176.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.925 ' O ' HG13 ' B' ' 9' ' ' VAL . 12.6 mt -108.9 142.74 39.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.56000000000000005 109.49 175.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.625 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.8 tt0 -107.88 139.8 41.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.869 -1.144 . . . . 1.1699999999999999 109.793 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 72.1 mt -112.61 136.85 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.393 -0.817 . . . . 0.83999999999999997 110.68 -172.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.577 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 14.6 m-85 -114.16 158.61 21.08 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.977 -0.379 . . . . 0.45000000000000001 109.977 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.581 ' HB ' HG23 ' B' ' 6' ' ' THR . 83.9 t -130.66 121.92 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.973 -1.079 . . . . 0.27000000000000002 110.739 172.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.576 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.9 p-10 -147.17 140.51 25.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 1.77 110.216 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 52.4 t0 43.56 48.39 6.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.02 -1.05 . . . . 1.22 111.154 175.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.8 mt-10 58.55 14.05 2.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.134 -0.979 . . . . 1.9299999999999999 110.656 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -117.12 147.11 42.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 2.0099999999999998 110.024 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.577 ' CD1' HD11 ' B' ' 20' ' ' ILE . 60.4 mt -99.98 128.17 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 1.25 110.093 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 24.1 mt -111.52 118.62 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.352 -0.843 . . . . 0.5 110.209 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.837 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -108.04 136.54 47.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.067 -1.021 . . . . 1.6599999999999999 110.093 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.548 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 27.2 pttt -138.64 162.23 35.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.501 -0.749 . . . . 1.74 110.189 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -58.84 146.55 36.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.09 -1.006 . . . . 1.6499999999999999 109.965 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.588 ' CD2' HG11 ' B' ' 9' ' ' VAL . 9.1 t80 -105.95 119.23 38.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.34999999999999998 110.726 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.82 122.84 49.62 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.359 -0.838 . . . . 3.21 109.307 171.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -63.05 145.12 93.92 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.74 1.389 . . . . 0.47999999999999998 110.299 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.03 -0.986 . . . . 2.4100000000000001 110.258 -179.878 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.184 0.516 . . . . 11.66 110.183 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 50.9 ttm -89.48 126.09 35.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 8.6999999999999993 110.183 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -99.65 144.27 28.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 9.1699999999999999 110.363 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.45 ' OG ' ' CD2' ' A' ' 39' ' ' TYR . 25.9 t -119.47 145.51 46.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.882 . . . . 5.2000000000000002 109.971 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.581 HG23 ' HB ' ' A' ' 40' ' ' VAL . 79.7 p -62.62 -34.33 76.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.134 -0.979 . . . . 2.98 110.166 -178.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.01 46.73 42.35 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.642 -1.383 . . . . 0.82999999999999996 109.642 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.4 mt -114.88 134.38 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.118 -1.225 . . . . 1.3600000000000001 109.978 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.925 HG13 ' O ' ' A' ' 36' ' ' LEU . 90.7 t -116.72 144.09 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.928 -1.107 . . . . 0.37 110.937 -175.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 27.8 tpt180 -128.16 159.03 36.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.49 -0.756 . . . . 1.9199999999999999 109.793 177.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.421 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 70.4 mttt -85.65 147.6 26.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.013 . . . . 2.21 110.419 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.921 HG22 HD11 ' A' ' 36' ' ' LEU . 3.8 t -83.98 129.11 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.891 . . . . 0.28999999999999998 109.844 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.449 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.93 -175.16 5.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.116 -0.99 . . . . 0.55000000000000004 110.126 179.411 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.422 ' OE1' ' CD ' ' A' ' 32' ' ' GLU . 46.9 tp10 -54.37 -40.84 68.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.147 -0.971 . . . . 2.1899999999999999 111.599 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.868 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.0 tp -84.12 -5.74 59.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.76 -1.213 . . . . 1.3899999999999999 111.568 -173.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.519 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.05 47.02 7.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.521 -1.432 . . . . 0.20999999999999999 109.521 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.928 ' CD ' HG22 ' A' ' 19' ' ' VAL . 72.7 mtm180 -114.93 154.08 29.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.102 -1.234 . . . . 1.1399999999999999 109.94 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.703 HG12 HD13 ' A' ' 36' ' ' LEU . 19.7 m -124.04 153.09 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.28000000000000003 109.891 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.919 HG22 ' CD ' ' A' ' 17' ' ' ARG . 24.3 t -111.4 134.76 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.23999999999999999 110.619 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.597 HG23 ' HB2' ' B' ' 24' ' ' LEU . 6.4 mt -82.57 135.16 46.67 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 1.3799999999999999 109.472 174.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.538 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.2 Cg_endo -58.21 143.0 97.63 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.797 1.419 . . . . 0.35999999999999999 110.049 177.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.879 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.3 -32.59 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.135 -0.978 . . . . 1.1100000000000001 110.336 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -57.86 -36.4 72.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.091 -1.006 . . . . 2.3700000000000001 109.774 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.597 ' HB2' HG23 ' B' ' 20' ' ' ILE . 54.7 mt -81.97 -30.16 31.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.478 -0.764 . . . . 1.75 110.605 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.879 ' HD2' HD12 ' B' ' 22' ' ' ILE . 72.2 mtt180 -57.44 -43.92 84.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.89 -1.131 . . . . 0.29999999999999999 109.204 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -73.37 -49.32 27.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 3.27 110.621 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 61.0 m -63.81 -31.73 73.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.177 -0.952 . . . . 0.77000000000000002 110.862 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.934 HD23 HG13 ' B' ' 30' ' ' ILE . 22.4 tp -87.1 -5.17 59.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.053 -1.03 . . . . 1.05 110.701 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.415 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.07 43.65 95.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.578 -1.409 . . . . 0.32000000000000001 109.578 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.934 HG13 HD23 ' B' ' 28' ' ' LEU . 31.1 mm -115.27 138.81 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -1.176 . . . . 0.40999999999999998 110.725 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.48 167.27 22.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.628 -0.67 . . . . 0.23000000000000001 109.935 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.527 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.55 146.12 13.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.988 . . . . 1.1299999999999999 110.554 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 40.6 tttt 74.84 -4.77 2.29 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.688 -0.633 . . . . 1.8799999999999999 111.164 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.649 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.0 m-20 -76.98 165.21 24.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.791 -1.193 . . . . 1.1000000000000001 110.014 174.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.594 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.93 132.48 51.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.35999999999999999 110.833 -176.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.938 HD11 HG22 ' A' ' 12' ' ' VAL . 12.5 mt -108.93 142.61 39.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.397 -0.815 . . . . 0.56000000000000005 109.531 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.61 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.6 tt0 -107.7 139.79 41.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.902 -1.124 . . . . 1.1699999999999999 109.92 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 72.1 mt -112.6 136.79 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.299 -0.876 . . . . 0.83999999999999997 110.651 -172.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 14.3 m-85 -114.0 158.63 20.92 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 116.35 -0.386 . . . . 0.45000000000000001 109.993 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.418 ' HB ' HG23 ' A' ' 6' ' ' THR . 83.8 t -130.52 122.26 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.907 -1.121 . . . . 0.26000000000000001 110.502 172.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.572 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.9 p-10 -147.6 140.5 24.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 1.77 110.176 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 53.3 t0 43.69 48.46 6.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.134 -0.979 . . . . 1.21 111.059 175.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.7 mt-10 58.41 14.01 2.74 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.199 -0.938 . . . . 1.9199999999999999 110.679 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -117.0 147.37 42.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 2.0 109.959 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.575 ' CD1' HD11 ' A' ' 20' ' ' ILE . 60.2 mt -100.23 128.22 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -0.928 . . . . 1.24 110.102 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 25.0 mt -111.7 118.61 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.5 110.148 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.822 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.3 mp -107.9 136.45 47.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 1.6599999999999999 110.124 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.552 ' HD3' ' CE1' ' B' ' 39' ' ' TYR . 27.3 pttt -138.57 162.43 34.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.489 -0.757 . . . . 1.74 110.07 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -58.82 146.44 37.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.124 -0.985 . . . . 1.6499999999999999 109.93 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.71 ' CD2' HG11 ' A' ' 9' ' ' VAL . 9.3 t80 -106.03 114.54 28.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.65000000000000002 110.644 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.89 85.53 50.3 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.176 -0.953 . . . . 4.3499999999999996 110.295 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.568 ' HG3' ' CZ ' ' B' ' 50' ' ' TYR . 35.8 Cg_exo -55.48 144.99 71.15 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.977 1.514 . . . . 3.5800000000000001 110.296 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.958 -1.02 . . . . 5.9699999999999998 110.169 -179.949 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.312 0.577 . . . . 10.99 110.206 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.4 mtm -121.65 152.67 39.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.184 -0.947 . . . . 8.7599999999999998 110.169 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -80.98 132.71 35.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 8.8499999999999996 110.314 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 85.1 p -142.48 159.61 41.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 4.2000000000000002 110.185 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.444 HG21 ' CG2' ' B' ' 40' ' ' VAL . 55.8 p -63.07 -40.46 97.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.258 -0.901 . . . . 3.77 110.171 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.22 45.68 90.34 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.582 -1.407 . . . . 0.82999999999999996 109.582 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.5 mt -118.08 134.09 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.11 -1.23 . . . . 1.3600000000000001 110.115 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.935 HG13 ' O ' ' B' ' 36' ' ' LEU . 93.0 t -115.95 144.35 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.001 -1.062 . . . . 0.37 110.916 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -129.23 160.66 32.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.494 -0.753 . . . . 1.9099999999999999 109.679 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -85.25 147.7 26.44 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.067 -1.021 . . . . 2.21 110.385 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.899 HG22 HD11 ' B' ' 36' ' ' LEU . 4.0 t -83.09 129.94 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.28000000000000003 109.88 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.36 -175.18 5.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.96 . . . . 0.55000000000000004 110.082 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.74 -39.51 74.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.073 -1.017 . . . . 2.1899999999999999 111.652 -172.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.891 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.2 tp -83.25 -6.61 59.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.831 -1.168 . . . . 1.3799999999999999 111.499 -174.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.36 46.76 7.28 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.259 -1.448 . . . . 0.20999999999999999 109.615 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.898 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.1 mtm180 -114.33 154.73 27.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.079 -1.247 . . . . 1.1499999999999999 110.078 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.818 HG12 HD13 ' B' ' 36' ' ' LEU . 17.9 m -123.87 152.37 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.28000000000000003 109.763 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.91 HG22 ' CD ' ' B' ' 17' ' ' ARG . 19.9 t -112.97 135.32 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.138 -0.976 . . . . 0.23999999999999999 110.643 -174.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.715 HD11 ' CD1' ' B' ' 45' ' ' ILE . 19.5 mt -81.57 135.96 49.15 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.255 -0.903 . . . . 1.3799999999999999 109.763 174.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HG2' HD12 ' A' ' 24' ' ' LEU . 11.0 Cg_endo -60.02 143.65 99.55 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.754 1.397 . . . . 0.34999999999999998 109.942 176.027 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.874 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.12 -33.15 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.952 -1.093 . . . . 1.1100000000000001 110.348 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.404 ' N ' HG23 ' A' ' 22' ' ' ILE . 48.6 tp10 -58.04 -35.41 71.29 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.181 -0.95 . . . . 2.3700000000000001 109.884 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.561 HD12 ' HG2' ' A' ' 21' ' ' PRO . 59.6 mt -84.5 -28.25 26.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 1.75 110.664 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.874 ' HD2' HD12 ' A' ' 22' ' ' ILE . 70.8 mtt180 -57.44 -44.38 84.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.843 -1.161 . . . . 0.29999999999999999 109.065 175.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.5 mmm180 -73.58 -49.12 27.88 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.862 -0.735 . . . . 3.2599999999999998 110.671 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.8 m -63.96 -30.96 72.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.141 -0.974 . . . . 0.77000000000000002 111.121 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.831 HD23 HG13 ' A' ' 30' ' ' ILE . 23.0 tp -87.59 -4.93 58.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.069 -1.019 . . . . 1.05 110.769 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.84 41.75 97.35 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.724 -1.35 . . . . 0.32000000000000001 109.724 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.831 HG13 HD23 ' A' ' 28' ' ' LEU . 38.3 mm -116.38 138.45 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -1.17 . . . . 0.40999999999999998 110.629 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.99 166.88 23.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.575 -0.703 . . . . 0.23000000000000001 110.002 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.41 146.25 12.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.055 -1.028 . . . . 1.1299999999999999 110.61 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 31.8 ttpt 74.35 -4.35 2.33 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.687 -0.633 . . . . 1.8799999999999999 111.177 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.732 ' O ' HG23 ' B' ' 12' ' ' VAL . 90.1 m-20 -77.23 166.52 23.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.75 -1.219 . . . . 1.1000000000000001 110.029 174.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.659 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.05 130.09 51.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.159 -0.963 . . . . 0.35999999999999999 110.77 -176.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.951 HD11 HG22 ' B' ' 12' ' ' VAL . 12.4 mt -106.41 142.54 35.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.349 -0.845 . . . . 0.56000000000000005 109.403 174.501 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.707 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.4 tt0 -106.33 138.45 42.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.773 -1.204 . . . . 1.1699999999999999 109.564 173.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.2 mt -108.28 132.06 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.404 -0.81 . . . . 0.83999999999999997 110.537 -171.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.606 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.0 m-85 -118.22 159.45 23.3 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 116.259 -0.428 . . . . 0.45000000000000001 110.001 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.594 HG21 HG21 ' B' ' 6' ' ' THR . 72.2 t -133.49 125.9 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.919 -1.113 . . . . 0.27000000000000002 110.637 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' OD1' HG12 ' A' ' 46' ' ' ILE . 42.3 p-10 -147.41 143.22 27.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 1.77 110.499 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 51.8 t0 43.44 43.95 4.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.014 -1.054 . . . . 1.22 111.149 174.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.7 tt0 60.82 11.76 3.41 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.121 -0.987 . . . . 1.9299999999999999 110.616 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 53.0 mtmt -111.54 154.64 24.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 2.0099999999999998 109.779 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.759 ' CD1' HD11 ' B' ' 20' ' ' ILE . 66.1 mt -95.16 129.27 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 1.25 109.968 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.606 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 22.9 mm -115.12 120.65 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.719 . . . . 0.5 109.915 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.882 ' CD2' HG21 ' B' ' 18' ' ' VAL . 4.2 mp -117.63 135.17 54.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.981 -1.075 . . . . 1.6599999999999999 110.25 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.567 ' HE3' ' CD1' ' A' ' 39' ' ' TYR . 8.2 ptpt -142.74 162.21 36.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.384 -0.823 . . . . 1.74 110.418 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.566 ' HD3' HD11 ' A' ' 30' ' ' ILE . 22.8 tptm -55.63 147.46 18.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.037 -1.039 . . . . 1.6499999999999999 109.789 176.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.733 ' CD2' HG11 ' B' ' 9' ' ' VAL . 5.2 t80 -100.3 119.72 38.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -0.843 . . . . 0.34999999999999998 110.524 -176.171 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 51' ' ' LYS . 13.7 pttt -99.31 123.15 49.57 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.395 -0.816 . . . . 3.21 109.71 174.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.11 145.96 90.06 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.766 1.403 . . . . 0.47999999999999998 110.34 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.0 t30 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.008 -0.996 . . . . 2.4100000000000001 110.267 179.477 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 67.5 t80 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.185 0.517 . . . . 11.66 110.103 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 87.5 mtp -125.0 161.52 26.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 8.6999999999999993 110.234 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.477 ' HD3' ' OE2' ' A' ' 37' ' ' GLU . 98.4 mttt -88.31 144.8 26.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 9.1699999999999999 110.147 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 66.2 m -71.92 -93.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 5.2000000000000002 110.418 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.594 HG21 HG21 ' A' ' 40' ' ' VAL . 54.9 p -73.85 -40.6 63.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.015 -1.053 . . . . 2.98 110.269 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.98 46.03 90.53 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.564 -1.414 . . . . 0.82999999999999996 109.564 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.0 mt -118.19 133.92 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.053 -1.263 . . . . 1.3600000000000001 110.085 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.946 HG13 ' O ' ' A' ' 36' ' ' LEU . 91.7 t -115.93 144.35 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.971 -1.08 . . . . 0.37 110.925 -176.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -129.19 160.45 32.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.457 -0.777 . . . . 1.9199999999999999 109.759 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -85.19 147.59 26.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.038 -1.039 . . . . 2.21 110.425 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.951 HG22 HD11 ' A' ' 36' ' ' LEU . 4.0 t -82.95 129.97 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.4 -0.813 . . . . 0.28999999999999998 109.894 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.61 -175.04 5.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.153 -0.967 . . . . 0.55000000000000004 110.135 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.489 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -56.87 -39.44 74.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.081 -1.012 . . . . 2.1899999999999999 111.496 -172.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.1 tp -83.27 -6.56 59.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.787 -1.196 . . . . 1.3899999999999999 111.527 -174.196 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.475 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.9 47.5 7.12 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.54 -1.424 . . . . 0.20999999999999999 109.54 -177.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.91 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.0 mtm180 -114.5 154.67 27.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.028 -1.278 . . . . 1.1399999999999999 110.131 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.882 HG21 ' CD2' ' A' ' 47' ' ' LEU . 17.8 m -123.93 152.31 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.28000000000000003 109.737 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.898 HG22 ' CD ' ' A' ' 17' ' ' ARG . 19.8 t -113.0 135.26 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.23999999999999999 110.712 -174.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.759 HD11 ' CD1' ' A' ' 45' ' ' ILE . 19.2 mt -81.5 135.96 49.36 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 1.3799999999999999 109.734 174.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 11.0 Cg_endo -60.15 143.53 99.53 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.801 1.422 . . . . 0.35999999999999999 110.036 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.87 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.2 tp -55.13 -32.92 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.018 -1.051 . . . . 1.1100000000000001 110.399 -178.496 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' GLU . . . . . 0.403 ' N ' HG23 ' B' ' 22' ' ' ILE . 48.4 tp10 -57.93 -36.12 72.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.058 -1.026 . . . . 2.3700000000000001 109.777 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.571 ' HB2' HG23 ' B' ' 20' ' ' ILE . 60.1 mt -83.74 -28.55 28.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.532 -0.73 . . . . 1.75 110.628 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.87 ' HD2' HD12 ' B' ' 22' ' ' ILE . 70.2 mtt180 -57.35 -44.32 84.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.792 -1.193 . . . . 0.29999999999999999 109.044 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 32.5 mmm180 -73.49 -49.31 27.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.357 -0.84 . . . . 3.27 110.664 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.1 m -63.68 -31.64 72.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.896 . . . . 0.77000000000000002 110.919 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.867 HD23 HG13 ' B' ' 30' ' ' ILE . 23.2 tp -87.01 -5.33 59.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.032 -1.042 . . . . 1.05 110.731 -176.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.24 41.53 96.75 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.562 -1.415 . . . . 0.32000000000000001 109.562 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.867 HG13 HD23 ' B' ' 28' ' ' LEU . 37.9 mm -116.27 138.39 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -1.182 . . . . 0.40999999999999998 110.694 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.78 167.04 23.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.612 -0.68 . . . . 0.23000000000000001 109.987 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.41 146.39 12.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.141 -0.975 . . . . 1.1299999999999999 110.523 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 31.7 ttpt 74.42 -4.64 2.27 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.699 -0.626 . . . . 1.8799999999999999 111.174 176.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.4 m-20 -77.21 166.26 23.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.853 -1.154 . . . . 1.1000000000000001 110.067 174.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.641 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.97 130.09 51.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.35999999999999999 110.753 -176.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.935 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.2 mt -106.47 142.25 36.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 0.56000000000000005 109.471 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.688 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.1 tt0 -106.06 138.44 42.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.825 -1.172 . . . . 1.1699999999999999 109.72 173.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.22 132.06 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.367 -0.833 . . . . 0.83999999999999997 110.486 -171.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.597 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 10.0 m-85 -118.31 159.34 23.56 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 116.261 -0.427 . . . . 0.45000000000000001 110.001 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.444 ' CG2' HG21 ' A' ' 6' ' ' THR . 72.4 t -133.22 126.27 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.936 -1.102 . . . . 0.26000000000000001 110.466 172.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.487 ' OD1' HG12 ' B' ' 46' ' ' ILE . 42.5 p-10 -147.81 143.22 27.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 1.77 110.466 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 52.4 t0 43.47 44.04 4.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.934 . . . . 1.21 111.108 174.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.5 tt0 60.67 11.87 3.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.028 -1.045 . . . . 1.9199999999999999 110.571 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 53.0 mtmt -111.56 154.76 24.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.185 -0.947 . . . . 2.0 109.71 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.754 HG22 HD11 ' B' ' 47' ' ' LEU . 66.2 mt -95.26 129.14 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 1.24 110.0 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.602 HD12 HD12 ' A' ' 46' ' ' ILE . 22.6 mm -115.15 120.7 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.5 109.817 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.823 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.3 mp -117.46 135.05 54.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.014 -1.054 . . . . 1.6599999999999999 110.294 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.572 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 8.1 ptpt -142.65 162.39 35.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.843 . . . . 1.74 110.392 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.551 ' HD3' ' CD1' ' B' ' 30' ' ' ILE . 22.8 tptm -55.63 147.3 18.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.114 -0.992 . . . . 1.6499999999999999 109.83 176.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.886 ' CD2' HG11 ' A' ' 9' ' ' VAL . 5.3 t80 -100.29 115.99 31.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.65000000000000002 110.525 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.418 ' HA ' ' HD2' ' B' ' 52' ' ' PRO . 0.0 OUTLIER -128.69 93.27 38.05 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.366 -0.834 . . . . 4.3499999999999996 110.181 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' B' ' 51' ' ' LYS . 9.9 Cg_endo -56.48 143.55 87.25 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.861 1.453 . . . . 3.5800000000000001 110.396 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 118.019 -0.991 . . . . 5.9699999999999998 110.201 -179.159 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.4 t80 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.342 0.592 . . . . 10.99 110.172 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.8 mtm -85.83 159.42 19.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.174 -0.954 . . . . 8.7599999999999998 110.316 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -79.52 157.1 27.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.867 . . . . 8.8499999999999996 110.368 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.3 m -58.52 158.68 7.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.856 . . . . 4.2000000000000002 110.323 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.523 HG21 HG21 ' B' ' 40' ' ' VAL . 59.1 p -62.37 -37.11 84.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.326 -0.859 . . . . 3.77 110.288 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.56 46.22 71.0 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.493 -1.443 . . . . 0.82999999999999996 109.493 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.4 mt -118.16 136.06 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.169 -1.195 . . . . 1.3600000000000001 110.087 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.081 HG11 ' CD2' ' B' ' 50' ' ' TYR . 92.7 t -115.1 144.34 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.033 -1.042 . . . . 0.37 110.856 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.9 ttt-85 -129.91 160.07 34.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.48 -0.762 . . . . 1.9099999999999999 109.684 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -86.44 149.03 25.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.103 -0.998 . . . . 2.21 110.466 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.99 HG22 HD11 ' B' ' 36' ' ' LEU . 3.9 t -82.99 129.64 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.241 -0.912 . . . . 0.28000000000000003 109.873 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.19 -174.67 5.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.145 -0.972 . . . . 0.55000000000000004 110.182 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -53.62 -41.81 67.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.18 -0.95 . . . . 2.1899999999999999 111.783 -173.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.88 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.2 tp -85.79 -4.26 59.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.709 -1.244 . . . . 1.3799999999999999 111.619 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.514 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.09 46.31 7.72 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.184 -1.484 . . . . 0.20999999999999999 109.645 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.918 ' CD ' HG22 ' B' ' 19' ' ' VAL . 74.6 mtm180 -115.56 154.35 29.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.15 -1.206 . . . . 1.1499999999999999 109.933 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.732 HG21 ' CD2' ' B' ' 47' ' ' LEU . 16.6 m -124.61 152.23 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 0.28000000000000003 109.898 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.943 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.9 t -112.25 135.44 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.932 . . . . 0.23999999999999999 110.514 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.593 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.04 134.57 46.11 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 1.3799999999999999 109.577 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.54 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.9 Cg_endo -58.73 143.8 98.54 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.793 1.417 . . . . 0.34999999999999998 110.104 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.886 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.19 -32.08 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.988 -1.07 . . . . 1.1100000000000001 110.386 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.29 -34.88 72.82 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.118 -0.989 . . . . 2.3700000000000001 109.901 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.593 ' HB2' HG23 ' A' ' 20' ' ' ILE . 62.4 mt -83.19 -29.68 28.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 1.75 110.57 178.416 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.886 ' HD2' HD12 ' A' ' 22' ' ' ILE . 73.6 mtt180 -57.55 -43.96 84.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.877 -1.139 . . . . 0.29999999999999999 109.107 175.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -71.64 -50.11 33.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.518 -0.739 . . . . 3.2599999999999998 110.707 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.0 m -63.38 -32.02 73.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.218 -0.926 . . . . 0.77000000000000002 111.088 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.894 HD23 HG13 ' A' ' 30' ' ' ILE . 21.0 tp -88.39 -4.86 58.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.064 -1.022 . . . . 1.05 110.751 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.42 42.82 97.46 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.667 -1.373 . . . . 0.32000000000000001 109.667 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.894 HG13 HD23 ' A' ' 28' ' ' LEU . 35.3 mm -116.36 138.75 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.242 -1.152 . . . . 0.40999999999999998 110.74 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.06 167.26 22.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.617 -0.677 . . . . 0.23000000000000001 110.092 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.2 tt0 -53.26 147.09 10.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.075 -1.016 . . . . 1.1299999999999999 110.542 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 29.3 tttt 74.65 -4.92 2.23 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.781 -0.574 . . . . 1.8799999999999999 111.123 177.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.71 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.9 m-20 -77.49 165.36 24.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.81 -1.181 . . . . 1.1000000000000001 110.019 174.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.785 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.69 131.61 51.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.209 -0.932 . . . . 0.35999999999999999 110.74 -176.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.968 HD11 HG22 ' B' ' 12' ' ' VAL . 13.6 mt -109.57 140.63 43.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 0.56000000000000005 109.575 175.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.764 ' HA ' HG22 ' B' ' 9' ' ' VAL . 84.8 tt0 -103.67 138.56 40.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.823 -1.173 . . . . 1.1699999999999999 109.528 171.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.6 mt -111.47 133.27 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.369 -0.832 . . . . 0.83999999999999997 110.512 -173.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.587 ' CE2' ' HE3' ' A' ' 48' ' ' LYS . 8.5 m-85 -114.53 160.76 18.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 122.068 -0.395 . . . . 0.45000000000000001 110.218 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.757 HG21 HG21 ' B' ' 6' ' ' THR . 94.1 t -133.9 117.69 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 0.27000000000000002 110.83 173.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.547 ' OD2' HD11 ' A' ' 46' ' ' ILE . 6.2 p-10 -147.69 160.23 42.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 1.77 110.031 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 22.5 t70 42.47 41.46 2.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.097 . . . . 1.22 111.332 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 75.5 mm-40 57.4 15.71 2.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.07 -1.019 . . . . 1.9299999999999999 110.651 175.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 56.1 pttt -130.78 163.21 27.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.156 -0.965 . . . . 2.0099999999999998 109.887 175.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.601 HD13 HG13 ' B' ' 20' ' ' ILE . 61.2 mt -104.21 134.74 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.046 -1.034 . . . . 1.25 110.516 -173.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 26.7 mt -112.96 119.27 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -0.833 . . . . 0.5 110.249 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.84 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.1 mp -108.12 134.84 50.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.932 . . . . 1.6599999999999999 109.987 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.587 ' HE3' ' CE2' ' A' ' 39' ' ' TYR . 1.8 ptpm? -140.79 163.5 32.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.417 -0.802 . . . . 1.74 110.296 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.7 tttp -55.12 148.08 14.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.109 -0.995 . . . . 1.6499999999999999 109.776 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.92 ' CD2' HG11 ' B' ' 9' ' ' VAL . 1.7 t80 -101.21 122.48 43.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.34999999999999998 110.565 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -99.38 123.2 49.27 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 3.21 109.796 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.447 ' O ' ' OXT' ' A' ' 53' ' ' ASN . 15.8 Cg_endo -62.98 146.0 94.6 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.733 1.386 . . . . 0.47999999999999998 110.22 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.447 ' OXT' ' O ' ' A' ' 52' ' ' PRO . 37.3 p-10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.019 -0.991 . . . . 2.4100000000000001 110.267 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 65.0 t80 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.277 0.561 . . . . 11.66 110.149 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 64.3 mtt -104.32 143.9 32.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 8.6999999999999993 110.168 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -100.76 135.8 41.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 9.1699999999999999 110.407 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 86.3 p -142.78 155.2 44.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 5.2000000000000002 109.852 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.757 HG21 HG21 ' A' ' 40' ' ' VAL . 58.6 p -68.66 -37.35 79.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 2.98 110.231 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.36 46.52 69.95 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.393 -1.483 . . . . 0.82999999999999996 109.393 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 61.8 mt -118.14 136.03 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.168 -1.195 . . . . 1.3600000000000001 110.134 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.934 HG13 ' O ' ' A' ' 36' ' ' LEU . 91.1 t -115.17 144.32 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.028 -1.045 . . . . 0.37 110.855 -176.492 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -129.85 159.89 35.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.479 -0.763 . . . . 1.9199999999999999 109.782 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -86.32 148.88 25.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 2.21 110.472 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.968 HG22 HD11 ' A' ' 36' ' ' LEU . 3.9 t -82.83 129.73 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.265 -0.897 . . . . 0.28999999999999998 109.867 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -85.46 -174.49 5.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.105 -0.997 . . . . 0.55000000000000004 110.239 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.462 ' OE1' ' OE2' ' A' ' 32' ' ' GLU . 47.5 tp10 -53.82 -41.61 67.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.17 -0.956 . . . . 2.1899999999999999 111.765 -173.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.9 tp -85.99 -4.14 59.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.722 -1.236 . . . . 1.3899999999999999 111.592 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.534 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.72 46.97 7.52 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.524 -1.431 . . . . 0.20999999999999999 109.524 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.943 ' CD ' HG22 ' A' ' 19' ' ' VAL . 74.2 mtm180 -115.76 154.28 29.89 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.083 -1.245 . . . . 1.1399999999999999 109.96 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.836 HG21 ' CD2' ' A' ' 47' ' ' LEU . 16.6 m -124.6 152.25 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.28000000000000003 109.899 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.918 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.9 t -112.34 135.38 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.93 . . . . 0.23999999999999999 110.505 -175.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.612 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.99 134.49 46.44 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 1.3799999999999999 109.554 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.536 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.8 Cg_endo -58.83 143.84 98.92 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.803 1.423 . . . . 0.35999999999999999 110.053 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.884 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.28 -31.86 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.042 -1.036 . . . . 1.1100000000000001 110.446 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.18 -35.57 73.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.057 -1.027 . . . . 2.3700000000000001 109.758 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.612 ' HB2' HG23 ' B' ' 20' ' ' ILE . 62.7 mt -82.49 -30.06 30.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.408 -0.808 . . . . 1.75 110.602 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.884 ' HD2' HD12 ' B' ' 22' ' ' ILE . 73.1 mtt180 -57.34 -43.85 83.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.877 -1.139 . . . . 0.29999999999999999 109.106 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -71.53 -50.54 30.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.418 -0.801 . . . . 3.27 110.614 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 60.8 m -62.98 -32.58 73.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.342 -0.849 . . . . 0.77000000000000002 110.948 -177.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.894 HD23 HG13 ' B' ' 30' ' ' ILE . 21.2 tp -87.84 -5.32 58.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.981 -1.074 . . . . 1.05 110.759 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.4 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.79 42.64 97.0 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.575 -1.41 . . . . 0.32000000000000001 109.575 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.894 HG13 HD23 ' B' ' 28' ' ' LEU . 34.8 mm -116.2 138.63 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -1.199 . . . . 0.40999999999999998 110.816 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.82 167.43 22.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.605 -0.685 . . . . 0.23000000000000001 109.97 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.25 147.18 10.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 1.1299999999999999 110.515 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 29.2 tttt 74.69 -5.01 2.21 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.733 -0.604 . . . . 1.8799999999999999 111.206 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.605 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.5 m-20 -77.63 164.98 24.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.821 -1.174 . . . . 1.1000000000000001 109.998 174.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.753 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.41 131.58 51.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.35999999999999999 110.833 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.99 HD11 HG22 ' A' ' 12' ' ' VAL . 13.4 mt -109.62 140.42 43.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 0.56000000000000005 109.632 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.743 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.7 tt0 -103.43 138.56 39.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.829 -1.169 . . . . 1.1699999999999999 109.749 171.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.8 mt -111.4 133.19 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.882 . . . . 0.83999999999999997 110.524 -172.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.575 ' CZ ' ' HE3' ' B' ' 48' ' ' LYS . 8.4 m-85 -114.48 160.7 18.9 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 120.958 0.409 . . . . 0.45000000000000001 110.275 -177.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.523 HG21 HG21 ' A' ' 6' ' ' THR . 94.8 t -133.64 118.14 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.986 -1.071 . . . . 0.26000000000000001 110.559 173.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.54 ' OD2' HD11 ' B' ' 46' ' ' ILE . 6.3 p-10 -148.29 160.2 43.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 1.77 110.033 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 22.7 t70 42.46 41.7 2.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -0.985 . . . . 1.21 111.225 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 75.5 mm-40 57.23 15.61 2.62 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.079 -1.013 . . . . 1.9199999999999999 110.71 175.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 56.1 pttt -130.58 163.45 27.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.955 . . . . 2.0 109.866 174.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.453 HD13 HG13 ' A' ' 20' ' ' ILE . 60.5 mt -104.31 134.67 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.153 -0.967 . . . . 1.24 110.616 -173.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 27.5 mt -113.05 119.31 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.5 110.21 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.822 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.2 mp -108.04 134.75 50.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.214 -0.929 . . . . 1.6599999999999999 109.978 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.575 ' HE3' ' CZ ' ' B' ' 39' ' ' TYR . 1.8 ptpm? -140.69 163.63 32.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.422 -0.798 . . . . 1.74 110.288 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -55.12 147.93 15.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 1.6499999999999999 109.696 176.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 1.081 ' CD2' HG11 ' A' ' 9' ' ' VAL . 1.7 t80 -101.25 120.92 40.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.65000000000000002 110.587 -175.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.568 ' CB ' ' HD3' ' B' ' 52' ' ' PRO . 0.0 OUTLIER -97.01 -56.25 0.2 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 4.3499999999999996 110.776 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.585 ' O ' ' CZ ' ' B' ' 50' ' ' TYR . 26.5 Cg_exo -54.59 154.42 20.24 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.491 1.258 . . . . 3.5800000000000001 110.373 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.972 -1.013 . . . . 5.9699999999999998 110.225 -178.462 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.203 0.525 . . . . 10.99 110.272 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.5 mtt -118.66 147.96 43.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.345 -0.847 . . . . 8.7599999999999998 110.125 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -102.99 137.06 41.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 8.8499999999999996 110.392 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -137.55 144.97 42.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 4.2000000000000002 110.031 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.494 HG21 ' CG2' ' B' ' 40' ' ' VAL . 72.5 p -63.1 -39.4 94.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.076 -1.015 . . . . 3.77 110.064 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.524 ' O ' HD13 ' A' ' 8' ' ' ILE . . . 68.08 46.1 67.83 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.711 -1.356 . . . . 0.82999999999999996 109.711 176.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 7' ' ' GLY . 19.1 mm -113.77 132.32 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.021 -1.282 . . . . 1.3600000000000001 110.016 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.932 HG13 ' O ' ' B' ' 36' ' ' LEU . 87.0 t -117.91 144.03 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.024 -1.048 . . . . 0.37 110.94 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.449 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 27.7 tpt180 -128.57 160.56 32.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.549 -0.72 . . . . 1.9099999999999999 109.65 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 94.8 mttt -84.92 146.87 27.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 2.21 110.297 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.916 HG22 HD11 ' B' ' 36' ' ' LEU . 4.1 t -82.27 127.49 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.28000000000000003 109.757 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.27 -175.07 5.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.128 -0.983 . . . . 0.55000000000000004 109.985 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.8 -39.14 73.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.998 -1.064 . . . . 2.1899999999999999 111.596 -172.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.89 HD23 ' HD3' ' A' ' 17' ' ' ARG . 16.4 tp -83.0 -6.62 59.56 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.805 -1.185 . . . . 1.3799999999999999 111.531 -174.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.48 46.62 7.3 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.173 -1.489 . . . . 0.20999999999999999 109.654 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.896 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.1 mtm180 -114.07 154.44 27.72 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.018 -1.283 . . . . 1.1499999999999999 110.007 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.866 HG12 HD13 ' B' ' 36' ' ' LEU . 17.7 m -123.56 151.97 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.28000000000000003 109.799 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.909 HG22 ' CD ' ' B' ' 17' ' ' ARG . 17.1 t -113.61 133.56 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.23999999999999999 110.762 -174.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.945 HD11 HD13 ' B' ' 45' ' ' ILE . 2.5 mm -85.28 136.97 37.23 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.908 . . . . 1.3799999999999999 109.483 174.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.55 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -58.85 141.18 97.76 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.676 1.356 . . . . 0.34999999999999998 109.965 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.949 ' O ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.83 -32.03 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.946 -1.096 . . . . 1.1100000000000001 110.407 -177.641 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.64 -35.31 72.31 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.034 -1.041 . . . . 2.3700000000000001 109.77 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.55 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 45.3 mt -81.4 -28.97 34.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 1.75 110.52 176.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.663 HH22 HD11 ' B' ' 15' ' ' LEU . 72.6 mtt180 -56.93 -44.25 82.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.916 -1.115 . . . . 0.29999999999999999 108.942 175.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -72.03 -49.26 38.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.574 -0.704 . . . . 3.2599999999999998 110.735 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.7 m -63.55 -31.22 72.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 0.77000000000000002 111.119 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.832 HD23 HG13 ' A' ' 30' ' ' ILE . 21.4 tp -87.24 -4.66 59.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.004 -1.06 . . . . 1.05 110.712 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.18 40.92 95.09 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.721 -1.352 . . . . 0.32000000000000001 109.721 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.832 HG13 HD23 ' A' ' 28' ' ' LEU . 35.4 mm -116.33 139.09 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.309 -1.112 . . . . 0.40999999999999998 110.623 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.55 166.5 24.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.546 -0.721 . . . . 0.23000000000000001 110.124 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.47 146.65 12.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.973 . . . . 1.1299999999999999 110.591 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 15.1 tptt 74.83 -4.62 2.32 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.759 -0.588 . . . . 1.8799999999999999 111.092 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.75 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.8 m-20 -77.42 166.74 22.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.792 -1.193 . . . . 1.1000000000000001 110.021 174.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.684 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.53 131.94 52.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.35999999999999999 110.748 -176.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.932 HD11 HG22 ' B' ' 12' ' ' VAL . 13.9 mt -109.03 142.05 40.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.422 -0.799 . . . . 0.56000000000000005 109.519 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.651 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.0 tt0 -108.29 139.89 42.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.879 -1.138 . . . . 1.1699999999999999 109.784 173.043 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.425 HD13 ' O ' ' A' ' 37' ' ' GLU . 22.0 mm -111.86 133.98 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.332 -0.855 . . . . 0.83999999999999997 110.553 -173.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.593 ' CE2' ' HE3' ' A' ' 48' ' ' LYS . 8.2 m-85 -115.34 162.03 17.69 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 120.955 0.407 . . . . 0.45000000000000001 110.045 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.651 HG21 HG21 ' B' ' 6' ' ' THR . 92.2 t -133.48 121.79 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.926 -1.108 . . . . 0.27000000000000002 110.92 173.085 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.605 ' CG ' HD11 ' A' ' 46' ' ' ILE . 6.3 p-10 -147.31 152.53 38.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 1.77 110.129 176.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 53.7 t0 43.02 45.34 4.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.122 -0.986 . . . . 1.22 111.32 173.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 96.0 mt-10 56.99 16.91 3.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.028 -1.045 . . . . 1.9299999999999999 110.548 175.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' A' ' 41' ' ' ASP . 16.2 ptpt -129.73 159.61 35.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 2.0099999999999998 109.872 176.114 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 1.059 HD13 HD11 ' B' ' 20' ' ' ILE . 57.8 mt -104.33 133.48 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 1.25 110.607 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.605 HD11 ' CG ' ' A' ' 41' ' ' ASP . 33.4 mt -112.11 120.53 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.507 -0.745 . . . . 0.5 110.283 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.845 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.5 mp -109.74 135.38 50.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.11 -0.994 . . . . 1.6599999999999999 110.015 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.593 ' HE3' ' CE2' ' A' ' 39' ' ' TYR . 1.8 ptpm? -141.09 162.83 34.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 1.74 110.3 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -57.94 146.54 31.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.171 -0.956 . . . . 1.6499999999999999 110.03 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.745 ' CD2' HG11 ' B' ' 9' ' ' VAL . 8.1 t80 -105.94 120.12 40.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.307 -0.871 . . . . 0.34999999999999998 110.655 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -99.64 122.71 50.43 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.275 -0.891 . . . . 3.21 109.47 172.462 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.04 146.62 87.74 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.743 1.391 . . . . 0.47999999999999998 110.291 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.958 -1.02 . . . . 2.4100000000000001 110.206 179.884 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 66.5 t80 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.248 0.547 . . . . 11.66 110.19 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 87.9 mtp -96.1 148.8 22.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.319 -0.863 . . . . 8.6999999999999993 110.139 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -87.38 142.32 27.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 9.1699999999999999 110.396 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 51.1 m -121.9 153.57 38.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.342 -0.849 . . . . 5.2000000000000002 110.047 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.651 HG21 HG21 ' A' ' 40' ' ' VAL . 72.7 p -55.42 -39.3 70.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 2.98 110.019 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLY . . . . . 0.538 ' O ' HD13 ' B' ' 8' ' ' ILE . . . 67.89 46.44 66.92 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.652 -1.379 . . . . 0.82999999999999996 109.652 176.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.538 HD13 ' O ' ' B' ' 7' ' ' GLY . 19.0 mm -113.88 132.32 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.093 -1.239 . . . . 1.3600000000000001 109.962 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 36' ' ' LEU . 86.7 t -118.03 144.0 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.014 -1.054 . . . . 0.37 110.925 -175.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.454 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 27.6 tpt180 -128.49 160.36 32.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.552 -0.717 . . . . 1.9199999999999999 109.76 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.454 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 94.8 mttt -84.82 146.8 27.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.038 -1.039 . . . . 2.21 110.283 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.932 HG22 HD11 ' A' ' 36' ' ' LEU . 4.1 t -82.29 127.52 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.28999999999999998 109.767 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -85.35 -174.86 5.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.18 -0.95 . . . . 0.55000000000000004 110.111 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.485 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.9 mt-10 -57.07 -38.91 73.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.099 -1.001 . . . . 2.1899999999999999 111.554 -172.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.8 tp -83.09 -6.74 59.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.796 -1.19 . . . . 1.3899999999999999 111.51 -174.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.18 47.31 7.07 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.508 -1.437 . . . . 0.20999999999999999 109.508 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.909 ' CD ' HG22 ' A' ' 19' ' ' VAL . 69.2 mtm180 -114.17 154.35 27.99 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.082 -1.246 . . . . 1.1399999999999999 110.074 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.892 HG12 HD13 ' A' ' 36' ' ' LEU . 17.7 m -123.52 152.0 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.86 . . . . 0.28000000000000003 109.794 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.896 HG22 ' CD ' ' A' ' 17' ' ' ARG . 16.8 t -113.57 133.57 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.158 -0.963 . . . . 0.23999999999999999 110.748 -174.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 1.059 HD11 HD13 ' A' ' 45' ' ' ILE . 2.6 mm -85.3 136.96 37.21 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 1.3799999999999999 109.526 174.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.0 Cg_endo -58.94 141.19 97.96 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.547 1.288 . . . . 0.35999999999999999 110.023 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.948 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -56.08 -31.7 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.09 -1.006 . . . . 1.1100000000000001 110.373 -177.368 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.58 -35.94 73.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.051 -1.03 . . . . 2.3700000000000001 109.661 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.556 ' HB2' HG23 ' B' ' 20' ' ' ILE . 45.4 mt -80.65 -29.35 36.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.448 -0.782 . . . . 1.75 110.526 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.61 HH22 HD11 ' A' ' 15' ' ' LEU . 72.1 mtt180 -56.81 -44.06 81.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.836 -1.165 . . . . 0.29999999999999999 109.001 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -71.98 -49.56 36.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.542 -0.723 . . . . 3.27 110.628 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.0 m -63.22 -31.8 73.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.286 -0.884 . . . . 0.77000000000000002 110.898 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.854 HD23 HG13 ' B' ' 30' ' ' ILE . 21.7 tp -86.72 -5.02 59.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.122 -0.986 . . . . 1.05 110.69 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.58 40.69 94.22 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.613 -1.395 . . . . 0.32000000000000001 109.613 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.854 HG13 HD23 ' B' ' 28' ' ' LEU . 34.8 mm -116.39 139.03 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -1.123 . . . . 0.40999999999999998 110.604 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.34 166.6 24.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.559 -0.713 . . . . 0.23000000000000001 110.071 -177.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.43 146.71 11.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 1.1299999999999999 110.508 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 15.1 tptt 74.88 -4.91 2.26 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.695 -0.628 . . . . 1.8799999999999999 111.184 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.665 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.1 m-20 -77.4 166.48 23.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.769 -1.207 . . . . 1.1000000000000001 110.094 174.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.7 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.32 131.86 52.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.134 -0.979 . . . . 0.35999999999999999 110.781 -176.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.932 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.7 mt -109.1 141.77 40.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.56000000000000005 109.6 175.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.625 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.9 tt0 -107.97 139.9 41.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.932 -1.105 . . . . 1.1699999999999999 109.892 173.011 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.429 HD13 ' O ' ' B' ' 37' ' ' GLU . 21.9 mm -111.95 134.14 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.352 -0.842 . . . . 0.83999999999999997 110.443 -173.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.583 ' CE2' ' HE3' ' B' ' 48' ' ' LYS . 8.0 m-85 -115.43 162.0 17.77 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 116.315 -0.402 . . . . 0.45000000000000001 110.078 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.494 ' CG2' HG21 ' A' ' 6' ' ' THR . 92.2 t -133.23 122.21 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.931 -1.106 . . . . 0.26000000000000001 110.633 173.162 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.597 ' OD2' HD11 ' B' ' 46' ' ' ILE . 6.5 p-10 -147.84 152.56 37.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 1.77 110.114 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' B' ' 42' ' ' ASP . 54.2 t0 42.98 45.54 4.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.164 -0.96 . . . . 1.21 111.258 173.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.9 mt-10 56.85 16.89 2.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.983 -1.073 . . . . 1.9199999999999999 110.594 175.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' B' ' 41' ' ' ASP . 16.2 ptpt -129.67 159.88 35.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 2.0 109.763 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.945 HD13 HD11 ' A' ' 20' ' ' ILE . 57.3 mt -104.39 133.51 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.124 -0.985 . . . . 1.24 110.687 -173.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.597 HD11 ' OD2' ' B' ' 41' ' ' ASP . 34.7 mt -112.34 120.57 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.389 -0.819 . . . . 0.5 110.181 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.835 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.6 mp -109.63 135.24 50.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.196 -0.94 . . . . 1.6599999999999999 110.071 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.583 ' HE3' ' CE2' ' B' ' 39' ' ' TYR . 1.8 ptpm? -140.99 163.03 34.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.454 -0.778 . . . . 1.74 110.248 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -57.93 146.55 31.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 1.6499999999999999 109.988 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.881 ' CD2' HG11 ' A' ' 9' ' ' VAL . 8.3 t80 -106.18 117.28 33.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.65000000000000002 110.596 -176.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.41 106.79 54.1 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.17 -0.956 . . . . 4.3499999999999996 110.205 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -55.57 145.33 70.3 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.977 1.514 . . . . 3.5800000000000001 110.308 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.009 -0.996 . . . . 5.9699999999999998 110.144 -179.78 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.1 t80 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.264 0.554 . . . . 10.99 110.142 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.7 mmm -88.98 165.95 14.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 8.7599999999999998 110.225 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -68.75 170.89 8.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.331 -0.855 . . . . 8.8499999999999996 110.17 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.917 ' O ' HG23 ' A' ' 6' ' ' THR . 36.8 m -53.46 153.07 4.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.176 -0.952 . . . . 4.2000000000000002 110.154 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.917 HG23 ' O ' ' A' ' 5' ' ' SER . 0.8 OUTLIER -170.24 64.4 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.852 . . . . 3.77 109.966 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.09 49.73 4.63 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.359 -1.4 . . . . 0.82999999999999996 110.045 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.8 mt -103.76 136.2 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.998 -1.295 . . . . 1.3600000000000001 109.594 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.906 HG13 ' O ' ' B' ' 36' ' ' LEU . 75.1 t -110.94 143.87 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.791 -1.193 . . . . 0.37 111.394 -170.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.489 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 28.7 tpt180 -125.85 163.11 23.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.645 -0.659 . . . . 1.9099999999999999 109.527 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.489 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 56.6 mttm -84.98 146.54 27.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.986 -1.071 . . . . 2.21 110.453 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.896 HG22 HD11 ' B' ' 36' ' ' LEU . 3.9 t -83.51 130.29 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.385 -0.822 . . . . 0.28000000000000003 109.876 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.74 -175.54 5.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.048 -1.032 . . . . 0.55000000000000004 110.03 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.85 -39.33 74.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.998 -1.064 . . . . 2.1899999999999999 111.677 -172.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.895 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.1 tp -83.26 -6.67 59.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.735 -1.228 . . . . 1.3799999999999999 111.524 -174.008 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.457 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.47 46.58 7.32 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.176 -1.488 . . . . 0.20999999999999999 109.715 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.911 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.5 mtm180 -113.88 154.73 27.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.953 -1.322 . . . . 1.1499999999999999 110.043 -177.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.905 HG12 HD13 ' B' ' 36' ' ' LEU . 15.4 m -123.84 152.72 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.28000000000000003 109.755 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.917 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.4 t -111.28 135.12 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.23999999999999999 110.671 -175.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.6 HD11 ' CD1' ' B' ' 45' ' ' ILE . 16.2 mt -81.63 135.05 49.8 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.274 -0.891 . . . . 1.3799999999999999 109.675 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.4 Cg_endo -58.32 142.61 97.68 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.67 1.352 . . . . 0.34999999999999998 109.954 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.884 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.18 -32.16 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.899 -1.126 . . . . 1.1100000000000001 110.389 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.39 -34.87 72.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.055 -1.028 . . . . 2.3700000000000001 109.888 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.546 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 52.3 mt -81.86 -30.72 31.89 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.277 -0.889 . . . . 1.75 110.532 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.884 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.1 mtt180 -57.94 -44.19 86.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.95 -1.093 . . . . 0.29999999999999999 109.2 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -73.82 -49.9 23.03 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.831 -0.748 . . . . 3.2599999999999998 110.653 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.6 m -64.12 -31.15 72.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.201 -0.937 . . . . 0.77000000000000002 111.11 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.862 HD23 HG13 ' A' ' 30' ' ' ILE . 18.7 tp -87.82 -4.68 58.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.039 -1.038 . . . . 1.05 110.739 -176.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 66.07 43.28 93.68 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.685 -1.366 . . . . 0.32000000000000001 109.685 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.862 HG13 HD23 ' A' ' 28' ' ' LEU . 32.8 mm -115.96 138.19 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -1.162 . . . . 0.40999999999999998 110.671 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.405 ' HB3' ' OD2' ' A' ' 34' ' ' ASP . . . -142.78 167.0 23.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.579 -0.7 . . . . 0.23000000000000001 110.049 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.58 145.79 14.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 1.1299999999999999 110.601 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 69.1 tttt 74.43 -4.34 2.34 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.708 -0.62 . . . . 1.8799999999999999 111.073 176.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.767 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.7 m-20 -76.97 168.29 20.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.816 -1.177 . . . . 1.1000000000000001 109.962 174.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.82 131.37 53.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.937 . . . . 0.35999999999999999 110.798 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.93 ' O ' HG13 ' B' ' 9' ' ' VAL . 9.5 mt -107.61 144.23 34.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.369 -0.832 . . . . 0.56000000000000005 109.267 174.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.532 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.4 tt0 -108.35 137.93 45.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.696 -1.253 . . . . 1.1699999999999999 109.648 173.514 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.5 mt -108.42 133.29 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.452 -0.78 . . . . 0.83999999999999997 110.571 -172.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.595 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.3 m-85 -119.38 159.98 23.16 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 116.319 -0.401 . . . . 0.45000000000000001 110.001 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.523 ' CG2' ' OG ' ' B' ' 5' ' ' SER . 76.8 t -133.22 127.25 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.98 -1.075 . . . . 0.27000000000000002 110.564 173.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.478 ' OD1' HG12 ' A' ' 46' ' ' ILE . 39.1 p-10 -147.23 137.99 23.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 1.77 110.658 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.7 t0 43.74 47.36 6.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.043 -1.035 . . . . 1.22 111.306 174.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.5 tt0 61.02 11.8 3.57 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.193 -0.942 . . . . 1.9299999999999999 110.622 175.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 35.4 mtmt -113.07 151.91 30.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 2.0099999999999998 109.71 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.809 HG22 HD11 ' A' ' 47' ' ' LEU . 65.9 mt -94.73 129.78 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 1.25 109.977 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 27.6 mm -114.95 120.93 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.465 -0.772 . . . . 0.5 109.928 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.845 HD13 ' CD1' ' B' ' 47' ' ' LEU . 4.4 mp -118.34 136.04 53.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.973 -1.079 . . . . 1.6599999999999999 110.257 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.559 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 5.0 ptpt -142.67 158.24 43.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.339 -0.85 . . . . 1.74 110.333 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -57.88 146.59 31.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -0.958 . . . . 1.6499999999999999 109.934 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.631 ' CD2' HG11 ' B' ' 9' ' ' VAL . 14.5 t80 -103.24 119.87 39.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.34999999999999998 110.729 -175.566 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -99.63 122.54 51.0 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.198 -0.938 . . . . 3.21 109.415 171.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.58 147.0 86.04 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.797 1.419 . . . . 0.47999999999999998 110.297 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.029 -0.986 . . . . 2.4100000000000001 110.241 179.627 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 49.7 p90 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.235 0.541 . . . . 11.66 110.211 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 3' ' ' MET . . . . . 0.407 ' SD ' ' OE2' ' B' ' 23' ' ' GLU . 50.3 ttm -111.18 91.32 3.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 8.6999999999999993 110.162 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -135.22 146.0 48.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.338 -0.851 . . . . 9.1699999999999999 110.056 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.898 ' O ' HG23 ' B' ' 6' ' ' THR . 54.4 p -58.98 153.61 17.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.22 -0.925 . . . . 5.2000000000000002 110.057 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.898 HG23 ' O ' ' B' ' 5' ' ' SER . 0.7 OUTLIER -170.84 64.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.407 -0.808 . . . . 2.98 110.071 -176.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.36 51.1 4.25 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.861 -1.296 . . . . 0.82999999999999996 109.861 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 61.9 mt -104.14 135.93 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.992 -1.299 . . . . 1.3600000000000001 109.725 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 36' ' ' LEU . 74.0 t -110.94 143.77 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.741 -1.225 . . . . 0.37 111.375 -170.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 28.8 tpt180 -125.69 162.96 23.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.527 -0.733 . . . . 1.9199999999999999 109.596 175.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.49 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 56.7 mttm -84.97 146.52 27.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.071 -1.018 . . . . 2.21 110.484 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.914 HG22 ' CD1' ' A' ' 36' ' ' LEU . 4.0 t -83.5 130.38 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.35 -0.844 . . . . 0.28999999999999998 109.763 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.0 -175.33 5.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.076 -1.015 . . . . 0.55000000000000004 110.054 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.486 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -57.11 -39.19 74.59 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.028 -1.045 . . . . 2.1899999999999999 111.554 -172.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.901 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.9 tp -83.23 -6.83 59.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.737 -1.227 . . . . 1.3899999999999999 111.589 -174.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.461 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.12 47.38 7.06 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.483 -1.447 . . . . 0.20999999999999999 109.483 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.917 ' CD ' HG22 ' A' ' 19' ' ' VAL . 69.6 mtm180 -114.08 154.67 27.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.026 -1.279 . . . . 1.1399999999999999 110.059 -177.75 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.922 HG12 HD13 ' A' ' 36' ' ' LEU . 15.1 m -123.73 152.74 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.28000000000000003 109.803 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.911 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.4 t -111.41 135.12 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.23999999999999999 110.655 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.635 HD11 ' CD1' ' A' ' 45' ' ' ILE . 15.9 mt -81.64 135.03 49.78 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.326 -0.859 . . . . 1.3799999999999999 109.602 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.538 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.5 Cg_endo -58.38 142.64 97.87 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.773 1.407 . . . . 0.35999999999999999 110.045 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.881 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.42 -31.79 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.06 -1.025 . . . . 1.1100000000000001 110.357 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' GLU . . . . . 0.407 ' OE2' ' SD ' ' B' ' 3' ' ' MET . 96.8 mt-10 -59.31 -35.59 74.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.019 -1.051 . . . . 2.3700000000000001 109.787 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.545 ' HB2' HG23 ' B' ' 20' ' ' ILE . 51.9 mt -81.15 -31.02 34.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 1.75 110.569 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.881 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.7 mtt180 -57.85 -43.93 86.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.848 -1.157 . . . . 0.29999999999999999 109.319 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -73.82 -50.1 22.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 3.27 110.62 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.5 m -63.81 -31.78 73.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.304 -0.872 . . . . 0.77000000000000002 110.854 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.875 HD23 HG13 ' B' ' 30' ' ' ILE . 18.8 tp -87.35 -4.95 59.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.124 -0.985 . . . . 1.05 110.732 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.446 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.4 43.12 93.3 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.626 -1.39 . . . . 0.32000000000000001 109.626 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.875 HG13 HD23 ' B' ' 28' ' ' LEU . 32.5 mm -115.96 138.11 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -1.144 . . . . 0.40999999999999998 110.64 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.55 167.11 22.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.478 -0.764 . . . . 0.23000000000000001 109.999 -177.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.64 145.93 14.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 1.1299999999999999 110.565 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 69.2 tttt 74.49 -4.58 2.29 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.656 -0.653 . . . . 1.8799999999999999 111.128 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.723 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.9 m-20 -76.97 168.07 20.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.83 -1.169 . . . . 1.1000000000000001 110.013 174.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.499 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.66 131.36 53.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 0.35999999999999999 110.805 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.906 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.4 mt -107.71 144.04 35.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.391 -0.818 . . . . 0.56000000000000005 109.291 174.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.473 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.3 tt0 -108.15 137.81 45.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.764 -1.21 . . . . 1.1699999999999999 109.881 173.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -108.32 133.35 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.322 -0.861 . . . . 0.83999999999999997 110.508 -172.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.602 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 10.3 m-85 -119.41 159.98 23.18 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 116.276 -0.42 . . . . 0.45000000000000001 110.03 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 76.7 t -133.12 127.56 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.945 -1.097 . . . . 0.26000000000000001 110.454 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.489 ' OD1' HG12 ' B' ' 46' ' ' ILE . 39.2 p-10 -147.6 137.98 23.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.34 -0.85 . . . . 1.77 110.58 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 54.4 t0 43.89 47.42 6.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.136 -0.977 . . . . 1.21 111.278 174.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.3 tt0 60.85 11.74 3.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.133 -0.979 . . . . 1.9199999999999999 110.636 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 35.3 mtmt -113.02 152.06 29.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.176 -0.952 . . . . 2.0 109.683 175.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.803 HG22 HD11 ' B' ' 47' ' ' LEU . 65.6 mt -94.81 129.57 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 1.24 110.108 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 27.2 mm -114.84 120.94 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.581 -0.699 . . . . 0.5 109.962 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.845 ' CD1' HD13 ' A' ' 47' ' ' LEU . 4.4 mp -118.2 135.88 53.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.999 -1.063 . . . . 1.6599999999999999 110.235 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.558 ' HD2' ' CE1' ' B' ' 39' ' ' TYR . 5.0 ptpt -142.53 158.41 43.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 1.74 110.346 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -57.83 146.47 31.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 1.6499999999999999 109.955 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.699 ' CD2' HG11 ' A' ' 9' ' ' VAL . 15.0 t80 -103.34 116.1 31.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.65000000000000002 110.697 -175.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.434 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -110.99 108.57 57.55 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 4.3499999999999996 110.111 176.396 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -55.83 145.0 74.89 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.011 1.532 . . . . 3.5800000000000001 110.337 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.993 -1.003 . . . . 5.9699999999999998 110.205 -179.877 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.233 0.54 . . . . 10.99 110.133 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 71.0 mtm -47.12 -39.91 14.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.146 -0.971 . . . . 8.7599999999999998 111.3 -174.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -86.36 138.75 31.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.748 -1.22 . . . . 8.8499999999999996 110.362 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.9 p -75.99 163.47 27.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -0.861 . . . . 4.2000000000000002 110.145 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.461 HG21 ' CG2' ' B' ' 40' ' ' VAL . 47.6 p -62.52 -38.89 91.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 3.77 110.152 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.22 45.38 70.95 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.72 -1.352 . . . . 0.82999999999999996 109.72 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.5 mt -118.51 133.7 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.059 -1.26 . . . . 1.3600000000000001 110.018 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.93 HG13 ' O ' ' B' ' 36' ' ' LEU . 89.2 t -115.71 144.25 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.013 -1.054 . . . . 0.37 110.855 -176.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -129.85 160.38 33.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.522 -0.736 . . . . 1.9099999999999999 109.658 177.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -85.62 147.73 26.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.029 -1.044 . . . . 2.21 110.33 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.93 HG22 HD11 ' B' ' 36' ' ' LEU . 3.8 t -82.33 130.78 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -0.864 . . . . 0.28000000000000003 109.825 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.8 -175.55 5.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.128 -0.982 . . . . 0.55000000000000004 110.02 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.9 -40.77 70.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.134 -0.979 . . . . 2.1899999999999999 111.733 -173.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.843 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.1 tp -84.09 -5.51 59.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.746 -1.221 . . . . 1.3799999999999999 111.493 -173.28 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.523 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.34 46.37 7.53 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.193 -1.479 . . . . 0.20999999999999999 109.704 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.919 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.0 mtm180 -114.93 154.53 28.57 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.028 -1.277 . . . . 1.1499999999999999 109.994 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.769 HG12 HD13 ' B' ' 36' ' ' LEU . 16.6 m -123.86 152.01 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.28000000000000003 109.768 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.929 HG22 ' CD ' ' B' ' 17' ' ' ARG . 36.0 t -111.23 134.87 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.23999999999999999 110.724 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.53 HG23 ' HB2' ' A' ' 24' ' ' LEU . 19.0 mt -81.36 133.28 53.7 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.277 -0.89 . . . . 1.3799999999999999 109.632 174.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' HD12 ' A' ' 24' ' ' LEU . 10.2 Cg_endo -58.85 143.32 99.34 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.701 1.369 . . . . 0.34999999999999998 109.985 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.883 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.07 -32.82 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.934 -1.104 . . . . 1.1100000000000001 110.33 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.11 -35.66 71.77 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.111 -0.993 . . . . 2.3700000000000001 109.852 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.552 HD12 ' HG2' ' A' ' 21' ' ' PRO . 57.2 mt -82.83 -29.8 29.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.429 -0.795 . . . . 1.75 110.645 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.883 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.0 mtt180 -57.54 -43.88 84.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.887 -1.133 . . . . 0.29999999999999999 109.166 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -73.06 -50.97 19.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.542 -0.724 . . . . 3.2599999999999998 110.645 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.3 m -63.53 -31.32 72.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.259 -0.9 . . . . 0.77000000000000002 111.195 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.886 HD23 HG13 ' A' ' 30' ' ' ILE . 20.8 tp -87.71 -4.8 58.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.037 -1.039 . . . . 1.05 110.783 -177.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.15 41.72 96.83 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.624 -1.391 . . . . 0.32000000000000001 109.624 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.886 HG13 HD23 ' A' ' 28' ' ' LEU . 34.9 mm -116.4 138.05 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.228 -1.16 . . . . 0.40999999999999998 110.633 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.68 166.74 23.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.652 -0.655 . . . . 0.23000000000000001 110.005 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.53 146.56 12.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.065 -1.022 . . . . 1.1299999999999999 110.532 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 28.6 tttm 74.57 -4.62 2.29 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.699 -0.626 . . . . 1.8799999999999999 111.097 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.715 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.3 m-20 -77.65 166.74 22.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.81 -1.182 . . . . 1.1000000000000001 110.078 174.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.14 130.69 51.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.35999999999999999 110.747 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.978 HD11 HG22 ' B' ' 12' ' ' VAL . 12.3 mt -107.3 143.21 35.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.351 -0.843 . . . . 0.56000000000000005 109.424 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.663 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.5 tt0 -107.27 137.85 44.56 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.839 -1.163 . . . . 1.1699999999999999 109.577 173.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.6 mt -108.6 133.44 53.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.361 -0.837 . . . . 0.83999999999999997 110.583 -171.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.625 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.7 m-85 -120.13 159.44 24.85 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 116.309 -0.405 . . . . 0.45000000000000001 110.014 -178.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.629 ' CG2' HG21 ' B' ' 6' ' ' THR . 80.8 t -133.16 124.55 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.85 -1.156 . . . . 0.27000000000000002 110.666 172.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.495 ' OD1' HG12 ' A' ' 46' ' ' ILE . 42.3 p-10 -147.54 145.08 28.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 1.77 110.577 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.1 t0 43.08 43.9 3.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.998 -1.064 . . . . 1.22 111.283 174.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 45.2 tp10 61.74 10.6 3.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.128 -0.983 . . . . 1.9299999999999999 110.676 175.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -109.77 153.44 24.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 2.0099999999999998 110.034 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.76 HG22 HD11 ' A' ' 47' ' ' LEU . 66.6 mt -93.32 128.34 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 1.25 109.752 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.0 mm -113.35 118.43 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.602 -0.687 . . . . 0.5 109.941 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.83 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -115.84 134.67 54.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.944 -1.097 . . . . 1.6599999999999999 110.284 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.57 ' HE3' ' CD1' ' A' ' 39' ' ' TYR . 15.9 ptpt -142.78 161.14 38.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.793 . . . . 1.74 110.317 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -56.59 147.67 21.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.042 -1.037 . . . . 1.6499999999999999 109.882 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.768 ' CD2' HG11 ' B' ' 9' ' ' VAL . 5.5 t80 -102.39 120.15 40.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.34999999999999998 110.653 -175.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -99.37 123.42 48.5 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.383 -0.823 . . . . 3.21 109.718 173.936 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.61 144.44 99.53 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.647 1.34 . . . . 0.47999999999999998 110.273 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.989 -1.005 . . . . 2.4100000000000001 110.204 -179.691 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 47.0 p90 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.284 0.564 . . . . 11.66 110.169 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 87.3 mtp -124.49 154.64 40.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 8.6999999999999993 110.202 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.522 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 67.0 mttm -94.5 142.36 27.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 9.1699999999999999 110.195 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.58 -94.59 0.22 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 5.2000000000000002 110.176 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.629 HG21 ' CG2' ' A' ' 40' ' ' VAL . 46.9 p -68.82 -39.07 80.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.022 . . . . 2.98 110.155 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.26 45.43 70.3 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.772 -1.331 . . . . 0.82999999999999996 109.772 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.1 mt -118.49 133.55 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.062 -1.257 . . . . 1.3600000000000001 109.99 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.942 HG13 ' O ' ' A' ' 36' ' ' LEU . 87.2 t -115.7 144.24 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.019 -1.051 . . . . 0.37 110.951 -176.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -129.79 160.16 34.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.53 -0.731 . . . . 1.9199999999999999 109.709 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -85.53 147.59 26.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.101 -1.0 . . . . 2.21 110.413 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.978 HG22 HD11 ' A' ' 36' ' ' LEU . 3.8 t -82.25 130.75 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.874 . . . . 0.28999999999999998 109.743 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -83.95 -175.59 5.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.049 -1.032 . . . . 0.55000000000000004 110.119 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.02 -40.62 70.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.133 -0.98 . . . . 2.1899999999999999 111.649 -172.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.865 HD23 ' HD3' ' B' ' 17' ' ' ARG . 13.9 tp -84.1 -5.52 59.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.766 -1.209 . . . . 1.3899999999999999 111.602 -173.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.529 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.92 47.12 7.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.606 -1.397 . . . . 0.20999999999999999 109.606 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.929 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.0 mtm180 -115.09 154.57 28.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.071 -1.253 . . . . 1.1399999999999999 109.996 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.801 HG12 HD13 ' A' ' 36' ' ' LEU . 16.6 m -123.96 152.01 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 0.28000000000000003 109.823 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.919 HG22 ' CD ' ' A' ' 17' ' ' ARG . 35.9 t -111.29 134.85 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.935 . . . . 0.23999999999999999 110.714 -175.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.532 HD11 ' CD1' ' A' ' 45' ' ' ILE . 18.5 mt -81.41 133.23 53.62 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.253 -0.904 . . . . 1.3799999999999999 109.609 174.207 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.544 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.1 Cg_endo -58.96 143.25 99.76 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.735 1.387 . . . . 0.35999999999999999 109.98 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.877 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.2 tp -55.09 -32.63 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.002 -1.061 . . . . 1.1100000000000001 110.412 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.98 -36.39 72.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.11 -0.994 . . . . 2.3700000000000001 109.747 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.544 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 57.6 mt -82.13 -30.01 31.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.494 -0.754 . . . . 1.75 110.638 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.877 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.6 mtt180 -57.56 -43.71 84.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.847 -1.158 . . . . 0.29999999999999999 109.076 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -72.97 -51.21 19.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.482 -0.761 . . . . 3.27 110.6 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.2 m -63.29 -31.87 73.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.261 -0.899 . . . . 0.77000000000000002 110.953 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.895 HD23 HG13 ' B' ' 30' ' ' ILE . 20.9 tp -87.12 -5.22 59.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.042 -1.036 . . . . 1.05 110.73 -176.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.429 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.46 41.54 96.29 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.563 -1.415 . . . . 0.32000000000000001 109.563 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.895 HG13 HD23 ' B' ' 28' ' ' LEU . 34.2 mm -116.37 137.94 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -1.199 . . . . 0.40999999999999998 110.598 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.41 166.86 23.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.624 -0.672 . . . . 0.23000000000000001 109.965 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.51 146.61 12.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 1.1299999999999999 110.48 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 28.5 tttm 74.66 -4.78 2.27 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.671 -0.643 . . . . 1.8799999999999999 111.17 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.622 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.9 m-20 -77.73 166.5 22.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.789 -1.194 . . . . 1.1000000000000001 110.092 175.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.693 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.06 130.63 51.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 0.35999999999999999 110.837 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.93 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.1 mt -107.27 143.06 36.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 0.56000000000000005 109.48 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.649 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.4 tt0 -107.05 137.85 44.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.763 -1.21 . . . . 1.1699999999999999 109.688 172.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.8 mt -108.72 133.53 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.292 -0.88 . . . . 0.83999999999999997 110.516 -171.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.616 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 10.7 m-85 -120.16 159.44 24.88 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 116.225 -0.443 . . . . 0.45000000000000001 109.978 -178.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.461 ' CG2' HG21 ' A' ' 6' ' ' THR . 81.5 t -133.03 125.02 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.885 -1.134 . . . . 0.26000000000000001 110.451 172.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.491 ' OD1' HG12 ' B' ' 46' ' ' ILE . 42.1 p-10 -148.03 145.06 28.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 1.77 110.556 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.7 t0 43.25 43.91 4.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.077 -1.014 . . . . 1.21 111.242 174.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 45.0 tp10 61.61 10.61 3.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.147 -0.971 . . . . 1.9199999999999999 110.703 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -109.87 153.66 24.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 2.0 109.963 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.759 HG22 HD11 ' B' ' 47' ' ' LEU . 66.2 mt -93.43 128.14 45.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.19 -0.944 . . . . 1.24 109.85 176.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 21.4 mm -113.28 118.42 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.508 -0.745 . . . . 0.5 109.95 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.821 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.3 mp -115.66 134.42 55.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.067 -1.021 . . . . 1.6599999999999999 110.255 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.57 ' HE3' ' CD1' ' B' ' 39' ' ' TYR . 15.8 ptpt -142.54 161.34 38.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.351 -0.843 . . . . 1.74 110.36 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -56.67 147.59 22.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.186 -0.946 . . . . 1.6499999999999999 109.893 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.929 ' CD2' HG11 ' A' ' 9' ' ' VAL . 5.6 t80 -102.36 116.77 33.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.65000000000000002 110.581 -175.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.08 80.28 72.47 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 4.3499999999999996 110.144 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.09 144.64 94.62 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.009 1.531 . . . . 3.5800000000000001 110.378 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.045 -0.979 . . . . 5.9699999999999998 110.19 -179.764 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.201 0.524 . . . . 10.99 110.264 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.2 mmm -87.11 138.82 31.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 8.7599999999999998 110.21 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -78.1 134.13 37.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -0.885 . . . . 8.8499999999999996 110.184 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.501 ' OG ' ' CD2' ' B' ' 39' ' ' TYR . 35.7 m -121.16 147.77 45.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 4.2000000000000002 110.275 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.0 p -64.67 -34.71 78.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -0.986 . . . . 3.77 110.027 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.92 45.45 51.35 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.852 -1.299 . . . . 0.82999999999999996 109.852 177.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.5 mt -116.82 132.79 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.254 . . . . 1.3600000000000001 109.954 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.05 HG11 ' CD2' ' B' ' 50' ' ' TYR . 88.5 t -117.45 144.26 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.014 -1.054 . . . . 0.37 110.875 -175.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -131.47 162.54 29.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.532 -0.73 . . . . 1.9099999999999999 109.726 177.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -85.32 148.06 26.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.041 -1.037 . . . . 2.21 110.385 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.916 HG22 HD11 ' B' ' 36' ' ' LEU . 3.8 t -82.3 129.8 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.216 -0.928 . . . . 0.28000000000000003 109.792 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.14 -175.66 5.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.037 -1.039 . . . . 0.55000000000000004 109.994 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -54.85 -40.69 69.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.083 -1.011 . . . . 2.1899999999999999 111.68 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.831 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.4 tp -84.51 -5.82 59.32 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.731 -1.231 . . . . 1.3799999999999999 111.572 -173.195 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.486 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.53 46.59 7.28 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.225 -1.464 . . . . 0.20999999999999999 109.646 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.898 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.0 mtm180 -114.03 153.74 28.88 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.942 -1.328 . . . . 1.1499999999999999 110.109 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.902 HG12 HD13 ' B' ' 36' ' ' LEU . 16.6 m -124.21 152.99 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.28000000000000003 109.771 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.9 HG22 ' CD ' ' B' ' 17' ' ' ARG . 18.1 t -112.24 134.36 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.983 . . . . 0.23999999999999999 110.708 -175.032 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.668 HD11 HG21 ' B' ' 45' ' ' ILE . 2.2 mm -82.97 134.13 47.14 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.181 -0.95 . . . . 1.3799999999999999 109.322 173.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.5 Cg_endo -58.86 141.57 98.18 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.701 1.369 . . . . 0.34999999999999998 109.906 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.962 ' O ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.76 -31.43 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.909 -1.12 . . . . 1.1100000000000001 110.412 -176.556 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.473 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 20.1 pt-20 -59.25 -34.67 72.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.024 -1.048 . . . . 2.3700000000000001 109.732 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.584 ' HB2' HG23 ' A' ' 20' ' ' ILE . 56.6 mt -80.73 -29.42 36.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 1.75 110.325 176.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.701 HH22 HD11 ' B' ' 15' ' ' LEU . 73.4 mtt180 -57.1 -44.19 82.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.958 -1.088 . . . . 0.29999999999999999 109.122 175.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -72.41 -50.45 26.34 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.893 -0.723 . . . . 3.2599999999999998 110.692 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.1 m -63.53 -31.49 72.66 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.77000000000000002 111.129 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.863 HD23 HG13 ' A' ' 30' ' ' ILE . 18.3 tp -87.85 -4.71 58.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.011 -1.055 . . . . 1.05 110.74 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.444 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.84 42.04 95.24 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.707 -1.357 . . . . 0.32000000000000001 109.707 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.863 HG13 HD23 ' A' ' 28' ' ' LEU . 32.5 mm -116.41 138.37 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -1.125 . . . . 0.40999999999999998 110.716 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.63 166.23 25.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.594 -0.691 . . . . 0.23000000000000001 109.993 -177.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.42 147.0 11.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.024 -1.048 . . . . 1.1299999999999999 110.584 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 26.6 ttpt 74.39 -4.47 2.31 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.644 -0.66 . . . . 1.8799999999999999 111.163 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.754 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.8 m-20 -77.79 167.82 20.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.827 -1.17 . . . . 1.1000000000000001 110.057 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.51 131.0 52.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 0.35999999999999999 110.777 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.935 ' CD1' HG22 ' B' ' 12' ' ' VAL . 12.2 mt -108.03 144.3 35.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.381 -0.824 . . . . 0.56000000000000005 109.461 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.63 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.0 tt0 -109.5 139.14 44.85 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.812 -1.18 . . . . 1.1699999999999999 109.614 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.25 132.86 54.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.462 -0.774 . . . . 0.83999999999999997 110.471 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.601 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 15.8 m-85 -119.19 157.21 28.43 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 116.294 -0.412 . . . . 0.45000000000000001 109.941 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.467 ' HB ' HG23 ' B' ' 6' ' ' THR . 84.1 t -132.14 122.69 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.795 -1.191 . . . . 0.27000000000000002 110.575 173.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.49 ' OD1' HG12 ' A' ' 46' ' ' ILE . 47.4 p-10 -147.8 149.71 32.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.909 . . . . 1.77 110.602 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 52.7 t0 42.96 44.19 3.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.011 -1.055 . . . . 1.22 111.317 173.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.7 mt-10 57.84 14.46 2.54 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.051 -1.03 . . . . 1.9299999999999999 110.54 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -114.09 153.32 29.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -0.929 . . . . 2.0099999999999998 109.984 175.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.835 HG22 HD11 ' A' ' 47' ' ' LEU . 66.0 mt -91.82 127.77 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.23 -0.919 . . . . 1.25 109.762 177.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 24.5 mm -112.96 120.07 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.633 -0.667 . . . . 0.5 109.896 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.843 ' CD2' HG21 ' B' ' 18' ' ' VAL . 4.1 mp -118.72 134.5 55.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.902 -1.124 . . . . 1.6599999999999999 110.256 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.533 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 9.8 pttp -141.81 164.49 30.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 1.74 110.451 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -58.68 147.08 34.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 1.6499999999999999 110.146 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.884 ' CD2' HG11 ' B' ' 9' ' ' VAL . 7.8 t80 -104.13 120.13 40.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.833 . . . . 0.34999999999999998 110.603 -176.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 1.6 mttp -99.38 123.01 49.94 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 3.21 109.459 171.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 24.0 Cg_exo -58.42 145.71 93.03 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.797 1.419 . . . . 0.47999999999999998 110.424 -178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.959 -1.02 . . . . 2.4100000000000001 110.238 -179.745 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.218 0.532 . . . . 11.66 110.187 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 94.5 mmm -100.91 146.06 27.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.342 -0.849 . . . . 8.6999999999999993 110.171 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -88.44 143.01 27.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 9.1699999999999999 110.272 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.512 ' OG ' ' CD2' ' A' ' 39' ' ' TYR . 47.3 t -123.8 145.1 49.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.864 . . . . 5.2000000000000002 110.2 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.467 HG23 ' HB ' ' A' ' 40' ' ' VAL . 71.5 p -63.8 -34.77 78.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.934 . . . . 2.98 109.961 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.94 45.6 50.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.74 -1.344 . . . . 0.82999999999999996 109.74 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 59.0 mt -116.85 132.72 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.095 -1.238 . . . . 1.3600000000000001 109.97 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.931 HG13 ' O ' ' A' ' 36' ' ' LEU . 89.2 t -117.46 144.25 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.977 -1.077 . . . . 0.37 110.919 -175.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -131.42 162.35 30.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.555 -0.716 . . . . 1.9199999999999999 109.72 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -85.16 148.01 26.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.083 -1.01 . . . . 2.21 110.393 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.935 HG22 ' CD1' ' A' ' 36' ' ' LEU . 3.9 t -82.29 129.85 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.213 -0.929 . . . . 0.28999999999999998 109.7 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.42 -175.55 5.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.956 . . . . 0.55000000000000004 110.097 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -54.89 -40.65 69.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 2.1899999999999999 111.674 -172.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.845 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.1 tp -84.42 -5.97 59.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.772 -1.205 . . . . 1.3899999999999999 111.599 -173.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.489 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.18 47.31 7.07 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.558 -1.417 . . . . 0.20999999999999999 109.558 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.9 ' CD ' HG22 ' A' ' 19' ' ' VAL . 68.7 mtm180 -114.29 153.69 29.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.085 -1.244 . . . . 1.1399999999999999 110.061 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.923 HG12 HD13 ' A' ' 36' ' ' LEU . 16.4 m -124.12 152.96 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 0.28000000000000003 109.813 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.898 HG22 ' CD ' ' A' ' 17' ' ' ARG . 18.0 t -112.37 134.36 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.23999999999999999 110.686 -175.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.696 HD11 HG21 ' A' ' 45' ' ' ILE . 2.3 mm -82.91 134.02 47.54 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.934 . . . . 1.3799999999999999 109.409 173.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.4 Cg_endo -58.96 141.57 98.39 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.807 1.425 . . . . 0.35999999999999999 109.899 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.956 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.95 -31.13 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.068 -1.02 . . . . 1.1100000000000001 110.409 -176.266 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 23' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' B' ' 21' ' ' PRO . 20.0 pt-20 -59.16 -35.38 73.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.023 -1.048 . . . . 2.3700000000000001 109.59 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.596 ' HB2' HG23 ' B' ' 20' ' ' ILE . 57.3 mt -80.03 -29.83 39.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.484 -0.76 . . . . 1.75 110.334 176.419 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.64 HH22 HD11 ' A' ' 15' ' ' LEU . 73.0 mtt180 -56.83 -44.08 81.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.01 -1.056 . . . . 0.29999999999999999 109.203 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -72.3 -50.78 24.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.468 -0.77 . . . . 3.27 110.642 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.3 m -63.2 -32.05 73.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.888 . . . . 0.77000000000000002 110.921 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.864 HD23 HG13 ' B' ' 30' ' ' ILE . 18.5 tp -87.39 -4.99 59.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.026 -1.047 . . . . 1.05 110.73 -176.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.447 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.31 41.8 94.4 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.603 -1.399 . . . . 0.32000000000000001 109.603 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.864 HG13 HD23 ' B' ' 28' ' ' LEU . 32.1 mm -116.41 138.29 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -1.183 . . . . 0.40999999999999998 110.616 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.39 166.44 24.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.562 -0.711 . . . . 0.23000000000000001 110.026 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.48 147.0 11.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.136 -0.978 . . . . 1.1299999999999999 110.486 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 26.6 ttpt 74.59 -4.76 2.26 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.661 -0.65 . . . . 1.8799999999999999 111.126 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.657 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.0 m-20 -77.76 167.54 21.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.825 -1.172 . . . . 1.1000000000000001 110.107 175.209 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.758 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.28 130.98 52.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.184 -0.948 . . . . 0.35999999999999999 110.803 -176.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.932 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.2 mt -108.02 144.08 35.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.842 . . . . 0.56000000000000005 109.551 174.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.617 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.7 tt0 -109.11 139.09 44.48 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.868 -1.145 . . . . 1.1699999999999999 109.8 172.754 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.32 132.84 55.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.363 -0.836 . . . . 0.83999999999999997 110.427 -172.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.591 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 15.6 m-85 -119.18 157.24 28.35 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 116.231 -0.44 . . . . 0.45000000000000001 109.874 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 85.7 t -131.96 123.08 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.958 -1.089 . . . . 0.26000000000000001 110.441 173.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.484 ' OD1' HG12 ' B' ' 46' ' ' ILE . 47.6 p-10 -148.35 149.63 32.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.16 -0.962 . . . . 1.77 110.561 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.46 ' O ' ' OD1' ' B' ' 42' ' ' ASP . 53.2 t0 42.87 44.48 3.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.129 -0.982 . . . . 1.21 111.287 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.7 mt-10 57.61 14.53 2.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.045 -1.034 . . . . 1.9199999999999999 110.503 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -114.08 153.49 29.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.292 -0.88 . . . . 2.0 109.989 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.832 HG22 HD11 ' B' ' 47' ' ' LEU . 65.7 mt -91.95 127.72 44.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.263 -0.898 . . . . 1.24 109.771 177.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.591 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 24.7 mm -113.02 120.1 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.513 -0.742 . . . . 0.5 109.903 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.832 HD11 HG22 ' B' ' 45' ' ' ILE . 4.2 mp -118.66 134.34 55.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.974 -1.079 . . . . 1.6599999999999999 110.196 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.535 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 10.1 pttp -141.62 164.81 29.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 1.74 110.406 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -58.89 147.04 35.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 1.6499999999999999 109.953 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 1.05 ' CD2' HG11 ' A' ' 9' ' ' VAL . 7.9 t80 -104.16 113.33 26.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.65000000000000002 110.583 -176.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.16 78.78 75.55 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 4.3499999999999996 110.266 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -58.64 143.98 98.04 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.004 1.528 . . . . 3.5800000000000001 110.302 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.026 -0.988 . . . . 5.9699999999999998 110.226 -179.765 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.201 0.524 . . . . 10.99 110.204 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 88.4 mtp -78.09 139.51 39.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 8.7599999999999998 110.103 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -49.09 -45.88 43.93 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.18 -0.95 . . . . 8.8499999999999996 111.156 -174.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.2 m -122.47 152.76 39.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.837 -1.164 . . . . 4.2000000000000002 110.192 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.1 p -59.15 -38.78 80.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 3.77 109.943 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.502 ' O ' HD13 ' A' ' 8' ' ' ILE . . . 65.72 45.9 86.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.665 -1.374 . . . . 0.82999999999999996 109.665 177.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.502 HD13 ' O ' ' A' ' 7' ' ' GLY . 25.1 mm -114.98 132.55 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.134 -1.215 . . . . 1.3600000000000001 110.061 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.943 HG13 ' O ' ' B' ' 36' ' ' LEU . 95.9 t -115.82 144.85 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.063 -1.023 . . . . 0.37 110.81 -176.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -131.44 160.27 35.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.515 -0.74 . . . . 1.9099999999999999 109.704 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -85.58 148.0 26.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.062 -1.024 . . . . 2.21 110.307 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.932 HG22 HD11 ' B' ' 36' ' ' LEU . 4.3 t -81.91 130.3 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.268 -0.895 . . . . 0.28000000000000003 109.855 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.74 -174.64 5.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.55000000000000004 110.157 -179.124 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.42 -41.95 66.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.123 -0.986 . . . . 2.1899999999999999 111.887 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.901 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.0 tp -87.48 -3.06 59.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.68 -1.262 . . . . 1.3799999999999999 111.755 -172.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.528 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 79.98 46.36 7.75 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.168 -1.491 . . . . 0.20999999999999999 109.674 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.935 ' CD ' HG22 ' B' ' 19' ' ' VAL . 76.9 mtm180 -116.2 154.28 30.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.098 -1.236 . . . . 1.1499999999999999 109.828 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.645 HG12 HD13 ' B' ' 36' ' ' LEU . 27.4 m -125.7 153.14 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 0.28000000000000003 109.938 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.935 HG22 ' CD ' ' B' ' 17' ' ' ARG . 22.7 t -111.55 135.52 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.23999999999999999 110.548 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.31 134.25 46.01 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.255 -0.903 . . . . 1.3799999999999999 109.577 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.54 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.4 Cg_endo -57.83 142.81 96.41 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.788 1.415 . . . . 0.34999999999999998 110.025 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.893 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.37 -32.56 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.034 -1.041 . . . . 1.1100000000000001 110.378 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.96 -35.9 71.8 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.143 -0.973 . . . . 2.3700000000000001 109.9 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.543 ' HB2' HG23 ' A' ' 20' ' ' ILE . 51.8 mt -81.03 -31.3 34.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 1.75 110.542 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.893 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.9 mtt180 -58.17 -43.51 87.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.954 -1.091 . . . . 0.29999999999999999 109.287 176.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -73.19 -49.66 26.81 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.797 -0.761 . . . . 3.2599999999999998 110.694 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.5 m -63.9 -31.86 73.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.77000000000000002 111.093 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.823 HD23 HG13 ' A' ' 30' ' ' ILE . 17.4 tp -88.16 -4.61 58.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.055 -1.028 . . . . 1.05 110.737 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.48 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.78 42.35 95.21 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.681 -1.367 . . . . 0.32000000000000001 109.681 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.823 HG13 HD23 ' A' ' 28' ' ' LEU . 31.4 mm -116.32 137.79 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.302 -1.116 . . . . 0.40999999999999998 110.715 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.43 168.65 19.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.589 -0.694 . . . . 0.23000000000000001 110.061 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.77 145.87 14.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.111 -0.993 . . . . 1.1299999999999999 110.616 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 41.3 tttp 74.0 -4.35 2.3 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.751 -0.593 . . . . 1.8799999999999999 111.231 176.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.718 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.1 m-20 -76.84 166.28 23.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.818 -1.176 . . . . 1.1000000000000001 110.047 174.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.727 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -103.7 131.08 51.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.953 . . . . 0.35999999999999999 110.823 -175.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.992 HD11 HG22 ' B' ' 12' ' ' VAL . 13.2 mt -108.05 144.48 35.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.372 -0.83 . . . . 0.56000000000000005 109.392 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.684 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.3 tt0 -108.81 138.28 45.39 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.732 -1.23 . . . . 1.1699999999999999 109.517 172.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.3 mt -109.09 131.79 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.419 -0.801 . . . . 0.83999999999999997 110.582 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.614 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.6 m-85 -117.58 159.26 23.18 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.83 -0.433 . . . . 0.45000000000000001 109.83 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.458 HG21 HG21 ' B' ' 6' ' ' THR . 73.3 t -133.26 120.93 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.876 -1.14 . . . . 0.27000000000000002 110.554 172.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 47.2 p-10 -148.4 159.96 43.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.167 -0.958 . . . . 1.77 110.603 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 53.9 t0 42.29 40.35 1.76 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.025 -1.047 . . . . 1.22 111.599 171.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 84.2 tt0 58.87 14.09 3.1 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.844 -1.16 . . . . 1.9299999999999999 110.567 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.529 ' CE ' HD11 ' A' ' 46' ' ' ILE . 14.0 pttt -127.18 164.45 21.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.96 . . . . 2.0099999999999998 109.691 174.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.595 HG22 HD11 ' A' ' 47' ' ' LEU . 68.9 mt -97.41 134.89 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.137 -0.977 . . . . 1.25 110.322 -176.059 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.614 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 22.3 mm -114.16 119.39 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.674 -0.641 . . . . 0.5 109.857 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.829 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.3 mp -115.95 135.07 54.32 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.021 -1.05 . . . . 1.6599999999999999 110.226 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.594 ' HE3' ' CE2' ' A' ' 39' ' ' TYR . 1.7 ptpm? -141.17 159.08 42.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.439 -0.788 . . . . 1.74 110.389 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -57.75 146.9 29.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.101 -1.0 . . . . 1.6499999999999999 109.96 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.727 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 6.0 t80 -103.72 120.07 40.19 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.228 -0.92 . . . . 0.34999999999999998 110.524 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -99.77 122.84 49.75 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.419 -0.8 . . . . 3.21 109.427 173.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.89 146.15 91.19 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.826 1.435 . . . . 0.47999999999999998 110.341 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.461 ' O ' ' OD1' ' A' ' 53' ' ' ASN . 37.4 p-10 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.003 -0.998 . . . . 2.4100000000000001 110.26 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.258 0.551 . . . . 11.66 110.246 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 86.9 mtp -128.05 164.1 23.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 8.6999999999999993 110.288 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.468 ' HD3' ' OE2' ' A' ' 37' ' ' GLU . 45.7 mttt -85.49 142.3 29.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 9.1699999999999999 110.152 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 68.8 m -73.87 -93.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.153 -0.967 . . . . 5.2000000000000002 110.327 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.458 HG21 HG21 ' A' ' 40' ' ' VAL . 60.0 p -75.56 -38.94 58.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.061 -1.025 . . . . 2.98 110.147 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLY . . . . . 0.504 ' O ' HD13 ' B' ' 8' ' ' ILE . . . 65.6 46.16 85.79 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.642 -1.383 . . . . 0.82999999999999996 109.642 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.504 HD13 ' O ' ' B' ' 7' ' ' GLY . 25.2 mm -115.03 132.48 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.097 -1.237 . . . . 1.3600000000000001 110.053 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 36' ' ' LEU . 96.3 t -115.81 144.86 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.065 -1.022 . . . . 0.37 110.81 -176.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -131.41 160.16 35.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.501 -0.75 . . . . 1.9199999999999999 109.736 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -85.6 148.01 26.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.076 -1.015 . . . . 2.21 110.442 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.992 HG22 HD11 ' A' ' 36' ' ' LEU . 4.4 t -81.9 130.38 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.28999999999999998 109.703 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.9 -174.47 5.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.115 -0.991 . . . . 0.55000000000000004 110.305 -179.35 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -53.66 -41.72 67.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.185 -0.947 . . . . 2.1899999999999999 111.79 -172.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.898 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.6 tp -87.51 -3.28 59.0 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.695 -1.253 . . . . 1.3899999999999999 111.665 -172.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.54 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.81 46.93 7.5 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.477 -1.449 . . . . 0.20999999999999999 109.477 -177.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.935 ' CD ' HG22 ' A' ' 19' ' ' VAL . 76.7 mtm180 -116.29 154.31 30.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.132 -1.217 . . . . 1.1399999999999999 109.864 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.646 HG12 HD13 ' A' ' 36' ' ' LEU . 27.2 m -125.68 153.19 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.28000000000000003 109.937 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.935 HG22 ' CD ' ' A' ' 17' ' ' ARG . 22.5 t -111.61 135.43 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 0.23999999999999999 110.559 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.557 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -83.15 134.23 46.46 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 1.3799999999999999 109.608 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.537 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.3 Cg_endo -57.94 142.82 96.73 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.765 1.403 . . . . 0.35999999999999999 109.992 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.89 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.54 -32.3 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.11 -0.994 . . . . 1.1100000000000001 110.359 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.98 -36.41 72.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.074 -1.016 . . . . 2.3700000000000001 109.794 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.557 ' HB2' HG23 ' B' ' 20' ' ' ILE . 52.3 mt -80.34 -31.62 37.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.494 -0.754 . . . . 1.75 110.574 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.89 ' HD2' HD12 ' B' ' 22' ' ' ILE . 72.3 mtt180 -58.02 -43.46 86.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.896 -1.128 . . . . 0.29999999999999999 109.246 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -73.17 -49.75 26.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 3.27 110.64 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.0 m -63.74 -32.44 73.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.193 -0.942 . . . . 0.77000000000000002 110.785 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.832 HD23 HG13 ' B' ' 30' ' ' ILE . 17.5 tp -87.71 -4.87 58.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.098 -1.001 . . . . 1.05 110.709 -176.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.482 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.04 42.15 94.77 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.624 -1.391 . . . . 0.32000000000000001 109.624 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.832 HG13 HD23 ' B' ' 28' ' ' LEU . 31.2 mm -116.24 137.67 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -1.221 . . . . 0.40999999999999998 110.705 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.16 168.89 18.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.518 -0.739 . . . . 0.23000000000000001 109.997 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.87 145.9 15.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.163 -0.961 . . . . 1.1299999999999999 110.493 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 41.2 tttp 74.13 -4.49 2.28 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.583 -0.698 . . . . 1.8799999999999999 111.179 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.611 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.1 m-20 -77.0 166.0 23.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.755 -1.216 . . . . 1.1000000000000001 109.979 174.814 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.738 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.45 131.19 50.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.35999999999999999 110.855 -175.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.943 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.2 mt -108.2 144.07 36.14 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.328 -0.858 . . . . 0.56000000000000005 109.448 174.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.662 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.0 tt0 -108.32 138.22 44.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.851 -1.155 . . . . 1.1699999999999999 109.729 172.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -109.07 131.87 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.293 -0.879 . . . . 0.83999999999999997 110.507 -171.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.624 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 10.6 m-85 -117.52 159.26 23.14 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 116.264 -0.425 . . . . 0.45000000000000001 109.914 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 74.4 t -133.11 121.37 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.876 -1.14 . . . . 0.26000000000000001 110.441 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 47.2 p-10 -148.93 159.97 43.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 1.77 110.543 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' B' ' 42' ' ' ASP . 54.7 t0 42.09 40.62 1.73 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.126 -0.984 . . . . 1.21 111.577 172.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' B' ' 43' ' ' GLU . 84.1 tt0 58.79 14.03 3.02 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.816 -1.178 . . . . 1.9199999999999999 110.529 174.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.534 ' CE ' HD11 ' B' ' 46' ' ' ILE . 13.9 pttt -127.19 164.65 21.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.089 -1.007 . . . . 2.0 109.571 174.195 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.633 HG22 HD11 ' B' ' 47' ' ' LEU . 68.9 mt -97.48 134.73 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 1.24 110.374 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 22.0 mm -114.15 119.45 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.714 -0.616 . . . . 0.5 109.869 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.818 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.4 mp -115.94 134.86 54.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.03 -1.044 . . . . 1.6599999999999999 110.208 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.58 ' HE3' ' CE2' ' B' ' 39' ' ' TYR . 1.7 ptpm? -140.99 159.3 42.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 1.74 110.316 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -57.9 146.78 30.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.954 . . . . 1.6499999999999999 109.909 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.927 ' CD2' HG11 ' A' ' 9' ' ' VAL . 6.1 t80 -103.72 114.7 29.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.65000000000000002 110.415 -176.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.04 81.68 28.18 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.295 -0.878 . . . . 4.3499999999999996 110.43 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.577 ' HG3' ' CZ ' ' B' ' 50' ' ' TYR . 27.9 Cg_exo -56.61 142.27 90.68 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.123 1.591 . . . . 3.5800000000000001 110.183 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' B' ' 52' ' ' PRO . 37.6 t30 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 117.994 -1.003 . . . . 5.9699999999999998 110.223 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.197 0.522 . . . . 10.99 110.304 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.9 mtm -91.9 126.19 36.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 8.7599999999999998 110.245 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -51.59 -50.2 60.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.167 -0.958 . . . . 8.8499999999999996 111.142 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.9 p -147.3 164.59 32.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.86 -1.15 . . . . 4.2000000000000002 110.2 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.498 HG21 HG21 ' B' ' 40' ' ' VAL . 71.4 p -62.47 -42.31 99.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 3.77 110.103 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.99 46.58 71.85 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.665 -1.374 . . . . 0.82999999999999996 109.665 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.6 mt -114.0 134.37 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.09 -1.241 . . . . 1.3600000000000001 110.088 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.076 HG11 ' CD2' ' B' ' 50' ' ' TYR . 85.9 t -120.04 144.37 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.988 -1.07 . . . . 0.37 110.809 -176.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -131.04 161.21 32.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.525 -0.734 . . . . 1.9099999999999999 109.69 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -85.39 148.09 26.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.133 -0.979 . . . . 2.21 110.34 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.908 HG22 HD11 ' B' ' 36' ' ' LEU . 3.6 t -82.93 129.94 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.89 . . . . 0.28000000000000003 109.831 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.8 -175.82 5.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.106 -0.996 . . . . 0.55000000000000004 109.923 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.06 -40.38 70.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.104 -0.997 . . . . 2.1899999999999999 111.677 -173.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.878 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.4 tp -83.25 -6.48 59.49 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.845 -1.159 . . . . 1.3799999999999999 111.539 -173.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.515 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.74 46.47 7.23 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.243 -1.455 . . . . 0.20999999999999999 109.652 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.908 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.7 mtm180 -114.47 154.82 27.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.05 -1.265 . . . . 1.1499999999999999 110.065 -177.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.815 HG12 HD13 ' B' ' 36' ' ' LEU . 19.4 m -123.69 152.56 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.398 -0.814 . . . . 0.28000000000000003 109.86 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.933 HG22 ' CD ' ' B' ' 17' ' ' ARG . 31.2 t -111.77 134.03 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.179 -0.951 . . . . 0.23999999999999999 110.69 -175.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.578 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.63 132.86 50.69 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 1.3799999999999999 109.437 173.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.547 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.7 Cg_endo -57.47 141.29 95.02 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.699 1.368 . . . . 0.34999999999999998 109.83 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.947 ' O ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.75 -31.93 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.107 . . . . 1.1100000000000001 110.303 -177.622 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.15 -36.48 70.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.017 . . . . 2.3700000000000001 109.79 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.578 ' HB2' HG23 ' A' ' 20' ' ' ILE . 52.8 mt -80.86 -29.04 35.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.262 -0.899 . . . . 1.75 110.487 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.71 HH22 HD11 ' B' ' 15' ' ' LEU . 75.8 mtt180 -56.85 -43.65 81.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.879 -1.138 . . . . 0.29999999999999999 109.18 175.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -72.85 -50.67 22.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.557 -0.715 . . . . 3.2599999999999998 110.755 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.6 m -63.43 -31.3 72.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.77000000000000002 111.117 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.846 HD23 HG13 ' A' ' 30' ' ' ILE . 26.3 tp -87.55 -4.93 58.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 1.05 110.782 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.464 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.39 42.86 97.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.626 -1.39 . . . . 0.32000000000000001 109.626 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.846 HG13 HD23 ' A' ' 28' ' ' LEU . 29.5 mm -116.12 139.0 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -1.149 . . . . 0.40999999999999998 110.7 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.5 166.99 23.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.625 -0.672 . . . . 0.23000000000000001 109.998 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.2 tt0 -53.41 146.31 12.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.966 . . . . 1.1299999999999999 110.553 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 77.2 tttt 74.86 -4.68 2.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.749 -0.594 . . . . 1.8799999999999999 111.164 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.748 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.4 m-20 -77.16 166.09 23.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.779 -1.2 . . . . 1.1000000000000001 110.044 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.755 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.83 132.57 50.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.941 . . . . 0.35999999999999999 110.855 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.96 HD11 HG22 ' B' ' 12' ' ' VAL . 13.0 mt -109.43 143.65 38.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.397 -0.814 . . . . 0.56000000000000005 109.555 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.667 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.4 tt0 -108.63 140.29 42.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.836 -1.165 . . . . 1.1699999999999999 109.824 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.414 HD13 ' O ' ' A' ' 37' ' ' GLU . 21.5 mm -111.15 133.18 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.435 -0.79 . . . . 0.83999999999999997 110.555 -173.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.614 ' CE2' ' HE3' ' B' ' 4' ' ' LYS . 14.4 m-85 -115.16 159.2 21.21 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 120.911 0.386 . . . . 0.45000000000000001 109.972 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.692 HG21 HG21 ' B' ' 6' ' ' THR . 79.5 t -130.45 128.92 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.931 -1.106 . . . . 0.27000000000000002 110.802 173.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.663 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.7 p-10 -146.54 129.5 16.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.866 . . . . 1.77 110.215 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 48.9 t0 46.12 50.11 11.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.007 -1.058 . . . . 1.22 110.96 175.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.4 mt-10 59.95 12.69 3.24 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.348 -0.845 . . . . 1.9299999999999999 110.714 176.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 9.6 mtmt -113.12 150.62 31.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 2.0099999999999998 109.811 175.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.634 HG22 HD11 ' A' ' 47' ' ' LEU . 62.8 mt -101.76 128.84 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.058 -1.026 . . . . 1.25 110.327 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.663 HD11 ' OD2' ' A' ' 41' ' ' ASP . 28.8 mt -112.06 121.47 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.391 -0.818 . . . . 0.5 110.14 176.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.843 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.3 mp -114.52 135.02 54.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.073 -1.017 . . . . 1.6599999999999999 110.237 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.541 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 10.6 pttp -141.48 165.0 28.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.454 -0.779 . . . . 1.74 110.273 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -58.2 147.5 30.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.978 . . . . 1.6499999999999999 110.009 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.934 ' CD2' HG11 ' B' ' 9' ' ' VAL . 5.9 t80 -104.07 123.16 46.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.885 . . . . 0.34999999999999998 110.566 -175.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -99.73 122.79 49.99 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 3.21 109.393 173.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.18 146.47 90.56 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.749 1.394 . . . . 0.47999999999999998 110.44 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.886 -1.054 . . . . 2.4100000000000001 110.278 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 67.6 t80 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.248 0.547 . . . . 11.66 110.105 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 70.2 mtm -105.17 145.73 30.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 8.6999999999999993 110.221 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.614 ' HE3' ' CE2' ' A' ' 39' ' ' TYR . 22.2 tptm -76.35 131.76 39.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 9.1699999999999999 110.211 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 40' ' ' VAL . 53.5 m -46.96 -53.03 13.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.209 -0.932 . . . . 5.2000000000000002 110.724 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.692 HG21 HG21 ' A' ' 40' ' ' VAL . 71.0 p -147.68 -42.68 0.17 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.931 -1.106 . . . . 2.98 109.993 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.85 47.07 68.78 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.586 -1.405 . . . . 0.82999999999999996 109.586 177.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.3 mt -114.23 134.31 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.074 -1.251 . . . . 1.3600000000000001 110.029 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.943 HG13 ' O ' ' A' ' 36' ' ' LEU . 85.9 t -120.07 144.29 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.055 -1.028 . . . . 0.37 110.779 -176.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -130.86 161.12 32.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.467 -0.771 . . . . 1.9199999999999999 109.845 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -85.43 147.98 26.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 2.21 110.404 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.96 HG22 HD11 ' A' ' 36' ' ' LEU . 3.6 t -82.87 129.99 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.918 . . . . 0.28999999999999998 109.764 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.449 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -83.97 -175.72 5.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.089 -1.007 . . . . 0.55000000000000004 110.087 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.13 -40.43 70.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.183 -0.948 . . . . 2.1899999999999999 111.558 -173.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.891 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.9 tp -83.07 -6.7 59.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.856 -1.152 . . . . 1.3899999999999999 111.563 -173.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.528 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.43 47.2 6.99 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.549 -1.421 . . . . 0.20999999999999999 109.549 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.933 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.9 mtm180 -114.67 154.72 27.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.096 -1.238 . . . . 1.1399999999999999 110.049 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.832 HG12 HD13 ' A' ' 36' ' ' LEU . 19.4 m -123.67 152.55 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.28000000000000003 109.858 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.908 HG22 ' CD ' ' A' ' 17' ' ' ARG . 30.8 t -111.76 134.06 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.13 -0.981 . . . . 0.23999999999999999 110.638 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.598 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.66 132.83 50.69 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 1.3799999999999999 109.392 173.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.7 Cg_endo -57.59 141.23 95.25 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.732 1.385 . . . . 0.35999999999999999 109.918 177.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.945 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.82 -31.71 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.991 -1.068 . . . . 1.1100000000000001 110.262 -177.345 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.03 -37.19 71.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.022 -1.049 . . . . 2.3700000000000001 109.649 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.598 ' HB2' HG23 ' B' ' 20' ' ' ILE . 53.6 mt -80.1 -29.39 39.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.437 -0.789 . . . . 1.75 110.438 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.642 HH22 HD11 ' A' ' 15' ' ' LEU . 75.7 mtt180 -56.75 -43.6 80.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.901 -1.124 . . . . 0.29999999999999999 109.109 175.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -72.72 -51.02 20.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 3.27 110.612 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 48.0 m -63.16 -31.76 72.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -0.869 . . . . 0.77000000000000002 110.944 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.851 HD23 HG13 ' B' ' 30' ' ' ILE . 26.6 tp -87.04 -5.34 59.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.102 -0.999 . . . . 1.05 110.681 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.464 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.67 42.74 97.11 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.539 -1.424 . . . . 0.32000000000000001 109.539 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.851 HG13 HD23 ' B' ' 28' ' ' LEU . 29.3 mm -116.02 138.78 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -1.162 . . . . 0.40999999999999998 110.747 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.18 167.22 22.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.61 -0.681 . . . . 0.23000000000000001 109.907 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.6 146.42 13.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.942 . . . . 1.1299999999999999 110.515 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 77.1 tttt 74.99 -4.9 2.27 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.662 -0.648 . . . . 1.8799999999999999 111.205 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.658 ' O ' HG23 ' A' ' 12' ' ' VAL . 88.7 m-20 -77.34 165.89 23.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.866 -1.146 . . . . 1.1000000000000001 110.065 174.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.755 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.64 132.51 50.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.35999999999999999 110.926 -175.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.937 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.9 mt -109.46 143.4 39.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.449 -0.782 . . . . 0.56000000000000005 109.622 175.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.651 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.3 tt0 -108.4 140.23 41.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.787 -1.195 . . . . 1.1699999999999999 110.017 173.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ILE . . . . . 0.416 HD13 ' O ' ' B' ' 37' ' ' GLU . 21.5 mm -111.03 133.16 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.315 -0.865 . . . . 0.83999999999999997 110.549 -173.302 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.593 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 14.1 m-85 -115.28 159.23 21.28 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 116.308 -0.405 . . . . 0.45000000000000001 109.956 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.498 HG21 HG21 ' A' ' 6' ' ' THR . 81.4 t -130.24 129.21 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.862 -1.149 . . . . 0.26000000000000001 110.612 173.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.662 ' CG ' HD11 ' B' ' 46' ' ' ILE . 9.8 p-10 -146.86 129.44 15.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 1.77 110.2 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 50.0 t0 46.29 50.13 12.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.012 -1.055 . . . . 1.21 110.959 175.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.4 mt-10 59.85 12.73 3.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.275 -0.891 . . . . 1.9199999999999999 110.694 176.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 9.6 mtmt -113.13 150.76 31.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 2.0 109.703 175.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.651 HG22 HD11 ' B' ' 47' ' ' LEU . 62.3 mt -101.77 128.82 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.01 . . . . 1.24 110.391 -176.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.662 HD11 ' CG ' ' B' ' 41' ' ' ASP . 29.9 mt -112.3 121.41 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.38 -0.825 . . . . 0.5 110.099 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.836 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.4 mp -114.42 134.96 54.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.006 -1.059 . . . . 1.6599999999999999 110.173 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.532 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 10.8 pttp -141.42 165.19 28.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 1.74 110.222 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -58.18 147.42 30.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 1.6499999999999999 109.984 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 1.076 ' CD2' HG11 ' A' ' 9' ' ' VAL . 6.0 t80 -104.29 121.71 43.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.65000000000000002 110.598 -176.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' B' ' 51' ' ' LYS . 3.9 pttt -119.74 75.67 19.68 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.043 -1.036 . . . . 4.3499999999999996 110.26 176.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.517 ' HB3' ' CZ ' ' B' ' 50' ' ' TYR . 11.8 Cg_endo -60.6 147.23 95.29 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.097 1.577 . . . . 3.5800000000000001 110.348 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.016 -0.992 . . . . 5.9699999999999998 110.163 179.718 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.2 t80 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.207 0.527 . . . . 10.99 110.169 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.0 ttp -105.69 140.5 38.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 8.7599999999999998 110.221 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -122.08 132.64 54.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 8.8499999999999996 110.166 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.2 m -121.29 150.69 41.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 4.2000000000000002 110.343 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.43 HG23 ' CG2' ' B' ' 40' ' ' VAL . 58.2 p -62.19 -35.58 79.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.941 . . . . 3.77 110.228 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.2 45.95 59.66 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.642 -1.383 . . . . 0.82999999999999996 109.642 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.6 mt -117.76 135.93 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.204 -1.174 . . . . 1.3600000000000001 110.02 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.934 HG11 ' CD2' ' B' ' 50' ' ' TYR . 88.8 t -115.8 143.92 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.089 -1.007 . . . . 0.37 110.806 -176.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -128.27 159.3 35.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.381 -0.824 . . . . 1.9099999999999999 109.613 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -84.21 148.08 26.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.041 -1.037 . . . . 2.21 110.317 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.96 HG22 HD11 ' B' ' 36' ' ' LEU . 4.3 t -82.96 130.0 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.301 -0.874 . . . . 0.28000000000000003 109.885 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.47 -174.74 5.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.55000000000000004 110.025 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.27 -39.5 72.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.009 -1.057 . . . . 2.1899999999999999 111.739 -172.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.853 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.7 tp -85.73 -4.24 59.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.766 -1.209 . . . . 1.3799999999999999 111.629 -173.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.472 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 79.95 46.45 7.72 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.173 -1.489 . . . . 0.20999999999999999 109.687 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.923 ' CD ' HG22 ' B' ' 19' ' ' VAL . 73.7 mtm180 -116.34 154.98 29.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.055 -1.262 . . . . 1.1499999999999999 109.945 -177.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.681 HG12 HD13 ' B' ' 36' ' ' LEU . 22.4 m -123.49 150.67 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.28000000000000003 109.786 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.946 HG22 ' CD ' ' B' ' 17' ' ' ARG . 23.1 t -112.62 134.96 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.23999999999999999 110.578 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.928 HD11 HD13 ' B' ' 45' ' ' ILE . 4.5 mm -84.49 134.42 42.6 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 1.3799999999999999 109.658 176.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.551 ' HG2' HD12 ' A' ' 24' ' ' LEU . 9.9 Cg_endo -58.49 143.67 97.74 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.812 1.428 . . . . 0.34999999999999998 110.089 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.89 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.02 -33.29 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.934 -1.104 . . . . 1.1100000000000001 110.377 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' N ' HG23 ' A' ' 22' ' ' ILE . 84.4 tt0 -58.05 -35.72 71.73 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.107 -0.996 . . . . 2.3700000000000001 109.808 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.574 ' HB2' HG23 ' A' ' 20' ' ' ILE . 52.3 mt -82.48 -29.95 30.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 1.75 110.591 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.89 ' HD2' HD12 ' A' ' 22' ' ' ILE . 71.9 mtt180 -57.6 -43.7 84.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.834 -1.166 . . . . 0.29999999999999999 109.093 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -71.43 -49.44 41.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.568 -0.707 . . . . 3.2599999999999998 110.724 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.1 m -63.32 -32.01 73.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.23 -0.919 . . . . 0.77000000000000002 111.114 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.885 HD23 HG13 ' A' ' 30' ' ' ILE . 22.1 tp -87.78 -4.82 58.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.084 -1.01 . . . . 1.05 110.75 -177.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.437 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.75 42.76 96.99 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.731 -1.348 . . . . 0.32000000000000001 109.731 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.885 HG13 HD23 ' A' ' 28' ' ' LEU . 32.4 mm -116.35 138.91 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -1.183 . . . . 0.40999999999999998 110.794 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.16 167.04 23.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.589 -0.694 . . . . 0.23000000000000001 109.982 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.37 146.48 12.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.082 -1.011 . . . . 1.1299999999999999 110.541 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 75.2 tttt 74.46 -4.64 2.28 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.702 -0.623 . . . . 1.8799999999999999 111.137 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.741 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.6 m-20 -77.41 165.95 23.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.73 -1.231 . . . . 1.1000000000000001 110.051 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.66 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.08 130.69 51.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.2 -0.938 . . . . 0.35999999999999999 110.715 -176.539 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.97 HD11 HG22 ' B' ' 12' ' ' VAL . 12.1 mt -107.89 142.21 38.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.375 -0.828 . . . . 0.56000000000000005 109.367 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.662 ' HA ' HG22 ' B' ' 9' ' ' VAL . 84.8 tt0 -106.25 137.96 43.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.791 -1.193 . . . . 1.1699999999999999 109.787 173.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.39 132.56 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.522 -0.736 . . . . 0.83999999999999997 110.44 -174.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.592 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 16.2 m-85 -115.03 158.04 22.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 122.061 -0.399 . . . . 0.45000000000000001 110.11 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.614 HG21 HG21 ' B' ' 6' ' ' THR . 93.2 t -129.8 123.97 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.935 -1.103 . . . . 0.27000000000000002 110.739 173.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.59 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.2 p-10 -147.17 139.03 24.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 1.77 110.263 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.3 t0 43.68 47.22 6.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.021 -1.049 . . . . 1.22 111.159 174.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 44.3 tp10 62.4 10.33 3.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.148 -0.97 . . . . 1.9299999999999999 110.723 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -115.66 148.33 39.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.91 . . . . 2.0099999999999998 109.995 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 1.011 HD13 HD11 ' B' ' 20' ' ' ILE . 58.5 mt -99.6 129.09 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 1.25 110.103 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.0 mt -109.21 115.84 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.378 -0.826 . . . . 0.5 110.141 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.842 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -108.75 133.49 52.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.062 -1.024 . . . . 1.6599999999999999 109.987 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.568 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 13.2 pttp -143.64 165.73 26.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.452 -0.78 . . . . 1.74 110.357 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -56.43 146.99 22.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 1.6499999999999999 109.937 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.801 ' CD2' HG11 ' B' ' 9' ' ' VAL . 6.4 t80 -102.43 120.02 39.8 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.362 -0.836 . . . . 0.34999999999999998 110.661 -175.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.55 123.11 49.26 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.366 -0.834 . . . . 3.21 109.571 173.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -61.98 144.75 96.68 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.787 1.414 . . . . 0.47999999999999998 110.311 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.993 -1.003 . . . . 2.4100000000000001 110.229 -179.871 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.23 0.538 . . . . 11.66 110.244 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 65.0 mtt -48.38 -42.25 31.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -0.929 . . . . 8.6999999999999993 111.332 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -107.3 138.38 43.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.788 -1.195 . . . . 9.1699999999999999 110.447 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 84.2 p -145.22 159.12 43.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.359 -0.838 . . . . 5.2000000000000002 109.971 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.614 HG21 HG21 ' A' ' 40' ' ' VAL . 58.4 p -65.87 -35.62 81.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.164 -0.96 . . . . 2.98 110.225 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.93 46.32 60.17 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.534 -1.426 . . . . 0.82999999999999996 109.534 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 61.1 mt -117.82 135.82 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.209 -1.171 . . . . 1.3600000000000001 110.084 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.948 HG13 ' O ' ' A' ' 36' ' ' LEU . 89.9 t -115.81 143.86 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.048 -1.033 . . . . 0.37 110.76 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -128.28 159.09 36.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.494 -0.754 . . . . 1.9199999999999999 109.768 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -84.03 148.03 27.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.042 -1.037 . . . . 2.21 110.403 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.97 HG22 HD11 ' A' ' 36' ' ' LEU . 4.3 t -82.91 130.1 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.33 -0.856 . . . . 0.28999999999999998 109.804 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.69 -174.47 5.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 0.55000000000000004 110.152 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.48 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.9 mt-10 -56.5 -39.45 73.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.086 -1.009 . . . . 2.1899999999999999 111.646 -172.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.891 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.2 tp -85.79 -4.18 59.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.799 -1.188 . . . . 1.3899999999999999 111.595 -173.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.491 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.56 47.19 7.48 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.514 -1.434 . . . . 0.20999999999999999 109.514 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.946 ' CD ' HG22 ' A' ' 19' ' ' VAL . 73.5 mtm180 -116.46 154.98 29.38 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.039 -1.271 . . . . 1.1399999999999999 109.982 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.687 HG12 HD13 ' A' ' 36' ' ' LEU . 22.4 m -123.54 150.59 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 0.28000000000000003 109.804 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.923 HG22 ' CD ' ' A' ' 17' ' ' ARG . 23.0 t -112.64 134.98 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.23999999999999999 110.505 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 1.011 HD11 HD13 ' A' ' 45' ' ' ILE . 4.5 mm -84.62 134.43 42.26 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 1.3799999999999999 109.625 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.547 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.9 Cg_endo -58.67 143.69 98.41 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.811 1.427 . . . . 0.35999999999999999 110.106 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.888 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.2 tp -55.16 -33.08 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.11 -0.993 . . . . 1.1100000000000001 110.364 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' GLU . . . . . 0.409 ' N ' HG23 ' B' ' 22' ' ' ILE . 84.3 tt0 -57.88 -36.35 72.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.09 -1.006 . . . . 2.3700000000000001 109.744 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.568 ' HB2' HG23 ' B' ' 20' ' ' ILE . 52.5 mt -81.74 -30.37 32.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.443 -0.785 . . . . 1.75 110.686 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.888 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.2 mtt180 -57.43 -43.59 83.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.877 -1.14 . . . . 0.29999999999999999 109.087 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -71.25 -49.77 39.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.39 -0.819 . . . . 3.27 110.666 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 51.0 m -63.04 -32.49 73.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.292 -0.88 . . . . 0.77000000000000002 110.946 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.886 HD23 HG13 ' B' ' 30' ' ' ILE . 22.3 tp -87.34 -5.2 58.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 1.05 110.68 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.442 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.05 42.65 96.57 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.538 -1.425 . . . . 0.32000000000000001 109.538 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.886 HG13 HD23 ' B' ' 28' ' ' LEU . 31.9 mm -116.27 138.87 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -1.181 . . . . 0.40999999999999998 110.766 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.91 167.09 23.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.498 -0.751 . . . . 0.23000000000000001 109.968 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.527 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.43 146.48 12.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 1.1299999999999999 110.555 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 75.0 tttt 74.63 -4.76 2.27 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.648 -0.657 . . . . 1.8799999999999999 111.166 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.64 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.2 m-20 -77.49 165.64 24.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.792 -1.193 . . . . 1.1000000000000001 110.042 174.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.638 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.92 130.65 51.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.35999999999999999 110.836 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.96 HD11 HG22 ' A' ' 12' ' ' VAL . 12.0 mt -107.84 142.1 38.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.56000000000000005 109.485 175.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.656 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.7 tt0 -106.08 137.84 43.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.87 -1.144 . . . . 1.1699999999999999 109.911 173.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 71.0 mt -111.25 132.61 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.388 -0.82 . . . . 0.83999999999999997 110.383 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.6 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 15.9 m-85 -115.06 157.92 22.85 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 120.896 0.379 . . . . 0.45000000000000001 110.122 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.43 ' CG2' HG23 ' A' ' 6' ' ' THR . 94.1 t -129.53 124.3 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.937 -1.102 . . . . 0.26000000000000001 110.55 173.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.601 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.4 p-10 -147.66 138.88 23.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.875 . . . . 1.77 110.208 177.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.9 t0 43.99 47.18 7.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.165 -0.959 . . . . 1.21 111.136 174.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 44.2 tp10 62.21 10.36 3.74 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.234 -0.916 . . . . 1.9199999999999999 110.725 175.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -115.57 148.6 39.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 2.0 109.928 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.928 HD13 HD11 ' A' ' 20' ' ' ILE . 58.2 mt -99.76 129.16 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 1.24 110.096 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.601 HD11 ' OD2' ' B' ' 41' ' ' ASP . 21.7 mt -109.39 115.8 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.472 -0.767 . . . . 0.5 110.136 177.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.842 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.3 mp -108.55 133.4 52.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.028 -1.045 . . . . 1.6599999999999999 109.934 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.572 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 13.5 pttp -143.65 165.96 26.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.447 -0.783 . . . . 1.74 110.294 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -56.48 146.94 23.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.95 . . . . 1.6499999999999999 109.92 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.934 ' CD2' HG11 ' A' ' 9' ' ' VAL . 6.5 t80 -102.59 117.12 33.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.65000000000000002 110.529 -175.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -122.6 85.14 48.68 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 4.3499999999999996 110.26 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.566 ' HG3' ' CZ ' ' B' ' 50' ' ' TYR . 34.5 Cg_exo -55.65 145.25 71.6 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.964 1.507 . . . . 3.5800000000000001 110.306 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 51.4 t30 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.992 -1.004 . . . . 5.9699999999999998 110.167 -179.904 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.145 0.498 . . . . 10.99 110.207 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.6 mtm -126.45 142.12 51.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.868 . . . . 8.7599999999999998 110.133 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 43.4 tttt -101.7 43.15 1.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.211 -0.931 . . . . 8.8499999999999996 110.602 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.584 ' CB ' ' CD2' ' B' ' 39' ' ' TYR . 54.6 p -157.65 163.49 38.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.987 -1.071 . . . . 4.2000000000000002 110.444 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.0 p -68.54 -31.38 70.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 3.77 110.046 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.504 ' O ' HD13 ' A' ' 8' ' ' ILE . . . 71.12 45.87 47.05 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.691 -1.364 . . . . 0.82999999999999996 109.691 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.504 HD13 ' O ' ' A' ' 7' ' ' GLY . 26.0 mm -115.3 133.73 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.189 -1.183 . . . . 1.3600000000000001 109.947 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.102 HG11 ' CD2' ' B' ' 50' ' ' TYR . 87.1 t -116.13 143.91 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.101 -0.999 . . . . 0.37 110.842 -175.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.401 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 17.4 tpt180 -128.07 157.11 41.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.472 -0.767 . . . . 1.9099999999999999 109.789 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 26.0 ttpt -83.14 144.97 29.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.141 -0.974 . . . . 2.21 110.35 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.984 HG22 HD11 ' B' ' 36' ' ' LEU . 4.0 t -80.55 128.68 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.337 -0.852 . . . . 0.28000000000000003 109.762 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.53 -175.01 5.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.55000000000000004 110.021 179.71 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.52 -40.56 68.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.097 -1.002 . . . . 2.1899999999999999 111.728 -173.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.872 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.8 tp -85.32 -4.18 59.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.798 -1.189 . . . . 1.3799999999999999 111.611 -173.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.29 46.18 7.67 Favored Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.133 -1.508 . . . . 0.20999999999999999 109.68 -177.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.931 ' CD ' HG22 ' B' ' 19' ' ' VAL . 73.1 mtm180 -116.15 154.72 29.51 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.012 -1.287 . . . . 1.1499999999999999 109.818 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.674 HG12 ' CD1' ' B' ' 36' ' ' LEU . 22.5 m -124.49 152.35 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.28000000000000003 110.001 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.953 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.5 t -113.71 133.95 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.23999999999999999 110.571 -175.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.653 HD11 HD13 ' B' ' 45' ' ' ILE . 2.5 mm -85.04 138.09 37.21 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.227 -0.921 . . . . 1.3799999999999999 109.636 175.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.7 Cg_endo -59.68 142.94 99.62 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.71 1.374 . . . . 0.34999999999999998 109.972 176.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.918 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.22 -32.39 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.962 -1.086 . . . . 1.1100000000000001 110.478 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -58.14 -35.67 71.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.147 -0.971 . . . . 2.3700000000000001 109.915 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.612 ' HB2' HG23 ' A' ' 20' ' ' ILE . 63.2 mt -82.21 -30.35 30.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 1.75 110.614 178.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.918 ' HD2' HD12 ' A' ' 22' ' ' ILE . 74.2 mtt180 -57.77 -43.86 85.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.926 -1.109 . . . . 0.29999999999999999 109.113 176.031 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -72.97 -48.48 36.26 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.848 -0.741 . . . . 3.2599999999999998 110.723 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.6 m -63.72 -31.57 72.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 0.77000000000000002 111.135 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.815 HD23 HG13 ' A' ' 30' ' ' ILE . 19.2 tp -87.94 -4.53 58.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.026 -1.046 . . . . 1.05 110.795 -177.066 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.09 40.87 95.24 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.714 -1.354 . . . . 0.32000000000000001 109.714 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.815 HG13 HD23 ' A' ' 28' ' ' LEU . 36.5 mm -116.54 139.03 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -1.123 . . . . 0.40999999999999998 110.632 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.0 166.76 23.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.623 -0.673 . . . . 0.23000000000000001 109.978 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.58 146.54 12.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.102 -0.999 . . . . 1.1299999999999999 110.534 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 19.9 tttt 74.96 -4.95 2.26 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.733 -0.605 . . . . 1.8799999999999999 111.12 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.712 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.9 m-20 -78.18 165.81 23.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.902 -1.124 . . . . 1.1000000000000001 110.054 174.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.745 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.61 131.01 52.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.35999999999999999 110.726 -176.463 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.932 ' O ' HG13 ' B' ' 9' ' ' VAL . 13.5 mt -107.87 142.66 37.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.825 . . . . 0.56000000000000005 109.458 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.687 ' HA ' HG22 ' B' ' 9' ' ' VAL . 84.8 tt0 -106.58 138.88 41.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.805 -1.184 . . . . 1.1699999999999999 109.685 172.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 68.4 mt -111.37 133.39 57.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.393 -0.817 . . . . 0.83999999999999997 110.561 -173.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.576 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 14.9 m-85 -114.81 157.94 22.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.99 -0.374 . . . . 0.45000000000000001 109.99 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.559 ' HB ' HG23 ' B' ' 6' ' ' THR . 93.1 t -130.7 120.43 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.942 -1.098 . . . . 0.27000000000000002 110.664 172.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.549 ' OD2' HD11 ' A' ' 46' ' ' ILE . 5.9 p-10 -147.35 155.14 41.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 1.77 110.189 177.151 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 54.0 t0 42.38 41.75 2.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.06 -1.025 . . . . 1.22 111.345 172.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 46.5 tp10 60.81 12.34 3.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.031 -1.043 . . . . 1.9299999999999999 110.778 174.433 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 19.3 pttt -128.77 161.29 30.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.114 -0.992 . . . . 2.0099999999999998 109.848 174.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.816 HD13 HD11 ' B' ' 20' ' ' ILE . 56.5 mt -104.04 134.99 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.055 -1.028 . . . . 1.25 110.717 -172.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 25.1 mt -111.33 121.36 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.46 -0.775 . . . . 0.5 110.272 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.846 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.4 mp -112.06 133.84 53.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.986 -1.071 . . . . 1.6599999999999999 110.117 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.543 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 14.0 pttp -141.6 166.08 25.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.45 -0.781 . . . . 1.74 110.359 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -55.94 147.73 18.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.196 -0.94 . . . . 1.6499999999999999 110.077 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.95 ' CD2' HG11 ' B' ' 9' ' ' VAL . 4.4 t80 -103.25 126.52 50.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.833 . . . . 0.34999999999999998 110.73 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -99.2 122.84 50.87 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.366 -0.834 . . . . 3.21 109.398 172.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -59.42 145.57 97.52 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.794 1.418 . . . . 0.47999999999999998 110.417 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.044 -0.979 . . . . 2.4100000000000001 110.219 -179.952 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.199 0.523 . . . . 11.66 110.299 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 96.2 mmm -109.67 139.19 45.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 8.6999999999999993 110.286 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -128.43 148.89 50.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 9.1699999999999999 110.146 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 54.2 p -68.47 159.0 32.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 5.2000000000000002 110.099 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.559 HG23 ' HB ' ' A' ' 40' ' ' VAL . 69.6 p -69.28 -31.36 69.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 2.98 110.173 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' GLY . . . . . 0.503 ' O ' HD13 ' B' ' 8' ' ' ILE . . . 70.93 46.17 46.65 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.647 -1.381 . . . . 0.82999999999999996 109.647 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.503 HD13 ' O ' ' B' ' 7' ' ' GLY . 26.2 mm -115.26 133.66 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.091 -1.241 . . . . 1.3600000000000001 109.931 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.95 HG11 ' CD2' ' A' ' 50' ' ' TYR . 87.1 t -116.18 143.87 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.956 -1.09 . . . . 0.37 110.736 -175.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 17.4 tpt180 -128.12 156.82 42.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.743 . . . . 1.9199999999999999 109.892 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.4 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 26.1 ttpt -82.93 144.85 29.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.102 -0.999 . . . . 2.21 110.414 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.927 HG22 HD11 ' A' ' 36' ' ' LEU . 4.0 t -80.56 128.88 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.367 -0.833 . . . . 0.28999999999999998 109.642 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -83.79 -174.9 5.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.045 -1.035 . . . . 0.55000000000000004 110.177 179.613 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.65 -40.48 69.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.191 -0.943 . . . . 2.1899999999999999 111.648 -173.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.898 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.4 tp -85.34 -4.22 59.09 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.755 -1.215 . . . . 1.3899999999999999 111.647 -172.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.53 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.97 46.86 7.45 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.54 -1.424 . . . . 0.20999999999999999 109.54 -177.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.953 ' CD ' HG22 ' A' ' 19' ' ' VAL . 72.6 mtm180 -116.33 154.69 29.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.153 -1.204 . . . . 1.1399999999999999 109.831 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.673 HG12 ' CD1' ' A' ' 36' ' ' LEU . 22.6 m -124.48 152.33 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.92 . . . . 0.28000000000000003 110.004 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.931 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.6 t -113.72 133.96 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.23999999999999999 110.542 -175.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.816 HD11 HD13 ' A' ' 45' ' ' ILE . 2.5 mm -85.11 138.1 37.04 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.219 -0.925 . . . . 1.3799999999999999 109.593 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.7 Cg_endo -59.78 142.91 99.54 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.755 1.397 . . . . 0.35999999999999999 110.043 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.919 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -55.28 -32.25 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.027 -1.046 . . . . 1.1100000000000001 110.44 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -57.99 -36.27 72.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.091 -1.006 . . . . 2.3700000000000001 109.811 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.598 ' HB2' HG23 ' B' ' 20' ' ' ILE . 63.2 mt -81.62 -30.76 32.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.401 -0.812 . . . . 1.75 110.601 178.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.919 ' HD2' HD12 ' B' ' 22' ' ' ILE . 73.8 mtt180 -57.54 -43.68 84.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.875 -1.141 . . . . 0.29999999999999999 109.207 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -72.96 -48.71 34.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.898 . . . . 3.27 110.61 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 52.0 m -63.45 -32.22 73.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.282 -0.886 . . . . 0.77000000000000002 110.895 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.815 HD23 HG13 ' B' ' 30' ' ' ILE . 19.4 tp -87.5 -4.79 58.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 1.05 110.711 -176.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.404 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.56 40.64 94.25 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.588 -1.405 . . . . 0.32000000000000001 109.588 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.815 HG13 HD23 ' B' ' 28' ' ' LEU . 36.2 mm -116.52 138.9 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -1.13 . . . . 0.40999999999999998 110.634 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.73 166.87 23.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.598 -0.689 . . . . 0.23000000000000001 109.991 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.4 tt0 -53.6 146.72 12.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 1.1299999999999999 110.421 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 19.8 tttt 75.03 -5.16 2.22 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.622 -0.674 . . . . 1.8799999999999999 111.123 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.617 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.6 m-20 -78.19 165.66 23.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.816 -1.178 . . . . 1.1000000000000001 110.03 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.751 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.55 130.92 52.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.35999999999999999 110.776 -176.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.984 HD11 HG22 ' A' ' 12' ' ' VAL . 13.3 mt -107.9 142.52 37.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.386 -0.821 . . . . 0.56000000000000005 109.494 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.666 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.7 tt0 -106.42 138.91 41.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.841 -1.162 . . . . 1.1699999999999999 109.832 172.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 68.5 mt -111.42 133.41 57.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.289 -0.882 . . . . 0.83999999999999997 110.469 -173.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.589 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 14.4 m-85 -114.77 157.86 22.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 122.096 -0.377 . . . . 0.45000000000000001 110.07 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 93.7 t -130.42 120.84 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.899 -1.126 . . . . 0.26000000000000001 110.464 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.549 ' OD2' HD11 ' B' ' 46' ' ' ILE . 6.0 p-10 -147.91 155.19 41.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 1.77 110.157 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 54.5 t0 42.19 41.99 2.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.115 -0.991 . . . . 1.21 111.375 173.025 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 46.3 tp10 60.75 12.3 3.66 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.088 -1.008 . . . . 1.9199999999999999 110.7 174.403 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 19.1 pttt -128.78 161.54 29.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.009 . . . . 2.0 109.775 174.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.653 HD13 HD11 ' A' ' 20' ' ' ILE . 56.8 mt -104.16 135.03 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.061 -1.024 . . . . 1.24 110.665 -172.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 25.8 mt -111.6 121.32 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.455 -0.778 . . . . 0.5 110.181 176.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.842 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.5 mp -111.89 133.76 53.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.03 -1.044 . . . . 1.6599999999999999 110.075 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.536 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 14.2 pttp -141.61 166.36 24.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.429 -0.794 . . . . 1.74 110.27 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -56.09 147.72 19.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 1.6499999999999999 109.974 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 1.102 ' CD2' HG11 ' A' ' 9' ' ' VAL . 4.5 t80 -103.35 122.19 44.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.65000000000000002 110.646 -175.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.42 81.49 53.29 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.176 -0.953 . . . . 4.3499999999999996 110.229 177.612 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -57.72 144.14 93.76 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.901 1.474 . . . . 3.5800000000000001 110.238 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.002 -0.999 . . . . 5.9699999999999998 110.261 -179.42 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.0 p90 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.218 0.532 . . . . 10.99 110.217 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.8 mtp -135.55 163.14 30.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.309 -0.869 . . . . 8.7599999999999998 110.204 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -87.68 149.27 24.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 8.8499999999999996 110.185 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.569 ' CB ' ' CD2' ' B' ' 39' ' ' TYR . 55.4 p -66.55 162.8 20.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 4.2000000000000002 110.312 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.9 p -62.11 -35.96 80.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.942 . . . . 3.77 110.181 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.13 45.58 55.36 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.655 -1.378 . . . . 0.82999999999999996 109.655 177.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.9 mt -118.16 134.43 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.153 -1.204 . . . . 1.3600000000000001 109.983 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.935 HG13 ' O ' ' B' ' 36' ' ' LEU . 99.0 t -114.29 144.58 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.025 -1.047 . . . . 0.37 110.915 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -129.75 160.79 32.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.458 -0.776 . . . . 1.9099999999999999 109.753 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -85.05 148.09 26.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.036 -1.04 . . . . 2.21 110.311 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.978 HG22 HD11 ' B' ' 36' ' ' LEU . 6.5 t -81.49 129.73 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.317 -0.865 . . . . 0.28000000000000003 109.821 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.29 -175.09 5.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.124 -0.985 . . . . 0.55000000000000004 109.941 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.07 -39.31 71.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 2.1899999999999999 111.723 -172.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.863 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.4 tp -86.01 -5.03 59.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.803 -1.186 . . . . 1.3799999999999999 111.5 -173.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.499 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.14 46.52 7.56 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.144 -1.503 . . . . 0.20999999999999999 109.699 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.906 ' CD ' HG22 ' B' ' 19' ' ' VAL . 73.8 mtm180 -115.6 154.85 28.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.005 -1.291 . . . . 1.1499999999999999 110.036 -177.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.749 HG12 HD13 ' B' ' 36' ' ' LEU . 24.8 m -124.3 151.72 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 0.28000000000000003 109.855 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.923 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.2 t -113.22 135.18 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 0.23999999999999999 110.601 -175.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.34 135.12 44.42 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 1.3799999999999999 109.532 175.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.555 ' HG2' HD12 ' A' ' 24' ' ' LEU . 10.0 Cg_endo -58.64 143.34 98.6 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.734 1.386 . . . . 0.34999999999999998 110.046 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.905 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.1 tp -55.08 -33.32 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.082 -1.012 . . . . 1.1100000000000001 110.429 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 22' ' ' ILE . 84.4 tt0 -58.2 -35.34 71.48 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.17 -0.956 . . . . 2.3700000000000001 109.893 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.555 HD12 ' HG2' ' A' ' 21' ' ' PRO . 50.0 mt -82.35 -29.97 30.66 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.35 -0.844 . . . . 1.75 110.65 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.905 ' HD2' HD12 ' A' ' 22' ' ' ILE . 71.4 mtt180 -57.74 -44.15 85.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.939 -1.1 . . . . 0.29999999999999999 109.087 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -72.63 -47.81 44.63 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.818 -0.753 . . . . 3.2599999999999998 110.756 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.1 m -63.68 -31.87 73.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.77000000000000002 111.093 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.875 HD23 HG13 ' A' ' 30' ' ' ILE . 20.8 tp -87.69 -4.6 58.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.1 -1.0 . . . . 1.05 110.669 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.453 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.25 41.47 96.77 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.637 -1.385 . . . . 0.32000000000000001 109.637 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.875 HG13 HD23 ' A' ' 28' ' ' LEU . 30.1 mm -116.4 139.75 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -1.144 . . . . 0.40999999999999998 110.654 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.91 167.19 22.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.567 -0.708 . . . . 0.23000000000000001 110.025 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.26 146.79 11.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.058 -1.026 . . . . 1.1299999999999999 110.54 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 12.9 tttp 74.22 -4.58 2.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.743 -0.598 . . . . 1.8799999999999999 111.273 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.716 ' O ' HG23 ' B' ' 12' ' ' VAL . 87.8 m-20 -77.01 166.63 23.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.751 -1.218 . . . . 1.1000000000000001 109.973 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.706 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -103.29 131.6 50.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 0.35999999999999999 110.757 -175.712 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 1.014 HD11 HG22 ' B' ' 12' ' ' VAL . 13.0 mt -108.76 144.3 36.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.342 -0.849 . . . . 0.56000000000000005 109.307 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.642 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.6 tt0 -108.37 138.34 44.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.856 -1.152 . . . . 1.1699999999999999 109.646 173.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.5 mt -107.87 131.31 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.489 -0.757 . . . . 0.83999999999999997 110.415 -173.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.605 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 21.4 m-85 -118.85 156.79 28.84 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 120.927 0.394 . . . . 0.45000000000000001 109.963 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.477 ' HB ' HG23 ' B' ' 6' ' ' THR . 74.2 t -130.82 126.68 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.848 -1.158 . . . . 0.27000000000000002 110.642 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.487 ' OD1' HG12 ' A' ' 46' ' ' ILE . 41.9 p-10 -147.23 142.23 27.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 1.77 110.607 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 52.3 t0 43.37 45.14 5.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.09 -1.006 . . . . 1.22 111.271 174.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.7 tt0 60.81 11.88 3.47 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.104 -0.997 . . . . 1.9299999999999999 110.608 175.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 54.1 mtmt -114.4 153.92 29.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 2.0099999999999998 109.628 175.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.929 HG22 HD11 ' A' ' 47' ' ' LEU . 67.8 mt -94.54 129.95 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.153 -0.967 . . . . 1.25 110.138 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.605 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 24.6 mm -113.15 121.79 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.659 -0.651 . . . . 0.5 109.877 178.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.929 HD11 HG22 ' A' ' 45' ' ' ILE . 4.0 mp -122.55 134.53 54.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.895 -1.128 . . . . 1.6599999999999999 110.262 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.538 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 14.0 pttp -141.73 162.68 34.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 1.74 110.435 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.4 tttt -58.82 146.89 35.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 1.6499999999999999 110.011 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.738 ' CD2' HG11 ' B' ' 9' ' ' VAL . 10.3 t80 -105.13 115.07 29.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.34999999999999998 110.586 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 2.5 ttmt -99.74 122.76 50.07 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.884 . . . . 3.21 109.508 173.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 51' ' ' LYS . 17.9 Cg_endo -63.57 144.7 90.64 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.798 1.42 . . . . 0.47999999999999998 110.2 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.051 -0.976 . . . . 2.4100000000000001 110.186 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 56.3 t80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.219 0.533 . . . . 11.66 110.004 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 89.4 mmm -116.11 144.18 44.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.913 . . . . 8.6999999999999993 110.131 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -126.06 149.35 48.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.2 -0.938 . . . . 9.1699999999999999 110.195 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 54.3 p -67.78 161.07 26.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.205 -0.934 . . . . 5.2000000000000002 110.066 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.477 HG23 ' HB ' ' A' ' 40' ' ' VAL . 69.0 p -65.2 -36.08 83.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 2.98 110.229 -178.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.16 45.63 54.92 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.644 -1.382 . . . . 0.82999999999999996 109.644 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.7 mt -118.16 134.32 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.124 -1.221 . . . . 1.3600000000000001 109.927 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.943 HG13 ' O ' ' A' ' 36' ' ' LEU . 98.5 t -114.28 144.62 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.04 -1.038 . . . . 0.37 110.898 -175.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -129.75 160.72 32.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.483 -0.76 . . . . 1.9199999999999999 109.707 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -85.16 148.02 26.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.962 -1.086 . . . . 2.21 110.331 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 1.014 HG22 HD11 ' A' ' 36' ' ' LEU . 6.6 t -81.47 129.85 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.369 -0.832 . . . . 0.28999999999999998 109.734 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.48 -174.83 5.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.148 -0.97 . . . . 0.55000000000000004 110.136 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.475 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.8 mt-10 -56.28 -39.28 72.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.057 . . . . 2.1899999999999999 111.569 -172.178 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.904 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.0 tp -86.05 -4.98 59.29 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.715 -1.241 . . . . 1.3899999999999999 111.52 -173.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.5 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.63 47.31 7.37 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.592 -1.403 . . . . 0.20999999999999999 109.592 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.923 ' CD ' HG22 ' A' ' 19' ' ' VAL . 73.8 mtm180 -115.79 154.87 28.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.1 -1.235 . . . . 1.1399999999999999 110.155 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.741 HG12 HD13 ' A' ' 36' ' ' LEU . 24.9 m -124.43 151.65 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.28000000000000003 109.814 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.906 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.2 t -113.17 135.17 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.23999999999999999 110.644 -175.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -83.33 135.0 44.56 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 1.3799999999999999 109.588 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.544 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.0 Cg_endo -58.71 143.37 98.82 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.749 1.394 . . . . 0.35999999999999999 110.169 177.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.903 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -55.08 -33.3 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.086 -1.009 . . . . 1.1100000000000001 110.372 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 23' ' ' GLU . . . . . 0.409 ' N ' HG23 ' B' ' 22' ' ' ILE . 84.4 tt0 -57.97 -36.15 72.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.023 -1.048 . . . . 2.3700000000000001 109.708 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.55 ' HB2' HG23 ' B' ' 20' ' ' ILE . 50.4 mt -81.49 -30.42 33.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.519 -0.738 . . . . 1.75 110.668 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.903 ' HD2' HD12 ' B' ' 22' ' ' ILE . 70.8 mtt180 -57.44 -44.1 84.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.834 -1.166 . . . . 0.29999999999999999 109.098 176.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -72.56 -48.1 42.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.431 -0.793 . . . . 3.27 110.645 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.5 m -63.36 -32.55 74.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.288 -0.883 . . . . 0.77000000000000002 110.857 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.892 HD23 HG13 ' B' ' 30' ' ' ILE . 20.9 tp -87.09 -5.0 59.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.052 -1.03 . . . . 1.05 110.678 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.46 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.57 41.33 96.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.564 -1.414 . . . . 0.32000000000000001 109.564 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.892 HG13 HD23 ' B' ' 28' ' ' LEU . 30.0 mm -116.33 139.57 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -1.182 . . . . 0.40999999999999998 110.717 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.58 167.3 22.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.471 -0.768 . . . . 0.23000000000000001 110.057 -177.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.12 146.74 10.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 1.1299999999999999 110.572 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 12.9 tttp 74.4 -4.89 2.21 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.657 -0.652 . . . . 1.8799999999999999 111.198 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.615 ' O ' HG23 ' A' ' 12' ' ' VAL . 88.2 m-20 -76.98 166.35 23.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.819 -1.176 . . . . 1.1000000000000001 110.039 174.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.719 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.04 131.53 49.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.35999999999999999 110.877 -175.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.978 HD11 HG22 ' A' ' 12' ' ' VAL . 12.9 mt -108.84 144.11 37.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.428 -0.795 . . . . 0.56000000000000005 109.362 174.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.624 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.4 tt0 -108.06 138.34 44.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.854 -1.154 . . . . 1.1699999999999999 109.847 172.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -107.87 131.37 58.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.405 -0.809 . . . . 0.83999999999999997 110.354 -173.031 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.608 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 21.1 m-85 -118.9 156.86 28.77 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.885 -0.413 . . . . 0.45000000000000001 109.885 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 74.8 t -130.71 127.08 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.854 -1.154 . . . . 0.26000000000000001 110.471 173.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.496 ' OD1' HG12 ' B' ' 46' ' ' ILE . 41.9 p-10 -147.69 142.22 26.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.883 . . . . 1.77 110.525 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.0 t0 43.32 45.46 5.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.087 -1.008 . . . . 1.21 111.217 174.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.5 tt0 60.44 12.05 3.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.081 -1.012 . . . . 1.9199999999999999 110.611 175.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 54.1 mtmt -114.41 154.01 28.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.162 -0.961 . . . . 2.0 109.633 175.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.927 HG22 HD11 ' B' ' 47' ' ' LEU . 67.3 mt -94.51 129.72 44.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.108 -0.995 . . . . 1.24 110.227 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.608 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 24.6 mm -113.28 121.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.681 -0.637 . . . . 0.5 109.823 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.927 HD11 HG22 ' B' ' 45' ' ' ILE . 4.1 mp -122.44 134.46 54.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.892 -1.13 . . . . 1.6599999999999999 110.271 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.542 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 14.1 pttp -141.62 162.84 34.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 1.74 110.435 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 43.2 tttt -58.81 146.72 36.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 1.6499999999999999 110.015 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.901 ' CD2' HG11 ' A' ' 9' ' ' VAL . 10.5 t80 -105.12 111.86 24.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.65000000000000002 110.575 -176.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 15.6 pttt -127.08 77.23 75.56 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 4.3499999999999996 110.27 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -60.68 144.61 99.56 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.957 1.504 . . . . 3.5800000000000001 110.426 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 118.064 -0.97 . . . . 5.9699999999999998 110.16 179.436 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 48.1 p90 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.259 0.552 . . . . 10.99 110.103 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.3 mtm -93.76 -89.38 0.22 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.281 -0.887 . . . . 8.7599999999999998 110.412 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -117.97 148.52 42.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.154 -0.966 . . . . 8.8499999999999996 110.314 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.1 p -119.58 157.37 28.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 4.2000000000000002 110.093 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.3 p -61.83 -38.69 89.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 3.77 110.054 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.26 45.87 76.46 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.739 -1.344 . . . . 0.82999999999999996 109.739 176.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.0 mt -117.02 133.02 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.093 -1.239 . . . . 1.3600000000000001 109.982 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.016 HG11 ' CD2' ' B' ' 50' ' ' TYR . 98.2 t -114.03 144.29 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.048 -1.032 . . . . 0.37 110.871 -176.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 28.9 tpt180 -130.03 158.62 39.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.513 -0.742 . . . . 1.9099999999999999 109.727 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 66.4 mmtt -85.44 148.18 26.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.006 . . . . 2.21 110.258 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.97 HG22 HD11 ' B' ' 36' ' ' LEU . 3.7 t -81.65 128.83 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.274 -0.891 . . . . 0.28000000000000003 109.778 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.45 -175.09 5.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.087 -1.008 . . . . 0.55000000000000004 110.061 -179.698 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -54.24 -41.13 68.4 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.114 -0.991 . . . . 2.1899999999999999 111.7 -173.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.886 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.7 tp -84.83 -5.31 59.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.656 -1.278 . . . . 1.3799999999999999 111.59 -173.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.516 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.26 46.45 7.53 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.136 -1.507 . . . . 0.20999999999999999 109.716 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.906 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.2 mtm180 -114.77 153.94 29.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.093 -1.239 . . . . 1.1499999999999999 110.031 -177.351 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.672 HG12 HD13 ' B' ' 36' ' ' LEU . 22.1 m -123.91 152.21 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.28000000000000003 109.83 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.921 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.3 t -112.93 133.97 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.947 . . . . 0.23999999999999999 110.742 -175.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.671 HD11 HD13 ' B' ' 45' ' ' ILE . 2.4 mm -84.22 133.04 45.92 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.175 -0.953 . . . . 1.3799999999999999 109.446 174.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.8 Cg_endo -57.63 141.39 95.37 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.646 1.34 . . . . 0.34999999999999998 109.957 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.93 ' O ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.81 -32.37 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.008 -1.058 . . . . 1.1100000000000001 110.301 -177.395 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.27 -36.35 70.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.018 -1.051 . . . . 2.3700000000000001 109.747 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.559 ' HB2' HG23 ' A' ' 20' ' ' ILE . 43.4 mt -80.87 -29.22 35.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 1.75 110.449 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.706 HH22 HD11 ' B' ' 15' ' ' LEU . 73.7 mtt180 -56.79 -44.03 81.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.864 -1.148 . . . . 0.29999999999999999 108.97 175.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.6 mmt180 -72.49 -47.68 46.69 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.826 -0.749 . . . . 3.2599999999999998 110.726 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.9 m -63.19 -32.45 73.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.202 -0.937 . . . . 0.77000000000000002 111.061 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.778 HD23 HG13 ' A' ' 30' ' ' ILE . 20.5 tp -88.56 -4.62 58.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.07 -1.019 . . . . 1.05 110.801 -177.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.415 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.98 41.82 95.08 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.732 -1.347 . . . . 0.32000000000000001 109.732 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.778 HG13 HD23 ' A' ' 28' ' ' LEU . 32.7 mm -116.52 139.49 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.27 -1.135 . . . . 0.40999999999999998 110.744 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.72 166.46 24.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.619 -0.675 . . . . 0.23000000000000001 110.006 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.73 146.51 13.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.027 -1.045 . . . . 1.1299999999999999 110.511 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 40.3 tttp 74.59 -4.56 2.31 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.684 -0.635 . . . . 1.8799999999999999 111.114 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.702 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.9 m-20 -76.87 165.87 24.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.782 -1.199 . . . . 1.1000000000000001 109.966 174.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.767 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.72 131.19 52.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.35999999999999999 110.771 -176.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.964 HD11 HG22 ' B' ' 12' ' ' VAL . 13.0 mt -108.66 144.1 36.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.33 -0.856 . . . . 0.56000000000000005 109.341 174.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.691 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.8 tt0 -106.59 139.02 41.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.744 -1.223 . . . . 1.1699999999999999 109.491 172.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.49 131.27 59.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.423 -0.798 . . . . 0.83999999999999997 110.504 -172.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.612 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 16.7 m-85 -117.67 157.46 26.41 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 116.263 -0.426 . . . . 0.45000000000000001 109.915 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.52 HG21 HG21 ' B' ' 6' ' ' THR . 74.2 t -131.78 120.09 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.903 -1.123 . . . . 0.27000000000000002 110.617 172.773 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 46.7 p-10 -148.32 161.93 40.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.274 -0.891 . . . . 1.77 110.586 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 54.0 t0 42.25 40.57 1.81 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.002 -1.061 . . . . 1.22 111.446 172.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 96.1 mt-10 56.53 16.18 2.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.941 -1.099 . . . . 1.9299999999999999 110.556 175.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 11.3 pttt -128.98 165.48 21.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 2.0099999999999998 109.734 174.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.818 HD13 HD11 ' B' ' 20' ' ' ILE . 67.7 mt -96.71 133.85 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.178 -0.951 . . . . 1.25 110.395 -175.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.612 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 23.5 mm -113.46 120.09 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.747 -0.596 . . . . 0.5 109.927 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.829 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.0 mp -118.52 134.34 55.16 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.888 -1.133 . . . . 1.6599999999999999 110.136 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.522 ' HE2' ' CE1' ' A' ' 39' ' ' TYR . 22.8 pttt -140.52 162.49 35.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.357 -0.839 . . . . 1.74 110.492 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -57.59 147.96 25.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.001 . . . . 1.6499999999999999 109.902 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.815 ' CD2' HG11 ' B' ' 9' ' ' VAL . 3.5 t80 -102.63 119.55 39.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.34999999999999998 110.466 -176.157 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -99.67 122.98 49.47 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.44 -0.787 . . . . 3.21 109.633 175.625 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 53' ' ' ASN . 17.8 Cg_endo -65.38 151.0 86.5 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.841 1.442 . . . . 0.47999999999999998 110.276 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 52' ' ' PRO . 30.1 t30 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.969 -1.015 . . . . 2.4100000000000001 110.301 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 65.6 t80 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.261 0.553 . . . . 11.66 110.162 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 88.4 mtp -82.76 134.31 35.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -0.936 . . . . 8.6999999999999993 110.158 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -117.82 141.76 48.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 9.1699999999999999 110.358 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 29.9 t -137.07 149.23 47.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.309 -0.87 . . . . 5.2000000000000002 110.063 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.52 HG21 HG21 ' A' ' 40' ' ' VAL . 76.1 p -60.69 -38.78 86.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 2.98 109.983 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.18 46.15 74.64 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.67 -1.372 . . . . 0.82999999999999996 109.67 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 59.4 mt -117.07 132.93 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.068 -1.254 . . . . 1.3600000000000001 109.966 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 36' ' ' LEU . 98.5 t -114.14 144.25 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.994 -1.066 . . . . 0.37 110.87 -176.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 29.0 tpt180 -129.96 158.53 39.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.504 -0.747 . . . . 1.9199999999999999 109.767 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.422 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 66.4 mmtt -85.49 148.09 26.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 2.21 110.319 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.964 HG22 HD11 ' A' ' 36' ' ' LEU . 3.7 t -81.59 128.85 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 0.28999999999999998 109.79 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.66 -174.99 5.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.157 -0.964 . . . . 0.55000000000000004 110.197 -179.795 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.36 -40.99 68.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.104 -0.997 . . . . 2.1899999999999999 111.597 -172.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.912 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.4 tp -84.82 -5.47 59.33 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.743 -1.223 . . . . 1.3899999999999999 111.583 -173.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.532 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.93 47.25 7.24 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.529 -1.428 . . . . 0.20999999999999999 109.529 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.921 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.0 mtm180 -114.99 153.89 29.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.089 -1.242 . . . . 1.1399999999999999 109.98 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.732 HG21 ' CD2' ' A' ' 47' ' ' LEU . 22.3 m -123.88 152.2 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 0.28000000000000003 109.807 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.906 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.3 t -112.95 134.04 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.137 -0.977 . . . . 0.23999999999999999 110.598 -175.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.818 HD11 HD13 ' A' ' 45' ' ' ILE . 2.5 mm -84.33 133.0 45.72 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 1.3799999999999999 109.41 174.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.7 Cg_endo -57.58 141.4 95.26 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.763 1.402 . . . . 0.35999999999999999 109.963 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.939 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -56.04 -32.08 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.994 -1.066 . . . . 1.1100000000000001 110.316 -177.217 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.19 -37.01 71.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.034 -1.041 . . . . 2.3700000000000001 109.667 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.553 ' HB2' HG23 ' B' ' 20' ' ' ILE . 43.4 mt -80.08 -29.6 39.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.516 -0.74 . . . . 1.75 110.48 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.607 HH22 HD11 ' A' ' 15' ' ' LEU . 73.4 mtt180 -56.67 -43.81 80.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.966 -1.084 . . . . 0.29999999999999999 109.076 175.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -72.51 -47.99 44.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 3.27 110.591 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.2 m -62.88 -32.9 74.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.183 -0.948 . . . . 0.77000000000000002 110.875 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.781 HD23 HG13 ' B' ' 30' ' ' ILE . 20.6 tp -88.16 -5.0 58.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.032 -1.043 . . . . 1.05 110.736 -176.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.423 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.41 41.46 94.38 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.656 -1.378 . . . . 0.32000000000000001 109.656 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.781 HG13 HD23 ' B' ' 28' ' ' LEU . 32.2 mm -116.48 139.36 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -1.153 . . . . 0.40999999999999998 110.728 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.43 166.6 24.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.632 -0.668 . . . . 0.23000000000000001 109.985 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.62 146.45 13.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.102 -0.999 . . . . 1.1299999999999999 110.55 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 40.3 tttp 74.67 -4.73 2.28 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.579 -0.701 . . . . 1.8799999999999999 111.194 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.586 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.0 m-20 -76.93 165.59 24.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.805 -1.184 . . . . 1.1000000000000001 110.023 174.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.747 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.53 131.17 52.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.35999999999999999 110.834 -176.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.97 HD11 HG22 ' A' ' 12' ' ' VAL . 12.9 mt -108.68 143.71 37.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.37 -0.831 . . . . 0.56000000000000005 109.481 174.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.663 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.5 tt0 -106.18 138.88 41.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.839 -1.163 . . . . 1.1699999999999999 109.786 172.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.4 131.34 59.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.348 -0.845 . . . . 0.83999999999999997 110.494 -171.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.613 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 16.5 m-85 -117.67 157.45 26.44 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 116.257 -0.428 . . . . 0.45000000000000001 109.904 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 75.0 t -131.69 120.51 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.868 -1.145 . . . . 0.26000000000000001 110.436 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.498 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 46.6 p-10 -148.96 161.95 40.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.205 -0.934 . . . . 1.77 110.533 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' B' ' 42' ' ' ASP . 54.4 t0 42.02 41.0 1.8 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.185 -0.947 . . . . 1.21 111.461 172.48 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 96.1 mt-10 56.32 16.12 2.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.926 -1.109 . . . . 1.9199999999999999 110.584 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 11.2 pttt -128.96 165.67 20.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 2.0 109.666 174.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.735 HG22 HD11 ' B' ' 47' ' ' LEU . 68.0 mt -96.82 133.83 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 1.24 110.363 -175.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 23.1 mm -113.53 120.17 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.739 -0.601 . . . . 0.5 109.865 177.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.833 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.1 mp -118.46 134.14 55.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.899 -1.125 . . . . 1.6599999999999999 110.174 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.516 ' HE2' ' CE1' ' B' ' 39' ' ' TYR . 23.3 pttt -140.41 162.55 35.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 1.74 110.371 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -57.47 147.82 25.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.977 . . . . 1.6499999999999999 109.871 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 1.016 ' CD2' HG11 ' A' ' 9' ' ' VAL . 3.6 t80 -102.77 118.96 37.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.908 . . . . 0.65000000000000002 110.551 -176.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -122.29 78.86 44.52 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.123 -0.986 . . . . 4.3499999999999996 110.237 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.22 145.6 97.26 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.064 1.56 . . . . 3.5800000000000001 110.323 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.008 -0.996 . . . . 5.9699999999999998 110.225 -179.83 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.565 ' CZ ' ' OE2' ' A' ' 23' ' ' GLU . 63.0 t80 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.206 0.527 . . . . 10.99 110.136 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.471 ' O ' ' OE2' ' A' ' 23' ' ' GLU . 93.2 mmm -122.4 143.24 49.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 8.7599999999999998 110.112 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -92.0 146.29 23.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.106 -0.996 . . . . 8.8499999999999996 110.277 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.91 ' O ' HG23 ' A' ' 6' ' ' THR . 52.9 p -67.16 158.38 31.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.946 . . . . 4.2000000000000002 109.864 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.91 HG23 ' O ' ' A' ' 5' ' ' SER . 0.8 OUTLIER -170.8 63.58 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.445 -0.784 . . . . 3.77 110.076 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.35 49.97 4.99 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.208 -1.472 . . . . 0.82999999999999996 109.979 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.7 mt -99.52 135.29 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.975 -1.309 . . . . 1.3600000000000001 109.636 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.906 HG13 ' O ' ' B' ' 36' ' ' LEU . 98.5 t -113.51 143.75 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.911 -1.118 . . . . 0.37 111.348 -171.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.43 ' NE ' ' HB ' ' A' ' 19' ' ' VAL . 59.5 ttm-85 -123.82 161.17 25.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.539 -0.725 . . . . 1.9099999999999999 109.621 176.809 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' B' ' 33' ' ' LYS . 82.1 tttt -82.54 145.01 29.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.138 -0.976 . . . . 2.21 110.563 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.908 HG22 HD11 ' B' ' 36' ' ' LEU . 4.1 t -82.97 129.38 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.412 -0.805 . . . . 0.28000000000000003 109.881 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.11 -175.06 5.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.55000000000000004 109.901 179.309 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.94 -39.28 74.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.991 -1.068 . . . . 2.1899999999999999 111.61 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.903 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.2 tp -83.47 -6.23 59.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.755 -1.215 . . . . 1.3799999999999999 111.542 -174.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.479 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 79.98 46.46 7.69 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.193 -1.479 . . . . 0.20999999999999999 109.648 -177.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.908 ' CD ' HG22 ' B' ' 19' ' ' VAL . 68.4 mtm180 -114.12 156.15 24.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.076 -1.249 . . . . 1.1499999999999999 110.019 -177.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.856 HG12 HD13 ' B' ' 36' ' ' LEU . 16.8 m -124.53 153.35 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.28000000000000003 109.805 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.938 HG22 ' CD ' ' B' ' 17' ' ' ARG . 35.2 t -111.06 134.47 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.23999999999999999 110.536 -176.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.39 133.38 50.32 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.314 -0.867 . . . . 1.3799999999999999 109.433 174.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.1 Cg_endo -57.18 142.86 94.54 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.761 1.401 . . . . 0.34999999999999998 110.018 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.861 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.28 -32.69 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.977 -1.077 . . . . 1.1100000000000001 110.357 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.565 ' OE2' ' CZ ' ' A' ' 2' ' ' PHE . 84.4 tt0 -58.22 -35.93 72.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.096 -1.002 . . . . 2.3700000000000001 109.839 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.563 ' HB2' HG23 ' A' ' 20' ' ' ILE . 48.7 mt -80.41 -31.4 37.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.818 . . . . 1.75 110.537 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.861 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.3 mtt180 -58.09 -43.38 87.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.883 -1.136 . . . . 0.29999999999999999 109.243 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -73.57 -49.95 23.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.767 . . . . 3.2599999999999998 110.804 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m -64.42 -30.97 72.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.24 -0.912 . . . . 0.77000000000000002 111.16 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.922 HD23 HG13 ' A' ' 30' ' ' ILE . 19.7 tp -87.14 -4.64 59.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.02 -1.05 . . . . 1.05 110.656 -177.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.63 43.73 96.02 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.673 -1.371 . . . . 0.32000000000000001 109.673 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.922 HG13 HD23 ' A' ' 28' ' ' LEU . 29.6 mm -114.74 138.07 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -1.152 . . . . 0.40999999999999998 110.664 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.406 ' HB3' ' OD2' ' A' ' 34' ' ' ASP . . . -141.22 166.57 24.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.548 -0.72 . . . . 0.23000000000000001 109.986 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.3 145.99 12.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.068 -1.02 . . . . 1.1299999999999999 110.51 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 45.6 tttp 74.91 -4.7 2.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.653 -0.654 . . . . 1.8799999999999999 111.084 177.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.772 ' O ' HG23 ' B' ' 12' ' ' VAL . 92.0 m-20 -78.04 167.73 20.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.812 -1.18 . . . . 1.1000000000000001 110.018 174.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -105.98 131.74 52.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.166 -0.959 . . . . 0.35999999999999999 110.762 -176.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.927 ' O ' HG13 ' B' ' 9' ' ' VAL . 10.3 mt -106.75 141.36 38.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.392 -0.817 . . . . 0.56000000000000005 109.319 175.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.678 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.6 tt0 -103.88 138.17 40.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.794 -1.191 . . . . 1.1699999999999999 109.892 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 74.5 mt -112.25 133.11 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.54 -0.725 . . . . 0.83999999999999997 110.575 -174.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.606 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 17.3 m-85 -115.17 158.32 22.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 122.045 -0.41 . . . . 0.45000000000000001 110.076 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.3 t -129.44 124.29 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.016 -1.053 . . . . 0.27000000000000002 110.707 173.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.623 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.1 p-10 -146.93 136.32 22.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 1.77 110.233 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 56.0 t0 44.05 49.84 7.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.017 -1.052 . . . . 1.22 111.071 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.3 mt-10 59.1 13.6 3.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.202 -0.936 . . . . 1.9299999999999999 110.636 175.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -117.24 147.6 42.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 2.0099999999999998 110.036 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.597 HG22 HD11 ' A' ' 47' ' ' LEU . 61.3 mt -99.65 129.16 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.148 -0.97 . . . . 1.25 110.183 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.623 HD11 ' OD2' ' A' ' 41' ' ' ASP . 23.3 mt -109.1 116.42 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.341 -0.849 . . . . 0.5 110.043 176.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.839 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.1 mp -111.05 134.76 52.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.029 -1.044 . . . . 1.6599999999999999 110.113 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.538 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 14.0 pttp -142.66 163.14 33.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.5 -0.75 . . . . 1.74 110.347 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -58.05 147.12 30.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.114 -0.991 . . . . 1.6499999999999999 109.93 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.491 ' CD2' HG11 ' B' ' 9' ' ' VAL . 14.6 t80 -104.71 112.26 25.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.34999999999999998 110.616 -176.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -100.16 122.67 49.54 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.459 -0.776 . . . . 3.21 109.385 172.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.29 144.07 99.5 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.753 1.396 . . . . 0.47999999999999998 110.104 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 21.4 m120 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.051 -0.976 . . . . 2.4100000000000001 110.231 -179.922 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.241 0.543 . . . . 11.66 110.151 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 87.6 mtp -97.09 43.68 1.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 8.6999999999999993 110.515 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -93.41 152.96 18.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.158 -0.963 . . . . 9.1699999999999999 110.283 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.881 ' O ' HG23 ' B' ' 6' ' ' THR . 50.5 m -59.79 154.12 19.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.23 -0.919 . . . . 5.2000000000000002 110.275 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.881 HG23 ' O ' ' B' ' 5' ' ' SER . 0.8 OUTLIER -168.72 63.55 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.27 -0.894 . . . . 2.98 110.243 -179.232 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.5 51.59 4.55 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.697 -1.361 . . . . 0.82999999999999996 109.697 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 61.9 mt -100.01 135.14 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.039 -1.271 . . . . 1.3600000000000001 109.707 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 36' ' ' LEU . 98.7 t -113.5 143.71 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.869 -1.145 . . . . 0.37 111.29 -171.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.419 ' NE ' ' HB ' ' B' ' 19' ' ' VAL . 59.5 ttm-85 -123.76 160.98 26.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.579 -0.701 . . . . 1.9199999999999999 109.776 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 33' ' ' LYS . 81.9 tttt -82.53 144.9 30.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.072 -1.017 . . . . 2.21 110.616 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.902 HG22 ' CD1' ' A' ' 36' ' ' LEU . 4.1 t -82.87 129.6 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.804 . . . . 0.28999999999999998 109.78 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.36 -174.89 5.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.129 -0.982 . . . . 0.55000000000000004 110.023 179.079 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.477 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.8 mt-10 -56.96 -39.28 74.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.065 -1.022 . . . . 2.1899999999999999 111.552 -172.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.905 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.6 tp -83.56 -6.26 59.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.767 -1.208 . . . . 1.3899999999999999 111.568 -174.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.482 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.63 47.15 7.46 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.484 -1.447 . . . . 0.20999999999999999 109.484 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.938 ' CD ' HG22 ' A' ' 19' ' ' VAL . 68.6 mtm180 -114.23 156.11 24.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.974 -1.309 . . . . 1.1399999999999999 110.058 -177.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.823 HG12 HD13 ' A' ' 36' ' ' LEU . 16.6 m -124.5 153.34 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.431 -0.793 . . . . 0.28000000000000003 109.846 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.908 HG22 ' CD ' ' A' ' 17' ' ' ARG . 35.4 t -111.06 134.5 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.23999999999999999 110.527 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.577 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.31 133.33 50.65 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.329 -0.857 . . . . 1.3799999999999999 109.493 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.551 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.3 Cg_endo -57.4 142.84 95.18 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.675 1.355 . . . . 0.35999999999999999 110.036 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.858 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.4 tp -55.39 -32.53 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.062 -1.024 . . . . 1.1100000000000001 110.343 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.03 -36.64 73.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.02 -1.05 . . . . 2.3700000000000001 109.714 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.577 ' HB2' HG23 ' B' ' 20' ' ' ILE . 48.0 mt -79.68 -31.75 41.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.483 -0.76 . . . . 1.75 110.514 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.858 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.9 mtt180 -57.93 -43.3 86.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.925 -1.11 . . . . 0.29999999999999999 109.28 176.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -73.54 -50.21 22.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.327 -0.858 . . . . 3.27 110.653 -177.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 55.4 m -64.17 -31.56 72.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.77000000000000002 110.86 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.971 HD23 HG13 ' B' ' 30' ' ' ILE . 20.0 tp -86.64 -5.09 59.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.124 -0.985 . . . . 1.05 110.63 -176.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.442 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.91 43.68 95.66 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.49 -1.444 . . . . 0.32000000000000001 109.49 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.971 HG13 HD23 ' B' ' 28' ' ' LEU . 29.4 mm -114.66 137.97 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -1.168 . . . . 0.40999999999999998 110.699 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.401 ' HB3' ' OD2' ' B' ' 34' ' ' ASP . . . -140.98 166.66 24.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.509 -0.745 . . . . 0.23000000000000001 109.99 -178.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.27 146.03 12.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.138 -0.976 . . . . 1.1299999999999999 110.536 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 45.5 tttp 75.0 -4.94 2.27 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.706 -0.621 . . . . 1.8799999999999999 111.16 177.114 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.724 ' O ' HG23 ' A' ' 12' ' ' VAL . 92.5 m-20 -78.03 167.56 21.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.914 -1.116 . . . . 1.1000000000000001 110.045 174.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.46 ' HB1' HG11 ' A' ' 9' ' ' VAL . . . -105.88 131.66 52.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.961 . . . . 0.35999999999999999 110.807 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.908 HD11 HG22 ' A' ' 12' ' ' VAL . 10.1 mt -106.72 141.16 38.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.887 . . . . 0.56000000000000005 109.421 175.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.635 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.5 tt0 -103.75 138.22 40.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.86 -1.15 . . . . 1.1699999999999999 109.975 173.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 74.5 mt -112.13 133.2 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.459 -0.775 . . . . 0.83999999999999997 110.507 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.61 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 17.2 m-85 -115.32 158.27 22.64 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 120.914 0.387 . . . . 0.45000000000000001 109.962 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.53 ' CG2' ' OG ' ' A' ' 5' ' ' SER . 83.9 t -129.2 124.66 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.99 -1.069 . . . . 0.26000000000000001 110.61 173.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.627 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.2 p-10 -147.32 136.26 22.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -0.838 . . . . 1.77 110.151 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 56.7 t0 44.26 49.85 7.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.119 -0.988 . . . . 1.21 111.012 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.3 mt-10 58.95 13.63 2.91 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.229 -0.919 . . . . 1.9199999999999999 110.607 176.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -117.23 147.87 42.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.945 . . . . 2.0 109.94 175.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.578 HG22 HD11 ' B' ' 47' ' ' LEU . 61.0 mt -99.83 129.15 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.102 -0.999 . . . . 1.24 110.153 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.627 HD11 ' OD2' ' B' ' 41' ' ' ASP . 23.8 mt -109.29 116.42 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.463 -0.773 . . . . 0.5 110.019 176.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.842 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.2 mp -110.91 134.7 52.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.004 -1.06 . . . . 1.6599999999999999 110.097 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.535 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 14.2 pttp -142.52 163.37 33.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.443 -0.785 . . . . 1.74 110.29 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -58.13 147.1 31.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 1.6499999999999999 109.885 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.548 ' CD2' HG11 ' A' ' 9' ' ' VAL . 14.8 t80 -104.94 111.99 24.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.18 -0.95 . . . . 0.65000000000000002 110.667 -176.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -123.35 79.44 53.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.078 -1.014 . . . . 4.3499999999999996 110.142 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.416 ' HG3' ' CE2' ' B' ' 50' ' ' TYR . 12.0 Cg_endo -60.4 146.24 97.1 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.075 1.566 . . . . 3.5800000000000001 110.358 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 39.1 p-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.069 -0.967 . . . . 5.9699999999999998 110.27 179.496 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.221 0.534 . . . . 10.99 110.227 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.458 ' SD ' ' HB2' ' B' ' 41' ' ' ASP . 70.2 mtm -120.92 149.33 42.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 8.7599999999999998 110.159 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' B' ' 40' ' ' VAL . 16.2 tttp -83.88 134.62 34.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.305 -0.872 . . . . 8.8499999999999996 110.331 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.578 ' HG ' ' HD2' ' B' ' 39' ' ' TYR . 48.0 m -119.1 147.38 44.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 4.2000000000000002 110.097 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.441 HG23 ' CG2' ' B' ' 40' ' ' VAL . 64.1 p -66.49 -32.31 73.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 3.77 110.285 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.1 46.18 52.46 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.567 -1.413 . . . . 0.82999999999999996 109.567 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.1 mt -116.87 135.38 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.161 -1.199 . . . . 1.3600000000000001 109.967 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.093 HG11 ' CD2' ' B' ' 50' ' ' TYR . 90.0 t -116.15 144.46 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.019 -1.051 . . . . 0.37 110.989 -175.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 57.5 ttm-85 -129.61 159.66 35.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.513 -0.742 . . . . 1.9099999999999999 109.736 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -86.49 148.03 25.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.2 -0.938 . . . . 2.21 110.328 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.987 HG22 HD11 ' B' ' 36' ' ' LEU . 3.7 t -82.58 129.29 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.266 -0.896 . . . . 0.28000000000000003 109.945 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.18 -174.7 5.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.051 -1.031 . . . . 0.55000000000000004 109.995 179.614 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -56.1 -39.93 72.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.025 -1.047 . . . . 2.1899999999999999 111.718 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.861 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.1 tp -85.41 -4.53 59.19 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.751 -1.218 . . . . 1.3799999999999999 111.674 -173.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.482 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.07 46.34 7.71 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.176 -1.488 . . . . 0.20999999999999999 109.662 -177.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.919 ' CD ' HG22 ' B' ' 19' ' ' VAL . 73.8 mtm180 -115.75 154.62 29.27 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.054 -1.262 . . . . 1.1499999999999999 109.995 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.54 HG12 HD13 ' B' ' 36' ' ' LEU . 22.7 m -123.81 151.76 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.28000000000000003 109.868 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.95 HG22 ' CD ' ' B' ' 17' ' ' ARG . 22.4 t -112.35 135.13 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.152 -0.968 . . . . 0.23999999999999999 110.54 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.569 HG23 ' HB2' ' A' ' 24' ' ' LEU . 3.0 mm -83.64 133.29 46.94 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 1.3799999999999999 109.606 175.371 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' HD12 ' A' ' 24' ' ' LEU . 9.2 Cg_endo -58.04 143.62 96.07 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.778 1.409 . . . . 0.34999999999999998 110.061 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.878 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.1 tp -54.85 -33.12 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.991 -1.068 . . . . 1.1100000000000001 110.347 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.409 ' N ' HG23 ' A' ' 22' ' ' ILE . 84.3 tt0 -58.03 -35.6 71.52 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.154 -0.966 . . . . 2.3700000000000001 109.833 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.569 ' HB2' HG23 ' A' ' 20' ' ' ILE . 51.4 mt -83.8 -28.81 27.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.335 -0.853 . . . . 1.75 110.789 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.878 ' HD2' HD12 ' A' ' 22' ' ' ILE . 71.5 mtt180 -57.44 -43.9 84.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.752 -1.218 . . . . 0.29999999999999999 108.957 175.011 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -71.49 -49.75 38.2 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.092 -0.643 . . . . 3.2599999999999998 110.714 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.8 m -63.59 -31.4 72.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.177 -0.952 . . . . 0.77000000000000002 111.15 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.805 HD23 HG13 ' A' ' 30' ' ' ILE . 23.8 tp -87.35 -5.03 59.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.061 -1.024 . . . . 1.05 110.729 -177.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.08 41.4 98.51 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.701 -1.36 . . . . 0.32000000000000001 109.701 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.805 HG13 HD23 ' A' ' 28' ' ' LEU . 34.3 mm -116.41 139.73 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -1.15 . . . . 0.40999999999999998 110.759 -178.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -139.89 167.46 22.05 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.654 -0.654 . . . . 0.23000000000000001 110.082 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 83.3 tt0 -52.41 150.87 4.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.047 -1.033 . . . . 1.1299999999999999 110.549 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 74.5 mttt 67.16 -3.32 1.01 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.857 -0.527 . . . . 1.8799999999999999 112.234 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.745 ' O ' HG23 ' B' ' 12' ' ' VAL . 90.1 m-20 -76.07 165.44 24.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.579 -1.326 . . . . 1.1000000000000001 109.952 174.152 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.799 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -103.87 130.98 51.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.35999999999999999 110.785 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.974 HD11 HG22 ' B' ' 12' ' ' VAL . 13.5 mt -109.14 142.36 40.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.388 -0.82 . . . . 0.56000000000000005 109.54 175.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.678 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.4 tt0 -107.4 140.35 40.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.795 -1.191 . . . . 1.1699999999999999 109.739 172.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.6 mt -111.57 135.41 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.345 -0.847 . . . . 0.83999999999999997 110.564 -172.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.588 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 12.4 m-85 -114.6 158.55 21.55 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 120.934 0.397 . . . . 0.45000000000000001 110.078 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.601 HG21 HG21 ' B' ' 6' ' ' THR . 77.7 t -130.89 128.39 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.924 -1.11 . . . . 0.27000000000000002 110.62 172.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.643 ' CG ' HD11 ' A' ' 46' ' ' ILE . 8.9 p-10 -146.62 128.34 15.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.86 . . . . 1.77 110.249 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 48.1 t0 46.57 49.11 13.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.022 -1.048 . . . . 1.22 110.948 175.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.1 tt0 62.53 10.35 4.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.337 -0.852 . . . . 1.9299999999999999 110.696 176.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 9.0 mtmm -110.59 148.38 32.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 2.0099999999999998 109.868 176.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.669 HD13 HD11 ' B' ' 20' ' ' ILE . 58.0 mt -101.92 127.98 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 1.25 110.331 -176.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.643 HD11 ' CG ' ' A' ' 41' ' ' ASP . 29.6 mt -114.99 123.33 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.343 -0.848 . . . . 0.5 110.233 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.822 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -114.11 136.74 52.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.961 -1.087 . . . . 1.6599999999999999 110.167 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 25.2 pttt -140.92 165.61 27.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.449 -0.782 . . . . 1.74 110.132 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -56.06 149.07 16.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.109 -0.995 . . . . 1.6499999999999999 109.819 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.971 ' CD2' HG11 ' B' ' 9' ' ' VAL . 2.2 t80 -100.43 126.53 46.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.29 -0.881 . . . . 0.34999999999999998 110.655 -175.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 9.6 mttt -99.28 123.24 49.32 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.311 -0.868 . . . . 3.21 109.605 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 25.9 Cg_exo -57.43 144.89 90.57 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.846 1.446 . . . . 0.47999999999999998 110.367 -178.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.011 -0.995 . . . . 2.4100000000000001 110.225 -179.889 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.282 0.563 . . . . 11.66 110.216 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 70.7 mtm -117.57 148.11 42.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -0.923 . . . . 8.6999999999999993 110.22 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -81.39 133.28 35.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 9.1699999999999999 110.242 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.477 ' HB2' ' HA ' ' A' ' 39' ' ' TYR . 97.3 p -139.05 159.32 42.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.9 . . . . 5.2000000000000002 110.222 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.601 HG21 HG21 ' A' ' 40' ' ' VAL . 63.4 p -65.18 -32.37 74.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 2.98 110.256 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.94 46.48 52.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.55 -1.42 . . . . 0.82999999999999996 109.55 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.6 mt -116.84 135.32 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.218 -1.166 . . . . 1.3600000000000001 110.052 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.971 HG11 ' CD2' ' A' ' 50' ' ' TYR . 90.1 t -116.23 144.45 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.974 -1.079 . . . . 0.37 110.959 -175.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 57.4 ttm-85 -129.44 159.5 36.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.488 -0.757 . . . . 1.9199999999999999 109.809 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -86.49 147.95 25.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.027 -1.046 . . . . 2.21 110.434 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.974 HG22 HD11 ' A' ' 36' ' ' LEU . 3.7 t -82.45 129.3 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.265 -0.897 . . . . 0.28999999999999998 109.823 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.3 -174.49 5.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.085 -1.009 . . . . 0.55000000000000004 110.171 179.359 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.485 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.5 mt-10 -56.24 -39.85 73.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.095 -1.003 . . . . 2.1899999999999999 111.679 -172.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.892 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.5 tp -85.54 -4.55 59.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.723 -1.235 . . . . 1.3899999999999999 111.624 -173.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.498 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.82 46.99 7.45 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.485 -1.446 . . . . 0.20999999999999999 109.485 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.95 ' CD ' HG22 ' A' ' 19' ' ' VAL . 73.7 mtm180 -115.9 154.66 29.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.102 -1.234 . . . . 1.1399999999999999 109.936 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 47' ' ' LEU . 22.6 m -123.91 151.7 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.822 . . . . 0.28000000000000003 109.866 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.919 HG22 ' CD ' ' A' ' 17' ' ' ARG . 22.6 t -112.37 135.09 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.23999999999999999 110.576 -175.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.669 HD11 HD13 ' A' ' 45' ' ' ILE . 3.0 mm -83.64 133.24 47.03 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 1.3799999999999999 109.594 175.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.539 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.2 Cg_endo -58.15 143.6 96.51 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.721 1.38 . . . . 0.35999999999999999 110.063 177.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.874 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -54.9 -33.04 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.043 -1.036 . . . . 1.1100000000000001 110.315 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' GLU . . . . . 0.41 ' N ' HG23 ' B' ' 22' ' ' ILE . 84.2 tt0 -57.79 -36.34 72.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.152 -0.968 . . . . 2.3700000000000001 109.724 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.562 ' HB2' HG23 ' B' ' 20' ' ' ILE . 51.4 mt -83.03 -29.28 28.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.496 -0.753 . . . . 1.75 110.752 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.874 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.0 mtt180 -57.22 -43.8 83.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.816 -1.178 . . . . 0.29999999999999999 108.987 175.402 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -71.32 -50.15 35.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.452 -0.78 . . . . 3.27 110.543 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.4 m -63.3 -31.92 73.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.258 -0.901 . . . . 0.77000000000000002 110.931 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.81 HD23 HG13 ' B' ' 30' ' ' ILE . 24.0 tp -86.84 -5.41 59.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.052 -1.03 . . . . 1.05 110.723 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.401 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.4 41.31 98.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.625 -1.39 . . . . 0.32000000000000001 109.625 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.81 HG13 HD23 ' B' ' 28' ' ' LEU . 33.6 mm -116.43 139.65 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.177 -1.19 . . . . 0.40999999999999998 110.707 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -139.69 167.62 21.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.516 -0.74 . . . . 0.23000000000000001 109.975 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' B' ' 33' ' ' LYS . 83.2 tt0 -52.33 151.07 4.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.129 -0.982 . . . . 1.1299999999999999 110.467 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' B' ' 32' ' ' GLU . 74.0 mttt 66.57 -2.74 0.99 Allowed 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 112.363 0.505 . . . . 1.8799999999999999 112.363 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.647 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.4 m-20 -76.55 165.31 24.96 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.506 -1.371 . . . . 1.1000000000000001 109.965 173.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.764 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.63 131.02 51.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.35999999999999999 110.802 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.987 HD11 HG22 ' A' ' 12' ' ' VAL . 13.3 mt -109.23 142.18 40.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.383 -0.823 . . . . 0.56000000000000005 109.558 175.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.655 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.2 tt0 -107.26 140.32 40.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.842 -1.161 . . . . 1.1699999999999999 109.824 172.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.8 mt -111.61 135.36 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.284 -0.885 . . . . 0.83999999999999997 110.58 -172.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.583 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 12.1 m-85 -114.4 158.57 21.35 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 120.946 0.403 . . . . 0.45000000000000001 110.09 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.441 ' CG2' HG23 ' A' ' 6' ' ' THR . 78.6 t -130.72 128.61 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.903 -1.123 . . . . 0.26000000000000001 110.476 172.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.641 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.0 p-10 -146.91 128.24 14.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 1.77 110.241 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 49.0 t0 46.77 49.08 14.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.093 -1.005 . . . . 1.21 110.934 175.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.0 tt0 62.4 10.4 3.92 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.224 -0.923 . . . . 1.9199999999999999 110.691 176.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 9.0 mtmm -110.61 148.66 31.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.942 . . . . 2.0 109.705 176.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.553 HG21 HD11 ' A' ' 20' ' ' ILE . 58.0 mt -102.08 128.0 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.981 . . . . 1.24 110.365 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.641 HD11 ' OD2' ' B' ' 41' ' ' ASP . 30.4 mt -115.17 123.4 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.415 -0.803 . . . . 0.5 110.146 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.817 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.2 mp -114.05 136.63 52.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.981 -1.074 . . . . 1.6599999999999999 110.145 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.523 ' HD3' ' CE1' ' B' ' 39' ' ' TYR . 25.2 pttt -140.78 165.84 26.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.44 -0.788 . . . . 1.74 110.079 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -56.3 148.87 17.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.992 -1.067 . . . . 1.6499999999999999 109.754 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 1.093 ' CD2' HG11 ' A' ' 9' ' ' VAL . 2.2 t80 -100.46 122.33 43.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.65000000000000002 110.667 -175.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.547 ' CB ' ' HD3' ' B' ' 52' ' ' PRO . 0.0 OUTLIER -97.03 -56.6 0.2 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.932 . . . . 4.3499999999999996 110.952 179.719 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.585 ' O ' ' CZ ' ' B' ' 50' ' ' TYR . 36.6 Cg_exo -52.75 155.35 10.77 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.505 1.266 . . . . 3.5800000000000001 110.604 -177.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 17.7 m120 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.997 -1.001 . . . . 5.9699999999999998 110.181 -178.561 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.0 t80 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.301 0.572 . . . . 10.99 110.227 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.3 mmm -98.4 138.9 34.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 8.7599999999999998 110.229 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -49.36 -39.68 32.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.269 -0.895 . . . . 8.8499999999999996 111.412 -174.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.8 m -110.63 159.13 17.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.737 -1.227 . . . . 4.2000000000000002 110.235 -177.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.2 p -60.76 -35.19 75.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.139 -0.976 . . . . 3.77 110.194 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.91 46.7 43.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.703 -1.359 . . . . 0.82999999999999996 109.703 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.5 mt -114.57 134.58 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.039 -1.271 . . . . 1.3600000000000001 110.014 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.92 HG13 ' O ' ' B' ' 36' ' ' LEU . 86.8 t -114.0 144.12 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.027 -1.046 . . . . 0.37 110.871 -175.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -126.29 157.88 37.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.398 -0.814 . . . . 1.9099999999999999 109.71 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' B' ' 33' ' ' LYS . 55.2 tttt -83.58 145.04 29.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.137 -0.977 . . . . 2.21 110.396 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.925 HG22 HD11 ' B' ' 36' ' ' LEU . 3.9 t -81.77 130.31 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.351 -0.843 . . . . 0.28000000000000003 109.929 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.38 -174.58 5.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.177 -0.952 . . . . 0.55000000000000004 110.131 -179.606 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.46 -39.74 73.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.07 -1.019 . . . . 2.1899999999999999 111.779 -172.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.864 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.3 tp -84.76 -4.33 59.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.765 -1.209 . . . . 1.3799999999999999 111.6 -173.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.474 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.06 46.23 7.79 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.172 -1.49 . . . . 0.20999999999999999 109.715 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.934 ' CD ' HG22 ' B' ' 19' ' ' VAL . 74.9 mtm180 -116.16 155.12 28.82 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.069 -1.254 . . . . 1.1499999999999999 110.05 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.697 HG12 HD13 ' B' ' 36' ' ' LEU . 21.9 m -122.23 148.4 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.28000000000000003 109.758 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.945 HG22 ' CD ' ' B' ' 17' ' ' ARG . 28.5 t -112.82 133.79 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.23999999999999999 110.623 -175.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.622 HD11 HD13 ' B' ' 45' ' ' ILE . 2.2 mm -84.75 130.86 51.31 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.294 -0.878 . . . . 1.3799999999999999 109.461 175.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.54 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -57.29 142.34 94.79 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.668 1.352 . . . . 0.34999999999999998 109.849 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.926 ' O ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.46 -32.39 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.952 -1.093 . . . . 1.1100000000000001 110.289 -177.624 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.54 -36.38 71.55 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.16 -0.963 . . . . 2.3700000000000001 109.747 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.595 ' HB2' HG23 ' A' ' 20' ' ' ILE . 52.9 mt -82.1 -27.59 32.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 1.75 110.471 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.68 HH22 HD11 ' B' ' 15' ' ' LEU . 73.0 mtt180 -56.97 -43.93 82.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.833 -1.167 . . . . 0.29999999999999999 108.966 174.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 61.0 ttm-85 -71.66 -49.31 40.96 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.956 -0.698 . . . . 3.2599999999999998 110.765 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.9 m -63.21 -31.84 73.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.186 -0.946 . . . . 0.77000000000000002 111.078 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.8 HD23 HG13 ' A' ' 30' ' ' ILE . 23.2 tp -88.09 -5.01 58.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.093 -1.004 . . . . 1.05 110.758 -177.254 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.414 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.52 41.57 97.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.651 -1.38 . . . . 0.32000000000000001 109.651 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.8 HG13 HD23 ' A' ' 28' ' ' LEU . 33.6 mm -116.53 139.1 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -1.169 . . . . 0.40999999999999998 110.732 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.32 166.65 24.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.645 -0.659 . . . . 0.23000000000000001 109.984 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.2 tt0 -53.29 146.39 12.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.056 -1.027 . . . . 1.1299999999999999 110.592 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 28.5 tttt 74.52 -4.63 2.28 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.674 -0.642 . . . . 1.8799999999999999 111.166 176.944 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.728 ' O ' HG23 ' B' ' 12' ' ' VAL . 90.6 m-20 -77.3 165.95 23.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.788 -1.195 . . . . 1.1000000000000001 110.03 174.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.21 130.14 53.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.35999999999999999 110.629 -176.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.949 ' O ' HG13 ' B' ' 9' ' ' VAL . 11.6 mt -106.25 141.64 37.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 0.56000000000000005 109.387 174.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.682 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.3 tt0 -104.65 139.01 40.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.758 -1.214 . . . . 1.1699999999999999 109.882 173.66 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.7 mt -109.82 132.67 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.514 -0.741 . . . . 0.83999999999999997 110.374 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.588 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 14.2 m-85 -114.65 157.54 22.96 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.929 -0.397 . . . . 0.45000000000000001 109.929 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.9 t -129.59 126.29 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.942 -1.099 . . . . 0.27000000000000002 110.746 174.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.638 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.4 p-10 -146.71 131.91 18.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 1.77 110.178 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.497 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 47.7 t0 46.09 48.19 12.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.952 -1.092 . . . . 1.22 111.008 175.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.0 tt0 62.02 10.98 3.95 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.202 -0.936 . . . . 1.9299999999999999 110.609 175.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 32.7 mtmt -113.07 150.98 31.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.072 -1.017 . . . . 2.0099999999999998 109.873 176.42 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.706 HD13 HD11 ' B' ' 20' ' ' ILE . 56.7 mt -101.9 129.58 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 1.25 110.284 -176.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.638 HD11 ' OD2' ' A' ' 41' ' ' ASP . 21.9 mt -112.5 120.83 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.5 110.193 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.849 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -112.39 134.08 54.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.984 -1.073 . . . . 1.6599999999999999 110.133 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.543 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 10.5 pttp -141.52 164.8 29.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.478 -0.764 . . . . 1.74 110.394 178.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.543 ' HD3' ' CD1' ' A' ' 30' ' ' ILE . 18.3 tptp -56.97 146.04 28.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.133 -0.979 . . . . 1.6499999999999999 109.938 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.595 ' CD2' HG11 ' B' ' 9' ' ' VAL . 9.9 t80 -101.9 114.03 27.76 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.331 -0.855 . . . . 0.34999999999999998 110.646 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.52 123.0 49.7 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.309 -0.869 . . . . 3.21 109.606 174.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -60.09 147.04 94.7 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.763 1.402 . . . . 0.47999999999999998 110.214 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.8 m120 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.046 -0.978 . . . . 2.4100000000000001 110.21 -179.382 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 68.2 t80 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.274 0.559 . . . . 11.66 110.28 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 64.7 mtt -89.13 140.65 29.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 8.6999999999999993 110.224 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -133.14 165.4 24.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -0.866 . . . . 9.1699999999999999 110.217 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 40.7 m -62.81 156.29 24.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 5.2000000000000002 110.209 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' THR . . . . . . . . . . . . . 70.4 p -63.77 -35.16 79.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 2.98 110.217 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.65 47.28 42.02 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.581 -1.408 . . . . 0.82999999999999996 109.581 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.0 mt -114.68 134.47 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.136 -1.214 . . . . 1.3600000000000001 110.037 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.949 HG13 ' O ' ' A' ' 36' ' ' LEU . 88.3 t -114.03 144.11 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.079 -1.013 . . . . 0.37 110.911 -175.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -126.29 157.6 37.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.456 -0.777 . . . . 1.9199999999999999 109.833 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -83.53 144.95 29.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.983 . . . . 2.21 110.453 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.911 HG22 HD11 ' A' ' 36' ' ' LEU . 4.0 t -81.72 130.49 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.354 -0.841 . . . . 0.28999999999999998 109.812 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.454 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.6 -174.4 5.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.103 -0.998 . . . . 0.55000000000000004 110.3 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.474 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -56.63 -39.62 73.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.103 -0.998 . . . . 2.1899999999999999 111.65 -172.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.892 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.0 tp -84.87 -4.39 59.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.741 -1.225 . . . . 1.3899999999999999 111.527 -173.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.481 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.75 47.04 7.46 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.495 -1.442 . . . . 0.20999999999999999 109.495 -177.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.945 ' CD ' HG22 ' A' ' 19' ' ' VAL . 74.8 mtm180 -116.44 155.1 29.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.001 -1.293 . . . . 1.1399999999999999 109.969 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.7 HG12 HD13 ' A' ' 36' ' ' LEU . 22.0 m -122.3 148.35 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.28000000000000003 109.756 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.934 HG22 ' CD ' ' A' ' 17' ' ' ARG . 28.4 t -112.75 133.76 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.948 . . . . 0.23999999999999999 110.636 -175.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.706 HD11 HD13 ' A' ' 45' ' ' ILE . 2.2 mm -84.76 130.86 51.28 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 1.3799999999999999 109.416 175.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.532 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.0 Cg_endo -57.42 142.28 95.11 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.771 1.406 . . . . 0.35999999999999999 109.888 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.948 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.52 -32.17 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.994 -1.066 . . . . 1.1100000000000001 110.291 -177.375 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.45 -37.05 72.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.103 -0.998 . . . . 2.3700000000000001 109.643 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.579 ' HB2' HG23 ' B' ' 20' ' ' ILE . 52.5 mt -81.42 -27.88 34.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 1.75 110.502 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.638 HH22 HD11 ' A' ' 15' ' ' LEU . 72.7 mtt180 -56.79 -43.8 81.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.912 -1.118 . . . . 0.29999999999999999 109.046 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 61.0 ttm-85 -71.56 -49.78 37.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.463 -0.773 . . . . 3.27 110.578 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 48.1 m -62.8 -32.43 73.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.3 -0.875 . . . . 0.77000000000000002 110.893 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.835 HD23 HG13 ' B' ' 30' ' ' ILE . 23.4 tp -87.55 -5.42 58.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.058 -1.027 . . . . 1.05 110.661 -176.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.419 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.86 41.33 97.52 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.605 -1.398 . . . . 0.32000000000000001 109.605 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.835 HG13 HD23 ' B' ' 28' ' ' LEU . 33.4 mm -116.45 138.93 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -1.199 . . . . 0.40999999999999998 110.725 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.99 166.78 23.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.59 -0.694 . . . . 0.23000000000000001 110.053 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.527 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.31 146.48 12.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.132 -0.98 . . . . 1.1299999999999999 110.516 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 28.5 tttt 74.54 -4.78 2.25 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.673 -0.642 . . . . 1.8799999999999999 111.225 176.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.666 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.7 m-20 -77.39 165.57 24.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.849 -1.157 . . . . 1.1000000000000001 110.05 175.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.95 130.1 53.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.35999999999999999 110.69 -176.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.925 HD11 HG22 ' A' ' 12' ' ' VAL . 11.4 mt -106.26 141.5 37.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.396 -0.815 . . . . 0.56000000000000005 109.426 174.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.669 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.2 tt0 -104.55 138.95 40.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.84 -1.163 . . . . 1.1699999999999999 110.008 173.624 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 72.0 mt -109.76 132.59 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.395 -0.816 . . . . 0.83999999999999997 110.329 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.591 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 13.9 m-85 -114.59 157.55 22.89 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.901 -0.407 . . . . 0.45000000000000001 109.901 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.7 t -129.41 126.6 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.958 -1.089 . . . . 0.26000000000000001 110.584 174.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.618 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.4 p-10 -146.99 131.83 18.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.354 -0.841 . . . . 1.77 110.14 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 48.7 t0 46.3 48.21 13.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.107 -0.996 . . . . 1.21 110.968 175.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 82.8 tt0 61.82 11.04 3.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.238 -0.914 . . . . 1.9199999999999999 110.617 175.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 32.7 mtmt -113.08 151.2 31.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.178 -0.951 . . . . 2.0 109.791 176.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.622 HD13 HD11 ' A' ' 20' ' ' ILE . 56.3 mt -102.01 129.67 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.174 -0.954 . . . . 1.24 110.294 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.618 HD11 ' OD2' ' B' ' 41' ' ' ASP . 22.3 mt -112.71 120.83 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.5 110.075 176.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.838 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.2 mp -112.28 134.02 54.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.077 -1.014 . . . . 1.6599999999999999 110.053 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.536 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 10.7 pttp -141.5 165.02 28.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 1.74 110.248 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.544 ' HD3' ' CD1' ' B' ' 30' ' ' ILE . 18.3 tptp -57.06 145.96 28.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 1.6499999999999999 109.878 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.692 ' CD2' HG11 ' A' ' 9' ' ' VAL . 10.1 t80 -102.01 112.14 24.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.65000000000000002 110.599 -176.23 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.42 76.74 77.18 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.881 . . . . 4.3499999999999996 110.067 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.508 ' HD3' ' CD1' ' B' ' 50' ' ' TYR . 10.6 Cg_endo -58.71 144.62 97.82 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.998 1.525 . . . . 3.5800000000000001 110.367 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.961 -1.019 . . . . 5.9699999999999998 110.267 -179.934 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.205 0.526 . . . . 10.99 110.203 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.9 mtt -96.92 131.12 44.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.246 -0.908 . . . . 8.7599999999999998 110.203 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -51.37 -42.15 61.14 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.225 -0.922 . . . . 8.8499999999999996 111.5 -174.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.0 t -110.86 148.86 31.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.668 -1.27 . . . . 4.2000000000000002 110.331 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.4 p -60.84 -39.32 88.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 3.77 110.181 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.565 ' O ' HD13 ' A' ' 8' ' ' ILE . . . 65.95 46.51 81.16 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.63 -1.388 . . . . 0.82999999999999996 109.63 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.565 HD13 ' O ' ' A' ' 7' ' ' GLY . 21.0 mm -115.05 133.75 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.138 -1.213 . . . . 1.3600000000000001 110.157 -178.558 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.069 HG11 ' CD2' ' B' ' 50' ' ' TYR . 98.9 t -115.28 144.46 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.996 -1.065 . . . . 0.37 110.893 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.447 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 14.8 tpt180 -130.22 160.62 33.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.514 -0.741 . . . . 1.9099999999999999 109.687 177.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 66.7 mttm -85.76 148.5 25.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.106 -0.996 . . . . 2.21 110.344 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.924 HG22 HD11 ' B' ' 36' ' ' LEU . 6.3 t -82.05 128.75 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.216 -0.927 . . . . 0.28000000000000003 109.816 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.464 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.37 -174.82 5.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.209 -0.932 . . . . 0.55000000000000004 110.164 -179.299 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -53.24 -41.99 65.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.087 -1.008 . . . . 2.1899999999999999 111.687 -173.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.918 HD23 ' HD3' ' A' ' 17' ' ' ARG . 16.3 tp -85.97 -4.89 59.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.717 -1.239 . . . . 1.3799999999999999 111.685 -172.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.51 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.23 46.44 7.55 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.094 -1.527 . . . . 0.20999999999999999 109.695 -177.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.918 ' HD3' HD23 ' A' ' 15' ' ' LEU . 69.2 mtm180 -114.78 154.63 28.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.079 -1.248 . . . . 1.1499999999999999 110.088 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.697 HG12 HD13 ' B' ' 36' ' ' LEU . 20.9 m -124.85 152.7 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.28000000000000003 109.819 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.914 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.4 t -112.61 134.91 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.23999999999999999 110.637 -175.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.547 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.95 132.11 52.02 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.279 -0.888 . . . . 1.3799999999999999 109.539 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.1 Cg_endo -57.28 141.23 94.6 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.729 1.384 . . . . 0.34999999999999998 109.947 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.925 ' O ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.66 -31.7 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.023 -1.048 . . . . 1.1100000000000001 110.371 -177.56 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.73 -35.33 72.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.071 -1.018 . . . . 2.3700000000000001 109.824 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.548 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 46.7 mt -81.39 -28.22 34.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.282 -0.887 . . . . 1.75 110.394 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.725 HH22 HD11 ' B' ' 15' ' ' LEU . 72.4 mtt180 -56.98 -44.72 82.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.897 -1.127 . . . . 0.29999999999999999 109.092 175.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.466 ' NE ' HD11 ' A' ' 22' ' ' ILE . 98.1 mtt180 -72.14 -47.83 48.05 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.775 -0.77 . . . . 3.2599999999999998 110.839 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.3 m -63.26 -32.19 73.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.158 -0.964 . . . . 0.77000000000000002 111.018 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.879 HD23 HG13 ' A' ' 30' ' ' ILE . 21.3 tp -88.62 -4.71 58.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.1 -1.0 . . . . 1.05 110.734 -177.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.439 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.05 41.81 97.01 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.718 -1.353 . . . . 0.32000000000000001 109.718 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.879 HG13 HD23 ' A' ' 28' ' ' LEU . 32.0 mm -116.48 139.24 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.313 -1.11 . . . . 0.40999999999999998 110.777 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.57 166.12 25.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.677 -0.64 . . . . 0.23000000000000001 109.987 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.24 147.09 10.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.081 -1.012 . . . . 1.1299999999999999 110.492 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 33.1 tttp 74.78 -4.97 2.24 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.77 -0.581 . . . . 1.8799999999999999 111.118 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.731 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.4 m-20 -77.38 166.52 23.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.79 -1.194 . . . . 1.1000000000000001 109.989 174.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.779 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.2 132.81 50.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 0.35999999999999999 110.842 -175.655 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.991 HD11 HG22 ' B' ' 12' ' ' VAL . 13.0 mt -110.11 144.82 38.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.376 -0.828 . . . . 0.56000000000000005 109.509 175.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.646 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.6 tt0 -108.81 139.79 43.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.726 -1.234 . . . . 1.1699999999999999 109.685 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.2 mt -109.04 131.17 60.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.434 -0.791 . . . . 0.83999999999999997 110.56 -172.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.607 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 16.7 m-85 -117.73 157.74 25.98 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 116.296 -0.411 . . . . 0.45000000000000001 110.02 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.403 ' H ' ' HB2' ' B' ' 5' ' ' SER . 80.7 t -131.79 125.17 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.891 -1.131 . . . . 0.27000000000000002 110.571 172.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.498 ' OD1' HG12 ' A' ' 46' ' ' ILE . 43.5 p-10 -147.49 144.84 28.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.106 -0.996 . . . . 1.77 110.768 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 52.8 t0 43.02 44.27 4.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.982 -1.074 . . . . 1.22 111.285 173.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 84.1 tt0 60.87 11.34 3.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.108 -0.995 . . . . 1.9299999999999999 110.679 176.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -111.07 153.53 25.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 2.0099999999999998 110.057 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.831 HG22 HD11 ' A' ' 47' ' ' LEU . 66.0 mt -93.51 128.8 44.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.279 -0.888 . . . . 1.25 109.846 177.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 23.9 mm -112.97 119.55 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.629 -0.669 . . . . 0.5 110.004 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.833 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -117.96 134.79 54.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 1.6599999999999999 110.202 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.514 ' HE2' ' CE1' ' A' ' 39' ' ' TYR . 22.7 pttt -141.28 162.42 35.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.377 -0.827 . . . . 1.74 110.326 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -57.79 147.17 28.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.147 -0.971 . . . . 1.6499999999999999 110.023 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.895 ' CD2' HG11 ' B' ' 9' ' ' VAL . 5.3 t80 -102.8 124.71 48.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.34999999999999998 110.575 -176.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -99.5 122.94 49.94 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.38 -0.825 . . . . 3.21 109.379 172.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -62.13 145.1 96.51 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.742 1.391 . . . . 0.47999999999999998 110.352 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.02 -0.991 . . . . 2.4100000000000001 110.233 -179.659 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.232 0.539 . . . . 11.66 110.238 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 69.0 mtm -134.95 157.55 46.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.289 -0.882 . . . . 8.6999999999999993 110.344 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -131.66 129.98 41.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 9.1699999999999999 109.988 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.403 ' HB2' ' H ' ' A' ' 40' ' ' VAL . 72.3 m -107.59 -100.14 0.36 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 5.2000000000000002 110.444 -177.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 6' ' ' THR . . . . . . . . . . . . . 52.5 p -70.02 -39.59 75.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.939 -1.101 . . . . 2.98 110.317 -176.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' GLY . . . . . 0.57 ' O ' HD13 ' B' ' 8' ' ' ILE . . . 65.56 47.18 80.27 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.495 -1.442 . . . . 0.82999999999999996 109.495 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.57 HD13 ' O ' ' B' ' 7' ' ' GLY . 20.8 mm -115.22 133.63 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.192 -1.181 . . . . 1.3600000000000001 110.222 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 36' ' ' LEU . 99.4 t -115.22 144.51 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.03 -1.044 . . . . 0.37 110.837 -176.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 14.8 tpt180 -130.23 160.51 33.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.573 -0.705 . . . . 1.9199999999999999 109.792 177.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.451 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 66.7 mttm -85.76 148.49 25.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.062 -1.024 . . . . 2.21 110.331 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.991 HG22 HD11 ' A' ' 36' ' ' LEU . 6.4 t -82.11 128.76 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.281 -0.887 . . . . 0.28999999999999998 109.728 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -85.52 -174.6 5.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.55000000000000004 110.217 -179.395 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.465 ' OE1' ' OE2' ' A' ' 32' ' ' GLU . 47.2 tp10 -53.41 -41.86 66.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 2.1899999999999999 111.689 -173.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.9 tp -85.97 -4.93 59.28 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.781 -1.2 . . . . 1.3899999999999999 111.732 -172.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.511 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.88 47.27 7.26 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.439 -1.464 . . . . 0.20999999999999999 109.439 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.914 ' CD ' HG22 ' A' ' 19' ' ' VAL . 69.2 mtm180 -114.94 154.64 28.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.057 -1.26 . . . . 1.1399999999999999 110.043 -177.392 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.712 HG12 HD13 ' A' ' 36' ' ' LEU . 21.0 m -124.93 152.71 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.367 -0.833 . . . . 0.28000000000000003 109.852 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.908 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.4 t -112.62 134.83 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 0.23999999999999999 110.666 -175.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.98 132.1 51.95 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.92 . . . . 1.3799999999999999 109.528 174.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.1 Cg_endo -57.45 141.26 94.97 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.73 1.384 . . . . 0.35999999999999999 109.964 177.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.922 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.9 -31.24 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.982 . . . . 1.1100000000000001 110.367 -177.216 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.83 -35.91 73.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.04 -1.038 . . . . 2.3700000000000001 109.633 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.55 ' HB2' HG23 ' B' ' 20' ' ' ILE . 47.1 mt -80.73 -28.5 36.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.44 -0.788 . . . . 1.75 110.438 176.78 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.659 HH22 HD11 ' A' ' 15' ' ' LEU . 72.1 mtt180 -56.93 -44.59 82.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.876 -1.14 . . . . 0.29999999999999999 109.037 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.471 ' NE ' HD11 ' B' ' 22' ' ' ILE . 98.1 mtt180 -72.1 -48.08 46.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.403 -0.811 . . . . 3.27 110.698 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.3 m -63.0 -32.66 74.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.244 -0.91 . . . . 0.77000000000000002 110.816 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.886 HD23 HG13 ' B' ' 30' ' ' ILE . 21.4 tp -88.12 -5.15 58.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.997 -1.064 . . . . 1.05 110.636 -177.021 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.446 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.44 41.69 96.25 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.519 -1.433 . . . . 0.32000000000000001 109.519 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.886 HG13 HD23 ' B' ' 28' ' ' LEU . 31.7 mm -116.49 139.24 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.14 -1.212 . . . . 0.40999999999999998 110.731 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.34 166.24 25.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.663 -0.648 . . . . 0.23000000000000001 109.948 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.19 147.1 10.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.028 -1.045 . . . . 1.1299999999999999 110.525 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 33.1 tttp 74.76 -5.0 2.22 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.737 -0.602 . . . . 1.8799999999999999 111.132 177.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.629 ' O ' HG23 ' A' ' 12' ' ' VAL . 88.7 m-20 -77.43 166.4 23.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.795 -1.19 . . . . 1.1000000000000001 109.992 174.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.14 132.79 50.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.35999999999999999 110.902 -175.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.942 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.7 mt -110.24 144.54 38.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.355 -0.841 . . . . 0.56000000000000005 109.533 175.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.63 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.4 tt0 -108.44 139.81 42.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.744 -1.223 . . . . 1.1699999999999999 109.832 172.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -109.01 131.26 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.353 -0.842 . . . . 0.83999999999999997 110.42 -172.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 16.5 m-85 -117.82 157.64 26.23 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 120.964 0.411 . . . . 0.45000000000000001 109.97 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 80.9 t -131.59 125.5 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.864 -1.148 . . . . 0.26000000000000001 110.427 172.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.501 ' OD1' HG12 ' B' ' 46' ' ' ILE . 43.4 p-10 -147.88 144.85 28.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 1.77 110.743 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.4 t0 43.02 44.44 4.08 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.059 -1.026 . . . . 1.21 111.237 174.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 84.1 tt0 60.65 11.44 3.1 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.027 -1.046 . . . . 1.9199999999999999 110.613 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -111.09 153.78 25.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.111 -0.993 . . . . 2.0 109.895 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.828 HG22 HD11 ' B' ' 47' ' ' LEU . 65.2 mt -93.69 128.6 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.198 -0.939 . . . . 1.24 109.967 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 23.4 mm -112.95 119.65 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.697 -0.627 . . . . 0.5 109.873 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.829 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.3 mp -117.89 134.68 54.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.007 -1.058 . . . . 1.6599999999999999 110.147 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.509 ' HE2' ' CE1' ' B' ' 39' ' ' TYR . 23.1 pttt -141.16 162.61 35.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.352 -0.843 . . . . 1.74 110.276 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -57.8 147.09 29.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.947 . . . . 1.6499999999999999 109.997 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 1.069 ' CD2' HG11 ' A' ' 9' ' ' VAL . 5.5 t80 -102.91 120.3 40.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.65000000000000002 110.516 -176.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.47 78.07 19.92 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 4.3499999999999996 110.327 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -60.21 144.67 99.48 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.161 1.611 . . . . 3.5800000000000001 110.28 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.004 -0.998 . . . . 5.9699999999999998 110.239 -179.867 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.1 t80 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.268 0.556 . . . . 10.99 110.272 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.6 mtm -104.53 142.02 35.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.283 -0.886 . . . . 8.7599999999999998 110.261 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -49.27 -54.34 17.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.15 -0.969 . . . . 8.8499999999999996 110.643 -176.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.0 p -80.45 161.55 24.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.945 -1.097 . . . . 4.2000000000000002 109.958 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.427 HG21 ' CG2' ' B' ' 40' ' ' VAL . 63.5 p -63.6 -37.32 86.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.112 -0.993 . . . . 3.77 110.051 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.28 45.53 60.76 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.715 -1.354 . . . . 0.82999999999999996 109.715 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 57.9 mt -117.79 132.77 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.142 -1.211 . . . . 1.3600000000000001 109.991 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.929 HG13 ' O ' ' B' ' 36' ' ' LEU . 92.6 t -112.65 143.71 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.975 -1.078 . . . . 0.37 110.782 -176.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 29.7 tpt180 -125.98 157.83 36.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.539 -0.726 . . . . 1.9099999999999999 109.832 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.461 ' HE3' ' HA ' ' B' ' 33' ' ' LYS . 33.2 tttp -82.81 143.82 30.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.915 . . . . 2.21 110.172 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.924 HG22 HD11 ' B' ' 36' ' ' LEU . 15.0 t -80.4 126.93 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.888 . . . . 0.28000000000000003 109.855 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.99 -174.93 5.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.975 . . . . 0.55000000000000004 110.013 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.34 -39.55 73.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.011 -1.056 . . . . 2.1899999999999999 111.689 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.914 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.1 tp -84.67 -6.17 59.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.728 -1.233 . . . . 1.3799999999999999 111.574 -173.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.32 46.69 7.35 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.108 -1.52 . . . . 0.20999999999999999 109.641 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.914 ' HD3' HD23 ' A' ' 15' ' ' LEU . 70.8 mtm180 -114.06 153.99 28.48 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.033 -1.275 . . . . 1.1499999999999999 110.078 -177.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.862 HG12 HD13 ' B' ' 36' ' ' LEU . 20.9 m -124.28 153.39 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.343 -0.848 . . . . 0.28000000000000003 109.789 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.903 HG22 ' CD ' ' B' ' 17' ' ' ARG . 17.0 t -113.42 133.66 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.23999999999999999 110.703 -175.337 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.594 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.42 136.19 43.11 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.163 -0.961 . . . . 1.3799999999999999 109.443 174.27 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.5 Cg_endo -58.56 141.12 97.14 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.702 1.369 . . . . 0.34999999999999998 109.893 176.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.954 ' O ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.89 -31.31 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.94 -1.1 . . . . 1.1100000000000001 110.382 -177.55 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.59 -35.38 72.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.049 -1.032 . . . . 2.3700000000000001 109.854 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.594 ' HB2' HG23 ' A' ' 20' ' ' ILE . 52.8 mt -81.02 -29.46 35.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 1.75 110.455 176.918 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.705 HH22 HD11 ' B' ' 15' ' ' LEU . 73.9 mtt180 -57.13 -44.02 82.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.969 -1.082 . . . . 0.29999999999999999 109.05 175.547 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -72.64 -50.12 27.29 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.539 -0.726 . . . . 3.2599999999999998 110.708 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m -63.56 -31.25 72.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.195 -0.941 . . . . 0.77000000000000002 111.09 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.722 HD23 HG13 ' A' ' 30' ' ' ILE . 18.2 tp -87.59 -4.37 58.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 1.05 110.759 -177.092 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.454 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 67.01 40.94 93.37 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.712 -1.355 . . . . 0.32000000000000001 109.712 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.722 HG13 HD23 ' A' ' 28' ' ' LEU . 31.2 mm -116.51 139.07 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.328 -1.101 . . . . 0.40999999999999998 110.674 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.83 166.53 24.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.529 -0.732 . . . . 0.23000000000000001 110.032 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.524 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.24 146.53 11.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 1.1299999999999999 110.602 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 56.2 tttt 74.7 -4.58 2.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.678 -0.639 . . . . 1.8799999999999999 111.139 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.764 ' O ' HG23 ' B' ' 12' ' ' VAL . 87.3 m-20 -76.75 168.09 20.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.189 . . . . 1.1000000000000001 110.034 174.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.681 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -106.23 131.69 53.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.35999999999999999 110.726 -175.818 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.925 ' O ' HG13 ' B' ' 9' ' ' VAL . 13.0 mt -109.04 144.55 36.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.425 -0.797 . . . . 0.56000000000000005 109.457 175.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.567 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.0 tt0 -109.65 138.67 45.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.74 -1.225 . . . . 1.1699999999999999 109.491 172.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.51 133.33 55.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.336 -0.853 . . . . 0.83999999999999997 110.607 -171.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.596 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 9.5 m-85 -118.3 161.48 19.86 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.905 -0.405 . . . . 0.45000000000000001 109.905 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.572 HG21 HG21 ' B' ' 6' ' ' THR . 77.4 t -133.8 120.53 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.854 -1.154 . . . . 0.27000000000000002 110.599 172.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 45.4 p-10 -148.25 160.99 42.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 1.77 110.55 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 53.0 t0 42.21 39.51 1.44 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.009 -1.057 . . . . 1.22 111.493 172.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 84.2 tt0 59.05 14.07 3.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.898 -1.127 . . . . 1.9299999999999999 110.567 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.558 ' CE ' HD11 ' A' ' 46' ' ' ILE . 11.2 pttt -127.66 166.25 18.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.147 -0.971 . . . . 2.0099999999999998 109.696 174.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.68 HG22 HD11 ' A' ' 47' ' ' LEU . 66.8 mt -97.95 134.37 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 1.25 110.388 -175.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.596 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 20.3 mm -113.95 120.13 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.643 -0.661 . . . . 0.5 109.959 178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.838 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.5 mp -115.83 135.63 53.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.965 -1.085 . . . . 1.6599999999999999 110.227 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.577 ' HE3' ' CD1' ' A' ' 39' ' ' TYR . 13.5 ptpt -141.28 158.64 43.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 1.74 110.368 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -58.42 146.75 33.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 1.6499999999999999 109.934 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.681 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 8.5 t80 -104.05 119.6 39.28 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.318 -0.864 . . . . 0.34999999999999998 110.602 -175.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -100.32 122.61 49.44 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.618 -0.677 . . . . 3.21 109.383 173.481 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 17.2 Cg_exo -62.28 145.44 96.03 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.723 1.381 . . . . 0.47999999999999998 110.207 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.018 -0.991 . . . . 2.4100000000000001 110.163 179.79 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 66.1 t80 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.148 0.499 . . . . 11.66 110.153 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 88.3 mtp -45.81 -41.58 11.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.218 -0.926 . . . . 8.6999999999999993 111.03 -175.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -78.1 132.48 37.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.745 -1.222 . . . . 9.1699999999999999 110.192 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 55.8 p -69.52 165.03 21.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 5.2000000000000002 110.107 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.572 HG21 HG21 ' A' ' 40' ' ' VAL . 64.4 p -57.9 -37.27 73.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 2.98 109.984 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.4 45.53 60.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.609 -1.396 . . . . 0.82999999999999996 109.609 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 58.6 mt -117.67 132.73 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.144 -1.21 . . . . 1.3600000000000001 109.964 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.925 HG13 ' O ' ' A' ' 36' ' ' LEU . 92.7 t -112.74 143.68 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.07 -1.019 . . . . 0.37 110.789 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -125.96 157.69 37.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.463 -0.773 . . . . 1.9199999999999999 109.912 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -82.78 143.67 30.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 2.21 110.173 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.914 HG22 HD11 ' A' ' 36' ' ' LEU . 15.1 t -80.23 127.08 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 0.28999999999999998 109.78 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -86.15 -174.79 5.25 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.082 -1.011 . . . . 0.55000000000000004 110.14 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.479 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.8 mt-10 -56.46 -39.51 73.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.017 -1.052 . . . . 2.1899999999999999 111.609 -172.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.901 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.7 tp -84.69 -6.21 59.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.733 -1.229 . . . . 1.3899999999999999 111.599 -173.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.88 47.65 7.03 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.474 -1.45 . . . . 0.20999999999999999 109.474 -177.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.903 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.6 mtm180 -114.39 154.05 28.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.037 -1.272 . . . . 1.1399999999999999 109.974 -177.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.858 HG12 HD13 ' A' ' 36' ' ' LEU . 20.6 m -124.35 153.49 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.28000000000000003 109.864 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.907 HG22 ' CD ' ' A' ' 17' ' ' ARG . 16.9 t -113.53 133.68 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.23999999999999999 110.672 -175.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.594 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -83.41 136.21 43.13 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.201 -0.937 . . . . 1.3799999999999999 109.475 174.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.542 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.4 Cg_endo -58.74 141.01 97.38 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.716 1.377 . . . . 0.35999999999999999 109.896 176.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.954 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -56.03 -31.01 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 1.1100000000000001 110.415 -177.268 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.56 -35.96 73.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.994 -1.066 . . . . 2.3700000000000001 109.714 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.594 ' HB2' HG23 ' B' ' 20' ' ' ILE . 52.6 mt -80.32 -29.83 38.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.416 -0.802 . . . . 1.75 110.435 176.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.647 HH22 HD11 ' A' ' 15' ' ' LEU . 73.3 mtt180 -56.98 -44.0 82.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.903 -1.123 . . . . 0.29999999999999999 109.036 175.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -72.4 -50.44 26.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 3.27 110.715 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 55.5 m -63.29 -31.78 73.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.33 -0.856 . . . . 0.77000000000000002 110.878 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.722 HD23 HG13 ' B' ' 30' ' ' ILE . 18.3 tp -87.16 -4.57 59.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.007 -1.058 . . . . 1.05 110.71 -176.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.459 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 67.34 40.73 91.81 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.597 -1.401 . . . . 0.32000000000000001 109.597 178.631 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.722 HG13 HD23 ' B' ' 28' ' ' LEU . 30.6 mm -116.53 139.05 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -1.175 . . . . 0.40999999999999998 110.586 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.62 166.53 24.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.545 -0.722 . . . . 0.23000000000000001 110.06 -177.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.33 146.64 11.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.944 . . . . 1.1299999999999999 110.511 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 56.1 tttt 74.71 -4.69 2.29 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.592 -0.693 . . . . 1.8799999999999999 111.264 177.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.698 ' O ' HG23 ' A' ' 12' ' ' VAL . 87.7 m-20 -76.75 167.74 21.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.8 -1.187 . . . . 1.1000000000000001 110.021 174.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.691 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.94 131.67 52.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 0.35999999999999999 110.856 -175.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.929 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.8 mt -109.03 144.26 37.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.858 . . . . 0.56000000000000005 109.626 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.55 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.7 tt0 -109.27 138.69 45.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.759 -1.213 . . . . 1.1699999999999999 109.734 172.229 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.3 mt -109.5 133.38 54.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.336 -0.853 . . . . 0.83999999999999997 110.531 -171.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.622 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 9.3 m-85 -118.33 161.31 20.15 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.954 -0.387 . . . . 0.45000000000000001 109.954 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.427 ' CG2' HG21 ' A' ' 6' ' ' THR . 78.9 t -133.5 121.01 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.861 -1.15 . . . . 0.26000000000000001 110.473 172.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 45.3 p-10 -148.86 160.95 42.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.98 . . . . 1.77 110.49 178.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.4 t0 41.99 39.82 1.42 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.204 -0.935 . . . . 1.21 111.481 172.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' B' ' 43' ' ' GLU . 84.2 tt0 58.89 14.04 3.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.91 -1.119 . . . . 1.9199999999999999 110.528 174.915 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.56 ' CE ' HD11 ' B' ' 46' ' ' ILE . 11.2 pttt -127.55 166.41 18.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 2.0 109.699 174.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.681 HG22 HD11 ' B' ' 47' ' ' LEU . 66.7 mt -98.09 134.32 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 1.24 110.399 -175.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 20.7 mm -113.94 120.09 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.683 -0.636 . . . . 0.5 109.975 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.83 ' CD1' HD13 ' A' ' 47' ' ' LEU . 4.6 mp -115.76 135.5 53.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.069 -1.019 . . . . 1.6599999999999999 110.192 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.574 ' HE3' ' CD1' ' B' ' 39' ' ' TYR . 13.5 ptpt -141.14 158.88 43.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.375 -0.828 . . . . 1.74 110.295 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -58.54 146.75 34.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.213 -0.929 . . . . 1.6499999999999999 109.908 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.771 ' CD2' HG11 ' A' ' 9' ' ' VAL . 8.8 t80 -104.25 119.34 38.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.65000000000000002 110.69 -175.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -109.08 77.1 0.81 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 4.3499999999999996 110.315 176.186 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -61.21 147.14 96.42 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.082 1.569 . . . . 3.5800000000000001 110.431 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.998 -1.001 . . . . 5.9699999999999998 110.21 179.693 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.201 0.524 . . . . 10.99 110.223 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.8 mtt -107.39 147.13 30.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 8.7599999999999998 110.234 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -94.1 148.29 22.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.211 -0.93 . . . . 8.8499999999999996 110.28 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.5 p -122.53 159.04 28.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -0.866 . . . . 4.2000000000000002 110.107 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.547 HG21 ' CG2' ' B' ' 40' ' ' VAL . 56.7 p -60.86 -38.25 84.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.25 -0.906 . . . . 3.77 110.003 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.72 45.4 84.59 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.697 -1.361 . . . . 0.82999999999999996 109.697 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.6 mt -117.81 133.95 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.128 -1.219 . . . . 1.3600000000000001 110.085 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.967 HG11 ' CD2' ' B' ' 50' ' ' TYR . 90.7 t -117.41 144.49 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.056 -1.027 . . . . 0.37 110.82 -176.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.417 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 23.9 tpt180 -129.77 158.95 38.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -0.793 . . . . 1.9099999999999999 109.798 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.417 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 35.5 ttpt -82.71 145.52 29.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.127 -0.983 . . . . 2.21 110.335 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.916 HG22 HD11 ' B' ' 36' ' ' LEU . 3.7 t -81.76 128.69 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.385 -0.822 . . . . 0.28000000000000003 109.807 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.55 -177.29 6.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.072 -1.017 . . . . 0.55000000000000004 109.997 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.99 -40.5 73.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.049 -1.032 . . . . 2.1899999999999999 111.539 -174.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.57 ' O ' ' CD1' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -76.83 -13.81 59.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.873 -1.142 . . . . 1.3799999999999999 110.542 -174.458 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.81 46.66 5.9 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.401 -1.479 . . . . 0.20999999999999999 109.401 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.893 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.5 mtm180 -114.41 155.04 27.06 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.024 -1.28 . . . . 1.1499999999999999 110.095 -176.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.952 HG12 HD13 ' B' ' 36' ' ' LEU . 13.1 m -122.91 152.46 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.318 -0.864 . . . . 0.28000000000000003 109.769 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.889 HG22 ' CD ' ' B' ' 17' ' ' ARG . 15.0 t -112.8 134.08 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.23999999999999999 110.659 -174.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.552 HD11 ' CG2' ' B' ' 45' ' ' ILE . 2.5 mm -84.3 137.24 39.68 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 1.3799999999999999 109.367 174.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.55 ' HG2' HD12 ' A' ' 24' ' ' LEU . 9.8 Cg_endo -58.63 140.77 96.24 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.718 1.378 . . . . 0.34999999999999998 109.785 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.954 ' O ' HD13 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.63 -32.21 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.862 -1.149 . . . . 1.1100000000000001 110.313 -177.679 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -58.73 -35.27 72.42 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.16 -0.962 . . . . 2.3700000000000001 109.763 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.55 HD12 ' HG2' ' A' ' 21' ' ' PRO . 41.3 mt -82.65 -27.62 31.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 1.75 110.517 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.523 ' CG ' ' HA ' ' A' ' 22' ' ' ILE . 71.2 mtt180 -56.85 -44.51 82.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.798 -1.189 . . . . 0.29999999999999999 108.84 175.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.463 ' HE ' HD11 ' A' ' 22' ' ' ILE . 31.5 mmt180 -72.77 -47.81 43.59 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.938 -0.705 . . . . 3.2599999999999998 110.657 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.4 m -63.69 -31.32 72.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.191 -0.943 . . . . 0.77000000000000002 111.069 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.84 HD23 HG13 ' A' ' 30' ' ' ILE . 20.9 tp -87.39 -4.65 59.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 1.05 110.683 -177.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 66.05 41.49 95.11 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.662 -1.375 . . . . 0.32000000000000001 109.662 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.84 HG13 HD23 ' A' ' 28' ' ' LEU . 33.3 mm -116.43 138.79 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.344 -1.092 . . . . 0.40999999999999998 110.675 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.64 166.07 25.76 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.55 -0.719 . . . . 0.23000000000000001 109.981 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.73 146.51 13.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.094 -1.004 . . . . 1.1299999999999999 110.533 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 43.5 tttm 75.02 -4.63 2.34 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.744 -0.598 . . . . 1.8799999999999999 111.068 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.743 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.9 m-20 -77.21 167.19 22.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.73 -1.231 . . . . 1.1000000000000001 110.05 174.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.718 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.49 130.74 53.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.35999999999999999 110.744 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.969 HD13 HG12 ' B' ' 18' ' ' VAL . 13.4 mt -107.58 143.9 35.36 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.336 -0.852 . . . . 0.56000000000000005 109.388 175.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.647 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.3 tt0 -108.77 139.22 43.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.809 -1.182 . . . . 1.1699999999999999 109.694 172.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.3 mt -109.84 133.1 56.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.425 -0.797 . . . . 0.83999999999999997 110.541 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.622 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 17.2 m-85 -119.45 158.85 25.38 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 116.262 -0.426 . . . . 0.45000000000000001 109.894 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.68 ' CG2' HG21 ' B' ' 6' ' ' THR . 85.3 t -132.01 123.32 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.833 -1.167 . . . . 0.27000000000000002 110.66 173.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.502 ' OD1' HG12 ' A' ' 46' ' ' ILE . 47.8 p-10 -147.69 149.12 31.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 1.77 110.632 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 52.7 t0 42.95 44.64 4.07 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.001 -1.062 . . . . 1.22 111.256 173.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 75.6 mm-40 57.67 14.55 2.45 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.053 -1.03 . . . . 1.9299999999999999 110.567 176.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -115.84 153.94 30.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 2.0099999999999998 109.955 175.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.901 HG22 HD11 ' A' ' 47' ' ' LEU . 67.7 mt -92.92 129.05 44.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.253 -0.904 . . . . 1.25 109.954 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.0 mm -111.91 119.36 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.561 -0.712 . . . . 0.5 109.907 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.901 HD11 HG22 ' A' ' 45' ' ' ILE . 4.2 mp -118.81 134.36 55.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.924 -1.11 . . . . 1.6599999999999999 110.281 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.556 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 12.1 pttp -141.99 163.69 32.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.451 -0.781 . . . . 1.74 110.478 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -59.26 147.02 37.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 1.6499999999999999 110.14 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.799 ' CD2' HG11 ' B' ' 9' ' ' VAL . 10.3 t80 -105.32 118.82 37.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.34999999999999998 110.67 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 8.3 tttp -99.45 123.12 49.39 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 3.21 109.447 171.45 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 51' ' ' LYS . 12.3 Cg_endo -60.85 144.27 99.53 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.764 1.402 . . . . 0.47999999999999998 110.418 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.2 t30 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.023 -0.989 . . . . 2.4100000000000001 110.223 -179.954 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.187 0.518 . . . . 11.66 110.207 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 71.1 mtm -46.73 -42.24 16.42 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.164 -0.96 . . . . 8.6999999999999993 111.103 -175.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 4' ' ' LYS . . . . . 0.465 ' HD2' ' OH ' ' A' ' 39' ' ' TYR . 25.1 mmtm -96.86 142.07 29.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.802 -1.186 . . . . 9.1699999999999999 110.129 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.405 ' CB ' ' H ' ' A' ' 40' ' ' VAL . 25.8 t -66.29 -99.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 5.2000000000000002 110.245 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.68 HG21 ' CG2' ' A' ' 40' ' ' VAL . 56.2 p -75.35 -38.35 60.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.948 -1.095 . . . . 2.98 109.995 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.65 45.6 83.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.636 -1.386 . . . . 0.82999999999999996 109.636 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.4 mt -117.84 133.82 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.15 -1.206 . . . . 1.3600000000000001 110.08 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 36' ' ' LEU . 89.4 t -117.34 144.45 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.009 -1.057 . . . . 0.37 110.804 -176.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 24.0 tpt180 -129.75 158.85 38.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.545 -0.722 . . . . 1.9199999999999999 109.907 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.421 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 35.5 ttpt -82.72 145.38 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.059 -1.026 . . . . 2.21 110.4 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.921 HG22 ' CD1' ' A' ' 36' ' ' LEU . 3.7 t -81.67 128.79 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.256 -0.903 . . . . 0.28999999999999998 109.704 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.76 -177.4 6.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.093 -1.005 . . . . 0.55000000000000004 110.073 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.97 -40.41 73.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.073 -1.017 . . . . 2.1899999999999999 111.489 -173.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.567 ' O ' ' CD1' ' B' ' 15' ' ' LEU . 0.1 OUTLIER -76.49 -14.26 60.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.894 -1.129 . . . . 1.3899999999999999 110.647 -174.69 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.63 47.32 5.69 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.319 -1.512 . . . . 0.20999999999999999 109.319 -177.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.889 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.5 mtm180 -114.61 154.95 27.44 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.155 -1.203 . . . . 1.1399999999999999 110.058 -176.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.969 HG12 HD13 ' A' ' 36' ' ' LEU . 13.2 m -122.93 152.48 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.28000000000000003 109.74 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.893 HG22 ' CD ' ' A' ' 17' ' ' ARG . 14.9 t -112.84 134.1 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.23999999999999999 110.678 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.589 HD11 ' CG2' ' A' ' 45' ' ' ILE . 2.5 mm -84.29 137.21 39.72 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.924 . . . . 1.3799999999999999 109.388 174.259 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.57 ' HG2' HD12 ' B' ' 24' ' ' LEU . 9.8 Cg_endo -58.74 140.77 96.39 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.656 1.345 . . . . 0.35999999999999999 109.837 176.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.941 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.78 -31.99 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.998 -1.064 . . . . 1.1100000000000001 110.294 -177.374 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -58.74 -35.85 73.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.024 -1.047 . . . . 2.3700000000000001 109.609 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.57 HD12 ' HG2' ' B' ' 21' ' ' PRO . 41.8 mt -81.89 -28.01 33.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.431 -0.793 . . . . 1.75 110.566 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.534 ' CG ' ' HA ' ' B' ' 22' ' ' ILE . 70.7 mtt180 -56.78 -44.27 81.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.901 -1.124 . . . . 0.29999999999999999 108.957 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 26' ' ' ARG . . . . . 0.467 ' HE ' HD11 ' B' ' 22' ' ' ILE . 31.4 mmt180 -72.74 -47.96 42.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.484 -0.76 . . . . 3.27 110.642 -178.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.3 m -63.45 -31.96 73.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.226 -0.921 . . . . 0.77000000000000002 110.84 -177.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.845 HD23 HG13 ' B' ' 30' ' ' ILE . 21.0 tp -86.83 -4.99 59.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.132 -0.98 . . . . 1.05 110.66 -177.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.419 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.48 41.17 94.41 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.603 -1.399 . . . . 0.32000000000000001 109.603 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.845 HG13 HD23 ' B' ' 28' ' ' LEU . 32.6 mm -116.34 138.65 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -1.199 . . . . 0.40999999999999998 110.667 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.33 166.24 25.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.633 -0.667 . . . . 0.23000000000000001 110.001 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.4 tt0 -53.74 146.6 13.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 1.1299999999999999 110.475 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 43.6 tttm 75.07 -4.87 2.28 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.621 -0.675 . . . . 1.8799999999999999 111.169 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.1 m-20 -77.37 166.99 22.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.91 -1.119 . . . . 1.1000000000000001 110.041 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.722 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.27 130.78 53.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 0.35999999999999999 110.816 -176.629 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.952 HD13 HG12 ' A' ' 18' ' ' VAL . 13.1 mt -107.7 143.56 36.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.375 -0.828 . . . . 0.56000000000000005 109.495 175.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.625 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.2 tt0 -108.43 139.18 43.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.932 -1.105 . . . . 1.1699999999999999 109.85 172.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.5 mt -109.85 133.01 56.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.39 -0.819 . . . . 0.83999999999999997 110.489 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.631 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 17.1 m-85 -119.43 158.85 25.37 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 116.244 -0.435 . . . . 0.45000000000000001 109.94 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.547 ' CG2' HG21 ' A' ' 6' ' ' THR . 86.5 t -131.82 123.65 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.863 -1.148 . . . . 0.26000000000000001 110.515 173.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.5 ' OD1' HG12 ' B' ' 46' ' ' ILE . 47.9 p-10 -148.18 149.14 31.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 1.77 110.613 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.459 ' O ' ' OD1' ' B' ' 42' ' ' ASP . 53.2 t0 42.83 44.94 4.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.101 -0.999 . . . . 1.21 111.188 174.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 75.6 mm-40 57.42 14.65 2.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.071 -1.018 . . . . 1.9199999999999999 110.562 176.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -115.87 154.18 30.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 2.0 109.896 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.894 HG22 HD11 ' B' ' 47' ' ' LEU . 67.6 mt -93.07 128.84 44.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.187 -0.946 . . . . 1.24 109.945 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 21.0 mm -111.93 119.51 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.572 -0.705 . . . . 0.5 109.946 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.894 HD11 HG22 ' B' ' 45' ' ' ILE . 4.4 mp -118.78 134.23 55.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.892 -1.13 . . . . 1.6599999999999999 110.15 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.563 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 12.3 pttp -141.85 163.89 31.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 1.74 110.371 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -59.24 146.91 37.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.135 -0.978 . . . . 1.6499999999999999 110.1 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.967 ' CD2' HG11 ' A' ' 9' ' ' VAL . 10.5 t80 -105.35 112.15 25.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.65000000000000002 110.542 -176.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 14.5 pttt -130.01 76.3 78.28 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.173 -0.954 . . . . 4.3499999999999996 110.303 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.423 ' HD3' ' CD1' ' B' ' 50' ' ' TYR . 11.7 Cg_endo -60.4 145.05 99.44 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.989 1.521 . . . . 3.5800000000000001 110.321 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.001 -1.0 . . . . 5.9699999999999998 110.226 -179.986 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.219 0.533 . . . . 10.99 110.196 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.4 mtm -114.49 149.96 35.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.31 -0.869 . . . . 8.7599999999999998 110.15 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.1 pttm -133.23 169.02 17.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 8.8499999999999996 110.245 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.1 m -117.41 151.89 36.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.897 . . . . 4.2000000000000002 110.023 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 81.1 p -60.97 -36.38 79.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 3.77 110.02 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 8' ' ' ILE . . . 71.05 46.23 45.37 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.814 -1.315 . . . . 0.82999999999999996 109.814 176.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 7' ' ' GLY . 18.5 mm -113.48 131.57 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.165 -1.197 . . . . 1.3600000000000001 109.811 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.07 HG11 ' CD2' ' B' ' 50' ' ' TYR . 85.7 t -118.84 144.75 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.969 -1.082 . . . . 0.37 110.904 -174.615 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -129.94 159.26 37.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.455 -0.778 . . . . 1.9099999999999999 109.83 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -82.87 146.03 29.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 2.21 110.265 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.924 HG22 HD11 ' B' ' 36' ' ' LEU . 3.4 t -80.42 129.28 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.357 -0.839 . . . . 0.28000000000000003 109.866 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.84 -175.35 5.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.179 -0.951 . . . . 0.55000000000000004 110.039 179.337 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -54.56 -40.82 69.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.069 -1.019 . . . . 2.1899999999999999 111.788 -173.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.884 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.9 tp -84.99 -5.41 59.35 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.758 -1.214 . . . . 1.3799999999999999 111.595 -173.168 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.526 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.44 46.52 7.38 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 119.178 -1.486 . . . . 0.20999999999999999 109.687 -177.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.917 ' CD ' HG22 ' B' ' 19' ' ' VAL . 71.1 mtm180 -114.83 154.51 28.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.031 -1.276 . . . . 1.1499999999999999 110.004 -177.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.838 HG21 ' CD2' ' B' ' 47' ' ' LEU . 18.8 m -124.47 153.15 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.28000000000000003 109.809 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.928 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.4 t -111.19 135.38 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.23999999999999999 110.569 -176.007 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.599 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.69 134.6 47.18 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 1.3799999999999999 109.524 175.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.542 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.3 Cg_endo -58.27 143.45 97.19 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.756 1.398 . . . . 0.34999999999999998 110.092 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.892 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.28 -31.81 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.934 -1.104 . . . . 1.1100000000000001 110.416 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.42 -34.95 73.11 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.15 -0.969 . . . . 2.3700000000000001 109.907 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.599 ' HB2' HG23 ' A' ' 20' ' ' ILE . 61.5 mt -81.96 -30.66 31.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.326 -0.858 . . . . 1.75 110.589 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.892 ' HD2' HD12 ' A' ' 22' ' ' ILE . 73.7 mtt180 -57.69 -43.92 85.45 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.044 -1.062 . . . . 0.29999999999999999 109.212 175.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -72.5 -50.51 25.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.559 -0.713 . . . . 3.2599999999999998 110.706 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.0 m -63.7 -31.21 72.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.144 -0.972 . . . . 0.77000000000000002 111.086 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.916 HD23 HG13 ' A' ' 30' ' ' ILE . 22.9 tp -87.56 -4.78 58.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.088 -1.007 . . . . 1.05 110.698 -177.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.442 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.72 43.47 96.26 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.614 -1.395 . . . . 0.32000000000000001 109.614 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.916 HG13 HD23 ' A' ' 28' ' ' LEU . 30.8 mm -115.69 139.08 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.272 -1.134 . . . . 0.40999999999999998 110.65 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -140.81 167.49 22.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.555 -0.716 . . . . 0.23000000000000001 110.003 -178.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 83.4 tt0 -52.48 150.44 4.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 1.1299999999999999 110.468 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.604 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 39.9 mttp 67.01 -2.97 1.02 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 112.294 0.479 . . . . 1.8799999999999999 112.294 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.77 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.3 m-20 -75.55 166.89 22.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.526 -1.359 . . . . 1.1000000000000001 109.922 173.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.79 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -103.83 130.23 51.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.35999999999999999 110.769 -175.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.934 ' O ' HG13 ' B' ' 9' ' ' VAL . 13.7 mt -108.3 140.67 41.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.56000000000000005 109.49 175.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.745 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.1 tt0 -105.4 140.1 39.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.834 -1.166 . . . . 1.1699999999999999 109.731 173.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.2 mt -111.49 133.88 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.44 -0.788 . . . . 0.83999999999999997 110.478 -173.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.58 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 8.6 m-85 -115.2 160.4 19.77 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 120.904 0.383 . . . . 0.45000000000000001 110.09 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.538 ' HB ' HG23 ' B' ' 6' ' ' THR . 94.0 t -133.58 123.13 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.132 -0.98 . . . . 0.27000000000000002 110.857 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.609 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.1 p-10 -147.3 141.61 26.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 1.77 110.22 177.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 53.4 t0 43.47 47.86 6.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.074 -1.016 . . . . 1.22 111.096 174.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.7 mt-10 58.74 13.77 2.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.186 -0.946 . . . . 1.9299999999999999 110.711 176.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -114.52 148.19 38.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 2.0099999999999998 110.07 175.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.586 HD13 HG13 ' B' ' 20' ' ' ILE . 61.2 mt -99.6 127.6 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 1.25 110.095 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.609 HD11 ' OD2' ' A' ' 41' ' ' ASP . 34.2 mt -111.87 118.15 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.331 -0.856 . . . . 0.5 110.275 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.94 ' CD2' HG21 ' B' ' 18' ' ' VAL . 4.2 mp -107.95 135.59 49.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 1.6599999999999999 110.122 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.575 ' HE3' ' CD1' ' A' ' 39' ' ' TYR . 16.2 ptpt -142.45 164.22 30.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.516 -0.74 . . . . 1.74 110.125 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -55.77 147.95 17.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.116 -0.99 . . . . 1.6499999999999999 109.721 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.924 ' CD2' HG11 ' B' ' 9' ' ' VAL . 1.7 t80 -100.56 123.68 45.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.34999999999999998 110.644 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.08 123.25 49.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.357 -0.839 . . . . 3.21 109.753 175.565 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 53' ' ' ASN . 24.2 Cg_exo -58.63 145.26 96.08 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.799 1.421 . . . . 0.47999999999999998 110.292 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 52' ' ' PRO . 84.7 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.939 -1.029 . . . . 2.4100000000000001 110.223 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' PHE . . . . . 0.508 ' CE2' ' OD2' ' A' ' 41' ' ' ASP . 97.8 m-85 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.203 0.525 . . . . 11.66 110.267 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 94.9 mmm -48.87 -40.5 29.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.18 -0.95 . . . . 8.6999999999999993 111.424 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -91.51 135.09 34.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.757 -1.214 . . . . 9.1699999999999999 110.46 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 27.9 t -149.96 152.61 35.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.329 -0.857 . . . . 5.2000000000000002 110.007 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.538 HG23 ' HB ' ' A' ' 40' ' ' VAL . 80.9 p -61.28 -36.42 80.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.141 -0.974 . . . . 2.98 110.059 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' GLY . . . . . 0.524 ' O ' HD13 ' B' ' 8' ' ' ILE . . . 70.78 46.58 45.15 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.786 -1.326 . . . . 0.82999999999999996 109.786 176.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.524 HD13 ' O ' ' B' ' 7' ' ' GLY . 18.5 mm -113.53 131.41 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.133 -1.216 . . . . 1.3600000000000001 109.879 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.934 HG13 ' O ' ' A' ' 36' ' ' LEU . 86.3 t -118.81 144.69 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.005 -1.059 . . . . 0.37 110.935 -174.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -129.93 159.08 37.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.468 -0.77 . . . . 1.9199999999999999 109.924 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -82.84 145.93 29.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 2.21 110.395 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.927 HG22 ' CD1' ' A' ' 36' ' ' LEU . 3.4 t -80.26 129.46 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.917 . . . . 0.28999999999999998 109.756 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.09 -175.29 5.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.122 -0.986 . . . . 0.55000000000000004 110.069 179.154 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.67 -40.78 69.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.177 -0.952 . . . . 2.1899999999999999 111.678 -173.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.904 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.2 tp -85.04 -5.43 59.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.764 -1.21 . . . . 1.3899999999999999 111.572 -173.144 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.531 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.11 47.24 7.15 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.523 -1.431 . . . . 0.20999999999999999 109.523 -177.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.928 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.9 mtm180 -115.06 154.49 28.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.05 -1.265 . . . . 1.1399999999999999 109.932 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.94 HG21 ' CD2' ' A' ' 47' ' ' LEU . 18.8 m -124.49 153.07 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.28000000000000003 109.822 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.917 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.4 t -111.23 135.3 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -0.956 . . . . 0.23999999999999999 110.605 -175.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.603 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.62 134.52 47.52 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.26 -0.9 . . . . 1.3799999999999999 109.545 175.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.541 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.3 Cg_endo -58.28 143.4 97.29 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.851 1.448 . . . . 0.35999999999999999 110.111 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.888 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.36 -31.66 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.098 -1.001 . . . . 1.1100000000000001 110.408 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.26 -35.63 74.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.121 -0.987 . . . . 2.3700000000000001 109.808 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.603 ' HB2' HG23 ' B' ' 20' ' ' ILE . 62.2 mt -81.23 -30.96 34.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.386 -0.822 . . . . 1.75 110.619 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.888 ' HD2' HD12 ' B' ' 22' ' ' ILE . 73.2 mtt180 -57.57 -43.86 84.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.883 -1.135 . . . . 0.29999999999999999 109.208 176.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -72.45 -50.81 23.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 3.27 110.599 -177.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.7 m -63.35 -31.8 73.05 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.77000000000000002 110.88 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.915 HD23 HG13 ' B' ' 30' ' ' ILE . 23.1 tp -87.0 -5.21 59.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.042 -1.036 . . . . 1.05 110.651 -176.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.445 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.01 43.25 96.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.55 -1.42 . . . . 0.32000000000000001 109.55 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.915 HG13 HD23 ' B' ' 28' ' ' LEU . 30.5 mm -115.53 138.97 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.213 -1.169 . . . . 0.40999999999999998 110.727 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -140.6 167.64 21.69 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.676 -0.64 . . . . 0.23000000000000001 110.003 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' B' ' 33' ' ' LYS . 83.5 tt0 -52.59 150.69 4.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 1.1299999999999999 110.454 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' B' ' 32' ' ' GLU . 40.5 mttp 66.52 -2.51 1.03 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 112.4 0.518 . . . . 1.8799999999999999 112.4 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.654 ' O ' HG23 ' A' ' 12' ' ' VAL . 88.5 m-20 -75.86 166.78 23.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.599 -1.313 . . . . 1.1000000000000001 109.895 173.492 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.762 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.64 130.14 51.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -0.91 . . . . 0.35999999999999999 110.807 -175.763 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.937 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.6 mt -108.28 140.5 41.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.866 . . . . 0.56000000000000005 109.513 175.065 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.722 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.8 tt0 -105.24 139.98 39.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.827 -1.171 . . . . 1.1699999999999999 109.86 173.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 71.4 mt -111.41 133.99 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.362 -0.836 . . . . 0.83999999999999997 110.455 -173.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.578 ' CD1' ' HE3' ' B' ' 48' ' ' LYS . 8.5 m-85 -115.2 160.38 19.8 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 120.972 0.415 . . . . 0.45000000000000001 110.18 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 94.3 t -133.31 123.45 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.922 -1.112 . . . . 0.26000000000000001 110.686 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.612 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.1 p-10 -147.69 141.55 25.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 1.77 110.197 176.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 54.1 t0 43.56 48.0 6.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.098 -1.001 . . . . 1.21 111.045 174.642 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.7 mt-10 58.55 13.85 2.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.132 -0.98 . . . . 1.9199999999999999 110.666 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -114.44 148.39 37.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 2.0 110.007 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.459 HD13 ' CG1' ' A' ' 20' ' ' ILE . 60.9 mt -99.71 127.61 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.909 . . . . 1.24 110.145 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.612 HD11 ' OD2' ' B' ' 41' ' ' ASP . 35.5 mt -112.03 118.16 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.428 -0.795 . . . . 0.5 110.216 178.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.838 ' CD2' HG21 ' A' ' 18' ' ' VAL . 4.3 mp -107.83 135.48 49.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 1.6599999999999999 110.009 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.578 ' HE3' ' CD1' ' B' ' 39' ' ' TYR . 16.2 ptpt -142.29 164.28 30.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.517 -0.739 . . . . 1.74 110.153 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -55.83 147.84 18.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.083 -1.011 . . . . 1.6499999999999999 109.764 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 1.07 ' CD2' HG11 ' A' ' 9' ' ' VAL . 1.7 t80 -100.53 120.07 39.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.65000000000000002 110.616 -175.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 51' ' ' LYS . . . . . 0.549 ' CB ' ' HD3' ' B' ' 52' ' ' PRO . 0.1 OUTLIER -100.44 -54.81 0.16 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 4.3499999999999996 110.885 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.582 ' O ' ' CZ ' ' B' ' 50' ' ' TYR . 38.0 Cg_exo -54.87 154.7 20.41 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.54 1.284 . . . . 3.5800000000000001 110.501 -178.107 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.037 -0.982 . . . . 5.9699999999999998 110.21 -178.425 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.269 0.557 . . . . 10.99 110.246 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.457 ' O ' ' OE1' ' A' ' 23' ' ' GLU . 69.8 mtm -126.77 161.54 27.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 8.7599999999999998 110.222 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -91.36 150.25 21.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 8.8499999999999996 110.196 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.904 ' O ' HG23 ' A' ' 6' ' ' THR . 28.4 t -87.08 135.62 33.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 4.2000000000000002 110.011 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.904 HG23 ' O ' ' A' ' 5' ' ' SER . 0.7 OUTLIER -171.0 62.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.436 -0.79 . . . . 3.77 110.121 -178.268 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.51 49.61 5.72 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.267 -1.444 . . . . 0.82999999999999996 109.991 178.658 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.4 mt -96.83 133.24 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.011 -1.288 . . . . 1.3600000000000001 109.633 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.91 HG13 ' O ' ' B' ' 36' ' ' LEU . 78.5 t -113.14 144.52 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.815 -1.178 . . . . 0.37 111.347 -170.404 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.444 ' NH1' ' HG2' ' A' ' 10' ' ' ARG . 57.4 ttp85 -129.19 167.08 18.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.536 -0.727 . . . . 1.9099999999999999 109.455 175.057 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -84.42 146.45 27.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.02 -1.05 . . . . 2.21 110.443 -178.233 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.907 HG22 ' CD1' ' B' ' 36' ' ' LEU . 3.9 t -82.47 131.8 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -0.839 . . . . 0.28000000000000003 109.758 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.46 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.14 -175.55 5.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.55000000000000004 110.058 -179.038 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.424 ' HG2' ' OE2' ' B' ' 32' ' ' GLU . 97.0 mt-10 -57.03 -39.34 74.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.064 -1.022 . . . . 2.1899999999999999 111.754 -172.675 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.882 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.7 tp -84.29 -5.96 59.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.734 -1.229 . . . . 1.3799999999999999 111.606 -173.616 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.413 ' HA2' HG12 ' A' ' 12' ' ' VAL . . . 79.99 46.9 7.41 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.161 -1.495 . . . . 0.20999999999999999 109.694 -177.744 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.915 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.5 mtm180 -114.58 154.5 28.21 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.954 -1.321 . . . . 1.1499999999999999 110.127 -177.221 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.853 HG12 HD13 ' B' ' 36' ' ' LEU . 15.5 m -123.26 150.69 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.311 -0.868 . . . . 0.28000000000000003 109.802 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.928 HG22 ' CD ' ' B' ' 17' ' ' ARG . 34.1 t -111.69 134.16 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.915 . . . . 0.23999999999999999 110.632 -175.571 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.714 HD11 HG21 ' B' ' 45' ' ' ILE . 2.9 mm -83.89 134.78 43.51 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 1.3799999999999999 109.507 174.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.555 ' HG2' HD12 ' A' ' 24' ' ' LEU . 9.3 Cg_endo -58.17 143.42 96.86 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.749 1.394 . . . . 0.34999999999999998 110.061 177.394 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.903 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.1 tp -54.92 -33.47 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.014 -1.054 . . . . 1.1100000000000001 110.429 -178.802 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 3' ' ' MET . 84.2 tt0 -58.06 -35.51 71.44 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.094 -1.003 . . . . 2.3700000000000001 109.816 178.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.562 ' HB2' HG23 ' A' ' 20' ' ' ILE . 48.2 mt -83.28 -29.17 28.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.39 -0.819 . . . . 1.75 110.636 178.865 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.903 ' HD2' HD12 ' A' ' 22' ' ' ILE . 71.4 mtt180 -57.71 -44.24 85.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.834 -1.166 . . . . 0.29999999999999999 109.069 175.451 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -72.97 -48.62 35.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.54 -0.725 . . . . 3.2599999999999998 110.719 -177.878 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.0 m -63.48 -32.06 73.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.153 -0.967 . . . . 0.77000000000000002 111.081 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.772 HD23 HG13 ' A' ' 30' ' ' ILE . 18.1 tp -88.28 -4.4 58.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.088 -1.008 . . . . 1.05 110.766 -176.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.42 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 66.31 42.05 94.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.818 -1.313 . . . . 0.32000000000000001 109.818 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.772 HG13 HD23 ' A' ' 28' ' ' LEU . 34.1 mm -116.49 137.76 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -1.156 . . . . 0.40999999999999998 110.682 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.4 ' HB3' ' OD2' ' A' ' 34' ' ' ASP . . . -142.14 166.5 24.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.594 -0.691 . . . . 0.23000000000000001 110.04 -178.149 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.2 146.68 11.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 1.1299999999999999 110.599 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 44.7 tttm 74.25 -4.52 2.28 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.666 -0.646 . . . . 1.8799999999999999 111.143 176.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.781 ' O ' HG23 ' B' ' 12' ' ' VAL . 91.2 m-20 -77.54 168.46 19.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.859 -1.151 . . . . 1.1000000000000001 110.064 175.147 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.605 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.34 130.56 52.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.35999999999999999 110.694 -176.754 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.961 ' CD1' HG22 ' B' ' 12' ' ' VAL . 9.1 mt -107.09 142.69 36.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.314 -0.866 . . . . 0.56000000000000005 109.312 174.618 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.699 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.1 tt0 -105.76 137.75 43.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.775 -1.203 . . . . 1.1699999999999999 109.585 172.915 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.0 mt -108.0 131.37 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -0.784 . . . . 0.83999999999999997 110.536 -172.441 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.609 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 23.3 m-85 -120.16 155.81 32.35 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.849 -0.426 . . . . 0.45000000000000001 109.849 -178.925 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' VAL . . . . . 0.551 HG21 HD11 ' B' ' 24' ' ' LEU . 71.3 t -131.23 120.75 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.88 -1.137 . . . . 0.27000000000000002 110.586 172.77 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 47.9 p-10 -148.25 160.86 42.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 1.77 110.583 178.659 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 42' ' ' ASP . 54.8 t0 42.13 41.23 1.96 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.065 -1.022 . . . . 1.22 111.575 172.03 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 96.0 mt-10 56.57 15.99 2.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.984 -1.072 . . . . 1.9299999999999999 110.541 175.491 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 27.3 pttt -129.54 164.77 23.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.96 . . . . 2.0099999999999998 109.738 174.564 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.725 HG21 HD11 ' B' ' 20' ' ' ILE . 64.7 mt -97.66 134.18 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 1.25 110.381 -174.67 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.609 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.6 mm -113.21 121.29 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.679 -0.638 . . . . 0.5 109.969 177.475 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.834 ' N ' HD12 ' A' ' 47' ' ' LEU . 3.9 mp -120.77 133.78 55.32 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.915 -1.116 . . . . 1.6599999999999999 110.021 178.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.595 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 12.9 pttp -143.62 165.53 27.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.232 -0.918 . . . . 1.74 110.631 -179.224 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.552 ' HD3' ' CD1' ' A' ' 30' ' ' ILE . 14.3 tptt -57.6 146.94 28.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 1.6499999999999999 110.127 177.301 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.853 ' CD2' HG11 ' B' ' 9' ' ' VAL . 11.2 t80 -102.73 120.93 41.43 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.324 -0.86 . . . . 0.34999999999999998 110.693 -176.632 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -99.59 122.81 50.18 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.296 -0.877 . . . . 3.21 109.47 172.384 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 22.1 Cg_exo -60.14 145.04 99.36 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.763 1.402 . . . . 0.47999999999999998 110.254 -178.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.017 -0.992 . . . . 2.4100000000000001 110.225 179.893 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.215 0.531 . . . . 11.66 110.28 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 69.0 mtm -47.13 -43.02 20.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.088 -1.008 . . . . 8.6999999999999993 111.083 -174.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -78.34 -84.59 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.729 -1.232 . . . . 9.1699999999999999 110.256 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.916 ' O ' HG23 ' B' ' 6' ' ' THR . 83.5 p -148.13 150.1 33.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.068 -1.02 . . . . 5.2000000000000002 110.017 176.81 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.916 HG23 ' O ' ' B' ' 5' ' ' SER . 0.7 OUTLIER -170.49 62.39 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.332 -0.855 . . . . 2.98 110.23 179.764 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.84 51.06 5.28 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.711 -1.355 . . . . 0.82999999999999996 109.711 178.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 59.0 mt -97.29 133.02 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.068 -1.254 . . . . 1.3600000000000001 109.691 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.943 HG13 ' O ' ' A' ' 36' ' ' LEU . 77.3 t -113.18 144.44 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.842 -1.161 . . . . 0.37 111.356 -170.465 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.442 ' NH1' ' HG2' ' B' ' 10' ' ' ARG . 57.4 ttp85 -129.07 166.99 18.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.519 -0.738 . . . . 1.9199999999999999 109.537 175.076 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -84.46 146.37 27.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.052 . . . . 2.21 110.551 -178.152 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.961 HG22 ' CD1' ' A' ' 36' ' ' LEU . 3.9 t -82.48 131.75 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.379 -0.826 . . . . 0.28999999999999998 109.699 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.08 -175.49 5.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.084 -1.01 . . . . 0.55000000000000004 110.212 -179.219 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.49 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -57.17 -39.24 74.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.143 -0.973 . . . . 2.1899999999999999 111.639 -172.358 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.901 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.4 tp -84.34 -5.96 59.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.811 -1.181 . . . . 1.3899999999999999 111.61 -173.637 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.411 ' HA2' HG12 ' B' ' 12' ' ' VAL . . . 79.53 47.8 7.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.533 -1.427 . . . . 0.20999999999999999 109.533 -177.83 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.928 ' CD ' HG22 ' A' ' 19' ' ' VAL . 69.5 mtm180 -114.88 154.48 28.59 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.091 -1.24 . . . . 1.1399999999999999 110.046 -177.539 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.877 HG12 HD13 ' A' ' 36' ' ' LEU . 15.5 m -123.27 150.65 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.326 -0.859 . . . . 0.28000000000000003 109.874 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.915 HG22 ' CD ' ' A' ' 17' ' ' ARG . 33.6 t -111.78 134.12 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.23999999999999999 110.56 -175.494 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.725 HD11 HG21 ' A' ' 45' ' ' ILE . 2.9 mm -83.81 134.75 43.77 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.22 -0.925 . . . . 1.3799999999999999 109.617 174.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.2 Cg_endo -58.24 143.35 97.2 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.727 1.383 . . . . 0.35999999999999999 110.066 177.517 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.898 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -55.07 -33.35 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.997 -1.065 . . . . 1.1100000000000001 110.334 -178.511 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 23' ' ' GLU . . . . . 0.412 ' N ' HG23 ' B' ' 22' ' ' ILE . 84.1 tt0 -57.83 -36.22 71.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.042 -1.036 . . . . 2.3700000000000001 109.709 178.498 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.565 ' HB2' HG23 ' B' ' 20' ' ' ILE . 48.5 mt -82.47 -29.58 30.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.388 -0.82 . . . . 1.75 110.654 178.877 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.898 ' HD2' HD12 ' B' ' 22' ' ' ILE . 70.6 mtt180 -57.59 -44.08 85.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.817 -1.177 . . . . 0.29999999999999999 109.046 175.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -73.0 -48.83 32.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.863 . . . . 3.27 110.566 -177.924 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.4 m -63.23 -32.54 73.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.254 -0.904 . . . . 0.77000000000000002 110.909 -178.177 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.774 HD23 HG13 ' B' ' 30' ' ' ILE . 18.2 tp -87.77 -4.91 58.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.045 -1.035 . . . . 1.05 110.667 -176.724 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.423 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.83 41.83 93.32 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.659 -1.377 . . . . 0.32000000000000001 109.659 178.525 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.774 HG13 HD23 ' B' ' 28' ' ' LEU . 33.7 mm -116.48 137.66 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -1.162 . . . . 0.40999999999999998 110.644 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 31' ' ' ALA . . . . . 0.4 ' HB3' ' OD2' ' B' ' 34' ' ' ASP . . . -141.96 166.55 24.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.602 -0.686 . . . . 0.23000000000000001 110.081 -178.27 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.13 146.72 10.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 1.1299999999999999 110.582 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 44.6 tttm 74.27 -4.56 2.27 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.645 -0.659 . . . . 1.8799999999999999 111.198 176.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.751 ' O ' HG23 ' A' ' 12' ' ' VAL . 91.1 m-20 -77.67 168.19 20.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.792 -1.192 . . . . 1.1000000000000001 110.031 175.204 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.597 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.12 130.69 51.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.35999999999999999 110.819 -176.868 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.91 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.1 mt -107.26 142.5 36.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.56000000000000005 109.318 174.68 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.653 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.0 tt0 -105.55 137.71 42.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.929 -1.107 . . . . 1.1699999999999999 109.721 172.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 71.5 mt -108.02 131.41 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.349 -0.844 . . . . 0.83999999999999997 110.538 -172.367 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.617 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 23.0 m-85 -120.1 155.85 32.19 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 116.294 -0.412 . . . . 0.45000000000000001 109.948 -178.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 40' ' ' VAL . . . . . 0.527 HG21 HD11 ' A' ' 24' ' ' LEU . 72.1 t -131.1 121.15 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.836 -1.165 . . . . 0.26000000000000001 110.402 172.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 47.9 p-10 -148.82 160.92 42.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -0.933 . . . . 1.77 110.519 178.461 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' B' ' 42' ' ' ASP . 55.2 t0 41.76 41.72 1.88 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.172 -0.955 . . . . 1.21 111.554 172.374 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 96.0 mt-10 56.26 16.11 2.2 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.881 -1.137 . . . . 1.9199999999999999 110.552 175.446 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 44' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 27.2 pttt -129.63 164.9 22.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 2.0 109.604 174.466 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.742 HG22 HD11 ' B' ' 47' ' ' LEU . 64.6 mt -97.67 134.08 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 1.24 110.416 -174.684 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 21.6 mm -113.21 121.47 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.748 -0.595 . . . . 0.5 109.914 177.497 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.833 ' N ' HD12 ' B' ' 47' ' ' LEU . 4.0 mp -120.73 133.5 55.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.931 -1.106 . . . . 1.6599999999999999 109.958 179.005 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.592 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 13.2 pttp -143.47 165.72 26.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.962 . . . . 1.74 110.657 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.557 ' HD3' ' CD1' ' B' ' 30' ' ' ILE . 14.4 tptt -57.6 146.87 28.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 1.6499999999999999 110.012 177.364 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.889 ' CD2' HG11 ' A' ' 9' ' ' VAL . 11.4 t80 -102.87 117.23 34.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 0.65000000000000002 110.643 -176.643 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.99 79.38 69.11 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.94 . . . . 4.3499999999999996 110.215 177.157 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.42 ' HB3' ' OH ' ' B' ' 50' ' ' TYR . 10.6 Cg_endo -58.84 145.02 98.12 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.066 1.561 . . . . 3.5800000000000001 110.281 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.979 -1.01 . . . . 5.9699999999999998 110.209 -179.829 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.483 ' HB2' ' OG ' ' A' ' 5' ' ' SER . 96.5 m-85 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.127 0.489 . . . . 10.99 110.078 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 95.6 mmm -64.74 -77.05 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.213 -0.93 . . . . 8.7599999999999998 110.387 -177.493 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.448 ' HD2' ' CD ' ' A' ' 23' ' ' GLU . 90.7 mttt -52.7 -43.47 65.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.15 -0.969 . . . . 8.8499999999999996 111.55 -173.828 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.928 ' O ' HG23 ' A' ' 6' ' ' THR . 12.1 p -87.35 121.5 29.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.49 -1.381 . . . . 4.2000000000000002 110.067 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.928 HG23 ' O ' ' A' ' 5' ' ' SER . 0.8 OUTLIER -172.44 62.88 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.624 -0.672 . . . . 3.77 110.03 -179.314 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.53 49.17 6.31 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.34 -1.409 . . . . 0.82999999999999996 110.011 178.946 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.1 mm -103.42 134.7 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.009 -1.289 . . . . 1.3600000000000001 109.669 179.331 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.899 HG13 ' O ' ' B' ' 36' ' ' LEU . 78.4 t -109.85 143.48 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.86 -1.15 . . . . 0.37 111.281 -171.281 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ARG . . . . . 0.449 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 15.5 tpt180 -121.27 161.62 21.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.571 -0.706 . . . . 1.9099999999999999 109.666 177.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' B' ' 33' ' ' LYS . 6.4 tptm -82.8 142.42 31.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.169 -0.957 . . . . 2.21 110.364 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.904 HG22 HD11 ' B' ' 36' ' ' LEU . 8.9 t -82.97 130.39 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.329 -0.857 . . . . 0.28000000000000003 109.886 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -83.96 -175.28 5.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.099 -1.001 . . . . 0.55000000000000004 110.036 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HG2' ' OE2' ' B' ' 32' ' ' GLU . 97.0 mt-10 -56.66 -39.71 74.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.998 -1.064 . . . . 2.1899999999999999 111.756 -172.514 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.4 tp -84.68 -5.73 59.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.794 -1.191 . . . . 1.3799999999999999 111.523 -173.831 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLY . . . . . 0.479 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.19 46.7 7.42 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.228 -1.463 . . . . 0.20999999999999999 109.643 -177.72 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.916 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.0 mtm180 -114.36 155.03 27.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.071 -1.252 . . . . 1.1499999999999999 110.024 -177.647 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.847 HG12 HD13 ' B' ' 36' ' ' LEU . 17.1 m -123.87 152.43 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.365 -0.834 . . . . 0.28000000000000003 109.817 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.925 HG22 ' CD ' ' B' ' 17' ' ' ARG . 33.6 t -110.03 135.82 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.23999999999999999 110.446 -176.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -80.63 130.46 64.43 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 1.3799999999999999 109.465 174.905 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -56.79 143.63 90.03 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.817 1.43 . . . . 0.34999999999999998 110.059 178.562 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.838 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.14 -32.54 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.005 -1.06 . . . . 1.1100000000000001 110.293 -178.18 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' CD ' ' HD2' ' A' ' 4' ' ' LYS . 83.8 tt0 -57.68 -36.48 71.98 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.055 -1.028 . . . . 2.3700000000000001 109.891 178.025 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.563 ' HB2' HG23 ' A' ' 20' ' ' ILE . 51.7 mt -82.07 -30.04 31.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.346 -0.847 . . . . 1.75 110.63 178.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.838 ' HD2' HD12 ' A' ' 22' ' ' ILE . 73.9 mtt180 -57.91 -43.61 86.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.923 -1.111 . . . . 0.29999999999999999 109.172 175.631 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -74.2 -51.7 14.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.469 -0.769 . . . . 3.2599999999999998 110.651 -177.08 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.6 m -64.04 -31.22 72.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.77000000000000002 111.182 -178.379 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.951 HD23 HG13 ' A' ' 30' ' ' ILE . 16.7 tp -88.6 -4.89 58.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.09 -1.006 . . . . 1.05 110.808 -176.742 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.471 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.69 43.97 95.59 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.738 -1.345 . . . . 0.32000000000000001 109.738 179.166 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.951 HG13 HD23 ' A' ' 28' ' ' LEU . 31.3 mm -115.82 136.94 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.266 -1.137 . . . . 0.40999999999999998 110.75 -178.082 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.43 167.12 23.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.62 -0.675 . . . . 0.23000000000000001 110.019 -177.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.22 146.05 12.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.037 -1.039 . . . . 1.1299999999999999 110.623 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 68.3 tttt 74.34 -4.24 2.36 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.665 . . . . 1.8799999999999999 111.144 176.921 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.792 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.2 m-20 -77.22 168.97 19.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.866 -1.146 . . . . 1.1000000000000001 110.06 174.736 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.05 130.97 54.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.35999999999999999 110.612 -177.205 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.924 ' O ' HG13 ' B' ' 9' ' ' VAL . 9.2 mt -107.06 141.97 37.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 0.56000000000000005 109.235 174.993 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.583 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.1 tt0 -104.3 137.6 41.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.769 -1.207 . . . . 1.1699999999999999 109.712 174.08 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.0 mt -108.73 132.57 56.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.456 -0.778 . . . . 0.83999999999999997 110.605 -172.656 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' TYR . . . . . 0.631 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 22.5 m-85 -121.07 157.25 30.45 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.868 -0.419 . . . . 0.45000000000000001 109.868 -178.775 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.2 t -131.56 125.91 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.811 -1.18 . . . . 0.27000000000000002 110.715 173.498 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.486 ' OD1' HG12 ' A' ' 46' ' ' ILE . 38.7 p-10 -147.48 140.87 25.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.92 . . . . 1.77 110.733 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.8 t0 43.32 46.74 5.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.001 -1.062 . . . . 1.22 111.449 173.336 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.8 tt0 61.3 10.87 3.28 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.132 -0.98 . . . . 1.9299999999999999 110.707 175.479 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -111.44 151.09 28.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 2.0099999999999998 109.885 175.179 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.874 HG22 HD11 ' A' ' 47' ' ' LEU . 67.2 mt -92.9 128.22 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.308 -0.87 . . . . 1.25 109.779 177.713 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 23.5 mm -111.45 118.29 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.543 -0.723 . . . . 0.5 109.91 178.817 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.874 HD11 HG22 ' A' ' 45' ' ' ILE . 3.9 mp -119.27 134.18 55.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.867 -1.146 . . . . 1.6599999999999999 110.164 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.586 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 13.0 pttp -143.26 163.26 33.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 1.74 110.44 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -58.18 147.52 29.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 1.6499999999999999 109.94 177.798 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.57 ' CD2' HG11 ' B' ' 9' ' ' VAL . 15.5 t80 -101.73 118.22 36.49 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.368 -0.833 . . . . 0.34999999999999998 110.688 -175.912 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.47 ' O ' ' CG ' ' A' ' 51' ' ' LYS . 18.2 pttm -99.89 122.86 49.46 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.37 -0.831 . . . . 3.21 109.399 172.139 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.3 144.77 92.14 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.761 1.401 . . . . 0.47999999999999998 110.259 -178.823 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.7 m120 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.971 -1.014 . . . . 2.4100000000000001 110.182 -179.976 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 46.3 p90 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.203 0.525 . . . . 11.66 110.145 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 69.8 mtm -111.03 147.22 35.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.915 . . . . 8.6999999999999993 110.207 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -89.71 146.57 24.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 9.1699999999999999 110.101 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 5' ' ' SER . . . . . 0.886 ' O ' HG23 ' B' ' 6' ' ' THR . 41.1 m -59.84 148.43 34.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 5.2000000000000002 109.996 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 6' ' ' THR . . . . . 0.886 HG23 ' O ' ' B' ' 5' ' ' SER . 0.7 OUTLIER -169.23 62.8 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 2.98 110.259 -179.037 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.89 50.49 5.89 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.733 -1.347 . . . . 0.82999999999999996 109.733 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 20.0 mm -103.8 134.58 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.082 -1.246 . . . . 1.3600000000000001 109.757 178.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 9' ' ' VAL . . . . . 0.924 HG13 ' O ' ' A' ' 36' ' ' LEU . 78.0 t -109.88 143.44 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.823 -1.173 . . . . 0.37 111.244 -171.261 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 10' ' ' ARG . . . . . 0.457 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 15.5 tpt180 -121.28 161.5 21.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.589 -0.695 . . . . 1.9199999999999999 109.753 177.619 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 11' ' ' LYS . . . . . 0.457 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 6.4 tptm -82.83 142.26 31.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.994 . . . . 2.21 110.37 -178.643 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.887 HG22 HD11 ' A' ' 36' ' ' LEU . 8.9 t -82.88 130.56 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.24 -0.913 . . . . 0.28999999999999998 109.855 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.01 -175.05 5.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.983 . . . . 0.55000000000000004 110.227 179.674 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' B' B ' 14' ' ' GLU . . . . . 0.492 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -56.91 -39.63 74.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.132 -0.98 . . . . 2.1899999999999999 111.634 -172.189 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 15' ' ' LEU . . . . . 0.9 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.3 tp -84.65 -5.89 59.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.786 -1.196 . . . . 1.3899999999999999 111.546 -173.802 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 16' ' ' GLY . . . . . 0.478 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.93 47.32 7.2 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.531 -1.428 . . . . 0.20999999999999999 109.531 -177.727 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 17' ' ' ARG . . . . . 0.925 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.0 mtm180 -114.43 154.99 27.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.089 -1.242 . . . . 1.1399999999999999 110.042 -177.884 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 18' ' ' VAL . . . . . 0.847 HG12 HD13 ' A' ' 36' ' ' LEU . 17.1 m -123.96 152.42 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.887 . . . . 0.28000000000000003 109.775 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 19' ' ' VAL . . . . . 0.916 HG22 ' CD ' ' A' ' 17' ' ' ARG . 34.2 t -110.06 135.72 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.146 -0.971 . . . . 0.23999999999999999 110.506 -176.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 20' ' ' ILE . . . . . 0.556 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -80.57 130.45 64.65 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 1.3799999999999999 109.537 174.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.1 Cg_endo -56.82 143.66 90.23 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.773 1.407 . . . . 0.35999999999999999 110.115 178.643 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 22' ' ' ILE . . . . . 0.866 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.27 -32.39 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.155 -0.966 . . . . 1.1100000000000001 110.281 -177.991 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -57.49 -37.18 72.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.046 -1.034 . . . . 2.3700000000000001 109.808 177.736 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 24' ' ' LEU . . . . . 0.556 ' HB2' HG23 ' B' ' 20' ' ' ILE . 51.1 mt -81.32 -30.52 33.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.468 -0.77 . . . . 1.75 110.561 178.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 25' ' ' ARG . . . . . 0.866 ' HD2' HD12 ' B' ' 22' ' ' ILE . 73.7 mtt180 -57.69 -43.43 85.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.9 -1.125 . . . . 0.29999999999999999 109.285 176.008 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -74.26 -51.82 14.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 3.27 110.571 -177.218 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.3 m -63.85 -31.85 73.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.77000000000000002 110.855 -178.107 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 28' ' ' LEU . . . . . 0.984 HD23 HG13 ' B' ' 30' ' ' ILE . 16.8 tp -88.07 -5.25 58.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.971 -1.081 . . . . 1.05 110.691 -176.356 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 29' ' ' GLY . . . . . 0.454 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.91 43.89 95.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.646 -1.382 . . . . 0.32000000000000001 109.646 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 30' ' ' ILE . . . . . 0.984 HG13 HD23 ' B' ' 28' ' ' LEU . 31.3 mm -115.68 136.79 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -1.162 . . . . 0.40999999999999998 110.797 -178.122 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.12 167.18 23.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.574 -0.704 . . . . 0.23000000000000001 109.951 -177.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 32' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.05 146.04 11.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.143 -0.973 . . . . 1.1299999999999999 110.634 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 33' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 68.1 tttt 74.34 -4.29 2.35 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.713 -0.617 . . . . 1.8799999999999999 111.168 176.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 34' ' ' ASP . . . . . 0.787 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.8 m-20 -77.42 168.76 19.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.846 -1.158 . . . . 1.1000000000000001 109.979 174.869 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 35' ' ' ALA . . . . . 0.449 ' HB1' HG11 ' A' ' 9' ' ' VAL . . . -106.81 130.93 54.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.35999999999999999 110.726 -177.256 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 36' ' ' LEU . . . . . 0.904 HD11 HG22 ' A' ' 12' ' ' VAL . 9.1 mt -107.08 141.79 37.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.265 -0.897 . . . . 0.56000000000000005 109.319 174.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 37' ' ' GLU . . . . . 0.565 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.0 tt0 -103.99 137.57 41.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.78 -1.2 . . . . 1.1699999999999999 109.881 174.06 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.2 mt -108.73 132.61 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.83999999999999997 110.493 -172.588 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 39' ' ' TYR . . . . . 0.616 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 22.0 m-85 -121.05 157.2 30.55 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 116.208 -0.451 . . . . 0.45000000000000001 109.886 -178.857 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 75.6 t -131.36 126.27 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.861 -1.149 . . . . 0.26000000000000001 110.545 173.536 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 41' ' ' ASP . . . . . 0.495 ' OD1' HG12 ' B' ' 46' ' ' ILE . 38.5 p-10 -147.99 140.77 24.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.333 -0.854 . . . . 1.77 110.638 179.005 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 42' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 54.3 t0 43.44 46.88 5.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.072 -1.018 . . . . 1.21 111.317 173.346 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.6 tt0 61.1 10.88 3.12 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.053 -1.029 . . . . 1.9199999999999999 110.71 175.504 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -111.38 151.3 28.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 2.0 109.913 175.062 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.868 HG22 HD11 ' B' ' 47' ' ' LEU . 66.8 mt -93.01 128.07 44.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.253 -0.904 . . . . 1.24 109.876 177.699 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 46' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 23.2 mm -111.55 118.42 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.611 -0.681 . . . . 0.5 109.886 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 47' ' ' LEU . . . . . 0.868 HD11 HG22 ' B' ' 45' ' ' ILE . 4.0 mp -119.2 134.07 55.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.957 -1.089 . . . . 1.6599999999999999 110.13 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 48' ' ' LYS . . . . . 0.589 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 13.3 pttp -143.2 163.33 33.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.206 -0.934 . . . . 1.74 110.455 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -58.1 147.43 29.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.908 . . . . 1.6499999999999999 109.917 177.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' B' B ' 50' ' ' TYR . . . . . 0.599 ' CD2' HG11 ' A' ' 9' ' ' VAL . 15.6 t80 -101.9 113.44 26.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.214 -0.929 . . . . 0.65000000000000002 110.605 -175.946 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.57 88.56 46.67 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 4.3499999999999996 110.339 178.37 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 52' ' ' PRO . . . . . 0.591 ' HG3' ' CE2' ' B' ' 50' ' ' TYR . 35.9 Cg_exo -55.64 145.44 70.46 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.007 1.53 . . . . 3.5800000000000001 110.347 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.973 -1.013 . . . . 5.9699999999999998 110.176 179.815 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.9 mt . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.014 0.435 . . . . 1.36 109.993 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.931 HG13 ' O ' ' B' ' 36' ' ' LEU . 90.3 t -116.68 144.06 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.041 -1.037 . . . . 0.37 110.961 -175.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 27.7 tpt180 -128.15 159.21 35.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.464 -0.773 . . . . 1.91 109.711 177.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.425 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 70.3 mttt -85.74 147.67 26.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.103 -0.998 . . . . 2.21 110.401 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.938 HG22 HD11 ' B' ' 36' ' ' LEU . 3.7 t -84.06 129.0 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.292 -0.88 . . . . 0.28 109.942 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.68 -175.29 5.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.55 110.08 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -54.24 -40.91 68.16 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.151 -0.968 . . . . 2.19 111.671 -173.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.851 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.3 tp -84.12 -5.64 59.28 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.739 -1.225 . . . . 1.38 111.581 -173.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.506 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.38 46.31 7.54 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.191 -1.48 . . . . 0.21 109.657 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.919 ' CD ' HG22 ' B' ' 19' ' ' VAL . 72.6 mtm180 -114.74 154.05 29.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.099 -1.236 . . . . 1.15 109.968 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.71 HG12 HD13 ' B' ' 36' ' ' LEU . 19.8 m -123.99 153.11 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.28 109.866 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.928 HG22 ' CD ' ' B' ' 17' ' ' ARG . 24.3 t -111.35 134.77 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.24 110.632 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.585 HG23 ' HB2' ' A' ' 24' ' ' LEU . 6.4 mt -82.53 135.14 46.81 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 1.38 109.487 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.2 Cg_endo -58.13 142.98 97.39 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.771 1.406 . . . . 0.35 110.044 177.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.885 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.14 -32.78 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.962 -1.086 . . . . 1.11 110.373 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -58.07 -35.64 71.66 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.113 -0.992 . . . . 2.37 109.861 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.585 ' HB2' HG23 ' A' ' 20' ' ' ILE . 54.9 mt -82.75 -29.78 29.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.382 -0.824 . . . . 1.75 110.627 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.885 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.8 mtt180 -57.56 -44.13 85.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.898 -1.126 . . . . 0.3 109.146 175.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -73.37 -49.14 28.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.537 -0.727 . . . . 3.26 110.742 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.0 m -63.94 -31.24 72.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.189 -0.944 . . . . 0.77 111.085 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.929 HD23 HG13 ' A' ' 30' ' ' ILE . 22.2 tp -87.57 -4.79 58.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.027 -1.046 . . . . 1.05 110.711 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.416 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.75 43.74 95.82 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.663 -1.375 . . . . 0.32 109.663 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.929 HG13 HD23 ' A' ' 28' ' ' LEU . 31.6 mm -115.28 138.99 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.241 -1.152 . . . . 0.41 110.699 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.79 167.11 22.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.631 -0.668 . . . . 0.23 109.945 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.52 146.02 13.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.047 -1.033 . . . . 1.13 110.554 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 40.7 tttt 74.81 -4.57 2.33 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.757 -0.589 . . . . 1.88 111.103 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.729 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.9 m-20 -76.93 165.54 24.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.773 -1.204 . . . . 1.1 110.028 174.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -106.26 132.52 52.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 0.36 110.734 -176.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.925 ' O ' HG13 ' B' ' 9' ' ' VAL . 12.6 mt -108.9 142.74 39.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.56 109.49 175.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.625 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.8 tt0 -107.88 139.8 41.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.869 -1.144 . . . . 1.17 109.793 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 72.1 mt -112.61 136.85 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.393 -0.817 . . . . 0.84 110.68 -172.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.577 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 14.6 m-85 -114.16 158.61 21.08 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.977 -0.379 . . . . 0.45 109.977 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 83.9 t -130.66 121.92 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.973 -1.079 . . . . 0.27 110.739 172.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.576 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.9 p-10 -147.17 140.51 25.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 1.77 110.216 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 52.4 t0 43.56 48.39 6.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.02 -1.05 . . . . 1.22 111.154 175.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.8 mt-10 58.55 14.05 2.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.134 -0.979 . . . . 1.93 110.656 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -117.12 147.11 42.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 2.01 110.024 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.577 ' CD1' HD11 ' B' ' 20' ' ' ILE . 60.4 mt -99.98 128.17 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 1.25 110.093 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 24.1 mt -111.52 118.62 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.352 -0.843 . . . . 0.5 110.209 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.837 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -108.04 136.54 47.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.067 -1.021 . . . . 1.66 110.093 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.548 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 27.2 pttt -138.64 162.23 35.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.501 -0.749 . . . . 1.74 110.189 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -58.84 146.55 36.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.09 -1.006 . . . . 1.65 109.965 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.588 ' CD2' HG11 ' B' ' 9' ' ' VAL . 9.1 t80 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.35 110.726 -176.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.925 HG13 ' O ' ' A' ' 36' ' ' LEU . 90.7 t . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.483 0.658 . . . . 0.37 110.937 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 27.8 tpt180 -128.16 159.03 36.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.49 -0.756 . . . . 1.92 109.793 177.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.421 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 70.4 mttt -85.65 147.6 26.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.013 . . . . 2.21 110.419 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.921 HG22 HD11 ' A' ' 36' ' ' LEU . 3.8 t -83.98 129.11 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.891 . . . . 0.29 109.844 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.449 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.93 -175.16 5.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.116 -0.99 . . . . 0.55 110.126 179.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.422 ' OE1' ' CD ' ' A' ' 32' ' ' GLU . 46.9 tp10 -54.37 -40.84 68.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.147 -0.971 . . . . 2.19 111.599 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.868 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.0 tp -84.12 -5.74 59.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.76 -1.213 . . . . 1.39 111.568 -173.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.519 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.05 47.02 7.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.521 -1.432 . . . . 0.21 109.521 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.928 ' CD ' HG22 ' A' ' 19' ' ' VAL . 72.7 mtm180 -114.93 154.08 29.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.102 -1.234 . . . . 1.14 109.94 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.703 HG12 HD13 ' A' ' 36' ' ' LEU . 19.7 m -124.04 153.09 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.28 109.891 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.919 HG22 ' CD ' ' A' ' 17' ' ' ARG . 24.3 t -111.4 134.76 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.24 110.619 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.597 HG23 ' HB2' ' B' ' 24' ' ' LEU . 6.4 mt -82.57 135.16 46.67 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 1.38 109.472 174.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.538 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.2 Cg_endo -58.21 143.0 97.63 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.797 1.419 . . . . 0.36 110.049 177.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.879 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.3 -32.59 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.135 -0.978 . . . . 1.11 110.336 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -57.86 -36.4 72.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.091 -1.006 . . . . 2.37 109.774 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.597 ' HB2' HG23 ' B' ' 20' ' ' ILE . 54.7 mt -81.97 -30.16 31.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.478 -0.764 . . . . 1.75 110.605 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.879 ' HD2' HD12 ' B' ' 22' ' ' ILE . 72.2 mtt180 -57.44 -43.92 84.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.89 -1.131 . . . . 0.3 109.204 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -73.37 -49.32 27.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 3.27 110.621 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 61.0 m -63.81 -31.73 73.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.177 -0.952 . . . . 0.77 110.862 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.934 HD23 HG13 ' B' ' 30' ' ' ILE . 22.4 tp -87.1 -5.17 59.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.053 -1.03 . . . . 1.05 110.701 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.415 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.07 43.65 95.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.578 -1.409 . . . . 0.32 109.578 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.934 HG13 HD23 ' B' ' 28' ' ' LEU . 31.1 mm -115.27 138.81 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -1.176 . . . . 0.41 110.725 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.48 167.27 22.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.628 -0.67 . . . . 0.23 109.935 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.527 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.55 146.12 13.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.988 . . . . 1.13 110.554 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 40.6 tttt 74.84 -4.77 2.29 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.688 -0.633 . . . . 1.88 111.164 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.649 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.0 m-20 -76.98 165.21 24.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.791 -1.193 . . . . 1.1 110.014 174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.594 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.93 132.48 51.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.36 110.833 -176.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.938 HD11 HG22 ' A' ' 12' ' ' VAL . 12.5 mt -108.93 142.61 39.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.397 -0.815 . . . . 0.56 109.531 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.61 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.6 tt0 -107.7 139.79 41.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.902 -1.124 . . . . 1.17 109.92 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 72.1 mt -112.6 136.79 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.299 -0.876 . . . . 0.84 110.651 -172.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 14.3 m-85 -114.0 158.63 20.92 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 116.35 -0.386 . . . . 0.45 109.993 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 83.8 t -130.52 122.26 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.907 -1.121 . . . . 0.26 110.502 172.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.572 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.9 p-10 -147.6 140.5 24.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 1.77 110.176 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 53.3 t0 43.69 48.46 6.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.134 -0.979 . . . . 1.21 111.059 175.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.7 mt-10 58.41 14.01 2.74 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.199 -0.938 . . . . 1.92 110.679 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -117.0 147.37 42.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 2.0 109.959 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.575 ' CD1' HD11 ' A' ' 20' ' ' ILE . 60.2 mt -100.23 128.22 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -0.928 . . . . 1.24 110.102 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 25.0 mt -111.7 118.61 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.5 110.148 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.822 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.3 mp -107.9 136.45 47.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 1.66 110.124 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.552 ' HD3' ' CE1' ' B' ' 39' ' ' TYR . 27.3 pttt -138.57 162.43 34.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.489 -0.757 . . . . 1.74 110.07 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -58.82 146.44 37.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.124 -0.985 . . . . 1.65 109.93 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.71 ' CD2' HG11 ' A' ' 9' ' ' VAL . 9.3 t80 . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.65 110.644 -176.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.5 mt . . . . . 0 N--CA 1.495 1.814 0 CA-C-O 121.089 0.471 . . . . 1.36 110.115 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.935 HG13 ' O ' ' B' ' 36' ' ' LEU . 93.0 t -115.95 144.35 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.001 -1.062 . . . . 0.37 110.916 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -129.23 160.66 32.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.494 -0.753 . . . . 1.91 109.679 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -85.25 147.7 26.44 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.067 -1.021 . . . . 2.21 110.385 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.899 HG22 HD11 ' B' ' 36' ' ' LEU . 4.0 t -83.09 129.94 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.28 109.88 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.36 -175.18 5.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.96 . . . . 0.55 110.082 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.74 -39.51 74.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.073 -1.017 . . . . 2.19 111.652 -172.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.891 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.2 tp -83.25 -6.61 59.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.831 -1.168 . . . . 1.38 111.499 -174.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.465 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.36 46.76 7.28 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.259 -1.448 . . . . 0.21 109.615 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.898 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.1 mtm180 -114.33 154.73 27.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.079 -1.247 . . . . 1.15 110.078 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.818 HG12 HD13 ' B' ' 36' ' ' LEU . 17.9 m -123.87 152.37 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.28 109.763 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.91 HG22 ' CD ' ' B' ' 17' ' ' ARG . 19.9 t -112.97 135.32 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.138 -0.976 . . . . 0.24 110.643 -174.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.715 HD11 ' CD1' ' B' ' 45' ' ' ILE . 19.5 mt -81.57 135.96 49.15 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.255 -0.903 . . . . 1.38 109.763 174.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HG2' HD12 ' A' ' 24' ' ' LEU . 11.0 Cg_endo -60.02 143.65 99.55 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.754 1.397 . . . . 0.35 109.942 176.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.874 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.12 -33.15 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.952 -1.093 . . . . 1.11 110.348 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.404 ' N ' HG23 ' A' ' 22' ' ' ILE . 48.6 tp10 -58.04 -35.41 71.29 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.181 -0.95 . . . . 2.37 109.884 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.561 HD12 ' HG2' ' A' ' 21' ' ' PRO . 59.6 mt -84.5 -28.25 26.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 1.75 110.664 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.874 ' HD2' HD12 ' A' ' 22' ' ' ILE . 70.8 mtt180 -57.44 -44.38 84.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.843 -1.161 . . . . 0.3 109.065 175.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.5 mmm180 -73.58 -49.12 27.88 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.862 -0.735 . . . . 3.26 110.671 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.8 m -63.96 -30.96 72.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.141 -0.974 . . . . 0.77 111.121 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.831 HD23 HG13 ' A' ' 30' ' ' ILE . 23.0 tp -87.59 -4.93 58.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.069 -1.019 . . . . 1.05 110.769 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.84 41.75 97.35 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.724 -1.35 . . . . 0.32 109.724 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.831 HG13 HD23 ' A' ' 28' ' ' LEU . 38.3 mm -116.38 138.45 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -1.17 . . . . 0.41 110.629 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.99 166.88 23.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.575 -0.703 . . . . 0.23 110.002 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.41 146.25 12.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.055 -1.028 . . . . 1.13 110.61 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 31.8 ttpt 74.35 -4.35 2.33 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.687 -0.633 . . . . 1.88 111.177 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.732 ' O ' HG23 ' B' ' 12' ' ' VAL . 90.1 m-20 -77.23 166.52 23.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.75 -1.219 . . . . 1.1 110.029 174.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.659 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.05 130.09 51.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.159 -0.963 . . . . 0.36 110.77 -176.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.951 HD11 HG22 ' B' ' 12' ' ' VAL . 12.4 mt -106.41 142.54 35.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.349 -0.845 . . . . 0.56 109.403 174.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.707 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.4 tt0 -106.33 138.45 42.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.773 -1.204 . . . . 1.17 109.564 173.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.2 mt -108.28 132.06 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.404 -0.81 . . . . 0.84 110.537 -171.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.606 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.0 m-85 -118.22 159.45 23.3 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 116.259 -0.428 . . . . 0.45 110.001 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 72.2 t -133.49 125.9 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.919 -1.113 . . . . 0.27 110.637 172.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.479 ' OD1' HG12 ' A' ' 46' ' ' ILE . 42.3 p-10 -147.41 143.22 27.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 1.77 110.499 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 51.8 t0 43.44 43.95 4.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.014 -1.054 . . . . 1.22 111.149 174.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.7 tt0 60.82 11.76 3.41 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.121 -0.987 . . . . 1.93 110.616 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 53.0 mtmt -111.54 154.64 24.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 2.01 109.779 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.759 ' CD1' HD11 ' B' ' 20' ' ' ILE . 66.1 mt -95.16 129.27 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 1.25 109.968 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.606 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 22.9 mm -115.12 120.65 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.719 . . . . 0.5 109.915 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.882 ' CD2' HG21 ' B' ' 18' ' ' VAL . 4.2 mp -117.63 135.17 54.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.981 -1.075 . . . . 1.66 110.25 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.567 ' HE3' ' CD1' ' A' ' 39' ' ' TYR . 8.2 ptpt -142.74 162.21 36.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.384 -0.823 . . . . 1.74 110.418 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.566 ' HD3' HD11 ' A' ' 30' ' ' ILE . 22.8 tptm -55.63 147.46 18.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.037 -1.039 . . . . 1.65 109.789 176.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.733 ' CD2' HG11 ' B' ' 9' ' ' VAL . 5.2 t80 . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.35 -0.843 . . . . 0.35 110.524 -176.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.946 HG13 ' O ' ' A' ' 36' ' ' LEU . 91.7 t . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.538 0.685 . . . . 0.37 110.925 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -129.19 160.45 32.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.457 -0.777 . . . . 1.92 109.759 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -85.19 147.59 26.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.038 -1.039 . . . . 2.21 110.425 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.951 HG22 HD11 ' A' ' 36' ' ' LEU . 4.0 t -82.95 129.97 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.4 -0.813 . . . . 0.29 109.894 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.61 -175.04 5.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.153 -0.967 . . . . 0.55 110.135 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.489 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -56.87 -39.44 74.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.081 -1.012 . . . . 2.19 111.496 -172.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.1 tp -83.27 -6.56 59.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.787 -1.196 . . . . 1.39 111.527 -174.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.475 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.9 47.5 7.12 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.54 -1.424 . . . . 0.21 109.54 -177.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.91 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.0 mtm180 -114.5 154.67 27.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.028 -1.278 . . . . 1.14 110.131 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.882 HG21 ' CD2' ' A' ' 47' ' ' LEU . 17.8 m -123.93 152.31 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.28 109.737 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.898 HG22 ' CD ' ' A' ' 17' ' ' ARG . 19.8 t -113.0 135.26 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.24 110.712 -174.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.759 HD11 ' CD1' ' A' ' 45' ' ' ILE . 19.2 mt -81.5 135.96 49.36 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 1.38 109.734 174.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 11.0 Cg_endo -60.15 143.53 99.53 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.801 1.422 . . . . 0.36 110.036 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.87 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.2 tp -55.13 -32.92 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.018 -1.051 . . . . 1.11 110.399 -178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . 0.403 ' N ' HG23 ' B' ' 22' ' ' ILE . 48.4 tp10 -57.93 -36.12 72.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.058 -1.026 . . . . 2.37 109.777 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.571 ' HB2' HG23 ' B' ' 20' ' ' ILE . 60.1 mt -83.74 -28.55 28.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.532 -0.73 . . . . 1.75 110.628 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.87 ' HD2' HD12 ' B' ' 22' ' ' ILE . 70.2 mtt180 -57.35 -44.32 84.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.792 -1.193 . . . . 0.3 109.044 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 32.5 mmm180 -73.49 -49.31 27.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.357 -0.84 . . . . 3.27 110.664 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.1 m -63.68 -31.64 72.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.896 . . . . 0.77 110.919 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.867 HD23 HG13 ' B' ' 30' ' ' ILE . 23.2 tp -87.01 -5.33 59.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.032 -1.042 . . . . 1.05 110.731 -176.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.24 41.53 96.75 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.562 -1.415 . . . . 0.32 109.562 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.867 HG13 HD23 ' B' ' 28' ' ' LEU . 37.9 mm -116.27 138.39 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -1.182 . . . . 0.41 110.694 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.78 167.04 23.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.612 -0.68 . . . . 0.23 109.987 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.41 146.39 12.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.141 -0.975 . . . . 1.13 110.523 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 31.7 ttpt 74.42 -4.64 2.27 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.699 -0.626 . . . . 1.88 111.174 176.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.4 m-20 -77.21 166.26 23.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.853 -1.154 . . . . 1.1 110.067 174.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.641 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.97 130.09 51.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.36 110.753 -176.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.935 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.2 mt -106.47 142.25 36.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 0.56 109.471 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.688 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.1 tt0 -106.06 138.44 42.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.825 -1.172 . . . . 1.17 109.72 173.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.22 132.06 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.367 -0.833 . . . . 0.84 110.486 -171.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.597 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 10.0 m-85 -118.31 159.34 23.56 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 116.261 -0.427 . . . . 0.45 110.001 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 72.4 t -133.22 126.27 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.936 -1.102 . . . . 0.26 110.466 172.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.487 ' OD1' HG12 ' B' ' 46' ' ' ILE . 42.5 p-10 -147.81 143.22 27.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 1.77 110.466 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 52.4 t0 43.47 44.04 4.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.934 . . . . 1.21 111.108 174.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.5 tt0 60.67 11.87 3.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.028 -1.045 . . . . 1.92 110.571 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 53.0 mtmt -111.56 154.76 24.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.185 -0.947 . . . . 2.0 109.71 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.754 HG22 HD11 ' B' ' 47' ' ' LEU . 66.2 mt -95.26 129.14 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 1.24 110.0 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.602 HD12 HD12 ' A' ' 46' ' ' ILE . 22.6 mm -115.15 120.7 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.5 109.817 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.823 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.3 mp -117.46 135.05 54.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.014 -1.054 . . . . 1.66 110.294 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.572 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 8.1 ptpt -142.65 162.39 35.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.843 . . . . 1.74 110.392 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.551 ' HD3' ' CD1' ' B' ' 30' ' ' ILE . 22.8 tptm -55.63 147.3 18.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.114 -0.992 . . . . 1.65 109.83 176.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.886 ' CD2' HG11 ' A' ' 9' ' ' VAL . 5.3 t80 . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.65 110.525 -176.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 N--CA 1.496 1.832 0 CA-C-O 121.139 0.495 . . . . 1.36 110.087 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.081 HG11 ' CD2' ' B' ' 50' ' ' TYR . 92.7 t -115.1 144.34 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.033 -1.042 . . . . 0.37 110.856 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.9 ttt-85 -129.91 160.07 34.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.48 -0.762 . . . . 1.91 109.684 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -86.44 149.03 25.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.103 -0.998 . . . . 2.21 110.466 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.99 HG22 HD11 ' B' ' 36' ' ' LEU . 3.9 t -82.99 129.64 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.241 -0.912 . . . . 0.28 109.873 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.466 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.19 -174.67 5.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.145 -0.972 . . . . 0.55 110.182 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -53.62 -41.81 67.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.18 -0.95 . . . . 2.19 111.783 -173.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.88 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.2 tp -85.79 -4.26 59.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.709 -1.244 . . . . 1.38 111.619 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.514 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.09 46.31 7.72 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.184 -1.484 . . . . 0.21 109.645 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.918 ' CD ' HG22 ' B' ' 19' ' ' VAL . 74.6 mtm180 -115.56 154.35 29.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.15 -1.206 . . . . 1.15 109.933 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.732 HG21 ' CD2' ' B' ' 47' ' ' LEU . 16.6 m -124.61 152.23 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 0.28 109.898 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.943 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.9 t -112.25 135.44 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.932 . . . . 0.24 110.514 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.593 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.04 134.57 46.11 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 1.38 109.577 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.54 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.9 Cg_endo -58.73 143.8 98.54 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.793 1.417 . . . . 0.35 110.104 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.886 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.19 -32.08 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.988 -1.07 . . . . 1.11 110.386 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.29 -34.88 72.82 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.118 -0.989 . . . . 2.37 109.901 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.593 ' HB2' HG23 ' A' ' 20' ' ' ILE . 62.4 mt -83.19 -29.68 28.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 1.75 110.57 178.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.886 ' HD2' HD12 ' A' ' 22' ' ' ILE . 73.6 mtt180 -57.55 -43.96 84.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.877 -1.139 . . . . 0.3 109.107 175.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -71.64 -50.11 33.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.518 -0.739 . . . . 3.26 110.707 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.0 m -63.38 -32.02 73.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.218 -0.926 . . . . 0.77 111.088 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.894 HD23 HG13 ' A' ' 30' ' ' ILE . 21.0 tp -88.39 -4.86 58.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.064 -1.022 . . . . 1.05 110.751 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.42 42.82 97.46 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.667 -1.373 . . . . 0.32 109.667 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.894 HG13 HD23 ' A' ' 28' ' ' LEU . 35.3 mm -116.36 138.75 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.242 -1.152 . . . . 0.41 110.74 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.06 167.26 22.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.617 -0.677 . . . . 0.23 110.092 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.2 tt0 -53.26 147.09 10.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.075 -1.016 . . . . 1.13 110.542 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 29.3 tttt 74.65 -4.92 2.23 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.781 -0.574 . . . . 1.88 111.123 177.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.71 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.9 m-20 -77.49 165.36 24.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.81 -1.181 . . . . 1.1 110.019 174.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.785 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.69 131.61 51.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.209 -0.932 . . . . 0.36 110.74 -176.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.968 HD11 HG22 ' B' ' 12' ' ' VAL . 13.6 mt -109.57 140.63 43.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 0.56 109.575 175.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.764 ' HA ' HG22 ' B' ' 9' ' ' VAL . 84.8 tt0 -103.67 138.56 40.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.823 -1.173 . . . . 1.17 109.528 171.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.6 mt -111.47 133.27 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.369 -0.832 . . . . 0.84 110.512 -173.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.587 ' CE2' ' HE3' ' A' ' 48' ' ' LYS . 8.5 m-85 -114.53 160.76 18.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 122.068 -0.395 . . . . 0.45 110.218 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.1 t -133.9 117.69 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 0.27 110.83 173.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.547 ' OD2' HD11 ' A' ' 46' ' ' ILE . 6.2 p-10 -147.69 160.23 42.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 1.77 110.031 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 22.5 t70 42.47 41.46 2.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.097 . . . . 1.22 111.332 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 75.5 mm-40 57.4 15.71 2.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.07 -1.019 . . . . 1.93 110.651 175.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 56.1 pttt -130.78 163.21 27.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.156 -0.965 . . . . 2.01 109.887 175.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.601 HD13 HG13 ' B' ' 20' ' ' ILE . 61.2 mt -104.21 134.74 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.046 -1.034 . . . . 1.25 110.516 -173.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 26.7 mt -112.96 119.27 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -0.833 . . . . 0.5 110.249 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.84 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.1 mp -108.12 134.84 50.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.932 . . . . 1.66 109.987 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.587 ' HE3' ' CE2' ' A' ' 39' ' ' TYR . 1.8 ptpm? -140.79 163.5 32.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.417 -0.802 . . . . 1.74 110.296 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.7 tttp -55.12 148.08 14.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.109 -0.995 . . . . 1.65 109.776 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.92 ' CD2' HG11 ' B' ' 9' ' ' VAL . 1.7 t80 . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.35 110.565 -175.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.934 HG13 ' O ' ' A' ' 36' ' ' LEU . 91.1 t . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.479 0.657 . . . . 0.37 110.855 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -129.85 159.89 35.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.479 -0.763 . . . . 1.92 109.782 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -86.32 148.88 25.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 2.21 110.472 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.968 HG22 HD11 ' A' ' 36' ' ' LEU . 3.9 t -82.83 129.73 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.265 -0.897 . . . . 0.29 109.867 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -85.46 -174.49 5.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.105 -0.997 . . . . 0.55 110.239 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.462 ' OE1' ' OE2' ' A' ' 32' ' ' GLU . 47.5 tp10 -53.82 -41.61 67.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.17 -0.956 . . . . 2.19 111.765 -173.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.9 tp -85.99 -4.14 59.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.722 -1.236 . . . . 1.39 111.592 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.534 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.72 46.97 7.52 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.524 -1.431 . . . . 0.21 109.524 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.943 ' CD ' HG22 ' A' ' 19' ' ' VAL . 74.2 mtm180 -115.76 154.28 29.89 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.083 -1.245 . . . . 1.14 109.96 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.836 HG21 ' CD2' ' A' ' 47' ' ' LEU . 16.6 m -124.6 152.25 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.28 109.899 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.918 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.9 t -112.34 135.38 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.93 . . . . 0.24 110.505 -175.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.612 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.99 134.49 46.44 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 1.38 109.554 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.536 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.8 Cg_endo -58.83 143.84 98.92 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.803 1.423 . . . . 0.36 110.053 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.884 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.28 -31.86 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.042 -1.036 . . . . 1.11 110.446 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.18 -35.57 73.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.057 -1.027 . . . . 2.37 109.758 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.612 ' HB2' HG23 ' B' ' 20' ' ' ILE . 62.7 mt -82.49 -30.06 30.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.408 -0.808 . . . . 1.75 110.602 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.884 ' HD2' HD12 ' B' ' 22' ' ' ILE . 73.1 mtt180 -57.34 -43.85 83.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.877 -1.139 . . . . 0.3 109.106 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -71.53 -50.54 30.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.418 -0.801 . . . . 3.27 110.614 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 60.8 m -62.98 -32.58 73.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.342 -0.849 . . . . 0.77 110.948 -177.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.894 HD23 HG13 ' B' ' 30' ' ' ILE . 21.2 tp -87.84 -5.32 58.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.981 -1.074 . . . . 1.05 110.759 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.4 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.79 42.64 97.0 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.575 -1.41 . . . . 0.32 109.575 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.894 HG13 HD23 ' B' ' 28' ' ' LEU . 34.8 mm -116.2 138.63 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -1.199 . . . . 0.41 110.816 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.82 167.43 22.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.605 -0.685 . . . . 0.23 109.97 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.25 147.18 10.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 1.13 110.515 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 29.2 tttt 74.69 -5.01 2.21 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.733 -0.604 . . . . 1.88 111.206 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.605 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.5 m-20 -77.63 164.98 24.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.821 -1.174 . . . . 1.1 109.998 174.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.753 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.41 131.58 51.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.36 110.833 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.99 HD11 HG22 ' A' ' 12' ' ' VAL . 13.4 mt -109.62 140.42 43.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 0.56 109.632 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.743 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.7 tt0 -103.43 138.56 39.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.829 -1.169 . . . . 1.17 109.749 171.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.8 mt -111.4 133.19 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.882 . . . . 0.84 110.524 -172.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.575 ' CZ ' ' HE3' ' B' ' 48' ' ' LYS . 8.4 m-85 -114.48 160.7 18.9 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 120.958 0.409 . . . . 0.45 110.275 -177.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 94.8 t -133.64 118.14 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.986 -1.071 . . . . 0.26 110.559 173.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.54 ' OD2' HD11 ' B' ' 46' ' ' ILE . 6.3 p-10 -148.29 160.2 43.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 1.77 110.033 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 22.7 t70 42.46 41.7 2.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -0.985 . . . . 1.21 111.225 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 75.5 mm-40 57.23 15.61 2.62 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.079 -1.013 . . . . 1.92 110.71 175.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 56.1 pttt -130.58 163.45 27.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.955 . . . . 2.0 109.866 174.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.453 HD13 HG13 ' A' ' 20' ' ' ILE . 60.5 mt -104.31 134.67 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.153 -0.967 . . . . 1.24 110.616 -173.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 27.5 mt -113.05 119.31 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.5 110.21 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.822 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.2 mp -108.04 134.75 50.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.214 -0.929 . . . . 1.66 109.978 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.575 ' HE3' ' CZ ' ' B' ' 39' ' ' TYR . 1.8 ptpm? -140.69 163.63 32.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.422 -0.798 . . . . 1.74 110.288 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -55.12 147.93 15.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 1.65 109.696 176.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 1.081 ' CD2' HG11 ' A' ' 9' ' ' VAL . 1.7 t80 . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.65 110.587 -175.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.1 mm . . . . . 0 N--CA 1.494 1.754 0 CA-C-O 120.978 0.418 . . . . 1.36 110.016 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.932 HG13 ' O ' ' B' ' 36' ' ' LEU . 87.0 t -117.91 144.03 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.024 -1.048 . . . . 0.37 110.94 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.449 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 27.7 tpt180 -128.57 160.56 32.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.549 -0.72 . . . . 1.91 109.65 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.449 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 94.8 mttt -84.92 146.87 27.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 2.21 110.297 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.916 HG22 HD11 ' B' ' 36' ' ' LEU . 4.1 t -82.27 127.49 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.28 109.757 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.27 -175.07 5.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.128 -0.983 . . . . 0.55 109.985 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.8 -39.14 73.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.998 -1.064 . . . . 2.19 111.596 -172.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.89 HD23 ' HD3' ' A' ' 17' ' ' ARG . 16.4 tp -83.0 -6.62 59.56 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.805 -1.185 . . . . 1.38 111.531 -174.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.48 46.62 7.3 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.173 -1.489 . . . . 0.21 109.654 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.896 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.1 mtm180 -114.07 154.44 27.72 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.018 -1.283 . . . . 1.15 110.007 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.866 HG12 HD13 ' B' ' 36' ' ' LEU . 17.7 m -123.56 151.97 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.28 109.799 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.909 HG22 ' CD ' ' B' ' 17' ' ' ARG . 17.1 t -113.61 133.56 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.24 110.762 -174.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.945 HD11 HD13 ' B' ' 45' ' ' ILE . 2.5 mm -85.28 136.97 37.23 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.908 . . . . 1.38 109.483 174.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.55 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -58.85 141.18 97.76 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.676 1.356 . . . . 0.35 109.965 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.949 HD13 ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.83 -32.03 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.946 -1.096 . . . . 1.11 110.407 -177.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.64 -35.31 72.31 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.034 -1.041 . . . . 2.37 109.77 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.55 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 45.3 mt -81.4 -28.97 34.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 1.75 110.52 176.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.663 HH22 HD11 ' B' ' 15' ' ' LEU . 72.6 mtt180 -56.93 -44.25 82.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.916 -1.115 . . . . 0.3 108.942 175.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -72.03 -49.26 38.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.574 -0.704 . . . . 3.26 110.735 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.7 m -63.55 -31.22 72.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 0.77 111.119 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.832 HD23 HG13 ' A' ' 30' ' ' ILE . 21.4 tp -87.24 -4.66 59.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.004 -1.06 . . . . 1.05 110.712 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.18 40.92 95.09 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.721 -1.352 . . . . 0.32 109.721 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.832 HG13 HD23 ' A' ' 28' ' ' LEU . 35.4 mm -116.33 139.09 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.309 -1.112 . . . . 0.41 110.623 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.55 166.5 24.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.546 -0.721 . . . . 0.23 110.124 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.47 146.65 12.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.973 . . . . 1.13 110.591 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 15.1 tptt 74.83 -4.62 2.32 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.759 -0.588 . . . . 1.88 111.092 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.75 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.8 m-20 -77.42 166.74 22.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.792 -1.193 . . . . 1.1 110.021 174.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.684 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.53 131.94 52.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.36 110.748 -176.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.932 HD11 HG22 ' B' ' 12' ' ' VAL . 13.9 mt -109.03 142.05 40.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.422 -0.799 . . . . 0.56 109.519 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.651 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.0 tt0 -108.29 139.89 42.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.879 -1.138 . . . . 1.17 109.784 173.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.425 HD13 ' O ' ' A' ' 37' ' ' GLU . 22.0 mm -111.86 133.98 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.332 -0.855 . . . . 0.84 110.553 -173.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.593 ' CE2' ' HE3' ' A' ' 48' ' ' LYS . 8.2 m-85 -115.34 162.03 17.69 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 120.955 0.407 . . . . 0.45 110.045 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 92.2 t -133.48 121.79 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.926 -1.108 . . . . 0.27 110.92 173.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.605 ' CG ' HD11 ' A' ' 46' ' ' ILE . 6.3 p-10 -147.31 152.53 38.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 1.77 110.129 176.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 53.7 t0 43.02 45.34 4.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.122 -0.986 . . . . 1.22 111.32 173.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 96.0 mt-10 56.99 16.91 3.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.028 -1.045 . . . . 1.93 110.548 175.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' A' ' 41' ' ' ASP . 16.2 ptpt -129.73 159.61 35.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 2.01 109.872 176.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 1.059 HD13 HD11 ' B' ' 20' ' ' ILE . 57.8 mt -104.33 133.48 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 1.25 110.607 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.605 HD11 ' CG ' ' A' ' 41' ' ' ASP . 33.4 mt -112.11 120.53 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.507 -0.745 . . . . 0.5 110.283 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.845 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.5 mp -109.74 135.38 50.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.11 -0.994 . . . . 1.66 110.015 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.593 ' HE3' ' CE2' ' A' ' 39' ' ' TYR . 1.8 ptpm? -141.09 162.83 34.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 1.74 110.3 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -57.94 146.54 31.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.171 -0.956 . . . . 1.65 110.03 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.745 ' CD2' HG11 ' B' ' 9' ' ' VAL . 8.1 t80 . . . . . 0 N--CA 1.491 1.625 0 O-C-N 121.307 -0.871 . . . . 0.35 110.655 -176.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 36' ' ' LEU . 86.7 t . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.453 0.644 . . . . 0.37 110.925 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.454 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 27.6 tpt180 -128.49 160.36 32.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.552 -0.717 . . . . 1.92 109.76 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.454 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 94.8 mttt -84.82 146.8 27.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.038 -1.039 . . . . 2.21 110.283 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.932 HG22 HD11 ' A' ' 36' ' ' LEU . 4.1 t -82.29 127.52 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.29 109.767 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -85.35 -174.86 5.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.18 -0.95 . . . . 0.55 110.111 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.485 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.9 mt-10 -57.07 -38.91 73.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.099 -1.001 . . . . 2.19 111.554 -172.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.8 tp -83.09 -6.74 59.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.796 -1.19 . . . . 1.39 111.51 -174.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.18 47.31 7.07 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.508 -1.437 . . . . 0.21 109.508 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.909 ' CD ' HG22 ' A' ' 19' ' ' VAL . 69.2 mtm180 -114.17 154.35 27.99 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.082 -1.246 . . . . 1.14 110.074 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.892 HG12 HD13 ' A' ' 36' ' ' LEU . 17.7 m -123.52 152.0 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.86 . . . . 0.28 109.794 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.896 HG22 ' CD ' ' A' ' 17' ' ' ARG . 16.8 t -113.57 133.57 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.158 -0.963 . . . . 0.24 110.748 -174.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 1.059 HD11 HD13 ' A' ' 45' ' ' ILE . 2.6 mm -85.3 136.96 37.21 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 1.38 109.526 174.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.0 Cg_endo -58.94 141.19 97.96 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.547 1.288 . . . . 0.36 110.023 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.948 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -56.08 -31.7 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.09 -1.006 . . . . 1.11 110.373 -177.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.58 -35.94 73.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.051 -1.03 . . . . 2.37 109.661 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.556 ' HB2' HG23 ' B' ' 20' ' ' ILE . 45.4 mt -80.65 -29.35 36.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.448 -0.782 . . . . 1.75 110.526 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.61 HH22 HD11 ' A' ' 15' ' ' LEU . 72.1 mtt180 -56.81 -44.06 81.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.836 -1.165 . . . . 0.3 109.001 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -71.98 -49.56 36.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.542 -0.723 . . . . 3.27 110.628 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.0 m -63.22 -31.8 73.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.286 -0.884 . . . . 0.77 110.898 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.854 HD23 HG13 ' B' ' 30' ' ' ILE . 21.7 tp -86.72 -5.02 59.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.122 -0.986 . . . . 1.05 110.69 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.58 40.69 94.22 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.613 -1.395 . . . . 0.32 109.613 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.854 HG13 HD23 ' B' ' 28' ' ' LEU . 34.8 mm -116.39 139.03 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -1.123 . . . . 0.41 110.604 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.34 166.6 24.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.559 -0.713 . . . . 0.23 110.071 -177.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.43 146.71 11.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 1.13 110.508 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 15.1 tptt 74.88 -4.91 2.26 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.695 -0.628 . . . . 1.88 111.184 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.665 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.1 m-20 -77.4 166.48 23.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.769 -1.207 . . . . 1.1 110.094 174.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.7 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.32 131.86 52.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.134 -0.979 . . . . 0.36 110.781 -176.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.932 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.7 mt -109.1 141.77 40.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.56 109.6 175.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.625 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.9 tt0 -107.97 139.9 41.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.932 -1.105 . . . . 1.17 109.892 173.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.429 HD13 ' O ' ' B' ' 37' ' ' GLU . 21.9 mm -111.95 134.14 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.352 -0.842 . . . . 0.84 110.443 -173.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.583 ' CE2' ' HE3' ' B' ' 48' ' ' LYS . 8.0 m-85 -115.43 162.0 17.77 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 116.315 -0.402 . . . . 0.45 110.078 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 92.2 t -133.23 122.21 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.931 -1.106 . . . . 0.26 110.633 173.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.597 ' OD2' HD11 ' B' ' 46' ' ' ILE . 6.5 p-10 -147.84 152.56 37.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 1.77 110.114 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 54.2 t0 42.98 45.54 4.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.164 -0.96 . . . . 1.21 111.258 173.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.9 mt-10 56.85 16.89 2.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.983 -1.073 . . . . 1.92 110.594 175.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' B' ' 41' ' ' ASP . 16.2 ptpt -129.67 159.88 35.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 2.0 109.763 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.945 HD13 HD11 ' A' ' 20' ' ' ILE . 57.3 mt -104.39 133.51 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.124 -0.985 . . . . 1.24 110.687 -173.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.597 HD11 ' OD2' ' B' ' 41' ' ' ASP . 34.7 mt -112.34 120.57 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.389 -0.819 . . . . 0.5 110.181 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.835 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.6 mp -109.63 135.24 50.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.196 -0.94 . . . . 1.66 110.071 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.583 ' HE3' ' CE2' ' B' ' 39' ' ' TYR . 1.8 ptpm? -140.99 163.03 34.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.454 -0.778 . . . . 1.74 110.248 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -57.93 146.55 31.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 1.65 109.988 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.881 ' CD2' HG11 ' A' ' 9' ' ' VAL . 8.3 t80 . . . . . 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.65 110.596 -176.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.8 mt . . . . . 0 N--CA 1.495 1.795 0 N-CA-C 109.594 -0.521 . . . . 1.36 109.594 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.906 HG13 ' O ' ' B' ' 36' ' ' LEU . 75.1 t -110.94 143.87 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.791 -1.193 . . . . 0.37 111.394 -170.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.489 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 28.7 tpt180 -125.85 163.11 23.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.645 -0.659 . . . . 1.91 109.527 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.489 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 56.6 mttm -84.98 146.54 27.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.986 -1.071 . . . . 2.21 110.453 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.896 HG22 HD11 ' B' ' 36' ' ' LEU . 3.9 t -83.51 130.29 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.385 -0.822 . . . . 0.28 109.876 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.74 -175.54 5.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.048 -1.032 . . . . 0.55 110.03 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.85 -39.33 74.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.998 -1.064 . . . . 2.19 111.677 -172.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.895 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.1 tp -83.26 -6.67 59.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.735 -1.228 . . . . 1.38 111.524 -174.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.457 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.47 46.58 7.32 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.176 -1.488 . . . . 0.21 109.715 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.911 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.5 mtm180 -113.88 154.73 27.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.953 -1.322 . . . . 1.15 110.043 -177.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.905 HG12 HD13 ' B' ' 36' ' ' LEU . 15.4 m -123.84 152.72 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.28 109.755 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.917 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.4 t -111.28 135.12 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.24 110.671 -175.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.6 HD11 ' CD1' ' B' ' 45' ' ' ILE . 16.2 mt -81.63 135.05 49.8 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.274 -0.891 . . . . 1.38 109.675 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.4 Cg_endo -58.32 142.61 97.68 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.67 1.352 . . . . 0.35 109.954 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.884 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.18 -32.16 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.899 -1.126 . . . . 1.11 110.389 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.39 -34.87 72.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.055 -1.028 . . . . 2.37 109.888 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.546 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 52.3 mt -81.86 -30.72 31.89 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.277 -0.889 . . . . 1.75 110.532 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.884 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.1 mtt180 -57.94 -44.19 86.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.95 -1.093 . . . . 0.3 109.2 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -73.82 -49.9 23.03 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.831 -0.748 . . . . 3.26 110.653 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.6 m -64.12 -31.15 72.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.201 -0.937 . . . . 0.77 111.11 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.862 HD23 HG13 ' A' ' 30' ' ' ILE . 18.7 tp -87.82 -4.68 58.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.039 -1.038 . . . . 1.05 110.739 -176.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 66.07 43.28 93.68 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.685 -1.366 . . . . 0.32 109.685 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.862 HG13 HD23 ' A' ' 28' ' ' LEU . 32.8 mm -115.96 138.19 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -1.162 . . . . 0.41 110.671 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.405 ' HB3' ' OD2' ' A' ' 34' ' ' ASP . . . -142.78 167.0 23.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.579 -0.7 . . . . 0.23 110.049 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.58 145.79 14.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 1.13 110.601 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 69.1 tttt 74.43 -4.34 2.34 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.708 -0.62 . . . . 1.88 111.073 176.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.767 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.7 m-20 -76.97 168.29 20.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.816 -1.177 . . . . 1.1 109.962 174.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.82 131.37 53.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.937 . . . . 0.36 110.798 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.93 ' O ' HG13 ' B' ' 9' ' ' VAL . 9.5 mt -107.61 144.23 34.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.369 -0.832 . . . . 0.56 109.267 174.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.532 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.4 tt0 -108.35 137.93 45.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.696 -1.253 . . . . 1.17 109.648 173.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.5 mt -108.42 133.29 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.452 -0.78 . . . . 0.84 110.571 -172.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.595 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.3 m-85 -119.38 159.98 23.16 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 116.319 -0.401 . . . . 0.45 110.001 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 76.8 t -133.22 127.25 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.98 -1.075 . . . . 0.27 110.564 173.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.478 ' OD1' HG12 ' A' ' 46' ' ' ILE . 39.1 p-10 -147.23 137.99 23.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 1.77 110.658 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.7 t0 43.74 47.36 6.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.043 -1.035 . . . . 1.22 111.306 174.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.5 tt0 61.02 11.8 3.57 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.193 -0.942 . . . . 1.93 110.622 175.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 35.4 mtmt -113.07 151.91 30.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 2.01 109.71 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.809 HG22 HD11 ' A' ' 47' ' ' LEU . 65.9 mt -94.73 129.78 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 1.25 109.977 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 27.6 mm -114.95 120.93 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.465 -0.772 . . . . 0.5 109.928 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.845 HD13 ' CD1' ' B' ' 47' ' ' LEU . 4.4 mp -118.34 136.04 53.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.973 -1.079 . . . . 1.66 110.257 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.559 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 5.0 ptpt -142.67 158.24 43.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.339 -0.85 . . . . 1.74 110.333 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -57.88 146.59 31.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -0.958 . . . . 1.65 109.934 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.631 ' CD2' HG11 ' B' ' 9' ' ' VAL . 14.5 t80 . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.35 110.729 -175.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 36' ' ' LEU . 74.0 t . . . . . 0 N--CA 1.493 1.681 0 CA-C-O 121.643 0.735 . . . . 0.37 111.375 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 28.8 tpt180 -125.69 162.96 23.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.527 -0.733 . . . . 1.92 109.596 175.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.49 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 56.7 mttm -84.97 146.52 27.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.071 -1.018 . . . . 2.21 110.484 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.914 HG22 ' CD1' ' A' ' 36' ' ' LEU . 4.0 t -83.5 130.38 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.35 -0.844 . . . . 0.29 109.763 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.0 -175.33 5.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.076 -1.015 . . . . 0.55 110.054 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.486 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -57.11 -39.19 74.59 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.028 -1.045 . . . . 2.19 111.554 -172.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.901 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.9 tp -83.23 -6.83 59.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.737 -1.227 . . . . 1.39 111.589 -174.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.461 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.12 47.38 7.06 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.483 -1.447 . . . . 0.21 109.483 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.917 ' CD ' HG22 ' A' ' 19' ' ' VAL . 69.6 mtm180 -114.08 154.67 27.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.026 -1.279 . . . . 1.14 110.059 -177.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.922 HG12 HD13 ' A' ' 36' ' ' LEU . 15.1 m -123.73 152.74 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.28 109.803 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.911 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.4 t -111.41 135.12 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.24 110.655 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.635 HD11 ' CD1' ' A' ' 45' ' ' ILE . 15.9 mt -81.64 135.03 49.78 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.326 -0.859 . . . . 1.38 109.602 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.538 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.5 Cg_endo -58.38 142.64 97.87 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.773 1.407 . . . . 0.36 110.045 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.881 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.42 -31.79 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.06 -1.025 . . . . 1.11 110.357 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.31 -35.59 74.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.019 -1.051 . . . . 2.37 109.787 178.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.545 ' HB2' HG23 ' B' ' 20' ' ' ILE . 51.9 mt -81.15 -31.02 34.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 1.75 110.569 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.881 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.7 mtt180 -57.85 -43.93 86.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.848 -1.157 . . . . 0.3 109.319 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -73.82 -50.1 22.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 3.27 110.62 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.5 m -63.81 -31.78 73.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.304 -0.872 . . . . 0.77 110.854 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.875 HD23 HG13 ' B' ' 30' ' ' ILE . 18.8 tp -87.35 -4.95 59.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.124 -0.985 . . . . 1.05 110.732 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.446 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.4 43.12 93.3 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.626 -1.39 . . . . 0.32 109.626 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.875 HG13 HD23 ' B' ' 28' ' ' LEU . 32.5 mm -115.96 138.11 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -1.144 . . . . 0.41 110.64 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.55 167.11 22.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.478 -0.764 . . . . 0.23 109.999 -177.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.64 145.93 14.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 1.13 110.565 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 69.2 tttt 74.49 -4.58 2.29 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.656 -0.653 . . . . 1.88 111.128 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.723 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.9 m-20 -76.97 168.07 20.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.83 -1.169 . . . . 1.1 110.013 174.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.499 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.66 131.36 53.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 0.36 110.805 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.906 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.4 mt -107.71 144.04 35.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.391 -0.818 . . . . 0.56 109.291 174.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.473 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.3 tt0 -108.15 137.81 45.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.764 -1.21 . . . . 1.17 109.881 173.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -108.32 133.35 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.322 -0.861 . . . . 0.84 110.508 -172.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.602 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 10.3 m-85 -119.41 159.98 23.18 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 116.276 -0.42 . . . . 0.45 110.03 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 76.7 t -133.12 127.56 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.945 -1.097 . . . . 0.26 110.454 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.489 ' OD1' HG12 ' B' ' 46' ' ' ILE . 39.2 p-10 -147.6 137.98 23.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.34 -0.85 . . . . 1.77 110.58 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 54.4 t0 43.89 47.42 6.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.136 -0.977 . . . . 1.21 111.278 174.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.3 tt0 60.85 11.74 3.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.133 -0.979 . . . . 1.92 110.636 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 35.3 mtmt -113.02 152.06 29.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.176 -0.952 . . . . 2.0 109.683 175.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.803 HG22 HD11 ' B' ' 47' ' ' LEU . 65.6 mt -94.81 129.57 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 1.24 110.108 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 27.2 mm -114.84 120.94 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.581 -0.699 . . . . 0.5 109.962 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.845 ' CD1' HD13 ' A' ' 47' ' ' LEU . 4.4 mp -118.2 135.88 53.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.999 -1.063 . . . . 1.66 110.235 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.558 ' HD2' ' CE1' ' B' ' 39' ' ' TYR . 5.0 ptpt -142.53 158.41 43.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 1.74 110.346 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -57.83 146.47 31.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 1.65 109.955 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.699 ' CD2' HG11 ' A' ' 9' ' ' VAL . 15.0 t80 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.65 110.697 -175.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.5 mt . . . . . 0 N--CA 1.496 1.83 0 CA-C-O 121.047 0.451 . . . . 1.36 110.018 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.93 HG13 ' O ' ' B' ' 36' ' ' LEU . 89.2 t -115.71 144.25 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.013 -1.054 . . . . 0.37 110.855 -176.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -129.85 160.38 33.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.522 -0.736 . . . . 1.91 109.658 177.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -85.62 147.73 26.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.029 -1.044 . . . . 2.21 110.33 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.93 HG22 HD11 ' B' ' 36' ' ' LEU . 3.8 t -82.33 130.78 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -0.864 . . . . 0.28 109.825 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.8 -175.55 5.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.128 -0.982 . . . . 0.55 110.02 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.9 -40.77 70.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.134 -0.979 . . . . 2.19 111.733 -173.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.843 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.1 tp -84.09 -5.51 59.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.746 -1.221 . . . . 1.38 111.493 -173.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.523 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.34 46.37 7.53 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.193 -1.479 . . . . 0.21 109.704 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.919 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.0 mtm180 -114.93 154.53 28.57 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.028 -1.277 . . . . 1.15 109.994 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.769 HG12 HD13 ' B' ' 36' ' ' LEU . 16.6 m -123.86 152.01 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.28 109.768 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.929 HG22 ' CD ' ' B' ' 17' ' ' ARG . 36.0 t -111.23 134.87 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.24 110.724 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.53 HG23 ' HB2' ' A' ' 24' ' ' LEU . 19.0 mt -81.36 133.28 53.7 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.277 -0.89 . . . . 1.38 109.632 174.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' HD12 ' A' ' 24' ' ' LEU . 10.2 Cg_endo -58.85 143.32 99.34 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.701 1.369 . . . . 0.35 109.985 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.883 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.07 -32.82 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.934 -1.104 . . . . 1.11 110.33 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.11 -35.66 71.77 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.111 -0.993 . . . . 2.37 109.852 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.552 HD12 ' HG2' ' A' ' 21' ' ' PRO . 57.2 mt -82.83 -29.8 29.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.429 -0.795 . . . . 1.75 110.645 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.883 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.0 mtt180 -57.54 -43.88 84.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.887 -1.133 . . . . 0.3 109.166 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -73.06 -50.97 19.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.542 -0.724 . . . . 3.26 110.645 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.3 m -63.53 -31.32 72.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.259 -0.9 . . . . 0.77 111.195 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.886 HD23 HG13 ' A' ' 30' ' ' ILE . 20.8 tp -87.71 -4.8 58.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.037 -1.039 . . . . 1.05 110.783 -177.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.15 41.72 96.83 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.624 -1.391 . . . . 0.32 109.624 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.886 HG13 HD23 ' A' ' 28' ' ' LEU . 34.9 mm -116.4 138.05 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.228 -1.16 . . . . 0.41 110.633 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.68 166.74 23.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.652 -0.655 . . . . 0.23 110.005 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.53 146.56 12.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.065 -1.022 . . . . 1.13 110.532 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 28.6 tttm 74.57 -4.62 2.29 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.699 -0.626 . . . . 1.88 111.097 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.715 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.3 m-20 -77.65 166.74 22.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.81 -1.182 . . . . 1.1 110.078 174.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.14 130.69 51.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.36 110.747 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.978 HD11 HG22 ' B' ' 12' ' ' VAL . 12.3 mt -107.3 143.21 35.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.351 -0.843 . . . . 0.56 109.424 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.663 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.5 tt0 -107.27 137.85 44.56 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.839 -1.163 . . . . 1.17 109.577 173.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.6 mt -108.6 133.44 53.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.361 -0.837 . . . . 0.84 110.583 -171.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.625 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.7 m-85 -120.13 159.44 24.85 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 116.309 -0.405 . . . . 0.45 110.014 -178.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.8 t -133.16 124.55 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.85 -1.156 . . . . 0.27 110.666 172.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.495 ' OD1' HG12 ' A' ' 46' ' ' ILE . 42.3 p-10 -147.54 145.08 28.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 1.77 110.577 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.1 t0 43.08 43.9 3.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.998 -1.064 . . . . 1.22 111.283 174.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 45.2 tp10 61.74 10.6 3.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.128 -0.983 . . . . 1.93 110.676 175.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -109.77 153.44 24.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 2.01 110.034 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.76 HG22 HD11 ' A' ' 47' ' ' LEU . 66.6 mt -93.32 128.34 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 1.25 109.752 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.0 mm -113.35 118.43 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.602 -0.687 . . . . 0.5 109.941 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.83 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -115.84 134.67 54.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.944 -1.097 . . . . 1.66 110.284 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.57 ' HE3' ' CD1' ' A' ' 39' ' ' TYR . 15.9 ptpt -142.78 161.14 38.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.793 . . . . 1.74 110.317 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -56.59 147.67 21.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.042 -1.037 . . . . 1.65 109.882 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.768 ' CD2' HG11 ' B' ' 9' ' ' VAL . 5.5 t80 . . . . . 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.35 110.653 -175.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.942 HG13 ' O ' ' A' ' 36' ' ' LEU . 87.2 t . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.504 0.669 . . . . 0.37 110.951 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -129.79 160.16 34.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.53 -0.731 . . . . 1.92 109.709 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -85.53 147.59 26.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.101 -1.0 . . . . 2.21 110.413 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.978 HG22 HD11 ' A' ' 36' ' ' LEU . 3.8 t -82.25 130.75 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.874 . . . . 0.29 109.743 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -83.95 -175.59 5.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.049 -1.032 . . . . 0.55 110.119 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.02 -40.62 70.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.133 -0.98 . . . . 2.19 111.649 -172.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.865 HD23 ' HD3' ' B' ' 17' ' ' ARG . 13.9 tp -84.1 -5.52 59.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.766 -1.209 . . . . 1.39 111.602 -173.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.529 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.92 47.12 7.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.606 -1.397 . . . . 0.21 109.606 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.929 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.0 mtm180 -115.09 154.57 28.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.071 -1.253 . . . . 1.14 109.996 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.801 HG12 HD13 ' A' ' 36' ' ' LEU . 16.6 m -123.96 152.01 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 0.28 109.823 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.919 HG22 ' CD ' ' A' ' 17' ' ' ARG . 35.9 t -111.29 134.85 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.935 . . . . 0.24 110.714 -175.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.532 HD11 ' CD1' ' A' ' 45' ' ' ILE . 18.5 mt -81.41 133.23 53.62 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.253 -0.904 . . . . 1.38 109.609 174.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.544 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.1 Cg_endo -58.96 143.25 99.76 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.735 1.387 . . . . 0.36 109.98 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.877 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.2 tp -55.09 -32.63 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.002 -1.061 . . . . 1.11 110.412 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.98 -36.39 72.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.11 -0.994 . . . . 2.37 109.747 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.544 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 57.6 mt -82.13 -30.01 31.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.494 -0.754 . . . . 1.75 110.638 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.877 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.6 mtt180 -57.56 -43.71 84.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.847 -1.158 . . . . 0.3 109.076 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -72.97 -51.21 19.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.482 -0.761 . . . . 3.27 110.6 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.2 m -63.29 -31.87 73.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.261 -0.899 . . . . 0.77 110.953 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.895 HD23 HG13 ' B' ' 30' ' ' ILE . 20.9 tp -87.12 -5.22 59.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.042 -1.036 . . . . 1.05 110.73 -176.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.429 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.46 41.54 96.29 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.563 -1.415 . . . . 0.32 109.563 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.895 HG13 HD23 ' B' ' 28' ' ' LEU . 34.2 mm -116.37 137.94 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -1.199 . . . . 0.41 110.598 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.41 166.86 23.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.624 -0.672 . . . . 0.23 109.965 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.51 146.61 12.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 1.13 110.48 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 28.5 tttm 74.66 -4.78 2.27 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.671 -0.643 . . . . 1.88 111.17 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.622 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.9 m-20 -77.73 166.5 22.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.789 -1.194 . . . . 1.1 110.092 175.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.693 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.06 130.63 51.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 0.36 110.837 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.93 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.1 mt -107.27 143.06 36.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 0.56 109.48 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.649 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.4 tt0 -107.05 137.85 44.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.763 -1.21 . . . . 1.17 109.688 172.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.8 mt -108.72 133.53 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.292 -0.88 . . . . 0.84 110.516 -171.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.616 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 10.7 m-85 -120.16 159.44 24.88 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 116.225 -0.443 . . . . 0.45 109.978 -178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 81.5 t -133.03 125.02 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.885 -1.134 . . . . 0.26 110.451 172.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.491 ' OD1' HG12 ' B' ' 46' ' ' ILE . 42.1 p-10 -148.03 145.06 28.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 1.77 110.556 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.7 t0 43.25 43.91 4.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.077 -1.014 . . . . 1.21 111.242 174.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 45.0 tp10 61.61 10.61 3.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.147 -0.971 . . . . 1.92 110.703 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -109.87 153.66 24.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 2.0 109.963 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.759 HG22 HD11 ' B' ' 47' ' ' LEU . 66.2 mt -93.43 128.14 45.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.19 -0.944 . . . . 1.24 109.85 176.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 21.4 mm -113.28 118.42 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.508 -0.745 . . . . 0.5 109.95 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.821 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.3 mp -115.66 134.42 55.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.067 -1.021 . . . . 1.66 110.255 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.57 ' HE3' ' CD1' ' B' ' 39' ' ' TYR . 15.8 ptpt -142.54 161.34 38.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.351 -0.843 . . . . 1.74 110.36 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -56.67 147.59 22.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.186 -0.946 . . . . 1.65 109.893 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.929 ' CD2' HG11 ' A' ' 9' ' ' VAL . 5.6 t80 . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.65 110.581 -175.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.5 mt . . . . . 0 N--CA 1.495 1.803 0 CA-C-O 120.962 0.411 . . . . 1.36 109.954 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.05 HG11 ' CD2' ' B' ' 50' ' ' TYR . 88.5 t -117.45 144.26 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.014 -1.054 . . . . 0.37 110.875 -175.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -131.47 162.54 29.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.532 -0.73 . . . . 1.91 109.726 177.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -85.32 148.06 26.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.041 -1.037 . . . . 2.21 110.385 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.916 HG22 HD11 ' B' ' 36' ' ' LEU . 3.8 t -82.3 129.8 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.216 -0.928 . . . . 0.28 109.792 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.14 -175.66 5.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.037 -1.039 . . . . 0.55 109.994 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -54.85 -40.69 69.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.083 -1.011 . . . . 2.19 111.68 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.831 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.4 tp -84.51 -5.82 59.32 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.731 -1.231 . . . . 1.38 111.572 -173.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.486 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.53 46.59 7.28 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.225 -1.464 . . . . 0.21 109.646 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.898 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.0 mtm180 -114.03 153.74 28.88 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.942 -1.328 . . . . 1.15 110.109 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.902 HG12 HD13 ' B' ' 36' ' ' LEU . 16.6 m -124.21 152.99 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.28 109.771 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.9 HG22 ' CD ' ' B' ' 17' ' ' ARG . 18.1 t -112.24 134.36 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.983 . . . . 0.24 110.708 -175.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.668 HD11 HG21 ' B' ' 45' ' ' ILE . 2.2 mm -82.97 134.13 47.14 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.181 -0.95 . . . . 1.38 109.322 173.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.5 Cg_endo -58.86 141.57 98.18 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.701 1.369 . . . . 0.35 109.906 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.962 HD13 ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.76 -31.43 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.909 -1.12 . . . . 1.11 110.412 -176.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.473 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 20.1 pt-20 -59.25 -34.67 72.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.024 -1.048 . . . . 2.37 109.732 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.584 ' HB2' HG23 ' A' ' 20' ' ' ILE . 56.6 mt -80.73 -29.42 36.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 1.75 110.325 176.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.701 HH22 HD11 ' B' ' 15' ' ' LEU . 73.4 mtt180 -57.1 -44.19 82.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.958 -1.088 . . . . 0.3 109.122 175.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -72.41 -50.45 26.34 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.893 -0.723 . . . . 3.26 110.692 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.1 m -63.53 -31.49 72.66 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.77 111.129 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.863 HD23 HG13 ' A' ' 30' ' ' ILE . 18.3 tp -87.85 -4.71 58.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.011 -1.055 . . . . 1.05 110.74 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.444 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.84 42.04 95.24 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.707 -1.357 . . . . 0.32 109.707 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.863 HG13 HD23 ' A' ' 28' ' ' LEU . 32.5 mm -116.41 138.37 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -1.125 . . . . 0.41 110.716 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.63 166.23 25.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.594 -0.691 . . . . 0.23 109.993 -177.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.42 147.0 11.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.024 -1.048 . . . . 1.13 110.584 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 26.6 ttpt 74.39 -4.47 2.31 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.644 -0.66 . . . . 1.88 111.163 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.754 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.8 m-20 -77.79 167.82 20.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.827 -1.17 . . . . 1.1 110.057 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.51 131.0 52.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 0.36 110.777 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.935 ' CD1' HG22 ' B' ' 12' ' ' VAL . 12.2 mt -108.03 144.3 35.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.381 -0.824 . . . . 0.56 109.461 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.63 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.0 tt0 -109.5 139.14 44.85 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.812 -1.18 . . . . 1.17 109.614 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.25 132.86 54.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.462 -0.774 . . . . 0.84 110.471 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.601 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 15.8 m-85 -119.19 157.21 28.43 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 116.294 -0.412 . . . . 0.45 109.941 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 84.1 t -132.14 122.69 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.795 -1.191 . . . . 0.27 110.575 173.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.49 ' OD1' HG12 ' A' ' 46' ' ' ILE . 47.4 p-10 -147.8 149.71 32.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.909 . . . . 1.77 110.602 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 52.7 t0 42.96 44.19 3.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.011 -1.055 . . . . 1.22 111.317 173.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.7 mt-10 57.84 14.46 2.54 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.051 -1.03 . . . . 1.93 110.54 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -114.09 153.32 29.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -0.929 . . . . 2.01 109.984 175.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.835 HG22 HD11 ' A' ' 47' ' ' LEU . 66.0 mt -91.82 127.77 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.23 -0.919 . . . . 1.25 109.762 177.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 24.5 mm -112.96 120.07 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.633 -0.667 . . . . 0.5 109.896 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.843 ' CD2' HG21 ' B' ' 18' ' ' VAL . 4.1 mp -118.72 134.5 55.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.902 -1.124 . . . . 1.66 110.256 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.533 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 9.8 pttp -141.81 164.49 30.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 1.74 110.451 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -58.68 147.08 34.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 1.65 110.146 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.884 ' CD2' HG11 ' B' ' 9' ' ' VAL . 7.8 t80 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.833 . . . . 0.35 110.603 -176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.931 HG13 ' O ' ' A' ' 36' ' ' LEU . 89.2 t . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 121.471 0.653 . . . . 0.37 110.919 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -131.42 162.35 30.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.555 -0.716 . . . . 1.92 109.72 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -85.16 148.01 26.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.083 -1.01 . . . . 2.21 110.393 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.935 HG22 ' CD1' ' A' ' 36' ' ' LEU . 3.9 t -82.29 129.85 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.213 -0.929 . . . . 0.29 109.7 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.42 -175.55 5.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.956 . . . . 0.55 110.097 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -54.89 -40.65 69.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 2.19 111.674 -172.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.845 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.1 tp -84.42 -5.97 59.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.772 -1.205 . . . . 1.39 111.599 -173.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.489 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.18 47.31 7.07 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.558 -1.417 . . . . 0.21 109.558 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.9 ' CD ' HG22 ' A' ' 19' ' ' VAL . 68.7 mtm180 -114.29 153.69 29.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.085 -1.244 . . . . 1.14 110.061 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.923 HG12 HD13 ' A' ' 36' ' ' LEU . 16.4 m -124.12 152.96 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 0.28 109.813 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.898 HG22 ' CD ' ' A' ' 17' ' ' ARG . 18.0 t -112.37 134.36 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.24 110.686 -175.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.696 HD11 HG21 ' A' ' 45' ' ' ILE . 2.3 mm -82.91 134.02 47.54 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.934 . . . . 1.38 109.409 173.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.4 Cg_endo -58.96 141.57 98.39 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.807 1.425 . . . . 0.36 109.899 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.956 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.95 -31.13 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.068 -1.02 . . . . 1.11 110.409 -176.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' B' ' 21' ' ' PRO . 20.0 pt-20 -59.16 -35.38 73.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.023 -1.048 . . . . 2.37 109.59 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.596 ' HB2' HG23 ' B' ' 20' ' ' ILE . 57.3 mt -80.03 -29.83 39.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.484 -0.76 . . . . 1.75 110.334 176.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.64 HH22 HD11 ' A' ' 15' ' ' LEU . 73.0 mtt180 -56.83 -44.08 81.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.01 -1.056 . . . . 0.3 109.203 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -72.3 -50.78 24.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.468 -0.77 . . . . 3.27 110.642 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.3 m -63.2 -32.05 73.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.888 . . . . 0.77 110.921 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.864 HD23 HG13 ' B' ' 30' ' ' ILE . 18.5 tp -87.39 -4.99 59.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.026 -1.047 . . . . 1.05 110.73 -176.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.447 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.31 41.8 94.4 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.603 -1.399 . . . . 0.32 109.603 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.864 HG13 HD23 ' B' ' 28' ' ' LEU . 32.1 mm -116.41 138.29 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -1.183 . . . . 0.41 110.616 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.39 166.44 24.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.562 -0.711 . . . . 0.23 110.026 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.48 147.0 11.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.136 -0.978 . . . . 1.13 110.486 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 26.6 ttpt 74.59 -4.76 2.26 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.661 -0.65 . . . . 1.88 111.126 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.657 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.0 m-20 -77.76 167.54 21.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.825 -1.172 . . . . 1.1 110.107 175.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.758 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.28 130.98 52.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.184 -0.948 . . . . 0.36 110.803 -176.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.932 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.2 mt -108.02 144.08 35.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.842 . . . . 0.56 109.551 174.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.617 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.7 tt0 -109.11 139.09 44.48 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.868 -1.145 . . . . 1.17 109.8 172.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.32 132.84 55.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.363 -0.836 . . . . 0.84 110.427 -172.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.591 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 15.6 m-85 -119.18 157.24 28.35 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 116.231 -0.44 . . . . 0.45 109.874 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 85.7 t -131.96 123.08 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.958 -1.089 . . . . 0.26 110.441 173.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.484 ' OD1' HG12 ' B' ' 46' ' ' ILE . 47.6 p-10 -148.35 149.63 32.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.16 -0.962 . . . . 1.77 110.561 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 53.2 t0 42.87 44.48 3.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.129 -0.982 . . . . 1.21 111.287 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.7 mt-10 57.61 14.53 2.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.045 -1.034 . . . . 1.92 110.503 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -114.08 153.49 29.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.292 -0.88 . . . . 2.0 109.989 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.832 HG22 HD11 ' B' ' 47' ' ' LEU . 65.7 mt -91.95 127.72 44.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.263 -0.898 . . . . 1.24 109.771 177.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.591 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 24.7 mm -113.02 120.1 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.513 -0.742 . . . . 0.5 109.903 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.832 HD11 HG22 ' B' ' 45' ' ' ILE . 4.2 mp -118.66 134.34 55.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.974 -1.079 . . . . 1.66 110.196 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.535 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 10.1 pttp -141.62 164.81 29.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 1.74 110.406 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -58.89 147.04 35.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 1.65 109.953 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 1.05 ' CD2' HG11 ' A' ' 9' ' ' VAL . 7.9 t80 . . . . . 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.65 110.583 -176.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.1 mm . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 120.979 0.419 . . . . 1.36 110.061 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.943 HG13 ' O ' ' B' ' 36' ' ' LEU . 95.9 t -115.82 144.85 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.063 -1.023 . . . . 0.37 110.81 -176.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -131.44 160.27 35.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.515 -0.74 . . . . 1.91 109.704 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -85.58 148.0 26.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.062 -1.024 . . . . 2.21 110.307 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.932 HG22 HD11 ' B' ' 36' ' ' LEU . 4.3 t -81.91 130.3 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.268 -0.895 . . . . 0.28 109.855 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.74 -174.64 5.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.55 110.157 -179.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.42 -41.95 66.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.123 -0.986 . . . . 2.19 111.887 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.901 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.0 tp -87.48 -3.06 59.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.68 -1.262 . . . . 1.38 111.755 -172.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.528 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 79.98 46.36 7.75 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.168 -1.491 . . . . 0.21 109.674 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.935 ' CD ' HG22 ' B' ' 19' ' ' VAL . 76.9 mtm180 -116.2 154.28 30.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.098 -1.236 . . . . 1.15 109.828 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.645 HG12 HD13 ' B' ' 36' ' ' LEU . 27.4 m -125.7 153.14 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 0.28 109.938 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.935 HG22 ' CD ' ' B' ' 17' ' ' ARG . 22.7 t -111.55 135.52 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.24 110.548 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.31 134.25 46.01 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.255 -0.903 . . . . 1.38 109.577 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.54 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.4 Cg_endo -57.83 142.81 96.41 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.788 1.415 . . . . 0.35 110.025 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.893 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.37 -32.56 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.034 -1.041 . . . . 1.11 110.378 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.96 -35.9 71.8 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.143 -0.973 . . . . 2.37 109.9 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.543 ' HB2' HG23 ' A' ' 20' ' ' ILE . 51.8 mt -81.03 -31.3 34.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 1.75 110.542 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.893 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.9 mtt180 -58.17 -43.51 87.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.954 -1.091 . . . . 0.3 109.287 176.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -73.19 -49.66 26.81 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.797 -0.761 . . . . 3.26 110.694 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.5 m -63.9 -31.86 73.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.77 111.093 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.823 HD23 HG13 ' A' ' 30' ' ' ILE . 17.4 tp -88.16 -4.61 58.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.055 -1.028 . . . . 1.05 110.737 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.48 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.78 42.35 95.21 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.681 -1.367 . . . . 0.32 109.681 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.823 HG13 HD23 ' A' ' 28' ' ' LEU . 31.4 mm -116.32 137.79 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.302 -1.116 . . . . 0.41 110.715 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.43 168.65 19.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.589 -0.694 . . . . 0.23 110.061 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.77 145.87 14.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.111 -0.993 . . . . 1.13 110.616 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 41.3 tttp 74.0 -4.35 2.3 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.751 -0.593 . . . . 1.88 111.231 176.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.718 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.1 m-20 -76.84 166.28 23.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.818 -1.176 . . . . 1.1 110.047 174.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.727 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -103.7 131.08 51.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.953 . . . . 0.36 110.823 -175.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.992 HD11 HG22 ' B' ' 12' ' ' VAL . 13.2 mt -108.05 144.48 35.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.372 -0.83 . . . . 0.56 109.392 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.684 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.3 tt0 -108.81 138.28 45.39 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.732 -1.23 . . . . 1.17 109.517 172.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.3 mt -109.09 131.79 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.419 -0.801 . . . . 0.84 110.582 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.614 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.6 m-85 -117.58 159.26 23.18 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.83 -0.433 . . . . 0.45 109.83 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 73.3 t -133.26 120.93 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.876 -1.14 . . . . 0.27 110.554 172.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 47.2 p-10 -148.4 159.96 43.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.167 -0.958 . . . . 1.77 110.603 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 53.9 t0 42.29 40.35 1.76 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.025 -1.047 . . . . 1.22 111.599 171.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 84.2 tt0 58.87 14.09 3.1 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.844 -1.16 . . . . 1.93 110.567 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.529 ' CE ' HD11 ' A' ' 46' ' ' ILE . 14.0 pttt -127.18 164.45 21.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.96 . . . . 2.01 109.691 174.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.595 HG22 HD11 ' A' ' 47' ' ' LEU . 68.9 mt -97.41 134.89 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.137 -0.977 . . . . 1.25 110.322 -176.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.614 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 22.3 mm -114.16 119.39 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.674 -0.641 . . . . 0.5 109.857 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.829 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.3 mp -115.95 135.07 54.32 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.021 -1.05 . . . . 1.66 110.226 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.594 ' HE3' ' CE2' ' A' ' 39' ' ' TYR . 1.7 ptpm? -141.17 159.08 42.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.439 -0.788 . . . . 1.74 110.389 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -57.75 146.9 29.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.101 -1.0 . . . . 1.65 109.96 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.727 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 6.0 t80 . . . . . 0 C--N 1.301 -1.542 0 O-C-N 121.228 -0.92 . . . . 0.35 110.524 -176.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 36' ' ' LEU . 96.3 t . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.553 0.692 . . . . 0.37 110.81 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -131.41 160.16 35.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.501 -0.75 . . . . 1.92 109.736 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -85.6 148.01 26.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.076 -1.015 . . . . 2.21 110.442 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.992 HG22 HD11 ' A' ' 36' ' ' LEU . 4.4 t -81.9 130.38 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.29 109.703 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.9 -174.47 5.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.115 -0.991 . . . . 0.55 110.305 -179.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -53.66 -41.72 67.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.185 -0.947 . . . . 2.19 111.79 -172.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.898 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.6 tp -87.51 -3.28 59.0 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.695 -1.253 . . . . 1.39 111.665 -172.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.54 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.81 46.93 7.5 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.477 -1.449 . . . . 0.21 109.477 -177.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.935 ' CD ' HG22 ' A' ' 19' ' ' VAL . 76.7 mtm180 -116.29 154.31 30.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.132 -1.217 . . . . 1.14 109.864 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.646 HG12 HD13 ' A' ' 36' ' ' LEU . 27.2 m -125.68 153.19 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.28 109.937 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.935 HG22 ' CD ' ' A' ' 17' ' ' ARG . 22.5 t -111.61 135.43 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 0.24 110.559 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.557 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -83.15 134.23 46.46 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 1.38 109.608 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.537 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.3 Cg_endo -57.94 142.82 96.73 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.765 1.403 . . . . 0.36 109.992 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.89 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.54 -32.3 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.11 -0.994 . . . . 1.11 110.359 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.98 -36.41 72.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.074 -1.016 . . . . 2.37 109.794 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.557 ' HB2' HG23 ' B' ' 20' ' ' ILE . 52.3 mt -80.34 -31.62 37.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.494 -0.754 . . . . 1.75 110.574 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.89 ' HD2' HD12 ' B' ' 22' ' ' ILE . 72.3 mtt180 -58.02 -43.46 86.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.896 -1.128 . . . . 0.3 109.246 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -73.17 -49.75 26.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 3.27 110.64 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.0 m -63.74 -32.44 73.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.193 -0.942 . . . . 0.77 110.785 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.832 HD23 HG13 ' B' ' 30' ' ' ILE . 17.5 tp -87.71 -4.87 58.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.098 -1.001 . . . . 1.05 110.709 -176.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.482 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.04 42.15 94.77 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.624 -1.391 . . . . 0.32 109.624 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.832 HG13 HD23 ' B' ' 28' ' ' LEU . 31.2 mm -116.24 137.67 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -1.221 . . . . 0.41 110.705 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.16 168.89 18.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.518 -0.739 . . . . 0.23 109.997 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.87 145.9 15.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.163 -0.961 . . . . 1.13 110.493 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 41.2 tttp 74.13 -4.49 2.28 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.583 -0.698 . . . . 1.88 111.179 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.611 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.1 m-20 -77.0 166.0 23.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.755 -1.216 . . . . 1.1 109.979 174.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.738 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.45 131.19 50.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.36 110.855 -175.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.943 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.2 mt -108.2 144.07 36.14 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.328 -0.858 . . . . 0.56 109.448 174.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.662 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.0 tt0 -108.32 138.22 44.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.851 -1.155 . . . . 1.17 109.729 172.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -109.07 131.87 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.293 -0.879 . . . . 0.84 110.507 -171.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.624 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 10.6 m-85 -117.52 159.26 23.14 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 116.264 -0.425 . . . . 0.45 109.914 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 74.4 t -133.11 121.37 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.876 -1.14 . . . . 0.26 110.441 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 47.2 p-10 -148.93 159.97 43.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 1.77 110.543 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 54.7 t0 42.09 40.62 1.73 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.126 -0.984 . . . . 1.21 111.577 172.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' B' ' 43' ' ' GLU . 84.1 tt0 58.79 14.03 3.02 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.816 -1.178 . . . . 1.92 110.529 174.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.534 ' CE ' HD11 ' B' ' 46' ' ' ILE . 13.9 pttt -127.19 164.65 21.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.089 -1.007 . . . . 2.0 109.571 174.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.633 HG22 HD11 ' B' ' 47' ' ' LEU . 68.9 mt -97.48 134.73 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 1.24 110.374 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 22.0 mm -114.15 119.45 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.714 -0.616 . . . . 0.5 109.869 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.818 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.4 mp -115.94 134.86 54.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.03 -1.044 . . . . 1.66 110.208 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.58 ' HE3' ' CE2' ' B' ' 39' ' ' TYR . 1.7 ptpm? -140.99 159.3 42.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 1.74 110.316 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -57.9 146.78 30.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.954 . . . . 1.65 109.909 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.927 ' CD2' HG11 ' A' ' 9' ' ' VAL . 6.1 t80 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.65 110.415 -176.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.6 mt . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 121.076 0.465 . . . . 1.36 110.088 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.076 HG11 ' CD2' ' B' ' 50' ' ' TYR . 85.9 t -120.04 144.37 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.988 -1.07 . . . . 0.37 110.809 -176.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -131.04 161.21 32.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.525 -0.734 . . . . 1.91 109.69 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -85.39 148.09 26.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.133 -0.979 . . . . 2.21 110.34 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.908 HG22 HD11 ' B' ' 36' ' ' LEU . 3.6 t -82.93 129.94 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.89 . . . . 0.28 109.831 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.8 -175.82 5.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.106 -0.996 . . . . 0.55 109.923 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.06 -40.38 70.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.104 -0.997 . . . . 2.19 111.677 -173.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.878 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.4 tp -83.25 -6.48 59.49 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.845 -1.159 . . . . 1.38 111.539 -173.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.515 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.74 46.47 7.23 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.243 -1.455 . . . . 0.21 109.652 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.908 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.7 mtm180 -114.47 154.82 27.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.05 -1.265 . . . . 1.15 110.065 -177.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.815 HG12 HD13 ' B' ' 36' ' ' LEU . 19.4 m -123.69 152.56 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.398 -0.814 . . . . 0.28 109.86 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.933 HG22 ' CD ' ' B' ' 17' ' ' ARG . 31.2 t -111.77 134.03 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.179 -0.951 . . . . 0.24 110.69 -175.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.578 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.63 132.86 50.69 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 1.38 109.437 173.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.547 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.7 Cg_endo -57.47 141.29 95.02 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.699 1.368 . . . . 0.35 109.83 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.947 HD13 ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.75 -31.93 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.107 . . . . 1.11 110.303 -177.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.15 -36.48 70.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.017 . . . . 2.37 109.79 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.578 ' HB2' HG23 ' A' ' 20' ' ' ILE . 52.8 mt -80.86 -29.04 35.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.262 -0.899 . . . . 1.75 110.487 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.71 HH22 HD11 ' B' ' 15' ' ' LEU . 75.8 mtt180 -56.85 -43.65 81.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.879 -1.138 . . . . 0.3 109.18 175.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -72.85 -50.67 22.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.557 -0.715 . . . . 3.26 110.755 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.6 m -63.43 -31.3 72.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.77 111.117 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.846 HD23 HG13 ' A' ' 30' ' ' ILE . 26.3 tp -87.55 -4.93 58.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 1.05 110.782 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.464 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.39 42.86 97.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.626 -1.39 . . . . 0.32 109.626 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.846 HG13 HD23 ' A' ' 28' ' ' LEU . 29.5 mm -116.12 139.0 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -1.149 . . . . 0.41 110.7 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.5 166.99 23.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.625 -0.672 . . . . 0.23 109.998 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.2 tt0 -53.41 146.31 12.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.966 . . . . 1.13 110.553 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 77.2 tttt 74.86 -4.68 2.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.749 -0.594 . . . . 1.88 111.164 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.748 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.4 m-20 -77.16 166.09 23.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.779 -1.2 . . . . 1.1 110.044 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.755 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.83 132.57 50.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.941 . . . . 0.36 110.855 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.96 HD11 HG22 ' B' ' 12' ' ' VAL . 13.0 mt -109.43 143.65 38.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.397 -0.814 . . . . 0.56 109.555 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.667 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.4 tt0 -108.63 140.29 42.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.836 -1.165 . . . . 1.17 109.824 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.414 HD13 ' O ' ' A' ' 37' ' ' GLU . 21.5 mm -111.15 133.18 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.435 -0.79 . . . . 0.84 110.555 -173.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.582 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 14.4 m-85 -115.16 159.2 21.21 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 120.911 0.386 . . . . 0.45 109.972 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.5 t -130.45 128.92 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.931 -1.106 . . . . 0.27 110.802 173.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.663 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.7 p-10 -146.54 129.5 16.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.866 . . . . 1.77 110.215 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 48.9 t0 46.12 50.11 11.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.007 -1.058 . . . . 1.22 110.96 175.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.4 mt-10 59.95 12.69 3.24 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.348 -0.845 . . . . 1.93 110.714 176.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 9.6 mtmt -113.12 150.62 31.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 2.01 109.811 175.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.634 HG22 HD11 ' A' ' 47' ' ' LEU . 62.8 mt -101.76 128.84 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.058 -1.026 . . . . 1.25 110.327 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.663 HD11 ' OD2' ' A' ' 41' ' ' ASP . 28.8 mt -112.06 121.47 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.391 -0.818 . . . . 0.5 110.14 176.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.843 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.3 mp -114.52 135.02 54.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.073 -1.017 . . . . 1.66 110.237 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.541 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 10.6 pttp -141.48 165.0 28.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.454 -0.779 . . . . 1.74 110.273 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -58.2 147.5 30.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.978 . . . . 1.65 110.009 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.934 ' CD2' HG11 ' B' ' 9' ' ' VAL . 5.9 t80 . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.885 . . . . 0.35 110.566 -175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.943 HG13 ' O ' ' A' ' 36' ' ' LEU . 85.9 t . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.479 0.656 . . . . 0.37 110.779 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -130.86 161.12 32.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.467 -0.771 . . . . 1.92 109.845 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -85.43 147.98 26.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 2.21 110.404 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.96 HG22 HD11 ' A' ' 36' ' ' LEU . 3.6 t -82.87 129.99 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.918 . . . . 0.29 109.764 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.449 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -83.97 -175.72 5.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.089 -1.007 . . . . 0.55 110.087 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.13 -40.43 70.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.183 -0.948 . . . . 2.19 111.558 -173.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.891 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.9 tp -83.07 -6.7 59.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.856 -1.152 . . . . 1.39 111.563 -173.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.528 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.43 47.2 6.99 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.549 -1.421 . . . . 0.21 109.549 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.933 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.9 mtm180 -114.67 154.72 27.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.096 -1.238 . . . . 1.14 110.049 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.832 HG12 HD13 ' A' ' 36' ' ' LEU . 19.4 m -123.67 152.55 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.28 109.858 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.908 HG22 ' CD ' ' A' ' 17' ' ' ARG . 30.8 t -111.76 134.06 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.13 -0.981 . . . . 0.24 110.638 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.598 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.66 132.83 50.69 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 1.38 109.392 173.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.7 Cg_endo -57.59 141.23 95.25 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.732 1.385 . . . . 0.36 109.918 177.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.945 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.82 -31.71 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.991 -1.068 . . . . 1.11 110.262 -177.345 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.03 -37.19 71.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.022 -1.049 . . . . 2.37 109.649 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.598 ' HB2' HG23 ' B' ' 20' ' ' ILE . 53.6 mt -80.1 -29.39 39.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.437 -0.789 . . . . 1.75 110.438 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.642 HH22 HD11 ' A' ' 15' ' ' LEU . 75.7 mtt180 -56.75 -43.6 80.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.901 -1.124 . . . . 0.3 109.109 175.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -72.72 -51.02 20.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 3.27 110.612 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 48.0 m -63.16 -31.76 72.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -0.869 . . . . 0.77 110.944 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.851 HD23 HG13 ' B' ' 30' ' ' ILE . 26.6 tp -87.04 -5.34 59.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.102 -0.999 . . . . 1.05 110.681 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.464 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.67 42.74 97.11 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.539 -1.424 . . . . 0.32 109.539 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.851 HG13 HD23 ' B' ' 28' ' ' LEU . 29.3 mm -116.02 138.78 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -1.162 . . . . 0.41 110.747 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.18 167.22 22.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.61 -0.681 . . . . 0.23 109.907 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.6 146.42 13.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.942 . . . . 1.13 110.515 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 77.1 tttt 74.99 -4.9 2.27 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.662 -0.648 . . . . 1.88 111.205 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.658 ' O ' HG23 ' A' ' 12' ' ' VAL . 88.7 m-20 -77.34 165.89 23.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.866 -1.146 . . . . 1.1 110.065 174.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.755 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.64 132.51 50.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.36 110.926 -175.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.937 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.9 mt -109.46 143.4 39.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.449 -0.782 . . . . 0.56 109.622 175.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.651 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.3 tt0 -108.4 140.23 41.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.787 -1.195 . . . . 1.17 110.017 173.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . 0.416 HD13 ' O ' ' B' ' 37' ' ' GLU . 21.5 mm -111.03 133.16 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.315 -0.865 . . . . 0.84 110.549 -173.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.593 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 14.1 m-85 -115.28 159.23 21.28 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 116.308 -0.405 . . . . 0.45 109.956 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 81.4 t -130.24 129.21 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.862 -1.149 . . . . 0.26 110.612 173.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.662 ' CG ' HD11 ' B' ' 46' ' ' ILE . 9.8 p-10 -146.86 129.44 15.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 1.77 110.2 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 50.0 t0 46.29 50.13 12.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.012 -1.055 . . . . 1.21 110.959 175.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.4 mt-10 59.85 12.73 3.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.275 -0.891 . . . . 1.92 110.694 176.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 9.6 mtmt -113.13 150.76 31.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 2.0 109.703 175.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.651 HG22 HD11 ' B' ' 47' ' ' LEU . 62.3 mt -101.77 128.82 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.01 . . . . 1.24 110.391 -176.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.662 HD11 ' CG ' ' B' ' 41' ' ' ASP . 29.9 mt -112.3 121.41 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.38 -0.825 . . . . 0.5 110.099 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.836 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.4 mp -114.42 134.96 54.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.006 -1.059 . . . . 1.66 110.173 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.532 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 10.8 pttp -141.42 165.19 28.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 1.74 110.222 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -58.18 147.42 30.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 1.65 109.984 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 1.076 ' CD2' HG11 ' A' ' 9' ' ' VAL . 6.0 t80 . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.65 110.598 -176.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.6 mt . . . . . 0 N--CA 1.495 1.781 0 CA-C-O 121.09 0.471 . . . . 1.36 110.02 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.934 HG11 ' CD2' ' B' ' 50' ' ' TYR . 88.8 t -115.8 143.92 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.089 -1.007 . . . . 0.37 110.806 -176.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -128.27 159.3 35.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.381 -0.824 . . . . 1.91 109.613 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -84.21 148.08 26.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.041 -1.037 . . . . 2.21 110.317 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.96 HG22 HD11 ' B' ' 36' ' ' LEU . 4.3 t -82.96 130.0 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.301 -0.874 . . . . 0.28 109.885 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.47 -174.74 5.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.55 110.025 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.27 -39.5 72.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.009 -1.057 . . . . 2.19 111.739 -172.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.853 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.7 tp -85.73 -4.24 59.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.766 -1.209 . . . . 1.38 111.629 -173.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.472 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 79.95 46.45 7.72 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.173 -1.489 . . . . 0.21 109.687 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.923 ' CD ' HG22 ' B' ' 19' ' ' VAL . 73.7 mtm180 -116.34 154.98 29.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.055 -1.262 . . . . 1.15 109.945 -177.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.681 HG12 HD13 ' B' ' 36' ' ' LEU . 22.4 m -123.49 150.67 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.28 109.786 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.946 HG22 ' CD ' ' B' ' 17' ' ' ARG . 23.1 t -112.62 134.96 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.24 110.578 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.928 HD11 HD13 ' B' ' 45' ' ' ILE . 4.5 mm -84.49 134.42 42.6 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 1.38 109.658 176.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.551 ' HG2' HD12 ' A' ' 24' ' ' LEU . 9.9 Cg_endo -58.49 143.67 97.74 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.812 1.428 . . . . 0.35 110.089 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.89 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.02 -33.29 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.934 -1.104 . . . . 1.11 110.377 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.411 ' N ' HG23 ' A' ' 22' ' ' ILE . 84.4 tt0 -58.05 -35.72 71.73 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.107 -0.996 . . . . 2.37 109.808 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.574 ' HB2' HG23 ' A' ' 20' ' ' ILE . 52.3 mt -82.48 -29.95 30.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 1.75 110.591 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.89 ' HD2' HD12 ' A' ' 22' ' ' ILE . 71.9 mtt180 -57.6 -43.7 84.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.834 -1.166 . . . . 0.3 109.093 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -71.43 -49.44 41.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.568 -0.707 . . . . 3.26 110.724 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.1 m -63.32 -32.01 73.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.23 -0.919 . . . . 0.77 111.114 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.885 HD23 HG13 ' A' ' 30' ' ' ILE . 22.1 tp -87.78 -4.82 58.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.084 -1.01 . . . . 1.05 110.75 -177.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.437 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.75 42.76 96.99 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.731 -1.348 . . . . 0.32 109.731 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.885 HG13 HD23 ' A' ' 28' ' ' LEU . 32.4 mm -116.35 138.91 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -1.183 . . . . 0.41 110.794 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.16 167.04 23.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.589 -0.694 . . . . 0.23 109.982 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.37 146.48 12.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.082 -1.011 . . . . 1.13 110.541 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 75.2 tttt 74.46 -4.64 2.28 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.702 -0.623 . . . . 1.88 111.137 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.741 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.6 m-20 -77.41 165.95 23.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.73 -1.231 . . . . 1.1 110.051 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.66 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.08 130.69 51.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.2 -0.938 . . . . 0.36 110.715 -176.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.97 HD11 HG22 ' B' ' 12' ' ' VAL . 12.1 mt -107.89 142.21 38.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.375 -0.828 . . . . 0.56 109.367 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.662 ' HA ' HG22 ' B' ' 9' ' ' VAL . 84.8 tt0 -106.25 137.96 43.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.791 -1.193 . . . . 1.17 109.787 173.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.39 132.56 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.522 -0.736 . . . . 0.84 110.44 -174.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.592 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 16.2 m-85 -115.03 158.04 22.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 122.061 -0.399 . . . . 0.45 110.11 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.2 t -129.8 123.97 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.935 -1.103 . . . . 0.27 110.739 173.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.59 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.2 p-10 -147.17 139.03 24.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 1.77 110.263 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.3 t0 43.68 47.22 6.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.021 -1.049 . . . . 1.22 111.159 174.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 44.3 tp10 62.4 10.33 3.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.148 -0.97 . . . . 1.93 110.723 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -115.66 148.33 39.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.91 . . . . 2.01 109.995 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 1.011 HD13 HD11 ' B' ' 20' ' ' ILE . 58.5 mt -99.6 129.09 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 1.25 110.103 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.0 mt -109.21 115.84 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.378 -0.826 . . . . 0.5 110.141 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.842 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -108.75 133.49 52.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.062 -1.024 . . . . 1.66 109.987 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.568 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 13.2 pttp -143.64 165.73 26.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.452 -0.78 . . . . 1.74 110.357 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -56.43 146.99 22.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 1.65 109.937 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.801 ' CD2' HG11 ' B' ' 9' ' ' VAL . 6.4 t80 . . . . . 0 C--N 1.298 -1.634 0 O-C-N 121.362 -0.836 . . . . 0.35 110.661 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.948 HG13 ' O ' ' A' ' 36' ' ' LEU . 89.9 t . . . . . 0 N--CA 1.494 1.741 0 CA-C-O 121.541 0.686 . . . . 0.37 110.76 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -128.28 159.09 36.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.494 -0.754 . . . . 1.92 109.768 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -84.03 148.03 27.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.042 -1.037 . . . . 2.21 110.403 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.97 HG22 HD11 ' A' ' 36' ' ' LEU . 4.3 t -82.91 130.1 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.33 -0.856 . . . . 0.29 109.804 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.69 -174.47 5.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 0.55 110.152 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.48 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.9 mt-10 -56.5 -39.45 73.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.086 -1.009 . . . . 2.19 111.646 -172.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.891 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.2 tp -85.79 -4.18 59.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.799 -1.188 . . . . 1.39 111.595 -173.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.491 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.56 47.19 7.48 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.514 -1.434 . . . . 0.21 109.514 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.946 ' CD ' HG22 ' A' ' 19' ' ' VAL . 73.5 mtm180 -116.46 154.98 29.38 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.039 -1.271 . . . . 1.14 109.982 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.687 HG12 HD13 ' A' ' 36' ' ' LEU . 22.4 m -123.54 150.59 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 0.28 109.804 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.923 HG22 ' CD ' ' A' ' 17' ' ' ARG . 23.0 t -112.64 134.98 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.24 110.505 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 1.011 HD11 HD13 ' A' ' 45' ' ' ILE . 4.5 mm -84.62 134.43 42.26 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 1.38 109.625 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.547 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.9 Cg_endo -58.67 143.69 98.41 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.811 1.427 . . . . 0.36 110.106 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.888 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.2 tp -55.16 -33.08 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.11 -0.993 . . . . 1.11 110.364 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . 0.409 ' N ' HG23 ' B' ' 22' ' ' ILE . 84.3 tt0 -57.88 -36.35 72.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.09 -1.006 . . . . 2.37 109.744 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.568 ' HB2' HG23 ' B' ' 20' ' ' ILE . 52.5 mt -81.74 -30.37 32.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.443 -0.785 . . . . 1.75 110.686 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.888 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.2 mtt180 -57.43 -43.59 83.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.877 -1.14 . . . . 0.3 109.087 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -71.25 -49.77 39.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.39 -0.819 . . . . 3.27 110.666 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 51.0 m -63.04 -32.49 73.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.292 -0.88 . . . . 0.77 110.946 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.886 HD23 HG13 ' B' ' 30' ' ' ILE . 22.3 tp -87.34 -5.2 58.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 1.05 110.68 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.442 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.05 42.65 96.57 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.538 -1.425 . . . . 0.32 109.538 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.886 HG13 HD23 ' B' ' 28' ' ' LEU . 31.9 mm -116.27 138.87 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -1.181 . . . . 0.41 110.766 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.91 167.09 23.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.498 -0.751 . . . . 0.23 109.968 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.527 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.43 146.48 12.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 1.13 110.555 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 75.0 tttt 74.63 -4.76 2.27 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.648 -0.657 . . . . 1.88 111.166 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.64 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.2 m-20 -77.49 165.64 24.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.792 -1.193 . . . . 1.1 110.042 174.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.638 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.92 130.65 51.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.36 110.836 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.96 HD11 HG22 ' A' ' 12' ' ' VAL . 12.0 mt -107.84 142.1 38.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.56 109.485 175.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.656 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.7 tt0 -106.08 137.84 43.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.87 -1.144 . . . . 1.17 109.911 173.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 71.0 mt -111.25 132.61 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.388 -0.82 . . . . 0.84 110.383 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.6 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 15.9 m-85 -115.06 157.92 22.85 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 120.896 0.379 . . . . 0.45 110.122 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 94.1 t -129.53 124.3 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.937 -1.102 . . . . 0.26 110.55 173.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.601 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.4 p-10 -147.66 138.88 23.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.875 . . . . 1.77 110.208 177.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.9 t0 43.99 47.18 7.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.165 -0.959 . . . . 1.21 111.136 174.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 44.2 tp10 62.21 10.36 3.74 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.234 -0.916 . . . . 1.92 110.725 175.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -115.57 148.6 39.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 2.0 109.928 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.928 HD13 HD11 ' A' ' 20' ' ' ILE . 58.2 mt -99.76 129.16 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 1.24 110.096 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.601 HD11 ' OD2' ' B' ' 41' ' ' ASP . 21.7 mt -109.39 115.8 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.472 -0.767 . . . . 0.5 110.136 177.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.842 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.3 mp -108.55 133.4 52.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.028 -1.045 . . . . 1.66 109.934 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.572 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 13.5 pttp -143.65 165.96 26.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.447 -0.783 . . . . 1.74 110.294 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -56.48 146.94 23.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.95 . . . . 1.65 109.92 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.934 ' CD2' HG11 ' A' ' 9' ' ' VAL . 6.5 t80 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.65 110.529 -175.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.0 mm . . . . . 0 N--CA 1.495 1.815 0 CA-C-O 120.996 0.427 . . . . 1.36 109.947 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.102 HG11 ' CD2' ' B' ' 50' ' ' TYR . 87.1 t -116.13 143.91 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.101 -0.999 . . . . 0.37 110.842 -175.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.401 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 17.4 tpt180 -128.07 157.11 41.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.472 -0.767 . . . . 1.91 109.789 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 26.0 ttpt -83.14 144.97 29.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.141 -0.974 . . . . 2.21 110.35 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.984 HG22 HD11 ' B' ' 36' ' ' LEU . 4.0 t -80.55 128.68 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.337 -0.852 . . . . 0.28 109.762 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.53 -175.01 5.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.55 110.021 179.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.52 -40.56 68.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.097 -1.002 . . . . 2.19 111.728 -173.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.872 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.8 tp -85.32 -4.18 59.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.798 -1.189 . . . . 1.38 111.611 -173.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.29 46.18 7.67 Favored Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.133 -1.508 . . . . 0.21 109.68 -177.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.931 ' CD ' HG22 ' B' ' 19' ' ' VAL . 73.1 mtm180 -116.15 154.72 29.51 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.012 -1.287 . . . . 1.15 109.818 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.674 HG12 ' CD1' ' B' ' 36' ' ' LEU . 22.5 m -124.49 152.35 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.28 110.001 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.953 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.5 t -113.71 133.95 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.24 110.571 -175.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.653 HD11 HD13 ' B' ' 45' ' ' ILE . 2.5 mm -85.04 138.09 37.21 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.227 -0.921 . . . . 1.38 109.636 175.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.7 Cg_endo -59.68 142.94 99.62 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.71 1.374 . . . . 0.35 109.972 176.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.918 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.22 -32.39 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.962 -1.086 . . . . 1.11 110.478 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -58.14 -35.67 71.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.147 -0.971 . . . . 2.37 109.915 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.612 ' HB2' HG23 ' A' ' 20' ' ' ILE . 63.2 mt -82.21 -30.35 30.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 1.75 110.614 178.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.918 ' HD2' HD12 ' A' ' 22' ' ' ILE . 74.2 mtt180 -57.77 -43.86 85.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.926 -1.109 . . . . 0.3 109.113 176.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -72.97 -48.48 36.26 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.848 -0.741 . . . . 3.26 110.723 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.6 m -63.72 -31.57 72.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 0.77 111.135 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.815 HD23 HG13 ' A' ' 30' ' ' ILE . 19.2 tp -87.94 -4.53 58.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.026 -1.046 . . . . 1.05 110.795 -177.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.09 40.87 95.24 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.714 -1.354 . . . . 0.32 109.714 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.815 HG13 HD23 ' A' ' 28' ' ' LEU . 36.5 mm -116.54 139.03 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -1.123 . . . . 0.41 110.632 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.0 166.76 23.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.623 -0.673 . . . . 0.23 109.978 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.58 146.54 12.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.102 -0.999 . . . . 1.13 110.534 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 19.9 tttt 74.96 -4.95 2.26 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.733 -0.605 . . . . 1.88 111.12 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.712 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.9 m-20 -78.18 165.81 23.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.902 -1.124 . . . . 1.1 110.054 174.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.745 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.61 131.01 52.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.36 110.726 -176.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.932 ' O ' HG13 ' B' ' 9' ' ' VAL . 13.5 mt -107.87 142.66 37.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.825 . . . . 0.56 109.458 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.687 ' HA ' HG22 ' B' ' 9' ' ' VAL . 84.8 tt0 -106.58 138.88 41.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.805 -1.184 . . . . 1.17 109.685 172.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 68.4 mt -111.37 133.39 57.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.393 -0.817 . . . . 0.84 110.561 -173.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.576 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 14.9 m-85 -114.81 157.94 22.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.99 -0.374 . . . . 0.45 109.99 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 93.1 t -130.7 120.43 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.942 -1.098 . . . . 0.27 110.664 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.549 ' OD2' HD11 ' A' ' 46' ' ' ILE . 5.9 p-10 -147.35 155.14 41.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 1.77 110.189 177.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 54.0 t0 42.38 41.75 2.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.06 -1.025 . . . . 1.22 111.345 172.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 46.5 tp10 60.81 12.34 3.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.031 -1.043 . . . . 1.93 110.778 174.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 19.3 pttt -128.77 161.29 30.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.114 -0.992 . . . . 2.01 109.848 174.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.816 HD13 HD11 ' B' ' 20' ' ' ILE . 56.5 mt -104.04 134.99 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.055 -1.028 . . . . 1.25 110.717 -172.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 25.1 mt -111.33 121.36 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.46 -0.775 . . . . 0.5 110.272 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.846 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.4 mp -112.06 133.84 53.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.986 -1.071 . . . . 1.66 110.117 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.543 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 14.0 pttp -141.6 166.08 25.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.45 -0.781 . . . . 1.74 110.359 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -55.94 147.73 18.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.196 -0.94 . . . . 1.65 110.077 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.95 ' CD2' HG11 ' B' ' 9' ' ' VAL . 4.4 t80 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.833 . . . . 0.35 110.73 -175.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.95 HG11 ' CD2' ' A' ' 50' ' ' TYR . 87.1 t . . . . . 0 N--CA 1.494 1.755 0 CA-C-O 121.527 0.68 . . . . 0.37 110.736 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 17.4 tpt180 -128.12 156.82 42.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.743 . . . . 1.92 109.892 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.4 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 26.1 ttpt -82.93 144.85 29.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.102 -0.999 . . . . 2.21 110.414 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.927 HG22 HD11 ' A' ' 36' ' ' LEU . 4.0 t -80.56 128.88 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.367 -0.833 . . . . 0.29 109.642 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -83.79 -174.9 5.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.045 -1.035 . . . . 0.55 110.177 179.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.65 -40.48 69.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.191 -0.943 . . . . 2.19 111.648 -173.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.898 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.4 tp -85.34 -4.22 59.09 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.755 -1.215 . . . . 1.39 111.647 -172.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.53 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.97 46.86 7.45 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.54 -1.424 . . . . 0.21 109.54 -177.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.953 ' CD ' HG22 ' A' ' 19' ' ' VAL . 72.6 mtm180 -116.33 154.69 29.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.153 -1.204 . . . . 1.14 109.831 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.673 HG12 ' CD1' ' A' ' 36' ' ' LEU . 22.6 m -124.48 152.33 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.92 . . . . 0.28 110.004 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.931 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.6 t -113.72 133.96 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.24 110.542 -175.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.816 HD11 HD13 ' A' ' 45' ' ' ILE . 2.5 mm -85.11 138.1 37.04 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.219 -0.925 . . . . 1.38 109.593 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.7 Cg_endo -59.78 142.91 99.54 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.755 1.397 . . . . 0.36 110.043 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.919 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -55.28 -32.25 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.027 -1.046 . . . . 1.11 110.44 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -57.99 -36.27 72.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.091 -1.006 . . . . 2.37 109.811 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.598 ' HB2' HG23 ' B' ' 20' ' ' ILE . 63.2 mt -81.62 -30.76 32.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.401 -0.812 . . . . 1.75 110.601 178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.919 ' HD2' HD12 ' B' ' 22' ' ' ILE . 73.8 mtt180 -57.54 -43.68 84.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.875 -1.141 . . . . 0.3 109.207 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -72.96 -48.71 34.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.898 . . . . 3.27 110.61 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 52.0 m -63.45 -32.22 73.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.282 -0.886 . . . . 0.77 110.895 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.815 HD23 HG13 ' B' ' 30' ' ' ILE . 19.4 tp -87.5 -4.79 58.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 1.05 110.711 -176.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.404 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.56 40.64 94.25 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.588 -1.405 . . . . 0.32 109.588 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.815 HG13 HD23 ' B' ' 28' ' ' LEU . 36.2 mm -116.52 138.9 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -1.13 . . . . 0.41 110.634 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.73 166.87 23.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.598 -0.689 . . . . 0.23 109.991 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.4 tt0 -53.6 146.72 12.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 1.13 110.421 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 19.8 tttt 75.03 -5.16 2.22 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.622 -0.674 . . . . 1.88 111.123 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.617 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.6 m-20 -78.19 165.66 23.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.816 -1.178 . . . . 1.1 110.03 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.751 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.55 130.92 52.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.36 110.776 -176.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.984 HD11 HG22 ' A' ' 12' ' ' VAL . 13.3 mt -107.9 142.52 37.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.386 -0.821 . . . . 0.56 109.494 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.666 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.7 tt0 -106.42 138.91 41.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.841 -1.162 . . . . 1.17 109.832 172.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 68.5 mt -111.42 133.41 57.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.289 -0.882 . . . . 0.84 110.469 -173.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.589 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 14.4 m-85 -114.77 157.86 22.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 122.096 -0.377 . . . . 0.45 110.07 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 93.7 t -130.42 120.84 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.899 -1.126 . . . . 0.26 110.464 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.549 ' OD2' HD11 ' B' ' 46' ' ' ILE . 6.0 p-10 -147.91 155.19 41.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 1.77 110.157 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 54.5 t0 42.19 41.99 2.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.115 -0.991 . . . . 1.21 111.375 173.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 46.3 tp10 60.75 12.3 3.66 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.088 -1.008 . . . . 1.92 110.7 174.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 19.1 pttt -128.78 161.54 29.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.009 . . . . 2.0 109.775 174.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.653 HD13 HD11 ' A' ' 20' ' ' ILE . 56.8 mt -104.16 135.03 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.061 -1.024 . . . . 1.24 110.665 -172.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 25.8 mt -111.6 121.32 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.455 -0.778 . . . . 0.5 110.181 176.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.842 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.5 mp -111.89 133.76 53.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.03 -1.044 . . . . 1.66 110.075 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.536 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 14.2 pttp -141.61 166.36 24.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.429 -0.794 . . . . 1.74 110.27 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -56.09 147.72 19.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 1.65 109.974 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 1.102 ' CD2' HG11 ' A' ' 9' ' ' VAL . 4.5 t80 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.65 110.646 -175.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.9 mt . . . . . 0 N--CA 1.496 1.844 0 CA-C-O 121.021 0.439 . . . . 1.36 109.983 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.935 HG13 ' O ' ' B' ' 36' ' ' LEU . 99.0 t -114.29 144.58 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.025 -1.047 . . . . 0.37 110.915 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -129.75 160.79 32.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.458 -0.776 . . . . 1.91 109.753 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -85.05 148.09 26.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.036 -1.04 . . . . 2.21 110.311 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.978 HG22 HD11 ' B' ' 36' ' ' LEU . 6.5 t -81.49 129.73 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.317 -0.865 . . . . 0.28 109.821 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.29 -175.09 5.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.124 -0.985 . . . . 0.55 109.941 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.07 -39.31 71.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 2.19 111.723 -172.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.863 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.4 tp -86.01 -5.03 59.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.803 -1.186 . . . . 1.38 111.5 -173.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.499 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.14 46.52 7.56 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.144 -1.503 . . . . 0.21 109.699 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.906 ' CD ' HG22 ' B' ' 19' ' ' VAL . 73.8 mtm180 -115.6 154.85 28.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.005 -1.291 . . . . 1.15 110.036 -177.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.749 HG12 HD13 ' B' ' 36' ' ' LEU . 24.8 m -124.3 151.72 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 0.28 109.855 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.923 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.2 t -113.22 135.18 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 0.24 110.601 -175.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.34 135.12 44.42 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 1.38 109.532 175.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.555 ' HG2' HD12 ' A' ' 24' ' ' LEU . 10.0 Cg_endo -58.64 143.34 98.6 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.734 1.386 . . . . 0.35 110.046 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.905 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.1 tp -55.08 -33.32 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.082 -1.012 . . . . 1.11 110.429 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 22' ' ' ILE . 84.4 tt0 -58.2 -35.34 71.48 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.17 -0.956 . . . . 2.37 109.893 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.555 HD12 ' HG2' ' A' ' 21' ' ' PRO . 50.0 mt -82.35 -29.97 30.66 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.35 -0.844 . . . . 1.75 110.65 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.905 ' HD2' HD12 ' A' ' 22' ' ' ILE . 71.4 mtt180 -57.74 -44.15 85.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.939 -1.1 . . . . 0.3 109.087 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -72.63 -47.81 44.63 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.818 -0.753 . . . . 3.26 110.756 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.1 m -63.68 -31.87 73.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.77 111.093 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.875 HD23 HG13 ' A' ' 30' ' ' ILE . 20.8 tp -87.69 -4.6 58.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.1 -1.0 . . . . 1.05 110.669 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.453 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.25 41.47 96.77 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.637 -1.385 . . . . 0.32 109.637 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.875 HG13 HD23 ' A' ' 28' ' ' LEU . 30.1 mm -116.4 139.75 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -1.144 . . . . 0.41 110.654 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.91 167.19 22.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.567 -0.708 . . . . 0.23 110.025 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.26 146.79 11.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.058 -1.026 . . . . 1.13 110.54 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 12.9 tttp 74.22 -4.58 2.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.743 -0.598 . . . . 1.88 111.273 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.716 ' O ' HG23 ' B' ' 12' ' ' VAL . 87.8 m-20 -77.01 166.63 23.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.751 -1.218 . . . . 1.1 109.973 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.706 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -103.29 131.6 50.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 0.36 110.757 -175.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 1.014 HD11 HG22 ' B' ' 12' ' ' VAL . 13.0 mt -108.76 144.3 36.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.342 -0.849 . . . . 0.56 109.307 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.642 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.6 tt0 -108.37 138.34 44.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.856 -1.152 . . . . 1.17 109.646 173.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.5 mt -107.87 131.31 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.489 -0.757 . . . . 0.84 110.415 -173.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.605 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 21.4 m-85 -118.85 156.79 28.84 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 120.927 0.394 . . . . 0.45 109.963 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.2 t -130.82 126.68 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.848 -1.158 . . . . 0.27 110.642 173.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.487 ' OD1' HG12 ' A' ' 46' ' ' ILE . 41.9 p-10 -147.23 142.23 27.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 1.77 110.607 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 52.3 t0 43.37 45.14 5.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.09 -1.006 . . . . 1.22 111.271 174.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.7 tt0 60.81 11.88 3.47 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.104 -0.997 . . . . 1.93 110.608 175.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 54.1 mtmt -114.4 153.92 29.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 2.01 109.628 175.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.929 HG22 HD11 ' A' ' 47' ' ' LEU . 67.8 mt -94.54 129.95 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.153 -0.967 . . . . 1.25 110.138 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.605 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 24.6 mm -113.15 121.79 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.659 -0.651 . . . . 0.5 109.877 178.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.929 HD11 HG22 ' A' ' 45' ' ' ILE . 4.0 mp -122.55 134.53 54.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.895 -1.128 . . . . 1.66 110.262 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.538 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 14.0 pttp -141.73 162.68 34.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 1.74 110.435 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.4 tttt -58.82 146.89 35.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 1.65 110.011 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.738 ' CD2' HG11 ' B' ' 9' ' ' VAL . 10.3 t80 . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.35 110.586 -176.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.943 HG13 ' O ' ' A' ' 36' ' ' LEU . 98.5 t . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.583 0.706 . . . . 0.37 110.898 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -129.75 160.72 32.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.483 -0.76 . . . . 1.92 109.707 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -85.16 148.02 26.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.962 -1.086 . . . . 2.21 110.331 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 1.014 HG22 HD11 ' A' ' 36' ' ' LEU . 6.6 t -81.47 129.85 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.369 -0.832 . . . . 0.29 109.734 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.48 -174.83 5.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.148 -0.97 . . . . 0.55 110.136 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.475 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.8 mt-10 -56.28 -39.28 72.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.057 . . . . 2.19 111.569 -172.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.904 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.0 tp -86.05 -4.98 59.29 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.715 -1.241 . . . . 1.39 111.52 -173.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.5 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.63 47.31 7.37 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.592 -1.403 . . . . 0.21 109.592 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.923 ' CD ' HG22 ' A' ' 19' ' ' VAL . 73.8 mtm180 -115.79 154.87 28.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.1 -1.235 . . . . 1.14 110.155 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.741 HG12 HD13 ' A' ' 36' ' ' LEU . 24.9 m -124.43 151.65 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.28 109.814 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.906 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.2 t -113.17 135.17 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.24 110.644 -175.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -83.33 135.0 44.56 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 1.38 109.588 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.544 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.0 Cg_endo -58.71 143.37 98.82 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.749 1.394 . . . . 0.36 110.169 177.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.903 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -55.08 -33.3 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.086 -1.009 . . . . 1.11 110.372 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . 0.409 ' N ' HG23 ' B' ' 22' ' ' ILE . 84.4 tt0 -57.97 -36.15 72.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.023 -1.048 . . . . 2.37 109.708 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.55 ' HB2' HG23 ' B' ' 20' ' ' ILE . 50.4 mt -81.49 -30.42 33.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.519 -0.738 . . . . 1.75 110.668 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.903 ' HD2' HD12 ' B' ' 22' ' ' ILE . 70.8 mtt180 -57.44 -44.1 84.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.834 -1.166 . . . . 0.3 109.098 176.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -72.56 -48.1 42.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.431 -0.793 . . . . 3.27 110.645 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.5 m -63.36 -32.55 74.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.288 -0.883 . . . . 0.77 110.857 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.892 HD23 HG13 ' B' ' 30' ' ' ILE . 20.9 tp -87.09 -5.0 59.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.052 -1.03 . . . . 1.05 110.678 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.46 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.57 41.33 96.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.564 -1.414 . . . . 0.32 109.564 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.892 HG13 HD23 ' B' ' 28' ' ' LEU . 30.0 mm -116.33 139.57 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -1.182 . . . . 0.41 110.717 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.58 167.3 22.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.471 -0.768 . . . . 0.23 110.057 -177.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.12 146.74 10.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 1.13 110.572 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 12.9 tttp 74.4 -4.89 2.21 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.657 -0.652 . . . . 1.88 111.198 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.615 ' O ' HG23 ' A' ' 12' ' ' VAL . 88.2 m-20 -76.98 166.35 23.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.819 -1.176 . . . . 1.1 110.039 174.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.719 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.04 131.53 49.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.36 110.877 -175.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.978 HD11 HG22 ' A' ' 12' ' ' VAL . 12.9 mt -108.84 144.11 37.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.428 -0.795 . . . . 0.56 109.362 174.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.624 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.4 tt0 -108.06 138.34 44.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.854 -1.154 . . . . 1.17 109.847 172.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -107.87 131.37 58.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.405 -0.809 . . . . 0.84 110.354 -173.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.608 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 21.1 m-85 -118.9 156.86 28.77 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.885 -0.413 . . . . 0.45 109.885 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 74.8 t -130.71 127.08 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.854 -1.154 . . . . 0.26 110.471 173.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.496 ' OD1' HG12 ' B' ' 46' ' ' ILE . 41.9 p-10 -147.69 142.22 26.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.883 . . . . 1.77 110.525 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.0 t0 43.32 45.46 5.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.087 -1.008 . . . . 1.21 111.217 174.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.5 tt0 60.44 12.05 3.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.081 -1.012 . . . . 1.92 110.611 175.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 54.1 mtmt -114.41 154.01 28.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.162 -0.961 . . . . 2.0 109.633 175.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.927 HG22 HD11 ' B' ' 47' ' ' LEU . 67.3 mt -94.51 129.72 44.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.108 -0.995 . . . . 1.24 110.227 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.608 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 24.6 mm -113.28 121.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.681 -0.637 . . . . 0.5 109.823 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.927 HD11 HG22 ' B' ' 45' ' ' ILE . 4.1 mp -122.44 134.46 54.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.892 -1.13 . . . . 1.66 110.271 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.542 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 14.1 pttp -141.62 162.84 34.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 1.74 110.435 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 43.2 tttt -58.81 146.72 36.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 1.65 110.015 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.901 ' CD2' HG11 ' A' ' 9' ' ' VAL . 10.5 t80 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.65 110.575 -176.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.0 mt . . . . . 0 N--CA 1.494 1.77 0 CA-C-O 121.083 0.468 . . . . 1.36 109.982 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.016 HG11 ' CD2' ' B' ' 50' ' ' TYR . 98.2 t -114.03 144.29 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.048 -1.032 . . . . 0.37 110.871 -176.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 28.9 tpt180 -130.03 158.62 39.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.513 -0.742 . . . . 1.91 109.727 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.422 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 66.4 mmtt -85.44 148.18 26.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.006 . . . . 2.21 110.258 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.97 HG22 HD11 ' B' ' 36' ' ' LEU . 3.7 t -81.65 128.83 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.274 -0.891 . . . . 0.28 109.778 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.45 -175.09 5.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.087 -1.008 . . . . 0.55 110.061 -179.698 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -54.24 -41.13 68.4 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.114 -0.991 . . . . 2.19 111.7 -173.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.886 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.7 tp -84.83 -5.31 59.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.656 -1.278 . . . . 1.38 111.59 -173.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.516 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.26 46.45 7.53 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.136 -1.507 . . . . 0.21 109.716 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.906 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.2 mtm180 -114.77 153.94 29.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.093 -1.239 . . . . 1.15 110.031 -177.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.672 HG12 HD13 ' B' ' 36' ' ' LEU . 22.1 m -123.91 152.21 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.28 109.83 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.921 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.3 t -112.93 133.97 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.947 . . . . 0.24 110.742 -175.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.671 HD11 HD13 ' B' ' 45' ' ' ILE . 2.4 mm -84.22 133.04 45.92 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.175 -0.953 . . . . 1.38 109.446 174.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.8 Cg_endo -57.63 141.39 95.37 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.646 1.34 . . . . 0.35 109.957 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.93 HD13 ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.81 -32.37 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.008 -1.058 . . . . 1.11 110.301 -177.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.27 -36.35 70.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.018 -1.051 . . . . 2.37 109.747 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.559 ' HB2' HG23 ' A' ' 20' ' ' ILE . 43.4 mt -80.87 -29.22 35.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 1.75 110.449 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.706 HH22 HD11 ' B' ' 15' ' ' LEU . 73.7 mtt180 -56.79 -44.03 81.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.864 -1.148 . . . . 0.3 108.97 175.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.6 mmt180 -72.49 -47.68 46.69 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.826 -0.749 . . . . 3.26 110.726 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.9 m -63.19 -32.45 73.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.202 -0.937 . . . . 0.77 111.061 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.778 HD23 HG13 ' A' ' 30' ' ' ILE . 20.5 tp -88.56 -4.62 58.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.07 -1.019 . . . . 1.05 110.801 -177.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.415 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.98 41.82 95.08 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.732 -1.347 . . . . 0.32 109.732 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.778 HG13 HD23 ' A' ' 28' ' ' LEU . 32.7 mm -116.52 139.49 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.27 -1.135 . . . . 0.41 110.744 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.72 166.46 24.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.619 -0.675 . . . . 0.23 110.006 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.73 146.51 13.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.027 -1.045 . . . . 1.13 110.511 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 40.3 tttp 74.59 -4.56 2.31 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.684 -0.635 . . . . 1.88 111.114 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.702 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.9 m-20 -76.87 165.87 24.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.782 -1.199 . . . . 1.1 109.966 174.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.767 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.72 131.19 52.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.36 110.771 -176.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.964 HD11 HG22 ' B' ' 12' ' ' VAL . 13.0 mt -108.66 144.1 36.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.33 -0.856 . . . . 0.56 109.341 174.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.691 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.8 tt0 -106.59 139.02 41.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.744 -1.223 . . . . 1.17 109.491 172.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.49 131.27 59.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.423 -0.798 . . . . 0.84 110.504 -172.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.612 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 16.7 m-85 -117.67 157.46 26.41 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 116.263 -0.426 . . . . 0.45 109.915 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 74.2 t -131.78 120.09 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.903 -1.123 . . . . 0.27 110.617 172.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 46.7 p-10 -148.32 161.93 40.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.274 -0.891 . . . . 1.77 110.586 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 54.0 t0 42.25 40.57 1.81 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.002 -1.061 . . . . 1.22 111.446 172.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 96.1 mt-10 56.53 16.18 2.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.941 -1.099 . . . . 1.93 110.556 175.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 11.3 pttt -128.98 165.48 21.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 2.01 109.734 174.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.818 HD13 HD11 ' B' ' 20' ' ' ILE . 67.7 mt -96.71 133.85 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.178 -0.951 . . . . 1.25 110.395 -175.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.612 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 23.5 mm -113.46 120.09 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.747 -0.596 . . . . 0.5 109.927 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.829 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.0 mp -118.52 134.34 55.16 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.888 -1.133 . . . . 1.66 110.136 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.522 ' HE2' ' CE1' ' A' ' 39' ' ' TYR . 22.8 pttt -140.52 162.49 35.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.357 -0.839 . . . . 1.74 110.492 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -57.59 147.96 25.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.001 . . . . 1.65 109.902 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.815 ' CD2' HG11 ' B' ' 9' ' ' VAL . 3.5 t80 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.35 110.466 -176.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 36' ' ' LEU . 98.5 t . . . . . 0 N--CA 1.492 1.658 0 CA-C-O 121.526 0.679 . . . . 0.37 110.87 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 29.0 tpt180 -129.96 158.53 39.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.504 -0.747 . . . . 1.92 109.767 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.422 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 66.4 mmtt -85.49 148.09 26.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 2.21 110.319 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.964 HG22 HD11 ' A' ' 36' ' ' LEU . 3.7 t -81.59 128.85 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 0.29 109.79 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.66 -174.99 5.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.157 -0.964 . . . . 0.55 110.197 -179.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.36 -40.99 68.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.104 -0.997 . . . . 2.19 111.597 -172.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.912 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.4 tp -84.82 -5.47 59.33 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.743 -1.223 . . . . 1.39 111.583 -173.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.532 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.93 47.25 7.24 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.529 -1.428 . . . . 0.21 109.529 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.921 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.0 mtm180 -114.99 153.89 29.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.089 -1.242 . . . . 1.14 109.98 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.732 HG21 ' CD2' ' A' ' 47' ' ' LEU . 22.3 m -123.88 152.2 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 0.28 109.807 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.906 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.3 t -112.95 134.04 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.137 -0.977 . . . . 0.24 110.598 -175.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.818 HD11 HD13 ' A' ' 45' ' ' ILE . 2.5 mm -84.33 133.0 45.72 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 1.38 109.41 174.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.7 Cg_endo -57.58 141.4 95.26 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.763 1.402 . . . . 0.36 109.963 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.939 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -56.04 -32.08 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.994 -1.066 . . . . 1.11 110.316 -177.217 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.19 -37.01 71.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.034 -1.041 . . . . 2.37 109.667 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.553 ' HB2' HG23 ' B' ' 20' ' ' ILE . 43.4 mt -80.08 -29.6 39.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.516 -0.74 . . . . 1.75 110.48 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.607 HH22 HD11 ' A' ' 15' ' ' LEU . 73.4 mtt180 -56.67 -43.81 80.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.966 -1.084 . . . . 0.3 109.076 175.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -72.51 -47.99 44.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 3.27 110.591 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.2 m -62.88 -32.9 74.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.183 -0.948 . . . . 0.77 110.875 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.781 HD23 HG13 ' B' ' 30' ' ' ILE . 20.6 tp -88.16 -5.0 58.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.032 -1.043 . . . . 1.05 110.736 -176.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.423 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.41 41.46 94.38 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.656 -1.378 . . . . 0.32 109.656 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.781 HG13 HD23 ' B' ' 28' ' ' LEU . 32.2 mm -116.48 139.36 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -1.153 . . . . 0.41 110.728 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.43 166.6 24.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.632 -0.668 . . . . 0.23 109.985 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.62 146.45 13.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.102 -0.999 . . . . 1.13 110.55 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 40.3 tttp 74.67 -4.73 2.28 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.579 -0.701 . . . . 1.88 111.194 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.586 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.0 m-20 -76.93 165.59 24.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.805 -1.184 . . . . 1.1 110.023 174.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.747 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.53 131.17 52.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.36 110.834 -176.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.97 HD11 HG22 ' A' ' 12' ' ' VAL . 12.9 mt -108.68 143.71 37.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.37 -0.831 . . . . 0.56 109.481 174.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.663 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.5 tt0 -106.18 138.88 41.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.839 -1.163 . . . . 1.17 109.786 172.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.4 131.34 59.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.348 -0.845 . . . . 0.84 110.494 -171.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.613 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 16.5 m-85 -117.67 157.45 26.44 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 116.257 -0.428 . . . . 0.45 109.904 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 75.0 t -131.69 120.51 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.868 -1.145 . . . . 0.26 110.436 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.498 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 46.6 p-10 -148.96 161.95 40.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.205 -0.934 . . . . 1.77 110.533 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 54.4 t0 42.02 41.0 1.8 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.185 -0.947 . . . . 1.21 111.461 172.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 96.1 mt-10 56.32 16.12 2.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.926 -1.109 . . . . 1.92 110.584 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 11.2 pttt -128.96 165.67 20.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 2.0 109.666 174.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.735 HG22 HD11 ' B' ' 47' ' ' LEU . 68.0 mt -96.82 133.83 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 1.24 110.363 -175.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 23.1 mm -113.53 120.17 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.739 -0.601 . . . . 0.5 109.865 177.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.833 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.1 mp -118.46 134.14 55.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.899 -1.125 . . . . 1.66 110.174 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.516 ' HE2' ' CE1' ' B' ' 39' ' ' TYR . 23.3 pttt -140.41 162.55 35.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 1.74 110.371 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -57.47 147.82 25.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.977 . . . . 1.65 109.871 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 1.016 ' CD2' HG11 ' A' ' 9' ' ' VAL . 3.6 t80 . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.908 . . . . 0.65 110.551 -176.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.7 mt . . . . . 0 N--CA 1.494 1.775 0 N-CA-C 109.636 -0.505 . . . . 1.36 109.636 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.906 HG13 ' O ' ' B' ' 36' ' ' LEU . 98.5 t -113.51 143.75 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.911 -1.118 . . . . 0.37 111.348 -171.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.43 ' NE ' ' HB ' ' A' ' 19' ' ' VAL . 59.5 ttm-85 -123.82 161.17 25.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.539 -0.725 . . . . 1.91 109.621 176.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' B' ' 33' ' ' LYS . 82.1 tttt -82.54 145.01 29.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.138 -0.976 . . . . 2.21 110.563 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.908 HG22 HD11 ' B' ' 36' ' ' LEU . 4.1 t -82.97 129.38 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.412 -0.805 . . . . 0.28 109.881 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.11 -175.06 5.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.55 109.901 179.309 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.94 -39.28 74.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.991 -1.068 . . . . 2.19 111.61 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.903 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.2 tp -83.47 -6.23 59.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.755 -1.215 . . . . 1.38 111.542 -174.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.479 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 79.98 46.46 7.69 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.193 -1.479 . . . . 0.21 109.648 -177.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.908 ' CD ' HG22 ' B' ' 19' ' ' VAL . 68.4 mtm180 -114.12 156.15 24.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.076 -1.249 . . . . 1.15 110.019 -177.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.856 HG12 HD13 ' B' ' 36' ' ' LEU . 16.8 m -124.53 153.35 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.28 109.805 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.938 HG22 ' CD ' ' B' ' 17' ' ' ARG . 35.2 t -111.06 134.47 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.24 110.536 -176.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.39 133.38 50.32 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.314 -0.867 . . . . 1.38 109.433 174.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.1 Cg_endo -57.18 142.86 94.54 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.761 1.401 . . . . 0.35 110.018 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.861 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.28 -32.69 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.977 -1.077 . . . . 1.11 110.357 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -58.22 -35.93 72.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.096 -1.002 . . . . 2.37 109.839 178.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.563 ' HB2' HG23 ' A' ' 20' ' ' ILE . 48.7 mt -80.41 -31.4 37.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.818 . . . . 1.75 110.537 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.861 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.3 mtt180 -58.09 -43.38 87.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.883 -1.136 . . . . 0.3 109.243 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -73.57 -49.95 23.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.767 . . . . 3.26 110.804 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m -64.42 -30.97 72.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.24 -0.912 . . . . 0.77 111.16 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.922 HD23 HG13 ' A' ' 30' ' ' ILE . 19.7 tp -87.14 -4.64 59.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.02 -1.05 . . . . 1.05 110.656 -177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.63 43.73 96.02 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.673 -1.371 . . . . 0.32 109.673 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.922 HG13 HD23 ' A' ' 28' ' ' LEU . 29.6 mm -114.74 138.07 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -1.152 . . . . 0.41 110.664 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.406 ' HB3' ' OD2' ' A' ' 34' ' ' ASP . . . -141.22 166.57 24.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.548 -0.72 . . . . 0.23 109.986 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.3 145.99 12.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.068 -1.02 . . . . 1.13 110.51 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 45.6 tttp 74.91 -4.7 2.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.653 -0.654 . . . . 1.88 111.084 177.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.772 ' O ' HG23 ' B' ' 12' ' ' VAL . 92.0 m-20 -78.04 167.73 20.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.812 -1.18 . . . . 1.1 110.018 174.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -105.98 131.74 52.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.166 -0.959 . . . . 0.36 110.762 -176.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.927 ' O ' HG13 ' B' ' 9' ' ' VAL . 10.3 mt -106.75 141.36 38.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.392 -0.817 . . . . 0.56 109.319 175.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.678 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.6 tt0 -103.88 138.17 40.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.794 -1.191 . . . . 1.17 109.892 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 74.5 mt -112.25 133.11 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.54 -0.725 . . . . 0.84 110.575 -174.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.606 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 17.3 m-85 -115.17 158.32 22.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 122.045 -0.41 . . . . 0.45 110.076 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.3 t -129.44 124.29 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.016 -1.053 . . . . 0.27 110.707 173.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.623 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.1 p-10 -146.93 136.32 22.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 1.77 110.233 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 56.0 t0 44.05 49.84 7.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.017 -1.052 . . . . 1.22 111.071 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.3 mt-10 59.1 13.6 3.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.202 -0.936 . . . . 1.93 110.636 175.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -117.24 147.6 42.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 2.01 110.036 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.597 HG22 HD11 ' A' ' 47' ' ' LEU . 61.3 mt -99.65 129.16 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.148 -0.97 . . . . 1.25 110.183 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.623 HD11 ' OD2' ' A' ' 41' ' ' ASP . 23.3 mt -109.1 116.42 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.341 -0.849 . . . . 0.5 110.043 176.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.839 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.1 mp -111.05 134.76 52.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.029 -1.044 . . . . 1.66 110.113 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.538 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 14.0 pttp -142.66 163.14 33.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.5 -0.75 . . . . 1.74 110.347 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -58.05 147.12 30.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.114 -0.991 . . . . 1.65 109.93 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.491 ' CD2' HG11 ' B' ' 9' ' ' VAL . 14.6 t80 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.35 110.616 -176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 36' ' ' LEU . 98.7 t . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.572 0.701 . . . . 0.37 111.29 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.419 ' NE ' ' HB ' ' B' ' 19' ' ' VAL . 59.5 ttm-85 -123.76 160.98 26.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.579 -0.701 . . . . 1.92 109.776 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 33' ' ' LYS . 81.9 tttt -82.53 144.9 30.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.072 -1.017 . . . . 2.21 110.616 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.902 HG22 ' CD1' ' A' ' 36' ' ' LEU . 4.1 t -82.87 129.6 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.804 . . . . 0.29 109.78 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.36 -174.89 5.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.129 -0.982 . . . . 0.55 110.023 179.079 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.477 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.8 mt-10 -56.96 -39.28 74.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.065 -1.022 . . . . 2.19 111.552 -172.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.905 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.6 tp -83.56 -6.26 59.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.767 -1.208 . . . . 1.39 111.568 -174.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.482 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.63 47.15 7.46 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.484 -1.447 . . . . 0.21 109.484 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.938 ' CD ' HG22 ' A' ' 19' ' ' VAL . 68.6 mtm180 -114.23 156.11 24.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.974 -1.309 . . . . 1.14 110.058 -177.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.823 HG12 HD13 ' A' ' 36' ' ' LEU . 16.6 m -124.5 153.34 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.431 -0.793 . . . . 0.28 109.846 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.908 HG22 ' CD ' ' A' ' 17' ' ' ARG . 35.4 t -111.06 134.5 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.24 110.527 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.577 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.31 133.33 50.65 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.329 -0.857 . . . . 1.38 109.493 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.551 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.3 Cg_endo -57.4 142.84 95.18 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.675 1.355 . . . . 0.36 110.036 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.858 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.4 tp -55.39 -32.53 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.062 -1.024 . . . . 1.11 110.343 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.03 -36.64 73.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.02 -1.05 . . . . 2.37 109.714 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.577 ' HB2' HG23 ' B' ' 20' ' ' ILE . 48.0 mt -79.68 -31.75 41.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.483 -0.76 . . . . 1.75 110.514 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.858 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.9 mtt180 -57.93 -43.3 86.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.925 -1.11 . . . . 0.3 109.28 176.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -73.54 -50.21 22.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.327 -0.858 . . . . 3.27 110.653 -177.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 55.4 m -64.17 -31.56 72.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.77 110.86 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.971 HD23 HG13 ' B' ' 30' ' ' ILE . 20.0 tp -86.64 -5.09 59.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.124 -0.985 . . . . 1.05 110.63 -176.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.442 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.91 43.68 95.66 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.49 -1.444 . . . . 0.32 109.49 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.971 HG13 HD23 ' B' ' 28' ' ' LEU . 29.4 mm -114.66 137.97 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -1.168 . . . . 0.41 110.699 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.401 ' HB3' ' OD2' ' B' ' 34' ' ' ASP . . . -140.98 166.66 24.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.509 -0.745 . . . . 0.23 109.99 -178.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.27 146.03 12.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.138 -0.976 . . . . 1.13 110.536 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 45.5 tttp 75.0 -4.94 2.27 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.706 -0.621 . . . . 1.88 111.16 177.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.724 ' O ' HG23 ' A' ' 12' ' ' VAL . 92.5 m-20 -78.03 167.56 21.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.914 -1.116 . . . . 1.1 110.045 174.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.46 ' HB1' HG11 ' A' ' 9' ' ' VAL . . . -105.88 131.66 52.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.961 . . . . 0.36 110.807 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.908 HD11 HG22 ' A' ' 12' ' ' VAL . 10.1 mt -106.72 141.16 38.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.887 . . . . 0.56 109.421 175.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.635 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.5 tt0 -103.75 138.22 40.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.86 -1.15 . . . . 1.17 109.975 173.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 74.5 mt -112.13 133.2 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.459 -0.775 . . . . 0.84 110.507 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.61 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 17.2 m-85 -115.32 158.27 22.64 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 120.914 0.387 . . . . 0.45 109.962 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 83.9 t -129.2 124.66 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.99 -1.069 . . . . 0.26 110.61 173.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.627 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.2 p-10 -147.32 136.26 22.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -0.838 . . . . 1.77 110.151 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 56.7 t0 44.26 49.85 7.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.119 -0.988 . . . . 1.21 111.012 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.3 mt-10 58.95 13.63 2.91 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.229 -0.919 . . . . 1.92 110.607 176.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -117.23 147.87 42.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.945 . . . . 2.0 109.94 175.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.578 HG22 HD11 ' B' ' 47' ' ' LEU . 61.0 mt -99.83 129.15 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.102 -0.999 . . . . 1.24 110.153 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.627 HD11 ' OD2' ' B' ' 41' ' ' ASP . 23.8 mt -109.29 116.42 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.463 -0.773 . . . . 0.5 110.019 176.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.842 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.2 mp -110.91 134.7 52.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.004 -1.06 . . . . 1.66 110.097 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.535 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 14.2 pttp -142.52 163.37 33.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.443 -0.785 . . . . 1.74 110.29 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -58.13 147.1 31.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 1.65 109.885 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.548 ' CD2' HG11 ' A' ' 9' ' ' VAL . 14.8 t80 . . . . . 0 N--CA 1.489 1.5 0 O-C-N 121.18 -0.95 . . . . 0.65 110.667 -176.006 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.1 mt . . . . . 0 N--CA 1.494 1.771 0 CA-C-O 121.043 0.449 . . . . 1.36 109.967 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.093 HG11 ' CD2' ' B' ' 50' ' ' TYR . 90.0 t -116.15 144.46 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.019 -1.051 . . . . 0.37 110.989 -175.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 57.5 ttm-85 -129.61 159.66 35.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.513 -0.742 . . . . 1.91 109.736 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -86.49 148.03 25.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.2 -0.938 . . . . 2.21 110.328 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.987 HG22 HD11 ' B' ' 36' ' ' LEU . 3.7 t -82.58 129.29 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.266 -0.896 . . . . 0.28 109.945 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.18 -174.7 5.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.051 -1.031 . . . . 0.55 109.995 179.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -56.1 -39.93 72.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.025 -1.047 . . . . 2.19 111.718 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.861 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.1 tp -85.41 -4.53 59.19 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.751 -1.218 . . . . 1.38 111.674 -173.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.482 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.07 46.34 7.71 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.176 -1.488 . . . . 0.21 109.662 -177.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.919 ' CD ' HG22 ' B' ' 19' ' ' VAL . 73.8 mtm180 -115.75 154.62 29.27 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.054 -1.262 . . . . 1.15 109.995 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.54 HG12 HD13 ' B' ' 36' ' ' LEU . 22.7 m -123.81 151.76 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.28 109.868 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.95 HG22 ' CD ' ' B' ' 17' ' ' ARG . 22.4 t -112.35 135.13 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.152 -0.968 . . . . 0.24 110.54 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.569 HG23 ' HB2' ' A' ' 24' ' ' LEU . 3.0 mm -83.64 133.29 46.94 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 1.38 109.606 175.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' HD12 ' A' ' 24' ' ' LEU . 9.2 Cg_endo -58.04 143.62 96.07 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.778 1.409 . . . . 0.35 110.061 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.878 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.1 tp -54.85 -33.12 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.991 -1.068 . . . . 1.11 110.347 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.409 ' N ' HG23 ' A' ' 22' ' ' ILE . 84.3 tt0 -58.03 -35.6 71.52 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.154 -0.966 . . . . 2.37 109.833 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.569 ' HB2' HG23 ' A' ' 20' ' ' ILE . 51.4 mt -83.8 -28.81 27.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.335 -0.853 . . . . 1.75 110.789 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.878 ' HD2' HD12 ' A' ' 22' ' ' ILE . 71.5 mtt180 -57.44 -43.9 84.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.752 -1.218 . . . . 0.3 108.957 175.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -71.49 -49.75 38.2 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.092 -0.643 . . . . 3.26 110.714 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.8 m -63.59 -31.4 72.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.177 -0.952 . . . . 0.77 111.15 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.805 HD23 HG13 ' A' ' 30' ' ' ILE . 23.8 tp -87.35 -5.03 59.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.061 -1.024 . . . . 1.05 110.729 -177.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.08 41.4 98.51 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.701 -1.36 . . . . 0.32 109.701 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.805 HG13 HD23 ' A' ' 28' ' ' LEU . 34.3 mm -116.41 139.73 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -1.15 . . . . 0.41 110.759 -178.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -139.89 167.46 22.05 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.654 -0.654 . . . . 0.23 110.082 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 83.3 tt0 -52.41 150.87 4.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.047 -1.033 . . . . 1.13 110.549 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 74.5 mttt 67.16 -3.32 1.01 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.857 -0.527 . . . . 1.88 112.234 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.745 ' O ' HG23 ' B' ' 12' ' ' VAL . 90.1 m-20 -76.07 165.44 24.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.579 -1.326 . . . . 1.1 109.952 174.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.799 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -103.87 130.98 51.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.36 110.785 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.974 HD11 HG22 ' B' ' 12' ' ' VAL . 13.5 mt -109.14 142.36 40.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.388 -0.82 . . . . 0.56 109.54 175.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.678 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.4 tt0 -107.4 140.35 40.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.795 -1.191 . . . . 1.17 109.739 172.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.6 mt -111.57 135.41 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.345 -0.847 . . . . 0.84 110.564 -172.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.588 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 12.4 m-85 -114.6 158.55 21.55 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 120.934 0.397 . . . . 0.45 110.078 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 77.7 t -130.89 128.39 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.924 -1.11 . . . . 0.27 110.62 172.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.643 ' CG ' HD11 ' A' ' 46' ' ' ILE . 8.9 p-10 -146.62 128.34 15.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.86 . . . . 1.77 110.249 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 48.1 t0 46.57 49.11 13.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.022 -1.048 . . . . 1.22 110.948 175.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.1 tt0 62.53 10.35 4.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.337 -0.852 . . . . 1.93 110.696 176.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 9.0 mtmm -110.59 148.38 32.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 2.01 109.868 176.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.669 HD13 HD11 ' B' ' 20' ' ' ILE . 58.0 mt -101.92 127.98 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 1.25 110.331 -176.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.643 HD11 ' CG ' ' A' ' 41' ' ' ASP . 29.6 mt -114.99 123.33 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.343 -0.848 . . . . 0.5 110.233 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.822 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -114.11 136.74 52.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.961 -1.087 . . . . 1.66 110.167 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 25.2 pttt -140.92 165.61 27.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.449 -0.782 . . . . 1.74 110.132 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -56.06 149.07 16.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.109 -0.995 . . . . 1.65 109.819 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.971 ' CD2' HG11 ' B' ' 9' ' ' VAL . 2.2 t80 . . . . . 0 N--CA 1.493 1.679 0 O-C-N 121.29 -0.881 . . . . 0.35 110.655 -175.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.971 HG11 ' CD2' ' A' ' 50' ' ' TYR . 90.1 t . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.515 0.674 . . . . 0.37 110.959 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 57.4 ttm-85 -129.44 159.5 36.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.488 -0.757 . . . . 1.92 109.809 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -86.49 147.95 25.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.027 -1.046 . . . . 2.21 110.434 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.974 HG22 HD11 ' A' ' 36' ' ' LEU . 3.7 t -82.45 129.3 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.265 -0.897 . . . . 0.29 109.823 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.3 -174.49 5.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.085 -1.009 . . . . 0.55 110.171 179.359 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.485 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.5 mt-10 -56.24 -39.85 73.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.095 -1.003 . . . . 2.19 111.679 -172.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.892 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.5 tp -85.54 -4.55 59.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.723 -1.235 . . . . 1.39 111.624 -173.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.498 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.82 46.99 7.45 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.485 -1.446 . . . . 0.21 109.485 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.95 ' CD ' HG22 ' A' ' 19' ' ' VAL . 73.7 mtm180 -115.9 154.66 29.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.102 -1.234 . . . . 1.14 109.936 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 47' ' ' LEU . 22.6 m -123.91 151.7 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.822 . . . . 0.28 109.866 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.919 HG22 ' CD ' ' A' ' 17' ' ' ARG . 22.6 t -112.37 135.09 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.24 110.576 -175.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.669 HD11 HD13 ' A' ' 45' ' ' ILE . 3.0 mm -83.64 133.24 47.03 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 1.38 109.594 175.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.539 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.2 Cg_endo -58.15 143.6 96.51 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.721 1.38 . . . . 0.36 110.063 177.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.874 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -54.9 -33.04 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.043 -1.036 . . . . 1.11 110.315 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . 0.41 ' N ' HG23 ' B' ' 22' ' ' ILE . 84.2 tt0 -57.79 -36.34 72.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.152 -0.968 . . . . 2.37 109.724 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.562 ' HB2' HG23 ' B' ' 20' ' ' ILE . 51.4 mt -83.03 -29.28 28.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.496 -0.753 . . . . 1.75 110.752 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.874 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.0 mtt180 -57.22 -43.8 83.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.816 -1.178 . . . . 0.3 108.987 175.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -71.32 -50.15 35.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.452 -0.78 . . . . 3.27 110.543 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.4 m -63.3 -31.92 73.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.258 -0.901 . . . . 0.77 110.931 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.81 HD23 HG13 ' B' ' 30' ' ' ILE . 24.0 tp -86.84 -5.41 59.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.052 -1.03 . . . . 1.05 110.723 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.401 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.4 41.31 98.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.625 -1.39 . . . . 0.32 109.625 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.81 HG13 HD23 ' B' ' 28' ' ' LEU . 33.6 mm -116.43 139.65 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.177 -1.19 . . . . 0.41 110.707 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -139.69 167.62 21.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.516 -0.74 . . . . 0.23 109.975 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' B' ' 33' ' ' LYS . 83.2 tt0 -52.33 151.07 4.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.129 -0.982 . . . . 1.13 110.467 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' B' ' 32' ' ' GLU . 74.0 mttt 66.57 -2.74 0.99 Allowed 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 112.363 0.505 . . . . 1.88 112.363 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.647 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.4 m-20 -76.55 165.31 24.96 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.506 -1.371 . . . . 1.1 109.965 173.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.764 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.63 131.02 51.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.36 110.802 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.987 HD11 HG22 ' A' ' 12' ' ' VAL . 13.3 mt -109.23 142.18 40.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.383 -0.823 . . . . 0.56 109.558 175.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.655 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.2 tt0 -107.26 140.32 40.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.842 -1.161 . . . . 1.17 109.824 172.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.8 mt -111.61 135.36 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.284 -0.885 . . . . 0.84 110.58 -172.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.583 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 12.1 m-85 -114.4 158.57 21.35 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 120.946 0.403 . . . . 0.45 110.09 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 78.6 t -130.72 128.61 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.903 -1.123 . . . . 0.26 110.476 172.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.641 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.0 p-10 -146.91 128.24 14.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 1.77 110.241 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 49.0 t0 46.77 49.08 14.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.093 -1.005 . . . . 1.21 110.934 175.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.0 tt0 62.4 10.4 3.92 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.224 -0.923 . . . . 1.92 110.691 176.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 9.0 mtmm -110.61 148.66 31.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.942 . . . . 2.0 109.705 176.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.553 HG21 HD11 ' A' ' 20' ' ' ILE . 58.0 mt -102.08 128.0 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.981 . . . . 1.24 110.365 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.641 HD11 ' OD2' ' B' ' 41' ' ' ASP . 30.4 mt -115.17 123.4 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.415 -0.803 . . . . 0.5 110.146 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.817 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.2 mp -114.05 136.63 52.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.981 -1.074 . . . . 1.66 110.145 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.523 ' HD3' ' CE1' ' B' ' 39' ' ' TYR . 25.2 pttt -140.78 165.84 26.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.44 -0.788 . . . . 1.74 110.079 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -56.3 148.87 17.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.992 -1.067 . . . . 1.65 109.754 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 1.093 ' CD2' HG11 ' A' ' 9' ' ' VAL . 2.2 t80 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.65 110.667 -175.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.5 mt . . . . . 0 N--CA 1.495 1.785 0 CA-C-O 121.053 0.454 . . . . 1.36 110.014 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.92 HG13 ' O ' ' B' ' 36' ' ' LEU . 86.8 t -114.0 144.12 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.027 -1.046 . . . . 0.37 110.871 -175.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -126.29 157.88 37.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.398 -0.814 . . . . 1.91 109.71 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' B' ' 33' ' ' LYS . 55.2 tttt -83.58 145.04 29.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.137 -0.977 . . . . 2.21 110.396 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.925 HG22 HD11 ' B' ' 36' ' ' LEU . 3.9 t -81.77 130.31 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.351 -0.843 . . . . 0.28 109.929 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.38 -174.58 5.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.177 -0.952 . . . . 0.55 110.131 -179.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.46 -39.74 73.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.07 -1.019 . . . . 2.19 111.779 -172.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.864 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.3 tp -84.76 -4.33 59.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.765 -1.209 . . . . 1.38 111.6 -173.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.474 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.06 46.23 7.79 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.172 -1.49 . . . . 0.21 109.715 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.934 ' CD ' HG22 ' B' ' 19' ' ' VAL . 74.9 mtm180 -116.16 155.12 28.82 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.069 -1.254 . . . . 1.15 110.05 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.697 HG12 HD13 ' B' ' 36' ' ' LEU . 21.9 m -122.23 148.4 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.28 109.758 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.945 HG22 ' CD ' ' B' ' 17' ' ' ARG . 28.5 t -112.82 133.79 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.24 110.623 -175.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.622 HD11 HD13 ' B' ' 45' ' ' ILE . 2.2 mm -84.75 130.86 51.31 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.294 -0.878 . . . . 1.38 109.461 175.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.54 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -57.29 142.34 94.79 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.668 1.352 . . . . 0.35 109.849 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.926 HD13 ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.46 -32.39 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.952 -1.093 . . . . 1.11 110.289 -177.624 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.54 -36.38 71.55 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.16 -0.963 . . . . 2.37 109.747 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.595 ' HB2' HG23 ' A' ' 20' ' ' ILE . 52.9 mt -82.1 -27.59 32.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 1.75 110.471 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.68 HH22 HD11 ' B' ' 15' ' ' LEU . 73.0 mtt180 -56.97 -43.93 82.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.833 -1.167 . . . . 0.3 108.966 174.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 61.0 ttm-85 -71.66 -49.31 40.96 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.956 -0.698 . . . . 3.26 110.765 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.9 m -63.21 -31.84 73.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.186 -0.946 . . . . 0.77 111.078 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.8 HD23 HG13 ' A' ' 30' ' ' ILE . 23.2 tp -88.09 -5.01 58.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.093 -1.004 . . . . 1.05 110.758 -177.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.414 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.52 41.57 97.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.651 -1.38 . . . . 0.32 109.651 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.8 HG13 HD23 ' A' ' 28' ' ' LEU . 33.6 mm -116.53 139.1 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -1.169 . . . . 0.41 110.732 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.32 166.65 24.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.645 -0.659 . . . . 0.23 109.984 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.2 tt0 -53.29 146.39 12.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.056 -1.027 . . . . 1.13 110.592 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 28.5 tttt 74.52 -4.63 2.28 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.674 -0.642 . . . . 1.88 111.166 176.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.728 ' O ' HG23 ' B' ' 12' ' ' VAL . 90.6 m-20 -77.3 165.95 23.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.788 -1.195 . . . . 1.1 110.03 174.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.21 130.14 53.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.36 110.629 -176.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.949 ' O ' HG13 ' B' ' 9' ' ' VAL . 11.6 mt -106.25 141.64 37.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 0.56 109.387 174.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.682 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.3 tt0 -104.65 139.01 40.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.758 -1.214 . . . . 1.17 109.882 173.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.7 mt -109.82 132.67 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.514 -0.741 . . . . 0.84 110.374 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.588 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 14.2 m-85 -114.65 157.54 22.96 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.929 -0.397 . . . . 0.45 109.929 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.9 t -129.59 126.29 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.942 -1.099 . . . . 0.27 110.746 174.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.638 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.4 p-10 -146.71 131.91 18.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 1.77 110.178 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.497 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 47.7 t0 46.09 48.19 12.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.952 -1.092 . . . . 1.22 111.008 175.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.0 tt0 62.02 10.98 3.95 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.202 -0.936 . . . . 1.93 110.609 175.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 32.7 mtmt -113.07 150.98 31.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.072 -1.017 . . . . 2.01 109.873 176.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.706 HD13 HD11 ' B' ' 20' ' ' ILE . 56.7 mt -101.9 129.58 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 1.25 110.284 -176.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.638 HD11 ' OD2' ' A' ' 41' ' ' ASP . 21.9 mt -112.5 120.83 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.5 110.193 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.849 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -112.39 134.08 54.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.984 -1.073 . . . . 1.66 110.133 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.543 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 10.5 pttp -141.52 164.8 29.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.478 -0.764 . . . . 1.74 110.394 178.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.543 ' HD3' ' CD1' ' A' ' 30' ' ' ILE . 18.3 tptp -56.97 146.04 28.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.133 -0.979 . . . . 1.65 109.938 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.595 ' CD2' HG11 ' B' ' 9' ' ' VAL . 9.9 t80 . . . . . 0 C--N 1.299 -1.619 0 O-C-N 121.331 -0.855 . . . . 0.35 110.646 -176.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.949 HG13 ' O ' ' A' ' 36' ' ' LEU . 88.3 t . . . . . 0 N--CA 1.493 1.722 0 CA-C-O 121.503 0.668 . . . . 0.37 110.911 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -126.29 157.6 37.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.456 -0.777 . . . . 1.92 109.833 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -83.53 144.95 29.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.983 . . . . 2.21 110.453 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.911 HG22 HD11 ' A' ' 36' ' ' LEU . 4.0 t -81.72 130.49 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.354 -0.841 . . . . 0.29 109.812 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.454 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.6 -174.4 5.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.103 -0.998 . . . . 0.55 110.3 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.474 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -56.63 -39.62 73.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.103 -0.998 . . . . 2.19 111.65 -172.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.892 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.0 tp -84.87 -4.39 59.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.741 -1.225 . . . . 1.39 111.527 -173.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.481 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.75 47.04 7.46 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.495 -1.442 . . . . 0.21 109.495 -177.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.945 ' CD ' HG22 ' A' ' 19' ' ' VAL . 74.8 mtm180 -116.44 155.1 29.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.001 -1.293 . . . . 1.14 109.969 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.7 HG12 HD13 ' A' ' 36' ' ' LEU . 22.0 m -122.3 148.35 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.28 109.756 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.934 HG22 ' CD ' ' A' ' 17' ' ' ARG . 28.4 t -112.75 133.76 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.948 . . . . 0.24 110.636 -175.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.706 HD11 HD13 ' A' ' 45' ' ' ILE . 2.2 mm -84.76 130.86 51.28 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 1.38 109.416 175.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.532 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.0 Cg_endo -57.42 142.28 95.11 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.771 1.406 . . . . 0.36 109.888 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.948 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.52 -32.17 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.994 -1.066 . . . . 1.11 110.291 -177.375 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.45 -37.05 72.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.103 -0.998 . . . . 2.37 109.643 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.579 ' HB2' HG23 ' B' ' 20' ' ' ILE . 52.5 mt -81.42 -27.88 34.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 1.75 110.502 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.638 HH22 HD11 ' A' ' 15' ' ' LEU . 72.7 mtt180 -56.79 -43.8 81.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.912 -1.118 . . . . 0.3 109.046 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 61.0 ttm-85 -71.56 -49.78 37.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.463 -0.773 . . . . 3.27 110.578 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 48.1 m -62.8 -32.43 73.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.3 -0.875 . . . . 0.77 110.893 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.835 HD23 HG13 ' B' ' 30' ' ' ILE . 23.4 tp -87.55 -5.42 58.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.058 -1.027 . . . . 1.05 110.661 -176.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.419 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.86 41.33 97.52 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.605 -1.398 . . . . 0.32 109.605 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.835 HG13 HD23 ' B' ' 28' ' ' LEU . 33.4 mm -116.45 138.93 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -1.199 . . . . 0.41 110.725 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.99 166.78 23.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.59 -0.694 . . . . 0.23 110.053 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.527 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.31 146.48 12.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.132 -0.98 . . . . 1.13 110.516 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 28.5 tttt 74.54 -4.78 2.25 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.673 -0.642 . . . . 1.88 111.225 176.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.666 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.7 m-20 -77.39 165.57 24.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.849 -1.157 . . . . 1.1 110.05 175.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.95 130.1 53.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.36 110.69 -176.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.925 HD11 HG22 ' A' ' 12' ' ' VAL . 11.4 mt -106.26 141.5 37.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.396 -0.815 . . . . 0.56 109.426 174.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.669 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.2 tt0 -104.55 138.95 40.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.84 -1.163 . . . . 1.17 110.008 173.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 72.0 mt -109.76 132.59 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.395 -0.816 . . . . 0.84 110.329 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.591 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 13.9 m-85 -114.59 157.55 22.89 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.901 -0.407 . . . . 0.45 109.901 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.7 t -129.41 126.6 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.958 -1.089 . . . . 0.26 110.584 174.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.618 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.4 p-10 -146.99 131.83 18.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.354 -0.841 . . . . 1.77 110.14 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 48.7 t0 46.3 48.21 13.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.107 -0.996 . . . . 1.21 110.968 175.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 82.8 tt0 61.82 11.04 3.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.238 -0.914 . . . . 1.92 110.617 175.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 32.7 mtmt -113.08 151.2 31.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.178 -0.951 . . . . 2.0 109.791 176.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.622 HD13 HD11 ' A' ' 20' ' ' ILE . 56.3 mt -102.01 129.67 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.174 -0.954 . . . . 1.24 110.294 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.618 HD11 ' OD2' ' B' ' 41' ' ' ASP . 22.3 mt -112.71 120.83 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.5 110.075 176.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.838 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.2 mp -112.28 134.02 54.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.077 -1.014 . . . . 1.66 110.053 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.536 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 10.7 pttp -141.5 165.02 28.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 1.74 110.248 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.544 ' HD3' ' CD1' ' B' ' 30' ' ' ILE . 18.3 tptp -57.06 145.96 28.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 1.65 109.878 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.692 ' CD2' HG11 ' A' ' 9' ' ' VAL . 10.1 t80 . . . . . 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.65 110.599 -176.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.0 mm . . . . . 0 N--CA 1.496 1.843 0 CA-C-O 121.107 0.479 . . . . 1.36 110.157 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.069 HG11 ' CD2' ' B' ' 50' ' ' TYR . 98.9 t -115.28 144.46 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.996 -1.065 . . . . 0.37 110.893 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.447 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 14.8 tpt180 -130.22 160.62 33.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.514 -0.741 . . . . 1.91 109.687 177.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.447 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 66.7 mttm -85.76 148.5 25.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.106 -0.996 . . . . 2.21 110.344 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.924 HG22 HD11 ' B' ' 36' ' ' LEU . 6.3 t -82.05 128.75 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.216 -0.927 . . . . 0.28 109.816 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.464 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.37 -174.82 5.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.209 -0.932 . . . . 0.55 110.164 -179.299 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -53.24 -41.99 65.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.087 -1.008 . . . . 2.19 111.687 -173.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.918 HD23 ' HD3' ' A' ' 17' ' ' ARG . 16.3 tp -85.97 -4.89 59.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.717 -1.239 . . . . 1.38 111.685 -172.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.51 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.23 46.44 7.55 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.094 -1.527 . . . . 0.21 109.695 -177.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.918 ' HD3' HD23 ' A' ' 15' ' ' LEU . 69.2 mtm180 -114.78 154.63 28.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.079 -1.248 . . . . 1.15 110.088 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.697 HG12 HD13 ' B' ' 36' ' ' LEU . 20.9 m -124.85 152.7 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.28 109.819 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.914 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.4 t -112.61 134.91 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.24 110.637 -175.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.547 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.95 132.11 52.02 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.279 -0.888 . . . . 1.38 109.539 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.1 Cg_endo -57.28 141.23 94.6 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.729 1.384 . . . . 0.35 109.947 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.925 HD13 ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.66 -31.7 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.023 -1.048 . . . . 1.11 110.371 -177.56 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.73 -35.33 72.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.071 -1.018 . . . . 2.37 109.824 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.548 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 46.7 mt -81.39 -28.22 34.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.282 -0.887 . . . . 1.75 110.394 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.725 HH22 HD11 ' B' ' 15' ' ' LEU . 72.4 mtt180 -56.98 -44.72 82.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.897 -1.127 . . . . 0.3 109.092 175.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.466 ' NE ' HD11 ' A' ' 22' ' ' ILE . 98.1 mtt180 -72.14 -47.83 48.05 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.775 -0.77 . . . . 3.26 110.839 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.3 m -63.26 -32.19 73.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.158 -0.964 . . . . 0.77 111.018 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.879 HD23 HG13 ' A' ' 30' ' ' ILE . 21.3 tp -88.62 -4.71 58.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.1 -1.0 . . . . 1.05 110.734 -177.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.439 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.05 41.81 97.01 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.718 -1.353 . . . . 0.32 109.718 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.879 HG13 HD23 ' A' ' 28' ' ' LEU . 32.0 mm -116.48 139.24 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.313 -1.11 . . . . 0.41 110.777 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.57 166.12 25.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.677 -0.64 . . . . 0.23 109.987 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.24 147.09 10.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.081 -1.012 . . . . 1.13 110.492 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 33.1 tttp 74.78 -4.97 2.24 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.77 -0.581 . . . . 1.88 111.118 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.731 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.4 m-20 -77.38 166.52 23.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.79 -1.194 . . . . 1.1 109.989 174.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.779 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.2 132.81 50.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 0.36 110.842 -175.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.991 HD11 HG22 ' B' ' 12' ' ' VAL . 13.0 mt -110.11 144.82 38.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.376 -0.828 . . . . 0.56 109.509 175.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.646 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.6 tt0 -108.81 139.79 43.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.726 -1.234 . . . . 1.17 109.685 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.2 mt -109.04 131.17 60.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.434 -0.791 . . . . 0.84 110.56 -172.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.607 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 16.7 m-85 -117.73 157.74 25.98 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 116.296 -0.411 . . . . 0.45 110.02 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 80.7 t -131.79 125.17 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.891 -1.131 . . . . 0.27 110.571 172.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.498 ' OD1' HG12 ' A' ' 46' ' ' ILE . 43.5 p-10 -147.49 144.84 28.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.106 -0.996 . . . . 1.77 110.768 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 52.8 t0 43.02 44.27 4.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.982 -1.074 . . . . 1.22 111.285 173.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 84.1 tt0 60.87 11.34 3.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.108 -0.995 . . . . 1.93 110.679 176.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -111.07 153.53 25.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 2.01 110.057 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.831 HG22 HD11 ' A' ' 47' ' ' LEU . 66.0 mt -93.51 128.8 44.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.279 -0.888 . . . . 1.25 109.846 177.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 23.9 mm -112.97 119.55 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.629 -0.669 . . . . 0.5 110.004 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.833 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -117.96 134.79 54.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 1.66 110.202 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.514 ' HE2' ' CE1' ' A' ' 39' ' ' TYR . 22.7 pttt -141.28 162.42 35.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.377 -0.827 . . . . 1.74 110.326 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -57.79 147.17 28.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.147 -0.971 . . . . 1.65 110.023 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.895 ' CD2' HG11 ' B' ' 9' ' ' VAL . 5.3 t80 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.35 110.575 -176.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 36' ' ' LEU . 99.4 t . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.464 0.65 . . . . 0.37 110.837 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 14.8 tpt180 -130.23 160.51 33.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.573 -0.705 . . . . 1.92 109.792 177.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.451 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 66.7 mttm -85.76 148.49 25.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.062 -1.024 . . . . 2.21 110.331 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.991 HG22 HD11 ' A' ' 36' ' ' LEU . 6.4 t -82.11 128.76 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.281 -0.887 . . . . 0.29 109.728 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -85.52 -174.6 5.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.55 110.217 -179.395 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.465 ' OE1' ' OE2' ' A' ' 32' ' ' GLU . 47.2 tp10 -53.41 -41.86 66.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 2.19 111.689 -173.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.9 tp -85.97 -4.93 59.28 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.781 -1.2 . . . . 1.39 111.732 -172.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.511 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.88 47.27 7.26 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.439 -1.464 . . . . 0.21 109.439 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.914 ' CD ' HG22 ' A' ' 19' ' ' VAL . 69.2 mtm180 -114.94 154.64 28.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.057 -1.26 . . . . 1.14 110.043 -177.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.712 HG12 HD13 ' A' ' 36' ' ' LEU . 21.0 m -124.93 152.71 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.367 -0.833 . . . . 0.28 109.852 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.908 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.4 t -112.62 134.83 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 0.24 110.666 -175.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.98 132.1 51.95 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.92 . . . . 1.38 109.528 174.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.1 Cg_endo -57.45 141.26 94.97 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.73 1.384 . . . . 0.36 109.964 177.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.922 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.9 -31.24 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.982 . . . . 1.11 110.367 -177.216 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.83 -35.91 73.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.04 -1.038 . . . . 2.37 109.633 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.55 ' HB2' HG23 ' B' ' 20' ' ' ILE . 47.1 mt -80.73 -28.5 36.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.44 -0.788 . . . . 1.75 110.438 176.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.659 HH22 HD11 ' A' ' 15' ' ' LEU . 72.1 mtt180 -56.93 -44.59 82.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.876 -1.14 . . . . 0.3 109.037 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.471 ' NE ' HD11 ' B' ' 22' ' ' ILE . 98.1 mtt180 -72.1 -48.08 46.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.403 -0.811 . . . . 3.27 110.698 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.3 m -63.0 -32.66 74.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.244 -0.91 . . . . 0.77 110.816 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.886 HD23 HG13 ' B' ' 30' ' ' ILE . 21.4 tp -88.12 -5.15 58.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.997 -1.064 . . . . 1.05 110.636 -177.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.446 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.44 41.69 96.25 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.519 -1.433 . . . . 0.32 109.519 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.886 HG13 HD23 ' B' ' 28' ' ' LEU . 31.7 mm -116.49 139.24 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.14 -1.212 . . . . 0.41 110.731 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.34 166.24 25.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.663 -0.648 . . . . 0.23 109.948 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.19 147.1 10.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.028 -1.045 . . . . 1.13 110.525 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 33.1 tttp 74.76 -5.0 2.22 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.737 -0.602 . . . . 1.88 111.132 177.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.629 ' O ' HG23 ' A' ' 12' ' ' VAL . 88.7 m-20 -77.43 166.4 23.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.795 -1.19 . . . . 1.1 109.992 174.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.14 132.79 50.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.36 110.902 -175.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.942 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.7 mt -110.24 144.54 38.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.355 -0.841 . . . . 0.56 109.533 175.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.63 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.4 tt0 -108.44 139.81 42.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.744 -1.223 . . . . 1.17 109.832 172.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -109.01 131.26 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.353 -0.842 . . . . 0.84 110.42 -172.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 16.5 m-85 -117.82 157.64 26.23 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 120.964 0.411 . . . . 0.45 109.97 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 80.9 t -131.59 125.5 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.864 -1.148 . . . . 0.26 110.427 172.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.501 ' OD1' HG12 ' B' ' 46' ' ' ILE . 43.4 p-10 -147.88 144.85 28.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 1.77 110.743 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.4 t0 43.02 44.44 4.08 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.059 -1.026 . . . . 1.21 111.237 174.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 84.1 tt0 60.65 11.44 3.1 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.027 -1.046 . . . . 1.92 110.613 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -111.09 153.78 25.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.111 -0.993 . . . . 2.0 109.895 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.828 HG22 HD11 ' B' ' 47' ' ' LEU . 65.2 mt -93.69 128.6 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.198 -0.939 . . . . 1.24 109.967 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 23.4 mm -112.95 119.65 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.697 -0.627 . . . . 0.5 109.873 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.829 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.3 mp -117.89 134.68 54.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.007 -1.058 . . . . 1.66 110.147 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.509 ' HE2' ' CE1' ' B' ' 39' ' ' TYR . 23.1 pttt -141.16 162.61 35.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.352 -0.843 . . . . 1.74 110.276 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -57.8 147.09 29.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.947 . . . . 1.65 109.997 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 1.069 ' CD2' HG11 ' A' ' 9' ' ' VAL . 5.5 t80 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.65 110.516 -176.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 57.9 mt . . . . . 0 N--CA 1.494 1.743 0 CA-C-O 121.058 0.456 . . . . 1.36 109.991 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.929 HG13 ' O ' ' B' ' 36' ' ' LEU . 92.6 t -112.65 143.71 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.975 -1.078 . . . . 0.37 110.782 -176.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 29.7 tpt180 -125.98 157.83 36.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.539 -0.726 . . . . 1.91 109.832 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.461 ' HE3' ' HA ' ' B' ' 33' ' ' LYS . 33.2 tttp -82.81 143.82 30.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.915 . . . . 2.21 110.172 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.924 HG22 HD11 ' B' ' 36' ' ' LEU . 15.0 t -80.4 126.93 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.888 . . . . 0.28 109.855 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.99 -174.93 5.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.975 . . . . 0.55 110.013 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.34 -39.55 73.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.011 -1.056 . . . . 2.19 111.689 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.914 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.1 tp -84.67 -6.17 59.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.728 -1.233 . . . . 1.38 111.574 -173.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.32 46.69 7.35 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.108 -1.52 . . . . 0.21 109.641 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.914 ' HD3' HD23 ' A' ' 15' ' ' LEU . 70.8 mtm180 -114.06 153.99 28.48 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.033 -1.275 . . . . 1.15 110.078 -177.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.862 HG12 HD13 ' B' ' 36' ' ' LEU . 20.9 m -124.28 153.39 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.343 -0.848 . . . . 0.28 109.789 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.903 HG22 ' CD ' ' B' ' 17' ' ' ARG . 17.0 t -113.42 133.66 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.24 110.703 -175.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.594 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.42 136.19 43.11 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.163 -0.961 . . . . 1.38 109.443 174.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.5 Cg_endo -58.56 141.12 97.14 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.702 1.369 . . . . 0.35 109.893 176.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.954 HD13 ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.89 -31.31 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.94 -1.1 . . . . 1.11 110.382 -177.55 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.59 -35.38 72.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.049 -1.032 . . . . 2.37 109.854 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.594 ' HB2' HG23 ' A' ' 20' ' ' ILE . 52.8 mt -81.02 -29.46 35.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 1.75 110.455 176.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.705 HH22 HD11 ' B' ' 15' ' ' LEU . 73.9 mtt180 -57.13 -44.02 82.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.969 -1.082 . . . . 0.3 109.05 175.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -72.64 -50.12 27.29 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.539 -0.726 . . . . 3.26 110.708 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m -63.56 -31.25 72.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.195 -0.941 . . . . 0.77 111.09 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.722 HD23 HG13 ' A' ' 30' ' ' ILE . 18.2 tp -87.59 -4.37 58.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 1.05 110.759 -177.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.454 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 67.01 40.94 93.37 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.712 -1.355 . . . . 0.32 109.712 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.722 HG13 HD23 ' A' ' 28' ' ' LEU . 31.2 mm -116.51 139.07 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.328 -1.101 . . . . 0.41 110.674 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.83 166.53 24.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.529 -0.732 . . . . 0.23 110.032 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.524 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.24 146.53 11.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 1.13 110.602 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 56.2 tttt 74.7 -4.58 2.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.678 -0.639 . . . . 1.88 111.139 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.764 ' O ' HG23 ' B' ' 12' ' ' VAL . 87.3 m-20 -76.75 168.09 20.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.189 . . . . 1.1 110.034 174.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.681 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -106.23 131.69 53.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.36 110.726 -175.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.925 ' O ' HG13 ' B' ' 9' ' ' VAL . 13.0 mt -109.04 144.55 36.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.425 -0.797 . . . . 0.56 109.457 175.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.567 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.0 tt0 -109.65 138.67 45.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.74 -1.225 . . . . 1.17 109.491 172.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.51 133.33 55.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.336 -0.853 . . . . 0.84 110.607 -171.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.596 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 9.5 m-85 -118.3 161.48 19.86 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.905 -0.405 . . . . 0.45 109.905 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.464 HG21 HD11 ' B' ' 24' ' ' LEU . 77.4 t -133.8 120.53 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.854 -1.154 . . . . 0.27 110.599 172.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 45.4 p-10 -148.25 160.99 42.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 1.77 110.55 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 53.0 t0 42.21 39.51 1.44 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.009 -1.057 . . . . 1.22 111.493 172.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 84.2 tt0 59.05 14.07 3.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.898 -1.127 . . . . 1.93 110.567 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.558 ' CE ' HD11 ' A' ' 46' ' ' ILE . 11.2 pttt -127.66 166.25 18.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.147 -0.971 . . . . 2.01 109.696 174.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.68 HG22 HD11 ' A' ' 47' ' ' LEU . 66.8 mt -97.95 134.37 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 1.25 110.388 -175.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.596 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 20.3 mm -113.95 120.13 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.643 -0.661 . . . . 0.5 109.959 178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.838 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.5 mp -115.83 135.63 53.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.965 -1.085 . . . . 1.66 110.227 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.577 ' HE3' ' CD1' ' A' ' 39' ' ' TYR . 13.5 ptpt -141.28 158.64 43.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 1.74 110.368 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -58.42 146.75 33.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 1.65 109.934 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.681 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 8.5 t80 . . . . . 0 C--N 1.301 -1.537 0 O-C-N 121.318 -0.864 . . . . 0.35 110.602 -175.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.925 HG13 ' O ' ' A' ' 36' ' ' LEU . 92.7 t . . . . . 0 N--CA 1.493 1.693 0 CA-C-O 121.556 0.693 . . . . 0.37 110.789 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -125.96 157.69 37.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.463 -0.773 . . . . 1.92 109.912 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -82.78 143.67 30.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 2.21 110.173 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.914 HG22 HD11 ' A' ' 36' ' ' LEU . 15.1 t -80.23 127.08 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 0.29 109.78 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -86.15 -174.79 5.25 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.082 -1.011 . . . . 0.55 110.14 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.479 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.8 mt-10 -56.46 -39.51 73.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.017 -1.052 . . . . 2.19 111.609 -172.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.901 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.7 tp -84.69 -6.21 59.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.733 -1.229 . . . . 1.39 111.599 -173.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.88 47.65 7.03 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.474 -1.45 . . . . 0.21 109.474 -177.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.903 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.6 mtm180 -114.39 154.05 28.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.037 -1.272 . . . . 1.14 109.974 -177.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.858 HG12 HD13 ' A' ' 36' ' ' LEU . 20.6 m -124.35 153.49 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.28 109.864 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.907 HG22 ' CD ' ' A' ' 17' ' ' ARG . 16.9 t -113.53 133.68 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.24 110.672 -175.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.594 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -83.41 136.21 43.13 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.201 -0.937 . . . . 1.38 109.475 174.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.542 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.4 Cg_endo -58.74 141.01 97.38 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.716 1.377 . . . . 0.36 109.896 176.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.954 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -56.03 -31.01 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 1.11 110.415 -177.268 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.56 -35.96 73.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.994 -1.066 . . . . 2.37 109.714 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.594 ' HB2' HG23 ' B' ' 20' ' ' ILE . 52.6 mt -80.32 -29.83 38.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.416 -0.802 . . . . 1.75 110.435 176.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.647 HH22 HD11 ' A' ' 15' ' ' LEU . 73.3 mtt180 -56.98 -44.0 82.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.903 -1.123 . . . . 0.3 109.036 175.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -72.4 -50.44 26.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 3.27 110.715 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 55.5 m -63.29 -31.78 73.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.33 -0.856 . . . . 0.77 110.878 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.722 HD23 HG13 ' B' ' 30' ' ' ILE . 18.3 tp -87.16 -4.57 59.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.007 -1.058 . . . . 1.05 110.71 -176.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.459 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 67.34 40.73 91.81 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.597 -1.401 . . . . 0.32 109.597 178.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.722 HG13 HD23 ' B' ' 28' ' ' LEU . 30.6 mm -116.53 139.05 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -1.175 . . . . 0.41 110.586 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.62 166.53 24.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.545 -0.722 . . . . 0.23 110.06 -177.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.33 146.64 11.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.944 . . . . 1.13 110.511 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 56.1 tttt 74.71 -4.69 2.29 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.592 -0.693 . . . . 1.88 111.264 177.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.698 ' O ' HG23 ' A' ' 12' ' ' VAL . 87.7 m-20 -76.75 167.74 21.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.8 -1.187 . . . . 1.1 110.021 174.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.691 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.94 131.67 52.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 0.36 110.856 -175.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.929 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.8 mt -109.03 144.26 37.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.858 . . . . 0.56 109.626 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.55 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.7 tt0 -109.27 138.69 45.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.759 -1.213 . . . . 1.17 109.734 172.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.3 mt -109.5 133.38 54.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.336 -0.853 . . . . 0.84 110.531 -171.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.622 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 9.3 m-85 -118.33 161.31 20.15 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.954 -0.387 . . . . 0.45 109.954 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.413 HG21 HD11 ' A' ' 24' ' ' LEU . 78.9 t -133.5 121.01 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.861 -1.15 . . . . 0.26 110.473 172.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 45.3 p-10 -148.86 160.95 42.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.98 . . . . 1.77 110.49 178.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.4 t0 41.99 39.82 1.42 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.204 -0.935 . . . . 1.21 111.481 172.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' B' ' 43' ' ' GLU . 84.2 tt0 58.89 14.04 3.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.91 -1.119 . . . . 1.92 110.528 174.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.56 ' CE ' HD11 ' B' ' 46' ' ' ILE . 11.2 pttt -127.55 166.41 18.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 2.0 109.699 174.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.681 HG22 HD11 ' B' ' 47' ' ' LEU . 66.7 mt -98.09 134.32 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 1.24 110.399 -175.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 20.7 mm -113.94 120.09 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.683 -0.636 . . . . 0.5 109.975 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.83 ' CD1' HD13 ' A' ' 47' ' ' LEU . 4.6 mp -115.76 135.5 53.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.069 -1.019 . . . . 1.66 110.192 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.574 ' HE3' ' CD1' ' B' ' 39' ' ' TYR . 13.5 ptpt -141.14 158.88 43.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.375 -0.828 . . . . 1.74 110.295 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -58.54 146.75 34.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.213 -0.929 . . . . 1.65 109.908 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.771 ' CD2' HG11 ' A' ' 9' ' ' VAL . 8.8 t80 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.65 110.69 -175.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.6 mt . . . . . 0 N--CA 1.495 1.789 0 CA-C-O 121.075 0.464 . . . . 1.36 110.085 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.967 HG11 ' CD2' ' B' ' 50' ' ' TYR . 90.7 t -117.41 144.49 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.056 -1.027 . . . . 0.37 110.82 -176.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.417 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 23.9 tpt180 -129.77 158.95 38.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -0.793 . . . . 1.91 109.798 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.417 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 35.5 ttpt -82.71 145.52 29.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.127 -0.983 . . . . 2.21 110.335 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.916 HG22 HD11 ' B' ' 36' ' ' LEU . 3.7 t -81.76 128.69 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.385 -0.822 . . . . 0.28 109.807 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.55 -177.29 6.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.072 -1.017 . . . . 0.55 109.997 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.99 -40.5 73.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.049 -1.032 . . . . 2.19 111.539 -174.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.57 ' CD1' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -76.83 -13.81 59.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.873 -1.142 . . . . 1.38 110.542 -174.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.81 46.66 5.9 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.401 -1.479 . . . . 0.21 109.401 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.893 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.5 mtm180 -114.41 155.04 27.06 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.024 -1.28 . . . . 1.15 110.095 -176.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.952 HG12 HD13 ' B' ' 36' ' ' LEU . 13.1 m -122.91 152.46 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.318 -0.864 . . . . 0.28 109.769 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.889 HG22 ' CD ' ' B' ' 17' ' ' ARG . 15.0 t -112.8 134.08 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.24 110.659 -174.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.552 HD11 ' CG2' ' B' ' 45' ' ' ILE . 2.5 mm -84.3 137.24 39.68 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 1.38 109.367 174.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.55 ' HG2' HD12 ' A' ' 24' ' ' LEU . 9.8 Cg_endo -58.63 140.77 96.24 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.718 1.378 . . . . 0.35 109.785 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.954 HD13 ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.63 -32.21 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.862 -1.149 . . . . 1.11 110.313 -177.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -58.73 -35.27 72.42 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.16 -0.962 . . . . 2.37 109.763 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.55 HD12 ' HG2' ' A' ' 21' ' ' PRO . 41.3 mt -82.65 -27.62 31.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 1.75 110.517 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.523 ' CG ' ' HA ' ' A' ' 22' ' ' ILE . 71.2 mtt180 -56.85 -44.51 82.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.798 -1.189 . . . . 0.3 108.84 175.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . 0.463 ' HE ' HD11 ' A' ' 22' ' ' ILE . 31.5 mmt180 -72.77 -47.81 43.59 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.938 -0.705 . . . . 3.26 110.657 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.4 m -63.69 -31.32 72.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.191 -0.943 . . . . 0.77 111.069 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.84 HD23 HG13 ' A' ' 30' ' ' ILE . 20.9 tp -87.39 -4.65 59.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 1.05 110.683 -177.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.413 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 66.05 41.49 95.11 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.662 -1.375 . . . . 0.32 109.662 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.84 HG13 HD23 ' A' ' 28' ' ' LEU . 33.3 mm -116.43 138.79 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.344 -1.092 . . . . 0.41 110.675 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.64 166.07 25.76 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.55 -0.719 . . . . 0.23 109.981 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.73 146.51 13.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.094 -1.004 . . . . 1.13 110.533 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 43.5 tttm 75.02 -4.63 2.34 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.744 -0.598 . . . . 1.88 111.068 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.743 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.9 m-20 -77.21 167.19 22.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.73 -1.231 . . . . 1.1 110.05 174.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.718 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.49 130.74 53.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.36 110.744 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.969 HD13 HG12 ' B' ' 18' ' ' VAL . 13.4 mt -107.58 143.9 35.36 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.336 -0.852 . . . . 0.56 109.388 175.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.647 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.3 tt0 -108.77 139.22 43.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.809 -1.182 . . . . 1.17 109.694 172.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.3 mt -109.84 133.1 56.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.425 -0.797 . . . . 0.84 110.541 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.622 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 17.2 m-85 -119.45 158.85 25.38 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 116.262 -0.426 . . . . 0.45 109.894 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.511 HG21 HD11 ' B' ' 24' ' ' LEU . 85.3 t -132.01 123.32 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.833 -1.167 . . . . 0.27 110.66 173.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.502 ' OD1' HG12 ' A' ' 46' ' ' ILE . 47.8 p-10 -147.69 149.12 31.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 1.77 110.632 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 52.7 t0 42.95 44.64 4.07 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.001 -1.062 . . . . 1.22 111.256 173.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 75.6 mm-40 57.67 14.55 2.45 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.053 -1.03 . . . . 1.93 110.567 176.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -115.84 153.94 30.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 2.01 109.955 175.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.901 HG22 HD11 ' A' ' 47' ' ' LEU . 67.7 mt -92.92 129.05 44.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.253 -0.904 . . . . 1.25 109.954 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.0 mm -111.91 119.36 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.561 -0.712 . . . . 0.5 109.907 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.901 HD11 HG22 ' A' ' 45' ' ' ILE . 4.2 mp -118.81 134.36 55.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.924 -1.11 . . . . 1.66 110.281 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.556 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 12.1 pttp -141.99 163.69 32.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.451 -0.781 . . . . 1.74 110.478 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -59.26 147.02 37.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 1.65 110.14 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.799 ' CD2' HG11 ' B' ' 9' ' ' VAL . 10.3 t80 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.35 110.67 -176.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 36' ' ' LEU . 89.4 t . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 121.514 0.673 . . . . 0.37 110.804 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 24.0 tpt180 -129.75 158.85 38.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.545 -0.722 . . . . 1.92 109.907 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.421 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 35.5 ttpt -82.72 145.38 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.059 -1.026 . . . . 2.21 110.4 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.921 HG22 ' CD1' ' A' ' 36' ' ' LEU . 3.7 t -81.67 128.79 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.256 -0.903 . . . . 0.29 109.704 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.76 -177.4 6.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.093 -1.005 . . . . 0.55 110.073 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.97 -40.41 73.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.073 -1.017 . . . . 2.19 111.489 -173.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.567 ' CD1' ' O ' ' B' ' 15' ' ' LEU . 0.1 OUTLIER -76.49 -14.26 60.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.894 -1.129 . . . . 1.39 110.647 -174.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.63 47.32 5.69 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.319 -1.512 . . . . 0.21 109.319 -177.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.889 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.5 mtm180 -114.61 154.95 27.44 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.155 -1.203 . . . . 1.14 110.058 -176.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.969 HG12 HD13 ' A' ' 36' ' ' LEU . 13.2 m -122.93 152.48 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.28 109.74 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.893 HG22 ' CD ' ' A' ' 17' ' ' ARG . 14.9 t -112.84 134.1 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.24 110.678 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.589 HD11 ' CG2' ' A' ' 45' ' ' ILE . 2.5 mm -84.29 137.21 39.72 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.924 . . . . 1.38 109.388 174.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.57 ' HG2' HD12 ' B' ' 24' ' ' LEU . 9.8 Cg_endo -58.74 140.77 96.39 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.656 1.345 . . . . 0.36 109.837 176.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.941 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.78 -31.99 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.998 -1.064 . . . . 1.11 110.294 -177.374 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -58.74 -35.85 73.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.024 -1.047 . . . . 2.37 109.609 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.57 HD12 ' HG2' ' B' ' 21' ' ' PRO . 41.8 mt -81.89 -28.01 33.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.431 -0.793 . . . . 1.75 110.566 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.534 ' CG ' ' HA ' ' B' ' 22' ' ' ILE . 70.7 mtt180 -56.78 -44.27 81.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.901 -1.124 . . . . 0.3 108.957 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . 0.467 ' HE ' HD11 ' B' ' 22' ' ' ILE . 31.4 mmt180 -72.74 -47.96 42.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.484 -0.76 . . . . 3.27 110.642 -178.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.3 m -63.45 -31.96 73.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.226 -0.921 . . . . 0.77 110.84 -177.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.845 HD23 HG13 ' B' ' 30' ' ' ILE . 21.0 tp -86.83 -4.99 59.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.132 -0.98 . . . . 1.05 110.66 -177.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.419 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.48 41.17 94.41 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.603 -1.399 . . . . 0.32 109.603 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.845 HG13 HD23 ' B' ' 28' ' ' LEU . 32.6 mm -116.34 138.65 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -1.199 . . . . 0.41 110.667 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.33 166.24 25.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.633 -0.667 . . . . 0.23 110.001 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.4 tt0 -53.74 146.6 13.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 1.13 110.475 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 43.6 tttm 75.07 -4.87 2.28 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.621 -0.675 . . . . 1.88 111.169 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.1 m-20 -77.37 166.99 22.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.91 -1.119 . . . . 1.1 110.041 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.722 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.27 130.78 53.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 0.36 110.816 -176.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.952 HD13 HG12 ' A' ' 18' ' ' VAL . 13.1 mt -107.7 143.56 36.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.375 -0.828 . . . . 0.56 109.495 175.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.625 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.2 tt0 -108.43 139.18 43.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.932 -1.105 . . . . 1.17 109.85 172.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.5 mt -109.85 133.01 56.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.39 -0.819 . . . . 0.84 110.489 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.631 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 17.1 m-85 -119.43 158.85 25.37 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 116.244 -0.435 . . . . 0.45 109.94 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.432 HG21 HD11 ' A' ' 24' ' ' LEU . 86.5 t -131.82 123.65 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.863 -1.148 . . . . 0.26 110.515 173.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.5 ' OD1' HG12 ' B' ' 46' ' ' ILE . 47.9 p-10 -148.18 149.14 31.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 1.77 110.613 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 53.2 t0 42.83 44.94 4.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.101 -0.999 . . . . 1.21 111.188 174.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 75.6 mm-40 57.42 14.65 2.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.071 -1.018 . . . . 1.92 110.562 176.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -115.87 154.18 30.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 2.0 109.896 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.894 HG22 HD11 ' B' ' 47' ' ' LEU . 67.6 mt -93.07 128.84 44.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.187 -0.946 . . . . 1.24 109.945 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 21.0 mm -111.93 119.51 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.572 -0.705 . . . . 0.5 109.946 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.894 HD11 HG22 ' B' ' 45' ' ' ILE . 4.4 mp -118.78 134.23 55.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.892 -1.13 . . . . 1.66 110.15 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.563 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 12.3 pttp -141.85 163.89 31.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 1.74 110.371 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -59.24 146.91 37.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.135 -0.978 . . . . 1.65 110.1 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.967 ' CD2' HG11 ' A' ' 9' ' ' VAL . 10.5 t80 . . . . . 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.65 110.542 -176.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.5 mm . . . . . 0 N--CA 1.495 1.821 0 CA-C-O 121.026 0.441 . . . . 1.36 109.811 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.07 HG11 ' CD2' ' B' ' 50' ' ' TYR . 85.7 t -118.84 144.75 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.969 -1.082 . . . . 0.37 110.904 -174.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -129.94 159.26 37.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.455 -0.778 . . . . 1.91 109.83 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -82.87 146.03 29.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 2.21 110.265 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.924 HG22 HD11 ' B' ' 36' ' ' LEU . 3.4 t -80.42 129.28 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.357 -0.839 . . . . 0.28 109.866 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.84 -175.35 5.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.179 -0.951 . . . . 0.55 110.039 179.337 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -54.56 -40.82 69.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.069 -1.019 . . . . 2.19 111.788 -173.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.884 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.9 tp -84.99 -5.41 59.35 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.758 -1.214 . . . . 1.38 111.595 -173.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.526 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.44 46.52 7.38 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 119.178 -1.486 . . . . 0.21 109.687 -177.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.917 ' CD ' HG22 ' B' ' 19' ' ' VAL . 71.1 mtm180 -114.83 154.51 28.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.031 -1.276 . . . . 1.15 110.004 -177.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.838 HG21 ' CD2' ' B' ' 47' ' ' LEU . 18.8 m -124.47 153.15 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.28 109.809 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.928 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.4 t -111.19 135.38 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.24 110.569 -176.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.599 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.69 134.6 47.18 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 1.38 109.524 175.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.542 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.3 Cg_endo -58.27 143.45 97.19 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.756 1.398 . . . . 0.35 110.092 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.892 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.28 -31.81 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.934 -1.104 . . . . 1.11 110.416 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.42 -34.95 73.11 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.15 -0.969 . . . . 2.37 109.907 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.599 ' HB2' HG23 ' A' ' 20' ' ' ILE . 61.5 mt -81.96 -30.66 31.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.326 -0.858 . . . . 1.75 110.589 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.892 ' HD2' HD12 ' A' ' 22' ' ' ILE . 73.7 mtt180 -57.69 -43.92 85.45 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.044 -1.062 . . . . 0.3 109.212 175.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -72.5 -50.51 25.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.559 -0.713 . . . . 3.26 110.706 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.0 m -63.7 -31.21 72.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.144 -0.972 . . . . 0.77 111.086 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.916 HD23 HG13 ' A' ' 30' ' ' ILE . 22.9 tp -87.56 -4.78 58.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.088 -1.007 . . . . 1.05 110.698 -177.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.442 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.72 43.47 96.26 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.614 -1.395 . . . . 0.32 109.614 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.916 HG13 HD23 ' A' ' 28' ' ' LEU . 30.8 mm -115.69 139.08 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.272 -1.134 . . . . 0.41 110.65 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -140.81 167.49 22.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.555 -0.716 . . . . 0.23 110.003 -178.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 83.4 tt0 -52.48 150.44 4.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 1.13 110.468 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.604 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 39.9 mttp 67.01 -2.97 1.02 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 112.294 0.479 . . . . 1.88 112.294 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.77 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.3 m-20 -75.55 166.89 22.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.526 -1.359 . . . . 1.1 109.922 173.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.79 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -103.83 130.23 51.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.36 110.769 -175.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.934 ' O ' HG13 ' B' ' 9' ' ' VAL . 13.7 mt -108.3 140.67 41.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.56 109.49 175.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.745 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.1 tt0 -105.4 140.1 39.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.834 -1.166 . . . . 1.17 109.731 173.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.2 mt -111.49 133.88 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.44 -0.788 . . . . 0.84 110.478 -173.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.58 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 8.6 m-85 -115.2 160.4 19.77 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 120.904 0.383 . . . . 0.45 110.09 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 94.0 t -133.58 123.13 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.132 -0.98 . . . . 0.27 110.857 173.53 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.609 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.1 p-10 -147.3 141.61 26.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 1.77 110.22 177.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 53.4 t0 43.47 47.86 6.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.074 -1.016 . . . . 1.22 111.096 174.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.7 mt-10 58.74 13.77 2.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.186 -0.946 . . . . 1.93 110.711 176.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -114.52 148.19 38.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 2.01 110.07 175.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.586 HD13 HG13 ' B' ' 20' ' ' ILE . 61.2 mt -99.6 127.6 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 1.25 110.095 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.609 HD11 ' OD2' ' A' ' 41' ' ' ASP . 34.2 mt -111.87 118.15 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.331 -0.856 . . . . 0.5 110.275 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.94 ' CD2' HG21 ' B' ' 18' ' ' VAL . 4.2 mp -107.95 135.59 49.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 1.66 110.122 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.575 ' HE3' ' CD1' ' A' ' 39' ' ' TYR . 16.2 ptpt -142.45 164.22 30.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.516 -0.74 . . . . 1.74 110.125 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -55.77 147.95 17.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.116 -0.99 . . . . 1.65 109.721 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.924 ' CD2' HG11 ' B' ' 9' ' ' VAL . 1.7 t80 . . . . . 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.35 110.644 -175.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.934 HG13 ' O ' ' A' ' 36' ' ' LEU . 86.3 t . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.456 0.645 . . . . 0.37 110.935 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -129.93 159.08 37.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.468 -0.77 . . . . 1.92 109.924 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -82.84 145.93 29.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 2.21 110.395 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.927 HG22 ' CD1' ' A' ' 36' ' ' LEU . 3.4 t -80.26 129.46 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.917 . . . . 0.29 109.756 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.09 -175.29 5.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.122 -0.986 . . . . 0.55 110.069 179.154 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.67 -40.78 69.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.177 -0.952 . . . . 2.19 111.678 -173.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.904 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.2 tp -85.04 -5.43 59.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.764 -1.21 . . . . 1.39 111.572 -173.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.531 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.11 47.24 7.15 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.523 -1.431 . . . . 0.21 109.523 -177.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.928 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.9 mtm180 -115.06 154.49 28.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.05 -1.265 . . . . 1.14 109.932 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.94 HG21 ' CD2' ' A' ' 47' ' ' LEU . 18.8 m -124.49 153.07 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.28 109.822 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.917 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.4 t -111.23 135.3 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -0.956 . . . . 0.24 110.605 -175.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.603 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.62 134.52 47.52 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.26 -0.9 . . . . 1.38 109.545 175.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.541 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.3 Cg_endo -58.28 143.4 97.29 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.851 1.448 . . . . 0.36 110.111 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.888 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.36 -31.66 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.098 -1.001 . . . . 1.11 110.408 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.26 -35.63 74.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.121 -0.987 . . . . 2.37 109.808 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.603 ' HB2' HG23 ' B' ' 20' ' ' ILE . 62.2 mt -81.23 -30.96 34.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.386 -0.822 . . . . 1.75 110.619 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.888 ' HD2' HD12 ' B' ' 22' ' ' ILE . 73.2 mtt180 -57.57 -43.86 84.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.883 -1.135 . . . . 0.3 109.208 176.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -72.45 -50.81 23.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 3.27 110.599 -177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.7 m -63.35 -31.8 73.05 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.77 110.88 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.915 HD23 HG13 ' B' ' 30' ' ' ILE . 23.1 tp -87.0 -5.21 59.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.042 -1.036 . . . . 1.05 110.651 -176.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.445 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.01 43.25 96.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.55 -1.42 . . . . 0.32 109.55 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.915 HG13 HD23 ' B' ' 28' ' ' LEU . 30.5 mm -115.53 138.97 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.213 -1.169 . . . . 0.41 110.727 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -140.6 167.64 21.69 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.676 -0.64 . . . . 0.23 110.003 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' B' ' 33' ' ' LYS . 83.5 tt0 -52.59 150.69 4.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 1.13 110.454 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' B' ' 32' ' ' GLU . 40.5 mttp 66.52 -2.51 1.03 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 112.4 0.518 . . . . 1.88 112.4 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.654 ' O ' HG23 ' A' ' 12' ' ' VAL . 88.5 m-20 -75.86 166.78 23.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.599 -1.313 . . . . 1.1 109.895 173.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.762 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.64 130.14 51.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -0.91 . . . . 0.36 110.807 -175.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.937 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.6 mt -108.28 140.5 41.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.866 . . . . 0.56 109.513 175.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.722 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.8 tt0 -105.24 139.98 39.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.827 -1.171 . . . . 1.17 109.86 173.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 71.4 mt -111.41 133.99 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.362 -0.836 . . . . 0.84 110.455 -173.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.578 ' CD1' ' HE3' ' B' ' 48' ' ' LYS . 8.5 m-85 -115.2 160.38 19.8 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 120.972 0.415 . . . . 0.45 110.18 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 94.3 t -133.31 123.45 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.922 -1.112 . . . . 0.26 110.686 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.612 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.1 p-10 -147.69 141.55 25.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 1.77 110.197 176.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 54.1 t0 43.56 48.0 6.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.098 -1.001 . . . . 1.21 111.045 174.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.7 mt-10 58.55 13.85 2.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.132 -0.98 . . . . 1.92 110.666 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -114.44 148.39 37.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 2.0 110.007 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.459 HD13 ' CG1' ' A' ' 20' ' ' ILE . 60.9 mt -99.71 127.61 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.909 . . . . 1.24 110.145 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.612 HD11 ' OD2' ' B' ' 41' ' ' ASP . 35.5 mt -112.03 118.16 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.428 -0.795 . . . . 0.5 110.216 178.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.838 ' CD2' HG21 ' A' ' 18' ' ' VAL . 4.3 mp -107.83 135.48 49.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 1.66 110.009 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.578 ' HE3' ' CD1' ' B' ' 39' ' ' TYR . 16.2 ptpt -142.29 164.28 30.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.517 -0.739 . . . . 1.74 110.153 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -55.83 147.84 18.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.083 -1.011 . . . . 1.65 109.764 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 1.07 ' CD2' HG11 ' A' ' 9' ' ' VAL . 1.7 t80 . . . . . 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.65 110.616 -175.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.4 mt . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 109.633 -0.506 . . . . 1.36 109.633 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.91 HG13 ' O ' ' B' ' 36' ' ' LEU . 78.5 t -113.14 144.52 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.815 -1.178 . . . . 0.37 111.347 -170.404 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.444 ' HG2' ' NH1' ' A' ' 10' ' ' ARG . 57.4 ttp85 -129.19 167.08 18.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.536 -0.727 . . . . 1.91 109.455 175.057 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -84.42 146.45 27.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.02 -1.05 . . . . 2.21 110.443 -178.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.907 HG22 ' CD1' ' B' ' 36' ' ' LEU . 3.9 t -82.47 131.8 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -0.839 . . . . 0.28 109.758 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.46 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.14 -175.55 5.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.55 110.058 -179.038 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.424 ' HG2' ' OE2' ' B' ' 32' ' ' GLU . 97.0 mt-10 -57.03 -39.34 74.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.064 -1.022 . . . . 2.19 111.754 -172.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.882 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.7 tp -84.29 -5.96 59.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.734 -1.229 . . . . 1.38 111.606 -173.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.413 ' HA2' HG12 ' A' ' 12' ' ' VAL . . . 79.99 46.9 7.41 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.161 -1.495 . . . . 0.21 109.694 -177.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.915 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.5 mtm180 -114.58 154.5 28.21 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.954 -1.321 . . . . 1.15 110.127 -177.221 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.853 HG12 HD13 ' B' ' 36' ' ' LEU . 15.5 m -123.26 150.69 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.311 -0.868 . . . . 0.28 109.802 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.928 HG22 ' CD ' ' B' ' 17' ' ' ARG . 34.1 t -111.69 134.16 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.915 . . . . 0.24 110.632 -175.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.714 HD11 HG21 ' B' ' 45' ' ' ILE . 2.9 mm -83.89 134.78 43.51 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 1.38 109.507 174.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.555 ' HG2' HD12 ' A' ' 24' ' ' LEU . 9.3 Cg_endo -58.17 143.42 96.86 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.749 1.394 . . . . 0.35 110.061 177.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.903 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.1 tp -54.92 -33.47 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.014 -1.054 . . . . 1.11 110.429 -178.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.416 ' N ' HG23 ' A' ' 22' ' ' ILE . 84.2 tt0 -58.06 -35.51 71.44 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.094 -1.003 . . . . 2.37 109.816 178.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.562 ' HB2' HG23 ' A' ' 20' ' ' ILE . 48.2 mt -83.28 -29.17 28.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.39 -0.819 . . . . 1.75 110.636 178.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.903 ' HD2' HD12 ' A' ' 22' ' ' ILE . 71.4 mtt180 -57.71 -44.24 85.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.834 -1.166 . . . . 0.3 109.069 175.451 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -72.97 -48.62 35.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.54 -0.725 . . . . 3.26 110.719 -177.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.0 m -63.48 -32.06 73.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.153 -0.967 . . . . 0.77 111.081 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.772 HD23 HG13 ' A' ' 30' ' ' ILE . 18.1 tp -88.28 -4.4 58.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.088 -1.008 . . . . 1.05 110.766 -176.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.42 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 66.31 42.05 94.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.818 -1.313 . . . . 0.32 109.818 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.772 HG13 HD23 ' A' ' 28' ' ' LEU . 34.1 mm -116.49 137.76 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -1.156 . . . . 0.41 110.682 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.4 ' HB3' ' OD2' ' A' ' 34' ' ' ASP . . . -142.14 166.5 24.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.594 -0.691 . . . . 0.23 110.04 -178.149 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.2 146.68 11.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 1.13 110.599 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 44.7 tttm 74.25 -4.52 2.28 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.666 -0.646 . . . . 1.88 111.143 176.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.781 ' O ' HG23 ' B' ' 12' ' ' VAL . 91.2 m-20 -77.54 168.46 19.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.859 -1.151 . . . . 1.1 110.064 175.147 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.605 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.34 130.56 52.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.36 110.694 -176.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.961 ' CD1' HG22 ' B' ' 12' ' ' VAL . 9.1 mt -107.09 142.69 36.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.314 -0.866 . . . . 0.56 109.312 174.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.699 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.1 tt0 -105.76 137.75 43.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.775 -1.203 . . . . 1.17 109.585 172.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.0 mt -108.0 131.37 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -0.784 . . . . 0.84 110.536 -172.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.609 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 23.3 m-85 -120.16 155.81 32.35 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.849 -0.426 . . . . 0.45 109.849 -178.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . 0.551 HG21 HD11 ' B' ' 24' ' ' LEU . 71.3 t -131.23 120.75 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.88 -1.137 . . . . 0.27 110.586 172.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 47.9 p-10 -148.25 160.86 42.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 1.77 110.583 178.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 54.8 t0 42.13 41.23 1.96 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.065 -1.022 . . . . 1.22 111.575 172.03 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 96.0 mt-10 56.57 15.99 2.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.984 -1.072 . . . . 1.93 110.541 175.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 27.3 pttt -129.54 164.77 23.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.96 . . . . 2.01 109.738 174.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.725 HG21 HD11 ' B' ' 20' ' ' ILE . 64.7 mt -97.66 134.18 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 1.25 110.381 -174.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.609 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.6 mm -113.21 121.29 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.679 -0.638 . . . . 0.5 109.969 177.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.834 ' N ' HD12 ' A' ' 47' ' ' LEU . 3.9 mp -120.77 133.78 55.32 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.915 -1.116 . . . . 1.66 110.021 178.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.595 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 12.9 pttp -143.62 165.53 27.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.232 -0.918 . . . . 1.74 110.631 -179.224 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.552 ' HD3' ' CD1' ' A' ' 30' ' ' ILE . 14.3 tptt -57.6 146.94 28.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 1.65 110.127 177.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.853 ' CD2' HG11 ' B' ' 9' ' ' VAL . 11.2 t80 . . . . . 0 C--N 1.3 -1.568 0 O-C-N 121.324 -0.86 . . . . 0.35 110.693 -176.632 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.943 HG13 ' O ' ' A' ' 36' ' ' LEU . 77.3 t . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.585 0.707 . . . . 0.37 111.356 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.442 ' NH1' ' HG2' ' B' ' 10' ' ' ARG . 57.4 ttp85 -129.07 166.99 18.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.519 -0.738 . . . . 1.92 109.537 175.076 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -84.46 146.37 27.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.052 . . . . 2.21 110.551 -178.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.961 HG22 ' CD1' ' A' ' 36' ' ' LEU . 3.9 t -82.48 131.75 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.379 -0.826 . . . . 0.29 109.699 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.08 -175.49 5.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.084 -1.01 . . . . 0.55 110.212 -179.219 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.49 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -57.17 -39.24 74.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.143 -0.973 . . . . 2.19 111.639 -172.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.901 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.4 tp -84.34 -5.96 59.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.811 -1.181 . . . . 1.39 111.61 -173.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.411 ' HA2' HG12 ' B' ' 12' ' ' VAL . . . 79.53 47.8 7.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.533 -1.427 . . . . 0.21 109.533 -177.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.928 ' CD ' HG22 ' A' ' 19' ' ' VAL . 69.5 mtm180 -114.88 154.48 28.59 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.091 -1.24 . . . . 1.14 110.046 -177.539 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.877 HG12 HD13 ' A' ' 36' ' ' LEU . 15.5 m -123.27 150.65 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.326 -0.859 . . . . 0.28 109.874 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.915 HG22 ' CD ' ' A' ' 17' ' ' ARG . 33.6 t -111.78 134.12 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.24 110.56 -175.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.725 HD11 HG21 ' A' ' 45' ' ' ILE . 2.9 mm -83.81 134.75 43.77 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.22 -0.925 . . . . 1.38 109.617 174.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.2 Cg_endo -58.24 143.35 97.2 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.727 1.383 . . . . 0.36 110.066 177.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.898 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -55.07 -33.35 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.997 -1.065 . . . . 1.11 110.334 -178.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . 0.412 ' N ' HG23 ' B' ' 22' ' ' ILE . 84.1 tt0 -57.83 -36.22 71.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.042 -1.036 . . . . 2.37 109.709 178.498 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.565 ' HB2' HG23 ' B' ' 20' ' ' ILE . 48.5 mt -82.47 -29.58 30.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.388 -0.82 . . . . 1.75 110.654 178.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.898 ' HD2' HD12 ' B' ' 22' ' ' ILE . 70.6 mtt180 -57.59 -44.08 85.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.817 -1.177 . . . . 0.3 109.046 175.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -73.0 -48.83 32.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.863 . . . . 3.27 110.566 -177.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.4 m -63.23 -32.54 73.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.254 -0.904 . . . . 0.77 110.909 -178.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.774 HD23 HG13 ' B' ' 30' ' ' ILE . 18.2 tp -87.77 -4.91 58.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.045 -1.035 . . . . 1.05 110.667 -176.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.423 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.83 41.83 93.32 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.659 -1.377 . . . . 0.32 109.659 178.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.774 HG13 HD23 ' B' ' 28' ' ' LEU . 33.7 mm -116.48 137.66 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -1.162 . . . . 0.41 110.644 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . 0.4 ' HB3' ' OD2' ' B' ' 34' ' ' ASP . . . -141.96 166.55 24.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.602 -0.686 . . . . 0.23 110.081 -178.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.13 146.72 10.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 1.13 110.582 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 44.6 tttm 74.27 -4.56 2.27 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.645 -0.659 . . . . 1.88 111.198 176.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.751 ' O ' HG23 ' A' ' 12' ' ' VAL . 91.1 m-20 -77.67 168.19 20.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.792 -1.192 . . . . 1.1 110.031 175.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.597 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.12 130.69 51.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.36 110.819 -176.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.91 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.1 mt -107.26 142.5 36.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.56 109.318 174.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.653 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.0 tt0 -105.55 137.71 42.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.929 -1.107 . . . . 1.17 109.721 172.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 71.5 mt -108.02 131.41 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.349 -0.844 . . . . 0.84 110.538 -172.367 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.617 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 23.0 m-85 -120.1 155.85 32.19 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 116.294 -0.412 . . . . 0.45 109.948 -178.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . 0.527 HG21 HD11 ' A' ' 24' ' ' LEU . 72.1 t -131.1 121.15 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.836 -1.165 . . . . 0.26 110.402 172.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 47.9 p-10 -148.82 160.92 42.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -0.933 . . . . 1.77 110.519 178.461 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 55.2 t0 41.76 41.72 1.88 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.172 -0.955 . . . . 1.21 111.554 172.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 96.0 mt-10 56.26 16.11 2.2 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.881 -1.137 . . . . 1.92 110.552 175.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 27.2 pttt -129.63 164.9 22.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 2.0 109.604 174.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.742 HG22 HD11 ' B' ' 47' ' ' LEU . 64.6 mt -97.67 134.08 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 1.24 110.416 -174.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 21.6 mm -113.21 121.47 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.748 -0.595 . . . . 0.5 109.914 177.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.833 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.0 mp -120.73 133.5 55.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.931 -1.106 . . . . 1.66 109.958 179.005 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.592 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 13.2 pttp -143.47 165.72 26.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.962 . . . . 1.74 110.657 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.557 ' HD3' ' CD1' ' B' ' 30' ' ' ILE . 14.4 tptt -57.6 146.87 28.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 1.65 110.012 177.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.889 ' CD2' HG11 ' A' ' 9' ' ' VAL . 11.4 t80 . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 0.65 110.643 -176.643 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.1 mm . . . . . 0 N--CA 1.495 1.813 0 N-CA-C 109.669 -0.493 . . . . 1.36 109.669 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.899 HG13 ' O ' ' B' ' 36' ' ' LEU . 78.4 t -109.85 143.48 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.86 -1.15 . . . . 0.37 111.281 -171.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ARG . . . . . 0.449 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 15.5 tpt180 -121.27 161.62 21.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.571 -0.706 . . . . 1.91 109.666 177.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' B' ' 33' ' ' LYS . 6.4 tptm -82.8 142.42 31.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.169 -0.957 . . . . 2.21 110.364 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.904 HG22 HD11 ' B' ' 36' ' ' LEU . 8.9 t -82.97 130.39 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.329 -0.857 . . . . 0.28 109.886 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -83.96 -175.28 5.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.099 -1.001 . . . . 0.55 110.036 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HG2' ' OE2' ' B' ' 32' ' ' GLU . 97.0 mt-10 -56.66 -39.71 74.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.998 -1.064 . . . . 2.19 111.756 -172.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.4 tp -84.68 -5.73 59.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.794 -1.191 . . . . 1.38 111.523 -173.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . 0.479 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.19 46.7 7.42 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.228 -1.463 . . . . 0.21 109.643 -177.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.916 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.0 mtm180 -114.36 155.03 27.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.071 -1.252 . . . . 1.15 110.024 -177.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.847 HG12 HD13 ' B' ' 36' ' ' LEU . 17.1 m -123.87 152.43 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.365 -0.834 . . . . 0.28 109.817 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.925 HG22 ' CD ' ' B' ' 17' ' ' ARG . 33.6 t -110.03 135.82 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.24 110.446 -176.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -80.63 130.46 64.43 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 1.38 109.465 174.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -56.79 143.63 90.03 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.817 1.43 . . . . 0.35 110.059 178.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.838 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.14 -32.54 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.005 -1.06 . . . . 1.11 110.293 -178.18 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -57.68 -36.48 71.98 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.055 -1.028 . . . . 2.37 109.891 178.025 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.563 ' HB2' HG23 ' A' ' 20' ' ' ILE . 51.7 mt -82.07 -30.04 31.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.346 -0.847 . . . . 1.75 110.63 178.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.838 ' HD2' HD12 ' A' ' 22' ' ' ILE . 73.9 mtt180 -57.91 -43.61 86.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.923 -1.111 . . . . 0.3 109.172 175.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -74.2 -51.7 14.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.469 -0.769 . . . . 3.26 110.651 -177.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.6 m -64.04 -31.22 72.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.77 111.182 -178.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.951 HD23 HG13 ' A' ' 30' ' ' ILE . 16.7 tp -88.6 -4.89 58.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.09 -1.006 . . . . 1.05 110.808 -176.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.471 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.69 43.97 95.59 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.738 -1.345 . . . . 0.32 109.738 179.166 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.951 HG13 HD23 ' A' ' 28' ' ' LEU . 31.3 mm -115.82 136.94 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.266 -1.137 . . . . 0.41 110.75 -178.082 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.43 167.12 23.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.62 -0.675 . . . . 0.23 110.019 -177.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.22 146.05 12.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.037 -1.039 . . . . 1.13 110.623 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 68.3 tttt 74.34 -4.24 2.36 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.665 . . . . 1.88 111.144 176.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.792 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.2 m-20 -77.22 168.97 19.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.866 -1.146 . . . . 1.1 110.06 174.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.05 130.97 54.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.36 110.612 -177.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.924 ' O ' HG13 ' B' ' 9' ' ' VAL . 9.2 mt -107.06 141.97 37.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 0.56 109.235 174.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.583 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.1 tt0 -104.3 137.6 41.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.769 -1.207 . . . . 1.17 109.712 174.08 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.0 mt -108.73 132.57 56.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.456 -0.778 . . . . 0.84 110.605 -172.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' TYR . . . . . 0.631 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 22.5 m-85 -121.07 157.25 30.45 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.868 -0.419 . . . . 0.45 109.868 -178.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.2 t -131.56 125.91 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.811 -1.18 . . . . 0.27 110.715 173.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.486 ' OD1' HG12 ' A' ' 46' ' ' ILE . 38.7 p-10 -147.48 140.87 25.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.92 . . . . 1.77 110.733 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.8 t0 43.32 46.74 5.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.001 -1.062 . . . . 1.22 111.449 173.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.8 tt0 61.3 10.87 3.28 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.132 -0.98 . . . . 1.93 110.707 175.479 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -111.44 151.09 28.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 2.01 109.885 175.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.874 HG22 HD11 ' A' ' 47' ' ' LEU . 67.2 mt -92.9 128.22 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.308 -0.87 . . . . 1.25 109.779 177.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 23.5 mm -111.45 118.29 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.543 -0.723 . . . . 0.5 109.91 178.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.874 HD11 HG22 ' A' ' 45' ' ' ILE . 3.9 mp -119.27 134.18 55.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.867 -1.146 . . . . 1.66 110.164 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.586 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 13.0 pttp -143.26 163.26 33.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 1.74 110.44 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -58.18 147.52 29.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 1.65 109.94 177.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.57 ' CD2' HG11 ' B' ' 9' ' ' VAL . 15.5 t80 . . . . . 0 C--N 1.3 -1.566 0 O-C-N 121.368 -0.833 . . . . 0.35 110.688 -175.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 9' ' ' VAL . . . . . 0.924 HG13 ' O ' ' A' ' 36' ' ' LEU . 78.0 t . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.601 0.715 . . . . 0.37 111.244 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 10' ' ' ARG . . . . . 0.457 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 15.5 tpt180 -121.28 161.5 21.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.589 -0.695 . . . . 1.92 109.753 177.619 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 11' ' ' LYS . . . . . 0.457 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 6.4 tptm -82.83 142.26 31.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.994 . . . . 2.21 110.37 -178.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.887 HG22 HD11 ' A' ' 36' ' ' LEU . 8.9 t -82.88 130.56 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.24 -0.913 . . . . 0.29 109.855 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.01 -175.05 5.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.983 . . . . 0.55 110.227 179.674 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' B' B ' 14' ' ' GLU . . . . . 0.492 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -56.91 -39.63 74.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.132 -0.98 . . . . 2.19 111.634 -172.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 15' ' ' LEU . . . . . 0.9 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.3 tp -84.65 -5.89 59.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.786 -1.196 . . . . 1.39 111.546 -173.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 16' ' ' GLY . . . . . 0.478 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.93 47.32 7.2 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.531 -1.428 . . . . 0.21 109.531 -177.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 17' ' ' ARG . . . . . 0.925 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.0 mtm180 -114.43 154.99 27.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.089 -1.242 . . . . 1.14 110.042 -177.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 18' ' ' VAL . . . . . 0.847 HG12 HD13 ' A' ' 36' ' ' LEU . 17.1 m -123.96 152.42 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.887 . . . . 0.28 109.775 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 19' ' ' VAL . . . . . 0.916 HG22 ' CD ' ' A' ' 17' ' ' ARG . 34.2 t -110.06 135.72 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.146 -0.971 . . . . 0.24 110.506 -176.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 20' ' ' ILE . . . . . 0.556 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -80.57 130.45 64.65 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 1.38 109.537 174.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.1 Cg_endo -56.82 143.66 90.23 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.773 1.407 . . . . 0.36 110.115 178.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 22' ' ' ILE . . . . . 0.866 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.27 -32.39 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.155 -0.966 . . . . 1.11 110.281 -177.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -57.49 -37.18 72.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.046 -1.034 . . . . 2.37 109.808 177.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 24' ' ' LEU . . . . . 0.556 ' HB2' HG23 ' B' ' 20' ' ' ILE . 51.1 mt -81.32 -30.52 33.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.468 -0.77 . . . . 1.75 110.561 178.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 25' ' ' ARG . . . . . 0.866 ' HD2' HD12 ' B' ' 22' ' ' ILE . 73.7 mtt180 -57.69 -43.43 85.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.9 -1.125 . . . . 0.3 109.285 176.008 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -74.26 -51.82 14.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 3.27 110.571 -177.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.3 m -63.85 -31.85 73.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.77 110.855 -178.107 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 28' ' ' LEU . . . . . 0.984 HD23 HG13 ' B' ' 30' ' ' ILE . 16.8 tp -88.07 -5.25 58.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.971 -1.081 . . . . 1.05 110.691 -176.356 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 29' ' ' GLY . . . . . 0.454 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.91 43.89 95.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.646 -1.382 . . . . 0.32 109.646 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 30' ' ' ILE . . . . . 0.984 HG13 HD23 ' B' ' 28' ' ' LEU . 31.3 mm -115.68 136.79 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -1.162 . . . . 0.41 110.797 -178.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.12 167.18 23.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.574 -0.704 . . . . 0.23 109.951 -177.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 32' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.05 146.04 11.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.143 -0.973 . . . . 1.13 110.634 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 33' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 68.1 tttt 74.34 -4.29 2.35 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.713 -0.617 . . . . 1.88 111.168 176.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 34' ' ' ASP . . . . . 0.787 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.8 m-20 -77.42 168.76 19.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.846 -1.158 . . . . 1.1 109.979 174.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 35' ' ' ALA . . . . . 0.449 ' HB1' HG11 ' A' ' 9' ' ' VAL . . . -106.81 130.93 54.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.36 110.726 -177.256 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 36' ' ' LEU . . . . . 0.904 HD11 HG22 ' A' ' 12' ' ' VAL . 9.1 mt -107.08 141.79 37.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.265 -0.897 . . . . 0.56 109.319 174.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 37' ' ' GLU . . . . . 0.565 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.0 tt0 -103.99 137.57 41.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.78 -1.2 . . . . 1.17 109.881 174.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.2 mt -108.73 132.61 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.84 110.493 -172.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 39' ' ' TYR . . . . . 0.616 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 22.0 m-85 -121.05 157.2 30.55 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 116.208 -0.451 . . . . 0.45 109.886 -178.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 75.6 t -131.36 126.27 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.861 -1.149 . . . . 0.26 110.545 173.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 41' ' ' ASP . . . . . 0.495 ' OD1' HG12 ' B' ' 46' ' ' ILE . 38.5 p-10 -147.99 140.77 24.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.333 -0.854 . . . . 1.77 110.638 179.005 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 42' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 54.3 t0 43.44 46.88 5.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.072 -1.018 . . . . 1.21 111.317 173.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.6 tt0 61.1 10.88 3.12 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.053 -1.029 . . . . 1.92 110.71 175.504 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -111.38 151.3 28.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 2.0 109.913 175.062 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 45' ' ' ILE . . . . . 0.868 HG22 HD11 ' B' ' 47' ' ' LEU . 66.8 mt -93.01 128.07 44.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.253 -0.904 . . . . 1.24 109.876 177.699 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 46' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 23.2 mm -111.55 118.42 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.611 -0.681 . . . . 0.5 109.886 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 47' ' ' LEU . . . . . 0.868 HD11 HG22 ' B' ' 45' ' ' ILE . 4.0 mp -119.2 134.07 55.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.957 -1.089 . . . . 1.66 110.13 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 48' ' ' LYS . . . . . 0.589 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 13.3 pttp -143.2 163.33 33.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.206 -0.934 . . . . 1.74 110.455 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -58.1 147.43 29.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.908 . . . . 1.65 109.917 177.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' B' B ' 50' ' ' TYR . . . . . 0.599 ' CD2' HG11 ' A' ' 9' ' ' VAL . 15.6 t80 . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.214 -0.929 . . . . 0.65 110.605 -175.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.2 t80 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.213 0.53 . . . . 10.99 110.22 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.6 mtp -128.38 160.65 31.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 8.76 110.185 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 25.0 mttm -88.49 140.15 29.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.229 -0.919 . . . . 8.85 110.124 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.553 ' CB ' ' CD2' ' B' ' 39' ' ' TYR . 82.7 p -146.27 165.53 28.98 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 4.2 110.237 -179.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.418 HG23 ' HB ' ' B' ' 40' ' ' VAL . 80.4 p -62.34 -34.11 76.01 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.231 -0.918 . . . . 3.77 110.181 179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.18 46.32 43.71 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.737 -1.345 . . . . 0.83 109.737 177.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.9 mt -114.83 134.5 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.083 -1.245 . . . . 1.36 109.993 179.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.931 HG13 ' O ' ' B' ' 36' ' ' LEU . 90.3 t -116.68 144.06 25.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.041 -1.037 . . . . 0.37 110.961 -175.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.425 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 27.7 tpt180 -128.15 159.21 35.84 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.464 -0.773 . . . . 1.91 109.711 177.279 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.425 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 70.3 mttt -85.74 147.67 26.22 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.103 -0.998 . . . . 2.21 110.401 -178.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.938 HG22 HD11 ' B' ' 36' ' ' LEU . 3.7 t -84.06 129.0 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.292 -0.88 . . . . 0.28 109.942 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.68 -175.29 5.71 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.182 -0.949 . . . . 0.55 110.08 179.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.8 tp10 -54.24 -40.91 68.16 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.151 -0.968 . . . . 2.19 111.671 -173.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.851 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.3 tp -84.12 -5.64 59.28 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.739 -1.225 . . . . 1.38 111.581 -173.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.506 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.38 46.31 7.54 Favored Glycine 0 N--CA 1.49 2.277 0 C-N-CA 119.191 -1.48 . . . . 0.21 109.657 -177.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.919 ' CD ' HG22 ' B' ' 19' ' ' VAL . 72.6 mtm180 -114.74 154.05 29.2 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.099 -1.236 . . . . 1.15 109.968 -177.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.71 HG12 HD13 ' B' ' 36' ' ' LEU . 19.8 m -123.99 153.11 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.274 -0.891 . . . . 0.28 109.866 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.928 HG22 ' CD ' ' B' ' 17' ' ' ARG . 24.3 t -111.35 134.77 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.206 -0.934 . . . . 0.24 110.632 -175.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.585 HG23 ' HB2' ' A' ' 24' ' ' LEU . 6.4 mt -82.53 135.14 46.81 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 1.38 109.487 174.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.2 Cg_endo -58.13 142.98 97.39 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.771 1.406 . . . . 0.35 110.044 177.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.885 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.14 -32.78 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.962 -1.086 . . . . 1.11 110.373 -178.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.7 tp10 -58.07 -35.64 71.66 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.113 -0.992 . . . . 2.37 109.861 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.585 ' HB2' HG23 ' A' ' 20' ' ' ILE . 54.9 mt -82.75 -29.78 29.47 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.382 -0.824 . . . . 1.75 110.627 178.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.885 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.8 mtt180 -57.56 -44.13 85.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.898 -1.126 . . . . 0.3 109.146 175.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -73.37 -49.14 28.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.537 -0.727 . . . . 3.26 110.742 -177.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 59.0 m -63.94 -31.24 72.35 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.189 -0.944 . . . . 0.77 111.085 -178.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.929 HD23 HG13 ' A' ' 30' ' ' ILE . 22.2 tp -87.57 -4.79 58.95 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.027 -1.046 . . . . 1.05 110.711 -177.194 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.416 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.75 43.74 95.82 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.663 -1.375 . . . . 0.32 109.663 179.181 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.929 HG13 HD23 ' A' ' 28' ' ' LEU . 31.6 mm -115.28 138.99 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.241 -1.152 . . . . 0.41 110.699 -178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.79 167.11 22.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.631 -0.668 . . . . 0.23 109.945 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.52 146.02 13.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.047 -1.033 . . . . 1.13 110.554 -179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 40.7 tttt 74.81 -4.57 2.33 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.757 -0.589 . . . . 1.88 111.103 176.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.729 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.9 m-20 -76.93 165.54 24.54 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.773 -1.204 . . . . 1.1 110.028 174.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.585 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -106.26 132.52 52.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 0.36 110.734 -176.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.925 ' O ' HG13 ' B' ' 9' ' ' VAL . 12.6 mt -108.9 142.74 39.09 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.56 109.49 175.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.625 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.8 tt0 -107.88 139.8 41.94 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.869 -1.144 . . . . 1.17 109.793 173.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 72.1 mt -112.61 136.85 47.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.393 -0.817 . . . . 0.84 110.68 -172.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.577 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 14.6 m-85 -114.16 158.61 21.08 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.977 -0.379 . . . . 0.45 109.977 -179.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.581 ' HB ' HG23 ' B' ' 6' ' ' THR . 83.9 t -130.66 121.92 51.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.973 -1.079 . . . . 0.27 110.739 172.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.576 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.9 p-10 -147.17 140.51 25.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.296 -0.878 . . . . 1.77 110.216 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 52.4 t0 43.56 48.39 6.34 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.02 -1.05 . . . . 1.22 111.154 175.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.8 mt-10 58.55 14.05 2.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.134 -0.979 . . . . 1.93 110.656 176.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -117.12 147.11 42.71 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.245 -0.909 . . . . 2.01 110.024 175.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.577 ' CD1' HD11 ' B' ' 20' ' ' ILE . 60.4 mt -99.98 128.17 52.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.203 -0.936 . . . . 1.25 110.093 -179.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.577 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 24.1 mt -111.52 118.62 57.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.352 -0.843 . . . . 0.5 110.209 177.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.837 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -108.04 136.54 47.56 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.067 -1.021 . . . . 1.66 110.093 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.548 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 27.2 pttt -138.64 162.23 35.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.501 -0.749 . . . . 1.74 110.189 178.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -58.84 146.55 36.9 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.09 -1.006 . . . . 1.65 109.965 176.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.588 ' CD2' HG11 ' B' ' 9' ' ' VAL . 9.1 t80 -105.95 119.23 38.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.318 -0.864 . . . . 0.35 110.726 -176.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.82 122.84 49.62 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.359 -0.838 . . . . 3.21 109.307 171.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -63.05 145.12 93.92 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.74 1.389 . . . . 0.48 110.299 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 118.03 -0.986 . . . . 2.41 110.258 -179.878 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.184 0.516 . . . . 11.66 110.183 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 50.9 ttm -89.48 126.09 35.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 8.7 110.183 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 23.7 mttt -99.65 144.27 28.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 9.17 110.363 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.45 ' OG ' ' CD2' ' A' ' 39' ' ' TYR . 25.9 t -119.47 145.51 46.22 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.288 -0.882 . . . . 5.2 109.971 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.581 HG23 ' HB ' ' A' ' 40' ' ' VAL . 79.7 p -62.62 -34.33 76.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.134 -0.979 . . . . 2.98 110.166 -178.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 71.01 46.73 42.35 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.642 -1.383 . . . . 0.83 109.642 177.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.4 mt -114.88 134.38 58.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.118 -1.225 . . . . 1.36 109.978 179.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.925 HG13 ' O ' ' A' ' 36' ' ' LEU . 90.7 t -116.72 144.09 25.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.928 -1.107 . . . . 0.37 110.937 -175.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 27.8 tpt180 -128.16 159.03 36.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.49 -0.756 . . . . 1.92 109.793 177.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.421 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 70.4 mttt -85.65 147.6 26.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.08 -1.013 . . . . 2.21 110.419 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.921 HG22 HD11 ' A' ' 36' ' ' LEU . 3.8 t -83.98 129.11 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.891 . . . . 0.29 109.844 -179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.449 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.93 -175.16 5.65 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.116 -0.99 . . . . 0.55 110.126 179.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.422 ' OE1' ' CD ' ' A' ' 32' ' ' GLU . 46.9 tp10 -54.37 -40.84 68.52 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.147 -0.971 . . . . 2.19 111.599 -173.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.868 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.0 tp -84.12 -5.74 59.29 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.76 -1.213 . . . . 1.39 111.568 -173.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.519 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.05 47.02 7.3 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.521 -1.432 . . . . 0.21 109.521 -177.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.928 ' CD ' HG22 ' A' ' 19' ' ' VAL . 72.7 mtm180 -114.93 154.08 29.39 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.102 -1.234 . . . . 1.14 109.94 -178.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.703 HG12 HD13 ' A' ' 36' ' ' LEU . 19.7 m -124.04 153.09 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.282 -0.886 . . . . 0.28 109.891 -179.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.919 HG22 ' CD ' ' A' ' 17' ' ' ARG . 24.3 t -111.4 134.76 52.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.266 -0.896 . . . . 0.24 110.619 -175.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.597 HG23 ' HB2' ' B' ' 24' ' ' LEU . 6.4 mt -82.57 135.16 46.67 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.308 -0.87 . . . . 1.38 109.472 174.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.538 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.2 Cg_endo -58.21 143.0 97.63 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.797 1.419 . . . . 0.36 110.049 177.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.879 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.3 -32.59 29.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.135 -0.978 . . . . 1.11 110.336 -178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -57.86 -36.4 72.29 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.091 -1.006 . . . . 2.37 109.774 178.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.597 ' HB2' HG23 ' B' ' 20' ' ' ILE . 54.7 mt -81.97 -30.16 31.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.478 -0.764 . . . . 1.75 110.605 178.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.879 ' HD2' HD12 ' B' ' 22' ' ' ILE . 72.2 mtt180 -57.44 -43.92 84.28 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.89 -1.131 . . . . 0.3 109.204 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 82.0 mtp180 -73.37 -49.32 27.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.351 -0.843 . . . . 3.27 110.621 -177.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 61.0 m -63.81 -31.73 73.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.177 -0.952 . . . . 0.77 110.862 -177.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.934 HD23 HG13 ' B' ' 30' ' ' ILE . 22.4 tp -87.1 -5.17 59.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.053 -1.03 . . . . 1.05 110.701 -176.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.415 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.07 43.65 95.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.578 -1.409 . . . . 0.32 109.578 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.934 HG13 HD23 ' B' ' 28' ' ' LEU . 31.1 mm -115.27 138.81 44.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -1.176 . . . . 0.41 110.725 -178.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.48 167.27 22.55 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.628 -0.67 . . . . 0.23 109.935 -178.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.527 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.55 146.12 13.61 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.12 -0.988 . . . . 1.13 110.554 -179.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 40.6 tttt 74.84 -4.77 2.29 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.688 -0.633 . . . . 1.88 111.164 176.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.649 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.0 m-20 -76.98 165.21 24.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.791 -1.193 . . . . 1.1 110.014 174.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.594 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.93 132.48 51.98 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.274 -0.891 . . . . 0.36 110.833 -176.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.938 HD11 HG22 ' A' ' 12' ' ' VAL . 12.5 mt -108.93 142.61 39.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.397 -0.815 . . . . 0.56 109.531 175.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.61 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.6 tt0 -107.7 139.79 41.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.902 -1.124 . . . . 1.17 109.92 173.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 72.1 mt -112.6 136.79 47.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.299 -0.876 . . . . 0.84 110.651 -172.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 14.3 m-85 -114.0 158.63 20.92 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 116.35 -0.386 . . . . 0.45 109.993 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.418 ' HB ' HG23 ' A' ' 6' ' ' THR . 83.8 t -130.52 122.26 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.907 -1.121 . . . . 0.26 110.502 172.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.572 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.9 p-10 -147.6 140.5 24.92 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.348 -0.845 . . . . 1.77 110.176 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 53.3 t0 43.69 48.46 6.64 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.134 -0.979 . . . . 1.21 111.059 175.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.7 mt-10 58.41 14.01 2.74 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.199 -0.938 . . . . 1.92 110.679 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.7 mttp -117.0 147.37 42.38 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.231 -0.918 . . . . 2.0 109.959 175.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.575 ' CD1' HD11 ' A' ' 20' ' ' ILE . 60.2 mt -100.23 128.22 52.43 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.215 -0.928 . . . . 1.24 110.102 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 25.0 mt -111.7 118.61 57.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.5 110.148 177.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.822 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.3 mp -107.9 136.45 47.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 1.66 110.124 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.552 ' HD3' ' CE1' ' B' ' 39' ' ' TYR . 27.3 pttt -138.57 162.43 34.59 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.489 -0.757 . . . . 1.74 110.07 178.75 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -58.82 146.44 37.19 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.124 -0.985 . . . . 1.65 109.93 176.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.71 ' CD2' HG11 ' A' ' 9' ' ' VAL . 9.3 t80 -106.03 114.54 28.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.175 -0.953 . . . . 0.65 110.644 -176.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.89 85.53 50.3 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.176 -0.953 . . . . 4.35 110.295 177.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.568 ' HG3' ' CZ ' ' B' ' 50' ' ' TYR . 35.8 Cg_exo -55.48 144.99 71.15 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.977 1.514 . . . . 3.58 110.296 -179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.958 -1.02 . . . . 5.97 110.169 -179.949 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.312 0.577 . . . . 10.99 110.206 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.4 mtm -121.65 152.67 39.07 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.184 -0.947 . . . . 8.76 110.169 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.6 tttm -80.98 132.71 35.4 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.307 -0.871 . . . . 8.85 110.314 -179.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 85.1 p -142.48 159.61 41.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 4.2 110.185 179.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.444 HG21 ' CG2' ' B' ' 40' ' ' VAL . 55.8 p -63.07 -40.46 97.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.258 -0.901 . . . . 3.77 110.171 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 65.22 45.68 90.34 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.582 -1.407 . . . . 0.83 109.582 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.5 mt -118.08 134.09 62.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.11 -1.23 . . . . 1.36 110.115 179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.935 HG13 ' O ' ' B' ' 36' ' ' LEU . 93.0 t -115.95 144.35 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.001 -1.062 . . . . 0.37 110.916 -176.272 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 61.1 ttm-85 -129.23 160.66 32.23 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.494 -0.753 . . . . 1.91 109.679 177.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 87.4 mttt -85.25 147.7 26.44 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.067 -1.021 . . . . 2.21 110.385 -178.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.899 HG22 HD11 ' B' ' 36' ' ' LEU . 4.0 t -83.09 129.94 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.28 109.88 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.36 -175.18 5.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.165 -0.96 . . . . 0.55 110.082 179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.74 -39.51 74.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.073 -1.017 . . . . 2.19 111.652 -172.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.891 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.2 tp -83.25 -6.61 59.53 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.831 -1.168 . . . . 1.38 111.499 -174.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.465 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.36 46.76 7.28 Favored Glycine 0 N--CA 1.491 2.334 0 C-N-CA 119.259 -1.448 . . . . 0.21 109.615 -177.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.898 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.1 mtm180 -114.33 154.73 27.52 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.079 -1.247 . . . . 1.15 110.078 -177.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.818 HG12 HD13 ' B' ' 36' ' ' LEU . 17.9 m -123.87 152.37 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.292 -0.88 . . . . 0.28 109.763 179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.91 HG22 ' CD ' ' B' ' 17' ' ' ARG . 19.9 t -112.97 135.32 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.138 -0.976 . . . . 0.24 110.643 -174.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.715 HD11 ' CD1' ' B' ' 45' ' ' ILE . 19.5 mt -81.57 135.96 49.15 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.255 -0.903 . . . . 1.38 109.763 174.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.561 ' HG2' HD12 ' A' ' 24' ' ' LEU . 11.0 Cg_endo -60.02 143.65 99.55 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.754 1.397 . . . . 0.35 109.942 176.027 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.874 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.12 -33.15 29.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 120.952 -1.093 . . . . 1.11 110.348 -178.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.404 ' N ' HG23 ' A' ' 22' ' ' ILE . 48.6 tp10 -58.04 -35.41 71.29 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.181 -0.95 . . . . 2.37 109.884 178.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.561 HD12 ' HG2' ' A' ' 21' ' ' PRO . 59.6 mt -84.5 -28.25 26.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.375 -0.828 . . . . 1.75 110.664 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.874 ' HD2' HD12 ' A' ' 22' ' ' ILE . 70.8 mtt180 -57.44 -44.38 84.65 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.843 -1.161 . . . . 0.3 109.065 175.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 32.5 mmm180 -73.58 -49.12 27.88 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.862 -0.735 . . . . 3.26 110.671 -177.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.8 m -63.96 -30.96 72.0 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.141 -0.974 . . . . 0.77 111.121 -178.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.831 HD23 HG13 ' A' ' 30' ' ' ILE . 23.0 tp -87.59 -4.93 58.94 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.069 -1.019 . . . . 1.05 110.769 -177.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.84 41.75 97.35 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.724 -1.35 . . . . 0.32 109.724 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.831 HG13 HD23 ' A' ' 28' ' ' LEU . 38.3 mm -116.38 138.45 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.211 -1.17 . . . . 0.41 110.629 -179.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.99 166.88 23.5 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.575 -0.703 . . . . 0.23 110.002 -177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.41 146.25 12.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.055 -1.028 . . . . 1.13 110.61 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 31.8 ttpt 74.35 -4.35 2.33 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.687 -0.633 . . . . 1.88 111.177 177.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.732 ' O ' HG23 ' B' ' 12' ' ' VAL . 90.1 m-20 -77.23 166.52 23.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.75 -1.219 . . . . 1.1 110.029 174.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.659 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.05 130.09 51.73 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.159 -0.963 . . . . 0.36 110.77 -176.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.951 HD11 HG22 ' B' ' 12' ' ' VAL . 12.4 mt -106.41 142.54 35.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.349 -0.845 . . . . 0.56 109.403 174.501 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.707 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.4 tt0 -106.33 138.45 42.5 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.773 -1.204 . . . . 1.17 109.564 173.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.2 mt -108.28 132.06 57.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.404 -0.81 . . . . 0.84 110.537 -171.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.606 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.0 m-85 -118.22 159.45 23.3 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 116.259 -0.428 . . . . 0.45 110.001 -178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.594 HG21 HG21 ' B' ' 6' ' ' THR . 72.2 t -133.49 125.9 51.03 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.919 -1.113 . . . . 0.27 110.637 172.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' OD1' HG12 ' A' ' 46' ' ' ILE . 42.3 p-10 -147.41 143.22 27.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.315 -0.866 . . . . 1.77 110.499 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.474 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 51.8 t0 43.44 43.95 4.69 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.014 -1.054 . . . . 1.22 111.149 174.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.474 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.7 tt0 60.82 11.76 3.41 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.121 -0.987 . . . . 1.93 110.616 176.04 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.45 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 53.0 mtmt -111.54 154.64 24.49 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.196 -0.94 . . . . 2.01 109.779 175.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.759 ' CD1' HD11 ' B' ' 20' ' ' ILE . 66.1 mt -95.16 129.27 45.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.199 -0.938 . . . . 1.25 109.968 -179.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.606 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 22.9 mm -115.12 120.65 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.549 -0.719 . . . . 0.5 109.915 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.882 ' CD2' HG21 ' B' ' 18' ' ' VAL . 4.2 mp -117.63 135.17 54.16 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.981 -1.075 . . . . 1.66 110.25 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.567 ' HE3' ' CD1' ' A' ' 39' ' ' TYR . 8.2 ptpt -142.74 162.21 36.07 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.384 -0.823 . . . . 1.74 110.418 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.566 ' HD3' HD11 ' A' ' 30' ' ' ILE . 22.8 tptm -55.63 147.46 18.23 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.037 -1.039 . . . . 1.65 109.789 176.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.733 ' CD2' HG11 ' B' ' 9' ' ' VAL . 5.2 t80 -100.3 119.72 38.83 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -0.843 . . . . 0.35 110.524 -176.171 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.475 ' O ' ' CG ' ' A' ' 51' ' ' LYS . 13.7 pttt -99.31 123.15 49.57 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.395 -0.816 . . . . 3.21 109.71 174.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -64.11 145.96 90.06 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.766 1.403 . . . . 0.48 110.34 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 51.0 t30 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 118.008 -0.996 . . . . 2.41 110.267 179.477 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 67.5 t80 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 121.185 0.517 . . . . 11.66 110.103 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 87.5 mtp -125.0 161.52 26.52 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.248 -0.907 . . . . 8.7 110.234 -179.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.477 ' HD3' ' OE2' ' A' ' 37' ' ' GLU . 98.4 mttt -88.31 144.8 26.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.358 -0.839 . . . . 9.17 110.147 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 66.2 m -71.92 -93.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.228 -0.92 . . . . 5.2 110.418 -178.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.594 HG21 HG21 ' A' ' 40' ' ' VAL . 54.9 p -73.85 -40.6 63.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.015 -1.053 . . . . 2.98 110.269 -179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.98 46.03 90.53 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.564 -1.414 . . . . 0.83 109.564 177.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.0 mt -118.19 133.92 63.47 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.053 -1.263 . . . . 1.36 110.085 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.946 HG13 ' O ' ' A' ' 36' ' ' LEU . 91.7 t -115.93 144.35 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.971 -1.08 . . . . 0.37 110.925 -176.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 61.2 ttm-85 -129.19 160.45 32.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.457 -0.777 . . . . 1.92 109.759 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -85.19 147.59 26.52 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.038 -1.039 . . . . 2.21 110.425 -178.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.951 HG22 HD11 ' A' ' 36' ' ' LEU . 4.0 t -82.95 129.97 36.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.4 -0.813 . . . . 0.29 109.894 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.61 -175.04 5.6 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.153 -0.967 . . . . 0.55 110.135 179.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.489 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -56.87 -39.44 74.35 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.081 -1.012 . . . . 2.19 111.496 -172.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.1 tp -83.27 -6.56 59.51 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.787 -1.196 . . . . 1.39 111.527 -174.196 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.475 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.9 47.5 7.12 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.54 -1.424 . . . . 0.21 109.54 -177.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.91 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.0 mtm180 -114.5 154.67 27.82 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.028 -1.278 . . . . 1.14 110.131 -177.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.882 HG21 ' CD2' ' A' ' 47' ' ' LEU . 17.8 m -123.93 152.31 29.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.295 -0.878 . . . . 0.28 109.737 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.898 HG22 ' CD ' ' A' ' 17' ' ' ARG . 19.8 t -113.0 135.26 53.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.185 -0.947 . . . . 0.24 110.712 -174.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.759 HD11 ' CD1' ' A' ' 45' ' ' ILE . 19.2 mt -81.5 135.96 49.36 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 1.38 109.734 174.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 11.0 Cg_endo -60.15 143.53 99.53 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.801 1.422 . . . . 0.36 110.036 176.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.87 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.2 tp -55.13 -32.92 28.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.018 -1.051 . . . . 1.11 110.399 -178.496 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . 0.403 ' N ' HG23 ' B' ' 22' ' ' ILE . 48.4 tp10 -57.93 -36.12 72.04 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.058 -1.026 . . . . 2.37 109.777 178.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.571 ' HB2' HG23 ' B' ' 20' ' ' ILE . 60.1 mt -83.74 -28.55 28.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.532 -0.73 . . . . 1.75 110.628 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.87 ' HD2' HD12 ' B' ' 22' ' ' ILE . 70.2 mtt180 -57.35 -44.32 84.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.792 -1.193 . . . . 0.3 109.044 175.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 32.5 mmm180 -73.49 -49.31 27.32 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.357 -0.84 . . . . 3.27 110.664 -177.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.1 m -63.68 -31.64 72.87 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.896 . . . . 0.77 110.919 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.867 HD23 HG13 ' B' ' 30' ' ' ILE . 23.2 tp -87.01 -5.33 59.11 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.032 -1.042 . . . . 1.05 110.731 -176.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 65.24 41.53 96.75 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.562 -1.415 . . . . 0.32 109.562 179.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.867 HG13 HD23 ' B' ' 28' ' ' LEU . 37.9 mm -116.27 138.39 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.191 -1.182 . . . . 0.41 110.694 -179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.78 167.04 23.08 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.612 -0.68 . . . . 0.23 109.987 -177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.41 146.39 12.55 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.141 -0.975 . . . . 1.13 110.523 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 31.7 ttpt 74.42 -4.64 2.27 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.699 -0.626 . . . . 1.88 111.174 176.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.648 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.4 m-20 -77.21 166.26 23.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.853 -1.154 . . . . 1.1 110.067 174.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.641 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.97 130.09 51.58 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.36 110.753 -176.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.935 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.2 mt -106.47 142.25 36.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.304 -0.873 . . . . 0.56 109.471 174.566 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.688 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.1 tt0 -106.06 138.44 42.24 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.825 -1.172 . . . . 1.17 109.72 173.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.22 132.06 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.367 -0.833 . . . . 0.84 110.486 -171.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.597 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 10.0 m-85 -118.31 159.34 23.56 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 116.261 -0.427 . . . . 0.45 110.001 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.444 ' CG2' HG21 ' A' ' 6' ' ' THR . 72.4 t -133.22 126.27 52.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 120.936 -1.102 . . . . 0.26 110.466 172.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.487 ' OD1' HG12 ' B' ' 46' ' ' ILE . 42.5 p-10 -147.81 143.22 27.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 1.77 110.466 179.006 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.481 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 52.4 t0 43.47 44.04 4.78 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.205 -0.934 . . . . 1.21 111.108 174.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.481 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.5 tt0 60.67 11.87 3.36 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.028 -1.045 . . . . 1.92 110.571 176.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 53.0 mtmt -111.56 154.76 24.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.185 -0.947 . . . . 2.0 109.71 175.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.754 HG22 HD11 ' B' ' 47' ' ' LEU . 66.2 mt -95.26 129.14 45.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.194 -0.941 . . . . 1.24 110.0 -179.508 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.602 HD12 HD12 ' A' ' 46' ' ' ILE . 22.6 mm -115.15 120.7 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.537 -0.727 . . . . 0.5 109.817 179.93 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.823 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.3 mp -117.46 135.05 54.18 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.014 -1.054 . . . . 1.66 110.294 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.572 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 8.1 ptpt -142.65 162.39 35.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.35 -0.843 . . . . 1.74 110.392 -179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.551 ' HD3' ' CD1' ' B' ' 30' ' ' ILE . 22.8 tptm -55.63 147.3 18.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.114 -0.992 . . . . 1.65 109.83 176.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.886 ' CD2' HG11 ' A' ' 9' ' ' VAL . 5.3 t80 -100.29 115.99 31.24 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.229 -0.919 . . . . 0.65 110.525 -176.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.418 ' HA ' ' HD2' ' B' ' 52' ' ' PRO . 0.0 OUTLIER -128.69 93.27 38.05 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.366 -0.834 . . . . 4.35 110.181 179.295 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.418 ' HD2' ' HA ' ' B' ' 51' ' ' LYS . 9.9 Cg_endo -56.48 143.55 87.25 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.861 1.453 . . . . 3.58 110.396 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 118.019 -0.991 . . . . 5.97 110.201 -179.159 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.4 t80 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.342 0.592 . . . . 10.99 110.172 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.8 mtm -85.83 159.42 19.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.174 -0.954 . . . . 8.76 110.316 -179.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -79.52 157.1 27.51 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.314 -0.867 . . . . 8.85 110.368 -178.635 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 41.3 m -58.52 158.68 7.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.331 -0.856 . . . . 4.2 110.323 -179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.523 HG21 HG21 ' B' ' 40' ' ' VAL . 59.1 p -62.37 -37.11 84.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.326 -0.859 . . . . 3.77 110.288 -179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.56 46.22 71.0 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.493 -1.443 . . . . 0.83 109.493 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.4 mt -118.16 136.06 56.58 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 121.169 -1.195 . . . . 1.36 110.087 -179.017 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.081 HG11 ' CD2' ' B' ' 50' ' ' TYR . 92.7 t -115.1 144.34 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.033 -1.042 . . . . 0.37 110.856 -176.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 68.9 ttt-85 -129.91 160.07 34.7 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.48 -0.762 . . . . 1.91 109.684 177.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 33.2 mttm -86.44 149.03 25.28 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.103 -0.998 . . . . 2.21 110.466 -177.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.99 HG22 HD11 ' B' ' 36' ' ' LEU . 3.9 t -82.99 129.64 37.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.241 -0.912 . . . . 0.28 109.873 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.466 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.19 -174.67 5.36 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.145 -0.972 . . . . 0.55 110.182 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.5 tp10 -53.62 -41.81 67.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.18 -0.95 . . . . 2.19 111.783 -173.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.88 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.2 tp -85.79 -4.26 59.12 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.709 -1.244 . . . . 1.38 111.619 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.514 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.09 46.31 7.72 Favored Glycine 0 N--CA 1.49 2.269 0 C-N-CA 119.184 -1.484 . . . . 0.21 109.645 -177.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.918 ' CD ' HG22 ' B' ' 19' ' ' VAL . 74.6 mtm180 -115.56 154.35 29.56 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.15 -1.206 . . . . 1.15 109.933 -177.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.732 HG21 ' CD2' ' B' ' 47' ' ' LEU . 16.6 m -124.61 152.23 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 0.28 109.898 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.943 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.9 t -112.25 135.44 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.208 -0.932 . . . . 0.24 110.514 -175.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.593 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.04 134.57 46.11 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.231 -0.918 . . . . 1.38 109.577 175.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.54 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.9 Cg_endo -58.73 143.8 98.54 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.793 1.417 . . . . 0.35 110.104 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.886 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.19 -32.08 27.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.988 -1.07 . . . . 1.11 110.386 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.29 -34.88 72.82 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.118 -0.989 . . . . 2.37 109.901 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.593 ' HB2' HG23 ' A' ' 20' ' ' ILE . 62.4 mt -83.19 -29.68 28.36 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 1.75 110.57 178.416 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.886 ' HD2' HD12 ' A' ' 22' ' ' ILE . 73.6 mtt180 -57.55 -43.96 84.86 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.877 -1.139 . . . . 0.3 109.107 175.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 74.1 ttt180 -71.64 -50.11 33.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.518 -0.739 . . . . 3.26 110.707 -178.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 60.0 m -63.38 -32.02 73.34 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.218 -0.926 . . . . 0.77 111.088 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.894 HD23 HG13 ' A' ' 30' ' ' ILE . 21.0 tp -88.39 -4.86 58.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.064 -1.022 . . . . 1.05 110.751 -176.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.42 42.82 97.46 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.667 -1.373 . . . . 0.32 109.667 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.894 HG13 HD23 ' A' ' 28' ' ' LEU . 35.3 mm -116.36 138.75 45.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.242 -1.152 . . . . 0.41 110.74 -178.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.06 167.26 22.54 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.617 -0.677 . . . . 0.23 110.092 -178.08 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.2 tt0 -53.26 147.09 10.7 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.075 -1.016 . . . . 1.13 110.542 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 29.3 tttt 74.65 -4.92 2.23 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.781 -0.574 . . . . 1.88 111.123 177.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.71 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.9 m-20 -77.49 165.36 24.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.81 -1.181 . . . . 1.1 110.019 174.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.785 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.69 131.61 51.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.209 -0.932 . . . . 0.36 110.74 -176.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.968 HD11 HG22 ' B' ' 12' ' ' VAL . 13.6 mt -109.57 140.63 43.14 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.348 -0.845 . . . . 0.56 109.575 175.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.764 ' HA ' HG22 ' B' ' 9' ' ' VAL . 84.8 tt0 -103.67 138.56 40.16 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.823 -1.173 . . . . 1.17 109.528 171.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.6 mt -111.47 133.27 57.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.369 -0.832 . . . . 0.84 110.512 -173.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.587 ' CE2' ' HE3' ' A' ' 48' ' ' LYS . 8.5 m-85 -114.53 160.76 18.88 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 122.068 -0.395 . . . . 0.45 110.218 -177.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.757 HG21 HG21 ' B' ' 6' ' ' THR . 94.1 t -133.9 117.69 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 0.27 110.83 173.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.547 ' OD2' HD11 ' A' ' 46' ' ' ILE . 6.2 p-10 -147.69 160.23 42.92 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 1.77 110.031 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.456 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 22.5 t70 42.47 41.46 2.3 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.946 -1.097 . . . . 1.22 111.332 173.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 75.5 mm-40 57.4 15.71 2.82 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.07 -1.019 . . . . 1.93 110.651 175.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 56.1 pttt -130.78 163.21 27.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.156 -0.965 . . . . 2.01 109.887 175.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.601 HD13 HG13 ' B' ' 20' ' ' ILE . 61.2 mt -104.21 134.74 44.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.046 -1.034 . . . . 1.25 110.516 -173.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 26.7 mt -112.96 119.27 60.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.367 -0.833 . . . . 0.5 110.249 176.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.84 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.1 mp -108.12 134.84 50.42 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.21 -0.932 . . . . 1.66 109.987 178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.587 ' HE3' ' CE2' ' A' ' 39' ' ' TYR . 1.8 ptpm? -140.79 163.5 32.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.417 -0.802 . . . . 1.74 110.296 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 19.7 tttp -55.12 148.08 14.8 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.109 -0.995 . . . . 1.65 109.776 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.92 ' CD2' HG11 ' B' ' 9' ' ' VAL . 1.7 t80 -101.21 122.48 43.72 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.35 110.565 -175.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 mmtt -99.38 123.2 49.27 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.353 -0.842 . . . . 3.21 109.796 176.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.447 ' O ' ' OXT' ' A' ' 53' ' ' ASN . 15.8 Cg_endo -62.98 146.0 94.6 Favored 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.733 1.386 . . . . 0.48 110.22 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.447 ' OXT' ' O ' ' A' ' 52' ' ' PRO . 37.3 p-10 . . . . . 0 N--CA 1.49 1.532 0 CA-C-O 118.019 -0.991 . . . . 2.41 110.267 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 65.0 t80 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.277 0.561 . . . . 11.66 110.149 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 64.3 mtt -104.32 143.9 32.35 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.209 -0.932 . . . . 8.7 110.168 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 17.3 mmtp -100.76 135.8 41.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.193 -0.942 . . . . 9.17 110.407 -178.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 86.3 p -142.78 155.2 44.8 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.223 -0.923 . . . . 5.2 109.852 176.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.757 HG21 HG21 ' A' ' 40' ' ' VAL . 58.6 p -68.66 -37.35 79.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.014 -1.054 . . . . 2.98 110.231 -179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.36 46.52 69.95 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.393 -1.483 . . . . 0.83 109.393 178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 61.8 mt -118.14 136.03 56.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.168 -1.195 . . . . 1.36 110.134 -179.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.934 HG13 ' O ' ' A' ' 36' ' ' LEU . 91.1 t -115.17 144.32 23.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.028 -1.045 . . . . 0.37 110.855 -176.492 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 68.8 ttt-85 -129.85 159.89 35.21 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.479 -0.763 . . . . 1.92 109.782 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -86.32 148.88 25.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.086 -1.009 . . . . 2.21 110.472 -177.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.968 HG22 HD11 ' A' ' 36' ' ' LEU . 3.9 t -82.83 129.73 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.265 -0.897 . . . . 0.29 109.867 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -85.46 -174.49 5.22 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.105 -0.997 . . . . 0.55 110.239 -179.751 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.462 ' OE1' ' OE2' ' A' ' 32' ' ' GLU . 47.5 tp10 -53.82 -41.61 67.53 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.17 -0.956 . . . . 2.19 111.765 -173.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.9 tp -85.99 -4.14 59.1 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.722 -1.236 . . . . 1.39 111.592 -172.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.534 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.72 46.97 7.52 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.524 -1.431 . . . . 0.21 109.524 -177.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.943 ' CD ' HG22 ' A' ' 19' ' ' VAL . 74.2 mtm180 -115.76 154.28 29.89 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.083 -1.245 . . . . 1.14 109.96 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.836 HG21 ' CD2' ' A' ' 47' ' ' LEU . 16.6 m -124.6 152.25 30.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.25 -0.906 . . . . 0.28 109.899 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.918 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.9 t -112.34 135.38 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.213 -0.93 . . . . 0.24 110.505 -175.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.612 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.99 134.49 46.44 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.243 -0.91 . . . . 1.38 109.554 175.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.536 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.8 Cg_endo -58.83 143.84 98.92 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.803 1.423 . . . . 0.36 110.053 177.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.884 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.28 -31.86 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.042 -1.036 . . . . 1.11 110.446 -178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.18 -35.57 73.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.057 -1.027 . . . . 2.37 109.758 179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.612 ' HB2' HG23 ' B' ' 20' ' ' ILE . 62.7 mt -82.49 -30.06 30.13 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.408 -0.808 . . . . 1.75 110.602 178.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.884 ' HD2' HD12 ' B' ' 22' ' ' ILE . 73.1 mtt180 -57.34 -43.85 83.77 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.877 -1.139 . . . . 0.3 109.106 175.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 74.2 ttt180 -71.53 -50.54 30.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.418 -0.801 . . . . 3.27 110.614 -178.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 60.8 m -62.98 -32.58 73.95 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.342 -0.849 . . . . 0.77 110.948 -177.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.894 HD23 HG13 ' B' ' 30' ' ' ILE . 21.2 tp -87.84 -5.32 58.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.981 -1.074 . . . . 1.05 110.759 -176.669 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.4 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.79 42.64 97.0 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.575 -1.41 . . . . 0.32 109.575 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.894 HG13 HD23 ' B' ' 28' ' ' LEU . 34.8 mm -116.2 138.63 46.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.162 -1.199 . . . . 0.41 110.816 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.82 167.43 22.15 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.605 -0.685 . . . . 0.23 109.97 -178.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.25 147.18 10.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.162 -0.961 . . . . 1.13 110.515 179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 29.2 tttt 74.69 -5.01 2.21 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.733 -0.604 . . . . 1.88 111.206 177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.605 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.5 m-20 -77.63 164.98 24.84 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.821 -1.174 . . . . 1.1 109.998 174.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.753 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.41 131.58 51.61 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.36 110.833 -176.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.99 HD11 HG22 ' A' ' 12' ' ' VAL . 13.4 mt -109.62 140.42 43.47 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.256 -0.903 . . . . 0.56 109.632 175.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.743 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.7 tt0 -103.43 138.56 39.99 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.829 -1.169 . . . . 1.17 109.749 171.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.8 mt -111.4 133.19 57.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.882 . . . . 0.84 110.524 -172.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.575 ' CZ ' ' HE3' ' B' ' 48' ' ' LYS . 8.4 m-85 -114.48 160.7 18.9 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 120.958 0.409 . . . . 0.45 110.275 -177.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.523 HG21 HG21 ' A' ' 6' ' ' THR . 94.8 t -133.64 118.14 29.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.986 -1.071 . . . . 0.26 110.559 173.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.54 ' OD2' HD11 ' B' ' 46' ' ' ILE . 6.3 p-10 -148.29 160.2 43.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.281 -0.887 . . . . 1.77 110.033 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.464 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 22.7 t70 42.46 41.7 2.39 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.124 -0.985 . . . . 1.21 111.225 173.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 75.5 mm-40 57.23 15.61 2.62 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.079 -1.013 . . . . 1.92 110.71 175.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 56.1 pttt -130.58 163.45 27.08 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.173 -0.955 . . . . 2.0 109.866 174.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.453 HD13 HG13 ' A' ' 20' ' ' ILE . 60.5 mt -104.31 134.67 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.153 -0.967 . . . . 1.24 110.616 -173.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.572 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 27.5 mt -113.05 119.31 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.399 -0.813 . . . . 0.5 110.21 176.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.822 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.2 mp -108.04 134.75 50.49 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.214 -0.929 . . . . 1.66 109.978 178.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.575 ' HE3' ' CZ ' ' B' ' 39' ' ' TYR . 1.8 ptpm? -140.69 163.63 32.38 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.422 -0.798 . . . . 1.74 110.288 -179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 19.8 tttp -55.12 147.93 15.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -0.963 . . . . 1.65 109.696 176.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 1.081 ' CD2' HG11 ' A' ' 9' ' ' VAL . 1.7 t80 -101.25 120.92 40.96 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.167 -0.958 . . . . 0.65 110.587 -175.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.568 ' CB ' ' HD3' ' B' ' 52' ' ' PRO . 0.0 OUTLIER -97.01 -56.25 0.2 Allowed Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.202 -0.936 . . . . 4.35 110.776 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.585 ' O ' ' CZ ' ' B' ' 50' ' ' TYR . 26.5 Cg_exo -54.59 154.42 20.24 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 O-C-N 123.491 1.258 . . . . 3.58 110.373 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 117.972 -1.013 . . . . 5.97 110.225 -178.462 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.203 0.525 . . . . 10.99 110.272 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.5 mtt -118.66 147.96 43.24 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.345 -0.847 . . . . 8.76 110.125 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 95.3 mttt -102.99 137.06 41.68 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 8.85 110.392 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.7 t -137.55 144.97 42.36 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.273 -0.892 . . . . 4.2 110.031 178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.494 HG21 ' CG2' ' B' ' 40' ' ' VAL . 72.5 p -63.1 -39.4 94.59 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.076 -1.015 . . . . 3.77 110.064 -179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.524 ' O ' HD13 ' A' ' 8' ' ' ILE . . . 68.08 46.1 67.83 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.711 -1.356 . . . . 0.83 109.711 176.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.524 HD13 ' O ' ' A' ' 7' ' ' GLY . 19.1 mm -113.77 132.32 63.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.021 -1.282 . . . . 1.36 110.016 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.932 HG13 ' O ' ' B' ' 36' ' ' LEU . 87.0 t -117.91 144.03 27.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.024 -1.048 . . . . 0.37 110.94 -175.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.449 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 27.7 tpt180 -128.57 160.56 32.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.549 -0.72 . . . . 1.91 109.65 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.449 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 94.8 mttt -84.92 146.87 27.04 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.15 -0.969 . . . . 2.21 110.297 -178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.916 HG22 HD11 ' B' ' 36' ' ' LEU . 4.1 t -82.27 127.49 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.28 109.757 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.446 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.27 -175.07 5.56 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.128 -0.983 . . . . 0.55 109.985 -179.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.8 -39.14 73.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.998 -1.064 . . . . 2.19 111.596 -172.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.89 HD23 ' HD3' ' A' ' 17' ' ' ARG . 16.4 tp -83.0 -6.62 59.56 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.805 -1.185 . . . . 1.38 111.531 -174.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.48 46.62 7.3 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.173 -1.489 . . . . 0.21 109.654 -177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.896 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.1 mtm180 -114.07 154.44 27.72 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.018 -1.283 . . . . 1.15 110.007 -177.49 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.866 HG12 HD13 ' B' ' 36' ' ' LEU . 17.7 m -123.56 151.97 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.302 -0.874 . . . . 0.28 109.799 -179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.909 HG22 ' CD ' ' B' ' 17' ' ' ARG . 17.1 t -113.61 133.56 59.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.242 -0.911 . . . . 0.24 110.762 -174.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.945 HD11 HD13 ' B' ' 45' ' ' ILE . 2.5 mm -85.28 136.97 37.23 Favored Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.248 -0.908 . . . . 1.38 109.483 174.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.55 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -58.85 141.18 97.76 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.676 1.356 . . . . 0.35 109.965 176.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.949 HD13 ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.83 -32.03 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.946 -1.096 . . . . 1.11 110.407 -177.641 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.64 -35.31 72.31 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.034 -1.041 . . . . 2.37 109.77 178.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.55 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 45.3 mt -81.4 -28.97 34.1 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.299 -0.876 . . . . 1.75 110.52 176.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.663 HH22 HD11 ' B' ' 15' ' ' LEU . 72.6 mtt180 -56.93 -44.25 82.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.916 -1.115 . . . . 0.3 108.942 175.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -72.03 -49.26 38.25 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.574 -0.704 . . . . 3.26 110.735 -178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.7 m -63.55 -31.22 72.32 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.293 -0.879 . . . . 0.77 111.119 -177.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.832 HD23 HG13 ' A' ' 30' ' ' ILE . 21.4 tp -87.24 -4.66 59.1 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.004 -1.06 . . . . 1.05 110.712 -177.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.18 40.92 95.09 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.721 -1.352 . . . . 0.32 109.721 178.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.832 HG13 HD23 ' A' ' 28' ' ' LEU . 35.4 mm -116.33 139.09 44.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.309 -1.112 . . . . 0.41 110.623 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.55 166.5 24.58 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.546 -0.721 . . . . 0.23 110.124 -177.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.47 146.65 12.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.144 -0.973 . . . . 1.13 110.591 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 15.1 tptt 74.83 -4.62 2.32 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.759 -0.588 . . . . 1.88 111.092 177.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.75 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.8 m-20 -77.42 166.74 22.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.792 -1.193 . . . . 1.1 110.021 174.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.684 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.53 131.94 52.31 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.249 -0.907 . . . . 0.36 110.748 -176.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.932 HD11 HG22 ' B' ' 12' ' ' VAL . 13.9 mt -109.03 142.05 40.29 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.422 -0.799 . . . . 0.56 109.519 175.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.651 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.0 tt0 -108.29 139.89 42.34 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.879 -1.138 . . . . 1.17 109.784 173.043 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.425 HD13 ' O ' ' A' ' 37' ' ' GLU . 22.0 mm -111.86 133.98 55.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.332 -0.855 . . . . 0.84 110.553 -173.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.593 ' CE2' ' HE3' ' A' ' 48' ' ' LYS . 8.2 m-85 -115.34 162.03 17.69 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 120.955 0.407 . . . . 0.45 110.045 -179.046 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.651 HG21 HG21 ' B' ' 6' ' ' THR . 92.2 t -133.48 121.79 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 120.926 -1.108 . . . . 0.27 110.92 173.085 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.605 ' CG ' HD11 ' A' ' 46' ' ' ILE . 6.3 p-10 -147.31 152.53 38.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.246 -0.909 . . . . 1.77 110.129 176.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 53.7 t0 43.02 45.34 4.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.122 -0.986 . . . . 1.22 111.32 173.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 96.0 mt-10 56.99 16.91 3.07 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.028 -1.045 . . . . 1.93 110.548 175.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.514 ' CG ' ' O ' ' A' ' 41' ' ' ASP . 16.2 ptpt -129.73 159.61 35.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.229 -0.919 . . . . 2.01 109.872 176.114 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 1.059 HD13 HD11 ' B' ' 20' ' ' ILE . 57.8 mt -104.33 133.48 48.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 1.25 110.607 -173.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.605 HD11 ' CG ' ' A' ' 41' ' ' ASP . 33.4 mt -112.11 120.53 62.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.507 -0.745 . . . . 0.5 110.283 176.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.845 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.5 mp -109.74 135.38 50.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.11 -0.994 . . . . 1.66 110.015 178.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.593 ' HE3' ' CE2' ' A' ' 39' ' ' TYR . 1.8 ptpm? -141.09 162.83 34.55 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.483 -0.761 . . . . 1.74 110.3 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 tttp -57.94 146.54 31.95 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.171 -0.956 . . . . 1.65 110.03 177.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.745 ' CD2' HG11 ' B' ' 9' ' ' VAL . 8.1 t80 -105.94 120.12 40.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.307 -0.871 . . . . 0.35 110.655 -176.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -99.64 122.71 50.43 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.275 -0.891 . . . . 3.21 109.47 172.462 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -65.04 146.62 87.74 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 123.743 1.391 . . . . 0.48 110.291 -178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.958 -1.02 . . . . 2.41 110.206 179.884 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 66.5 t80 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.248 0.547 . . . . 11.66 110.19 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 87.9 mtp -96.1 148.8 22.31 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.319 -0.863 . . . . 8.7 110.139 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 31.7 mttm -87.38 142.32 27.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.263 -0.898 . . . . 9.17 110.396 -178.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 51.1 m -121.9 153.57 38.26 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.342 -0.849 . . . . 5.2 110.047 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.651 HG21 HG21 ' A' ' 40' ' ' VAL . 72.7 p -55.42 -39.3 70.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.205 -0.934 . . . . 2.98 110.019 -179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . 0.538 ' O ' HD13 ' B' ' 8' ' ' ILE . . . 67.89 46.44 66.92 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.652 -1.379 . . . . 0.83 109.652 176.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.538 HD13 ' O ' ' B' ' 7' ' ' GLY . 19.0 mm -113.88 132.32 63.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.093 -1.239 . . . . 1.36 109.962 179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 36' ' ' LEU . 86.7 t -118.03 144.0 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.014 -1.054 . . . . 0.37 110.925 -175.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.454 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 27.6 tpt180 -128.49 160.36 32.55 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.552 -0.717 . . . . 1.92 109.76 177.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.454 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 94.8 mttt -84.82 146.8 27.15 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.038 -1.039 . . . . 2.21 110.283 -178.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.932 HG22 HD11 ' A' ' 36' ' ' LEU . 4.1 t -82.29 127.52 39.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.202 -0.936 . . . . 0.29 109.767 179.489 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -85.35 -174.86 5.43 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.18 -0.95 . . . . 0.55 110.111 179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.485 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.9 mt-10 -57.07 -38.91 73.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.099 -1.001 . . . . 2.19 111.554 -172.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.8 tp -83.09 -6.74 59.6 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.796 -1.19 . . . . 1.39 111.51 -174.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.18 47.31 7.07 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.508 -1.437 . . . . 0.21 109.508 -177.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.909 ' CD ' HG22 ' A' ' 19' ' ' VAL . 69.2 mtm180 -114.17 154.35 27.99 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.082 -1.246 . . . . 1.14 110.074 -177.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.892 HG12 HD13 ' A' ' 36' ' ' LEU . 17.7 m -123.52 152.0 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.86 . . . . 0.28 109.794 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.896 HG22 ' CD ' ' A' ' 17' ' ' ARG . 16.8 t -113.57 133.57 59.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.158 -0.963 . . . . 0.24 110.748 -174.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 1.059 HD11 HD13 ' A' ' 45' ' ' ILE . 2.6 mm -85.3 136.96 37.21 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 1.38 109.526 174.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.0 Cg_endo -58.94 141.19 97.96 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.547 1.288 . . . . 0.36 110.023 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.948 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -56.08 -31.7 32.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.09 -1.006 . . . . 1.11 110.373 -177.368 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.58 -35.94 73.19 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.051 -1.03 . . . . 2.37 109.661 178.226 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.556 ' HB2' HG23 ' B' ' 20' ' ' ILE . 45.4 mt -80.65 -29.35 36.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.448 -0.782 . . . . 1.75 110.526 176.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.61 HH22 HD11 ' A' ' 15' ' ' LEU . 72.1 mtt180 -56.81 -44.06 81.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.836 -1.165 . . . . 0.3 109.001 175.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 76.2 ttt180 -71.98 -49.56 36.15 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.542 -0.723 . . . . 3.27 110.628 -178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.0 m -63.22 -31.8 73.04 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.286 -0.884 . . . . 0.77 110.898 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.854 HD23 HG13 ' B' ' 30' ' ' ILE . 21.7 tp -86.72 -5.02 59.24 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.122 -0.986 . . . . 1.05 110.69 -177.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.58 40.69 94.22 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.613 -1.395 . . . . 0.32 109.613 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.854 HG13 HD23 ' B' ' 28' ' ' LEU . 34.8 mm -116.39 139.03 44.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.291 -1.123 . . . . 0.41 110.604 -179.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.34 166.6 24.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.559 -0.713 . . . . 0.23 110.071 -177.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.538 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.43 146.71 11.99 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.148 -0.97 . . . . 1.13 110.508 -179.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.538 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 15.1 tptt 74.88 -4.91 2.26 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.695 -0.628 . . . . 1.88 111.184 177.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.665 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.1 m-20 -77.4 166.48 23.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.769 -1.207 . . . . 1.1 110.094 174.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.7 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.32 131.86 52.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.134 -0.979 . . . . 0.36 110.781 -176.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.932 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.7 mt -109.1 141.77 40.79 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.29 -0.881 . . . . 0.56 109.6 175.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.625 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.9 tt0 -107.97 139.9 41.9 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.932 -1.105 . . . . 1.17 109.892 173.011 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.429 HD13 ' O ' ' B' ' 37' ' ' GLU . 21.9 mm -111.95 134.14 55.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.352 -0.842 . . . . 0.84 110.443 -173.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.583 ' CE2' ' HE3' ' B' ' 48' ' ' LYS . 8.0 m-85 -115.43 162.0 17.77 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 116.315 -0.402 . . . . 0.45 110.078 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.494 ' CG2' HG21 ' A' ' 6' ' ' THR . 92.2 t -133.23 122.21 44.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.931 -1.106 . . . . 0.26 110.633 173.162 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.597 ' OD2' HD11 ' B' ' 46' ' ' ILE . 6.5 p-10 -147.84 152.56 37.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.299 -0.876 . . . . 1.77 110.114 175.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 54.2 t0 42.98 45.54 4.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.164 -0.96 . . . . 1.21 111.258 173.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.9 mt-10 56.85 16.89 2.96 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.983 -1.073 . . . . 1.92 110.594 175.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.523 ' CG ' ' O ' ' B' ' 41' ' ' ASP . 16.2 ptpt -129.67 159.88 35.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.28 -0.888 . . . . 2.0 109.763 176.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.945 HD13 HD11 ' A' ' 20' ' ' ILE . 57.3 mt -104.39 133.51 48.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.124 -0.985 . . . . 1.24 110.687 -173.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.597 HD11 ' OD2' ' B' ' 41' ' ' ASP . 34.7 mt -112.34 120.57 62.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.389 -0.819 . . . . 0.5 110.181 176.474 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.835 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.6 mp -109.63 135.24 50.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.196 -0.94 . . . . 1.66 110.071 178.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.583 ' HE3' ' CE2' ' B' ' 39' ' ' TYR . 1.8 ptpm? -140.99 163.03 34.07 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.454 -0.778 . . . . 1.74 110.248 -179.603 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 17.1 tttp -57.93 146.55 31.87 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 1.65 109.988 177.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.881 ' CD2' HG11 ' A' ' 9' ' ' VAL . 8.3 t80 -106.18 117.28 33.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.24 -0.912 . . . . 0.65 110.596 -176.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -113.41 106.79 54.1 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.17 -0.956 . . . . 4.35 110.205 176.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -55.57 145.33 70.3 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.977 1.514 . . . . 3.58 110.308 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 . . . . . 0 N--CA 1.492 1.659 0 CA-C-O 118.009 -0.996 . . . . 5.97 110.144 -179.78 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.1 t80 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.264 0.554 . . . . 10.99 110.142 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.7 mmm -88.98 165.95 14.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.235 -0.916 . . . . 8.76 110.225 -179.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -68.75 170.89 8.63 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.331 -0.855 . . . . 8.85 110.17 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.917 ' O ' HG23 ' A' ' 6' ' ' THR . 36.8 m -53.46 153.07 4.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.176 -0.952 . . . . 4.2 110.154 -178.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.917 HG23 ' O ' ' A' ' 5' ' ' SER . 0.8 OUTLIER -170.24 64.4 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.336 -0.852 . . . . 3.77 109.966 -179.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 84.09 49.73 4.63 Favored Glycine 0 N--CA 1.491 2.363 0 C-N-CA 119.359 -1.4 . . . . 0.83 110.045 179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.8 mt -103.76 136.2 37.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 120.998 -1.295 . . . . 1.36 109.594 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.906 HG13 ' O ' ' B' ' 36' ' ' LEU . 75.1 t -110.94 143.87 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 120.791 -1.193 . . . . 0.37 111.394 -170.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.489 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 28.7 tpt180 -125.85 163.11 23.62 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.645 -0.659 . . . . 1.91 109.527 175.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.489 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 56.6 mttm -84.98 146.54 27.16 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.986 -1.071 . . . . 2.21 110.453 -177.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.896 HG22 HD11 ' B' ' 36' ' ' LEU . 3.9 t -83.51 130.29 36.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.385 -0.822 . . . . 0.28 109.876 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.74 -175.54 5.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.048 -1.032 . . . . 0.55 110.03 179.654 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.85 -39.33 74.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.998 -1.064 . . . . 2.19 111.677 -172.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.895 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.1 tp -83.26 -6.67 59.55 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.735 -1.228 . . . . 1.38 111.524 -174.008 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.457 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.47 46.58 7.32 Favored Glycine 0 N--CA 1.49 2.285 0 C-N-CA 119.176 -1.488 . . . . 0.21 109.715 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.911 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.5 mtm180 -113.88 154.73 27.0 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.953 -1.322 . . . . 1.15 110.043 -177.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.905 HG12 HD13 ' B' ' 36' ' ' LEU . 15.4 m -123.84 152.72 29.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.329 -0.857 . . . . 0.28 109.755 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.917 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.4 t -111.28 135.12 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.182 -0.949 . . . . 0.24 110.671 -175.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.6 HD11 ' CD1' ' B' ' 45' ' ' ILE . 16.2 mt -81.63 135.05 49.8 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.274 -0.891 . . . . 1.38 109.675 174.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.4 Cg_endo -58.32 142.61 97.68 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.67 1.352 . . . . 0.35 109.954 177.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.884 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.18 -32.16 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.899 -1.126 . . . . 1.11 110.389 -178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -59.39 -34.87 72.96 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.055 -1.028 . . . . 2.37 109.888 179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.546 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 52.3 mt -81.86 -30.72 31.89 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.277 -0.889 . . . . 1.75 110.532 178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.884 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.1 mtt180 -57.94 -44.19 86.78 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.95 -1.093 . . . . 0.3 109.2 176.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 81.0 mtm180 -73.82 -49.9 23.03 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.831 -0.748 . . . . 3.26 110.653 -177.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.6 m -64.12 -31.15 72.24 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.201 -0.937 . . . . 0.77 111.11 -178.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.862 HD23 HG13 ' A' ' 30' ' ' ILE . 18.7 tp -87.82 -4.68 58.85 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.039 -1.038 . . . . 1.05 110.739 -176.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 66.07 43.28 93.68 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.685 -1.366 . . . . 0.32 109.685 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.862 HG13 HD23 ' A' ' 28' ' ' LEU . 32.8 mm -115.96 138.19 47.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.224 -1.162 . . . . 0.41 110.671 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.405 ' HB3' ' OD2' ' A' ' 34' ' ' ASP . . . -142.78 167.0 23.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.579 -0.7 . . . . 0.23 110.049 -177.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.58 145.79 14.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.114 -0.991 . . . . 1.13 110.601 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.521 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 69.1 tttt 74.43 -4.34 2.34 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.708 -0.62 . . . . 1.88 111.073 176.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.767 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.7 m-20 -76.97 168.29 20.36 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.816 -1.177 . . . . 1.1 109.962 174.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.82 131.37 53.24 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.202 -0.937 . . . . 0.36 110.798 -176.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.93 ' O ' HG13 ' B' ' 9' ' ' VAL . 9.5 mt -107.61 144.23 34.95 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.369 -0.832 . . . . 0.56 109.267 174.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.532 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.4 tt0 -108.35 137.93 45.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.696 -1.253 . . . . 1.17 109.648 173.514 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.5 mt -108.42 133.29 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.452 -0.78 . . . . 0.84 110.571 -172.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.595 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.3 m-85 -119.38 159.98 23.16 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 116.319 -0.401 . . . . 0.45 110.001 -178.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.523 ' CG2' ' OG ' ' B' ' 5' ' ' SER . 76.8 t -133.22 127.25 54.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 120.98 -1.075 . . . . 0.27 110.564 173.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.478 ' OD1' HG12 ' A' ' 46' ' ' ILE . 39.1 p-10 -147.23 137.99 23.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -0.866 . . . . 1.77 110.658 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.476 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.7 t0 43.74 47.36 6.63 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.043 -1.035 . . . . 1.22 111.306 174.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.476 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.5 tt0 61.02 11.8 3.57 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.193 -0.942 . . . . 1.93 110.622 175.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.457 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 35.4 mtmt -113.07 151.91 30.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 2.01 109.71 175.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.809 HG22 HD11 ' A' ' 47' ' ' LEU . 65.9 mt -94.73 129.78 44.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.164 -0.96 . . . . 1.25 109.977 -179.316 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.595 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 27.6 mm -114.95 120.93 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.465 -0.772 . . . . 0.5 109.928 179.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.845 HD13 ' CD1' ' B' ' 47' ' ' LEU . 4.4 mp -118.34 136.04 53.96 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.973 -1.079 . . . . 1.66 110.257 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.559 ' HD2' ' CE1' ' A' ' 39' ' ' TYR . 5.0 ptpt -142.67 158.24 43.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.339 -0.85 . . . . 1.74 110.333 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 tttt -57.88 146.59 31.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.168 -0.958 . . . . 1.65 109.934 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.631 ' CD2' HG11 ' B' ' 9' ' ' VAL . 14.5 t80 -103.24 119.87 39.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.324 -0.86 . . . . 0.35 110.729 -175.566 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.5 mtmt -99.63 122.54 51.0 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.198 -0.938 . . . . 3.21 109.415 171.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -65.58 147.0 86.04 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.797 1.419 . . . . 0.48 110.297 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.2 p-10 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.029 -0.986 . . . . 2.41 110.241 179.627 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 49.7 p90 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.235 0.541 . . . . 11.66 110.211 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . 0.407 ' SD ' ' OE2' ' B' ' 23' ' ' GLU . 50.3 ttm -111.18 91.32 3.61 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.196 -0.94 . . . . 8.7 110.162 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 20.5 tttt -135.22 146.0 48.22 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.338 -0.851 . . . . 9.17 110.056 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.898 ' O ' HG23 ' B' ' 6' ' ' THR . 54.4 p -58.98 153.61 17.17 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.22 -0.925 . . . . 5.2 110.057 -179.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.898 HG23 ' O ' ' B' ' 5' ' ' SER . 0.7 OUTLIER -170.84 64.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.407 -0.808 . . . . 2.98 110.071 -176.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 83.36 51.1 4.25 Favored Glycine 0 N--CA 1.494 2.515 0 N-CA-C 109.861 -1.296 . . . . 0.83 109.861 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 61.9 mt -104.14 135.93 39.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 O-C-N 120.992 -1.299 . . . . 1.36 109.725 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 36' ' ' LEU . 74.0 t -110.94 143.77 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 120.741 -1.225 . . . . 0.37 111.375 -170.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.49 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 28.8 tpt180 -125.69 162.96 23.87 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.527 -0.733 . . . . 1.92 109.596 175.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.49 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 56.7 mttm -84.97 146.52 27.18 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.071 -1.018 . . . . 2.21 110.484 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.914 HG22 ' CD1' ' A' ' 36' ' ' LEU . 4.0 t -83.5 130.38 35.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.35 -0.844 . . . . 0.29 109.763 179.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.445 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.0 -175.33 5.75 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.076 -1.015 . . . . 0.55 110.054 179.595 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.486 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -57.11 -39.19 74.59 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.028 -1.045 . . . . 2.19 111.554 -172.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.901 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.9 tp -83.23 -6.83 59.61 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.737 -1.227 . . . . 1.39 111.589 -174.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.461 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.12 47.38 7.06 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.483 -1.447 . . . . 0.21 109.483 -177.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.917 ' CD ' HG22 ' A' ' 19' ' ' VAL . 69.6 mtm180 -114.08 154.67 27.34 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.026 -1.279 . . . . 1.14 110.059 -177.75 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.922 HG12 HD13 ' A' ' 36' ' ' LEU . 15.1 m -123.73 152.74 29.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.282 -0.886 . . . . 0.28 109.803 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.911 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.4 t -111.41 135.12 51.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.135 -0.978 . . . . 0.24 110.655 -175.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.635 HD11 ' CD1' ' A' ' 45' ' ' ILE . 15.9 mt -81.64 135.03 49.78 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.326 -0.859 . . . . 1.38 109.602 174.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.538 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.5 Cg_endo -58.38 142.64 97.87 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.773 1.407 . . . . 0.36 110.045 177.083 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.881 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.42 -31.79 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.06 -1.025 . . . . 1.11 110.357 -177.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . 0.407 ' OE2' ' SD ' ' B' ' 3' ' ' MET . 96.8 mt-10 -59.31 -35.59 74.08 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.019 -1.051 . . . . 2.37 109.787 178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.545 ' HB2' HG23 ' B' ' 20' ' ' ILE . 51.9 mt -81.15 -31.02 34.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.423 -0.798 . . . . 1.75 110.569 178.088 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.881 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.7 mtt180 -57.85 -43.93 86.21 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.848 -1.157 . . . . 0.3 109.319 176.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 81.1 mtm180 -73.82 -50.1 22.05 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.332 -0.855 . . . . 3.27 110.62 -177.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.5 m -63.81 -31.78 73.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.304 -0.872 . . . . 0.77 110.854 -178.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.875 HD23 HG13 ' B' ' 30' ' ' ILE . 18.8 tp -87.35 -4.95 59.06 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.124 -0.985 . . . . 1.05 110.732 -176.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.446 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.4 43.12 93.3 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.626 -1.39 . . . . 0.32 109.626 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.875 HG13 HD23 ' B' ' 28' ' ' LEU . 32.5 mm -115.96 138.11 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.255 -1.144 . . . . 0.41 110.64 -178.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.406 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.55 167.11 22.87 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.478 -0.764 . . . . 0.23 109.999 -177.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.64 145.93 14.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.173 -0.954 . . . . 1.13 110.565 -179.462 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 69.2 tttt 74.49 -4.58 2.29 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.656 -0.653 . . . . 1.88 111.128 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.723 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.9 m-20 -76.97 168.07 20.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.83 -1.169 . . . . 1.1 110.013 174.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.499 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.66 131.36 53.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.189 -0.944 . . . . 0.36 110.805 -176.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.906 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.4 mt -107.71 144.04 35.38 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.391 -0.818 . . . . 0.56 109.291 174.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.473 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.3 tt0 -108.15 137.81 45.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.764 -1.21 . . . . 1.17 109.881 173.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -108.32 133.35 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.322 -0.861 . . . . 0.84 110.508 -172.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.602 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 10.3 m-85 -119.41 159.98 23.18 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-N 116.276 -0.42 . . . . 0.45 110.03 -178.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 76.7 t -133.12 127.56 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.945 -1.097 . . . . 0.26 110.454 173.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.489 ' OD1' HG12 ' B' ' 46' ' ' ILE . 39.2 p-10 -147.6 137.98 23.14 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.34 -0.85 . . . . 1.77 110.58 179.569 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 54.4 t0 43.89 47.42 6.96 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.136 -0.977 . . . . 1.21 111.278 174.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.3 tt0 60.85 11.74 3.42 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.133 -0.979 . . . . 1.92 110.636 175.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.449 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 35.3 mtmt -113.02 152.06 29.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.176 -0.952 . . . . 2.0 109.683 175.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.803 HG22 HD11 ' B' ' 47' ' ' LEU . 65.6 mt -94.81 129.57 44.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.22 -0.925 . . . . 1.24 110.108 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.602 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 27.2 mm -114.84 120.94 65.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.581 -0.699 . . . . 0.5 109.962 179.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.845 ' CD1' HD13 ' A' ' 47' ' ' LEU . 4.4 mp -118.2 135.88 53.98 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.999 -1.063 . . . . 1.66 110.235 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.558 ' HD2' ' CE1' ' B' ' 39' ' ' TYR . 5.0 ptpt -142.53 158.41 43.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 1.74 110.346 -179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -57.83 146.47 31.56 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.135 -0.978 . . . . 1.65 109.955 177.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.699 ' CD2' HG11 ' A' ' 9' ' ' VAL . 15.0 t80 -103.34 116.1 31.79 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.322 -0.861 . . . . 0.65 110.697 -175.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.434 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -110.99 108.57 57.55 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.271 -0.893 . . . . 4.35 110.111 176.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -55.83 145.0 74.89 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.011 1.532 . . . . 3.58 110.337 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.993 -1.003 . . . . 5.97 110.205 -179.877 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.233 0.54 . . . . 10.99 110.133 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 71.0 mtm -47.12 -39.91 14.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.146 -0.971 . . . . 8.76 111.3 -174.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -86.36 138.75 31.56 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.748 -1.22 . . . . 8.85 110.362 -178.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.9 p -75.99 163.47 27.13 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.322 -0.861 . . . . 4.2 110.145 178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.461 HG21 ' CG2' ' B' ' 40' ' ' VAL . 47.6 p -62.52 -38.89 91.74 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.207 -0.933 . . . . 3.77 110.152 179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.22 45.38 70.95 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.72 -1.352 . . . . 0.83 109.72 177.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.5 mt -118.51 133.7 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 O-C-N 121.059 -1.26 . . . . 1.36 110.018 178.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.93 HG13 ' O ' ' B' ' 36' ' ' LEU . 89.2 t -115.71 144.25 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.013 -1.054 . . . . 0.37 110.855 -176.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -129.85 160.38 33.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.522 -0.736 . . . . 1.91 109.658 177.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -85.62 147.73 26.25 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.029 -1.044 . . . . 2.21 110.33 -177.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.93 HG22 HD11 ' B' ' 36' ' ' LEU . 3.8 t -82.33 130.78 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -0.864 . . . . 0.28 109.825 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.8 -175.55 5.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.128 -0.982 . . . . 0.55 110.02 -179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.9 -40.77 70.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.134 -0.979 . . . . 2.19 111.733 -173.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.843 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.1 tp -84.09 -5.51 59.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.746 -1.221 . . . . 1.38 111.493 -173.28 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.523 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.34 46.37 7.53 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.193 -1.479 . . . . 0.21 109.704 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.919 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.0 mtm180 -114.93 154.53 28.57 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.028 -1.277 . . . . 1.15 109.994 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.769 HG12 HD13 ' B' ' 36' ' ' LEU . 16.6 m -123.86 152.01 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.323 -0.861 . . . . 0.28 109.768 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.929 HG22 ' CD ' ' B' ' 17' ' ' ARG . 36.0 t -111.23 134.87 52.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.172 -0.955 . . . . 0.24 110.724 -175.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.53 HG23 ' HB2' ' A' ' 24' ' ' LEU . 19.0 mt -81.36 133.28 53.7 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.277 -0.89 . . . . 1.38 109.632 174.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' HD12 ' A' ' 24' ' ' LEU . 10.2 Cg_endo -58.85 143.32 99.34 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.701 1.369 . . . . 0.35 109.985 176.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.883 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.07 -32.82 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.934 -1.104 . . . . 1.11 110.33 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.11 -35.66 71.77 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.111 -0.993 . . . . 2.37 109.852 178.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.552 HD12 ' HG2' ' A' ' 21' ' ' PRO . 57.2 mt -82.83 -29.8 29.19 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.429 -0.795 . . . . 1.75 110.645 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.883 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.0 mtt180 -57.54 -43.88 84.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.887 -1.133 . . . . 0.3 109.166 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 25.8 tpt180 -73.06 -50.97 19.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.542 -0.724 . . . . 3.26 110.645 -177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.3 m -63.53 -31.32 72.44 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.259 -0.9 . . . . 0.77 111.195 -177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.886 HD23 HG13 ' A' ' 30' ' ' ILE . 20.8 tp -87.71 -4.8 58.89 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.037 -1.039 . . . . 1.05 110.783 -177.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.425 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.15 41.72 96.83 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.624 -1.391 . . . . 0.32 109.624 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.886 HG13 HD23 ' A' ' 28' ' ' LEU . 34.9 mm -116.4 138.05 48.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.228 -1.16 . . . . 0.41 110.633 -179.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.68 166.74 23.83 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.652 -0.655 . . . . 0.23 110.005 -177.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.53 146.56 12.62 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.065 -1.022 . . . . 1.13 110.532 -179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 28.6 tttm 74.57 -4.62 2.29 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.699 -0.626 . . . . 1.88 111.097 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.715 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.3 m-20 -77.65 166.74 22.62 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.81 -1.182 . . . . 1.1 110.078 174.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.692 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.14 130.69 51.88 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.164 -0.96 . . . . 0.36 110.747 -176.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.978 HD11 HG22 ' B' ' 12' ' ' VAL . 12.3 mt -107.3 143.21 35.88 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.351 -0.843 . . . . 0.56 109.424 174.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.663 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.5 tt0 -107.27 137.85 44.56 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 120.839 -1.163 . . . . 1.17 109.577 173.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.6 mt -108.6 133.44 53.61 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.361 -0.837 . . . . 0.84 110.583 -171.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.625 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.7 m-85 -120.13 159.44 24.85 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-N 116.309 -0.405 . . . . 0.45 110.014 -178.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.629 ' CG2' HG21 ' B' ' 6' ' ' THR . 80.8 t -133.16 124.55 49.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.85 -1.156 . . . . 0.27 110.666 172.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.495 ' OD1' HG12 ' A' ' 46' ' ' ILE . 42.3 p-10 -147.54 145.08 28.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 1.77 110.577 178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.478 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.1 t0 43.08 43.9 3.96 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.998 -1.064 . . . . 1.22 111.283 174.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.478 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 45.2 tp10 61.74 10.6 3.5 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.128 -0.983 . . . . 1.93 110.676 175.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -109.77 153.44 24.35 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.17 -0.956 . . . . 2.01 110.034 175.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.76 HG22 HD11 ' A' ' 47' ' ' LEU . 66.6 mt -93.32 128.34 44.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.265 -0.897 . . . . 1.25 109.752 176.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.625 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.0 mm -113.35 118.43 58.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.602 -0.687 . . . . 0.5 109.941 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.83 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -115.84 134.67 54.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.944 -1.097 . . . . 1.66 110.284 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.57 ' HE3' ' CD1' ' A' ' 39' ' ' TYR . 15.9 ptpt -142.78 161.14 38.87 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.432 -0.793 . . . . 1.74 110.317 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -56.59 147.67 21.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.042 -1.037 . . . . 1.65 109.882 176.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.768 ' CD2' HG11 ' B' ' 9' ' ' VAL . 5.5 t80 -102.39 120.15 40.02 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.924 . . . . 0.35 110.653 -175.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.45 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -99.37 123.42 48.5 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.383 -0.823 . . . . 3.21 109.718 173.936 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -60.61 144.44 99.53 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.647 1.34 . . . . 0.48 110.273 -178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.989 -1.005 . . . . 2.41 110.204 -179.691 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 47.0 p90 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.284 0.564 . . . . 11.66 110.169 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 87.3 mtp -124.49 154.64 40.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.3 -0.875 . . . . 8.7 110.202 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.522 ' HA ' ' CE2' ' A' ' 39' ' ' TYR . 67.0 mttm -94.5 142.36 27.52 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.206 -0.934 . . . . 9.17 110.195 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.58 -94.59 0.22 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.246 -0.909 . . . . 5.2 110.176 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.629 HG21 ' CG2' ' A' ' 40' ' ' VAL . 46.9 p -68.82 -39.07 80.23 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.064 -1.022 . . . . 2.98 110.155 179.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.26 45.43 70.3 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.772 -1.331 . . . . 0.83 109.772 177.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.1 mt -118.49 133.55 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.796 0 O-C-N 121.062 -1.257 . . . . 1.36 109.99 178.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.942 HG13 ' O ' ' A' ' 36' ' ' LEU . 87.2 t -115.7 144.24 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.019 -1.051 . . . . 0.37 110.951 -176.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 69.8 ttt-85 -129.79 160.16 34.3 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.53 -0.731 . . . . 1.92 109.709 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.4 mttm -85.53 147.59 26.36 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.101 -1.0 . . . . 2.21 110.413 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.978 HG22 HD11 ' A' ' 36' ' ' LEU . 3.8 t -82.25 130.75 35.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.874 . . . . 0.29 109.743 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -83.95 -175.59 5.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.049 -1.032 . . . . 0.55 110.119 179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.02 -40.62 70.37 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.133 -0.98 . . . . 2.19 111.649 -172.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.865 HD23 ' HD3' ' B' ' 17' ' ' ARG . 13.9 tp -84.1 -5.52 59.25 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.766 -1.209 . . . . 1.39 111.602 -173.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.529 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.92 47.12 7.32 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.606 -1.397 . . . . 0.21 109.606 -177.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.929 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.0 mtm180 -115.09 154.57 28.65 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.071 -1.253 . . . . 1.14 109.996 -177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.801 HG12 HD13 ' A' ' 36' ' ' LEU . 16.6 m -123.96 152.01 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.286 -0.884 . . . . 0.28 109.823 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.919 HG22 ' CD ' ' A' ' 17' ' ' ARG . 35.9 t -111.29 134.85 52.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.935 . . . . 0.24 110.714 -175.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.532 HD11 ' CD1' ' A' ' 45' ' ' ILE . 18.5 mt -81.41 133.23 53.62 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.253 -0.904 . . . . 1.38 109.609 174.207 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.544 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.1 Cg_endo -58.96 143.25 99.76 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.735 1.387 . . . . 0.36 109.98 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.877 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.2 tp -55.09 -32.63 27.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.002 -1.061 . . . . 1.11 110.412 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.98 -36.39 72.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.11 -0.994 . . . . 2.37 109.747 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.544 ' CD1' ' HG2' ' B' ' 21' ' ' PRO . 57.6 mt -82.13 -30.01 31.36 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.494 -0.754 . . . . 1.75 110.638 178.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.877 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.6 mtt180 -57.56 -43.71 84.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.847 -1.158 . . . . 0.3 109.076 176.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 25.7 tpt180 -72.97 -51.21 19.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.482 -0.761 . . . . 3.27 110.6 -177.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.2 m -63.29 -31.87 73.14 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.261 -0.899 . . . . 0.77 110.953 -177.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.895 HD23 HG13 ' B' ' 30' ' ' ILE . 20.9 tp -87.12 -5.22 59.09 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.042 -1.036 . . . . 1.05 110.73 -176.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.429 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.46 41.54 96.29 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.563 -1.415 . . . . 0.32 109.563 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.895 HG13 HD23 ' B' ' 28' ' ' LEU . 34.2 mm -116.37 137.94 48.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.162 -1.199 . . . . 0.41 110.598 -178.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.411 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.41 166.86 23.51 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.624 -0.672 . . . . 0.23 109.965 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.51 146.61 12.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 1.13 110.48 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 28.5 tttm 74.66 -4.78 2.27 Favored 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.671 -0.643 . . . . 1.88 111.17 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.622 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.9 m-20 -77.73 166.5 22.89 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.789 -1.194 . . . . 1.1 110.092 175.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.693 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.06 130.63 51.75 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.24 -0.912 . . . . 0.36 110.837 -176.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.93 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.1 mt -107.27 143.06 36.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 0.56 109.48 174.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.649 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.4 tt0 -107.05 137.85 44.34 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.763 -1.21 . . . . 1.17 109.688 172.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.8 mt -108.72 133.53 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 121.292 -0.88 . . . . 0.84 110.516 -171.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.616 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 10.7 m-85 -120.16 159.44 24.88 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 116.225 -0.443 . . . . 0.45 109.978 -178.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.461 ' CG2' HG21 ' A' ' 6' ' ' THR . 81.5 t -133.03 125.02 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.885 -1.134 . . . . 0.26 110.451 172.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.491 ' OD1' HG12 ' B' ' 46' ' ' ILE . 42.1 p-10 -148.03 145.06 28.33 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.24 -0.913 . . . . 1.77 110.556 178.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.7 t0 43.25 43.91 4.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.077 -1.014 . . . . 1.21 111.242 174.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 45.0 tp10 61.61 10.61 3.4 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 121.147 -0.971 . . . . 1.92 110.703 175.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -109.87 153.66 24.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 2.0 109.963 175.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.759 HG22 HD11 ' B' ' 47' ' ' LEU . 66.2 mt -93.43 128.14 45.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.19 -0.944 . . . . 1.24 109.85 176.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 21.4 mm -113.28 118.42 58.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.508 -0.745 . . . . 0.5 109.95 -179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.821 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.3 mp -115.66 134.42 55.06 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.067 -1.021 . . . . 1.66 110.255 -179.659 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.57 ' HE3' ' CD1' ' B' ' 39' ' ' TYR . 15.8 ptpt -142.54 161.34 38.31 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.351 -0.843 . . . . 1.74 110.36 -179.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 84.5 tttt -56.67 147.59 22.26 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.186 -0.946 . . . . 1.65 109.893 176.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.929 ' CD2' HG11 ' A' ' 9' ' ' VAL . 5.6 t80 -102.36 116.77 33.32 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.65 110.581 -175.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.08 80.28 72.47 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.305 -0.872 . . . . 4.35 110.144 178.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -58.09 144.64 94.62 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.009 1.531 . . . . 3.58 110.378 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 118.045 -0.979 . . . . 5.97 110.19 -179.764 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.201 0.524 . . . . 10.99 110.264 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.2 mmm -87.11 138.82 31.17 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 8.76 110.21 -178.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 10.2 tptt -78.1 134.13 37.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.284 -0.885 . . . . 8.85 110.184 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.501 ' OG ' ' CD2' ' B' ' 39' ' ' TYR . 35.7 m -121.16 147.77 45.12 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.307 -0.871 . . . . 4.2 110.275 -179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 71.0 p -64.67 -34.71 78.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.122 -0.986 . . . . 3.77 110.027 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.92 45.45 51.35 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.852 -1.299 . . . . 0.83 109.852 177.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.5 mt -116.82 132.79 65.5 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.068 -1.254 . . . . 1.36 109.954 178.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.05 HG11 ' CD2' ' B' ' 50' ' ' TYR . 88.5 t -117.45 144.26 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.014 -1.054 . . . . 0.37 110.875 -175.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -131.47 162.54 29.99 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.532 -0.73 . . . . 1.91 109.726 177.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 59.8 mttm -85.32 148.06 26.23 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.041 -1.037 . . . . 2.21 110.385 -178.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.916 HG22 HD11 ' B' ' 36' ' ' LEU . 3.8 t -82.3 129.8 36.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.216 -0.928 . . . . 0.28 109.792 179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.456 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.14 -175.66 5.9 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.037 -1.039 . . . . 0.55 109.994 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -54.85 -40.69 69.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.083 -1.011 . . . . 2.19 111.68 -173.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.831 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.4 tp -84.51 -5.82 59.32 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.731 -1.231 . . . . 1.38 111.572 -173.195 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.486 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.53 46.59 7.28 Favored Glycine 0 N--CA 1.491 2.313 0 C-N-CA 119.225 -1.464 . . . . 0.21 109.646 -178.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.898 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.0 mtm180 -114.03 153.74 28.88 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.942 -1.328 . . . . 1.15 110.109 -177.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.902 HG12 HD13 ' B' ' 36' ' ' LEU . 16.6 m -124.21 152.99 30.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.35 -0.844 . . . . 0.28 109.771 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.9 HG22 ' CD ' ' B' ' 17' ' ' ARG . 18.1 t -112.24 134.36 55.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.128 -0.983 . . . . 0.24 110.708 -175.032 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.668 HD11 HG21 ' B' ' 45' ' ' ILE . 2.2 mm -82.97 134.13 47.14 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.181 -0.95 . . . . 1.38 109.322 173.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.5 Cg_endo -58.86 141.57 98.18 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.701 1.369 . . . . 0.35 109.906 177.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.962 HD13 ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.76 -31.43 29.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.909 -1.12 . . . . 1.11 110.412 -176.556 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.473 ' HG2' ' HB2' ' A' ' 21' ' ' PRO . 20.1 pt-20 -59.25 -34.67 72.51 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.024 -1.048 . . . . 2.37 109.732 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.584 ' HB2' HG23 ' A' ' 20' ' ' ILE . 56.6 mt -80.73 -29.42 36.32 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 1.75 110.325 176.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.701 HH22 HD11 ' B' ' 15' ' ' LEU . 73.4 mtt180 -57.1 -44.19 82.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.958 -1.088 . . . . 0.3 109.122 175.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -72.41 -50.45 26.34 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 119.893 -0.723 . . . . 3.26 110.692 -177.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.1 m -63.53 -31.49 72.66 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 0.77 111.129 -177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.863 HD23 HG13 ' A' ' 30' ' ' ILE . 18.3 tp -87.85 -4.71 58.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.011 -1.055 . . . . 1.05 110.74 -177.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.444 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.84 42.04 95.24 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.707 -1.357 . . . . 0.32 109.707 178.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.863 HG13 HD23 ' A' ' 28' ' ' LEU . 32.5 mm -116.41 138.37 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.288 -1.125 . . . . 0.41 110.716 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.63 166.23 25.23 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.594 -0.691 . . . . 0.23 109.993 -177.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.42 147.0 11.36 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.024 -1.048 . . . . 1.13 110.584 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 26.6 ttpt 74.39 -4.47 2.31 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.644 -0.66 . . . . 1.88 111.163 177.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.754 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.8 m-20 -77.79 167.82 20.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.827 -1.17 . . . . 1.1 110.057 175.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.51 131.0 52.4 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.181 -0.949 . . . . 0.36 110.777 -176.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.935 ' CD1' HG22 ' B' ' 12' ' ' VAL . 12.2 mt -108.03 144.3 35.55 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.381 -0.824 . . . . 0.56 109.461 174.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.63 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.0 tt0 -109.5 139.14 44.85 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.812 -1.18 . . . . 1.17 109.614 172.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.25 132.86 54.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.462 -0.774 . . . . 0.84 110.471 -172.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.601 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 15.8 m-85 -119.19 157.21 28.43 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 116.294 -0.412 . . . . 0.45 109.941 -178.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.467 ' HB ' HG23 ' B' ' 6' ' ' THR . 84.1 t -132.14 122.69 49.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 120.795 -1.191 . . . . 0.27 110.575 173.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.49 ' OD1' HG12 ' A' ' 46' ' ' ILE . 47.4 p-10 -147.8 149.71 32.86 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.246 -0.909 . . . . 1.77 110.602 178.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.467 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 52.7 t0 42.96 44.19 3.89 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.011 -1.055 . . . . 1.22 111.317 173.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.7 mt-10 57.84 14.46 2.54 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.051 -1.03 . . . . 1.93 110.54 176.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -114.09 153.32 29.67 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.213 -0.929 . . . . 2.01 109.984 175.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.835 HG22 HD11 ' A' ' 47' ' ' LEU . 66.0 mt -91.82 127.77 43.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.23 -0.919 . . . . 1.25 109.762 177.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 24.5 mm -112.96 120.07 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.633 -0.667 . . . . 0.5 109.896 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.843 ' CD2' HG21 ' B' ' 18' ' ' VAL . 4.1 mp -118.72 134.5 55.08 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.902 -1.124 . . . . 1.66 110.256 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.533 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 9.8 pttp -141.81 164.49 30.05 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.308 -0.87 . . . . 1.74 110.451 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 67.5 tttt -58.68 147.08 34.15 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.201 -0.937 . . . . 1.65 110.146 177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.884 ' CD2' HG11 ' B' ' 9' ' ' VAL . 7.8 t80 -104.13 120.13 40.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.368 -0.833 . . . . 0.35 110.603 -176.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 1.6 mttp -99.38 123.01 49.94 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.231 -0.918 . . . . 3.21 109.459 171.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 24.0 Cg_exo -58.42 145.71 93.03 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.797 1.419 . . . . 0.48 110.424 -178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 117.959 -1.02 . . . . 2.41 110.238 -179.745 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.218 0.532 . . . . 11.66 110.187 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 94.5 mmm -100.91 146.06 27.84 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.342 -0.849 . . . . 8.7 110.171 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 57.9 mttp -88.44 143.01 27.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 9.17 110.272 -179.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.512 ' OG ' ' CD2' ' A' ' 39' ' ' TYR . 47.3 t -123.8 145.1 49.29 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.318 -0.864 . . . . 5.2 110.2 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.467 HG23 ' HB ' ' A' ' 40' ' ' VAL . 71.5 p -63.8 -34.77 78.65 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.205 -0.934 . . . . 2.98 109.961 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.94 45.6 50.23 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.74 -1.344 . . . . 0.83 109.74 177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 59.0 mt -116.85 132.72 65.75 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.095 -1.238 . . . . 1.36 109.97 178.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.931 HG13 ' O ' ' A' ' 36' ' ' LEU . 89.2 t -117.46 144.25 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.977 -1.077 . . . . 0.37 110.919 -175.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 69.4 ttt-85 -131.42 162.35 30.37 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.555 -0.716 . . . . 1.92 109.72 177.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 59.9 mttm -85.16 148.01 26.32 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.083 -1.01 . . . . 2.21 110.393 -178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.935 HG22 ' CD1' ' A' ' 36' ' ' LEU . 3.9 t -82.29 129.85 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.213 -0.929 . . . . 0.29 109.7 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.42 -175.55 5.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.171 -0.956 . . . . 0.55 110.097 -179.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -54.89 -40.65 69.99 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.177 -0.952 . . . . 2.19 111.674 -172.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.845 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.1 tp -84.42 -5.97 59.33 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.772 -1.205 . . . . 1.39 111.599 -173.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.489 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.18 47.31 7.07 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.558 -1.417 . . . . 0.21 109.558 -177.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.9 ' CD ' HG22 ' A' ' 19' ' ' VAL . 68.7 mtm180 -114.29 153.69 29.28 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.085 -1.244 . . . . 1.14 110.061 -177.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.923 HG12 HD13 ' A' ' 36' ' ' LEU . 16.4 m -124.12 152.96 30.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.314 -0.866 . . . . 0.28 109.813 -179.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.898 HG22 ' CD ' ' A' ' 17' ' ' ARG . 18.0 t -112.37 134.36 55.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.175 -0.953 . . . . 0.24 110.686 -175.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.696 HD11 HG21 ' A' ' 45' ' ' ILE . 2.3 mm -82.91 134.02 47.54 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.205 -0.934 . . . . 1.38 109.409 173.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.4 Cg_endo -58.96 141.57 98.39 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.807 1.425 . . . . 0.36 109.899 177.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.956 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.95 -31.13 29.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.068 -1.02 . . . . 1.11 110.409 -176.266 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' B' ' 21' ' ' PRO . 20.0 pt-20 -59.16 -35.38 73.43 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.023 -1.048 . . . . 2.37 109.59 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.596 ' HB2' HG23 ' B' ' 20' ' ' ILE . 57.3 mt -80.03 -29.83 39.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.484 -0.76 . . . . 1.75 110.334 176.419 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.64 HH22 HD11 ' A' ' 15' ' ' LEU . 73.0 mtt180 -56.83 -44.08 81.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.01 -1.056 . . . . 0.3 109.203 175.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 78.9 ttt180 -72.3 -50.78 24.44 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.468 -0.77 . . . . 3.27 110.642 -177.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.3 m -63.2 -32.05 73.34 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.28 -0.888 . . . . 0.77 110.921 -177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.864 HD23 HG13 ' B' ' 30' ' ' ILE . 18.5 tp -87.39 -4.99 59.04 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.026 -1.047 . . . . 1.05 110.73 -176.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.447 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.31 41.8 94.4 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.603 -1.399 . . . . 0.32 109.603 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.864 HG13 HD23 ' B' ' 28' ' ' LEU . 32.1 mm -116.41 138.29 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.189 -1.183 . . . . 0.41 110.616 -178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -142.39 166.44 24.67 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.562 -0.711 . . . . 0.23 110.026 -177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.537 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.48 147.0 11.56 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.136 -0.978 . . . . 1.13 110.486 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.537 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 26.6 ttpt 74.59 -4.76 2.26 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.661 -0.65 . . . . 1.88 111.126 177.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.657 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.0 m-20 -77.76 167.54 21.38 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.825 -1.172 . . . . 1.1 110.107 175.209 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.758 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.28 130.98 52.08 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.184 -0.948 . . . . 0.36 110.803 -176.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.932 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.2 mt -108.02 144.08 35.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.352 -0.842 . . . . 0.56 109.551 174.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.617 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.7 tt0 -109.11 139.09 44.48 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.868 -1.145 . . . . 1.17 109.8 172.754 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.32 132.84 55.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.363 -0.836 . . . . 0.84 110.427 -172.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.591 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 15.6 m-85 -119.18 157.24 28.35 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 116.231 -0.44 . . . . 0.45 109.874 -178.856 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 85.7 t -131.96 123.08 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.958 -1.089 . . . . 0.26 110.441 173.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.484 ' OD1' HG12 ' B' ' 46' ' ' ILE . 47.6 p-10 -148.35 149.63 32.13 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.16 -0.962 . . . . 1.77 110.561 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.46 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 53.2 t0 42.87 44.48 3.93 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.129 -0.982 . . . . 1.21 111.287 174.136 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.7 mt-10 57.61 14.53 2.4 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.045 -1.034 . . . . 1.92 110.503 176.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -114.08 153.49 29.37 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.292 -0.88 . . . . 2.0 109.989 175.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.832 HG22 HD11 ' B' ' 47' ' ' LEU . 65.7 mt -91.95 127.72 44.05 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 O-C-N 121.263 -0.898 . . . . 1.24 109.771 177.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.591 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 24.7 mm -113.02 120.1 62.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.513 -0.742 . . . . 0.5 109.903 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.832 HD11 HG22 ' B' ' 45' ' ' ILE . 4.2 mp -118.66 134.34 55.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.974 -1.079 . . . . 1.66 110.196 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.535 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 10.1 pttp -141.62 164.81 29.21 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.38 -0.825 . . . . 1.74 110.406 179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 67.7 tttt -58.89 147.04 35.4 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 1.65 109.953 177.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 1.05 ' CD2' HG11 ' A' ' 9' ' ' VAL . 7.9 t80 -104.16 113.33 26.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.306 -0.871 . . . . 0.65 110.583 -176.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -129.16 78.78 75.55 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.223 -0.923 . . . . 4.35 110.266 179.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -58.64 143.98 98.04 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.004 1.528 . . . . 3.58 110.302 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.026 -0.988 . . . . 5.97 110.226 -179.765 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.201 0.524 . . . . 10.99 110.204 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 88.4 mtp -78.09 139.51 39.06 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.227 -0.92 . . . . 8.76 110.103 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 64.8 mttp -49.09 -45.88 43.93 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.18 -0.95 . . . . 8.85 111.156 -174.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.2 m -122.47 152.76 39.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.837 -1.164 . . . . 4.2 110.192 -179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 64.1 p -59.15 -38.78 80.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.145 -0.972 . . . . 3.77 109.943 178.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.502 ' O ' HD13 ' A' ' 8' ' ' ILE . . . 65.72 45.9 86.43 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.665 -1.374 . . . . 0.83 109.665 177.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.502 HD13 ' O ' ' A' ' 7' ' ' GLY . 25.1 mm -114.98 132.55 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.134 -1.215 . . . . 1.36 110.061 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.943 HG13 ' O ' ' B' ' 36' ' ' LEU . 95.9 t -115.82 144.85 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.063 -1.023 . . . . 0.37 110.81 -176.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.0 ttt-85 -131.44 160.27 35.64 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.515 -0.74 . . . . 1.91 109.704 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -85.58 148.0 26.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.062 -1.024 . . . . 2.21 110.307 -178.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.932 HG22 HD11 ' B' ' 36' ' ' LEU . 4.3 t -81.91 130.3 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.268 -0.895 . . . . 0.28 109.855 179.218 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.74 -174.64 5.39 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.09 -1.006 . . . . 0.55 110.157 -179.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -53.42 -41.95 66.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.123 -0.986 . . . . 2.19 111.887 -172.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.901 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.0 tp -87.48 -3.06 59.0 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.68 -1.262 . . . . 1.38 111.755 -172.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.528 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 79.98 46.36 7.75 Favored Glycine 0 N--CA 1.49 2.292 0 C-N-CA 119.168 -1.491 . . . . 0.21 109.674 -177.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.935 ' CD ' HG22 ' B' ' 19' ' ' VAL . 76.9 mtm180 -116.2 154.28 30.35 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.098 -1.236 . . . . 1.15 109.828 -177.528 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.645 HG12 HD13 ' B' ' 36' ' ' LEU . 27.4 m -125.7 153.14 33.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.184 -0.947 . . . . 0.28 109.938 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.935 HG22 ' CD ' ' B' ' 17' ' ' ARG . 22.7 t -111.55 135.52 50.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.24 110.548 -176.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.543 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.31 134.25 46.01 Favored Pre-proline 0 N--CA 1.488 1.456 0 O-C-N 121.255 -0.903 . . . . 1.38 109.577 175.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.54 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.4 Cg_endo -57.83 142.81 96.41 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.788 1.415 . . . . 0.35 110.025 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.893 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.37 -32.56 29.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.034 -1.041 . . . . 1.11 110.378 -178.451 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.96 -35.9 71.8 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.143 -0.973 . . . . 2.37 109.9 178.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.543 ' HB2' HG23 ' A' ' 20' ' ' ILE . 51.8 mt -81.03 -31.3 34.63 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.249 -0.907 . . . . 1.75 110.542 178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.893 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.9 mtt180 -58.17 -43.51 87.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.954 -1.091 . . . . 0.3 109.287 176.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -73.19 -49.66 26.81 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.797 -0.761 . . . . 3.26 110.694 -177.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.5 m -63.9 -31.86 73.19 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.228 -0.92 . . . . 0.77 111.093 -178.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.823 HD23 HG13 ' A' ' 30' ' ' ILE . 17.4 tp -88.16 -4.61 58.72 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.055 -1.028 . . . . 1.05 110.737 -176.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.48 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.78 42.35 95.21 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.681 -1.367 . . . . 0.32 109.681 178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.823 HG13 HD23 ' A' ' 28' ' ' LEU . 31.4 mm -116.32 137.79 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.302 -1.116 . . . . 0.41 110.715 -178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.43 168.65 19.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.589 -0.694 . . . . 0.23 110.061 -177.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.525 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.77 145.87 14.91 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.111 -0.993 . . . . 1.13 110.616 -179.464 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 41.3 tttp 74.0 -4.35 2.3 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.751 -0.593 . . . . 1.88 111.231 176.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.718 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.1 m-20 -76.84 166.28 23.55 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.818 -1.176 . . . . 1.1 110.047 174.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.727 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -103.7 131.08 51.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.176 -0.953 . . . . 0.36 110.823 -175.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.992 HD11 HG22 ' B' ' 12' ' ' VAL . 13.2 mt -108.05 144.48 35.34 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.372 -0.83 . . . . 0.56 109.392 174.578 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.684 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.3 tt0 -108.81 138.28 45.39 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.732 -1.23 . . . . 1.17 109.517 172.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.3 mt -109.09 131.79 58.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.419 -0.801 . . . . 0.84 110.582 -171.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.614 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 10.6 m-85 -117.58 159.26 23.18 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 109.83 -0.433 . . . . 0.45 109.83 -179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.458 HG21 HG21 ' B' ' 6' ' ' THR . 73.3 t -133.26 120.93 41.32 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 120.876 -1.14 . . . . 0.27 110.554 172.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.506 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 47.2 p-10 -148.4 159.96 43.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.167 -0.958 . . . . 1.77 110.603 178.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.464 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 53.9 t0 42.29 40.35 1.76 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.025 -1.047 . . . . 1.22 111.599 171.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 84.2 tt0 58.87 14.09 3.1 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.844 -1.16 . . . . 1.93 110.567 174.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.529 ' CE ' HD11 ' A' ' 46' ' ' ILE . 14.0 pttt -127.18 164.45 21.62 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.163 -0.96 . . . . 2.01 109.691 174.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.595 HG22 HD11 ' A' ' 47' ' ' LEU . 68.9 mt -97.41 134.89 33.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.137 -0.977 . . . . 1.25 110.322 -176.059 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.614 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 22.3 mm -114.16 119.39 61.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.674 -0.641 . . . . 0.5 109.857 178.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.829 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.3 mp -115.95 135.07 54.32 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.021 -1.05 . . . . 1.66 110.226 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.594 ' HE3' ' CE2' ' A' ' 39' ' ' TYR . 1.7 ptpm? -141.17 159.08 42.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.439 -0.788 . . . . 1.74 110.389 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 59.4 tttt -57.75 146.9 29.67 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.101 -1.0 . . . . 1.65 109.96 177.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.727 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 6.0 t80 -103.72 120.07 40.19 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.228 -0.92 . . . . 0.35 110.524 -176.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.0 tptm -99.77 122.84 49.75 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.419 -0.8 . . . . 3.21 109.427 173.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -63.89 146.15 91.19 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 123.826 1.435 . . . . 0.48 110.341 -178.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.461 ' O ' ' OD1' ' A' ' 53' ' ' ASN . 37.4 p-10 . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.003 -0.998 . . . . 2.41 110.26 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.258 0.551 . . . . 11.66 110.246 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 86.9 mtp -128.05 164.1 23.14 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.249 -0.907 . . . . 8.7 110.288 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.468 ' HD3' ' OE2' ' A' ' 37' ' ' GLU . 45.7 mttt -85.49 142.3 29.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.216 -0.928 . . . . 9.17 110.152 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 68.8 m -73.87 -93.16 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.153 -0.967 . . . . 5.2 110.327 -179.466 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.458 HG21 HG21 ' A' ' 40' ' ' VAL . 60.0 p -75.56 -38.94 58.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.061 -1.025 . . . . 2.98 110.147 -179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . 0.504 ' O ' HD13 ' B' ' 8' ' ' ILE . . . 65.6 46.16 85.79 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.642 -1.383 . . . . 0.83 109.642 177.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.504 HD13 ' O ' ' B' ' 7' ' ' GLY . 25.2 mm -115.03 132.48 64.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.097 -1.237 . . . . 1.36 110.053 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.926 HG13 ' O ' ' A' ' 36' ' ' LEU . 96.3 t -115.81 144.86 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.065 -1.022 . . . . 0.37 110.81 -176.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 71.1 ttt-85 -131.41 160.16 35.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.501 -0.75 . . . . 1.92 109.736 177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -85.6 148.01 26.13 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.076 -1.015 . . . . 2.21 110.442 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.992 HG22 HD11 ' A' ' 36' ' ' LEU . 4.4 t -81.9 130.38 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.874 . . . . 0.29 109.703 179.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.457 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.9 -174.47 5.29 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.115 -0.991 . . . . 0.55 110.305 -179.35 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -53.66 -41.72 67.13 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.185 -0.947 . . . . 2.19 111.79 -172.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.898 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.6 tp -87.51 -3.28 59.0 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.695 -1.253 . . . . 1.39 111.665 -172.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.54 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.81 46.93 7.5 Favored Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.477 -1.449 . . . . 0.21 109.477 -177.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.935 ' CD ' HG22 ' A' ' 19' ' ' VAL . 76.7 mtm180 -116.29 154.31 30.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.132 -1.217 . . . . 1.14 109.864 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.646 HG12 HD13 ' A' ' 36' ' ' LEU . 27.2 m -125.68 153.19 33.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.237 -0.914 . . . . 0.28 109.937 -179.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.935 HG22 ' CD ' ' A' ' 17' ' ' ARG . 22.5 t -111.61 135.43 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.191 -0.943 . . . . 0.24 110.559 -176.321 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.557 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -83.15 134.23 46.46 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.284 -0.885 . . . . 1.38 109.608 175.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.537 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.3 Cg_endo -57.94 142.82 96.73 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.765 1.403 . . . . 0.36 109.992 177.454 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.89 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.54 -32.3 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.11 -0.994 . . . . 1.11 110.359 -178.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.98 -36.41 72.57 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.074 -1.016 . . . . 2.37 109.794 178.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.557 ' HB2' HG23 ' B' ' 20' ' ' ILE . 52.3 mt -80.34 -31.62 37.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.494 -0.754 . . . . 1.75 110.574 178.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.89 ' HD2' HD12 ' B' ' 22' ' ' ILE . 72.3 mtt180 -58.02 -43.46 86.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.896 -1.128 . . . . 0.3 109.246 176.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 94.2 mtt-85 -73.17 -49.75 26.41 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 3.27 110.64 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.0 m -63.74 -32.44 73.94 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.193 -0.942 . . . . 0.77 110.785 -177.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.832 HD23 HG13 ' B' ' 30' ' ' ILE . 17.5 tp -87.71 -4.87 58.89 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.098 -1.001 . . . . 1.05 110.709 -176.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.482 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.04 42.15 94.77 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.624 -1.391 . . . . 0.32 109.624 178.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.832 HG13 HD23 ' B' ' 28' ' ' LEU . 31.2 mm -116.24 137.67 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.124 -1.221 . . . . 0.41 110.705 -178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.16 168.89 18.67 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.518 -0.739 . . . . 0.23 109.997 -177.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.87 145.9 15.2 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.163 -0.961 . . . . 1.13 110.493 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 41.2 tttp 74.13 -4.49 2.28 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.583 -0.698 . . . . 1.88 111.179 176.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.611 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.1 m-20 -77.0 166.0 23.91 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.755 -1.216 . . . . 1.1 109.979 174.814 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.738 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.45 131.19 50.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.36 110.855 -175.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.943 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.2 mt -108.2 144.07 36.14 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.328 -0.858 . . . . 0.56 109.448 174.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.662 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.0 tt0 -108.32 138.22 44.97 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.851 -1.155 . . . . 1.17 109.729 172.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -109.07 131.87 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.464 0 O-C-N 121.293 -0.879 . . . . 0.84 110.507 -171.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.624 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 10.6 m-85 -117.52 159.26 23.14 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 116.264 -0.425 . . . . 0.45 109.914 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 74.4 t -133.11 121.37 43.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 120.876 -1.14 . . . . 0.26 110.441 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 47.2 p-10 -148.93 159.97 43.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.241 -0.912 . . . . 1.77 110.543 177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 54.7 t0 42.09 40.62 1.73 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.126 -0.984 . . . . 1.21 111.577 172.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' B' ' 43' ' ' GLU . 84.1 tt0 58.79 14.03 3.02 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.816 -1.178 . . . . 1.92 110.529 174.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.534 ' CE ' HD11 ' B' ' 46' ' ' ILE . 13.9 pttt -127.19 164.65 21.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.089 -1.007 . . . . 2.0 109.571 174.195 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.633 HG22 HD11 ' B' ' 47' ' ' LEU . 68.9 mt -97.48 134.73 34.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.175 -0.953 . . . . 1.24 110.374 -176.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 22.0 mm -114.15 119.45 61.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.714 -0.616 . . . . 0.5 109.869 178.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.818 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.4 mp -115.94 134.86 54.54 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.03 -1.044 . . . . 1.66 110.208 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.58 ' HE3' ' CE2' ' B' ' 39' ' ' TYR . 1.7 ptpm? -140.99 159.3 42.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 1.74 110.316 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 60.0 tttt -57.9 146.78 30.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.173 -0.954 . . . . 1.65 109.909 177.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.927 ' CD2' HG11 ' A' ' 9' ' ' VAL . 6.1 t80 -103.72 114.7 29.16 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.282 -0.886 . . . . 0.65 110.415 -176.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.04 81.68 28.18 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.295 -0.878 . . . . 4.35 110.43 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.577 ' HG3' ' CZ ' ' B' ' 50' ' ' TYR . 27.9 Cg_exo -56.61 142.27 90.68 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.123 1.591 . . . . 3.58 110.183 178.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . 0.457 ' HB2' ' O ' ' B' ' 52' ' ' PRO . 37.6 t30 . . . . . 0 N--CA 1.492 1.671 0 CA-C-O 117.994 -1.003 . . . . 5.97 110.223 -179.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 92.0 m-85 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 121.197 0.522 . . . . 10.99 110.304 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.9 mtm -91.9 126.19 36.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.252 -0.905 . . . . 8.76 110.245 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 49.5 mttm -51.59 -50.2 60.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.167 -0.958 . . . . 8.85 111.142 -175.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 82.9 p -147.3 164.59 32.75 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.86 -1.15 . . . . 4.2 110.2 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.498 HG21 HG21 ' B' ' 40' ' ' VAL . 71.4 p -62.47 -42.31 99.4 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.228 -0.92 . . . . 3.77 110.103 178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.99 46.58 71.85 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.665 -1.374 . . . . 0.83 109.665 177.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.6 mt -114.0 134.37 57.08 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 121.09 -1.241 . . . . 1.36 110.088 -179.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.076 HG11 ' CD2' ' B' ' 50' ' ' TYR . 85.9 t -120.04 144.37 28.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.988 -1.07 . . . . 0.37 110.809 -176.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -131.04 161.21 32.5 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.525 -0.734 . . . . 1.91 109.69 178.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 55.3 mttm -85.39 148.09 26.18 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.133 -0.979 . . . . 2.21 110.34 -178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.908 HG22 HD11 ' B' ' 36' ' ' LEU . 3.6 t -82.93 129.94 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.275 -0.89 . . . . 0.28 109.831 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.455 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.8 -175.82 5.99 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.106 -0.996 . . . . 0.55 109.923 179.524 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.06 -40.38 70.25 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.104 -0.997 . . . . 2.19 111.677 -173.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.878 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.4 tp -83.25 -6.48 59.49 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.845 -1.159 . . . . 1.38 111.539 -173.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.515 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.74 46.47 7.23 Favored Glycine 0 N--CA 1.491 2.31 0 C-N-CA 119.243 -1.455 . . . . 0.21 109.652 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.908 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.7 mtm180 -114.47 154.82 27.52 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.05 -1.265 . . . . 1.15 110.065 -177.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.815 HG12 HD13 ' B' ' 36' ' ' LEU . 19.4 m -123.69 152.56 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.398 -0.814 . . . . 0.28 109.86 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.933 HG22 ' CD ' ' B' ' 17' ' ' ARG . 31.2 t -111.77 134.03 55.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.179 -0.951 . . . . 0.24 110.69 -175.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.578 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.63 132.86 50.69 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.225 -0.922 . . . . 1.38 109.437 173.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.547 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.7 Cg_endo -57.47 141.29 95.02 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.699 1.368 . . . . 0.35 109.83 177.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.947 HD13 ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.75 -31.93 30.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.928 -1.107 . . . . 1.11 110.303 -177.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.15 -36.48 70.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.072 -1.017 . . . . 2.37 109.79 177.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.578 ' HB2' HG23 ' A' ' 20' ' ' ILE . 52.8 mt -80.86 -29.04 35.85 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.262 -0.899 . . . . 1.75 110.487 177.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.71 HH22 HD11 ' B' ' 15' ' ' LEU . 75.8 mtt180 -56.85 -43.65 81.35 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.879 -1.138 . . . . 0.3 109.18 175.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -72.85 -50.67 22.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.557 -0.715 . . . . 3.26 110.755 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.6 m -63.43 -31.3 72.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.165 -0.959 . . . . 0.77 111.117 -177.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.846 HD23 HG13 ' A' ' 30' ' ' ILE . 26.3 tp -87.55 -4.93 58.96 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.049 -1.032 . . . . 1.05 110.782 -177.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.464 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.39 42.86 97.48 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.626 -1.39 . . . . 0.32 109.626 179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.846 HG13 HD23 ' A' ' 28' ' ' LEU . 29.5 mm -116.12 139.0 44.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.247 -1.149 . . . . 0.41 110.7 -178.299 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.5 166.99 23.17 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.625 -0.672 . . . . 0.23 109.998 -178.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.2 tt0 -53.41 146.31 12.7 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.154 -0.966 . . . . 1.13 110.553 -179.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 77.2 tttt 74.86 -4.68 2.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.749 -0.594 . . . . 1.88 111.164 177.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.748 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.4 m-20 -77.16 166.09 23.7 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.779 -1.2 . . . . 1.1 110.044 174.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.755 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.83 132.57 50.91 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.195 -0.941 . . . . 0.36 110.855 -175.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.96 HD11 HG22 ' B' ' 12' ' ' VAL . 13.0 mt -109.43 143.65 38.73 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.397 -0.814 . . . . 0.56 109.555 175.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.667 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.4 tt0 -108.63 140.29 42.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.836 -1.165 . . . . 1.17 109.824 173.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.414 HD13 ' O ' ' A' ' 37' ' ' GLU . 21.5 mm -111.15 133.18 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.435 -0.79 . . . . 0.84 110.555 -173.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.614 ' CE2' ' HE3' ' B' ' 4' ' ' LYS . 14.4 m-85 -115.16 159.2 21.21 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 120.911 0.386 . . . . 0.45 109.972 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.692 HG21 HG21 ' B' ' 6' ' ' THR . 79.5 t -130.45 128.92 64.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.931 -1.106 . . . . 0.27 110.802 173.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.663 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.7 p-10 -146.54 129.5 16.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.315 -0.866 . . . . 1.77 110.215 178.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 48.9 t0 46.12 50.11 11.99 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.007 -1.058 . . . . 1.22 110.96 175.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.4 mt-10 59.95 12.69 3.24 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.348 -0.845 . . . . 1.93 110.714 176.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 9.6 mtmt -113.12 150.62 31.89 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -0.938 . . . . 2.01 109.811 175.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.634 HG22 HD11 ' A' ' 47' ' ' LEU . 62.8 mt -101.76 128.84 53.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.058 -1.026 . . . . 1.25 110.327 -176.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.663 HD11 ' OD2' ' A' ' 41' ' ' ASP . 28.8 mt -112.06 121.47 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.391 -0.818 . . . . 0.5 110.14 176.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.843 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.3 mp -114.52 135.02 54.58 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.073 -1.017 . . . . 1.66 110.237 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.541 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 10.6 pttp -141.48 165.0 28.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.454 -0.779 . . . . 1.74 110.273 178.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -58.2 147.5 30.11 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.136 -0.978 . . . . 1.65 110.009 177.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.934 ' CD2' HG11 ' B' ' 9' ' ' VAL . 5.9 t80 -104.07 123.16 46.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.283 -0.885 . . . . 0.35 110.566 -175.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.3 mtpt -99.73 122.79 49.99 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.357 -0.839 . . . . 3.21 109.393 173.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -64.18 146.47 90.56 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.749 1.394 . . . . 0.48 110.44 -178.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 38.6 p-10 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.886 -1.054 . . . . 2.41 110.278 179.981 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 67.6 t80 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.248 0.547 . . . . 11.66 110.105 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 70.2 mtm -105.17 145.73 30.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.226 -0.921 . . . . 8.7 110.221 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.614 ' HE3' ' CE2' ' A' ' 39' ' ' TYR . 22.2 tptm -76.35 131.76 39.35 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.226 -0.921 . . . . 9.17 110.211 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.481 ' HB3' ' O ' ' A' ' 40' ' ' VAL . 53.5 m -46.96 -53.03 13.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.209 -0.932 . . . . 5.2 110.724 -176.529 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.692 HG21 HG21 ' A' ' 40' ' ' VAL . 71.0 p -147.68 -42.68 0.17 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.931 -1.106 . . . . 2.98 109.993 177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.85 47.07 68.78 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.586 -1.405 . . . . 0.83 109.586 177.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.3 mt -114.23 134.31 57.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.074 -1.251 . . . . 1.36 110.029 -179.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.943 HG13 ' O ' ' A' ' 36' ' ' LEU . 85.9 t -120.07 144.29 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.055 -1.028 . . . . 0.37 110.779 -176.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 52.8 ttt85 -130.86 161.12 32.51 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.467 -0.771 . . . . 1.92 109.845 177.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 55.2 mttm -85.43 147.98 26.22 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 2.21 110.404 -178.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.96 HG22 HD11 ' A' ' 36' ' ' LEU . 3.6 t -82.87 129.99 36.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.232 -0.918 . . . . 0.29 109.764 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.449 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -83.97 -175.72 5.94 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.089 -1.007 . . . . 0.55 110.087 179.343 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.13 -40.43 70.52 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.183 -0.948 . . . . 2.19 111.558 -173.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.891 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.9 tp -83.07 -6.7 59.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.856 -1.152 . . . . 1.39 111.563 -173.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.528 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.43 47.2 6.99 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.549 -1.421 . . . . 0.21 109.549 -177.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.933 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.9 mtm180 -114.67 154.72 27.92 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.096 -1.238 . . . . 1.14 110.049 -177.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.832 HG12 HD13 ' A' ' 36' ' ' LEU . 19.4 m -123.67 152.55 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.233 -0.917 . . . . 0.28 109.858 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.908 HG22 ' CD ' ' A' ' 17' ' ' ARG . 30.8 t -111.76 134.06 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.13 -0.981 . . . . 0.24 110.638 -175.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.598 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.66 132.83 50.69 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.255 -0.903 . . . . 1.38 109.392 173.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.7 Cg_endo -57.59 141.23 95.25 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.732 1.385 . . . . 0.36 109.918 177.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.945 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.82 -31.71 30.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.991 -1.068 . . . . 1.11 110.262 -177.345 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -57.03 -37.19 71.4 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.022 -1.049 . . . . 2.37 109.649 177.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.598 ' HB2' HG23 ' B' ' 20' ' ' ILE . 53.6 mt -80.1 -29.39 39.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.437 -0.789 . . . . 1.75 110.438 177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.642 HH22 HD11 ' A' ' 15' ' ' LEU . 75.7 mtt180 -56.75 -43.6 80.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.901 -1.124 . . . . 0.3 109.109 175.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -72.72 -51.02 20.96 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.319 -0.863 . . . . 3.27 110.612 -177.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 48.0 m -63.16 -31.76 72.99 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.309 -0.869 . . . . 0.77 110.944 -177.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.851 HD23 HG13 ' B' ' 30' ' ' ILE . 26.6 tp -87.04 -5.34 59.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.102 -0.999 . . . . 1.05 110.681 -176.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.464 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.67 42.74 97.11 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.539 -1.424 . . . . 0.32 109.539 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.851 HG13 HD23 ' B' ' 28' ' ' LEU . 29.3 mm -116.02 138.78 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.225 -1.162 . . . . 0.41 110.747 -178.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -142.18 167.22 22.62 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.61 -0.681 . . . . 0.23 109.907 -178.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.529 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.6 146.42 13.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.192 -0.942 . . . . 1.13 110.515 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.529 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 77.1 tttt 74.99 -4.9 2.27 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.662 -0.648 . . . . 1.88 111.205 177.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.658 ' O ' HG23 ' A' ' 12' ' ' VAL . 88.7 m-20 -77.34 165.89 23.86 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.866 -1.146 . . . . 1.1 110.065 174.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.755 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.64 132.51 50.81 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 0.36 110.926 -175.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.937 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.9 mt -109.46 143.4 39.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.449 -0.782 . . . . 0.56 109.622 175.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.651 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.3 tt0 -108.4 140.23 41.98 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 120.787 -1.195 . . . . 1.17 110.017 173.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . 0.416 HD13 ' O ' ' B' ' 37' ' ' GLU . 21.5 mm -111.03 133.16 57.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 O-C-N 121.315 -0.865 . . . . 0.84 110.549 -173.302 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.593 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 14.1 m-85 -115.28 159.23 21.28 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 116.308 -0.405 . . . . 0.45 109.956 -179.413 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.498 HG21 HG21 ' A' ' 6' ' ' THR . 81.4 t -130.24 129.21 65.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.862 -1.149 . . . . 0.26 110.612 173.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.662 ' CG ' HD11 ' B' ' 46' ' ' ILE . 9.8 p-10 -146.86 129.44 15.99 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.263 -0.898 . . . . 1.77 110.2 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.472 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 50.0 t0 46.29 50.13 12.39 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.012 -1.055 . . . . 1.21 110.959 175.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.4 mt-10 59.85 12.73 3.18 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.275 -0.891 . . . . 1.92 110.694 176.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 9.6 mtmt -113.13 150.76 31.72 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 2.0 109.703 175.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.651 HG22 HD11 ' B' ' 47' ' ' LEU . 62.3 mt -101.77 128.82 53.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.083 -1.01 . . . . 1.24 110.391 -176.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.662 HD11 ' CG ' ' B' ' 41' ' ' ASP . 29.9 mt -112.3 121.41 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.38 -0.825 . . . . 0.5 110.099 176.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.836 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.4 mp -114.42 134.96 54.61 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.006 -1.059 . . . . 1.66 110.173 -179.681 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.532 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 10.8 pttp -141.42 165.19 28.19 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.385 -0.822 . . . . 1.74 110.222 178.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 73.4 tttt -58.18 147.42 30.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.118 -0.989 . . . . 1.65 109.984 177.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 1.076 ' CD2' HG11 ' A' ' 9' ' ' VAL . 6.0 t80 -104.29 121.71 43.9 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.65 110.598 -176.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.525 ' CG ' ' O ' ' B' ' 51' ' ' LYS . 3.9 pttt -119.74 75.67 19.68 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.043 -1.036 . . . . 4.35 110.26 176.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.517 ' HB3' ' CZ ' ' B' ' 50' ' ' TYR . 11.8 Cg_endo -60.6 147.23 95.29 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.097 1.577 . . . . 3.58 110.348 179.176 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 118.016 -0.992 . . . . 5.97 110.163 179.718 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.2 t80 . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.207 0.527 . . . . 10.99 110.169 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 21.0 ttp -105.69 140.5 38.66 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.314 -0.866 . . . . 8.76 110.221 -179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 46.2 tptt -122.08 132.64 54.6 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 8.85 110.166 179.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 42.2 m -121.29 150.69 41.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.239 -0.913 . . . . 4.2 110.343 -178.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.43 HG23 ' CG2' ' B' ' 40' ' ' VAL . 58.2 p -62.19 -35.58 79.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.941 . . . . 3.77 110.228 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.2 45.95 59.66 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.642 -1.383 . . . . 0.83 109.642 178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.6 mt -117.76 135.93 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.204 -1.174 . . . . 1.36 110.02 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.934 HG11 ' CD2' ' B' ' 50' ' ' TYR . 88.8 t -115.8 143.92 24.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.089 -1.007 . . . . 0.37 110.806 -176.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -128.27 159.3 35.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.381 -0.824 . . . . 1.91 109.613 177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -84.21 148.08 26.92 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.041 -1.037 . . . . 2.21 110.317 -178.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.96 HG22 HD11 ' B' ' 36' ' ' LEU . 4.3 t -82.96 130.0 36.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.301 -0.874 . . . . 0.28 109.885 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.47 -174.74 5.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.55 110.025 -179.765 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.27 -39.5 72.75 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.009 -1.057 . . . . 2.19 111.739 -172.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.853 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.7 tp -85.73 -4.24 59.11 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.766 -1.209 . . . . 1.38 111.629 -173.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.472 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 79.95 46.45 7.72 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.173 -1.489 . . . . 0.21 109.687 -177.881 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.923 ' CD ' HG22 ' B' ' 19' ' ' VAL . 73.7 mtm180 -116.34 154.98 29.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.055 -1.262 . . . . 1.15 109.945 -177.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.681 HG12 HD13 ' B' ' 36' ' ' LEU . 22.4 m -123.49 150.67 27.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -0.877 . . . . 0.28 109.786 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.946 HG22 ' CD ' ' B' ' 17' ' ' ARG . 23.1 t -112.62 134.96 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.303 -0.873 . . . . 0.24 110.578 -175.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.928 HD11 HD13 ' B' ' 45' ' ' ILE . 4.5 mm -84.49 134.42 42.6 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.343 -0.848 . . . . 1.38 109.658 176.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.551 ' HG2' HD12 ' A' ' 24' ' ' LEU . 9.9 Cg_endo -58.49 143.67 97.74 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 123.812 1.428 . . . . 0.35 110.089 177.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.89 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.02 -33.29 28.82 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.934 -1.104 . . . . 1.11 110.377 -178.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.411 ' N ' HG23 ' A' ' 22' ' ' ILE . 84.4 tt0 -58.05 -35.72 71.73 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.107 -0.996 . . . . 2.37 109.808 178.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.574 ' HB2' HG23 ' A' ' 20' ' ' ILE . 52.3 mt -82.48 -29.95 30.23 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.334 -0.854 . . . . 1.75 110.591 178.644 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.89 ' HD2' HD12 ' A' ' 22' ' ' ILE . 71.9 mtt180 -57.6 -43.7 84.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.834 -1.166 . . . . 0.3 109.093 175.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -71.43 -49.44 41.72 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.568 -0.707 . . . . 3.26 110.724 -178.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.1 m -63.32 -32.01 73.31 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.23 -0.919 . . . . 0.77 111.114 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.885 HD23 HG13 ' A' ' 30' ' ' ILE . 22.1 tp -87.78 -4.82 58.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.084 -1.01 . . . . 1.05 110.75 -177.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.437 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.75 42.76 96.99 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.731 -1.348 . . . . 0.32 109.731 179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.885 HG13 HD23 ' A' ' 28' ' ' LEU . 32.4 mm -116.35 138.91 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.19 -1.183 . . . . 0.41 110.794 -178.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.16 167.04 23.14 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.589 -0.694 . . . . 0.23 109.982 -178.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.37 146.48 12.24 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.082 -1.011 . . . . 1.13 110.541 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 75.2 tttt 74.46 -4.64 2.28 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.702 -0.623 . . . . 1.88 111.137 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.741 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.6 m-20 -77.41 165.95 23.74 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.73 -1.231 . . . . 1.1 110.051 174.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.66 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.08 130.69 51.79 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.2 -0.938 . . . . 0.36 110.715 -176.539 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.97 HD11 HG22 ' B' ' 12' ' ' VAL . 12.1 mt -107.89 142.21 38.31 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.375 -0.828 . . . . 0.56 109.367 175.174 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.662 ' HA ' HG22 ' B' ' 9' ' ' VAL . 84.8 tt0 -106.25 137.96 43.28 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.791 -1.193 . . . . 1.17 109.787 173.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -111.39 132.56 59.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.522 -0.736 . . . . 0.84 110.44 -174.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.592 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 16.2 m-85 -115.03 158.04 22.65 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 122.061 -0.399 . . . . 0.45 110.11 -178.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.614 HG21 HG21 ' B' ' 6' ' ' THR . 93.2 t -129.8 123.97 57.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.935 -1.103 . . . . 0.27 110.739 173.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.59 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.2 p-10 -147.17 139.03 24.28 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.305 -0.872 . . . . 1.77 110.263 177.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.3 t0 43.68 47.22 6.46 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.021 -1.049 . . . . 1.22 111.159 174.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.496 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 44.3 tp10 62.4 10.33 3.88 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.148 -0.97 . . . . 1.93 110.723 175.322 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -115.66 148.33 39.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.243 -0.91 . . . . 2.01 109.995 176.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 1.011 HD13 HD11 ' B' ' 20' ' ' ILE . 58.5 mt -99.6 129.09 50.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 1.25 110.103 -178.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.592 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.0 mt -109.21 115.84 50.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.378 -0.826 . . . . 0.5 110.141 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.842 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -108.75 133.49 52.75 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.062 -1.024 . . . . 1.66 109.987 179.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.568 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 13.2 pttp -143.64 165.73 26.8 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.452 -0.78 . . . . 1.74 110.357 -179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -56.43 146.99 22.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.229 -0.919 . . . . 1.65 109.937 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.801 ' CD2' HG11 ' B' ' 9' ' ' VAL . 6.4 t80 -102.43 120.02 39.8 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.362 -0.836 . . . . 0.35 110.661 -175.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.55 123.11 49.26 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.366 -0.834 . . . . 3.21 109.571 173.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -61.98 144.75 96.68 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.787 1.414 . . . . 0.48 110.311 -178.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.993 -1.003 . . . . 2.41 110.229 -179.871 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.23 0.538 . . . . 11.66 110.244 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 65.0 mtt -48.38 -42.25 31.25 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.214 -0.929 . . . . 8.7 111.332 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 42.3 mttm -107.3 138.38 43.6 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.788 -1.195 . . . . 9.17 110.447 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 84.2 p -145.22 159.12 43.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.359 -0.838 . . . . 5.2 109.971 177.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.614 HG21 HG21 ' A' ' 40' ' ' VAL . 58.4 p -65.87 -35.62 81.15 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.164 -0.96 . . . . 2.98 110.225 -179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.93 46.32 60.17 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.534 -1.426 . . . . 0.83 109.534 178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 61.1 mt -117.82 135.82 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.209 -1.171 . . . . 1.36 110.084 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.948 HG13 ' O ' ' A' ' 36' ' ' LEU . 89.9 t -115.81 143.86 24.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.048 -1.033 . . . . 0.37 110.76 -176.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 53.4 ttt85 -128.28 159.09 36.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.494 -0.754 . . . . 1.92 109.768 177.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 11.9 pttp -84.03 148.03 27.08 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.042 -1.037 . . . . 2.21 110.403 -178.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.97 HG22 HD11 ' A' ' 36' ' ' LEU . 4.3 t -82.91 130.1 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.33 -0.856 . . . . 0.29 109.804 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.69 -174.47 5.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.098 -1.001 . . . . 0.55 110.152 -179.932 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.48 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.9 mt-10 -56.5 -39.45 73.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.086 -1.009 . . . . 2.19 111.646 -172.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.891 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.2 tp -85.79 -4.18 59.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.799 -1.188 . . . . 1.39 111.595 -173.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.491 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.56 47.19 7.48 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.514 -1.434 . . . . 0.21 109.514 -177.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.946 ' CD ' HG22 ' A' ' 19' ' ' VAL . 73.5 mtm180 -116.46 154.98 29.38 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.039 -1.271 . . . . 1.14 109.982 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.687 HG12 HD13 ' A' ' 36' ' ' LEU . 22.4 m -123.54 150.59 27.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.35 -0.844 . . . . 0.28 109.804 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.923 HG22 ' CD ' ' A' ' 17' ' ' ARG . 23.0 t -112.64 134.98 53.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.951 . . . . 0.24 110.505 -175.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 1.011 HD11 HD13 ' A' ' 45' ' ' ILE . 4.5 mm -84.62 134.43 42.26 Favored Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.274 -0.891 . . . . 1.38 109.625 176.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.547 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.9 Cg_endo -58.67 143.69 98.41 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.811 1.427 . . . . 0.36 110.106 177.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.888 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.2 tp -55.16 -33.08 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.11 -0.993 . . . . 1.11 110.364 -178.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . 0.409 ' N ' HG23 ' B' ' 22' ' ' ILE . 84.3 tt0 -57.88 -36.35 72.26 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.09 -1.006 . . . . 2.37 109.744 178.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.568 ' HB2' HG23 ' B' ' 20' ' ' ILE . 52.5 mt -81.74 -30.37 32.5 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.443 -0.785 . . . . 1.75 110.686 178.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.888 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.2 mtt180 -57.43 -43.59 83.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.877 -1.14 . . . . 0.3 109.087 175.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 74.8 ttt-85 -71.25 -49.77 39.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.39 -0.819 . . . . 3.27 110.666 -178.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 51.0 m -63.04 -32.49 73.87 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.292 -0.88 . . . . 0.77 110.946 -177.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.886 HD23 HG13 ' B' ' 30' ' ' ILE . 22.3 tp -87.34 -5.2 58.98 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.046 -1.034 . . . . 1.05 110.68 -176.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.442 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.05 42.65 96.57 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.538 -1.425 . . . . 0.32 109.538 179.057 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.886 HG13 HD23 ' B' ' 28' ' ' LEU . 31.9 mm -116.27 138.87 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.192 -1.181 . . . . 0.41 110.766 -178.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.91 167.09 23.01 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.498 -0.751 . . . . 0.23 109.968 -178.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.527 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.43 146.48 12.45 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.175 -0.953 . . . . 1.13 110.555 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 75.0 tttt 74.63 -4.76 2.27 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.648 -0.657 . . . . 1.88 111.166 177.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.64 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.2 m-20 -77.49 165.64 24.1 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.792 -1.193 . . . . 1.1 110.042 174.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.638 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.92 130.65 51.55 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.221 -0.924 . . . . 0.36 110.836 -176.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.96 HD11 HG22 ' A' ' 12' ' ' VAL . 12.0 mt -107.84 142.1 38.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.268 -0.895 . . . . 0.56 109.485 175.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.656 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.7 tt0 -106.08 137.84 43.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.87 -1.144 . . . . 1.17 109.911 173.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 71.0 mt -111.25 132.61 59.32 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.388 -0.82 . . . . 0.84 110.383 -174.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.6 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 15.9 m-85 -115.06 157.92 22.85 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 120.896 0.379 . . . . 0.45 110.122 -178.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.43 ' CG2' HG23 ' A' ' 6' ' ' THR . 94.1 t -129.53 124.3 59.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.937 -1.102 . . . . 0.26 110.55 173.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.601 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.4 p-10 -147.66 138.88 23.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.299 -0.875 . . . . 1.77 110.208 177.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.495 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.9 t0 43.99 47.18 7.15 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.165 -0.959 . . . . 1.21 111.136 174.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.495 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 44.2 tp10 62.21 10.36 3.74 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.234 -0.916 . . . . 1.92 110.725 175.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 27.5 mttt -115.57 148.6 39.38 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 2.0 109.928 176.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.928 HD13 HD11 ' A' ' 20' ' ' ILE . 58.2 mt -99.76 129.16 50.78 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.204 -0.935 . . . . 1.24 110.096 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.601 HD11 ' OD2' ' B' ' 41' ' ' ASP . 21.7 mt -109.39 115.8 50.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.472 -0.767 . . . . 0.5 110.136 177.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.842 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.3 mp -108.55 133.4 52.73 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.028 -1.045 . . . . 1.66 109.934 179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.572 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 13.5 pttp -143.65 165.96 26.17 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.447 -0.783 . . . . 1.74 110.294 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 51.7 tttm -56.48 146.94 23.13 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.181 -0.95 . . . . 1.65 109.92 177.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.934 ' CD2' HG11 ' A' ' 9' ' ' VAL . 6.5 t80 -102.59 117.12 33.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.205 -0.935 . . . . 0.65 110.529 -175.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -122.6 85.14 48.68 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 4.35 110.26 178.258 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.566 ' HG3' ' CZ ' ' B' ' 50' ' ' TYR . 34.5 Cg_exo -55.65 145.25 71.6 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.964 1.507 . . . . 3.58 110.306 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 51.4 t30 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.992 -1.004 . . . . 5.97 110.167 -179.904 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 121.145 0.498 . . . . 10.99 110.207 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 69.6 mtm -126.45 142.12 51.64 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.312 -0.868 . . . . 8.76 110.133 178.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 4' ' ' LYS . 43.4 tttt -101.7 43.15 1.08 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.211 -0.931 . . . . 8.85 110.602 -178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.584 ' CB ' ' CD2' ' B' ' 39' ' ' TYR . 54.6 p -157.65 163.49 38.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.987 -1.071 . . . . 4.2 110.444 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.0 p -68.54 -31.38 70.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.209 -0.932 . . . . 3.77 110.046 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.504 ' O ' HD13 ' A' ' 8' ' ' ILE . . . 71.12 45.87 47.05 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.691 -1.364 . . . . 0.83 109.691 178.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.504 HD13 ' O ' ' A' ' 7' ' ' GLY . 26.0 mm -115.3 133.73 60.66 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 121.189 -1.183 . . . . 1.36 109.947 179.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.102 HG11 ' CD2' ' B' ' 50' ' ' TYR . 87.1 t -116.13 143.91 25.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.101 -0.999 . . . . 0.37 110.842 -175.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.401 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 17.4 tpt180 -128.07 157.11 41.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.472 -0.767 . . . . 1.91 109.789 178.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.401 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 26.0 ttpt -83.14 144.97 29.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.141 -0.974 . . . . 2.21 110.35 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.984 HG22 HD11 ' B' ' 36' ' ' LEU . 4.0 t -80.55 128.68 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.337 -0.852 . . . . 0.28 109.762 178.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.53 -175.01 5.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.208 -0.932 . . . . 0.55 110.021 179.71 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.52 -40.56 68.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.097 -1.002 . . . . 2.19 111.728 -173.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.872 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.8 tp -85.32 -4.18 59.07 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.798 -1.189 . . . . 1.38 111.611 -173.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.518 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.29 46.18 7.67 Favored Glycine 0 N--CA 1.491 2.3 0 C-N-CA 119.133 -1.508 . . . . 0.21 109.68 -177.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.931 ' CD ' HG22 ' B' ' 19' ' ' VAL . 73.1 mtm180 -116.15 154.72 29.51 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.012 -1.287 . . . . 1.15 109.818 -178.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.674 HG12 ' CD1' ' B' ' 36' ' ' LEU . 22.5 m -124.49 152.35 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.209 -0.932 . . . . 0.28 110.001 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.953 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.5 t -113.71 133.95 58.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.249 -0.907 . . . . 0.24 110.571 -175.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.653 HD11 HD13 ' B' ' 45' ' ' ILE . 2.5 mm -85.04 138.09 37.21 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.227 -0.921 . . . . 1.38 109.636 175.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.7 Cg_endo -59.68 142.94 99.62 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.71 1.374 . . . . 0.35 109.972 176.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.918 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.2 tp -55.22 -32.39 28.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 120.962 -1.086 . . . . 1.11 110.478 -178.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 48.6 tp10 -58.14 -35.67 71.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.147 -0.971 . . . . 2.37 109.915 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.612 ' HB2' HG23 ' A' ' 20' ' ' ILE . 63.2 mt -82.21 -30.35 30.88 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.342 -0.849 . . . . 1.75 110.614 178.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.918 ' HD2' HD12 ' A' ' 22' ' ' ILE . 74.2 mtt180 -57.77 -43.86 85.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.926 -1.109 . . . . 0.3 109.113 176.031 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 89.9 mtt180 -72.97 -48.48 36.26 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 119.848 -0.741 . . . . 3.26 110.723 -177.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 49.6 m -63.72 -31.57 72.79 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.156 -0.965 . . . . 0.77 111.135 -178.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.815 HD23 HG13 ' A' ' 30' ' ' ILE . 19.2 tp -87.94 -4.53 58.81 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.026 -1.046 . . . . 1.05 110.795 -177.066 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 66.09 40.87 95.24 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.714 -1.354 . . . . 0.32 109.714 178.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.815 HG13 HD23 ' A' ' 28' ' ' LEU . 36.5 mm -116.54 139.03 45.15 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.291 -1.123 . . . . 0.41 110.632 -179.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -142.0 166.76 23.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.623 -0.673 . . . . 0.23 109.978 -177.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.531 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.58 146.54 12.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.102 -0.999 . . . . 1.13 110.534 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.531 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 19.9 tttt 74.96 -4.95 2.26 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.733 -0.605 . . . . 1.88 111.12 177.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.712 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.9 m-20 -78.18 165.81 23.5 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.902 -1.124 . . . . 1.1 110.054 174.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.745 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.61 131.01 52.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.192 -0.943 . . . . 0.36 110.726 -176.463 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.932 ' O ' HG13 ' B' ' 9' ' ' VAL . 13.5 mt -107.87 142.66 37.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.825 . . . . 0.56 109.458 175.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.687 ' HA ' HG22 ' B' ' 9' ' ' VAL . 84.8 tt0 -106.58 138.88 41.93 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.805 -1.184 . . . . 1.17 109.685 172.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 68.4 mt -111.37 133.39 57.12 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 O-C-N 121.393 -0.817 . . . . 0.84 110.561 -173.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.576 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 14.9 m-85 -114.81 157.94 22.57 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 109.99 -0.374 . . . . 0.45 109.99 -179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.559 ' HB ' HG23 ' B' ' 6' ' ' THR . 93.1 t -130.7 120.43 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 120.942 -1.098 . . . . 0.27 110.664 172.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.549 ' OD2' HD11 ' A' ' 46' ' ' ILE . 5.9 p-10 -147.35 155.14 41.72 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.268 -0.895 . . . . 1.77 110.189 177.151 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.487 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 54.0 t0 42.38 41.75 2.35 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.06 -1.025 . . . . 1.22 111.345 172.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.487 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 46.5 tp10 60.81 12.34 3.72 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.031 -1.043 . . . . 1.93 110.778 174.433 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 19.3 pttt -128.77 161.29 30.1 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.114 -0.992 . . . . 2.01 109.848 174.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.816 HD13 HD11 ' B' ' 20' ' ' ILE . 56.5 mt -104.04 134.99 43.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.055 -1.028 . . . . 1.25 110.717 -172.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.576 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 25.1 mt -111.33 121.36 63.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.46 -0.775 . . . . 0.5 110.272 176.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.846 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.4 mp -112.06 133.84 53.98 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.986 -1.071 . . . . 1.66 110.117 179.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.543 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 14.0 pttp -141.6 166.08 25.72 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.45 -0.781 . . . . 1.74 110.359 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.5 tttm -55.94 147.73 18.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.196 -0.94 . . . . 1.65 110.077 177.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.95 ' CD2' HG11 ' B' ' 9' ' ' VAL . 4.4 t80 -103.25 126.52 50.45 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.368 -0.833 . . . . 0.35 110.73 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -99.2 122.84 50.87 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.366 -0.834 . . . . 3.21 109.398 172.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -59.42 145.57 97.52 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.794 1.418 . . . . 0.48 110.417 -177.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 82.7 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 118.044 -0.979 . . . . 2.41 110.219 -179.952 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.491 1.586 0 CA-C-O 121.199 0.523 . . . . 11.66 110.299 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 96.2 mmm -109.67 139.19 45.0 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 8.7 110.286 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 29.0 mttm -128.43 148.89 50.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.239 -0.913 . . . . 9.17 110.146 179.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 54.2 p -68.47 159.0 32.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.193 -0.942 . . . . 5.2 110.099 179.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.559 HG23 ' HB ' ' A' ' 40' ' ' VAL . 69.6 p -69.28 -31.36 69.82 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.209 -0.932 . . . . 2.98 110.173 -179.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . 0.503 ' O ' HD13 ' B' ' 8' ' ' ILE . . . 70.93 46.17 46.65 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.647 -1.381 . . . . 0.83 109.647 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.503 HD13 ' O ' ' B' ' 7' ' ' GLY . 26.2 mm -115.26 133.66 60.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.091 -1.241 . . . . 1.36 109.931 179.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.95 HG11 ' CD2' ' A' ' 50' ' ' TYR . 87.1 t -116.18 143.87 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 O-C-N 120.956 -1.09 . . . . 0.37 110.736 -175.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.4 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 17.4 tpt180 -128.12 156.82 42.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.512 -0.743 . . . . 1.92 109.892 178.69 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.4 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 26.1 ttpt -82.93 144.85 29.74 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.102 -0.999 . . . . 2.21 110.414 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.927 HG22 HD11 ' A' ' 36' ' ' LEU . 4.0 t -80.56 128.88 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.367 -0.833 . . . . 0.29 109.642 178.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -83.79 -174.9 5.54 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.045 -1.035 . . . . 0.55 110.177 179.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -54.65 -40.48 69.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.191 -0.943 . . . . 2.19 111.648 -173.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.898 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.4 tp -85.34 -4.22 59.09 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.755 -1.215 . . . . 1.39 111.647 -172.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.53 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.97 46.86 7.45 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.54 -1.424 . . . . 0.21 109.54 -177.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.953 ' CD ' HG22 ' A' ' 19' ' ' VAL . 72.6 mtm180 -116.33 154.69 29.76 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.153 -1.204 . . . . 1.14 109.831 -178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.673 HG12 ' CD1' ' A' ' 36' ' ' LEU . 22.6 m -124.48 152.33 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.229 -0.92 . . . . 0.28 110.004 -178.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.931 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.6 t -113.72 133.96 58.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.251 -0.906 . . . . 0.24 110.542 -175.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.816 HD11 HD13 ' A' ' 45' ' ' ILE . 2.5 mm -85.11 138.1 37.04 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.219 -0.925 . . . . 1.38 109.593 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.7 Cg_endo -59.78 142.91 99.54 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.755 1.397 . . . . 0.36 110.043 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.919 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -55.28 -32.25 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.027 -1.046 . . . . 1.11 110.44 -178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -57.99 -36.27 72.4 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.091 -1.006 . . . . 2.37 109.811 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.598 ' HB2' HG23 ' B' ' 20' ' ' ILE . 63.2 mt -81.62 -30.76 32.75 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.401 -0.812 . . . . 1.75 110.601 178.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.919 ' HD2' HD12 ' B' ' 22' ' ' ILE . 73.8 mtt180 -57.54 -43.68 84.57 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.875 -1.141 . . . . 0.3 109.207 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 90.1 mtt180 -72.96 -48.71 34.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.264 -0.898 . . . . 3.27 110.61 -177.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 52.0 m -63.45 -32.22 73.61 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.282 -0.886 . . . . 0.77 110.895 -177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.815 HD23 HG13 ' B' ' 30' ' ' ILE . 19.4 tp -87.5 -4.79 58.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.018 -1.051 . . . . 1.05 110.711 -176.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.404 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.56 40.64 94.25 Favored Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.588 -1.405 . . . . 0.32 109.588 178.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.815 HG13 HD23 ' B' ' 28' ' ' LEU . 36.2 mm -116.52 138.9 45.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.278 -1.13 . . . . 0.41 110.634 -179.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.73 166.87 23.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.598 -0.689 . . . . 0.23 109.991 -177.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.4 tt0 -53.6 146.72 12.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 1.13 110.421 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 19.8 tttt 75.03 -5.16 2.22 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.622 -0.674 . . . . 1.88 111.123 177.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.617 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.6 m-20 -78.19 165.66 23.67 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.816 -1.178 . . . . 1.1 110.03 175.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.751 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.55 130.92 52.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.254 -0.904 . . . . 0.36 110.776 -176.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.984 HD11 HG22 ' A' ' 12' ' ' VAL . 13.3 mt -107.9 142.52 37.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.386 -0.821 . . . . 0.56 109.494 175.302 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.666 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.7 tt0 -106.42 138.91 41.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.841 -1.162 . . . . 1.17 109.832 172.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 68.5 mt -111.42 133.41 57.12 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.289 -0.882 . . . . 0.84 110.469 -173.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.589 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 14.4 m-85 -114.77 157.86 22.64 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 122.096 -0.377 . . . . 0.45 110.07 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 93.7 t -130.42 120.84 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.899 -1.126 . . . . 0.26 110.464 172.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.549 ' OD2' HD11 ' B' ' 46' ' ' ILE . 6.0 p-10 -147.91 155.19 41.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.301 -0.874 . . . . 1.77 110.157 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.48 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 54.5 t0 42.19 41.99 2.31 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.115 -0.991 . . . . 1.21 111.375 173.025 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.48 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 46.3 tp10 60.75 12.3 3.66 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.088 -1.008 . . . . 1.92 110.7 174.403 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 19.1 pttt -128.78 161.54 29.52 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.085 -1.009 . . . . 2.0 109.775 174.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.653 HD13 HD11 ' A' ' 20' ' ' ILE . 56.8 mt -104.16 135.03 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.061 -1.024 . . . . 1.24 110.665 -172.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.589 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 25.8 mt -111.6 121.32 63.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.455 -0.778 . . . . 0.5 110.181 176.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.842 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.5 mp -111.89 133.76 53.88 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.03 -1.044 . . . . 1.66 110.075 179.316 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.536 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 14.2 pttp -141.61 166.36 24.95 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.429 -0.794 . . . . 1.74 110.27 178.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -56.09 147.72 19.55 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.194 -0.941 . . . . 1.65 109.974 177.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 1.102 ' CD2' HG11 ' A' ' 9' ' ' VAL . 4.5 t80 -103.35 122.19 44.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.242 -0.911 . . . . 0.65 110.646 -175.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.42 81.49 53.29 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.176 -0.953 . . . . 4.35 110.229 177.612 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -57.72 144.14 93.76 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.901 1.474 . . . . 3.58 110.238 -179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 37.9 t-20 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.002 -0.999 . . . . 5.97 110.261 -179.42 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.0 p90 . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.218 0.532 . . . . 10.99 110.217 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 85.8 mtp -135.55 163.14 30.78 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.309 -0.869 . . . . 8.76 110.204 179.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.3 mttp -87.68 149.27 24.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.246 -0.909 . . . . 8.85 110.185 179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.569 ' CB ' ' CD2' ' B' ' 39' ' ' TYR . 55.4 p -66.55 162.8 20.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.236 -0.915 . . . . 4.2 110.312 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 68.9 p -62.11 -35.96 80.29 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.192 -0.942 . . . . 3.77 110.181 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.13 45.58 55.36 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.655 -1.378 . . . . 0.83 109.655 177.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.9 mt -118.16 134.43 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.153 -1.204 . . . . 1.36 109.983 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.935 HG13 ' O ' ' B' ' 36' ' ' LEU . 99.0 t -114.29 144.58 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.025 -1.047 . . . . 0.37 110.915 -175.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 71.2 ttt-85 -129.75 160.79 32.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.458 -0.776 . . . . 1.91 109.753 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -85.05 148.09 26.34 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.036 -1.04 . . . . 2.21 110.311 -178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.978 HG22 HD11 ' B' ' 36' ' ' LEU . 6.5 t -81.49 129.73 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.317 -0.865 . . . . 0.28 109.821 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.29 -175.09 5.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.124 -0.985 . . . . 0.55 109.941 -179.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.07 -39.31 71.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.079 -1.013 . . . . 2.19 111.723 -172.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.863 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.4 tp -86.01 -5.03 59.29 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.803 -1.186 . . . . 1.38 111.5 -173.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.499 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.14 46.52 7.56 Favored Glycine 0 N--CA 1.491 2.316 0 C-N-CA 119.144 -1.503 . . . . 0.21 109.699 -177.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.906 ' CD ' HG22 ' B' ' 19' ' ' VAL . 73.8 mtm180 -115.6 154.85 28.7 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.005 -1.291 . . . . 1.15 110.036 -177.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.749 HG12 HD13 ' B' ' 36' ' ' LEU . 24.8 m -124.3 151.72 29.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 0.28 109.855 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.923 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.2 t -113.22 135.18 53.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.191 -0.943 . . . . 0.24 110.601 -175.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.551 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.34 135.12 44.42 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.249 -0.907 . . . . 1.38 109.532 175.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.555 ' HG2' HD12 ' A' ' 24' ' ' LEU . 10.0 Cg_endo -58.64 143.34 98.6 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.734 1.386 . . . . 0.35 110.046 177.518 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.905 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.1 tp -55.08 -33.32 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.082 -1.012 . . . . 1.11 110.429 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.415 ' N ' HG23 ' A' ' 22' ' ' ILE . 84.4 tt0 -58.2 -35.34 71.48 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.17 -0.956 . . . . 2.37 109.893 178.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.555 HD12 ' HG2' ' A' ' 21' ' ' PRO . 50.0 mt -82.35 -29.97 30.66 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.35 -0.844 . . . . 1.75 110.65 178.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.905 ' HD2' HD12 ' A' ' 22' ' ' ILE . 71.4 mtt180 -57.74 -44.15 85.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.939 -1.1 . . . . 0.3 109.087 175.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 91.4 mtt-85 -72.63 -47.81 44.63 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 119.818 -0.753 . . . . 3.26 110.756 -178.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.1 m -63.68 -31.87 73.17 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.212 -0.93 . . . . 0.77 111.093 -178.322 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.875 HD23 HG13 ' A' ' 30' ' ' ILE . 20.8 tp -87.69 -4.6 58.91 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.1 -1.0 . . . . 1.05 110.669 -177.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.453 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.25 41.47 96.77 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.637 -1.385 . . . . 0.32 109.637 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.875 HG13 HD23 ' A' ' 28' ' ' LEU . 30.1 mm -116.4 139.75 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -1.144 . . . . 0.41 110.654 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.91 167.19 22.72 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.567 -0.708 . . . . 0.23 110.025 -177.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.26 146.79 11.24 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.058 -1.026 . . . . 1.13 110.54 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 12.9 tttp 74.22 -4.58 2.26 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 121.743 -0.598 . . . . 1.88 111.273 176.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.716 ' O ' HG23 ' B' ' 12' ' ' VAL . 87.8 m-20 -77.01 166.63 23.05 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.751 -1.218 . . . . 1.1 109.973 174.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.706 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -103.29 131.6 50.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 0.36 110.757 -175.712 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 1.014 HD11 HG22 ' B' ' 12' ' ' VAL . 13.0 mt -108.76 144.3 36.76 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.342 -0.849 . . . . 0.56 109.307 174.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.642 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.6 tt0 -108.37 138.34 44.83 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.856 -1.152 . . . . 1.17 109.646 173.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.5 mt -107.87 131.31 58.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.489 -0.757 . . . . 0.84 110.415 -173.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.605 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 21.4 m-85 -118.85 156.79 28.84 Favored 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 120.927 0.394 . . . . 0.45 109.963 -178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.477 ' HB ' HG23 ' B' ' 6' ' ' THR . 74.2 t -130.82 126.68 60.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.848 -1.158 . . . . 0.27 110.642 173.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.487 ' OD1' HG12 ' A' ' 46' ' ' ILE . 41.9 p-10 -147.23 142.23 27.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.21 -0.931 . . . . 1.77 110.607 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 44' ' ' LYS . 52.3 t0 43.37 45.14 5.13 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.09 -1.006 . . . . 1.22 111.271 174.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.471 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.7 tt0 60.81 11.88 3.47 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.104 -0.997 . . . . 1.93 110.608 175.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 54.1 mtmt -114.4 153.92 29.02 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.166 -0.959 . . . . 2.01 109.628 175.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.929 HG22 HD11 ' A' ' 47' ' ' LEU . 67.8 mt -94.54 129.95 44.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.153 -0.967 . . . . 1.25 110.138 -178.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.605 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 24.6 mm -113.15 121.79 66.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.659 -0.651 . . . . 0.5 109.877 178.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.929 HD11 HG22 ' A' ' 45' ' ' ILE . 4.0 mp -122.55 134.53 54.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.895 -1.128 . . . . 1.66 110.262 -179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.538 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 14.0 pttp -141.73 162.68 34.89 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.314 -0.866 . . . . 1.74 110.435 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 43.4 tttt -58.82 146.89 35.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.222 -0.924 . . . . 1.65 110.011 177.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.738 ' CD2' HG11 ' B' ' 9' ' ' VAL . 10.3 t80 -105.13 115.07 29.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.284 -0.885 . . . . 0.35 110.586 -176.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 2.5 ttmt -99.74 122.76 50.07 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.285 -0.884 . . . . 3.21 109.508 173.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 51' ' ' LYS . 17.9 Cg_endo -63.57 144.7 90.64 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.798 1.42 . . . . 0.48 110.2 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 118.051 -0.976 . . . . 2.41 110.186 -179.966 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 56.3 t80 . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.219 0.533 . . . . 11.66 110.004 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 89.4 mmm -116.11 144.18 44.49 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.24 -0.913 . . . . 8.7 110.131 178.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -126.06 149.35 48.94 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.2 -0.938 . . . . 9.17 110.195 179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 54.3 p -67.78 161.07 26.93 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.205 -0.934 . . . . 5.2 110.066 179.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.477 HG23 ' HB ' ' A' ' 40' ' ' VAL . 69.0 p -65.2 -36.08 83.06 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 2.98 110.229 -178.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.16 45.63 54.92 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.644 -1.382 . . . . 0.83 109.644 177.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.7 mt -118.16 134.32 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 O-C-N 121.124 -1.221 . . . . 1.36 109.927 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.943 HG13 ' O ' ' A' ' 36' ' ' LEU . 98.5 t -114.28 144.62 21.48 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.04 -1.038 . . . . 0.37 110.898 -175.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 71.4 ttt-85 -129.75 160.72 32.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.483 -0.76 . . . . 1.92 109.707 177.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 27.8 mttt -85.16 148.02 26.32 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.962 -1.086 . . . . 2.21 110.331 -178.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 1.014 HG22 HD11 ' A' ' 36' ' ' LEU . 6.6 t -81.47 129.85 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.369 -0.832 . . . . 0.29 109.734 179.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.448 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.48 -174.83 5.49 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.148 -0.97 . . . . 0.55 110.136 -179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.475 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.8 mt-10 -56.28 -39.28 72.42 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.009 -1.057 . . . . 2.19 111.569 -172.178 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.904 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.0 tp -86.05 -4.98 59.29 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.715 -1.241 . . . . 1.39 111.52 -173.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.5 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.63 47.31 7.37 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.592 -1.403 . . . . 0.21 109.592 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.923 ' CD ' HG22 ' A' ' 19' ' ' VAL . 73.8 mtm180 -115.79 154.87 28.85 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.1 -1.235 . . . . 1.14 110.155 -177.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.741 HG12 HD13 ' A' ' 36' ' ' LEU . 24.9 m -124.43 151.65 29.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.28 109.814 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.906 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.2 t -113.17 135.17 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.254 -0.904 . . . . 0.24 110.644 -175.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -83.33 135.0 44.56 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.226 -0.921 . . . . 1.38 109.588 175.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.544 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.0 Cg_endo -58.71 143.37 98.82 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.749 1.394 . . . . 0.36 110.169 177.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.903 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -55.08 -33.3 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.086 -1.009 . . . . 1.11 110.372 -178.483 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . 0.409 ' N ' HG23 ' B' ' 22' ' ' ILE . 84.4 tt0 -57.97 -36.15 72.17 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.023 -1.048 . . . . 2.37 109.708 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.55 ' HB2' HG23 ' B' ' 20' ' ' ILE . 50.4 mt -81.49 -30.42 33.31 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.519 -0.738 . . . . 1.75 110.668 178.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.903 ' HD2' HD12 ' B' ' 22' ' ' ILE . 70.8 mtt180 -57.44 -44.1 84.45 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.834 -1.166 . . . . 0.3 109.098 176.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -72.56 -48.1 42.8 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.431 -0.793 . . . . 3.27 110.645 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.5 m -63.36 -32.55 74.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.288 -0.883 . . . . 0.77 110.857 -178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.892 HD23 HG13 ' B' ' 30' ' ' ILE . 20.9 tp -87.09 -5.0 59.18 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.052 -1.03 . . . . 1.05 110.678 -176.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.46 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.57 41.33 96.19 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.564 -1.414 . . . . 0.32 109.564 179.33 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.892 HG13 HD23 ' B' ' 28' ' ' LEU . 30.0 mm -116.33 139.57 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.191 -1.182 . . . . 0.41 110.717 -178.62 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.58 167.3 22.47 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.471 -0.768 . . . . 0.23 110.057 -177.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.534 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.12 146.74 10.91 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -0.922 . . . . 1.13 110.572 -179.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.534 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 12.9 tttp 74.4 -4.89 2.21 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 121.657 -0.652 . . . . 1.88 111.198 176.859 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.615 ' O ' HG23 ' A' ' 12' ' ' VAL . 88.2 m-20 -76.98 166.35 23.44 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.819 -1.176 . . . . 1.1 110.039 174.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.719 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.04 131.53 49.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.25 -0.906 . . . . 0.36 110.877 -175.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.978 HD11 HG22 ' A' ' 12' ' ' VAL . 12.9 mt -108.84 144.11 37.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.428 -0.795 . . . . 0.56 109.362 174.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.624 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.4 tt0 -108.06 138.34 44.49 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.854 -1.154 . . . . 1.17 109.847 172.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -107.87 131.37 58.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.405 -0.809 . . . . 0.84 110.354 -173.031 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.608 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 21.1 m-85 -118.9 156.86 28.77 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 109.885 -0.413 . . . . 0.45 109.885 -178.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 74.8 t -130.71 127.08 61.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.854 -1.154 . . . . 0.26 110.471 173.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.496 ' OD1' HG12 ' B' ' 46' ' ' ILE . 41.9 p-10 -147.69 142.22 26.5 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.883 . . . . 1.77 110.525 179.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.488 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.0 t0 43.32 45.46 5.13 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.087 -1.008 . . . . 1.21 111.217 174.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.488 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.5 tt0 60.44 12.05 3.29 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.081 -1.012 . . . . 1.92 110.611 175.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 54.1 mtmt -114.41 154.01 28.87 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.162 -0.961 . . . . 2.0 109.633 175.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.927 HG22 HD11 ' B' ' 47' ' ' LEU . 67.3 mt -94.51 129.72 44.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 O-C-N 121.108 -0.995 . . . . 1.24 110.227 -178.77 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.608 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 24.6 mm -113.28 121.86 66.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.681 -0.637 . . . . 0.5 109.823 178.187 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.927 HD11 HG22 ' B' ' 45' ' ' ILE . 4.1 mp -122.44 134.46 54.59 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.892 -1.13 . . . . 1.66 110.271 -179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.542 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 14.1 pttp -141.62 162.84 34.51 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.248 -0.908 . . . . 1.74 110.435 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 43.2 tttt -58.81 146.72 36.11 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.225 -0.922 . . . . 1.65 110.015 177.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.901 ' CD2' HG11 ' A' ' 9' ' ' VAL . 10.5 t80 -105.12 111.86 24.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.65 110.575 -176.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 15.6 pttt -127.08 77.23 75.56 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.272 -0.892 . . . . 4.35 110.27 177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -60.68 144.61 99.56 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.957 1.504 . . . . 3.58 110.426 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 118.064 -0.97 . . . . 5.97 110.16 179.436 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 48.1 p90 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.259 0.552 . . . . 10.99 110.103 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.3 mtm -93.76 -89.38 0.22 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.281 -0.887 . . . . 8.76 110.412 -178.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 68.0 mttm -117.97 148.52 42.13 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.154 -0.966 . . . . 8.85 110.314 -179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 88.1 p -119.58 157.37 28.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 4.2 110.093 179.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 74.3 p -61.83 -38.69 89.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 3.77 110.054 -179.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.26 45.87 76.46 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.739 -1.344 . . . . 0.83 109.739 176.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.0 mt -117.02 133.02 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.093 -1.239 . . . . 1.36 109.982 179.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.016 HG11 ' CD2' ' B' ' 50' ' ' TYR . 98.2 t -114.03 144.29 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.048 -1.032 . . . . 0.37 110.871 -176.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 28.9 tpt180 -130.03 158.62 39.09 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.513 -0.742 . . . . 1.91 109.727 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 66.4 mmtt -85.44 148.18 26.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.091 -1.006 . . . . 2.21 110.258 -178.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.97 HG22 HD11 ' B' ' 36' ' ' LEU . 3.7 t -81.65 128.83 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.274 -0.891 . . . . 0.28 109.778 179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.462 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.45 -175.09 5.63 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.087 -1.008 . . . . 0.55 110.061 -179.698 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -54.24 -41.13 68.4 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.114 -0.991 . . . . 2.19 111.7 -173.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.886 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.7 tp -84.83 -5.31 59.33 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.656 -1.278 . . . . 1.38 111.59 -173.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.516 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.26 46.45 7.53 Favored Glycine 0 N--CA 1.49 2.266 0 C-N-CA 119.136 -1.507 . . . . 0.21 109.716 -177.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.906 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.2 mtm180 -114.77 153.94 29.44 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.093 -1.239 . . . . 1.15 110.031 -177.351 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.672 HG12 HD13 ' B' ' 36' ' ' LEU . 22.1 m -123.91 152.21 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.337 -0.852 . . . . 0.28 109.83 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.921 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.3 t -112.93 133.97 57.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.186 -0.947 . . . . 0.24 110.742 -175.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.671 HD11 HD13 ' B' ' 45' ' ' ILE . 2.4 mm -84.22 133.04 45.92 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.175 -0.953 . . . . 1.38 109.446 174.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.8 Cg_endo -57.63 141.39 95.37 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.646 1.34 . . . . 0.35 109.957 177.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.93 HD13 ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.81 -32.37 31.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.008 -1.058 . . . . 1.11 110.301 -177.395 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -57.27 -36.35 70.89 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.018 -1.051 . . . . 2.37 109.747 177.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.559 ' HB2' HG23 ' A' ' 20' ' ' ILE . 43.4 mt -80.87 -29.22 35.78 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.399 -0.813 . . . . 1.75 110.449 177.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.706 HH22 HD11 ' B' ' 15' ' ' LEU . 73.7 mtt180 -56.79 -44.03 81.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.864 -1.148 . . . . 0.3 108.97 175.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.6 mmt180 -72.49 -47.68 46.69 Favored 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.826 -0.749 . . . . 3.26 110.726 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.9 m -63.19 -32.45 73.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.202 -0.937 . . . . 0.77 111.061 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.778 HD23 HG13 ' A' ' 30' ' ' ILE . 20.5 tp -88.56 -4.62 58.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.07 -1.019 . . . . 1.05 110.801 -177.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.415 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.98 41.82 95.08 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.732 -1.347 . . . . 0.32 109.732 178.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.778 HG13 HD23 ' A' ' 28' ' ' LEU . 32.7 mm -116.52 139.49 43.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.27 -1.135 . . . . 0.41 110.744 -179.19 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.72 166.46 24.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.619 -0.675 . . . . 0.23 110.006 -178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.73 146.51 13.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.027 -1.045 . . . . 1.13 110.511 -179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 40.3 tttp 74.59 -4.56 2.31 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.684 -0.635 . . . . 1.88 111.114 177.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.702 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.9 m-20 -76.87 165.87 24.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.782 -1.199 . . . . 1.1 109.966 174.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.767 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.72 131.19 52.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.236 -0.915 . . . . 0.36 110.771 -176.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.964 HD11 HG22 ' B' ' 12' ' ' VAL . 13.0 mt -108.66 144.1 36.86 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.33 -0.856 . . . . 0.56 109.341 174.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.691 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.8 tt0 -106.59 139.02 41.71 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.744 -1.223 . . . . 1.17 109.491 172.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.49 131.27 59.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.423 -0.798 . . . . 0.84 110.504 -172.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.612 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 16.7 m-85 -117.67 157.46 26.41 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 116.263 -0.426 . . . . 0.45 109.915 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.52 HG21 HG21 ' B' ' 6' ' ' THR . 74.2 t -131.78 120.09 43.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 120.903 -1.123 . . . . 0.27 110.617 172.773 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.505 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 46.7 p-10 -148.32 161.93 40.54 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.274 -0.891 . . . . 1.77 110.586 178.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 54.0 t0 42.25 40.57 1.81 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.002 -1.061 . . . . 1.22 111.446 172.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 96.1 mt-10 56.53 16.18 2.41 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.941 -1.099 . . . . 1.93 110.556 175.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.505 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 11.3 pttt -128.98 165.48 21.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 2.01 109.734 174.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.818 HD13 HD11 ' B' ' 20' ' ' ILE . 67.7 mt -96.71 133.85 36.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.178 -0.951 . . . . 1.25 110.395 -175.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.612 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 23.5 mm -113.46 120.09 62.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.747 -0.596 . . . . 0.5 109.927 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.829 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.0 mp -118.52 134.34 55.16 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.888 -1.133 . . . . 1.66 110.136 179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.522 ' HE2' ' CE1' ' A' ' 39' ' ' TYR . 22.8 pttt -140.52 162.49 35.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.357 -0.839 . . . . 1.74 110.492 179.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -57.59 147.96 25.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.098 -1.001 . . . . 1.65 109.902 177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.815 ' CD2' HG11 ' B' ' 9' ' ' VAL . 3.5 t80 -102.63 119.55 39.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -0.86 . . . . 0.35 110.466 -176.157 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.411 ' O ' ' HG3' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -99.67 122.98 49.47 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.44 -0.787 . . . . 3.21 109.633 175.625 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.426 ' O ' ' C ' ' A' ' 53' ' ' ASN . 17.8 Cg_endo -65.38 151.0 86.5 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.841 1.442 . . . . 0.48 110.276 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.426 ' C ' ' O ' ' A' ' 52' ' ' PRO . 30.1 t30 . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 117.969 -1.015 . . . . 2.41 110.301 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 65.6 t80 . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.261 0.553 . . . . 11.66 110.162 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 88.4 mtp -82.76 134.31 35.13 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.203 -0.936 . . . . 8.7 110.158 -179.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 41.1 mttt -117.82 141.76 48.06 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.238 -0.914 . . . . 9.17 110.358 -179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 29.9 t -137.07 149.23 47.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.309 -0.87 . . . . 5.2 110.063 178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.52 HG21 HG21 ' A' ' 40' ' ' VAL . 76.1 p -60.69 -38.78 86.11 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 2.98 109.983 179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.18 46.15 74.64 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.67 -1.372 . . . . 0.83 109.67 176.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 59.4 mt -117.07 132.93 65.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.068 -1.254 . . . . 1.36 109.966 178.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 36' ' ' LEU . 98.5 t -114.14 144.25 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.994 -1.066 . . . . 0.37 110.87 -176.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.422 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 29.0 tpt180 -129.96 158.53 39.3 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.504 -0.747 . . . . 1.92 109.767 177.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.422 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 66.4 mmtt -85.49 148.09 26.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.021 . . . . 2.21 110.319 -178.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.964 HG22 HD11 ' A' ' 36' ' ' LEU . 3.7 t -81.59 128.85 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.285 -0.884 . . . . 0.29 109.79 179.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.453 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.66 -174.99 5.58 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.157 -0.964 . . . . 0.55 110.197 -179.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.36 -40.99 68.63 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.104 -0.997 . . . . 2.19 111.597 -172.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.912 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.4 tp -84.82 -5.47 59.33 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.743 -1.223 . . . . 1.39 111.583 -173.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.532 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.93 47.25 7.24 Favored Glycine 0 N--CA 1.493 2.456 0 N-CA-C 109.529 -1.428 . . . . 0.21 109.529 -177.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.921 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.0 mtm180 -114.99 153.89 29.8 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.089 -1.242 . . . . 1.14 109.98 -177.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.732 HG21 ' CD2' ' A' ' 47' ' ' LEU . 22.3 m -123.88 152.2 29.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.32 -0.863 . . . . 0.28 109.807 -179.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.906 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.3 t -112.95 134.04 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.137 -0.977 . . . . 0.24 110.598 -175.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.818 HD11 HD13 ' A' ' 45' ' ' ILE . 2.5 mm -84.33 133.0 45.72 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.918 . . . . 1.38 109.41 174.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.7 Cg_endo -57.58 141.4 95.26 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.763 1.402 . . . . 0.36 109.963 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.939 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -56.04 -32.08 32.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.994 -1.066 . . . . 1.11 110.316 -177.217 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -57.19 -37.01 71.51 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.034 -1.041 . . . . 2.37 109.667 177.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.553 ' HB2' HG23 ' B' ' 20' ' ' ILE . 43.4 mt -80.08 -29.6 39.13 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.516 -0.74 . . . . 1.75 110.48 177.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.607 HH22 HD11 ' A' ' 15' ' ' LEU . 73.4 mtt180 -56.67 -43.81 80.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.966 -1.084 . . . . 0.3 109.076 175.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -72.51 -47.99 44.12 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.374 -0.829 . . . . 3.27 110.591 -178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.2 m -62.88 -32.9 74.24 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.183 -0.948 . . . . 0.77 110.875 -178.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.781 HD23 HG13 ' B' ' 30' ' ' ILE . 20.6 tp -88.16 -5.0 58.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.032 -1.043 . . . . 1.05 110.736 -176.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.423 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.41 41.46 94.38 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 109.656 -1.378 . . . . 0.32 109.656 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.781 HG13 HD23 ' B' ' 28' ' ' LEU . 32.2 mm -116.48 139.36 43.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.24 -1.153 . . . . 0.41 110.728 -179.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.43 166.6 24.3 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.632 -0.668 . . . . 0.23 109.985 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.62 146.45 13.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.102 -0.999 . . . . 1.13 110.55 -179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 40.3 tttp 74.67 -4.73 2.28 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.579 -0.701 . . . . 1.88 111.194 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.586 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.0 m-20 -76.93 165.59 24.47 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.805 -1.184 . . . . 1.1 110.023 174.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.747 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.53 131.17 52.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.215 -0.928 . . . . 0.36 110.834 -176.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.97 HD11 HG22 ' A' ' 12' ' ' VAL . 12.9 mt -108.68 143.71 37.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.37 -0.831 . . . . 0.56 109.481 174.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.663 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.5 tt0 -106.18 138.88 41.58 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.839 -1.163 . . . . 1.17 109.786 172.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.9 mt -108.4 131.34 59.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.348 -0.845 . . . . 0.84 110.494 -171.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.613 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 16.5 m-85 -117.67 157.45 26.44 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 116.257 -0.428 . . . . 0.45 109.904 -179.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 75.0 t -131.69 120.51 45.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 120.868 -1.145 . . . . 0.26 110.436 172.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.498 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 46.6 p-10 -148.96 161.95 40.86 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.205 -0.934 . . . . 1.77 110.533 178.2 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.464 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 54.4 t0 42.02 41.0 1.8 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.185 -0.947 . . . . 1.21 111.461 172.48 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 96.1 mt-10 56.32 16.12 2.25 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.926 -1.109 . . . . 1.92 110.584 175.372 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 11.2 pttt -128.96 165.67 20.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.151 -0.968 . . . . 2.0 109.666 174.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.735 HG22 HD11 ' B' ' 47' ' ' LEU . 68.0 mt -96.82 133.83 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.188 -0.945 . . . . 1.24 110.363 -175.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.613 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 23.1 mm -113.53 120.17 62.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.739 -0.601 . . . . 0.5 109.865 177.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.833 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.1 mp -118.46 134.14 55.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.899 -1.125 . . . . 1.66 110.174 179.578 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.516 ' HE2' ' CE1' ' B' ' 39' ' ' TYR . 23.3 pttt -140.41 162.55 35.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.252 -0.905 . . . . 1.74 110.371 179.473 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 20.1 tttt -57.47 147.82 25.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.136 -0.977 . . . . 1.65 109.871 177.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 1.016 ' CD2' HG11 ' A' ' 9' ' ' VAL . 3.6 t80 -102.77 118.96 37.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.248 -0.908 . . . . 0.65 110.551 -176.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -122.29 78.86 44.52 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.123 -0.986 . . . . 4.35 110.237 177.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -59.22 145.6 97.26 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.064 1.56 . . . . 3.58 110.323 179.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 118.008 -0.996 . . . . 5.97 110.225 -179.83 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.565 ' CZ ' ' OE2' ' A' ' 23' ' ' GLU . 63.0 t80 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.206 0.527 . . . . 10.99 110.136 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.471 ' O ' ' OE2' ' A' ' 23' ' ' GLU . 93.2 mmm -122.4 143.24 49.79 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.255 -0.903 . . . . 8.76 110.112 179.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 75.6 mttt -92.0 146.29 23.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.106 -0.996 . . . . 8.85 110.277 -178.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.91 ' O ' HG23 ' A' ' 6' ' ' THR . 52.9 p -67.16 158.38 31.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.187 -0.946 . . . . 4.2 109.864 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.91 HG23 ' O ' ' A' ' 5' ' ' SER . 0.8 OUTLIER -170.8 63.58 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.445 -0.784 . . . . 3.77 110.076 -179.133 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 82.35 49.97 4.99 Favored Glycine 0 N--CA 1.492 2.38 0 C-N-CA 119.208 -1.472 . . . . 0.83 109.979 179.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 61.7 mt -99.52 135.29 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.775 0 O-C-N 120.975 -1.309 . . . . 1.36 109.636 -179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.906 HG13 ' O ' ' B' ' 36' ' ' LEU . 98.5 t -113.51 143.75 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.911 -1.118 . . . . 0.37 111.348 -171.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.43 ' NE ' ' HB ' ' A' ' 19' ' ' VAL . 59.5 ttm-85 -123.82 161.17 25.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.539 -0.725 . . . . 1.91 109.621 176.809 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HE2' ' HA ' ' B' ' 33' ' ' LYS . 82.1 tttt -82.54 145.01 29.99 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.138 -0.976 . . . . 2.21 110.563 -178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.908 HG22 HD11 ' B' ' 36' ' ' LEU . 4.1 t -82.97 129.38 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.412 -0.805 . . . . 0.28 109.881 179.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.11 -175.06 5.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.168 -0.958 . . . . 0.55 109.901 179.309 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -56.94 -39.28 74.23 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.991 -1.068 . . . . 2.19 111.61 -172.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.903 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.2 tp -83.47 -6.23 59.39 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.755 -1.215 . . . . 1.38 111.542 -174.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.479 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 79.98 46.46 7.69 Favored Glycine 0 N--CA 1.49 2.251 0 C-N-CA 119.193 -1.479 . . . . 0.21 109.648 -177.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.908 ' CD ' HG22 ' B' ' 19' ' ' VAL . 68.4 mtm180 -114.12 156.15 24.71 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.076 -1.249 . . . . 1.15 110.019 -177.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.856 HG12 HD13 ' B' ' 36' ' ' LEU . 16.8 m -124.53 153.35 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.24 -0.912 . . . . 0.28 109.805 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.938 HG22 ' CD ' ' B' ' 17' ' ' ARG . 35.2 t -111.06 134.47 53.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.24 110.536 -176.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.39 133.38 50.32 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.314 -0.867 . . . . 1.38 109.433 174.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.1 Cg_endo -57.18 142.86 94.54 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.761 1.401 . . . . 0.35 110.018 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.861 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.28 -32.69 29.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.977 -1.077 . . . . 1.11 110.357 -177.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.565 ' OE2' ' CZ ' ' A' ' 2' ' ' PHE . 84.4 tt0 -58.22 -35.93 72.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.096 -1.002 . . . . 2.37 109.839 178.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.563 ' HB2' HG23 ' A' ' 20' ' ' ILE . 48.7 mt -80.41 -31.4 37.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.818 . . . . 1.75 110.537 178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.861 ' HD2' HD12 ' A' ' 22' ' ' ILE . 72.3 mtt180 -58.09 -43.38 87.01 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.883 -1.136 . . . . 0.3 109.243 176.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -73.57 -49.95 23.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.472 -0.767 . . . . 3.26 110.804 -177.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m -64.42 -30.97 72.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.24 -0.912 . . . . 0.77 111.16 -178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.922 HD23 HG13 ' A' ' 30' ' ' ILE . 19.7 tp -87.14 -4.64 59.14 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.02 -1.05 . . . . 1.05 110.656 -177.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.452 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.63 43.73 96.02 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.673 -1.371 . . . . 0.32 109.673 179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.922 HG13 HD23 ' A' ' 28' ' ' LEU . 29.6 mm -114.74 138.07 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -1.152 . . . . 0.41 110.664 -178.031 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.406 ' HB3' ' OD2' ' A' ' 34' ' ' ASP . . . -141.22 166.57 24.4 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.548 -0.72 . . . . 0.23 109.986 -178.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.3 145.99 12.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.068 -1.02 . . . . 1.13 110.51 -179.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 45.6 tttp 74.91 -4.7 2.31 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.653 -0.654 . . . . 1.88 111.084 177.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.772 ' O ' HG23 ' B' ' 12' ' ' VAL . 92.0 m-20 -78.04 167.73 20.98 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.812 -1.18 . . . . 1.1 110.018 174.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' TYR . . . -105.98 131.74 52.91 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.166 -0.959 . . . . 0.36 110.762 -176.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.927 ' O ' HG13 ' B' ' 9' ' ' VAL . 10.3 mt -106.75 141.36 38.12 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.392 -0.817 . . . . 0.56 109.319 175.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.678 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.6 tt0 -103.88 138.17 40.84 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.794 -1.191 . . . . 1.17 109.892 174.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 74.5 mt -112.25 133.11 59.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.54 -0.725 . . . . 0.84 110.575 -174.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.606 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 17.3 m-85 -115.17 158.32 22.41 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 122.045 -0.41 . . . . 0.45 110.076 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 82.3 t -129.44 124.29 59.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.016 -1.053 . . . . 0.27 110.707 173.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.623 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.1 p-10 -146.93 136.32 22.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.358 -0.839 . . . . 1.77 110.233 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.468 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 56.0 t0 44.05 49.84 7.38 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.017 -1.052 . . . . 1.22 111.071 174.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.3 mt-10 59.1 13.6 3.02 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.202 -0.936 . . . . 1.93 110.636 175.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -117.24 147.6 42.38 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 2.01 110.036 175.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.597 HG22 HD11 ' A' ' 47' ' ' LEU . 61.3 mt -99.65 129.16 50.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.148 -0.97 . . . . 1.25 110.183 -179.271 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.623 HD11 ' OD2' ' A' ' 41' ' ' ASP . 23.3 mt -109.1 116.42 52.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.341 -0.849 . . . . 0.5 110.043 176.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.839 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.1 mp -111.05 134.76 52.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.029 -1.044 . . . . 1.66 110.113 -179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.538 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 14.0 pttp -142.66 163.14 33.63 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.5 -0.75 . . . . 1.74 110.347 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -58.05 147.12 30.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.114 -0.991 . . . . 1.65 109.93 177.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.491 ' CD2' HG11 ' B' ' 9' ' ' VAL . 14.6 t80 -104.71 112.26 25.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.345 -0.847 . . . . 0.35 110.616 -176.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -100.16 122.67 49.54 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.459 -0.776 . . . . 3.21 109.385 172.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.29 144.07 99.5 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.753 1.396 . . . . 0.48 110.104 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 21.4 m120 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.051 -0.976 . . . . 2.41 110.231 -179.922 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.241 0.543 . . . . 11.66 110.151 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 87.6 mtp -97.09 43.68 1.07 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.252 -0.905 . . . . 8.7 110.515 -178.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 26.4 mttm -93.41 152.96 18.77 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.158 -0.963 . . . . 9.17 110.283 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.881 ' O ' HG23 ' B' ' 6' ' ' THR . 50.5 m -59.79 154.12 19.02 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.23 -0.919 . . . . 5.2 110.275 -179.174 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.881 HG23 ' O ' ' B' ' 5' ' ' SER . 0.8 OUTLIER -168.72 63.55 0.06 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.27 -0.894 . . . . 2.98 110.243 -179.232 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 81.5 51.59 4.55 Favored Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.697 -1.361 . . . . 0.83 109.697 179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 61.9 mt -100.01 135.14 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.039 -1.271 . . . . 1.36 109.707 179.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 36' ' ' LEU . 98.7 t -113.5 143.71 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 120.869 -1.145 . . . . 0.37 111.29 -171.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.419 ' NE ' ' HB ' ' B' ' 19' ' ' VAL . 59.5 ttm-85 -123.76 160.98 26.14 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.579 -0.701 . . . . 1.92 109.776 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.445 ' HE2' ' HA ' ' A' ' 33' ' ' LYS . 81.9 tttt -82.53 144.9 30.07 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.072 -1.017 . . . . 2.21 110.616 -178.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.902 HG22 ' CD1' ' A' ' 36' ' ' LEU . 4.1 t -82.87 129.6 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.414 -0.804 . . . . 0.29 109.78 179.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.36 -174.89 5.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.129 -0.982 . . . . 0.55 110.023 179.079 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.477 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.8 mt-10 -56.96 -39.28 74.3 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.065 -1.022 . . . . 2.19 111.552 -172.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.905 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.6 tp -83.56 -6.26 59.4 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.767 -1.208 . . . . 1.39 111.568 -174.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.482 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.63 47.15 7.46 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.484 -1.447 . . . . 0.21 109.484 -177.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.938 ' CD ' HG22 ' A' ' 19' ' ' VAL . 68.6 mtm180 -114.23 156.11 24.9 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 120.974 -1.309 . . . . 1.14 110.058 -177.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.823 HG12 HD13 ' A' ' 36' ' ' LEU . 16.6 m -124.5 153.34 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.431 -0.793 . . . . 0.28 109.846 -179.289 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.908 HG22 ' CD ' ' A' ' 17' ' ' ARG . 35.4 t -111.06 134.5 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.205 -0.934 . . . . 0.24 110.527 -176.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.577 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.31 133.33 50.65 Favored Pre-proline 0 N--CA 1.489 1.479 0 O-C-N 121.329 -0.857 . . . . 1.38 109.493 174.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.551 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.3 Cg_endo -57.4 142.84 95.18 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.675 1.355 . . . . 0.36 110.036 177.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.858 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.4 tp -55.39 -32.53 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.062 -1.024 . . . . 1.11 110.343 -177.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.03 -36.64 73.0 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.02 -1.05 . . . . 2.37 109.714 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.577 ' HB2' HG23 ' B' ' 20' ' ' ILE . 48.0 mt -79.68 -31.75 41.37 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.483 -0.76 . . . . 1.75 110.514 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.858 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.9 mtt180 -57.93 -43.3 86.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.925 -1.11 . . . . 0.3 109.28 176.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 42.5 mmt180 -73.54 -50.21 22.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.327 -0.858 . . . . 3.27 110.653 -177.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 55.4 m -64.17 -31.56 72.8 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.215 -0.928 . . . . 0.77 110.86 -177.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.971 HD23 HG13 ' B' ' 30' ' ' ILE . 20.0 tp -86.64 -5.09 59.23 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.124 -0.985 . . . . 1.05 110.63 -176.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.442 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.91 43.68 95.66 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.49 -1.444 . . . . 0.32 109.49 179.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.971 HG13 HD23 ' B' ' 28' ' ' LEU . 29.4 mm -114.66 137.97 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.215 -1.168 . . . . 0.41 110.699 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.401 ' HB3' ' OD2' ' B' ' 34' ' ' ASP . . . -140.98 166.66 24.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.509 -0.745 . . . . 0.23 109.99 -178.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.27 146.03 12.77 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.138 -0.976 . . . . 1.13 110.536 -179.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 45.5 tttp 75.0 -4.94 2.27 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.706 -0.621 . . . . 1.88 111.16 177.114 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.724 ' O ' HG23 ' A' ' 12' ' ' VAL . 92.5 m-20 -78.03 167.56 21.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.914 -1.116 . . . . 1.1 110.045 174.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.46 ' HB1' HG11 ' A' ' 9' ' ' VAL . . . -105.88 131.66 52.93 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.163 -0.961 . . . . 0.36 110.807 -176.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.908 HD11 HG22 ' A' ' 12' ' ' VAL . 10.1 mt -106.72 141.16 38.43 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.28 -0.887 . . . . 0.56 109.421 175.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.635 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.5 tt0 -103.75 138.22 40.67 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.86 -1.15 . . . . 1.17 109.975 173.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 74.5 mt -112.13 133.2 58.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.459 -0.775 . . . . 0.84 110.507 -174.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.61 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 17.2 m-85 -115.32 158.27 22.64 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 120.914 0.387 . . . . 0.45 109.962 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.53 ' CG2' ' OG ' ' A' ' 5' ' ' SER . 83.9 t -129.2 124.66 60.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.99 -1.069 . . . . 0.26 110.61 173.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.627 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.2 p-10 -147.32 136.26 22.22 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.36 -0.838 . . . . 1.77 110.151 177.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 56.7 t0 44.26 49.85 7.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.119 -0.988 . . . . 1.21 111.012 174.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.3 mt-10 58.95 13.63 2.91 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.229 -0.919 . . . . 1.92 110.607 176.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 25.4 mttp -117.23 147.87 42.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.187 -0.945 . . . . 2.0 109.94 175.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.578 HG22 HD11 ' B' ' 47' ' ' LEU . 61.0 mt -99.83 129.15 50.89 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.102 -0.999 . . . . 1.24 110.153 -179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.627 HD11 ' OD2' ' B' ' 41' ' ' ASP . 23.8 mt -109.29 116.42 52.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.463 -0.773 . . . . 0.5 110.019 176.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.842 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.2 mp -110.91 134.7 52.35 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.004 -1.06 . . . . 1.66 110.097 -179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.535 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 14.2 pttp -142.52 163.37 33.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.443 -0.785 . . . . 1.74 110.29 179.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 62.2 tttm -58.13 147.1 31.03 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.143 -0.973 . . . . 1.65 109.885 177.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.548 ' CD2' HG11 ' A' ' 9' ' ' VAL . 14.8 t80 -104.94 111.99 24.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.18 -0.95 . . . . 0.65 110.667 -176.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -123.35 79.44 53.46 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.078 -1.014 . . . . 4.35 110.142 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.416 ' HG3' ' CE2' ' B' ' 50' ' ' TYR . 12.0 Cg_endo -60.4 146.24 97.1 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 124.075 1.566 . . . . 3.58 110.358 -179.414 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 39.1 p-10 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 118.069 -0.967 . . . . 5.97 110.27 179.496 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.221 0.534 . . . . 10.99 110.227 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.458 ' SD ' ' HB2' ' B' ' 41' ' ' ASP . 70.2 mtm -120.92 149.33 42.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.253 -0.904 . . . . 8.76 110.159 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.402 ' O ' ' O ' ' B' ' 40' ' ' VAL . 16.2 tttp -83.88 134.62 34.68 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.305 -0.872 . . . . 8.85 110.331 -179.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.578 ' HG ' ' HD2' ' B' ' 39' ' ' TYR . 48.0 m -119.1 147.38 44.22 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.266 -0.896 . . . . 4.2 110.097 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.441 HG23 ' CG2' ' B' ' 40' ' ' VAL . 64.1 p -66.49 -32.31 73.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.185 -0.947 . . . . 3.77 110.285 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.1 46.18 52.46 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.567 -1.413 . . . . 0.83 109.567 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 60.1 mt -116.87 135.38 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.161 -1.199 . . . . 1.36 109.967 -179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.093 HG11 ' CD2' ' B' ' 50' ' ' TYR . 90.0 t -116.15 144.46 23.75 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.019 -1.051 . . . . 0.37 110.989 -175.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 57.5 ttm-85 -129.61 159.66 35.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.513 -0.742 . . . . 1.91 109.736 177.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.8 mttt -86.49 148.03 25.71 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.2 -0.938 . . . . 2.21 110.328 -178.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.987 HG22 HD11 ' B' ' 36' ' ' LEU . 3.7 t -82.58 129.29 37.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.266 -0.896 . . . . 0.28 109.945 179.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.465 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.18 -174.7 5.43 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.051 -1.031 . . . . 0.55 109.995 179.614 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -56.1 -39.93 72.92 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.025 -1.047 . . . . 2.19 111.718 -172.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.861 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.1 tp -85.41 -4.53 59.19 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.751 -1.218 . . . . 1.38 111.674 -173.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.482 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.07 46.34 7.71 Favored Glycine 0 N--CA 1.491 2.325 0 C-N-CA 119.176 -1.488 . . . . 0.21 109.662 -177.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.919 ' CD ' HG22 ' B' ' 19' ' ' VAL . 73.8 mtm180 -115.75 154.62 29.27 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.054 -1.262 . . . . 1.15 109.995 -177.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.54 HG12 HD13 ' B' ' 36' ' ' LEU . 22.7 m -123.81 151.76 28.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.241 -0.912 . . . . 0.28 109.868 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.95 HG22 ' CD ' ' B' ' 17' ' ' ARG . 22.4 t -112.35 135.13 52.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.152 -0.968 . . . . 0.24 110.54 -175.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.569 HG23 ' HB2' ' A' ' 24' ' ' LEU . 3.0 mm -83.64 133.29 46.94 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.246 -0.909 . . . . 1.38 109.606 175.371 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.552 ' HG2' HD12 ' A' ' 24' ' ' LEU . 9.2 Cg_endo -58.04 143.62 96.07 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.778 1.409 . . . . 0.35 110.061 177.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.878 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.1 tp -54.85 -33.12 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 120.991 -1.068 . . . . 1.11 110.347 -178.756 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.409 ' N ' HG23 ' A' ' 22' ' ' ILE . 84.3 tt0 -58.03 -35.6 71.52 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.154 -0.966 . . . . 2.37 109.833 178.583 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.569 ' HB2' HG23 ' A' ' 20' ' ' ILE . 51.4 mt -83.8 -28.81 27.84 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.335 -0.853 . . . . 1.75 110.789 178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.878 ' HD2' HD12 ' A' ' 22' ' ' ILE . 71.5 mtt180 -57.44 -43.9 84.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.752 -1.218 . . . . 0.3 108.957 175.011 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -71.49 -49.75 38.2 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 120.092 -0.643 . . . . 3.26 110.714 -178.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.8 m -63.59 -31.4 72.55 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.177 -0.952 . . . . 0.77 111.15 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.805 HD23 HG13 ' A' ' 30' ' ' ILE . 23.8 tp -87.35 -5.03 59.05 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.061 -1.024 . . . . 1.05 110.729 -177.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 64.08 41.4 98.51 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.701 -1.36 . . . . 0.32 109.701 179.175 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.805 HG13 HD23 ' A' ' 28' ' ' LEU . 34.3 mm -116.41 139.73 41.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.246 -1.15 . . . . 0.41 110.759 -178.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -139.89 167.46 22.05 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.654 -0.654 . . . . 0.23 110.082 -178.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.606 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 83.3 tt0 -52.41 150.87 4.45 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.047 -1.033 . . . . 1.13 110.549 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.606 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 74.5 mttt 67.16 -3.32 1.01 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.857 -0.527 . . . . 1.88 112.234 178.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.745 ' O ' HG23 ' B' ' 12' ' ' VAL . 90.1 m-20 -76.07 165.44 24.94 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.579 -1.326 . . . . 1.1 109.952 174.152 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.799 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -103.87 130.98 51.51 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.266 -0.896 . . . . 0.36 110.785 -175.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.974 HD11 HG22 ' B' ' 12' ' ' VAL . 13.5 mt -109.14 142.36 40.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.388 -0.82 . . . . 0.56 109.54 175.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.678 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.4 tt0 -107.4 140.35 40.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.795 -1.191 . . . . 1.17 109.739 172.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.6 mt -111.57 135.41 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.345 -0.847 . . . . 0.84 110.564 -172.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.588 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 12.4 m-85 -114.6 158.55 21.55 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 120.934 0.397 . . . . 0.45 110.078 -178.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.601 HG21 HG21 ' B' ' 6' ' ' THR . 77.7 t -130.89 128.39 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.924 -1.11 . . . . 0.27 110.62 172.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.643 ' CG ' HD11 ' A' ' 46' ' ' ILE . 8.9 p-10 -146.62 128.34 15.24 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.323 -0.86 . . . . 1.77 110.249 179.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.503 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 48.1 t0 46.57 49.11 13.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.022 -1.048 . . . . 1.22 110.948 175.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.503 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.1 tt0 62.53 10.35 4.0 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.337 -0.852 . . . . 1.93 110.696 176.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 9.0 mtmm -110.59 148.38 32.29 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.188 -0.945 . . . . 2.01 109.868 176.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.669 HD13 HD11 ' B' ' 20' ' ' ILE . 58.0 mt -101.92 127.98 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.209 -0.932 . . . . 1.25 110.331 -176.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.643 HD11 ' CG ' ' A' ' 41' ' ' ASP . 29.6 mt -114.99 123.33 70.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.343 -0.848 . . . . 0.5 110.233 178.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.822 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -114.11 136.74 52.6 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.961 -1.087 . . . . 1.66 110.167 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.528 ' HD3' ' CE1' ' A' ' 39' ' ' TYR . 25.2 pttt -140.92 165.61 27.05 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.449 -0.782 . . . . 1.74 110.132 179.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -56.06 149.07 16.26 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.109 -0.995 . . . . 1.65 109.819 175.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.971 ' CD2' HG11 ' B' ' 9' ' ' VAL . 2.2 t80 -100.43 126.53 46.84 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.29 -0.881 . . . . 0.35 110.655 -175.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 9.6 mttt -99.28 123.24 49.32 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.311 -0.868 . . . . 3.21 109.605 174.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 25.9 Cg_exo -57.43 144.89 90.57 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.846 1.446 . . . . 0.48 110.367 -178.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.011 -0.995 . . . . 2.41 110.225 -179.889 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.282 0.563 . . . . 11.66 110.216 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 70.7 mtm -117.57 148.11 42.2 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -0.923 . . . . 8.7 110.22 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -81.39 133.28 35.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.22 -0.925 . . . . 9.17 110.242 -179.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.477 ' HB2' ' HA ' ' A' ' 39' ' ' TYR . 97.3 p -139.05 159.32 42.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.261 -0.9 . . . . 5.2 110.222 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.601 HG21 HG21 ' A' ' 40' ' ' VAL . 63.4 p -65.18 -32.37 74.02 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.306 -0.871 . . . . 2.98 110.256 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.94 46.48 52.03 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.55 -1.42 . . . . 0.83 109.55 178.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.6 mt -116.84 135.32 57.56 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.218 -1.166 . . . . 1.36 110.052 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.971 HG11 ' CD2' ' A' ' 50' ' ' TYR . 90.1 t -116.23 144.45 23.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.974 -1.079 . . . . 0.37 110.959 -175.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 57.4 ttm-85 -129.44 159.5 36.06 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.488 -0.757 . . . . 1.92 109.809 177.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 41.9 mttt -86.49 147.95 25.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.027 -1.046 . . . . 2.21 110.434 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.974 HG22 HD11 ' A' ' 36' ' ' LEU . 3.7 t -82.45 129.3 37.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.265 -0.897 . . . . 0.29 109.823 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.452 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.3 -174.49 5.31 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.085 -1.009 . . . . 0.55 110.171 179.359 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.485 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.5 mt-10 -56.24 -39.85 73.21 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.095 -1.003 . . . . 2.19 111.679 -172.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.892 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.5 tp -85.54 -4.55 59.19 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.723 -1.235 . . . . 1.39 111.624 -173.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.498 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.82 46.99 7.45 Favored Glycine 0 N--CA 1.493 2.457 0 N-CA-C 109.485 -1.446 . . . . 0.21 109.485 -177.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.95 ' CD ' HG22 ' A' ' 19' ' ' VAL . 73.7 mtm180 -115.9 154.66 29.36 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.102 -1.234 . . . . 1.14 109.936 -178.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.561 HG21 ' CD2' ' A' ' 47' ' ' LEU . 22.6 m -123.91 151.7 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.822 . . . . 0.28 109.866 179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.919 HG22 ' CD ' ' A' ' 17' ' ' ARG . 22.6 t -112.37 135.09 52.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.258 -0.901 . . . . 0.24 110.576 -175.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.669 HD11 HD13 ' A' ' 45' ' ' ILE . 3.0 mm -83.64 133.24 47.03 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.258 -0.901 . . . . 1.38 109.594 175.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.539 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.2 Cg_endo -58.15 143.6 96.51 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.721 1.38 . . . . 0.36 110.063 177.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.874 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -54.9 -33.04 27.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.043 -1.036 . . . . 1.11 110.315 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . 0.41 ' N ' HG23 ' B' ' 22' ' ' ILE . 84.2 tt0 -57.79 -36.34 72.04 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.152 -0.968 . . . . 2.37 109.724 178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.562 ' HB2' HG23 ' B' ' 20' ' ' ILE . 51.4 mt -83.03 -29.28 28.99 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.496 -0.753 . . . . 1.75 110.752 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.874 ' HD2' HD12 ' B' ' 22' ' ' ILE . 71.0 mtt180 -57.22 -43.8 83.18 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.816 -1.178 . . . . 0.3 108.987 175.402 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 42.1 ttp180 -71.32 -50.15 35.32 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.452 -0.78 . . . . 3.27 110.543 -179.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.4 m -63.3 -31.92 73.19 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.258 -0.901 . . . . 0.77 110.931 -177.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.81 HD23 HG13 ' B' ' 30' ' ' ILE . 24.0 tp -86.84 -5.41 59.11 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.052 -1.03 . . . . 1.05 110.723 -177.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.401 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.4 41.31 98.12 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.625 -1.39 . . . . 0.32 109.625 179.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.81 HG13 HD23 ' B' ' 28' ' ' LEU . 33.6 mm -116.43 139.65 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.177 -1.19 . . . . 0.41 110.707 -178.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -139.69 167.62 21.69 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.516 -0.74 . . . . 0.23 109.975 -178.623 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.573 ' O ' ' HB2' ' B' ' 33' ' ' LYS . 83.2 tt0 -52.33 151.07 4.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.129 -0.982 . . . . 1.13 110.467 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.573 ' HB2' ' O ' ' B' ' 32' ' ' GLU . 74.0 mttt 66.57 -2.74 0.99 Allowed 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 112.363 0.505 . . . . 1.88 112.363 178.297 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.647 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.4 m-20 -76.55 165.31 24.96 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.506 -1.371 . . . . 1.1 109.965 173.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.764 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.63 131.02 51.16 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.256 -0.902 . . . . 0.36 110.802 -175.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.987 HD11 HG22 ' A' ' 12' ' ' VAL . 13.3 mt -109.23 142.18 40.43 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.383 -0.823 . . . . 0.56 109.558 175.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.655 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.2 tt0 -107.26 140.32 40.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.842 -1.161 . . . . 1.17 109.824 172.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.8 mt -111.61 135.36 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.284 -0.885 . . . . 0.84 110.58 -172.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.583 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 12.1 m-85 -114.4 158.57 21.35 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 120.946 0.403 . . . . 0.45 110.09 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.441 ' CG2' HG23 ' A' ' 6' ' ' THR . 78.6 t -130.72 128.61 63.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.903 -1.123 . . . . 0.26 110.476 172.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.641 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.0 p-10 -146.91 128.24 14.86 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.854 . . . . 1.77 110.241 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 49.0 t0 46.77 49.08 14.5 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.093 -1.005 . . . . 1.21 110.934 175.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.0 tt0 62.4 10.4 3.92 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.224 -0.923 . . . . 1.92 110.691 176.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.447 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 9.0 mtmm -110.61 148.66 31.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.192 -0.942 . . . . 2.0 109.705 176.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.553 HG21 HD11 ' A' ' 20' ' ' ILE . 58.0 mt -102.08 128.0 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.131 -0.981 . . . . 1.24 110.365 -176.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.641 HD11 ' OD2' ' B' ' 41' ' ' ASP . 30.4 mt -115.17 123.4 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.415 -0.803 . . . . 0.5 110.146 178.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.817 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.2 mp -114.05 136.63 52.71 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.981 -1.074 . . . . 1.66 110.145 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.523 ' HD3' ' CE1' ' B' ' 39' ' ' TYR . 25.2 pttt -140.78 165.84 26.39 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.44 -0.788 . . . . 1.74 110.079 178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -56.3 148.87 17.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.992 -1.067 . . . . 1.65 109.754 175.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 1.093 ' CD2' HG11 ' A' ' 9' ' ' VAL . 2.2 t80 -100.46 122.33 43.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.931 . . . . 0.65 110.667 -175.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.547 ' CB ' ' HD3' ' B' ' 52' ' ' PRO . 0.0 OUTLIER -97.03 -56.6 0.2 Allowed Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.208 -0.932 . . . . 4.35 110.952 179.719 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.585 ' O ' ' CZ ' ' B' ' 50' ' ' TYR . 36.6 Cg_exo -52.75 155.35 10.77 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.505 1.266 . . . . 3.58 110.604 -177.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 17.7 m120 . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 117.997 -1.001 . . . . 5.97 110.181 -178.561 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 68.0 t80 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.301 0.572 . . . . 10.99 110.227 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.3 mmm -98.4 138.9 34.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.201 -0.937 . . . . 8.76 110.229 -179.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -49.36 -39.68 32.8 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.269 -0.895 . . . . 8.85 111.412 -174.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 48.8 m -110.63 159.13 17.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.737 -1.227 . . . . 4.2 110.235 -177.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.2 p -60.76 -35.19 75.79 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.139 -0.976 . . . . 3.77 110.194 -177.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.91 46.7 43.34 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.703 -1.359 . . . . 0.83 109.703 177.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.5 mt -114.57 134.58 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.039 -1.271 . . . . 1.36 110.014 -179.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.92 HG13 ' O ' ' B' ' 36' ' ' LEU . 86.8 t -114.0 144.12 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.027 -1.046 . . . . 0.37 110.871 -175.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -126.29 157.88 37.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.398 -0.814 . . . . 1.91 109.71 177.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.501 ' HE3' ' HA ' ' B' ' 33' ' ' LYS . 55.2 tttt -83.58 145.04 29.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.137 -0.977 . . . . 2.21 110.396 -178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.925 HG22 HD11 ' B' ' 36' ' ' LEU . 3.9 t -81.77 130.31 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.351 -0.843 . . . . 0.28 109.929 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.468 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.38 -174.58 5.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.177 -0.952 . . . . 0.55 110.131 -179.606 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -56.46 -39.74 73.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.07 -1.019 . . . . 2.19 111.779 -172.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.864 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.3 tp -84.76 -4.33 59.01 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.765 -1.209 . . . . 1.38 111.6 -173.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.474 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.06 46.23 7.79 Favored Glycine 0 N--CA 1.49 2.235 0 C-N-CA 119.172 -1.49 . . . . 0.21 109.715 -177.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.934 ' CD ' HG22 ' B' ' 19' ' ' VAL . 74.9 mtm180 -116.16 155.12 28.82 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.069 -1.254 . . . . 1.15 110.05 -177.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.697 HG12 HD13 ' B' ' 36' ' ' LEU . 21.9 m -122.23 148.4 25.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.29 -0.881 . . . . 0.28 109.758 178.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.945 HG22 ' CD ' ' B' ' 17' ' ' ARG . 28.5 t -112.82 133.79 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.162 -0.961 . . . . 0.24 110.623 -175.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.622 HD11 HD13 ' B' ' 45' ' ' ILE . 2.2 mm -84.75 130.86 51.31 Favored Pre-proline 0 N--CA 1.488 1.474 0 O-C-N 121.294 -0.878 . . . . 1.38 109.461 175.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.54 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -57.29 142.34 94.79 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.668 1.352 . . . . 0.35 109.849 177.31 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.926 HD13 ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.46 -32.39 29.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 120.952 -1.093 . . . . 1.11 110.289 -177.624 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -57.54 -36.38 71.55 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.16 -0.963 . . . . 2.37 109.747 177.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.595 ' HB2' HG23 ' A' ' 20' ' ' ILE . 52.9 mt -82.1 -27.59 32.78 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.309 -0.869 . . . . 1.75 110.471 177.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.68 HH22 HD11 ' B' ' 15' ' ' LEU . 73.0 mtt180 -56.97 -43.93 82.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.833 -1.167 . . . . 0.3 108.966 174.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 61.0 ttm-85 -71.66 -49.31 40.96 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.956 -0.698 . . . . 3.26 110.765 -178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 45.9 m -63.21 -31.84 73.09 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.186 -0.946 . . . . 0.77 111.078 -177.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.8 HD23 HG13 ' A' ' 30' ' ' ILE . 23.2 tp -88.09 -5.01 58.69 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.093 -1.004 . . . . 1.05 110.758 -177.254 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.414 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.52 41.57 97.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.651 -1.38 . . . . 0.32 109.651 179.022 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.8 HG13 HD23 ' A' ' 28' ' ' LEU . 33.6 mm -116.53 139.1 44.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -1.169 . . . . 0.41 110.732 -178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.32 166.65 24.17 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.645 -0.659 . . . . 0.23 109.984 -178.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.2 tt0 -53.29 146.39 12.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.056 -1.027 . . . . 1.13 110.592 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 28.5 tttt 74.52 -4.63 2.28 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.674 -0.642 . . . . 1.88 111.166 176.944 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.728 ' O ' HG23 ' B' ' 12' ' ' VAL . 90.6 m-20 -77.3 165.95 23.81 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.788 -1.195 . . . . 1.1 110.03 174.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.511 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.21 130.14 53.43 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.265 -0.897 . . . . 0.36 110.629 -176.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.949 ' O ' HG13 ' B' ' 9' ' ' VAL . 11.6 mt -106.25 141.64 37.26 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.253 -0.904 . . . . 0.56 109.387 174.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.682 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.3 tt0 -104.65 139.01 40.11 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.758 -1.214 . . . . 1.17 109.882 173.66 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.7 mt -109.82 132.67 57.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.514 -0.741 . . . . 0.84 110.374 -174.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.588 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 14.2 m-85 -114.65 157.54 22.96 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 109.929 -0.397 . . . . 0.45 109.929 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 79.9 t -129.59 126.29 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.942 -1.099 . . . . 0.27 110.746 174.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.638 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.4 p-10 -146.71 131.91 18.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.332 -0.855 . . . . 1.77 110.178 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.497 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 47.7 t0 46.09 48.19 12.76 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.952 -1.092 . . . . 1.22 111.008 175.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.0 tt0 62.02 10.98 3.95 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.202 -0.936 . . . . 1.93 110.609 175.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 42' ' ' ASP . 32.7 mtmt -113.07 150.98 31.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.072 -1.017 . . . . 2.01 109.873 176.42 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.706 HD13 HD11 ' B' ' 20' ' ' ILE . 56.7 mt -101.9 129.58 52.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 1.25 110.284 -176.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.638 HD11 ' OD2' ' A' ' 41' ' ' ASP . 21.9 mt -112.5 120.83 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.298 -0.876 . . . . 0.5 110.193 176.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.849 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -112.39 134.08 54.12 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.984 -1.073 . . . . 1.66 110.133 -179.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.543 ' CE ' ' OH ' ' A' ' 39' ' ' TYR . 10.5 pttp -141.52 164.8 29.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.478 -0.764 . . . . 1.74 110.394 178.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.543 ' HD3' ' CD1' ' A' ' 30' ' ' ILE . 18.3 tptp -56.97 146.04 28.24 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.133 -0.979 . . . . 1.65 109.938 177.003 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.595 ' CD2' HG11 ' B' ' 9' ' ' VAL . 9.9 t80 -101.9 114.03 27.76 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.331 -0.855 . . . . 0.35 110.646 -176.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -99.52 123.0 49.7 Favored Pre-proline 0 N--CA 1.489 1.485 0 O-C-N 121.309 -0.869 . . . . 3.21 109.606 174.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -60.09 147.04 94.7 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 123.763 1.402 . . . . 0.48 110.214 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.8 m120 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 118.046 -0.978 . . . . 2.41 110.21 -179.382 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 68.2 t80 . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.274 0.559 . . . . 11.66 110.28 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 64.7 mtt -89.13 140.65 29.24 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.214 -0.929 . . . . 8.7 110.224 -179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 25.3 pttm -133.14 165.4 24.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -0.866 . . . . 9.17 110.217 -179.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 40.7 m -62.81 156.29 24.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.23 -0.919 . . . . 5.2 110.209 179.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . . . . . . . . . 70.4 p -63.77 -35.16 79.67 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 2.98 110.217 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.65 47.28 42.02 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.581 -1.408 . . . . 0.83 109.581 177.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.0 mt -114.68 134.47 57.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 O-C-N 121.136 -1.214 . . . . 1.36 110.037 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.949 HG13 ' O ' ' A' ' 36' ' ' LEU . 88.3 t -114.03 144.11 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.079 -1.013 . . . . 0.37 110.911 -175.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 58.2 ttt85 -126.29 157.6 37.92 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.456 -0.777 . . . . 1.92 109.833 177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -83.53 144.95 29.18 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.128 -0.983 . . . . 2.21 110.453 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.911 HG22 HD11 ' A' ' 36' ' ' LEU . 4.0 t -81.72 130.49 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.354 -0.841 . . . . 0.29 109.812 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.454 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.6 -174.4 5.25 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.103 -0.998 . . . . 0.55 110.3 -179.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.474 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -56.63 -39.62 73.97 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.103 -0.998 . . . . 2.19 111.65 -172.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.892 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.0 tp -84.87 -4.39 59.08 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.741 -1.225 . . . . 1.39 111.527 -173.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.481 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.75 47.04 7.46 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.495 -1.442 . . . . 0.21 109.495 -177.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.945 ' CD ' HG22 ' A' ' 19' ' ' VAL . 74.8 mtm180 -116.44 155.1 29.16 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.001 -1.293 . . . . 1.14 109.969 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.7 HG12 HD13 ' A' ' 36' ' ' LEU . 22.0 m -122.3 148.35 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.28 109.756 178.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.934 HG22 ' CD ' ' A' ' 17' ' ' ARG . 28.4 t -112.75 133.76 57.52 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.184 -0.948 . . . . 0.24 110.636 -175.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.706 HD11 HD13 ' A' ' 45' ' ' ILE . 2.2 mm -84.76 130.86 51.28 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.318 -0.864 . . . . 1.38 109.416 175.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.532 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.0 Cg_endo -57.42 142.28 95.11 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.771 1.406 . . . . 0.36 109.888 177.301 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.948 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.52 -32.17 29.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.994 -1.066 . . . . 1.11 110.291 -177.375 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.45 -37.05 72.22 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.103 -0.998 . . . . 2.37 109.643 177.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.579 ' HB2' HG23 ' B' ' 20' ' ' ILE . 52.5 mt -81.42 -27.88 34.52 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.471 -0.768 . . . . 1.75 110.502 177.326 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.638 HH22 HD11 ' A' ' 15' ' ' LEU . 72.7 mtt180 -56.79 -43.8 81.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.912 -1.118 . . . . 0.3 109.046 175.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 61.0 ttm-85 -71.56 -49.78 37.43 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.463 -0.773 . . . . 3.27 110.578 -178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 48.1 m -62.8 -32.43 73.61 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.3 -0.875 . . . . 0.77 110.893 -177.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.835 HD23 HG13 ' B' ' 30' ' ' ILE . 23.4 tp -87.55 -5.42 58.78 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.058 -1.027 . . . . 1.05 110.661 -176.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.419 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.86 41.33 97.52 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.605 -1.398 . . . . 0.32 109.605 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.835 HG13 HD23 ' B' ' 28' ' ' LEU . 33.4 mm -116.45 138.93 45.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.161 -1.199 . . . . 0.41 110.725 -178.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -140.99 166.78 23.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.59 -0.694 . . . . 0.23 110.053 -178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.527 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.31 146.48 12.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.132 -0.98 . . . . 1.13 110.516 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.527 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 28.5 tttt 74.54 -4.78 2.25 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.673 -0.642 . . . . 1.88 111.225 176.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.666 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.7 m-20 -77.39 165.57 24.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.849 -1.157 . . . . 1.1 110.05 175.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.95 130.1 53.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.23 -0.919 . . . . 0.36 110.69 -176.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.925 HD11 HG22 ' A' ' 12' ' ' VAL . 11.4 mt -106.26 141.5 37.5 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.396 -0.815 . . . . 0.56 109.426 174.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.669 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.2 tt0 -104.55 138.95 40.14 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.84 -1.163 . . . . 1.17 110.008 173.624 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 72.0 mt -109.76 132.59 57.57 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.395 -0.816 . . . . 0.84 110.329 -173.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.591 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 13.9 m-85 -114.59 157.55 22.89 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 109.901 -0.407 . . . . 0.45 109.901 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 79.7 t -129.41 126.6 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.958 -1.089 . . . . 0.26 110.584 174.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.618 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.4 p-10 -146.99 131.83 18.03 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.354 -0.841 . . . . 1.77 110.14 178.068 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 48.7 t0 46.3 48.21 13.4 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.107 -0.996 . . . . 1.21 110.968 175.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 82.8 tt0 61.82 11.04 3.82 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.238 -0.914 . . . . 1.92 110.617 175.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' B' ' 42' ' ' ASP . 32.7 mtmt -113.08 151.2 31.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.178 -0.951 . . . . 2.0 109.791 176.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.622 HD13 HD11 ' A' ' 20' ' ' ILE . 56.3 mt -102.01 129.67 52.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.174 -0.954 . . . . 1.24 110.294 -176.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.618 HD11 ' OD2' ' B' ' 41' ' ' ASP . 22.3 mt -112.71 120.83 63.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.321 -0.862 . . . . 0.5 110.075 176.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.838 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.2 mp -112.28 134.02 54.06 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.077 -1.014 . . . . 1.66 110.053 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.536 ' CE ' ' OH ' ' B' ' 39' ' ' TYR . 10.7 pttp -141.5 165.02 28.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.33 -0.856 . . . . 1.74 110.248 178.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.544 ' HD3' ' CD1' ' B' ' 30' ' ' ILE . 18.3 tptp -57.06 145.96 28.98 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.201 -0.937 . . . . 1.65 109.878 177.05 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.692 ' CD2' HG11 ' A' ' 9' ' ' VAL . 10.1 t80 -102.01 112.14 24.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.65 110.599 -176.23 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.42 76.74 77.18 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.29 -0.881 . . . . 4.35 110.067 177.02 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.508 ' HD3' ' CD1' ' B' ' 50' ' ' TYR . 10.6 Cg_endo -58.71 144.62 97.82 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.998 1.525 . . . . 3.58 110.367 -179.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 18.2 m120 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 117.961 -1.019 . . . . 5.97 110.267 -179.934 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.205 0.526 . . . . 10.99 110.203 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.9 mtt -96.92 131.12 44.02 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.246 -0.908 . . . . 8.76 110.203 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 61.4 mttm -51.37 -42.15 61.14 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.225 -0.922 . . . . 8.85 111.5 -174.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 26.0 t -110.86 148.86 31.52 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.668 -1.27 . . . . 4.2 110.331 -177.457 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.4 p -60.84 -39.32 88.61 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.272 -0.892 . . . . 3.77 110.181 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.565 ' O ' HD13 ' A' ' 8' ' ' ILE . . . 65.95 46.51 81.16 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.63 -1.388 . . . . 0.83 109.63 178.192 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.565 HD13 ' O ' ' A' ' 7' ' ' GLY . 21.0 mm -115.05 133.75 60.29 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 O-C-N 121.138 -1.213 . . . . 1.36 110.157 -178.558 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.069 HG11 ' CD2' ' B' ' 50' ' ' TYR . 98.9 t -115.28 144.46 22.81 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 120.996 -1.065 . . . . 0.37 110.893 -176.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.447 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 14.8 tpt180 -130.22 160.62 33.31 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.514 -0.741 . . . . 1.91 109.687 177.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.447 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 66.7 mttm -85.76 148.5 25.82 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.106 -0.996 . . . . 2.21 110.344 -178.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.924 HG22 HD11 ' B' ' 36' ' ' LEU . 6.3 t -82.05 128.75 38.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.216 -0.927 . . . . 0.28 109.816 179.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.464 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.37 -174.82 5.41 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.209 -0.932 . . . . 0.55 110.164 -179.299 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -53.24 -41.99 65.99 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.087 -1.008 . . . . 2.19 111.687 -173.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.918 HD23 ' HD3' ' A' ' 17' ' ' ARG . 16.3 tp -85.97 -4.89 59.27 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.717 -1.239 . . . . 1.38 111.685 -172.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.51 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.23 46.44 7.55 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.094 -1.527 . . . . 0.21 109.695 -177.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.918 ' HD3' HD23 ' A' ' 15' ' ' LEU . 69.2 mtm180 -114.78 154.63 28.2 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.079 -1.248 . . . . 1.15 110.088 -177.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.697 HG12 HD13 ' B' ' 36' ' ' LEU . 20.9 m -124.85 152.7 31.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.254 -0.904 . . . . 0.28 109.819 179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.914 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.4 t -112.61 134.91 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.196 -0.94 . . . . 0.24 110.637 -175.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.547 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.95 132.11 52.02 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.279 -0.888 . . . . 1.38 109.539 174.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.1 Cg_endo -57.28 141.23 94.6 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.729 1.384 . . . . 0.35 109.947 177.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.925 HD13 ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.66 -31.7 29.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.023 -1.048 . . . . 1.11 110.371 -177.56 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.73 -35.33 72.54 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.071 -1.018 . . . . 2.37 109.824 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.548 ' CD1' ' HG2' ' A' ' 21' ' ' PRO . 46.7 mt -81.39 -28.22 34.44 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.282 -0.887 . . . . 1.75 110.394 176.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.725 HH22 HD11 ' B' ' 15' ' ' LEU . 72.4 mtt180 -56.98 -44.72 82.94 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.897 -1.127 . . . . 0.3 109.092 175.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.466 ' NE ' HD11 ' A' ' 22' ' ' ILE . 98.1 mtt180 -72.14 -47.83 48.05 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 119.775 -0.77 . . . . 3.26 110.839 -178.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.3 m -63.26 -32.19 73.53 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.158 -0.964 . . . . 0.77 111.018 -178.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.879 HD23 HG13 ' A' ' 30' ' ' ILE . 21.3 tp -88.62 -4.71 58.5 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.1 -1.0 . . . . 1.05 110.734 -177.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.439 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 65.05 41.81 97.01 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.718 -1.353 . . . . 0.32 109.718 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.879 HG13 HD23 ' A' ' 28' ' ' LEU . 32.0 mm -116.48 139.24 44.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.313 -1.11 . . . . 0.41 110.777 -178.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.57 166.12 25.61 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.677 -0.64 . . . . 0.23 109.987 -178.537 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.24 147.09 10.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.081 -1.012 . . . . 1.13 110.492 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.53 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 33.1 tttp 74.78 -4.97 2.24 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.77 -0.581 . . . . 1.88 111.118 177.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.731 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.4 m-20 -77.38 166.52 23.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.79 -1.194 . . . . 1.1 109.989 174.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.779 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.2 132.81 50.94 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.224 -0.923 . . . . 0.36 110.842 -175.655 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.991 HD11 HG22 ' B' ' 12' ' ' VAL . 13.0 mt -110.11 144.82 38.17 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.376 -0.828 . . . . 0.56 109.509 175.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.646 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.6 tt0 -108.81 139.79 43.14 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.726 -1.234 . . . . 1.17 109.685 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.2 mt -109.04 131.17 60.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.5 0 O-C-N 121.434 -0.791 . . . . 0.84 110.56 -172.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.607 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 16.7 m-85 -117.73 157.74 25.98 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 116.296 -0.411 . . . . 0.45 110.02 -178.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.403 ' H ' ' HB2' ' B' ' 5' ' ' SER . 80.7 t -131.79 125.17 55.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.891 -1.131 . . . . 0.27 110.571 172.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.498 ' OD1' HG12 ' A' ' 46' ' ' ILE . 43.5 p-10 -147.49 144.84 28.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.106 -0.996 . . . . 1.77 110.768 179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.473 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 52.8 t0 43.02 44.27 4.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.982 -1.074 . . . . 1.22 111.285 173.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.473 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 84.1 tt0 60.87 11.34 3.2 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.108 -0.995 . . . . 1.93 110.679 176.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.2 mttp -111.07 153.53 25.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.182 -0.949 . . . . 2.01 110.057 175.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.831 HG22 HD11 ' A' ' 47' ' ' LEU . 66.0 mt -93.51 128.8 44.7 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.279 -0.888 . . . . 1.25 109.846 177.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 23.9 mm -112.97 119.55 60.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.629 -0.669 . . . . 0.5 110.004 179.122 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.833 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.2 mp -117.96 134.79 54.62 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.985 -1.072 . . . . 1.66 110.202 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.514 ' HE2' ' CE1' ' A' ' 39' ' ' TYR . 22.7 pttt -141.28 162.42 35.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.377 -0.827 . . . . 1.74 110.326 179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 11.6 ttpp -57.79 147.17 28.98 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.147 -0.971 . . . . 1.65 110.023 177.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.895 ' CD2' HG11 ' B' ' 9' ' ' VAL . 5.3 t80 -102.8 124.71 48.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.35 110.575 -176.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 10.0 mtmt -99.5 122.94 49.94 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.38 -0.825 . . . . 3.21 109.379 172.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 13.9 Cg_endo -62.13 145.1 96.51 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.742 1.391 . . . . 0.48 110.352 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.2 m120 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 118.02 -0.991 . . . . 2.41 110.233 -179.659 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.232 0.539 . . . . 11.66 110.238 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 69.0 mtm -134.95 157.55 46.59 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.289 -0.882 . . . . 8.7 110.344 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 54.9 tttp -131.66 129.98 41.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.276 -0.89 . . . . 9.17 109.988 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.403 ' HB2' ' H ' ' A' ' 40' ' ' VAL . 72.3 m -107.59 -100.14 0.36 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.182 -0.949 . . . . 5.2 110.444 -177.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . . . . . . . . . 52.5 p -70.02 -39.59 75.72 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.939 -1.101 . . . . 2.98 110.317 -176.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . 0.57 ' O ' HD13 ' B' ' 8' ' ' ILE . . . 65.56 47.18 80.27 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.495 -1.442 . . . . 0.83 109.495 178.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.57 HD13 ' O ' ' B' ' 7' ' ' GLY . 20.8 mm -115.22 133.63 60.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.192 -1.181 . . . . 1.36 110.222 -178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.93 HG13 ' O ' ' A' ' 36' ' ' LEU . 99.4 t -115.22 144.51 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.03 -1.044 . . . . 0.37 110.837 -176.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 14.8 tpt180 -130.23 160.51 33.64 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.573 -0.705 . . . . 1.92 109.792 177.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.451 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 66.7 mttm -85.76 148.49 25.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.062 -1.024 . . . . 2.21 110.331 -178.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.991 HG22 HD11 ' A' ' 36' ' ' LEU . 6.4 t -82.11 128.76 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.281 -0.887 . . . . 0.29 109.728 179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -85.52 -174.6 5.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.167 -0.958 . . . . 0.55 110.217 -179.395 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.465 ' OE1' ' OE2' ' A' ' 32' ' ' GLU . 47.2 tp10 -53.41 -41.86 66.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 2.19 111.689 -173.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.9 tp -85.97 -4.93 59.28 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.781 -1.2 . . . . 1.39 111.732 -172.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.511 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.88 47.27 7.26 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.439 -1.464 . . . . 0.21 109.439 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.914 ' CD ' HG22 ' A' ' 19' ' ' VAL . 69.2 mtm180 -114.94 154.64 28.37 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.057 -1.26 . . . . 1.14 110.043 -177.392 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.712 HG12 HD13 ' A' ' 36' ' ' LEU . 21.0 m -124.93 152.71 31.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.367 -0.833 . . . . 0.28 109.852 179.613 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.908 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.4 t -112.62 134.83 53.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.221 -0.924 . . . . 0.24 110.666 -175.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.55 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.98 132.1 51.95 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.92 . . . . 1.38 109.528 174.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.545 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.1 Cg_endo -57.45 141.26 94.97 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.73 1.384 . . . . 0.36 109.964 177.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.922 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.9 -31.24 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.128 -0.982 . . . . 1.11 110.367 -177.216 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.83 -35.91 73.68 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.04 -1.038 . . . . 2.37 109.633 178.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.55 ' HB2' HG23 ' B' ' 20' ' ' ILE . 47.1 mt -80.73 -28.5 36.56 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.44 -0.788 . . . . 1.75 110.438 176.78 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.659 HH22 HD11 ' A' ' 15' ' ' LEU . 72.1 mtt180 -56.93 -44.59 82.64 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.876 -1.14 . . . . 0.3 109.037 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.471 ' NE ' HD11 ' B' ' 22' ' ' ILE . 98.1 mtt180 -72.1 -48.08 46.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.403 -0.811 . . . . 3.27 110.698 -178.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 47.3 m -63.0 -32.66 74.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.244 -0.91 . . . . 0.77 110.816 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.886 HD23 HG13 ' B' ' 30' ' ' ILE . 21.4 tp -88.12 -5.15 58.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.997 -1.064 . . . . 1.05 110.636 -177.021 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.446 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.44 41.69 96.25 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.519 -1.433 . . . . 0.32 109.519 179.375 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.886 HG13 HD23 ' B' ' 28' ' ' LEU . 31.7 mm -116.49 139.24 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.14 -1.212 . . . . 0.41 110.731 -178.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.403 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -141.34 166.24 25.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.663 -0.648 . . . . 0.23 109.948 -178.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.3 tt0 -53.19 147.1 10.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.028 -1.045 . . . . 1.13 110.525 -179.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 33.1 tttp 74.76 -5.0 2.22 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.737 -0.602 . . . . 1.88 111.132 177.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.629 ' O ' HG23 ' A' ' 12' ' ' VAL . 88.7 m-20 -77.43 166.4 23.16 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.795 -1.19 . . . . 1.1 109.992 174.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.757 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.14 132.79 50.92 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.162 -0.961 . . . . 0.36 110.902 -175.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.942 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.7 mt -110.24 144.54 38.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.355 -0.841 . . . . 0.56 109.533 175.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.63 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.4 tt0 -108.44 139.81 42.64 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.744 -1.223 . . . . 1.17 109.832 172.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.7 mt -109.01 131.26 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.353 -0.842 . . . . 0.84 110.42 -172.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.599 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 16.5 m-85 -117.82 157.64 26.23 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-O 120.964 0.411 . . . . 0.45 109.97 -179.046 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 80.9 t -131.59 125.5 56.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.864 -1.148 . . . . 0.26 110.427 172.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.501 ' OD1' HG12 ' B' ' 46' ' ' ILE . 43.4 p-10 -147.88 144.85 28.38 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 1.77 110.743 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.4 t0 43.02 44.44 4.08 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.059 -1.026 . . . . 1.21 111.237 174.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.489 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 84.1 tt0 60.65 11.44 3.1 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.027 -1.046 . . . . 1.92 110.613 176.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -111.09 153.78 25.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.111 -0.993 . . . . 2.0 109.895 175.149 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.828 HG22 HD11 ' B' ' 47' ' ' LEU . 65.2 mt -93.69 128.6 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.198 -0.939 . . . . 1.24 109.967 177.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.599 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 23.4 mm -112.95 119.65 61.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.697 -0.627 . . . . 0.5 109.873 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.829 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.3 mp -117.89 134.68 54.7 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.007 -1.058 . . . . 1.66 110.147 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.509 ' HE2' ' CE1' ' B' ' 39' ' ' TYR . 23.1 pttt -141.16 162.61 35.08 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.352 -0.843 . . . . 1.74 110.276 178.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 11.5 ttpp -57.8 147.09 29.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.184 -0.947 . . . . 1.65 109.997 177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 1.069 ' CD2' HG11 ' A' ' 9' ' ' VAL . 5.5 t80 -102.91 120.3 40.38 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.283 -0.886 . . . . 0.65 110.516 -176.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.47 78.07 19.92 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 4.35 110.327 178.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 11.6 Cg_endo -60.21 144.67 99.48 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.161 1.611 . . . . 3.58 110.28 178.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 118.004 -0.998 . . . . 5.97 110.239 -179.867 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 66.1 t80 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.268 0.556 . . . . 10.99 110.272 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.6 mtm -104.53 142.02 35.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.283 -0.886 . . . . 8.76 110.261 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 24.4 tttt -49.27 -54.34 17.36 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.15 -0.969 . . . . 8.85 110.643 -176.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.0 p -80.45 161.55 24.86 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.945 -1.097 . . . . 4.2 109.958 177.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.427 HG21 ' CG2' ' B' ' 40' ' ' VAL . 63.5 p -63.6 -37.32 86.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.112 -0.993 . . . . 3.77 110.051 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.28 45.53 60.76 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.715 -1.354 . . . . 0.83 109.715 176.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 57.9 mt -117.79 132.77 66.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.142 -1.211 . . . . 1.36 109.991 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.929 HG13 ' O ' ' B' ' 36' ' ' LEU . 92.6 t -112.65 143.71 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 120.975 -1.078 . . . . 0.37 110.782 -176.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.403 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 29.7 tpt180 -125.98 157.83 36.82 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.539 -0.726 . . . . 1.91 109.832 178.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.461 ' HE3' ' HA ' ' B' ' 33' ' ' LYS . 33.2 tttp -82.81 143.82 30.55 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.915 . . . . 2.21 110.172 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.924 HG22 HD11 ' B' ' 36' ' ' LEU . 15.0 t -80.4 126.93 39.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.278 -0.888 . . . . 0.28 109.855 179.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -85.99 -174.93 5.35 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.141 -0.975 . . . . 0.55 110.013 -179.959 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -56.34 -39.55 73.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.011 -1.056 . . . . 2.19 111.689 -172.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.914 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.1 tp -84.67 -6.17 59.35 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.728 -1.233 . . . . 1.38 111.574 -173.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 80.32 46.69 7.35 Favored Glycine 0 N--CA 1.491 2.342 0 C-N-CA 119.108 -1.52 . . . . 0.21 109.641 -177.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.914 ' HD3' HD23 ' A' ' 15' ' ' LEU . 70.8 mtm180 -114.06 153.99 28.48 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.033 -1.275 . . . . 1.15 110.078 -177.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.862 HG12 HD13 ' B' ' 36' ' ' LEU . 20.9 m -124.28 153.39 30.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.343 -0.848 . . . . 0.28 109.789 -179.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.903 HG22 ' CD ' ' B' ' 17' ' ' ARG . 17.0 t -113.42 133.66 58.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.163 -0.961 . . . . 0.24 110.703 -175.337 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.594 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -83.42 136.19 43.11 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.163 -0.961 . . . . 1.38 109.443 174.27 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.5 Cg_endo -58.56 141.12 97.14 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.702 1.369 . . . . 0.35 109.893 176.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.954 HD13 ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.89 -31.31 29.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.94 -1.1 . . . . 1.11 110.382 -177.55 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.59 -35.38 72.32 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.049 -1.032 . . . . 2.37 109.854 178.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.594 ' HB2' HG23 ' A' ' 20' ' ' ILE . 52.8 mt -81.02 -29.46 35.13 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.28 -0.887 . . . . 1.75 110.455 176.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.705 HH22 HD11 ' B' ' 15' ' ' LEU . 73.9 mtt180 -57.13 -44.02 82.97 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.969 -1.082 . . . . 0.3 109.05 175.547 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -72.64 -50.12 27.29 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.539 -0.726 . . . . 3.26 110.708 -177.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 52.4 m -63.56 -31.25 72.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.195 -0.941 . . . . 0.77 111.09 -177.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.722 HD23 HG13 ' A' ' 30' ' ' ILE . 18.2 tp -87.59 -4.37 58.96 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.122 -0.986 . . . . 1.05 110.759 -177.092 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.454 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 67.01 40.94 93.37 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.712 -1.355 . . . . 0.32 109.712 178.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.722 HG13 HD23 ' A' ' 28' ' ' LEU . 31.2 mm -116.51 139.07 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.328 -1.101 . . . . 0.41 110.674 -179.412 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.83 166.53 24.49 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.529 -0.732 . . . . 0.23 110.032 -177.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.524 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.24 146.53 11.72 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.122 -0.986 . . . . 1.13 110.602 -179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.524 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 56.2 tttt 74.7 -4.58 2.32 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.678 -0.639 . . . . 1.88 111.139 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.764 ' O ' HG23 ' B' ' 12' ' ' VAL . 87.3 m-20 -76.75 168.09 20.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.798 -1.189 . . . . 1.1 110.034 174.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.681 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -106.23 131.69 53.17 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.22 -0.925 . . . . 0.36 110.726 -175.818 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.925 ' O ' HG13 ' B' ' 9' ' ' VAL . 13.0 mt -109.04 144.55 36.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.425 -0.797 . . . . 0.56 109.457 175.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.567 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.0 tt0 -109.65 138.67 45.68 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.74 -1.225 . . . . 1.17 109.491 172.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.2 mt -109.51 133.33 55.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 O-C-N 121.336 -0.853 . . . . 0.84 110.607 -171.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.596 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 9.5 m-85 -118.3 161.48 19.86 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.905 -0.405 . . . . 0.45 109.905 -178.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.572 HG21 HG21 ' B' ' 6' ' ' THR . 77.4 t -133.8 120.53 36.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.854 -1.154 . . . . 0.27 110.599 172.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.502 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 45.4 p-10 -148.25 160.99 42.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.154 -0.966 . . . . 1.77 110.55 178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.463 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 53.0 t0 42.21 39.51 1.44 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.009 -1.057 . . . . 1.22 111.493 172.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 43' ' ' GLU . 84.2 tt0 59.05 14.07 3.23 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.898 -1.127 . . . . 1.93 110.567 175.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.558 ' CE ' HD11 ' A' ' 46' ' ' ILE . 11.2 pttt -127.66 166.25 18.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.147 -0.971 . . . . 2.01 109.696 174.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.68 HG22 HD11 ' A' ' 47' ' ' LEU . 66.8 mt -97.95 134.37 36.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.124 -0.985 . . . . 1.25 110.388 -175.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.596 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 20.3 mm -113.95 120.13 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.643 -0.661 . . . . 0.5 109.959 178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.838 ' N ' HD12 ' A' ' 47' ' ' LEU . 4.5 mp -115.83 135.63 53.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.965 -1.085 . . . . 1.66 110.227 179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.577 ' HE3' ' CD1' ' A' ' 39' ' ' TYR . 13.5 ptpt -141.28 158.64 43.61 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.267 -0.896 . . . . 1.74 110.368 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -58.42 146.75 33.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.108 -0.995 . . . . 1.65 109.934 177.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.681 ' HD2' ' HB1' ' A' ' 35' ' ' ALA . 8.5 t80 -104.05 119.6 39.28 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.318 -0.864 . . . . 0.35 110.602 -175.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 0.3 OUTLIER -100.32 122.61 49.44 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.618 -0.677 . . . . 3.21 109.383 173.481 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 17.2 Cg_exo -62.28 145.44 96.03 Favored 'Trans proline' 0 C--N 1.303 -1.837 0 O-C-N 123.723 1.381 . . . . 0.48 110.207 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 35.3 p-10 . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 118.018 -0.991 . . . . 2.41 110.163 179.79 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 66.1 t80 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.148 0.499 . . . . 11.66 110.153 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 88.3 mtp -45.81 -41.58 11.2 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.218 -0.926 . . . . 8.7 111.03 -175.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 53.2 tttp -78.1 132.48 37.72 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.745 -1.222 . . . . 9.17 110.192 179.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 55.8 p -69.52 165.03 21.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 5.2 110.107 179.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.572 HG21 HG21 ' A' ' 40' ' ' VAL . 64.4 p -57.9 -37.27 73.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.199 -0.938 . . . . 2.98 109.984 179.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.4 45.53 60.04 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.609 -1.396 . . . . 0.83 109.609 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 58.6 mt -117.67 132.73 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.144 -1.21 . . . . 1.36 109.964 178.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.925 HG13 ' O ' ' A' ' 36' ' ' LEU . 92.7 t -112.74 143.68 21.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.07 -1.019 . . . . 0.37 110.789 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 29.7 tpt180 -125.96 157.69 37.13 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.463 -0.773 . . . . 1.92 109.912 178.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 33.0 tttp -82.78 143.67 30.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.153 -0.967 . . . . 2.21 110.173 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.914 HG22 HD11 ' A' ' 36' ' ' LEU . 15.1 t -80.23 127.08 39.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 0.29 109.78 179.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -86.15 -174.79 5.25 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.082 -1.011 . . . . 0.55 110.14 179.789 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.479 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 96.8 mt-10 -56.46 -39.51 73.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.017 -1.052 . . . . 2.19 111.609 -172.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.901 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.7 tp -84.69 -6.21 59.35 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.733 -1.229 . . . . 1.39 111.599 -173.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 79.88 47.65 7.03 Favored Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.474 -1.45 . . . . 0.21 109.474 -177.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.903 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.6 mtm180 -114.39 154.05 28.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.037 -1.272 . . . . 1.14 109.974 -177.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.858 HG12 HD13 ' A' ' 36' ' ' LEU . 20.6 m -124.35 153.49 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.873 . . . . 0.28 109.864 -179.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.907 HG22 ' CD ' ' A' ' 17' ' ' ARG . 16.9 t -113.53 133.68 58.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.24 110.672 -175.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.594 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -83.41 136.21 43.13 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.201 -0.937 . . . . 1.38 109.475 174.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.542 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.4 Cg_endo -58.74 141.01 97.38 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.716 1.377 . . . . 0.36 109.896 176.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.954 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -56.03 -31.01 30.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.065 -1.022 . . . . 1.11 110.415 -177.268 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -58.56 -35.96 73.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.994 -1.066 . . . . 2.37 109.714 178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.594 ' HB2' HG23 ' B' ' 20' ' ' ILE . 52.6 mt -80.32 -29.83 38.1 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.416 -0.802 . . . . 1.75 110.435 176.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.647 HH22 HD11 ' A' ' 15' ' ' LEU . 73.3 mtt180 -56.98 -44.0 82.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.903 -1.123 . . . . 0.3 109.036 175.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -72.4 -50.44 26.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.403 -0.811 . . . . 3.27 110.715 -177.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 55.5 m -63.29 -31.78 73.02 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.33 -0.856 . . . . 0.77 110.878 -177.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.722 HD23 HG13 ' B' ' 30' ' ' ILE . 18.3 tp -87.16 -4.57 59.12 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.007 -1.058 . . . . 1.05 110.71 -176.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.459 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 67.34 40.73 91.81 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.597 -1.401 . . . . 0.32 109.597 178.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.722 HG13 HD23 ' B' ' 28' ' ' LEU . 30.6 mm -116.53 139.05 45.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.203 -1.175 . . . . 0.41 110.586 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.62 166.53 24.48 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.545 -0.722 . . . . 0.23 110.06 -177.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.33 146.64 11.8 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.189 -0.944 . . . . 1.13 110.511 -179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 56.1 tttt 74.71 -4.69 2.29 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.592 -0.693 . . . . 1.88 111.264 177.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.698 ' O ' HG23 ' A' ' 12' ' ' VAL . 87.7 m-20 -76.75 167.74 21.3 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.8 -1.187 . . . . 1.1 110.021 174.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.691 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.94 131.67 52.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 0.36 110.856 -175.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.929 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.8 mt -109.03 144.26 37.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.326 -0.858 . . . . 0.56 109.626 175.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.55 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.7 tt0 -109.27 138.69 45.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.759 -1.213 . . . . 1.17 109.734 172.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.3 mt -109.5 133.38 54.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.336 -0.853 . . . . 0.84 110.531 -171.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.622 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 9.3 m-85 -118.33 161.31 20.15 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 109.954 -0.387 . . . . 0.45 109.954 -178.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.427 ' CG2' HG21 ' A' ' 6' ' ' THR . 78.9 t -133.5 121.01 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 120.861 -1.15 . . . . 0.26 110.473 172.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.49 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 45.3 p-10 -148.86 160.95 42.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.133 -0.98 . . . . 1.77 110.49 178.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 53.4 t0 41.99 39.82 1.42 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.204 -0.935 . . . . 1.21 111.481 172.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' B' ' 43' ' ' GLU . 84.2 tt0 58.89 14.04 3.09 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 120.91 -1.119 . . . . 1.92 110.528 174.915 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.56 ' CE ' HD11 ' B' ' 46' ' ' ILE . 11.2 pttt -127.55 166.41 18.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 2.0 109.699 174.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.681 HG22 HD11 ' B' ' 47' ' ' LEU . 66.7 mt -98.09 134.32 36.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.14 -0.975 . . . . 1.24 110.399 -175.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 20.7 mm -113.94 120.09 62.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.683 -0.636 . . . . 0.5 109.975 178.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.83 ' CD1' HD13 ' A' ' 47' ' ' LEU . 4.6 mp -115.76 135.5 53.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.069 -1.019 . . . . 1.66 110.192 179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.574 ' HE3' ' CD1' ' B' ' 39' ' ' TYR . 13.5 ptpt -141.14 158.88 43.3 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.375 -0.828 . . . . 1.74 110.295 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -58.54 146.75 34.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.213 -0.929 . . . . 1.65 109.908 177.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.771 ' CD2' HG11 ' A' ' 9' ' ' VAL . 8.8 t80 -104.25 119.34 38.73 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.23 -0.919 . . . . 0.65 110.69 -175.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.524 ' CG ' ' O ' ' B' ' 51' ' ' LYS . 0.0 OUTLIER -109.08 77.1 0.81 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.1 -1.0 . . . . 4.35 110.315 176.186 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_endo -61.21 147.14 96.42 Favored 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.082 1.569 . . . . 3.58 110.431 179.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 117.998 -1.001 . . . . 5.97 110.21 179.693 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.201 0.524 . . . . 10.99 110.223 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 64.8 mtt -107.39 147.13 30.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.186 -0.946 . . . . 8.76 110.234 -179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 18.3 mttp -94.1 148.29 22.32 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.211 -0.93 . . . . 8.85 110.28 -179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.5 p -122.53 159.04 28.54 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.314 -0.866 . . . . 4.2 110.107 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.547 HG21 ' CG2' ' B' ' 40' ' ' VAL . 56.7 p -60.86 -38.25 84.91 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.25 -0.906 . . . . 3.77 110.003 -179.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.72 45.4 84.59 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.697 -1.361 . . . . 0.83 109.697 177.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 59.6 mt -117.81 133.95 62.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 121.128 -1.219 . . . . 1.36 110.085 179.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.967 HG11 ' CD2' ' B' ' 50' ' ' TYR . 90.7 t -117.41 144.49 25.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.799 0 O-C-N 121.056 -1.027 . . . . 0.37 110.82 -176.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.417 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 23.9 tpt180 -129.77 158.95 38.01 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.431 -0.793 . . . . 1.91 109.798 178.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.417 ' N ' ' HG3' ' A' ' 10' ' ' ARG . 35.5 ttpt -82.71 145.52 29.55 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.127 -0.983 . . . . 2.21 110.335 -179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.916 HG22 HD11 ' B' ' 36' ' ' LEU . 3.7 t -81.76 128.69 38.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.385 -0.822 . . . . 0.28 109.807 179.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.55 -177.29 6.39 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.072 -1.017 . . . . 0.55 109.997 179.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.99 -40.5 73.42 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.049 -1.032 . . . . 2.19 111.539 -174.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.57 ' CD1' ' O ' ' A' ' 15' ' ' LEU . 0.1 OUTLIER -76.83 -13.81 59.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.873 -1.142 . . . . 1.38 110.542 -174.458 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.81 46.66 5.9 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.401 -1.479 . . . . 0.21 109.401 -177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.893 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.5 mtm180 -114.41 155.04 27.06 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.024 -1.28 . . . . 1.15 110.095 -176.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.952 HG12 HD13 ' B' ' 36' ' ' LEU . 13.1 m -122.91 152.46 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.318 -0.864 . . . . 0.28 109.769 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.889 HG22 ' CD ' ' B' ' 17' ' ' ARG . 15.0 t -112.8 134.08 56.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.093 -1.004 . . . . 0.24 110.659 -174.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.552 HD11 ' CG2' ' B' ' 45' ' ' ILE . 2.5 mm -84.3 137.24 39.68 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.266 -0.896 . . . . 1.38 109.367 174.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.55 ' HG2' HD12 ' A' ' 24' ' ' LEU . 9.8 Cg_endo -58.63 140.77 96.24 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.718 1.378 . . . . 0.35 109.785 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.954 HD13 ' O ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -55.63 -32.21 30.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.862 -1.149 . . . . 1.11 110.313 -177.679 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -58.73 -35.27 72.42 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.16 -0.962 . . . . 2.37 109.763 178.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.55 HD12 ' HG2' ' A' ' 21' ' ' PRO . 41.3 mt -82.65 -27.62 31.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.238 -0.914 . . . . 1.75 110.517 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.523 ' CG ' ' HA ' ' A' ' 22' ' ' ILE . 71.2 mtt180 -56.85 -44.51 82.21 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.798 -1.189 . . . . 0.3 108.84 175.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.463 ' HE ' HD11 ' A' ' 22' ' ' ILE . 31.5 mmt180 -72.77 -47.81 43.59 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 119.938 -0.705 . . . . 3.26 110.657 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.4 m -63.69 -31.32 72.46 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.191 -0.943 . . . . 0.77 111.069 -178.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.84 HD23 HG13 ' A' ' 30' ' ' ILE . 20.9 tp -87.39 -4.65 59.03 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.078 -1.014 . . . . 1.05 110.683 -177.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.413 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 66.05 41.49 95.11 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.662 -1.375 . . . . 0.32 109.662 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.84 HG13 HD23 ' A' ' 28' ' ' LEU . 33.3 mm -116.43 138.79 45.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.344 -1.092 . . . . 0.41 110.675 -179.345 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.64 166.07 25.76 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.55 -0.719 . . . . 0.23 109.981 -177.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.528 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.4 tt0 -53.73 146.51 13.4 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.094 -1.004 . . . . 1.13 110.533 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.528 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 43.5 tttm 75.02 -4.63 2.34 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 121.744 -0.598 . . . . 1.88 111.068 177.372 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.743 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.9 m-20 -77.21 167.19 22.16 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.73 -1.231 . . . . 1.1 110.05 174.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.718 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -105.49 130.74 53.5 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.199 -0.938 . . . . 0.36 110.744 -176.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.969 HD13 HG12 ' B' ' 18' ' ' VAL . 13.4 mt -107.58 143.9 35.36 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.336 -0.852 . . . . 0.56 109.388 175.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.647 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.3 tt0 -108.77 139.22 43.88 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.809 -1.182 . . . . 1.17 109.694 172.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 69.3 mt -109.84 133.1 56.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.425 -0.797 . . . . 0.84 110.541 -172.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.622 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 17.2 m-85 -119.45 158.85 25.38 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 116.262 -0.426 . . . . 0.45 109.894 -178.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.68 ' CG2' HG21 ' B' ' 6' ' ' THR . 85.3 t -132.01 123.32 50.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.833 -1.167 . . . . 0.27 110.66 173.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.502 ' OD1' HG12 ' A' ' 46' ' ' ILE . 47.8 p-10 -147.69 149.12 31.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.244 -0.91 . . . . 1.77 110.632 178.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 52.7 t0 42.95 44.64 4.07 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.001 -1.062 . . . . 1.22 111.256 173.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 75.6 mm-40 57.67 14.55 2.45 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.053 -1.03 . . . . 1.93 110.567 176.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -115.84 153.94 30.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.202 -0.936 . . . . 2.01 109.955 175.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.901 HG22 HD11 ' A' ' 47' ' ' LEU . 67.7 mt -92.92 129.05 44.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.253 -0.904 . . . . 1.25 109.954 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.622 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.0 mm -111.91 119.36 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.561 -0.712 . . . . 0.5 109.907 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.901 HD11 HG22 ' A' ' 45' ' ' ILE . 4.2 mp -118.81 134.36 55.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.924 -1.11 . . . . 1.66 110.281 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.556 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 12.1 pttp -141.99 163.69 32.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.451 -0.781 . . . . 1.74 110.478 179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 22.1 ttpt -59.26 147.02 37.22 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.268 -0.895 . . . . 1.65 110.14 178.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.799 ' CD2' HG11 ' B' ' 9' ' ' VAL . 10.3 t80 -105.32 118.82 37.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.35 110.67 -176.381 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 52' ' ' PRO . 8.3 tttp -99.45 123.12 49.39 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.353 -0.842 . . . . 3.21 109.447 171.45 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 51' ' ' LYS . 12.3 Cg_endo -60.85 144.27 99.53 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 123.764 1.402 . . . . 0.48 110.418 -177.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 33.2 t30 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.023 -0.989 . . . . 2.41 110.223 -179.954 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.187 0.518 . . . . 11.66 110.207 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 71.1 mtm -46.73 -42.24 16.42 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.164 -0.96 . . . . 8.7 111.103 -175.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . 0.465 ' HD2' ' OH ' ' A' ' 39' ' ' TYR . 25.1 mmtm -96.86 142.07 29.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.802 -1.186 . . . . 9.17 110.129 179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.405 ' CB ' ' H ' ' A' ' 40' ' ' VAL . 25.8 t -66.29 -99.32 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.287 -0.883 . . . . 5.2 110.245 -179.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.68 HG21 ' CG2' ' A' ' 40' ' ' VAL . 56.2 p -75.35 -38.35 60.15 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.948 -1.095 . . . . 2.98 109.995 178.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 66.65 45.6 83.19 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.636 -1.386 . . . . 0.83 109.636 177.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 60.4 mt -117.84 133.82 63.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 O-C-N 121.15 -1.206 . . . . 1.36 110.08 179.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.929 HG13 ' O ' ' A' ' 36' ' ' LEU . 89.4 t -117.34 144.45 25.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.009 -1.057 . . . . 0.37 110.804 -176.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.421 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 24.0 tpt180 -129.75 158.85 38.25 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.545 -0.722 . . . . 1.92 109.907 178.317 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.421 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 35.5 ttpt -82.72 145.38 29.62 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.059 -1.026 . . . . 2.21 110.4 -179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.921 HG22 ' CD1' ' A' ' 36' ' ' LEU . 3.7 t -81.67 128.79 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.256 -0.903 . . . . 0.29 109.704 179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.76 -177.4 6.36 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.093 -1.005 . . . . 0.55 110.073 179.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.97 -40.41 73.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.073 -1.017 . . . . 2.19 111.489 -173.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.567 ' CD1' ' O ' ' B' ' 15' ' ' LEU . 0.1 OUTLIER -76.49 -14.26 60.05 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.894 -1.129 . . . . 1.39 110.647 -174.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . . . . . . . . . . . 83.63 47.32 5.69 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.319 -1.512 . . . . 0.21 109.319 -177.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.889 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.5 mtm180 -114.61 154.95 27.44 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.155 -1.203 . . . . 1.14 110.058 -176.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.969 HG12 HD13 ' A' ' 36' ' ' LEU . 13.2 m -122.93 152.48 27.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.275 -0.891 . . . . 0.28 109.74 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.893 HG22 ' CD ' ' A' ' 17' ' ' ARG . 14.9 t -112.84 134.1 56.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.185 -0.947 . . . . 0.24 110.678 -174.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.589 HD11 ' CG2' ' A' ' 45' ' ' ILE . 2.5 mm -84.29 137.21 39.72 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.221 -0.924 . . . . 1.38 109.388 174.259 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.57 ' HG2' HD12 ' B' ' 24' ' ' LEU . 9.8 Cg_endo -58.74 140.77 96.39 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.656 1.345 . . . . 0.36 109.837 176.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.941 HD13 ' O ' ' B' ' 22' ' ' ILE . 0.0 OUTLIER -55.78 -31.99 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 120.998 -1.064 . . . . 1.11 110.294 -177.374 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -58.74 -35.85 73.38 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.024 -1.047 . . . . 2.37 109.609 178.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.57 HD12 ' HG2' ' B' ' 21' ' ' PRO . 41.8 mt -81.89 -28.01 33.14 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.431 -0.793 . . . . 1.75 110.566 177.191 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.534 ' CG ' ' HA ' ' B' ' 22' ' ' ILE . 70.7 mtt180 -56.78 -44.27 81.71 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.901 -1.124 . . . . 0.3 108.957 175.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . 0.467 ' HE ' HD11 ' B' ' 22' ' ' ILE . 31.4 mmt180 -72.74 -47.96 42.53 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.484 -0.76 . . . . 3.27 110.642 -178.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.3 m -63.45 -31.96 73.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.226 -0.921 . . . . 0.77 110.84 -177.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.845 HD23 HG13 ' B' ' 30' ' ' ILE . 21.0 tp -86.83 -4.99 59.24 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.132 -0.98 . . . . 1.05 110.66 -177.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.419 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.48 41.17 94.41 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.603 -1.399 . . . . 0.32 109.603 178.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.845 HG13 HD23 ' B' ' 28' ' ' LEU . 32.6 mm -116.34 138.65 46.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.162 -1.199 . . . . 0.41 110.667 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -141.33 166.24 25.3 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.633 -0.667 . . . . 0.23 110.001 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.535 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.4 tt0 -53.74 146.6 13.24 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.175 -0.953 . . . . 1.13 110.475 -179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.535 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 43.6 tttm 75.07 -4.87 2.28 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.621 -0.675 . . . . 1.88 111.169 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.651 ' O ' HG23 ' A' ' 12' ' ' VAL . 90.1 m-20 -77.37 166.99 22.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.91 -1.119 . . . . 1.1 110.041 174.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.722 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -105.27 130.78 53.33 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.235 -0.915 . . . . 0.36 110.816 -176.629 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.952 HD13 HG12 ' A' ' 18' ' ' VAL . 13.1 mt -107.7 143.56 36.03 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.375 -0.828 . . . . 0.56 109.495 175.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.625 ' HA ' HG22 ' A' ' 9' ' ' VAL . 85.2 tt0 -108.43 139.18 43.54 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.932 -1.105 . . . . 1.17 109.85 172.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 69.5 mt -109.85 133.01 56.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.455 0 O-C-N 121.39 -0.819 . . . . 0.84 110.489 -172.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.631 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 17.1 m-85 -119.43 158.85 25.37 Favored 'General case' 0 N--CA 1.49 1.525 0 CA-C-N 116.244 -0.435 . . . . 0.45 109.94 -178.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.547 ' CG2' HG21 ' A' ' 6' ' ' THR . 86.5 t -131.82 123.65 52.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 120.863 -1.148 . . . . 0.26 110.515 173.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.5 ' OD1' HG12 ' B' ' 46' ' ' ILE . 47.9 p-10 -148.18 149.14 31.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.278 -0.889 . . . . 1.77 110.613 177.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 53.2 t0 42.83 44.94 4.08 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.101 -0.999 . . . . 1.21 111.188 174.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 75.6 mm-40 57.42 14.65 2.31 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.071 -1.018 . . . . 1.92 110.562 176.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.2 mttp -115.87 154.18 30.19 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.262 -0.899 . . . . 2.0 109.896 175.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.894 HG22 HD11 ' B' ' 47' ' ' LEU . 67.6 mt -93.07 128.84 44.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.187 -0.946 . . . . 1.24 109.945 178.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 21.0 mm -111.93 119.51 60.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.572 -0.705 . . . . 0.5 109.946 178.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.894 HD11 HG22 ' B' ' 45' ' ' ILE . 4.4 mp -118.78 134.23 55.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.892 -1.13 . . . . 1.66 110.15 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.563 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 12.3 pttp -141.85 163.89 31.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.336 -0.852 . . . . 1.74 110.371 178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.2 ttpt -59.24 146.91 37.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.135 -0.978 . . . . 1.65 110.1 178.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.967 ' CD2' HG11 ' A' ' 9' ' ' VAL . 10.5 t80 -105.35 112.15 25.14 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.269 -0.894 . . . . 0.65 110.542 -176.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' B' ' 51' ' ' LYS . 14.5 pttt -130.01 76.3 78.28 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.173 -0.954 . . . . 4.35 110.303 178.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.423 ' HD3' ' CD1' ' B' ' 50' ' ' TYR . 11.7 Cg_endo -60.4 145.05 99.44 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.989 1.521 . . . . 3.58 110.321 179.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 85.9 m-20 . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 118.001 -1.0 . . . . 5.97 110.226 -179.986 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.219 0.533 . . . . 10.99 110.196 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.4 mtm -114.49 149.96 35.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.31 -0.869 . . . . 8.76 110.15 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 11.1 pttm -133.23 169.02 17.5 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.178 -0.951 . . . . 8.85 110.245 -179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.1 m -117.41 151.89 36.11 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.264 -0.897 . . . . 4.2 110.023 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 81.1 p -60.97 -36.38 79.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -0.917 . . . . 3.77 110.02 -179.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.527 ' O ' HD13 ' A' ' 8' ' ' ILE . . . 71.05 46.23 45.37 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.814 -1.315 . . . . 0.83 109.814 176.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.527 HD13 ' O ' ' A' ' 7' ' ' GLY . 18.5 mm -113.48 131.57 64.87 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.821 0 O-C-N 121.165 -1.197 . . . . 1.36 109.811 178.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.07 HG11 ' CD2' ' B' ' 50' ' ' TYR . 85.7 t -118.84 144.75 26.23 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 120.969 -1.082 . . . . 0.37 110.904 -174.615 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -129.94 159.26 37.21 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.455 -0.778 . . . . 1.91 109.83 177.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -82.87 146.03 29.12 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 2.21 110.265 -179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.924 HG22 HD11 ' B' ' 36' ' ' LEU . 3.4 t -80.42 129.28 37.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.357 -0.839 . . . . 0.28 109.866 179.146 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.463 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -83.84 -175.35 5.77 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.179 -0.951 . . . . 0.55 110.039 179.337 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -54.56 -40.82 69.11 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.069 -1.019 . . . . 2.19 111.788 -173.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.884 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.9 tp -84.99 -5.41 59.35 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.758 -1.214 . . . . 1.38 111.595 -173.168 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.526 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.44 46.52 7.38 Favored Glycine 0 N--CA 1.49 2.295 0 C-N-CA 119.178 -1.486 . . . . 0.21 109.687 -177.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.917 ' CD ' HG22 ' B' ' 19' ' ' VAL . 71.1 mtm180 -114.83 154.51 28.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.031 -1.276 . . . . 1.15 110.004 -177.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.838 HG21 ' CD2' ' B' ' 47' ' ' LEU . 18.8 m -124.47 153.15 30.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.28 109.809 -179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.928 HG22 ' CD ' ' B' ' 17' ' ' ARG . 21.4 t -111.19 135.38 50.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.26 -0.9 . . . . 0.24 110.569 -176.007 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.599 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -82.69 134.6 47.18 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 1.38 109.524 175.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.542 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 9.3 Cg_endo -58.27 143.45 97.19 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.756 1.398 . . . . 0.35 110.092 177.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.892 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.28 -31.81 27.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.934 -1.104 . . . . 1.11 110.416 -178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.42 -34.95 73.11 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.15 -0.969 . . . . 2.37 109.907 179.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.599 ' HB2' HG23 ' A' ' 20' ' ' ILE . 61.5 mt -81.96 -30.66 31.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.326 -0.858 . . . . 1.75 110.589 178.014 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.892 ' HD2' HD12 ' A' ' 22' ' ' ILE . 73.7 mtt180 -57.69 -43.92 85.45 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 119.044 -1.062 . . . . 0.3 109.212 175.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -72.5 -50.51 25.41 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.559 -0.713 . . . . 3.26 110.706 -177.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.0 m -63.7 -31.21 72.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.144 -0.972 . . . . 0.77 111.086 -177.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.916 HD23 HG13 ' A' ' 30' ' ' ILE . 22.9 tp -87.56 -4.78 58.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.088 -1.007 . . . . 1.05 110.698 -177.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.442 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.72 43.47 96.26 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.614 -1.395 . . . . 0.32 109.614 179.043 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.916 HG13 HD23 ' A' ' 28' ' ' LEU . 30.8 mm -115.69 139.08 43.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.272 -1.134 . . . . 0.41 110.65 -178.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.404 ' O ' ' HB2' ' A' ' 34' ' ' ASP . . . -140.81 167.49 22.06 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.555 -0.716 . . . . 0.23 110.003 -178.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.604 ' O ' ' HB2' ' A' ' 33' ' ' LYS . 83.4 tt0 -52.48 150.44 4.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 1.13 110.468 -179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.604 ' HB2' ' O ' ' A' ' 32' ' ' GLU . 39.9 mttp 67.01 -2.97 1.02 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 112.294 0.479 . . . . 1.88 112.294 178.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.77 ' O ' HG23 ' B' ' 12' ' ' VAL . 88.3 m-20 -75.55 166.89 22.88 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.526 -1.359 . . . . 1.1 109.922 173.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.79 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -103.83 130.23 51.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.19 -0.944 . . . . 0.36 110.769 -175.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.934 ' O ' HG13 ' B' ' 9' ' ' VAL . 13.7 mt -108.3 140.67 41.21 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.56 109.49 175.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.745 ' HA ' HG22 ' B' ' 9' ' ' VAL . 85.1 tt0 -105.4 140.1 39.03 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.834 -1.166 . . . . 1.17 109.731 173.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.2 mt -111.49 133.88 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.44 -0.788 . . . . 0.84 110.478 -173.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.58 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 8.6 m-85 -115.2 160.4 19.77 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 120.904 0.383 . . . . 0.45 110.09 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.538 ' HB ' HG23 ' B' ' 6' ' ' THR . 94.0 t -133.58 123.13 45.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.132 -0.98 . . . . 0.27 110.857 173.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.609 ' OD2' HD11 ' A' ' 46' ' ' ILE . 9.1 p-10 -147.3 141.61 26.29 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.306 -0.871 . . . . 1.77 110.22 177.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.466 ' O ' ' HB2' ' A' ' 43' ' ' GLU . 53.4 t0 43.47 47.86 6.07 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.074 -1.016 . . . . 1.22 111.096 174.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 95.7 mt-10 58.74 13.77 2.85 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.186 -0.946 . . . . 1.93 110.711 176.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -114.52 148.19 38.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.269 -0.894 . . . . 2.01 110.07 175.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.586 HD13 HG13 ' B' ' 20' ' ' ILE . 61.2 mt -99.6 127.6 52.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.209 -0.932 . . . . 1.25 110.095 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.609 HD11 ' OD2' ' A' ' 41' ' ' ASP . 34.2 mt -111.87 118.15 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.331 -0.856 . . . . 0.5 110.275 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.94 ' CD2' HG21 ' B' ' 18' ' ' VAL . 4.2 mp -107.95 135.59 49.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.15 -0.969 . . . . 1.66 110.122 178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.575 ' HE3' ' CD1' ' A' ' 39' ' ' TYR . 16.2 ptpt -142.45 164.22 30.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.516 -0.74 . . . . 1.74 110.125 -179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 45.7 tttp -55.77 147.95 17.71 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.116 -0.99 . . . . 1.65 109.721 176.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.924 ' CD2' HG11 ' B' ' 9' ' ' VAL . 1.7 t80 -100.56 123.68 45.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.263 -0.898 . . . . 0.35 110.644 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.08 123.25 49.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.357 -0.839 . . . . 3.21 109.753 175.565 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.407 ' O ' ' C ' ' A' ' 53' ' ' ASN . 24.2 Cg_exo -58.63 145.26 96.08 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.799 1.421 . . . . 0.48 110.292 -179.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.407 ' C ' ' O ' ' A' ' 52' ' ' PRO . 84.7 m-20 . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 117.939 -1.029 . . . . 2.41 110.223 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . 0.508 ' CE2' ' OD2' ' A' ' 41' ' ' ASP . 97.8 m-85 . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.203 0.525 . . . . 11.66 110.267 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 94.9 mmm -48.87 -40.5 29.91 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.18 -0.95 . . . . 8.7 111.424 -174.059 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 77.8 mttt -91.51 135.09 34.1 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.757 -1.214 . . . . 9.17 110.46 -178.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . . . . . . . . . 27.9 t -149.96 152.61 35.24 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.329 -0.857 . . . . 5.2 110.007 178.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.538 HG23 ' HB ' ' A' ' 40' ' ' VAL . 80.9 p -61.28 -36.42 80.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.141 -0.974 . . . . 2.98 110.059 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . 0.524 ' O ' HD13 ' B' ' 8' ' ' ILE . . . 70.78 46.58 45.15 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.786 -1.326 . . . . 0.83 109.786 176.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.524 HD13 ' O ' ' B' ' 7' ' ' GLY . 18.5 mm -113.53 131.41 65.37 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.133 -1.216 . . . . 1.36 109.879 178.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.934 HG13 ' O ' ' A' ' 36' ' ' LEU . 86.3 t -118.81 144.69 26.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.005 -1.059 . . . . 0.37 110.935 -174.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . . . . . . . . . 70.6 ttt-85 -129.93 159.08 37.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.468 -0.77 . . . . 1.92 109.924 177.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt -82.84 145.93 29.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.11 -0.994 . . . . 2.21 110.395 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.927 HG22 ' CD1' ' A' ' 36' ' ' LEU . 3.4 t -80.26 129.46 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.234 -0.917 . . . . 0.29 109.756 179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.3 OUTLIER -84.09 -175.29 5.73 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.122 -0.986 . . . . 0.55 110.069 179.154 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -54.67 -40.78 69.41 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.177 -0.952 . . . . 2.19 111.678 -173.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.904 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.2 tp -85.04 -5.43 59.35 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.764 -1.21 . . . . 1.39 111.572 -173.144 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.531 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 80.11 47.24 7.15 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.523 -1.431 . . . . 0.21 109.523 -177.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.928 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.9 mtm180 -115.06 154.49 28.78 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.05 -1.265 . . . . 1.14 109.932 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.94 HG21 ' CD2' ' A' ' 47' ' ' LEU . 18.8 m -124.49 153.07 30.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.28 109.822 -179.519 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.917 HG22 ' CD ' ' A' ' 17' ' ' ARG . 21.4 t -111.23 135.3 50.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.17 -0.956 . . . . 0.24 110.605 -175.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.603 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -82.62 134.52 47.52 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.26 -0.9 . . . . 1.38 109.545 175.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.541 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.3 Cg_endo -58.28 143.4 97.29 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 123.851 1.448 . . . . 0.36 110.111 177.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.888 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.36 -31.66 27.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.098 -1.001 . . . . 1.11 110.408 -178.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.26 -35.63 74.06 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.121 -0.987 . . . . 2.37 109.808 179.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.603 ' HB2' HG23 ' B' ' 20' ' ' ILE . 62.2 mt -81.23 -30.96 34.06 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.386 -0.822 . . . . 1.75 110.619 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.888 ' HD2' HD12 ' B' ' 22' ' ' ILE . 73.2 mtt180 -57.57 -43.86 84.87 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.883 -1.135 . . . . 0.3 109.208 176.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 29.2 tpt180 -72.45 -50.81 23.52 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.373 -0.829 . . . . 3.27 110.599 -177.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.7 m -63.35 -31.8 73.05 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.241 -0.912 . . . . 0.77 110.88 -177.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.915 HD23 HG13 ' B' ' 30' ' ' ILE . 23.1 tp -87.0 -5.21 59.16 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.042 -1.036 . . . . 1.05 110.651 -176.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.445 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 65.01 43.25 96.12 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.55 -1.42 . . . . 0.32 109.55 179.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.915 HG13 HD23 ' B' ' 28' ' ' LEU . 30.5 mm -115.53 138.97 44.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.213 -1.169 . . . . 0.41 110.727 -178.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' B' ' 34' ' ' ASP . . . -140.6 167.64 21.69 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.676 -0.64 . . . . 0.23 110.003 -178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' B' ' 33' ' ' LYS . 83.5 tt0 -52.59 150.69 4.83 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.22 -0.925 . . . . 1.13 110.454 -179.457 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' B' ' 32' ' ' GLU . 40.5 mttp 66.52 -2.51 1.03 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 112.4 0.518 . . . . 1.88 112.4 178.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.654 ' O ' HG23 ' A' ' 12' ' ' VAL . 88.5 m-20 -75.86 166.78 23.01 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.599 -1.313 . . . . 1.1 109.895 173.492 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.762 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -103.64 130.14 51.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.244 -0.91 . . . . 0.36 110.807 -175.763 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.937 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.6 mt -108.28 140.5 41.45 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.315 -0.866 . . . . 0.56 109.513 175.065 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.722 ' HA ' HG22 ' A' ' 9' ' ' VAL . 84.8 tt0 -105.24 139.98 39.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.827 -1.171 . . . . 1.17 109.86 173.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 71.4 mt -111.41 133.99 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.362 -0.836 . . . . 0.84 110.455 -173.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.578 ' CD1' ' HE3' ' B' ' 48' ' ' LYS . 8.5 m-85 -115.2 160.38 19.8 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 120.972 0.415 . . . . 0.45 110.18 -178.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 94.3 t -133.31 123.45 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.922 -1.112 . . . . 0.26 110.686 173.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.612 ' OD2' HD11 ' B' ' 46' ' ' ILE . 9.1 p-10 -147.69 141.55 25.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.32 -0.863 . . . . 1.77 110.197 176.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.475 ' O ' ' HB2' ' B' ' 43' ' ' GLU . 54.1 t0 43.56 48.0 6.3 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.098 -1.001 . . . . 1.21 111.045 174.642 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 95.7 mt-10 58.55 13.85 2.75 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.132 -0.98 . . . . 1.92 110.666 176.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 23.6 mttp -114.44 148.39 37.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.194 -0.941 . . . . 2.0 110.007 175.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.459 HD13 ' CG1' ' A' ' 20' ' ' ILE . 60.9 mt -99.71 127.61 52.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.245 -0.909 . . . . 1.24 110.145 -179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.612 HD11 ' OD2' ' B' ' 41' ' ' ASP . 35.5 mt -112.03 118.16 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.428 -0.795 . . . . 0.5 110.216 178.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.838 ' CD2' HG21 ' A' ' 18' ' ' VAL . 4.3 mp -107.83 135.48 49.16 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.264 -0.897 . . . . 1.66 110.009 178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.578 ' HE3' ' CD1' ' B' ' 39' ' ' TYR . 16.2 ptpt -142.29 164.28 30.56 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.517 -0.739 . . . . 1.74 110.153 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 46.0 tttp -55.83 147.84 18.17 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.083 -1.011 . . . . 1.65 109.764 176.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 1.07 ' CD2' HG11 ' A' ' 9' ' ' VAL . 1.7 t80 -100.53 120.07 39.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.19 -0.944 . . . . 0.65 110.616 -175.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . 0.549 ' CB ' ' HD3' ' B' ' 52' ' ' PRO . 0.1 OUTLIER -100.44 -54.81 0.16 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.332 -0.855 . . . . 4.35 110.885 179.835 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.582 ' O ' ' CZ ' ' B' ' 50' ' ' TYR . 38.0 Cg_exo -54.87 154.7 20.41 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.54 1.284 . . . . 3.58 110.501 -178.107 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 118.037 -0.982 . . . . 5.97 110.21 -178.425 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.269 0.557 . . . . 10.99 110.246 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.457 ' O ' ' OE1' ' A' ' 23' ' ' GLU . 69.8 mtm -126.77 161.54 27.93 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.291 -0.881 . . . . 8.76 110.222 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -91.36 150.25 21.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.232 -0.918 . . . . 8.85 110.196 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.904 ' O ' HG23 ' A' ' 6' ' ' THR . 28.4 t -87.08 135.62 33.22 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 4.2 110.011 179.496 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.904 HG23 ' O ' ' A' ' 5' ' ' SER . 0.7 OUTLIER -171.0 62.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.436 -0.79 . . . . 3.77 110.121 -178.268 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 80.51 49.61 5.72 Favored Glycine 0 N--CA 1.491 2.317 0 C-N-CA 119.267 -1.444 . . . . 0.83 109.991 178.658 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 58.4 mt -96.83 133.24 39.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.011 -1.288 . . . . 1.36 109.633 179.569 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.91 HG13 ' O ' ' B' ' 36' ' ' LEU . 78.5 t -113.14 144.52 20.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.815 -1.178 . . . . 0.37 111.347 -170.404 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.444 ' HG2' ' NH1' ' A' ' 10' ' ' ARG . 57.4 ttp85 -129.19 167.08 18.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.536 -0.727 . . . . 1.91 109.455 175.057 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -84.42 146.45 27.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.02 -1.05 . . . . 2.21 110.443 -178.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.907 HG22 ' CD1' ' B' ' 36' ' ' LEU . 3.9 t -82.47 131.8 32.91 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -0.839 . . . . 0.28 109.758 179.342 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.46 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -84.14 -175.55 5.85 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.55 110.058 -179.038 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.424 ' HG2' ' OE2' ' B' ' 32' ' ' GLU . 97.0 mt-10 -57.03 -39.34 74.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.064 -1.022 . . . . 2.19 111.754 -172.675 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.882 HD23 ' HD3' ' A' ' 17' ' ' ARG . 14.7 tp -84.29 -5.96 59.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.734 -1.229 . . . . 1.38 111.606 -173.616 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.413 ' HA2' HG12 ' A' ' 12' ' ' VAL . . . 79.99 46.9 7.41 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.161 -1.495 . . . . 0.21 109.694 -177.744 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.915 ' CD ' HG22 ' B' ' 19' ' ' VAL . 69.5 mtm180 -114.58 154.5 28.21 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 120.954 -1.321 . . . . 1.15 110.127 -177.221 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.853 HG12 HD13 ' B' ' 36' ' ' LEU . 15.5 m -123.26 150.69 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.311 -0.868 . . . . 0.28 109.802 179.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.928 HG22 ' CD ' ' B' ' 17' ' ' ARG . 34.1 t -111.69 134.16 55.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.235 -0.915 . . . . 0.24 110.632 -175.571 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.714 HD11 HG21 ' B' ' 45' ' ' ILE . 2.9 mm -83.89 134.78 43.51 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.288 -0.883 . . . . 1.38 109.507 174.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.555 ' HG2' HD12 ' A' ' 24' ' ' LEU . 9.3 Cg_endo -58.17 143.42 96.86 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.749 1.394 . . . . 0.35 110.061 177.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.903 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.1 tp -54.92 -33.47 28.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.014 -1.054 . . . . 1.11 110.429 -178.802 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.457 ' OE1' ' O ' ' A' ' 3' ' ' MET . 84.2 tt0 -58.06 -35.51 71.44 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.094 -1.003 . . . . 2.37 109.816 178.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.562 ' HB2' HG23 ' A' ' 20' ' ' ILE . 48.2 mt -83.28 -29.17 28.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.39 -0.819 . . . . 1.75 110.636 178.865 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.903 ' HD2' HD12 ' A' ' 22' ' ' ILE . 71.4 mtt180 -57.71 -44.24 85.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.834 -1.166 . . . . 0.3 109.069 175.451 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -72.97 -48.62 35.02 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.54 -0.725 . . . . 3.26 110.719 -177.878 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.0 m -63.48 -32.06 73.4 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.153 -0.967 . . . . 0.77 111.081 -178.446 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.772 HD23 HG13 ' A' ' 30' ' ' ILE . 18.1 tp -88.28 -4.4 58.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.088 -1.008 . . . . 1.05 110.766 -176.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.42 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 66.31 42.05 94.28 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.818 -1.313 . . . . 0.32 109.818 178.589 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.772 HG13 HD23 ' A' ' 28' ' ' LEU . 34.1 mm -116.49 137.76 49.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.235 -1.156 . . . . 0.41 110.682 -179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.4 ' HB3' ' OD2' ' A' ' 34' ' ' ASP . . . -142.14 166.5 24.52 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.594 -0.691 . . . . 0.23 110.04 -178.149 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.532 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.1 tt0 -53.2 146.68 11.27 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.105 -0.997 . . . . 1.13 110.599 -179.765 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 44.7 tttm 74.25 -4.52 2.28 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.666 -0.646 . . . . 1.88 111.143 176.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.781 ' O ' HG23 ' B' ' 12' ' ' VAL . 91.2 m-20 -77.54 168.46 19.96 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.859 -1.151 . . . . 1.1 110.064 175.147 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.605 ' HB1' ' HD2' ' A' ' 50' ' ' TYR . . . -104.34 130.56 52.18 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.268 -0.895 . . . . 0.36 110.694 -176.754 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.961 ' CD1' HG22 ' B' ' 12' ' ' VAL . 9.1 mt -107.09 142.69 36.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.314 -0.866 . . . . 0.56 109.312 174.618 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.699 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.1 tt0 -105.76 137.75 43.1 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.775 -1.203 . . . . 1.17 109.585 172.915 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 71.0 mt -108.0 131.37 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.446 -0.784 . . . . 0.84 110.536 -172.441 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.609 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 23.3 m-85 -120.16 155.81 32.35 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.849 -0.426 . . . . 0.45 109.849 -178.925 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . 0.551 HG21 HD11 ' B' ' 24' ' ' LEU . 71.3 t -131.23 120.75 47.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.88 -1.137 . . . . 0.27 110.586 172.77 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 44' ' ' LYS . 47.9 p-10 -148.25 160.86 42.52 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.216 -0.928 . . . . 1.77 110.583 178.659 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 42' ' ' ASP . 54.8 t0 42.13 41.23 1.96 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.065 -1.022 . . . . 1.22 111.575 172.03 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 42' ' ' ASP . 96.0 mt-10 56.57 15.99 2.35 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 120.984 -1.072 . . . . 1.93 110.541 175.491 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.513 ' HG2' ' O ' ' A' ' 41' ' ' ASP . 27.3 pttt -129.54 164.77 23.08 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.165 -0.96 . . . . 2.01 109.738 174.564 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.725 HG21 HD11 ' B' ' 20' ' ' ILE . 64.7 mt -97.66 134.18 36.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.193 -0.942 . . . . 1.25 110.381 -174.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.609 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 21.6 mm -113.21 121.29 65.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.679 -0.638 . . . . 0.5 109.969 177.475 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.834 ' N ' HD12 ' A' ' 47' ' ' LEU . 3.9 mp -120.77 133.78 55.32 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.915 -1.116 . . . . 1.66 110.021 178.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.595 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 12.9 pttp -143.62 165.53 27.36 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.232 -0.918 . . . . 1.74 110.631 -179.224 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.552 ' HD3' ' CD1' ' A' ' 30' ' ' ILE . 14.3 tptt -57.6 146.94 28.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.245 -0.909 . . . . 1.65 110.127 177.301 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.853 ' CD2' HG11 ' B' ' 9' ' ' VAL . 11.2 t80 -102.73 120.93 41.43 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.324 -0.86 . . . . 0.35 110.693 -176.632 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 52' ' ' PRO . 0.1 OUTLIER -99.59 122.81 50.18 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.296 -0.877 . . . . 3.21 109.47 172.384 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 51' ' ' LYS . 22.1 Cg_exo -60.14 145.04 99.36 Favored 'Trans proline' 0 C--N 1.304 -1.793 0 O-C-N 123.763 1.402 . . . . 0.48 110.254 -178.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.017 -0.992 . . . . 2.41 110.225 179.893 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.215 0.531 . . . . 11.66 110.28 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 69.0 mtm -47.13 -43.02 20.33 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.088 -1.008 . . . . 8.7 111.083 -174.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -78.34 -84.59 0.08 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.729 -1.232 . . . . 9.17 110.256 -179.478 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.916 ' O ' HG23 ' B' ' 6' ' ' THR . 83.5 p -148.13 150.1 33.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.068 -1.02 . . . . 5.2 110.017 176.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.916 HG23 ' O ' ' B' ' 5' ' ' SER . 0.7 OUTLIER -170.49 62.39 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.332 -0.855 . . . . 2.98 110.23 179.764 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.84 51.06 5.28 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.711 -1.355 . . . . 0.83 109.711 178.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 59.0 mt -97.29 133.02 40.53 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.068 -1.254 . . . . 1.36 109.691 179.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.943 HG13 ' O ' ' A' ' 36' ' ' LEU . 77.3 t -113.18 144.44 20.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.842 -1.161 . . . . 0.37 111.356 -170.465 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.442 ' NH1' ' HG2' ' B' ' 10' ' ' ARG . 57.4 ttp85 -129.07 166.99 18.18 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.519 -0.738 . . . . 1.92 109.537 175.076 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -84.46 146.37 27.66 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.016 -1.052 . . . . 2.21 110.551 -178.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.961 HG22 ' CD1' ' A' ' 36' ' ' LEU . 3.9 t -82.48 131.75 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.379 -0.826 . . . . 0.29 109.699 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.45 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.08 -175.49 5.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.084 -1.01 . . . . 0.55 110.212 -179.219 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.49 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -57.17 -39.24 74.92 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.143 -0.973 . . . . 2.19 111.639 -172.358 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.901 HD23 ' HD3' ' B' ' 17' ' ' ARG . 14.4 tp -84.34 -5.96 59.33 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.811 -1.181 . . . . 1.39 111.61 -173.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.411 ' HA2' HG12 ' B' ' 12' ' ' VAL . . . 79.53 47.8 7.12 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.533 -1.427 . . . . 0.21 109.533 -177.83 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.928 ' CD ' HG22 ' A' ' 19' ' ' VAL . 69.5 mtm180 -114.88 154.48 28.59 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.091 -1.24 . . . . 1.14 110.046 -177.539 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.877 HG12 HD13 ' A' ' 36' ' ' LEU . 15.5 m -123.27 150.65 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.326 -0.859 . . . . 0.28 109.874 179.929 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.915 HG22 ' CD ' ' A' ' 17' ' ' ARG . 33.6 t -111.78 134.12 55.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.222 -0.924 . . . . 0.24 110.56 -175.494 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.725 HD11 HG21 ' A' ' 45' ' ' ILE . 2.9 mm -83.81 134.75 43.77 Favored Pre-proline 0 N--CA 1.488 1.448 0 O-C-N 121.22 -0.925 . . . . 1.38 109.617 174.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.543 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 9.2 Cg_endo -58.24 143.35 97.2 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.727 1.383 . . . . 0.36 110.066 177.517 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.898 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.1 tp -55.07 -33.35 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.997 -1.065 . . . . 1.11 110.334 -178.511 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . 0.412 ' N ' HG23 ' B' ' 22' ' ' ILE . 84.1 tt0 -57.83 -36.22 71.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.042 -1.036 . . . . 2.37 109.709 178.498 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.565 ' HB2' HG23 ' B' ' 20' ' ' ILE . 48.5 mt -82.47 -29.58 30.49 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.388 -0.82 . . . . 1.75 110.654 178.877 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.898 ' HD2' HD12 ' B' ' 22' ' ' ILE . 70.6 mtt180 -57.59 -44.08 85.13 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.817 -1.177 . . . . 0.3 109.046 175.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 93.3 mtt-85 -73.0 -48.83 32.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.863 . . . . 3.27 110.566 -177.924 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 50.4 m -63.23 -32.54 73.97 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.254 -0.904 . . . . 0.77 110.909 -178.177 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.774 HD23 HG13 ' B' ' 30' ' ' ILE . 18.2 tp -87.77 -4.91 58.86 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.045 -1.035 . . . . 1.05 110.667 -176.724 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.423 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 66.83 41.83 93.32 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.659 -1.377 . . . . 0.32 109.659 178.525 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.774 HG13 HD23 ' B' ' 28' ' ' LEU . 33.7 mm -116.48 137.66 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -1.162 . . . . 0.41 110.644 -179.51 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . 0.4 ' HB3' ' OD2' ' B' ' 34' ' ' ASP . . . -141.96 166.55 24.41 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.602 -0.686 . . . . 0.23 110.081 -178.27 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.536 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.1 tt0 -53.13 146.72 10.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 1.13 110.582 -179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.536 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 44.6 tttm 74.27 -4.56 2.27 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 121.645 -0.659 . . . . 1.88 111.198 176.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.751 ' O ' HG23 ' A' ' 12' ' ' VAL . 91.1 m-20 -77.67 168.19 20.37 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.792 -1.192 . . . . 1.1 110.031 175.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.597 ' HB1' ' HD2' ' B' ' 50' ' ' TYR . . . -104.12 130.69 51.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.36 110.819 -176.868 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.91 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.1 mt -107.26 142.5 36.91 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.279 -0.888 . . . . 0.56 109.318 174.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.653 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.0 tt0 -105.55 137.71 42.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.929 -1.107 . . . . 1.17 109.721 172.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 71.5 mt -108.02 131.41 58.45 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.349 -0.844 . . . . 0.84 110.538 -172.367 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.617 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 23.0 m-85 -120.1 155.85 32.19 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 116.294 -0.412 . . . . 0.45 109.948 -178.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . 0.527 HG21 HD11 ' A' ' 24' ' ' LEU . 72.1 t -131.1 121.15 48.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.836 -1.165 . . . . 0.26 110.402 172.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' B' ' 44' ' ' LYS . 47.9 p-10 -148.82 160.92 42.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.206 -0.933 . . . . 1.77 110.519 178.461 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' B' ' 42' ' ' ASP . 55.2 t0 41.76 41.72 1.88 Allowed 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.172 -0.955 . . . . 1.21 111.554 172.374 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' B' ' 42' ' ' ASP . 96.0 mt-10 56.26 16.11 2.2 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.881 -1.137 . . . . 1.92 110.552 175.446 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' B' ' 41' ' ' ASP . 27.2 pttt -129.63 164.9 22.88 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.275 -0.891 . . . . 2.0 109.604 174.466 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.742 HG22 HD11 ' B' ' 47' ' ' LEU . 64.6 mt -97.67 134.08 37.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 1.24 110.416 -174.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.617 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 21.6 mm -113.21 121.47 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.748 -0.595 . . . . 0.5 109.914 177.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.833 HD12 ' N ' ' B' ' 47' ' ' LEU . 4.0 mp -120.73 133.5 55.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.931 -1.106 . . . . 1.66 109.958 179.005 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.592 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 13.2 pttp -143.47 165.72 26.76 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -0.962 . . . . 1.74 110.657 -179.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.557 ' HD3' ' CD1' ' B' ' 30' ' ' ILE . 14.4 tptt -57.6 146.87 28.91 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.244 -0.91 . . . . 1.65 110.012 177.364 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.889 ' CD2' HG11 ' A' ' 9' ' ' VAL . 11.4 t80 -102.87 117.23 34.17 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.271 -0.893 . . . . 0.65 110.643 -176.643 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.99 79.38 69.11 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.197 -0.94 . . . . 4.35 110.215 177.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.42 ' HB3' ' OH ' ' B' ' 50' ' ' TYR . 10.6 Cg_endo -58.84 145.02 98.12 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.066 1.561 . . . . 3.58 110.281 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 84.6 m-20 . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.979 -1.01 . . . . 5.97 110.209 -179.829 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.483 ' HB2' ' OG ' ' A' ' 5' ' ' SER . 96.5 m-85 . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 121.127 0.489 . . . . 10.99 110.078 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 95.6 mmm -64.74 -77.05 0.06 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.213 -0.93 . . . . 8.76 110.387 -177.493 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.448 ' HD2' ' CD ' ' A' ' 23' ' ' GLU . 90.7 mttt -52.7 -43.47 65.64 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.15 -0.969 . . . . 8.85 111.55 -173.828 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.928 ' O ' HG23 ' A' ' 6' ' ' THR . 12.1 p -87.35 121.5 29.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.49 -1.381 . . . . 4.2 110.067 179.616 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.928 HG23 ' O ' ' A' ' 5' ' ' SER . 0.8 OUTLIER -172.44 62.88 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.624 -0.672 . . . . 3.77 110.03 -179.314 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 79.53 49.17 6.31 Favored Glycine 0 N--CA 1.49 2.241 0 C-N-CA 119.34 -1.409 . . . . 0.83 110.011 178.946 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 20.1 mm -103.42 134.7 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.813 0 O-C-N 121.009 -1.289 . . . . 1.36 109.669 179.331 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.899 HG13 ' O ' ' B' ' 36' ' ' LEU . 78.4 t -109.85 143.48 19.85 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 120.86 -1.15 . . . . 0.37 111.281 -171.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . 0.449 ' HG3' ' N ' ' A' ' 11' ' ' LYS . 15.5 tpt180 -121.27 161.62 21.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.571 -0.706 . . . . 1.91 109.666 177.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HE2' ' HA ' ' B' ' 33' ' ' LYS . 6.4 tptm -82.8 142.42 31.57 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.169 -0.957 . . . . 2.21 110.364 -178.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.904 HG22 HD11 ' B' ' 36' ' ' LEU . 8.9 t -82.97 130.39 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.329 -0.857 . . . . 0.28 109.886 179.294 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' OD1' ' HB2' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -83.96 -175.28 5.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.099 -1.001 . . . . 0.55 110.036 179.892 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' HG2' ' OE2' ' B' ' 32' ' ' GLU . 97.0 mt-10 -56.66 -39.71 74.22 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.998 -1.064 . . . . 2.19 111.756 -172.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.907 HD23 ' HD3' ' A' ' 17' ' ' ARG . 15.4 tp -84.68 -5.73 59.33 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.794 -1.191 . . . . 1.38 111.523 -173.831 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . 0.479 ' HA2' ' CG1' ' A' ' 12' ' ' VAL . . . 80.19 46.7 7.42 Favored Glycine 0 N--CA 1.491 2.32 0 C-N-CA 119.228 -1.463 . . . . 0.21 109.643 -177.72 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.916 ' CD ' HG22 ' B' ' 19' ' ' VAL . 70.0 mtm180 -114.36 155.03 27.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.071 -1.252 . . . . 1.15 110.024 -177.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.847 HG12 HD13 ' B' ' 36' ' ' LEU . 17.1 m -123.87 152.43 29.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.365 -0.834 . . . . 0.28 109.817 -179.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.925 HG22 ' CD ' ' B' ' 17' ' ' ARG . 33.6 t -110.03 135.82 47.88 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.231 -0.918 . . . . 0.24 110.446 -176.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.563 HG23 ' HB2' ' A' ' 24' ' ' LEU . 1.7 mp -80.63 130.46 64.43 Favored Pre-proline 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 1.38 109.465 174.905 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.548 ' HG2' ' CD1' ' A' ' 24' ' ' LEU . 10.0 Cg_endo -56.79 143.63 90.03 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.817 1.43 . . . . 0.35 110.059 178.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.838 HD12 ' HD2' ' A' ' 25' ' ' ARG . 11.3 tp -55.14 -32.54 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.005 -1.06 . . . . 1.11 110.293 -178.18 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.448 ' CD ' ' HD2' ' A' ' 4' ' ' LYS . 83.8 tt0 -57.68 -36.48 71.98 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.055 -1.028 . . . . 2.37 109.891 178.025 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.563 ' HB2' HG23 ' A' ' 20' ' ' ILE . 51.7 mt -82.07 -30.04 31.52 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.346 -0.847 . . . . 1.75 110.63 178.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.838 ' HD2' HD12 ' A' ' 22' ' ' ILE . 73.9 mtt180 -57.91 -43.61 86.29 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.923 -1.111 . . . . 0.3 109.172 175.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -74.2 -51.7 14.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.469 -0.769 . . . . 3.26 110.651 -177.08 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.6 m -64.04 -31.22 72.33 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.185 -0.947 . . . . 0.77 111.182 -178.379 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.951 HD23 HG13 ' A' ' 30' ' ' ILE . 16.7 tp -88.6 -4.89 58.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.09 -1.006 . . . . 1.05 110.808 -176.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.471 ' O ' HD13 ' A' ' 30' ' ' ILE . . . 64.69 43.97 95.59 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.738 -1.345 . . . . 0.32 109.738 179.166 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.951 HG13 HD23 ' A' ' 28' ' ' LEU . 31.3 mm -115.82 136.94 51.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.266 -1.137 . . . . 0.41 110.75 -178.082 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.43 167.12 23.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.62 -0.675 . . . . 0.23 110.019 -177.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' A' ' 33' ' ' LYS . 84.3 tt0 -53.22 146.05 12.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.037 -1.039 . . . . 1.13 110.623 -179.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' A' ' 32' ' ' GLU . 68.3 tttt 74.34 -4.24 2.36 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.637 -0.665 . . . . 1.88 111.144 176.921 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.792 ' O ' HG23 ' B' ' 12' ' ' VAL . 89.2 m-20 -77.22 168.97 19.16 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.866 -1.146 . . . . 1.1 110.06 174.736 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -107.05 130.97 54.59 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.36 110.612 -177.205 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.924 ' O ' HG13 ' B' ' 9' ' ' VAL . 9.2 mt -107.06 141.97 37.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.346 -0.846 . . . . 0.56 109.235 174.993 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.583 ' HA ' HG22 ' B' ' 9' ' ' VAL . 86.1 tt0 -104.3 137.6 41.96 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.769 -1.207 . . . . 1.17 109.712 174.08 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 70.0 mt -108.73 132.57 56.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.456 -0.778 . . . . 0.84 110.605 -172.656 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' TYR . . . . . 0.631 ' HB2' ' HB ' ' A' ' 46' ' ' ILE . 22.5 m-85 -121.07 157.25 30.45 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 109.868 -0.419 . . . . 0.45 109.868 -178.775 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . . 75.2 t -131.56 125.91 57.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 120.811 -1.18 . . . . 0.27 110.715 173.498 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.486 ' OD1' HG12 ' A' ' 46' ' ' ILE . 38.7 p-10 -147.48 140.87 25.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.229 -0.92 . . . . 1.77 110.733 179.151 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . 0.484 ' O ' ' HB3' ' A' ' 43' ' ' GLU . 53.8 t0 43.32 46.74 5.54 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.001 -1.062 . . . . 1.22 111.449 173.336 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.484 ' HB3' ' O ' ' A' ' 42' ' ' ASP . 83.8 tt0 61.3 10.87 3.28 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.132 -0.98 . . . . 1.93 110.707 175.479 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -111.44 151.09 28.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.156 -0.965 . . . . 2.01 109.885 175.179 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.874 HG22 HD11 ' A' ' 47' ' ' LEU . 67.2 mt -92.9 128.22 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.308 -0.87 . . . . 1.25 109.779 177.713 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.631 ' HB ' ' HB2' ' A' ' 39' ' ' TYR . 23.5 mm -111.45 118.29 57.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.543 -0.723 . . . . 0.5 109.91 178.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.874 HD11 HG22 ' A' ' 45' ' ' ILE . 3.9 mp -119.27 134.18 55.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.867 -1.146 . . . . 1.66 110.164 -179.766 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.586 ' HE3' ' CE1' ' A' ' 39' ' ' TYR . 13.0 pttp -143.26 163.26 33.47 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.311 -0.868 . . . . 1.74 110.44 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -58.18 147.52 29.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.234 -0.916 . . . . 1.65 109.94 177.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.57 ' CD2' HG11 ' B' ' 9' ' ' VAL . 15.5 t80 -101.73 118.22 36.49 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.368 -0.833 . . . . 0.35 110.688 -175.912 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.47 ' CG ' ' O ' ' A' ' 51' ' ' LYS . 18.2 pttm -99.89 122.86 49.46 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.37 -0.831 . . . . 3.21 109.399 172.139 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -63.3 144.77 92.14 Favored 'Trans proline' 0 C--N 1.303 -1.852 0 O-C-N 123.761 1.401 . . . . 0.48 110.259 -178.823 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 19.7 m120 . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 117.971 -1.014 . . . . 2.41 110.182 -179.976 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 46.3 p90 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.203 0.525 . . . . 11.66 110.145 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' B' B ' 3' ' ' MET . . . . . . . . . . . . . 69.8 mtm -111.03 147.22 35.23 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.915 . . . . 8.7 110.207 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 4' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -89.71 146.57 24.41 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.237 -0.914 . . . . 9.17 110.101 179.748 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 5' ' ' SER . . . . . 0.886 ' O ' HG23 ' B' ' 6' ' ' THR . 41.1 m -59.84 148.43 34.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.266 -0.896 . . . . 5.2 109.996 179.627 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 6' ' ' THR . . . . . 0.886 HG23 ' O ' ' B' ' 5' ' ' SER . 0.7 OUTLIER -169.23 62.8 0.05 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.314 -0.866 . . . . 2.98 110.259 -179.037 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 7' ' ' GLY . . . . . . . . . . . . . . . 78.89 50.49 5.89 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.733 -1.347 . . . . 0.83 109.733 179.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 20.0 mm -103.8 134.58 44.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 O-C-N 121.082 -1.246 . . . . 1.36 109.757 178.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 9' ' ' VAL . . . . . 0.924 HG13 ' O ' ' A' ' 36' ' ' LEU . 78.0 t -109.88 143.44 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.823 -1.173 . . . . 0.37 111.244 -171.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 10' ' ' ARG . . . . . 0.457 ' HG3' ' N ' ' B' ' 11' ' ' LYS . 15.5 tpt180 -121.28 161.5 21.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.589 -0.695 . . . . 1.92 109.753 177.619 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 11' ' ' LYS . . . . . 0.457 ' N ' ' HG3' ' B' ' 10' ' ' ARG . 6.4 tptm -82.83 142.26 31.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.11 -0.994 . . . . 2.21 110.37 -178.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.887 HG22 HD11 ' A' ' 36' ' ' LEU . 8.9 t -82.88 130.56 35.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.24 -0.913 . . . . 0.29 109.855 179.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.447 ' OD1' ' HB2' ' B' ' 17' ' ' ARG . 0.2 OUTLIER -84.01 -175.05 5.62 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.128 -0.983 . . . . 0.55 110.227 179.674 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' B' B ' 14' ' ' GLU . . . . . 0.492 ' HG2' ' OE2' ' A' ' 32' ' ' GLU . 97.0 mt-10 -56.91 -39.63 74.81 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.132 -0.98 . . . . 2.19 111.634 -172.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 15' ' ' LEU . . . . . 0.9 HD23 ' HD3' ' B' ' 17' ' ' ARG . 15.3 tp -84.65 -5.89 59.33 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.786 -1.196 . . . . 1.39 111.546 -173.802 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 16' ' ' GLY . . . . . 0.478 ' HA2' ' CG1' ' B' ' 12' ' ' VAL . . . 79.93 47.32 7.2 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.531 -1.428 . . . . 0.21 109.531 -177.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 17' ' ' ARG . . . . . 0.925 ' CD ' HG22 ' A' ' 19' ' ' VAL . 70.0 mtm180 -114.43 154.99 27.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.089 -1.242 . . . . 1.14 110.042 -177.884 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 18' ' ' VAL . . . . . 0.847 HG12 HD13 ' A' ' 36' ' ' LEU . 17.1 m -123.96 152.42 29.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.28 -0.887 . . . . 0.28 109.775 -179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 19' ' ' VAL . . . . . 0.916 HG22 ' CD ' ' A' ' 17' ' ' ARG . 34.2 t -110.06 135.72 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.146 -0.971 . . . . 0.24 110.506 -176.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 20' ' ' ILE . . . . . 0.556 HG23 ' HB2' ' B' ' 24' ' ' LEU . 1.7 mp -80.57 130.45 64.65 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.255 -0.903 . . . . 1.38 109.537 174.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 21' ' ' PRO . . . . . 0.546 ' HG2' ' CD1' ' B' ' 24' ' ' LEU . 10.1 Cg_endo -56.82 143.66 90.23 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.773 1.407 . . . . 0.36 110.115 178.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 22' ' ' ILE . . . . . 0.866 HD12 ' HD2' ' B' ' 25' ' ' ARG . 11.3 tp -55.27 -32.39 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.155 -0.966 . . . . 1.11 110.281 -177.991 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 23' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -57.49 -37.18 72.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.046 -1.034 . . . . 2.37 109.808 177.736 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 24' ' ' LEU . . . . . 0.556 ' HB2' HG23 ' B' ' 20' ' ' ILE . 51.1 mt -81.32 -30.52 33.85 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.468 -0.77 . . . . 1.75 110.561 178.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 25' ' ' ARG . . . . . 0.866 ' HD2' HD12 ' B' ' 22' ' ' ILE . 73.7 mtt180 -57.69 -43.43 85.13 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.9 -1.125 . . . . 0.3 109.285 176.008 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 26' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -74.26 -51.82 14.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.281 -0.887 . . . . 3.27 110.571 -177.218 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 27' ' ' THR . . . . . . . . . . . . . 49.3 m -63.85 -31.85 73.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.77 110.855 -178.107 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 28' ' ' LEU . . . . . 0.984 HD23 HG13 ' B' ' 30' ' ' ILE . 16.8 tp -88.07 -5.25 58.57 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.971 -1.081 . . . . 1.05 110.691 -176.356 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 29' ' ' GLY . . . . . 0.454 ' O ' HD13 ' B' ' 30' ' ' ILE . . . 64.91 43.89 95.37 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.646 -1.382 . . . . 0.32 109.646 179.219 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 30' ' ' ILE . . . . . 0.984 HG13 HD23 ' B' ' 28' ' ' LEU . 31.3 mm -115.68 136.79 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -1.162 . . . . 0.41 110.797 -178.122 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 31' ' ' ALA . . . . . . . . . . . . . . . -144.12 167.18 23.0 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.574 -0.704 . . . . 0.23 109.951 -177.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 32' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' B' ' 33' ' ' LYS . 84.2 tt0 -53.05 146.04 11.98 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.143 -0.973 . . . . 1.13 110.634 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 33' ' ' LYS . . . . . 0.533 ' HB3' ' O ' ' B' ' 32' ' ' GLU . 68.1 tttt 74.34 -4.29 2.35 Favored 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.713 -0.617 . . . . 1.88 111.168 176.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 34' ' ' ASP . . . . . 0.787 ' O ' HG23 ' A' ' 12' ' ' VAL . 89.8 m-20 -77.42 168.76 19.49 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.846 -1.158 . . . . 1.1 109.979 174.869 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 35' ' ' ALA . . . . . 0.449 ' HB1' HG11 ' A' ' 9' ' ' VAL . . . -106.81 130.93 54.43 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.305 -0.872 . . . . 0.36 110.726 -177.256 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 36' ' ' LEU . . . . . 0.904 HD11 HG22 ' A' ' 12' ' ' VAL . 9.1 mt -107.08 141.79 37.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.265 -0.897 . . . . 0.56 109.319 174.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 37' ' ' GLU . . . . . 0.565 ' HA ' HG22 ' A' ' 9' ' ' VAL . 86.0 tt0 -103.99 137.57 41.78 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.78 -1.2 . . . . 1.17 109.881 174.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 38' ' ' ILE . . . . . . . . . . . . . 70.2 mt -108.73 132.61 56.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.394 -0.816 . . . . 0.84 110.493 -172.588 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 39' ' ' TYR . . . . . 0.616 ' HB2' ' HB ' ' B' ' 46' ' ' ILE . 22.0 m-85 -121.05 157.2 30.55 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 116.208 -0.451 . . . . 0.45 109.886 -178.857 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 40' ' ' VAL . . . . . . . . . . . . . 75.6 t -131.36 126.27 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 120.861 -1.149 . . . . 0.26 110.545 173.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 41' ' ' ASP . . . . . 0.495 ' OD1' HG12 ' B' ' 46' ' ' ILE . 38.5 p-10 -147.99 140.77 24.71 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.333 -0.854 . . . . 1.77 110.638 179.005 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 42' ' ' ASP . . . . . 0.491 ' O ' ' HB3' ' B' ' 43' ' ' GLU . 54.3 t0 43.44 46.88 5.85 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.072 -1.018 . . . . 1.21 111.317 173.346 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.491 ' HB3' ' O ' ' B' ' 42' ' ' ASP . 83.6 tt0 61.1 10.88 3.12 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.053 -1.029 . . . . 1.92 110.71 175.504 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 44' ' ' LYS . . . . . . . . . . . . . 28.0 mttp -111.38 151.3 28.64 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.219 -0.925 . . . . 2.0 109.913 175.062 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.868 HG22 HD11 ' B' ' 47' ' ' LEU . 66.8 mt -93.01 128.07 44.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.253 -0.904 . . . . 1.24 109.876 177.699 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 46' ' ' ILE . . . . . 0.616 ' HB ' ' HB2' ' B' ' 39' ' ' TYR . 23.2 mm -111.55 118.42 57.49 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.611 -0.681 . . . . 0.5 109.886 178.899 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 47' ' ' LEU . . . . . 0.868 HD11 HG22 ' B' ' 45' ' ' ILE . 4.0 mp -119.2 134.07 55.41 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.957 -1.089 . . . . 1.66 110.13 -179.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 48' ' ' LYS . . . . . 0.589 ' HE3' ' CE1' ' B' ' 39' ' ' TYR . 13.3 pttp -143.2 163.33 33.22 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.206 -0.934 . . . . 1.74 110.455 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 32.6 tttm -58.1 147.43 29.83 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.248 -0.908 . . . . 1.65 109.917 177.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' B' B ' 50' ' ' TYR . . . . . 0.599 ' CD2' HG11 ' A' ' 9' ' ' VAL . 15.6 t80 -101.9 113.44 26.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.214 -0.929 . . . . 0.65 110.605 -175.946 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 51' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -121.57 88.56 46.67 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.272 -0.893 . . . . 4.35 110.339 178.37 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 52' ' ' PRO . . . . . 0.591 ' HG3' ' CE2' ' B' ' 50' ' ' TYR . 35.9 Cg_exo -55.64 145.44 70.46 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.007 1.53 . . . . 3.58 110.347 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' B' B ' 53' ' ' ASN . . . . . . . . . . . . . 39.9 t-20 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 117.973 -1.013 . . . . 5.97 110.176 179.815 . . . . . . . . 0 0 . 1 stop_ save_